Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.7998502557737294,-1.836861546612251,0.0,0.42570553292717506,0.32,1/63,0.01%,CD44
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.9030957944051302,1.833126081367862,0.0,1.0,0.9,3/35,2.38%,CPA1;PLA2G10;CYP4Z1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.9132568829956783,-1.7996259748423966,0.0,0.3946645044845685,0.42,1/40,0.01%,CD44
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.8465570911408361,-1.7794422660287152,0.0,0.4197929560809643,0.56,4/42,1.97%,CD44;HLA-DPB1;HCK;HLA-C
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.858178684686913,-1.7764700840402916,0.0,0.34145131286867164,0.58,1/32,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.8881922762068709,1.7643607745826098,0.019230769230769232,1.0,0.99,2/24,0.12%,CPA1;ACE2
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.9117213395270201,-1.7536371311374594,0.0,0.42570553292717506,0.68,1/31,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.9418475397306348,-1.7464451922301711,0.0,0.3961426486961212,0.74,2/19,0.41%,CD44;HLA-DPB1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.7982806307515642,1.7384077985768618,0.019230769230769232,1.0,0.99,6/29,6.13%,SEMA3C;SEMA5A;SEMA6D;ROBO1;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.790956285007977,-1.731796732583357,0.0,0.43710835970201,0.82,5/63,1.97%,CD44;HLA-DPB1;GBP6;HCK;HLA-C
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9382575729373618,-1.7297028791282927,0.020833333333333332,0.39133868000857497,0.84,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.8742309517725992,-1.7288015269358905,0.0,0.35475461077264586,0.84,2/30,0.48%,CD44;CLDN4
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.6859762653102316,-1.7236174825271455,0.0,0.3565283838265091,0.87,13/174,6.15%,CD44;SLC25A10;LDHC;DEPDC1;SPAG4;AURKA;HK2;SDHC;CASP6;GPC1;XYLT2;GPC3;AGRN
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.889678954602977,-1.7210243774726055,0.045454545454545456,0.34266070358721473,0.87,3/26,3.48%,CD44;CLU;CD74
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.9660213312798119,-1.7155554806424467,0.0,0.34145131286867164,0.89,3/10,1.70%,CYP1A2;CYP19A1;HSD11B1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.9389093153143949,-1.709036933953737,0.0,0.35543683117797786,0.9,1/14,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.7052486627685334,-1.7087183675788402,0.0,0.331315466846596,0.91,9/106,4.63%,CD44;SELP;DYSF;SIGLEC1;HCK;HMGB3;RNASE1;MAFF;ITGA6
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.7933802869478103,-1.7084035942152336,0.0,0.30922776905682303,0.91,2/59,0.83%,CD44;TERF2IP
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.7634354812395091,-1.7082864905064357,0.0,0.2904553375701038,0.91,4/79,4.11%,CD44;SIGLEC1;RAC1;ADAMTS12
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.8481455101518532,-1.707381653214539,0.0,0.27806501109091214,0.91,2/39,0.63%,CD44;CCN3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8959542575177173,-1.7056171071303112,0.019230769230769232,0.2680368170282213,0.93,3/21,3.48%,CD44;CLU;CD74
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.7149704942980875,-1.7018169320182115,0.0,0.2693334347576535,0.94,6/110,3.90%,CD44;SIGLEC1;CRH;RAC1;NLRP3;ABCF1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9917730126589122,1.7017377279459633,0.0,1.0,0.99,1/12,0.01%,CPA1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.8097367404181519,-1.6945158973757228,0.0,0.2886815645162406,0.98,5/31,4.20%,KRT16P6;CBLC;ENTPD2;DUOXA1;FLG
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8951856746649559,-1.6944926616571538,0.03508771929824561,0.27493482334880054,0.98,4/23,5.05%,CD44;SPRED3;CD74;SPRED2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.8737190552020612,-1.6933846166248974,0.0,0.2705003907141425,0.98,1/37,0.01%,CD44
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.8224999084998308,-1.6890338687624877,0.0,0.2722356034842261,0.98,4/46,4.47%,CD44;LCP1;CD74;CD4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9294774753321505,-1.6882764679477853,0.0,0.26384874176215534,0.98,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9701355451313803,1.6882740908880602,0.020833333333333332,1.0,0.99,1/9,0.01%,CLEC2A
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.9385105349208553,-1.6792360850257682,0.0,0.2752759335514665,0.99,1/8,0.61%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.9385105349208553,-1.6792360850257682,0.0,0.2752759335514665,0.99,1/8,0.61%,NUPR1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.7711030178776119,-1.6695996462637162,0.0,0.31369504934062664,0.99,5/53,5.82%,TLCD2;DYSF;AHNAK2;STX4;PACSIN3
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.870474047409166,-1.6611459366423134,0.0196078431372549,0.3490531973852283,0.99,2/21,1.41%,CYP1A2;CYP2D6
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.9869690866434507,1.660683594029066,0.0,1.0,1.0,1/10,0.01%,CLEC2A
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.8628234441704241,1.66039118794103,0.0,1.0,1.0,7/16,8.64%,NLGN1;CEL;NRXN1;CNTN4;NRXN3;NCAM2;NLGN4X
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9352791175779411,-1.6588140436288896,0.03571428571428571,0.34772068314525717,0.99,1/12,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.6757463068168544,1.6557157185066451,0.024390243902439025,1.0,1.0,28/162,11.21%,CPA1;HPGDS;ALDH1A1;LSAMP;LDB2;MXRA5;PCDH7;ROR1;POSTN;ADAMTS9;GPM6A;HS2ST1;RNF128;GRIK2;SYNPO2;HGF;COBL;SOCS2;MITF;SLC4A4;CYBRD1;SHROOM4;MEIS2;RBFOX1;PDGFRB;GNAI1;CXCL12;HS3ST1
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.9637621117303129,-1.653434712247711,0.0,0.3615540741457882,0.99,1/18,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9378284138101651,-1.6509844310338346,0.0,0.34838011386032486,0.99,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9378284138101651,-1.6509844310338346,0.0,0.34838011386032486,0.99,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9317754696231368,-1.6504053839967778,0.0,0.3415856896151764,0.99,1/14,0.01%,CD44
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.8290206743636191,-1.6498691220382442,0.0,0.3336258435133927,0.99,3/41,2.94%,CD44;LCP1;ADAMTS15
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.7235381647282062,-1.6470205077329851,0.0,0.33600329563180603,1.0,2/57,1.16%,CD44;CD9
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.9469917247576302,1.6435877895880966,0.0,1.0,1.0,2/5,0.27%,ACE2;ENPEP
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.8292884278741803,1.6296794937133505,0.03773584905660377,1.0,1.0,5/23,5.02%,SEMA3C;SEMA5A;SEMA6D;DSCAM;NRP1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.8475854585478377,1.6280403163467358,0.01818181818181818,1.0,1.0,3/19,2.37%,SEMA3C;SEMA5A;SEMA6D
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8928634259496514,1.627564680379202,0.022222222222222223,1.0,1.0,6/17,6.79%,GPC6;IL1RAPL2;IL1RAPL1;PTPRD;LRFN5;SNCA
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8928634259496514,1.627564680379202,0.022222222222222223,1.0,1.0,6/17,6.79%,GPC6;IL1RAPL2;IL1RAPL1;PTPRD;LRFN5;SNCA
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8708767460596202,-1.6256838936031064,0.0,0.4510803418921629,1.0,2/18,1.70%,CYP1A2;HSD11B1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.7363734732057756,1.6245496446718874,0.020833333333333332,1.0,1.0,11/45,8.98%,GPC6;IL1RAPL2;IL1RAPL1;NLGN1;NRXN1;GRID2;ROBO2;PTPRD;LRFN5;SNCA;LHFPL4
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9420732929264811,-1.6231698609702712,0.0,0.43480180499826854,1.0,1/9,0.02%,CYP1A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9420732929264811,-1.6231698609702712,0.0,0.43480180499826854,1.0,1/9,0.02%,CYP1A2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9420732929264811,-1.6231698609702712,0.0,0.43480180499826854,1.0,1/9,0.02%,CYP1A2
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7584860634638229,-1.6230554783693076,0.019230769230769232,0.4241534815050447,1.0,4/78,1.97%,CD44;DYSF;HCK;AOAH
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.8688990708402944,1.6200153238251376,0.034482758620689655,1.0,1.0,1/10,0.28%,NLRP2B
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.9694668070460515,-1.6197907484927683,0.0,0.4360885947058866,1.0,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7546654630334608,1.6172436773275758,0.05263157894736842,1.0,1.0,13/35,13.91%,GRM7;PLCB1;GRM5;GRID2;GRM8;GRIA4;GRIK2;GRM6;GNAQ;GRIK1;GRM1;GRIA2;CPEB4
prerank,PanglaoDB_Augmented_2021__Basophils,-0.7042269549092633,-1.6151830969863743,0.017241379310344827,0.4487223499356383,1.0,6/81,3.14%,CD44;SIGLEC1;TEC;HCK;AOAH;RNF39
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.7010540961216097,-1.6081584880456248,0.0,0.48015624062716256,1.0,12/105,7.68%,CYP1A2;ACOT1;LDHC;AOAH;ACOT11;ACOT4;SLC16A8;MECR;PCCB;ACOT12;PDHX;ACSBG2
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.8211467290144245,-1.6077629774031823,0.0,0.47125924999229885,1.0,3/41,2.94%,CD44;LCP1;ADAMTS15
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.803996561657462,1.6065344064367009,0.038461538461538464,1.0,1.0,8/20,13.04%,NTF3;FGFR2;CCL5;FGFR3;ABL2;PDGFRB;GNA13;FGFR1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6447491146748283,-1.6058273114988948,0.0,0.4753711784353455,1.0,11/163,3.11%,CD44;GSTM5;TAGLN;COL6A2;COL6A1;HCK;FBLN2;ENTPD2;COL4A3;MEOX1;TNXB
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.7642806613632273,-1.6024005693306116,0.0,0.4879803912312862,1.0,7/45,6.48%,CD44;GPC2;HGSNAT;GPC1;GPC3;AGRN;CEMIP
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.9515520420682421,-1.5993628044214094,0.02127659574468085,0.4968451543427534,1.0,2/7,1.41%,PM20D1;CYP2D6
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.6706160078156075,-1.5984494116570174,0.0,0.49074387823549337,1.0,8/126,7.70%,CD44;CLU;CASP6;H1-0;GADD45A;BCL2L2;CCND1;VDAC2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.7613851732125589,-1.5968587609212492,0.0,0.4914075348202722,1.0,5/67,3.31%,CYP1A2;ACOT1;CYP2D6;CYP2E1;ACOT4
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8967732155610733,1.596641426489331,0.0,1.0,1.0,4/9,4.06%,ACE2;ENPEP;OXTR;CORIN
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.7274056788276546,-1.595750176369306,0.0196078431372549,0.488851853644706,1.0,9/90,5.99%,PM20D1;ACOT1;CPXM2;DHFR2;ACOT11;ACOT4;ST6GAL1;PCCB;ACOT12
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.891399647264821,1.5874944368770414,0.0,1.0,1.0,1/10,0.12%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.891399647264821,1.5874944368770414,0.0,1.0,1.0,1/10,0.12%,ACE2
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.9265967608661526,1.5850332101340074,0.02040816326530612,1.0,1.0,2/8,0.27%,ACE2;ENPEP
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.9265967608661526,1.5850332101340074,0.02040816326530612,1.0,1.0,2/8,0.27%,ACE2;ENPEP
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.7427911116580883,1.5800164727139925,0.02,1.0,1.0,3/26,7.01%,ACE2;KLF2;KEL
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.7008079179662364,-1.5797295091422332,0.0,0.5776935377385929,1.0,2/65,2.59%,SLC28A2;SLC1A7
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.8685574375618212,-1.5777208901992825,0.0,0.5829573363562036,1.0,2/10,3.68%,STX4;STX1B
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.9009637669181807,-1.5754691431327594,0.0,0.5901978831109066,1.0,1/10,0.09%,TLCD2
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.7620873789206922,-1.5724308524216186,0.0,0.5971702614672872,1.0,6/28,11.56%,STING1;DHX58;OAS3;POLR3A;OAS2;POLR3D
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.8682592519260481,1.5702193151286257,0.0,1.0,1.0,9/17,8.74%,FZD1;IL1RAPL1;NLGN1;CEL;LRRTM3;WNT5A;PTPRD;NLGN4X;LRP4
prerank,PanglaoDB_Augmented_2021__MÃ¼ller Cells,-0.6784379390833467,-1.5690220259854464,0.0,0.6117904514870084,1.0,4/125,1.73%,CD44;GSTM5;COL6A1;CLU
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.9141622951702174,-1.5687494986268324,0.0,0.6030828383134978,1.0,3/14,1.41%,CYP1A2;CYP19A1;CYP2D6
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7702439495578142,1.5680316134387533,0.044444444444444446,1.0,1.0,11/27,15.18%,ACE2;KCNJ3;NEDD4;SNCA;KCNJ16;KCNJ6;BCL2;KCNJ2;PRKCB;PIM1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9208854244516911,-1.5671196837412433,0.020833333333333332,0.605261156098944,1.0,1/10,0.01%,CD44
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8674919766723007,-1.5667216913130235,0.01818181818181818,0.5974251139175549,1.0,3/20,3.18%,CD44;LCP1;PLET1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.8832134808482931,-1.5661950257718602,0.0,0.5900050200350149,1.0,1/13,0.21%,SELP
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7483929891766399,-1.5661249033177789,0.06666666666666667,0.5804672318767419,1.0,9/24,15.33%,XPC;ERCC1;UBC;RBX1;CETN2;GTF2H2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.8624013808799715,1.5652463714071003,0.05660377358490566,1.0,1.0,4/14,6.56%,GPC6;LRRC4C;PTPRD;LRFN5
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.9676192751305372,1.5649552688184531,0.0,1.0,1.0,1/6,0.06%,TEX101
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.9427993368138642,1.564850015030315,0.0,1.0,1.0,1/5,1.54%,CSGALNACT1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.6401556975495252,1.5636476095925558,0.037037037037037035,1.0,1.0,39/127,15.20%,PMP2;CADM2;LRRC4C;LSAMP;LRRTM3;MAGI2;NRXN1;CDH20;GFAP;ADGRB3;EGFR;SLC39A12;ZEB2;GRM5;NRXN3;AMER2;GRIA4;CA10;SLC1A2;NPAS3;CTNNA2;DLG2;GPM6B;P2RY1;SYNPR;SLC4A4;RBFOX1;LRRC3B;PPFIA2;RGS7BP;AKAP6;GRIA2;RFTN2;GDF10;CHL1;SLCO1C1;P2RX7;GABRG1;VIM
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.6931635382738676,-1.5620083862596483,0.03125,0.6010473610385729,1.0,8/90,5.62%,CD44;TNFSF18;IL31RA;TEC;CD74;ENPP2;IL11;GHR
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.9210966621359806,-1.5605719226324073,0.0,0.6003649602470946,1.0,2/12,1.03%,DYSF;AHNAK2
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.7337324235733172,-1.5600288868569272,0.0196078431372549,0.5942139730441818,1.0,2/67,1.66%,CD44;TSPAN32
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.8979049763013324,1.5589179637889206,0.03773584905660377,1.0,1.0,2/10,2.88%,SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.8979049763013324,1.5589179637889206,0.03773584905660377,1.0,1.0,2/10,2.88%,SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.8239380334503948,1.558259170796513,0.045454545454545456,1.0,1.0,7/17,8.18%,SEMA3C;ZFPM2;FGFR2;ROBO1;NRP1;ROBO2;BMPR1A
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.9134364968884936,-1.5581067086811722,0.02,0.5971240694606762,1.0,2/12,1.41%,CYP1A2;CYP2D6
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6324096888175221,-1.5580095366763216,0.0,0.5887562098015258,1.0,44/88,28.19%,SRP54;SEC62;RPLP1;SRP68;RPL37A;RPL28;SRP14;RPS15;RPL4;RPL12;RPL34;RPL31;RPS27;RPL8;RPS8;RPL19;RPL23;RPL5;RPL7A;RPL38;RPL24;RPS24;SRPRA;RPS3;RPL6;RPL29;RPL13;RPS20;RPL11;RPL35A;RPL10A;RPL37;RPLP2;RPS14;RPS4X;RPS25;RPS6;RPL27A;RPL18;RPS2;RPS21;RPS29;RPL14;SRP9
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.9568206718478901,-1.557747311123109,0.0,0.581313805379722,1.0,2/8,1.70%,CYP1A2;HSD11B1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.7113009076135324,1.5567685881134354,0.08888888888888889,1.0,1.0,12/33,14.84%,KANK1;IRS1;ENPP1;PIP4K2A;NCK1;ZBTB7B;SNX5;SIRT1;PID1;SORBS1;PRKCB;OGT
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.6545290526547731,-1.5566985747441344,0.0,0.5788589227271568,1.0,14/116,9.41%,CD44;INHA;NOG;ARSL;ALX4;RFLNA;PAPSS2;DLX5;GNAS;PHEX;RBP4;PRDX1;NOTUM;BMP3
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.6443666308808619,-1.5563850723627022,0.024390243902439025,0.5723026588494008,1.0,9/58,7.52%,SYTL1;TMEM184A;PSD4;UPK1B;TMCO4;EPHA1;LLGL2;RHBDF2;TNK1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.9486260397341137,-1.554649635529815,0.0,0.5748052968750986,1.0,1/8,0.53%,DDX11
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.8946459588614443,-1.5542365706308696,0.0,0.5677340753115094,1.0,6/12,8.16%,NCKAP1L;TNFSF18;RAC1;BST1;MADCAM1;ZP3
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.6283044627677496,-1.5540305011990614,0.0,0.5613616974691092,1.0,5/111,4.47%,CD44;NTRK1;CD74;NODAL;CD4
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.872488972869198,1.5526469481130023,0.023255813953488372,1.0,1.0,3/12,4.59%,SEMA5A;CNTN4;EPHA3
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.9190578778732247,-1.552145666679947,0.0,0.5632961232858713,1.0,2/11,0.63%,SERPINB8;CCN3
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.8854027160702382,1.5491568679288557,0.0,1.0,1.0,6/11,8.74%,NLGN1;CEL;NRXN1;WNT5A;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.7562913259272561,1.5467863876951184,0.0784313725490196,1.0,1.0,5/22,8.71%,ROGDI;FGFR2;SSUH2;HDAC2;BCOR
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.6452268105060366,-1.5456156455576728,0.06521739130434782,0.6032043296185571,1.0,3/69,1.73%,PM20D1;CCN3;CLU
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.8731977789669225,1.5450678445377604,0.047619047619047616,1.0,1.0,6/11,8.74%,IL1RAPL1;NLGN1;CEL;PTPRD;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.7998404337962851,-1.5445242755190407,0.07142857142857142,0.6038019354974965,1.0,3/17,1.92%,SUN3;SPAG4;NEMP1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.6997370097487342,-1.544503543435472,0.01694915254237288,0.5959877460980451,1.0,4/39,6.55%,DDX11;TERF2IP;FOXM1;RAD51AP1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.6268570658073586,1.5440209397399738,0.05405405405405406,1.0,1.0,19/75,15.79%,TBC1D3L;ARHGAP25;ARHGAP42;NTF3;ECT2;TBC1D12;TBC1D8B;CCDC125;RABGAP1L;GRTP1;RUNDC1;SYDE2;TBC1D1;TIAM2;ARHGAP24;USP6NL;EVI5;TBC1D4;TBC1D5
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.7124928934634048,-1.5421342819413324,0.038461538461538464,0.607517270948156,1.0,6/38,11.56%,STING1;DHX58;OAS3;POLR3A;OAS2;POLR3D
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6378332557046058,-1.5420906262377165,0.0,0.6000881565342483,1.0,45/87,27.87%,TMA7;RPLP1;RPL37A;RPL28;RWDD1;RPS15;RPL4;RPL12;RPL34;RPL31;EIF4A2;RPS27;RPL8;DRG1;RPS8;RPL19;RPL23;RPL5;EIF3I;RPL7A;EIF2B3;ZC3H15;RPL38;RPL24;RPS24;RPS3;RPL6;RPL29;RPL13;RPS20;RPL22L1;RPL11;RPL35A;RPL10A;RPL37;RPS14;RPS4X;RPS25;RPS6;RPL27A;RPL18;RPS2;RPS21;RPS29;RPL14
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.9004653497961378,-1.5411038576794116,0.04,0.5998991430886152,1.0,3/10,3.10%,CYP1A2;CYP2D6;CYP2E1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7821695773068059,1.5407298511031262,0.15217391304347827,1.0,1.0,4/20,5.50%,ACE2;CHRM3;OXTR;TBXA2R
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.8429652609178315,-1.5396469903916188,0.0392156862745098,0.6025215177268325,1.0,1/13,0.53%,DDX11
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8912500425856197,-1.5393121521029893,0.04081632653061224,0.597207215072576,1.0,2/14,1.29%,CD44;LCP1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.8784743602755781,1.5368571572106795,0.024390243902439025,1.0,1.0,5/11,8.64%,FZD1;NLGN1;LRRTM3;WNT5A;NLGN4X
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.6121455072052358,1.5363286469987236,0.05263157894736842,1.0,1.0,4/195,0.90%,CPA1;ENPEP;PRSS57;KLKB1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.9329553891466047,-1.5352404530521342,0.020833333333333332,0.6192876785586682,1.0,1/9,0.53%,DDX11
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7888876272030968,-1.5352087974259667,0.037037037037037035,0.6117353897957577,1.0,3/27,4.20%,CYP1A2;ACOT4;ST6GAL1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.8821009271239582,-1.5349171043428975,0.01818181818181818,0.6059678908709863,1.0,4/16,1.62%,SELP;CELA2A;TXK;TEC
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5927793104539465,-1.5330261041650373,0.01694915254237288,0.610051232453675,1.0,23/286,7.19%,CD44;APIP;NCKAP1L;NUPR1;SFRP1;TNFSF18;SH3RF2;HMGN5;IL31RA;HCK;PLK3;ASCL1;NTRK1;CD74;ANXA5;AHI1;UBC;HTATIP2;PRLR;VIP;ANKLE2;BCL2L2;PTMA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.8371941179274873,-1.531571181255824,0.03571428571428571,0.6129950994968514,1.0,2/11,4.07%,SELP;ETS1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.9100373562909133,1.531356622608441,0.06,1.0,1.0,4/6,8.23%,HS6ST3;HS3ST5;HS2ST1;HS3ST3B1
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.8981069180088359,-1.529918493831291,0.04,0.616489262557813,1.0,3/11,3.10%,CYP1A2;CYP2D6;CYP2E1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.6120659265411714,-1.5282474768049588,0.0,0.6201069819913807,1.0,8/148,4.26%,CD44;DUSP4;SERPINB8;GEM;MARCKS;SERPINE1;MAFF;CEBPD
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.7495347390381748,-1.527679065656636,0.03508771929824561,0.6163861362174722,1.0,11/17,23.54%,RBM4;EIF2S2;EIF4A2;MCTS1;EIF3I;EIF2B3;EIF2S3;EIF4H;EIF3A;EIF4G1;DHX29
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.6227935197254545,-1.5272044520759294,0.016666666666666666,0.6123503042690754,1.0,15/151,6.60%,CD44;SELP;SPRY4;ETV4;COL6A1;HK2;PRKCH;MAFF;ITGA6;SPRED2;ADAM19;CKAP4;PLIN2;RGS16;GPR83
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.9388027759145876,-1.5271337833402934,0.0,0.6062362126314771,1.0,1/9,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.8754149541905089,-1.526916316101383,0.06521739130434782,0.6008412569816928,1.0,2/10,5.16%,CD9;GPC1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7813910354768268,1.526331557277813,0.0625,1.0,1.0,6/16,10.81%,SMAD7;ROBO1;TGFBR1;NRP1;ROBO2;PDE2A
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6334094881427254,1.5252534479328193,0.047619047619047616,1.0,1.0,41/110,15.03%,ESRRG;PDZRN4;GUCY1A2;PLCXD3;ERBB4;CXXC4;SEMA6D;UNC5C;NRXN1;PBX1;FLRT3;PCDH17;FGF12;PPARGC1A;TOX3;CNTN4;FGF14;MEIS1;CNTN3;PTPRD;HMGCLL1;PTGFR;PXK;LMO3;NOL4;CNTN1;THSD7A;NOVA1;ASXL3;ADGRL2;ANK2;PPFIA2;LIFR;RGS7BP;NFIB;GRIA2;CSRNP3;PCLO;PPP1R9A;MAP2;MAPK4
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.9697937269421864,-1.5250490437247033,0.01818181818181818,0.606360462434767,1.0,2/5,1.41%,CYP1A2;CYP2D6
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.8330015276628491,-1.5248624187153703,0.03508771929824561,0.6015570120306049,1.0,3/25,3.10%,CYP1A2;CYP2D6;CYP2E1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.9227033559842965,-1.5242412719011225,0.03333333333333333,0.5941206165676627,1.0,2/6,4.25%,HLA-C;AZGP1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.9227033559842965,-1.5242412719011225,0.03333333333333333,0.5941206165676627,1.0,2/6,4.25%,HLA-C;AZGP1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.9268296267830829,1.523429817597148,0.0,1.0,1.0,3/8,2.50%,GALNT3;GALNT13;GALNTL6
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7387165454061541,-1.5234291662391568,0.0392156862745098,0.5927358288326291,1.0,7/51,3.03%,CD44;P2RY10;CD5;KLRB1;AOAH;TRAF3IP3;TRBC2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6505153352192975,1.5231678068545798,0.08888888888888889,1.0,1.0,8/52,7.49%,VAPB;CERS3;PPM1L;SPHK1;ST8SIA6;ELOVL6;PRKD1;ACER1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.8667615196583935,-1.5220321667986334,0.020833333333333332,0.5960426050584737,1.0,1/8,0.83%,TERF2IP
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7636141501086681,1.5214616237349887,0.07142857142857142,1.0,1.0,6/17,14.36%,CDH8;GRID2;GRIK2;GRIK1;GRIA2;UNC13C
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.9355240274645055,1.5210949249157435,0.0,1.0,1.0,2/9,2.48%,GALNT3;GALNT13
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.8404416948803195,1.520786210971371,0.04878048780487805,1.0,1.0,9/13,14.73%,ZFPM2;ERBB4;FGFR2;BMPR1A;EDN1;AKAP6;MEF2C;TGFBR3;PIM1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.8464520974885618,-1.5202811067928987,0.01818181818181818,0.6028113424379067,1.0,1/13,0.28%,STING1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.8036209703372139,1.5194493170912047,0.01818181818181818,1.0,1.0,1/12,0.25%,SAMSN1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.8873092088606944,1.5171807508615855,0.0,1.0,1.0,2/7,2.56%,PTPRK;FGFR2
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.6018837166738485,-1.5159629474587586,0.014925373134328358,0.6246727022519342,1.0,10/163,5.05%,CD44;APIP;DUSP4;NTRK1;SPRED3;CD74;NODAL;CD4;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.879795228890681,1.515866516812131,0.043478260869565216,1.0,1.0,6/10,8.74%,IL1RAPL1;NLGN1;CEL;PTPRD;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6210149809295441,-1.514148430528622,0.0,0.6313745185226165,1.0,42/85,28.19%,SRP54;RPLP1;SRP68;RPL37A;RPL28;SRP14;RPS15;RPL4;RPL12;RPL34;RPL31;RPS27;RPL8;RPS8;RPL19;RPL23;RPL5;RPL7A;RPL38;RPL24;RPS24;RPS3;RPL6;RPL29;RPL13;RPS20;RPL11;RPL35A;RPL10A;RPL37;RPLP2;RPS14;RPS4X;RPS25;RPS6;RPL27A;RPL18;RPS2;RPS21;RPS29;RPL14;SRP9
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6708524452297708,1.5137144910708387,0.06521739130434782,1.0,1.0,19/61,14.60%,LTK;NTF3;NLGN1;ZEB1;HEY1;MOSMO;CNTN4;ECT2;NREP;TCF4;BRINP3;DLL1;DISP3;ZC4H2;NEUROD2;SOX11;FGFR1;MEF2C;KCTD11
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.7655123605845251,1.5118598697896242,0.057692307692307696,1.0,1.0,6/32,8.21%,SEMA3C;SEMA5A;ERBB4;SEMA6D;NRP1;RADIL
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.6458053890401261,1.5115848726479155,0.04081632653061224,1.0,1.0,11/60,11.08%,GALNT3;GALNT13;GALNTL6;NLK;TGFBR1;DYRK3;PRKD1;DYRK1A;PRKCA;DYRK2;ACVR1B
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7374718292766956,-1.510582952502558,0.0,0.6490077545100558,1.0,9/57,6.96%,CYP1A2;CYP19A1;CYP2D6;HSD11B1;CYP2E1;DHRS11;CYP21A2;PRLR;HSD17B10
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.7173162246935835,-1.5096718298590515,0.05357142857142857,0.6489053088716313,1.0,3/34,3.10%,CYP1A2;CYP2D6;CYP2E1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.8472863320701224,-1.5078503072686444,0.05357142857142857,0.656468240905498,1.0,3/10,3.79%,PLK3;PLK5;GOLGA2
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.7326816358053709,-1.5063634948102302,0.038461538461538464,0.6609010176653859,1.0,4/32,3.79%,STING1;PLK3;PLK5;GOLGA2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.785522400622318,-1.503268742702487,0.05263157894736842,0.6779191681098229,1.0,5/26,9.81%,NCKAP1L;RAC1;KIF17;PARVB;PARVG
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.9441112968282672,1.502875792697577,0.043478260869565216,1.0,1.0,2/5,2.60%,PLCB1;LHFPL2
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7502296070835245,1.502796560088782,0.037037037037037035,1.0,1.0,10/25,17.89%,NDNF;CHSY3;CSGALNACT1;CHSY1;UGDH;CHST7;CSGALNACT2;HEXB;CHST11;VCAN
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.8572841366818988,1.5022571910366749,0.041666666666666664,1.0,1.0,4/8,12.46%,SLC8A1;KEL;ACTA2;EDN1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.6018349656511893,-1.5016070271847866,0.01639344262295082,0.6835719740595558,1.0,14/159,6.35%,CD44;GEM;SFRP1;TAGLN;COL6A2;FBLN2;ADAM12;SERPINE1;PCOLCE2;TPM1;TPM4;GPC1;CALD1;GADD45A
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.6901624606173947,-1.5009432798625488,0.0,0.681825100050417,1.0,2/78,0.83%,CD44;TERF2IP
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.7121561151732004,-1.5002790030057176,0.05357142857142857,0.6808496476657423,1.0,7/50,10.51%,STING1;MAP1LC3B2;ATG14;WIPI1;NSFL1C;WIPI2;MAP1LC3A
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.7303860242320649,-1.5002147215250197,0.0,0.6749287835686003,1.0,4/60,3.24%,CYP1A2;CYP2D6;CYP2E1;DECR2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7498018034641611,-1.5001353875423016,0.022727272727272728,0.6695187017854662,1.0,8/20,15.33%,XPC;UBC;RBX1;CETN2;GTF2H2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.7380060204592216,1.4999748652492666,0.02564102564102564,1.0,1.0,5/33,7.59%,ACE2;AKR1C1;ITGAM;SYK;RAB27A
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.9551017073230317,1.498798768421308,0.018518518518518517,1.0,1.0,2/5,3.17%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9668903478328601,-1.4983052692240775,0.0,0.6754719548360243,1.0,1/6,0.03%,SLC28A2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.6389889797393795,-1.4974243622648649,0.031746031746031744,0.6763301630824036,1.0,16/153,7.93%,CD44;PLK4;MYB;CD9;ST6GALNAC2;ASCL1;CHST8;PAPSS2;FABP5;NMU;LLGL2;PRLR;CCND1;SORD;BLVRB;ETFB
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.7534580926636525,1.49702993962341,0.038461538461538464,1.0,1.0,3/29,2.37%,SEMA3C;SEMA5A;SEMA6D
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.9258636699391285,-1.4965452674573532,0.031746031746031744,0.6756034711351628,1.0,1/7,0.53%,DDX11
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.8517966198087913,1.496528167787647,0.02127659574468085,1.0,1.0,5/10,9.92%,HEY1;ROBO1;SLIT2;ROBO2;JAG1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.6807428901005202,-1.4945237298730858,0.03278688524590164,0.6836027993112367,1.0,2/70,1.66%,CD44;TSPAN32
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.8867749231218778,1.4943947699119169,0.023809523809523808,1.0,1.0,5/9,8.74%,NLGN1;CEL;NRXN1;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.9020783942412527,1.494136428815013,0.0,1.0,1.0,2/7,4.99%,PNP;HPRT1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.8018291879241073,1.4938774699376558,0.04,1.0,1.0,5/21,8.79%,ARHGAP25;ITGAM;IGLL1;SNX18;GULP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.9453075484731424,-1.4936010405629625,0.0,0.6840594342507325,1.0,1/5,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9730109251045529,-1.4930311750973442,0.0,0.6708018858359882,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9730109251045529,-1.4930311750973442,0.0,0.6708018858359882,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9730109251045529,-1.4930311750973442,0.0,0.6708018858359882,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.783772061798433,1.4920732263863226,0.0,1.0,1.0,6/21,12.96%,ITGAX;JAM2;PARD3;EIF2AK3;TMEM98;MYRF
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.8427588052841757,-1.4913574294810685,0.058823529411764705,0.6776856461671573,1.0,2/11,1.43%,TYMS;DHFR2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.7602251633447401,1.4907681895306673,0.08163265306122448,1.0,1.0,5/15,13.04%,NTF3;ABL2;BICD1;PDGFRB;FGFR1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.5799921449640285,-1.4905000451052164,0.0,0.6778769354180642,1.0,77/193,25.95%,NARS1;SARS1;WARS1;ABCF1;TMA7;MRPL23;RPLP1;MRPL16;RPL37A;RPL28;CARS1;RWDD1;MRPS18B;RARS1;RPS15;PPA1;MRPL55;RPL4;RPL12;RPL34;RPL31;MRPS21;TRMT112;RPS27;RPL8;MRPL9;DRG1;AIMP1;RPS8;RPL19;IARS2;PABPC4;RPL23;GARS1;MRPL27;RPL5;RPL7A;ZC3H15;RPL38;RRBP1;YARS1;RPL24;RPS24;MRPL51;EPRS1;MRPS18C;RPS3;RPL6;MRPL37;RPL29;IARS1;RPL13;MARS1;DARS2;RPS20;RPL22L1;RPL11;RPL35A;RPL10A;EIF4G1;RPL37;RPLP2;RPS14;RPS4X;RPS25;GTPBP1;EEF2;FARSB;IGHMBP2;RPS6;EEFSEC;MRPS11;EEF2K;RPL27A;EEF1B2;RPL18;MRPS33
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7235088739448796,1.4892074604924161,0.08695652173913043,1.0,1.0,12/33,12.18%,LRRC4C;NTF3;NLGN1;CEL;CX3CR1;NRG3;GRID2;GRIK2;PXK;NLGN4X;GRIK1;BTBD9
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.83945077145148,-1.488610632539023,0.018867924528301886,0.684881628731323,1.0,2/15,2.00%,STING1;CGAS
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.7908159349437897,1.4885538369372167,0.05357142857142857,1.0,1.0,5/12,10.38%,HEY1;ADAMTS9;BMPR1A;JAG1;PDGFRB
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.9441817571936281,1.486610414336463,0.0,1.0,1.0,1/5,0.30%,NOX5
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.9084332451222971,-1.4866004750997388,0.03333333333333333,0.6921349690914674,1.0,2/7,1.78%,LCP1;HCK
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.8693878079132147,-1.485554513036274,0.01818181818181818,0.6933577921117404,1.0,2/10,3.50%,DDX11;NCL
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.6139727158971651,1.48529784063658,0.027777777777777776,1.0,1.0,29/90,12.62%,ACE2;ESRRG;FRK;LPP;SLC12A3;SLC22A2;MUC20;PPARGC1A;CMYA5;SLC8A1;PKHD1;SLC5A8;ABO;GSTO2;BBOX1;TMEM213;COBL;EXPH5;PROM2;KCNJ16;COBLL1;SLC16A7;JAG1;TFCP2L1;BAZ2B;ITGB8;PIK3C2G;PLEKHA5;FGD4
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.9485715601548793,1.483714205103453,0.04081632653061224,1.0,1.0,1/6,0.18%,VAPB
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9437594393836114,-1.4837102277284822,0.0,0.7012840642390711,1.0,3/5,3.10%,CYP1A2;CYP2D6;CYP2E1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6911582683406449,-1.4834808499938674,0.017241379310344827,0.6970218592460946,1.0,8/71,5.62%,CD44;SFRP1;TEC;CD74;ENPP2;BST1;IL11;GHR
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8448426252235417,1.4834769904068392,0.0975609756097561,1.0,1.0,7/10,14.73%,ZFPM2;ERBB4;FGFR2;BMPR1A;MEF2C;TGFBR3;PIM1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.833344042137932,1.48328952458174,0.038461538461538464,1.0,1.0,6/11,10.81%,ROBO1;ADAMTS9;ROBO2;JAG1;PDGFRB;PDE2A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.8053972195919294,1.483205229806886,0.017241379310344827,1.0,1.0,1/13,1.31%,RUNX1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.7941864624783379,1.4831382212427116,0.06976744186046512,1.0,1.0,4/19,7.20%,SLC12A1;ATP6V0A4;SLC12A3;SCNN1B
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6818369430247406,-1.4830213296505634,0.0,0.6945870037905694,1.0,2/22,1.52%,HSF2BP;BRME1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9686210913516125,-1.4820751162447325,0.019230769230769232,0.6954028374161432,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.8946124601032495,1.4820305631616284,0.03571428571428571,1.0,1.0,1/9,0.96%,REP15
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.8273166195665352,1.4818474530960635,0.044444444444444446,1.0,1.0,4/15,5.64%,SAMSN1;ZFP36L2;CD22;IGLL1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6918847207887638,1.4815507481035866,0.024390243902439025,1.0,1.0,17/58,16.03%,SLC12A1;SLC26A7;GABRR1;GABRB1;SLC12A3;GABRG3;GLRA2;GABRB2;ANO7;GLRB;GABRA4;ANO5;GABRA2;GABRG1;SLC12A2;GABRB3;PACC1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6115320475226041,-1.4810753854518635,0.037037037037037035,0.6957901955818183,1.0,47/97,28.19%,SRP54;SEC62;RPLP1;SRP68;RPL37A;RPL28;SRP14;RPS15;RPL4;RPL12;RPL34;RPL31;SGTB;RPS27;RPL8;RPS8;RPL19;RPL23;RPL5;RPL7A;RPL38;RPL24;RPS24;SRPRA;RPS3;RPL6;RPL29;SPCS1;RPL13;RPS20;RPL11;RPL35A;RPL10A;RPL37;RPLP2;RPS14;RPS4X;RPS25;SEC61G;RPS6;RPL27A;RPL18;RPS2;RPS21;RPS29;RPL14;SRP9
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.7896054780602167,-1.4810048105885774,0.08,0.6908777293903718,1.0,5/19,13.05%,SELP;SERPINE1;NOS2;HMGB2;AZU1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.8549571949811865,1.4804458292745646,0.046511627906976744,1.0,1.0,3/10,10.56%,SGK2;SGK1;NR1H3
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7615822168295364,1.4803604388375016,0.04081632653061224,1.0,1.0,5/19,10.75%,RGPD5;RGPD3;RGPD4;RGPD2;CBLB
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.8332875522209717,1.4802975041147326,0.019230769230769232,1.0,1.0,3/8,8.89%,WNT5A;GRIP1;DVL2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8289760273315648,-1.4801999546776363,0.05660377358490566,0.6908163824391946,1.0,3/18,4.73%,SLC28A2;AZGP1;B2M
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7108944612008666,1.4799272547782312,0.044444444444444446,1.0,1.0,15/42,15.64%,SLC12A1;GABRR1;GABRB1;SLC12A3;GABRG3;GLRA2;GABRB2;ANO7;GLRB;GABRA4;ANO5;GABRA2;GABRG1;SLC12A2;GABRB3
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.8535422352982232,1.478548647134308,0.08695652173913043,1.0,1.0,2/10,4.15%,SEMA5A;CNTN4
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6393693680745668,1.4779344121802753,0.045454545454545456,1.0,1.0,30/105,14.93%,RIT2;KCNC2;LSAMP;OLFM3;LRRTM3;MAGI2;NRXN1;NXPH1;KCTD16;GRM5;AMER2;GRIA4;CA10;SLC1A2;CTNNA2;DLG2;FUT9;NOL4;SYNPR;MEIS2;RBFOX1;UNC79;GRM1;ASIC2;PPFIA2;CNTNAP5;GRIA2;CSRNP3;GABRA2;GABRG1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.831577336902577,-1.4750599727499492,0.0,0.7208830334937276,1.0,4/11,8.16%,NCKAP1L;TNFSF18;MADCAM1;ZP3
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.8689489332324968,1.4737478939209983,0.02631578947368421,1.0,1.0,4/8,11.73%,MYBPC3;PDE4B;PDE4D;ANK2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.723004704878581,1.4735294219394102,0.07017543859649122,1.0,1.0,5/24,13.69%,PLA2G10;ABHD4;NAPEPLD;SELENOI;PLA2G15
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.8076586785794823,-1.4721882779047042,0.09090909090909091,0.7351079917544543,1.0,2/14,10.27%,TERF2IP;TPP1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.8400033575591566,-1.47144981559245,0.07272727272727272,0.7346487870079398,1.0,2/16,2.00%,STING1;CGAS
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6679586096760753,1.4698230161683847,0.05128205128205128,1.0,1.0,8/38,14.07%,ACE2;KCNJ3;KCNJ16;KCNJ6;ANK2;AKAP6;ANK3;KCNJ2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.9397157081456692,1.4698194978682637,0.019230769230769232,1.0,1.0,1/5,1.31%,RUNX1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.9019233821716315,-1.4693663479987547,0.02040816326530612,0.7430653013329281,1.0,2/7,4.73%,HLA-C;B2M
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8662732822558412,-1.4691318418780484,0.03508771929824561,0.7388750198814719,1.0,2/8,6.19%,DUOX1;CPQ
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.6016566269428967,1.468767836868005,0.1282051282051282,1.0,1.0,12/93,8.07%,TEX101;GCNA;ASB17;SPAG6;CREB5;EGFR;FAM229A;UBE3D;PHF13;DMC1;PRNT;MYO1D
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.7580776608902926,-1.4686793829438474,0.0,0.7365723030656315,1.0,2/28,3.31%,ACOT1;ACOT4
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.883809697409661,1.4676266632891941,0.0,1.0,1.0,3/11,1.83%,NOX5;LOXL2;SEMA5A
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.6846919327190183,-1.4675492256926004,0.07142857142857142,0.7388347395525925,1.0,7/52,10.51%,STING1;MAP1LC3B2;ATG14;WIPI1;NSFL1C;WIPI2;MAP1LC3A
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.7770699913236873,1.466728318796411,0.06976744186046512,1.0,1.0,3/19,9.22%,MED17;TWIST1;MITF
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.7095957528466145,-1.4663153178547614,0.07547169811320754,0.742735332735411,1.0,9/47,4.51%,P2RY10;HLA-DPB1;CD5;SP140;KLRB1;AOAH;TRAF3IP3;CD4;SLA
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.7877715313198662,1.4655440754724638,0.10638297872340426,1.0,1.0,3/11,6.18%,ZFP36;ZFP36L2;NR3C1
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.876411902644029,-1.46536656014704,0.017241379310344827,0.7446018539058952,1.0,3/9,3.48%,TNFSF18;LCP1;CD74
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.8638303380344173,-1.465058758709429,0.0625,0.741247089401916,1.0,3/11,6.17%,FIP1L1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.8097627365066997,-1.464389637170735,0.05660377358490566,0.7400156020815919,1.0,4/19,6.62%,CSRP2;OBSCN;TPM1;SYNPO2L
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.8829296691940376,1.4641674806840668,0.061224489795918366,1.0,1.0,2/7,4.99%,PNP;HPRT1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.596020560698853,-1.4635217898019783,0.03389830508474576,0.7433608058831039,1.0,2/152,0.91%,CD44;MYB
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.9401402256156944,-1.4618938691846721,0.06666666666666667,0.7498842655335771,1.0,2/5,5.68%,LDB1;SLC6A9
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.7937559221054326,-1.460192897188062,0.05454545454545454,0.7559475855249054,1.0,3/17,6.45%,NCKAP1L;LCP1;LLGL2
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.925969458312726,-1.4588062403076234,0.06,0.7616826151640964,1.0,2/7,6.92%,CDHR5;CDHR2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7204302288010181,-1.4585811412416667,0.09433962264150944,0.757802015306294,1.0,13/30,22.73%,NDUFC1;NDUFB9;NDUFS5;NDUFA1;NDUFA3;NDUFS6;NDUFAB1;NDUFS2;NDUFA5;NDUFA10;NDUFB10;NDUFA12;NDUFS8
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.6189150923033738,-1.458314028198097,0.018867924528301886,0.7546378693102473,1.0,4/116,1.58%,CD44;TAGLN;COL6A2;COL6A1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.6485717383497052,1.4583014556777156,0.06818181818181818,1.0,1.0,9/42,10.34%,LOXL2;SEMA5A;ROBO1;SLIT2;NRP1;VEGFC;VEGFD;CDH13;DLL1
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.9412127469410418,-1.4567396272910709,0.0,0.762243015038523,1.0,1/5,0.51%,APOBEC3H
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.8482401926773716,1.4562263763658334,0.04918032786885246,1.0,1.0,2/8,6.79%,IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.9586401404177536,-1.4556790420948709,0.05357142857142857,0.7642104778036912,1.0,1/6,0.09%,TLCD2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.8125188279889113,-1.455660038953936,0.0784313725490196,0.7592339928219243,1.0,2/9,2.43%,RPS27L;FOXM1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6060101453731831,1.4547777144680654,0.11764705882352941,1.0,1.0,16/65,16.73%,VAPB;CERS3;PPM1L;SPHK1;ELOVL6;TLCD3B;PRKD1;ACER1;ASAH2;HACD2;PLPP1;ALDH3A2;SGMS1;CERS5;SMPD4;ELOVL7
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.8124920015645785,-1.454372900127923,0.06382978723404255,0.7628986157824333,1.0,2/10,2.43%,RPS27L;FOXM1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.8590813437360931,-1.453701139009749,0.05454545454545454,0.7635976301285552,1.0,2/9,1.37%,CYP19A1;NMB
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.730586673748787,1.452156148458711,0.06521739130434782,1.0,1.0,3/23,10.38%,DACH1;HGF;PDGFRB
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.7197101282104988,-1.4516734395270559,0.0784313725490196,0.7668688956247649,1.0,6/20,15.60%,TERF2IP;POLR2I;DAXX;POLR2J;POLR2G;POLR2C
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.7197101282104988,-1.4516734395270559,0.0784313725490196,0.7668688956247649,1.0,6/20,15.60%,TERF2IP;POLR2I;DAXX;POLR2J;POLR2G;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.7371549205877875,1.4515300819379033,0.0392156862745098,1.0,1.0,3/27,8.33%,VAPB;CCL5;NR5A2
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.8462840690620055,1.450919611739703,0.043478260869565216,1.0,1.0,1/7,0.14%,CHIT1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.7594795590124013,1.4507381547033296,0.06818181818181818,1.0,1.0,2/18,2.88%,SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6881565737467183,1.4501730839226346,0.08695652173913043,1.0,1.0,6/23,8.64%,NLGN1;CEL;SYNJ2;SYT1;SNCA;NLGN4X
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.8114928010500404,-1.4499189329676534,0.06,0.7739372363404529,1.0,2/15,3.68%,STX4;STX1B
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.9039755648997788,-1.4495689988523937,0.044444444444444446,0.7711933165273944,1.0,2/6,5.68%,LDB1;SLC6A9
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.7908414168501223,-1.448057812481496,0.022727272727272728,0.7770142788499591,1.0,1/11,0.38%,SLC19A3
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.834105975733957,1.4476426910331794,0.10638297872340426,1.0,1.0,4/7,13.63%,HEY1;MRTFA;MRTFB;MEF2C
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.9301947617381049,-1.446569742893374,0.0196078431372549,0.7829299542811495,1.0,3/7,4.74%,NCKAP1L;RAC1;BST1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.7308203833392205,1.4462408033964915,0.06382978723404255,1.0,1.0,6/18,9.92%,HEY1;ROBO1;SLIT2;ROBO2;TWIST1;JAG1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.7268380654332002,1.4458553340806244,0.06382978723404255,1.0,1.0,3/23,6.25%,ACE2;AGER;CELF2
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.8983058120402394,-1.4455598170012505,0.045454545454545456,0.7852013609821596,1.0,3/5,4.99%,NCKAP1L;MYB;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.9561401088972771,1.4449476096806235,0.021739130434782608,1.0,1.0,1/5,0.63%,EIF3E
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.8708004437732327,-1.4445602281726337,0.07692307692307693,0.7868900710200751,1.0,1/7,1.73%,CLU
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.8049874205453789,1.4432323714498583,0.018867924528301886,1.0,1.0,2/9,4.20%,WNT5A;CCL5
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.7566413288885017,1.4421060623475896,0.06521739130434782,1.0,1.0,2/13,7.04%,NLRP2B;ZNF675
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.846542082075662,-1.4417659497159632,0.037037037037037035,0.8010623524620832,1.0,2/8,4.99%,NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.9266433260245619,-1.4416531046931411,0.05357142857142857,0.7974314290917222,1.0,1/5,0.37%,APIP
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.6304640989903895,-1.440988007801366,0.06349206349206349,0.796892029045425,1.0,10/74,6.65%,DUSP4;CBLC;SPRY4;FOXM1;PEBP1;SPRED3;UCHL1;SPRY1;SPRED2;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.8891209268013933,-1.4400668470184423,0.08620689655172414,0.7989549724931511,1.0,2/9,3.61%,ETV4;PRKCH
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.9309356679912517,-1.4390751399310195,0.047619047619047616,0.8009929105657528,1.0,1/6,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8949095135113514,1.4368408490719362,0.018867924528301886,1.0,1.0,2/8,4.03%,CHRM3;CHRM2
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.8343016382280962,1.4359754493692696,0.16279069767441862,1.0,1.0,3/9,12.91%,CX3CR1;CSF1;MTUS1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.8350267037297128,-1.4356339465480437,0.12962962962962962,0.8203700374117435,1.0,4/15,6.17%,C2ORF49;TRPT1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.8117073754386572,1.4356011880838373,0.08163265306122448,1.0,1.0,5/12,9.92%,HEY1;ROBO1;SLIT2;ROBO2;JAG1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.9070912131564807,-1.4330002242812472,0.037037037037037035,0.8343106190476447,1.0,2/5,2.57%,WNT7B;DACT2
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.6238767474328327,-1.432846262810418,0.041666666666666664,0.8301891382456292,1.0,18/96,14.51%,STING1;DDX11;AURKA;GTF2F1;GOLGA2;B2M;TMC8;DTX3L;IFIT1;HDAC5;PRKACA;LRPAP1;PIN1;TTBK1;RACK1;IFIT2;ACTB;NVL
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.6438295419101034,-1.4326594046183867,0.05263157894736842,0.8264837818133728,1.0,8/56,12.84%,BUD23;TRMO;HENMT1;CMTR1;TARBP1;METTL6;METTL3;TRMT112
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.8637028014497866,-1.4324225442447553,0.03571428571428571,0.8238132439280663,1.0,2/12,2.00%,STING1;CGAS
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.6105621806460566,-1.4322785558130058,0.06779661016949153,0.8198773226745593,1.0,20/105,11.05%,CYP1A2;PAH;FGL1;CYP2D6;HSD11B1;CYP2E1;RND3;AZGP1;GHR;GPC3;A1CF;LIPC;HNF4A;AMBP;RBP4;SDC2;TM7SF2;NOS2;NR1H4;HPX
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.9188445727405523,-1.4321197989006673,0.018518518518518517,0.8161418574577672,1.0,3/6,3.79%,PLK3;PLK5;GOLGA2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7456408901695734,-1.4315307969394206,0.037037037037037035,0.815371688488285,1.0,8/23,14.35%,XPC;UBC;RBX1;COPS6;CETN2;DDB1;COPS7A;PARP1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7349512740591818,-1.4304885664938667,0.016666666666666666,0.8186370407499233,1.0,3/36,5.01%,EPN1;CBLC;SPRY1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.8486892798542586,-1.4301554256179727,0.07142857142857142,0.8158849255469752,1.0,1/10,0.56%,BUD23
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.8341466010100733,1.4294379140606985,0.08571428571428572,1.0,1.0,1/10,0.45%,FAS
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.773384694304598,1.42938176708556,0.025,1.0,1.0,8/12,17.35%,HJV;TGFBR1;ACVR2A;SMAD2;ACVR1B;ACVR1;SMAD3;INHBA
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.762888801529614,-1.428881221518431,0.0425531914893617,0.8208739502111365,1.0,1/16,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.7806381209976914,-1.4276996742705386,0.13636363636363635,0.824203191045092,1.0,2/19,0.46%,HLA-DPB1;NCKAP1L
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.8122623735209098,-1.4262214064148169,0.07407407407407407,0.8304347047398439,1.0,1/10,0.65%,OR2M4
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7994124723226695,1.4257417726193256,0.044444444444444446,1.0,1.0,3/13,8.77%,TRIM22;HS3ST5;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.8346524220850944,-1.4250342880620144,0.07017543859649122,0.8356552046496433,1.0,1/10,2.70%,APOD
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8885769987654956,1.424825051192358,0.06779661016949153,1.0,1.0,3/6,9.38%,CX3CR1;ITGAM;C3
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6200277399576374,1.4244825625128021,0.1111111111111111,1.0,1.0,12/42,11.68%,CADM2;CDH8;CDH20;SMAD7;NECTIN3;CDH18;CDH10;CDH2;CDH6;CADM1;CDH13;CTNNB1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.7581570973228864,1.4243320947498974,0.07692307692307693,1.0,1.0,5/16,6.18%,CALCR;ZFP36;ZFP36L2;SLIT2;NR3C1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.7909234782119476,-1.423857798332712,0.045454545454545456,0.839043925951026,1.0,2/15,7.58%,NCKAP1L;FOXP1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.736546364473855,1.4237748352468702,0.07317073170731707,1.0,1.0,2/21,2.22%,MARVELD3;NLGN1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.8264638509575715,-1.4233775226004268,0.05263157894736842,0.8378382720444022,1.0,2/14,3.50%,DDX11;NCL
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.7553501799877498,-1.4232975439085669,0.125,0.8337707953736223,1.0,7/14,20.63%,ENTPD2;NUDT1;NUDT16;NUDT18;ENTPD5;NUDT15;ENTPD1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8429524023112626,-1.4227986156049404,0.06349206349206349,0.833188697869307,1.0,2/10,1.08%,APIP;NLRP1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7168612738138772,1.42251813749497,0.09090909090909091,1.0,1.0,7/40,8.31%,SEMA3C;NRG1;SEMA5A;ERBB4;SEMA6D;RADIL;CDH2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.8611503475381709,1.422404529788417,0.07142857142857142,1.0,1.0,3/6,12.46%,SLC8A1;ACTA2;EDN1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.9286883051241164,-1.421436868476869,0.061224489795918366,0.8391681757543159,1.0,1/5,3.68%,STX1B
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7804102409806541,-1.4213448983574475,0.13333333333333333,0.8353032889327813,1.0,2/16,1.05%,INHA;CYP19A1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.8444981291032241,1.420839723236586,0.125,1.0,1.0,2/6,3.94%,ADGRV1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.7182455375151595,1.4206729183352722,0.09090909090909091,1.0,1.0,8/32,11.68%,LOXL2;TGFBR1;TWIST1;CRB2;SMAD2;JAG1;MDK;CTNNB1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7514087529318212,1.420546831007242,0.07692307692307693,1.0,1.0,9/18,19.68%,CHSY3;CSGALNACT1;CHSY1;UGDH;CHST7;CSGALNACT2;CHST11;VCAN;CHST15
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.849326419828889,-1.4194576693431438,0.03773584905660377,0.8445925296526715,1.0,3/11,4.99%,AZGP1;B2M;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6592352045697651,1.4193045937588784,0.09259259259259259,1.0,1.0,11/40,14.68%,IL1RAPL1;NLGN1;NRXN1;CX3CR1;GRID2;PTPRD;FAIM;LIG4;SOX11;RGS14;SERPINF1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.5717822988095488,1.4188605123106242,0.05555555555555555,1.0,1.0,34/124,15.61%,RUNX1;NLGN1;PBX1;FLRT3;GPRIN1;HMGB1;NEDD4;AGER;CNTN4;GPM6A;TENM2;MANF;CNTNAP2;PBX3;RP1;RYK;GPM6B;SH3GL2;TMEM108;UGDH;TENM3;NPY;PTPRM;TENM1;ATXN10;BTG2;EPHA5;MEF2C;NCDN;LRP12;PPP1R9A;MAP2;ATP8A2;HDGFL3
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.6508671417199821,-1.417769806667077,0.09259259259259259,0.853118440986411,1.0,12/46,21.91%,STING1;B2M;DTX3L;PIN1;NVL;TAF1;VTN;FLOT1;ADD2;PPP2CB;RPL11;NMD3
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.853360191010424,1.4171581272053055,0.037037037037037035,1.0,1.0,3/9,7.46%,HDAC9;HDAC3;HDAC2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6406937946103318,-1.4170559057226648,0.041666666666666664,0.8546189532921877,1.0,13/47,15.33%,DDX11;XPC;UBC;RBX1;TWNK;CETN2;GTF2H2;MCM2;DDB1;SUPV3L1;PIF1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.8393330058417207,1.4170360412008869,0.10344827586206896,1.0,1.0,3/8,7.86%,CEL;AKR1C1;LDLR
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.8195761827011822,-1.4167169374158977,0.0784313725490196,0.8525372709679141,1.0,3/14,5.06%,TERF2IP;SLX4;ERCC1
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.9199670037559496,1.4165167646891783,0.041666666666666664,1.0,1.0,3/5,4.00%,HS3ST5;SULT2B1;SULT2A1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7048654287202178,1.4163822590539064,0.0784313725490196,1.0,1.0,2/15,2.68%,FHDC1;PHACTR1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7048654287202178,1.4163822590539064,0.0784313725490196,1.0,1.0,2/15,2.68%,FHDC1;PHACTR1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6904466424551203,-1.4160707752531703,0.058823529411764705,0.8523913088578008,1.0,5/41,1.57%,DUSP4;CLDN4;CBLC;TMEM184A;SPDEF
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8348853339369554,1.415719357980396,0.03636363636363636,1.0,1.0,1/7,2.19%,PPARG
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.8293542191548475,1.4154001722589344,0.0,1.0,1.0,2/13,3.36%,P3H2;EGLN3
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8617620138952612,1.415257154402949,0.0,1.0,1.0,3/7,6.79%,ACE2;CHRM3;SNCA
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.8892117169397369,-1.4148564268867916,0.0851063829787234,0.8510415298014619,1.0,1/6,5.55%,ANAPC15
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.8892117169397369,-1.4148564268867916,0.0851063829787234,0.8510415298014619,1.0,1/6,5.55%,ANAPC15
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.9231622802275539,-1.4147569739638668,0.0392156862745098,0.8477808049410029,1.0,1/6,0.99%,PAH
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8714024986379221,1.41372332935562,0.06,1.0,1.0,2/6,3.79%,NFKBIZ;SMAD7
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7933837707880633,1.412850908307782,0.12727272727272726,1.0,1.0,5/7,16.40%,NRP1;RYK;NCAM1;NFIB;VEGFA
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.9054778657355501,-1.4126902924333506,0.04,0.8583141517083023,1.0,1/5,0.53%,PLK4
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),-0.8769214196983559,-1.4119030135443964,0.020833333333333332,0.8593248225562015,1.0,2/7,7.46%,DUSP4;DUSP5
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.7232463810872168,-1.4114686882584209,0.12195121951219512,0.8579269668685416,1.0,3/19,10.28%,NCKAP1L;PPP1R15A;PTPA
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.8465387458002059,1.4108569440307777,0.06779661016949153,1.0,1.0,3/7,7.86%,CEL;AKR1C1;LDLR
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5963071524353415,-1.409295708089924,0.03636363636363636,0.8686085609451052,1.0,14/167,5.25%,CD44;MMP26;COL6A2;COL6A1;HRNR;COL4A3;ADAM12;ADAMTS15;SERPINE1;COL9A1;ADAMTS12;MMP21;ITGA6;ADAM19
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.7719994594575632,1.4091722019196329,0.11764705882352941,1.0,1.0,1/11,1.31%,RUNX1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.7981306850884243,1.4084004727051824,0.08888888888888889,1.0,1.0,4/8,16.67%,PRELP;GLB1;HEXB;GNS
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8146508754115799,1.4072565580075762,0.05454545454545454,1.0,1.0,4/11,12.44%,VAPB;TRDN;LPCAT3;STX18
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.7178596262411395,1.4070803806664918,0.13725490196078433,1.0,1.0,6/18,10.68%,PLCB1;HMGB1;AGER;SYK;IL16;MDK
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.9091432101415401,1.4066013503834534,0.057692307692307696,1.0,1.0,2/5,4.01%,KANK1;ANLN
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.8994618231029393,1.406305328217265,0.0625,1.0,1.0,2/7,7.86%,CKM;CKMT1A
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.7389053814406279,-1.4043930916807776,0.07272727272727272,0.8938835713903213,1.0,4/26,5.99%,ACOT1;ACOT11;ACOT4;ACOT12
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.7389053814406279,-1.4043930916807776,0.07272727272727272,0.8938835713903213,1.0,4/26,5.99%,ACOT1;ACOT11;ACOT4;ACOT12
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.8066607205178862,1.4040399099914749,0.05555555555555555,1.0,1.0,2/8,4.20%,WNT5A;CCL5
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.8066607205178862,1.4040399099914749,0.05555555555555555,1.0,1.0,2/8,4.20%,WNT5A;CCL5
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.5386855323043509,-1.4036609677148453,0.018518518518518517,0.8946024397159198,1.0,34/360,9.60%,CD44;STING1;DSC1;NCKAP1L;HLA-C;HRNR;HEBP2;RNASET2;RAC1;HGSNAT;DNASE1L1;FLG2;B2M;BST1;FTH1;CKAP4;FABP5;PSMD7;PDAP1;PSMC3;CFD;STK10;AGA;CD63;ATP8B4;CRACR2A;RAB31;ATP6V1D;DBNL;CR1;MGAM;PKP1;SRP14;APRT
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7436258676432241,1.4036376975829832,0.14285714285714285,1.0,1.0,5/18,9.61%,NLRP2B;DDIT4;SMAD7;PDE4D;NCK1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.8037598841536382,1.403441336565181,0.09615384615384616,1.0,1.0,1/9,1.11%,PLA2G10
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.78132811536895,1.4019950303516198,0.13636363636363635,1.0,1.0,2/11,7.46%,ROGDI;HDAC2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.8330998965830899,-1.4019640572718788,0.06382978723404255,0.9023298246642547,1.0,1/10,0.91%,MYB
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5428349517431572,-1.4016517641540895,0.019230769230769232,0.9001459195619784,1.0,34/358,9.60%,CD44;STING1;DSC1;NCKAP1L;HLA-C;HRNR;HEBP2;RNASET2;RAC1;HGSNAT;DNASE1L1;FLG2;B2M;BST1;FTH1;CKAP4;FABP5;PSMD7;PDAP1;PSMC3;CFD;STK10;AGA;CD63;ATP8B4;CRACR2A;RAB31;ATP6V1D;DBNL;CR1;MGAM;PKP1;SRP14;APRT
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.7888223332079769,-1.4015132893110684,0.06666666666666667,0.8968476169877924,1.0,1/7,0.99%,PAH
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.8500122054392498,1.4015089237328895,0.04081632653061224,1.0,1.0,2/8,1.72%,PLA2G10;PLCB1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6217164789387442,1.4014544029910674,0.05454545454545454,1.0,1.0,7/32,12.62%,PLCB1;GNAT2;WNT5A;NLK;PPP3CA;CTNNB1;PDE6A
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.9442381434904997,-1.401170101195921,0.0425531914893617,0.8948424207761483,1.0,1/5,0.53%,DDX11
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.7434310557595315,-1.4011583283007267,0.11320754716981132,0.8905205985541638,1.0,5/23,4.72%,KRT16P6;NUPR1;ADIRF;DUOXA1;ANO1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.8642068374253056,-1.401122356078598,0.06382978723404255,0.8864129467473307,1.0,2/10,5.17%,KIF25;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.7222124570785514,1.4011053118037988,0.07692307692307693,1.0,1.0,6/24,10.63%,MARVELD3;SLIT2;ADAMTS9;PTPRG;ADIPOR1;PTPRM
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.8920669117941991,1.4005882460657995,0.06818181818181818,1.0,1.0,3/5,3.73%,ZBTB1;HMGB1;AGER
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.8517053902971421,1.4004907923407592,0.08,1.0,1.0,1/7,5.03%,PARD3
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.8517053902971421,1.4004907923407592,0.08,1.0,1.0,1/7,5.03%,PARD3
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.82905913968354,1.400285050198305,0.061224489795918366,1.0,1.0,1/8,0.45%,FAS
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7431148693975209,-1.399573798295947,0.14035087719298245,0.8933132408948872,1.0,3/14,4.36%,TYMS;DUOX1;TRPC3
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.885490295917633,-1.3989548960732245,0.0784313725490196,0.8934955371082685,1.0,2/5,6.74%,GHR;PRLR
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.7743960858012757,-1.3979529043769807,0.13725490196078433,0.8960524355353097,1.0,1/10,0.99%,PAH
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.9031601768083442,1.3978375901106406,0.06382978723404255,1.0,1.0,2/6,2.68%,NLGN1;PHACTR1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.8610370801512364,1.3977818635840606,0.061224489795918366,1.0,1.0,1/7,2.56%,FGFR2
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.6661679518077075,-1.3976691609369203,0.07142857142857142,0.8937282229965157,1.0,2/36,1.78%,NCKAP1L;HCK
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.7979291369844744,1.3969835878683405,0.047619047619047616,1.0,1.0,3/14,5.74%,FLRT2;LAMB4;NID2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.7309286667592448,1.396918847426394,0.07317073170731707,1.0,1.0,7/22,14.54%,KANK1;IRS1;ENPP1;PIP4K2A;NCK1;PID1;PRKCB
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.8161205131457571,1.396728558365652,0.10869565217391304,1.0,1.0,1/9,1.71%,RFWD3
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.6581578190354371,-1.3966402175498767,0.1,0.8972685635265014,1.0,14/35,21.03%,NARS1;SARS1;WARS1;CARS1;RARS1;PPA1;AIMP1;IARS2;GARS1;YARS1;EPRS1;IARS1;MARS1;DARS2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8751361355068803,1.3960832599626494,0.019230769230769232,1.0,1.0,1/5,2.19%,PPARG
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.8146162041981773,-1.3959656125660376,0.09090909090909091,0.8978889399779832,1.0,2/9,8.13%,SARDH;DMGDH
prerank,GO_Biological_Process_2021__negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),-0.9356097339903587,-1.3958573645258638,0.0392156862745098,0.8946311698428484,1.0,1/5,0.91%,MYB
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.9147243857230551,1.3957268108974237,0.023255813953488372,1.0,1.0,1/6,0.63%,EIF3E
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.5391395689984919,-1.3956228185192021,0.018867924528301886,0.8920669388879908,1.0,34/363,9.60%,CD44;STING1;DSC1;NCKAP1L;HLA-C;HRNR;HEBP2;RNASET2;RAC1;HGSNAT;DNASE1L1;FLG2;B2M;BST1;FTH1;CKAP4;FABP5;PSMD7;PDAP1;PSMC3;CFD;STK10;AGA;CD63;ATP8B4;CRACR2A;RAB31;ATP6V1D;DBNL;CR1;MGAM;PKP1;SRP14;APRT
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.8175617541578856,1.395553742486861,0.06666666666666667,1.0,1.0,5/11,15.67%,DOC2B;SYT1;RIMS2;UNC13C;SYT2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.6616436130967018,1.3952949659744274,0.0851063829787234,1.0,1.0,3/35,3.48%,IFI16;PPARG;HMGB1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.7082585449751746,1.3952666372781073,0.1346153846153846,1.0,1.0,6/20,17.61%,THRSP;PRKAB2;ACACA;ABCD3;CPT2;SLC25A20
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6768166818378942,1.3939647631131138,0.05660377358490566,1.0,1.0,5/27,6.34%,IL1RAPL1;NLGN1;NRXN1;GRID2;PTPRD
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.8506753198695772,-1.393748637769431,0.05555555555555555,0.9006229554650206,1.0,1/6,0.70%,DYSF
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.8284034745771589,-1.3936370185416325,0.08695652173913043,0.8975209533425077,1.0,2/6,6.58%,PLEKHH2;VIL1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6003590636817893,1.3934283919441126,0.020833333333333332,1.0,1.0,28/123,11.91%,KCND2;CADM2;RIT2;KCNC2;OXTR;OLFM3;NGB;LRRTM3;NRXN1;CDH20;GFAP;ADGRB3;AGER;NXPH1;GRM5;AMER2;GRIA4;CA10;ELAVL4;RAB3C;CTNNA2;SYNPR;KCNB2;RBFOX1;LRRC3B;PDE2A;GRM1;ASIC2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.9255783780341785,1.3932346701877187,0.1,1.0,1.0,1/5,4.89%,SLC6A13
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.5834771542458894,-1.393194341511163,0.06666666666666667,0.89600061428211,1.0,9/137,6.58%,CD44;SFRP1;NTRK1;PLK5;ADAMTS12;KNSTRN;PDCD5;DLX5;VIL1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7839241405274091,1.3925764208254654,0.09302325581395349,1.0,1.0,5/14,11.73%,GRM7;GRM5;GRM8;GRM6;GRM1
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.860047616981506,1.3919364287621487,0.16363636363636364,1.0,1.0,2/5,7.26%,OTUD4;TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.860047616981506,1.3919364287621487,0.16363636363636364,1.0,1.0,2/5,7.26%,OTUD4;TOX
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.8411439402118177,-1.391841439309606,0.057692307692307696,0.9015730423546565,1.0,3/10,5.95%,SIGIRR;APOD;OAS3
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.769183038225231,1.3908512949241705,0.11904761904761904,1.0,1.0,5/14,16.05%,LOXL2;SOX5;MDK;SCX;PKDCC
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.8035452624036561,-1.3906614726583217,0.07692307692307693,0.9064061299444475,1.0,4/19,9.81%,NCKAP1L;RAC1;PARVB;PARVG
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.6567113039571602,-1.3900715600195892,0.04838709677419355,0.9058739612127416,1.0,9/57,11.00%,EPN1;CBLC;SPRY1;WDR54;RHBDF2;BTC;BCAR3;DGKD;CEACAM1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.6903718336118605,-1.3896980667349526,0.04878048780487805,0.90406242890115,1.0,9/33,19.22%,ENOSF1;HK2;MAN2B2;DERA;ENO1;GAPDHS;LDHA;PGK1;ENO2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.8806784867926014,1.3895177166064328,0.08333333333333333,1.0,1.0,3/7,8.18%,NRG1;TGFBR1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.9123840977163886,1.389057061106023,0.09615384615384616,1.0,1.0,2/6,3.79%,DACH1;SMAD7
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6347003814590557,1.3884365786489756,0.07142857142857142,1.0,1.0,9/28,15.18%,KCNJ3;CHRM3;NEDD4;KCNJ16;KCNJ6;AKAP6;KCNJ2;P2RX7;NEDD4L
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.8312090852283678,1.387664978274923,0.10869565217391304,1.0,1.0,2/7,4.00%,ALDH1A1;SULT2A1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.7064284892709932,1.38716046740326,0.06818181818181818,1.0,1.0,11/29,17.00%,FAS;DAPK2;CX3CR1;TGFBR1;ASAH2;STYXL1;BCL2;DEPTOR;SGMS1;CRADD;TRAF1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.6222451296733229,1.3870571292540583,0.07692307692307693,1.0,1.0,16/63,15.16%,SLC12A1;KCNJ3;TRPV2;SLC12A3;SLC39A12;SLC8A1;ATP2B4;SLC39A8;KCNJ16;KCNJ6;SLC24A2;KCNK9;KCNJ2;ATP12A;SLC12A2;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.7493545886465428,1.3867317515969648,0.10526315789473684,1.0,1.0,5/9,13.68%,IRS1;ZBTB7B;SNX5;SIRT1;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.7493545886465428,1.3867317515969648,0.10526315789473684,1.0,1.0,5/9,13.68%,IRS1;ZBTB7B;SNX5;SIRT1;SORBS1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5881166229809305,1.3866732451599664,0.06666666666666667,1.0,1.0,36/133,13.83%,NDNF;CADM2;RCVRN;LSAMP;VWC2L;OLFM3;MAGI2;NRXN1;CDH20;ADGRB3;HCN1;CNTN4;NLK;GRM5;PCDH15;CNTNAP2;AMER2;GRIA4;CA10;SLC1A2;RAB3C;PCSK2;CTNNA2;SYNPR;GRM6;PRKCA;NCAM1;RBFOX1;UNC79;GRM1;ZNF536;PPFIA2;CNTNAP5;SLC24A2;GRIA2;QPCT
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.6468329417895147,-1.3859900235397697,0.08771929824561403,0.9260773234595387,1.0,7/38,14.35%,DDX11;FOXM1;RAD51AP1;DTX3L;WRAP53;KDM4D;PARP1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8243324223389026,1.3857257060119625,0.15217391304347827,1.0,1.0,1/8,0.32%,LOXL2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.7020414137463522,-1.3848772007088261,0.041666666666666664,0.929560484034647,1.0,10/32,20.48%,TERF2IP;H1-4;H1-0;RAD51AP1;KPNA2;H1-2;ZRANB3;ALYREF;CHEK1;USP51
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.8866498842357181,1.3848645091791019,0.04,1.0,1.0,3/9,4.00%,ENPP1;SULT2B1;SULT2A1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.693937842318143,-1.384783748762048,0.09090909090909091,0.92608374397011,1.0,4/37,2.99%,STING1;SFRP1;CYP19A1;PAQR7
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.8180209180166521,-1.3847066018392702,0.12280701754385964,0.9224408223668288,1.0,2/9,6.56%,TMSB4X;XRCC1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.791918222586979,1.384632306586587,0.09803921568627451,1.0,1.0,2/7,4.20%,HMGB1;CCL5
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.7286244282474352,1.3841434148246763,0.11363636363636363,1.0,1.0,7/23,14.54%,KANK1;IRS1;ENPP1;PIP4K2A;NCK1;PID1;PRKCB
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.8000768415293723,1.3836608759857238,0.12,1.0,1.0,2/13,3.59%,LOXL2;BAHD1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.8571577162631339,-1.38359368266904,0.125,0.9268356634102158,1.0,3/8,10.91%,ARR3;DRD3;GTF2H2
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.8012347787598626,1.3835443887427432,0.15789473684210525,1.0,1.0,1/6,5.80%,GLA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.8012347787598626,1.3835443887427432,0.15789473684210525,1.0,1.0,1/6,5.80%,GLA
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.6511806497104948,1.3831802554465706,0.13043478260869565,1.0,1.0,8/42,10.72%,PLCB1;ITPKB;NUDT10;INPP1;PLCE1;IP6K2;PLCB4;INPP4B
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.7028671044307954,-1.3823763732674264,0.14285714285714285,0.9304494554571103,1.0,4/17,7.24%,CCN3;NLRP3;TMSB4X;SPI1
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.7006037396414464,-1.3823554518751922,0.058823529411764705,0.9265630294522395,1.0,6/28,7.36%,CLDN4;DUOX1;SERPINE1;VIL1;ADRA2A;CLDN1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.9101600033934645,-1.3818276525533892,0.078125,0.9264672269545016,1.0,1/5,4.74%,IL11
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.6679517055594144,-1.3816182777558317,0.05555555555555555,0.9238272787925055,1.0,7/43,6.96%,APIP;KIF25;UPB1;GOLGA2;B2M;RYR1;HSD17B10
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.8672066137217125,1.3807669556226025,0.09803921568627451,1.0,1.0,1/5,2.21%,ENPP1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.8672066137217125,1.3807669556226025,0.09803921568627451,1.0,1.0,1/5,2.21%,ENPP1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.7275518123850646,-1.3805595051977588,0.07407407407407407,0.9273531243076286,1.0,1/16,0.81%,TYMS
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.7064743183097394,-1.3798591561672,0.14814814814814814,0.9283255353451435,1.0,6/28,5.46%,P2RY10;CD5;KLRB1;TRAF3IP3;TRBC2;ZNF831
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.7106275722017887,1.379253918258452,0.08333333333333333,1.0,1.0,9/28,16.92%,DOC2B;PPARGC1A;SORBS3;LIG4;STX18;TMED9;P2RX7;AKT2;ELAPOR1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.5249583198496122,-1.378676738583687,0.034482758620689655,0.9327534052557604,1.0,25/358,7.19%,CD44;APIP;NCKAP1L;NUPR1;SFRP1;TNFSF18;SH3RF2;HMGN5;IL31RA;HCK;PLK3;ASCL1;NTRK1;CD74;PRKCH;ANXA5;FGF20;AHI1;UBC;HTATIP2;PRLR;VIP;ANKLE2;BCL2L2;PTMA
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.6513279640189595,1.378175882345922,0.13043478260869565,1.0,1.0,8/41,10.72%,PLCB1;ITPKB;NUDT10;INPP1;PLCE1;IP6K2;PLCB4;INPP4B
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6951441609531217,1.377799000579445,0.10526315789473684,1.0,1.0,3/21,5.02%,SEMA5A;DSCAM;NRP1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.879524636345659,-1.3776542858501035,0.06521739130434782,0.9357410881801126,1.0,1/6,0.79%,SIGLEC1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.8648647893203217,1.3766492556653394,0.07407407407407407,1.0,1.0,3/9,5.36%,ANTXR2;SLC22A2;RAB29
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6840508291990584,-1.376642764924428,0.1,0.9392317019466848,1.0,2/28,2.12%,EPN1;FGF1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.6722532238538727,-1.376094857206341,0.09090909090909091,0.9379952420429281,1.0,17/39,21.03%,NARS1;SARS1;TARS3;WARS1;CARS1;RARS1;AARS2;PPA1;PARS2;AIMP1;IARS2;GARS1;YARS1;EPRS1;IARS1;MARS1;DARS2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.7085367391064341,1.3757370996452463,0.0851063829787234,1.0,1.0,3/21,8.04%,PNLDC1;ZFP36;CNOT4
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7833775851199604,-1.3756410601983957,0.11764705882352941,0.9366569522826294,1.0,3/11,8.23%,TNFSF18;DOCK8;BTN3A1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.8115334335600085,-1.3749465409916013,0.061224489795918366,0.9373421722032703,1.0,1/9,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6708152017345252,1.3749281846786217,0.10714285714285714,1.0,1.0,2/22,2.27%,NOX5;ATP6V0A4
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5731901596148173,-1.3746626217383198,0.10869565217391304,0.9353127577954538,1.0,6/64,2.46%,SYTL1;PSD4;HLA-C;B3GALT4;SIGIRR;ST6GALNAC2
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7310574049344247,1.3744804861324953,0.10638297872340426,1.0,1.0,4/19,1.63%,TEX101;GCNA;CYP4Z2P;ASB17
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.8403997169267962,-1.3740169500171804,0.14814814814814814,0.9356652859128535,1.0,3/6,5.05%,SPRED3;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.8714430865171992,1.3739297501640195,0.08,1.0,1.0,2/5,4.20%,HMGB1;CCL5
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8576666242410386,1.37312254855252,0.14545454545454545,1.0,1.0,3/7,11.89%,CSGALNACT1;HS2ST1;EXT1
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.7975599206101873,-1.3727925466603481,0.10869565217391304,0.9399893177350305,1.0,1/5,1.73%,CLU
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.8848749612884848,-1.3720996946035307,0.09433962264150944,0.941528998487608,1.0,1/5,2.70%,APOD
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7771632604812374,1.3718298723144446,0.08888888888888889,1.0,1.0,7/11,16.40%,NRP1;VEGFC;GAB1;NUS1;VEGFD;PIK3CA;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),0.8656504454519808,1.3716839426017582,0.1,1.0,1.0,1/5,4.20%,CCL5
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.8489330646271988,1.3716687251591064,0.058823529411764705,1.0,1.0,1/7,2.19%,PPARG
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7815991825391064,1.3714905192702038,0.1276595744680851,1.0,1.0,4/8,13.39%,CASS4;MCU;BCAR1;EFS
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.748784654330866,-1.3711817685258565,0.09090909090909091,0.9440779338329249,1.0,1/27,0.06%,PM20D1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6154435830059907,1.3710560004166437,0.09523809523809523,1.0,1.0,14/51,11.33%,RALA;CASS4;PHACTR1;THSD7B;FGF10;TNIK;NRP1;GAB1;MCU;AUTS2;FER;THSD7A;RAP2A;BCAR1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.8326809965976201,1.3705079535322817,0.0784313725490196,1.0,1.0,5/9,9.14%,ADIPOR2;PPARGC1A;ACSM1;PLA2G7;ADIPOR1
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.8885368732031147,-1.3701596591078027,0.08163265306122448,0.9471875412012682,1.0,1/5,0.21%,SELP
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.830648933626827,1.370096589093678,0.18181818181818182,1.0,1.0,3/7,11.33%,NRP1;HGF;BCAR1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.830648933626827,1.370096589093678,0.18181818181818182,1.0,1.0,3/7,11.33%,NRP1;HGF;BCAR1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.6218542284971711,-1.3692244906407838,0.0847457627118644,0.9503803623699025,1.0,7/58,6.96%,APIP;KIF25;UPB1;GOLGA2;B2M;RYR1;HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.8134591253359575,1.3690992273436249,0.06779661016949153,1.0,1.0,2/7,16.42%,ADIPOR1;VHL
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.9084071351480532,-1.367934240904107,0.04,0.9550614221522522,1.0,1/5,0.21%,SELP
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.8621291517246497,-1.3678589648904165,0.07142857142857142,0.9480387834256896,1.0,1/7,2.70%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.8621291517246497,-1.3678589648904165,0.07142857142857142,0.9480387834256896,1.0,1/7,2.70%,APOD
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7557684450586707,1.3675196473336653,0.10714285714285714,1.0,1.0,4/11,16.17%,PPARG;NFIB;NFATC3;RELA
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.6786632858910695,1.3673191977781873,0.11363636363636363,1.0,1.0,9/35,11.68%,FZD1;HEY1;CUL1;HDAC2;DVL2;JAG1;DLL1;GNAI1;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),0.8582231505157213,1.3672105736023912,0.10416666666666667,1.0,1.0,1/5,3.37%,SPHK1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.8657218300027307,-1.3666223417740764,0.05660377358490566,0.953135881955422,1.0,1/9,0.51%,APOBEC3H
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8039388886351221,-1.366587442765997,0.08620689655172414,0.9495361911940641,1.0,1/9,0.17%,EPN1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.5998305062284295,1.3665008404442076,0.06666666666666667,1.0,1.0,14/80,10.56%,ACE2;PLA2G10;NTF3;PPARG;MAGI2;AKR1C1;CSF1;CCL5;RAB29;SNCA;ACACA;PDGFRB;STARD4;NR1H3
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6245373149205448,-1.366178486597347,0.019230769230769232,0.9482619013252487,1.0,7/53,6.15%,CYP1A2;GPC2;CYP2D6;RBP1;GPC1;GPC3;AGRN
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.8942940602817834,1.3659685357267708,0.0425531914893617,1.0,1.0,1/5,3.19%,DSCAM
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6953895670757483,1.365920089770507,0.12195121951219512,1.0,1.0,9/24,15.45%,RALA;NLGN1;GPM6A;NRP1;TENM2;TENM1;FNBP1L;PIK3R1;PLPPR5
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5770279539304145,-1.3650507275867325,0.07142857142857142,0.9521008417889275,1.0,13/167,5.25%,CD44;MMP26;COL6A2;COL6A1;COL4A3;ADAM12;ADAMTS15;SERPINE1;COL9A1;ADAMTS12;MMP21;ITGA6;ADAM19
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7524063954192769,1.3634205003851854,0.1320754716981132,1.0,1.0,5/9,16.40%,NRP1;ZSWIM6;ZSWIM5;ZSWIM8;VEGFA
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6789276296383349,1.3631764762284129,0.12,1.0,1.0,6/32,7.80%,SLC12A1;SLC12A3;SLC8A1;SNCA;SCNN1B;TMTC2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.5918563502348814,1.3631292191686744,0.05555555555555555,1.0,1.0,17/77,12.66%,VAPB;SLC39A12;CCL5;SLC8A1;PKHD1;SLC30A8;ATP2B4;SLC30A10;MT1M;TRDN;SLC39A8;TMEM203;NPTN;CXCL12;ANK2;EDN1;SLC24A2
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7713337251695486,1.3626805185659814,0.16666666666666666,1.0,1.0,9/17,19.36%,PARD3;DLG2;CRB2;LRRC7;PARD3B;ERBIN;MTCL1;OOEP;CRB1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.6819964776060393,1.3619420750503097,0.14285714285714285,1.0,1.0,10/31,14.16%,SEMA3C;SEMA6D;UNC5C;ROBO1;SLIT2;EPHA7;ITGAV;LGR6;SEMA3B;LRTM2
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.9301152942984308,-1.361567313891357,0.03571428571428571,0.9734017818117422,1.0,2/6,3.10%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.7300955078578668,-1.3615398177649105,0.16326530612244897,0.9697789920865615,1.0,2/14,8.85%,NUPR1;PGP
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5582028494500494,1.3615211192885421,0.10204081632653061,1.0,1.0,30/109,15.03%,SEMA3C;HS6ST3;NKAIN2;CADM2;KCNC2;OLFM3;LRRTM3;GFAP;ADGRB3;NXPH1;KCTD16;GRM5;CA10;LRFN5;HMGCLL1;SH3GL2;SYNPR;RBFOX1;LRRC3B;GADD45B;ANK2;ASIC2;ZNF536;PPFIA2;RGS7BP;GRIA2;CTNND2;MAP2;PVALB;MAPK4
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.8808591323015647,1.3612793904851248,0.09803921568627451,1.0,1.0,2/5,4.55%,ROBO1;SLIT2
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.7750884300651609,-1.3609664050744454,0.1568627450980392,0.9697669423699692,1.0,1/9,0.81%,TYMS
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.821118036807943,-1.3609178771646622,0.13636363636363635,0.9665330943306686,1.0,2/8,7.06%,DDX11;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5173110794619984,-1.36073449498486,0.0,0.9642561609152988,1.0,7/190,4.74%,CD44;FGF1;NTRK1;CD74;NODAL;CD4;IL11
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.8228632237245551,-1.36053746204122,0.09803921568627451,0.9618593763594383,1.0,3/10,7.58%,SFRP1;NODAL;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.6265581627421207,-1.3603486037764574,0.08333333333333333,0.959652313407664,1.0,14/58,15.31%,DDX11;AURKA;GTF2F1;GOLGA2;B2M;TMC8;IFIT1;LRPAP1;PIN1;TTBK1;RACK1;IFIT2;ACTB;ATP2A3
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6534533660924265,1.3595720350444818,0.08888888888888889,1.0,1.0,7/27,13.96%,SHISA9;MCTP1;GRIK2;ZDHHC2;PPFIA3;NCDN;NETO1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.7232493286643453,1.3594948756584158,0.13043478260869565,1.0,1.0,1/10,2.63%,ZBTB1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.7506531975257376,1.3594321598297832,0.14285714285714285,1.0,1.0,4/13,14.14%,CHMP6;PDCD6IP;CEP55;CHMP1A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.704202173155561,-1.3594035963828404,0.1320754716981132,0.962169548660002,1.0,6/24,11.00%,NCKAP1L;FGL1;GLMN;CR1;IL4I1;CEACAM1
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.8620438152910594,-1.3589089381528268,0.10909090909090909,0.9618811079637247,1.0,1/5,3.11%,TNXB
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6617612572791655,-1.3585374596561495,0.1016949152542373,0.9605116489192582,1.0,8/40,8.02%,SLC28A2;CDH17;PBLD;A1CF;VIL1;LIPC;HNF4A;SLC3A1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.6053503312233307,1.358479702369977,0.1590909090909091,1.0,1.0,26/91,14.31%,GPC6;FIGN;PRTG;IL17RD;SERTAD4;CNN3;SLIT2;GLI3;PTPRG;CDR2L;GLRB;CDH2;DDAH1;LRP4;TRAM1L1;ZFHX4;ADGRL2;TENM3;BCAR1;TUSC3;FLNC;LIFR;ENAH;AMOTL2;MEIS3;SALL1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.7689687333271338,1.3582389114949602,0.06521739130434782,1.0,1.0,2/9,8.82%,CCL5;ADA
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.654380993469419,-1.3580797263062905,0.11290322580645161,0.9596921547508297,1.0,6/31,9.77%,FGF1;ANO1;TRPV4;DAXX;TCIM;PRKACA
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.8422476682057438,-1.357989775561365,0.02,0.9566280583676007,1.0,2/6,4.73%,NOG;B2M
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8011655688897413,1.3573184692946474,0.14,1.0,1.0,4/8,19.28%,PLA2G10;C3;LPL;NFKB1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.8035997563895242,1.3569212399039197,0.1,1.0,1.0,3/9,8.13%,SPX;RNLS;PDE4D
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.8308050477296325,1.3560254023576563,0.13953488372093023,1.0,1.0,3/8,4.60%,ZBTB1;TGFBR1;FGF10
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5631525160199364,1.355446351443538,0.1111111111111111,1.0,1.0,31/113,18.03%,SLC12A1;KCND2;KCNE4;KCNJ3;KCNH7;KCNC2;KCNQ5;KCNS3;SLC12A3;HCN1;KCNK1;LRRC38;KCNG3;KCNJ16;KCNJ6;KCNB2;KCNG1;SLC24A2;KCNK9;KCNJ2;ATP12A;SLC12A2;KCNA5;SLC9A1;KCNT2;KCNN1;KCNV1;SLC9A2;SLC24A4;ATP1A2;SLC1A3
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.6901273619751942,1.3552120037141355,0.1,1.0,1.0,4/16,14.14%,CHMP6;PDCD6IP;CEP55;CHMP1A
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.670701733100753,-1.3543651696480945,0.09836065573770492,0.9773154852625288,1.0,4/39,5.01%,CBLC;SPRY4;UCHL1;SPRY1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.6663641068877802,1.3542956697412525,0.15217391304347827,1.0,1.0,8/27,17.14%,MAP3K11;PPEF2;ZNF675;DVL2;EDN1;SASH1;AIDA;MAP3K5
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6853177030036454,-1.354266993683975,0.15384615384615385,0.9743415404707735,1.0,4/27,7.46%,DUSP4;COL6A1;NODAL;DUSP5
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5382582458223003,-1.3541434898544946,0.061224489795918366,0.9714895225905968,1.0,50/142,24.57%,SARS1;WARS1;ABCF1;MRPL23;RPLP1;RPL37A;RPL28;MRPS18B;RPS15;MRPL55;RPL4;RPL12;RPL34;RPL31;MRPS21;RPS27;RPL8;MRPL9;RPS8;RPL19;PABPC4;RPL23;MRPL27;RPL5;RPL7A;RPL38;RRBP1;RPL24;RPS24;MRPL51;MRPS18C;RPS3;RPL6;MRPL37;RPL29;RPL13;RPS20;RPL11;RPL35A;RPL10A;EIF4G1;RPL37;RPLP2;RPS14;RPS4X;RPS25;FARSB;IGHMBP2;RPS6;MRPS11
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.802778841467852,-1.354014575455642,0.16666666666666666,0.9685926028642324,1.0,3/6,15.33%,LDB1;NUP133;NUP155
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.815644382317884,-1.353925099908059,0.10416666666666667,0.9619105575802002,1.0,2/6,17.45%,CD4;CTSL
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.815644382317884,-1.353925099908059,0.10416666666666667,0.9619105575802002,1.0,2/6,17.45%,CD4;CTSL
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.6669030046581482,1.3531809248225188,0.14893617021276595,1.0,1.0,13/26,14.32%,ZFPM2;SMAD7;HEY1;ROBO1;TGFBR1;SLIT2;ROBO2;BMPR1A;PDE2A;SOX11;ACVR1;SALL1;TGFBR3
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.8602919165052311,-1.3529725515518214,0.11864406779661017,0.964317284227563,1.0,1/7,1.12%,RTF1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.7942655842783082,1.3524087964092881,0.125,1.0,1.0,1/9,0.98%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.7478721579464913,-1.351604266696886,0.13725490196078433,0.9700973510760809,1.0,4/10,21.82%,STX4;RANGRF;MAP1A;HSP90AB1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7735309107666852,1.3515164563371,0.1388888888888889,1.0,1.0,4/9,16.97%,HEY1;PDE2A;SALL1;TMEM65
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7678807031550972,1.3509867261681447,0.09259259259259259,1.0,1.0,5/13,15.85%,NAA50;AANAT;EP300;KAT2B;NAA30
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.6242163830892561,1.3506043620049195,0.021739130434782608,1.0,1.0,4/46,7.04%,NLRP2B;SPHK1;SYK;ZNF675
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.8733280305453279,1.3505742794397813,0.06382978723404255,1.0,1.0,1/7,1.11%,PLA2G10
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.9353850986412221,1.3503465250366626,0.0196078431372549,1.0,1.0,2/5,5.08%,NUDT10;FHIT
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5806024804763288,-1.3502710182043363,0.12698412698412698,0.9758350731125216,1.0,23/96,15.15%,SELP;CD9;F8;CLU;F5;SERPINE1;ANXA5;TMSB4X;PCYOX1L;CFD;CD63;CALM1;SCG3;F13A1;SPARC;SELENOP;APOA1;MAGED2;SERPINF2;ITIH4;ITGA2B;PDGFA;SRGN
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5989948638284613,-1.3501965415539476,0.09803921568627451,0.9726620486968985,1.0,1/75,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.7128942403020686,1.3500548884754324,0.13559322033898305,1.0,1.0,3/23,7.47%,NLRP2B;OTUD4;MFHAS1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.8301671258159556,1.3497356572911026,0.07317073170731707,1.0,1.0,3/10,7.07%,FGFR2;TGFBR1;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6588620214643826,-1.3497355069192427,0.09836065573770492,0.9720598839362109,1.0,4/39,6.44%,EPN1;CBLC;SPRY1;VPS25
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.7807634551036939,-1.3493655829081566,0.12962962962962962,0.9713335484090163,1.0,4/9,18.52%,SIGIRR;APOA1;PTPRC;TLE5
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.7554062085313371,-1.349045644079947,0.12962962962962962,0.9700041234628229,1.0,7/16,17.34%,CLDN4;PINK1;DDRGK1;CTSH;APH1B;PRELID1;PSME1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.7278985393661253,-1.3488171246126677,0.10526315789473684,0.9675676789679475,1.0,3/23,7.58%,SFRP1;NODAL;FOXP1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.6902147501294265,-1.3486408715553162,0.08771929824561403,0.9654983685481695,1.0,1/19,0.21%,SELP
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.8515302000643858,1.3484385095547875,0.06666666666666667,1.0,1.0,2/6,1.72%,PLA2G10;PLCB1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6813029242059964,1.3482921425618528,0.13043478260869565,1.0,1.0,12/28,16.40%,SPHK1;NRP1;VEGFC;HSPB1;GAB1;NUS1;PRKD1;ERN1;VEGFD;PIK3CA;RELA;VEGFA
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7345115218915828,-1.347243996649303,0.16981132075471697,0.9715841902535839,1.0,2/11,9.85%,CLU;LRPAP1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8200051124760122,1.3468040086384094,0.10204081632653061,1.0,1.0,3/8,5.71%,PLA2G10;CHPT1;PLA2G7
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8690418411461369,1.346557680443218,0.08928571428571429,1.0,1.0,3/6,9.63%,NOX5;SLC39A8;CYBRD1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.7311642549218552,1.346527849343625,0.1111111111111111,1.0,1.0,10/19,18.51%,CSF1;CCL5;MSTN;CSF1R;MDK;MTUS1;C5;CMKLR1;IL34;PTK2
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.9231755154984682,-1.3465211688206298,0.0196078431372549,0.9723874380155201,1.0,3/5,7.58%,FGF1;ADAMTS12;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.6122078423602517,1.3458715131920445,0.10638297872340426,1.0,1.0,8/51,11.96%,PLCB1;EGFR;UBE2E2;FGF10;RAD51B;ANKRD17;ESPL1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.8990809385611427,1.3455703126504288,0.1206896551724138,1.0,1.0,1/5,3.94%,WNT5A
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.7746227528821261,1.345044043671865,0.15384615384615385,1.0,1.0,3/11,6.18%,ZFP36;ZFP36L2;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.7519088450992955,-1.3443990611717431,0.11363636363636363,0.9842238957562015,1.0,1/14,0.61%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of SMAD protein signal transduction (GO:0060392),-0.9308845042624319,-1.3443968618716968,0.06521739130434782,0.9807460728029993,1.0,2/5,5.29%,CCN3;PBLD
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.7956076506493003,1.3443344590869926,0.13725490196078433,1.0,1.0,3/8,7.26%,NFIL3;PBX1;TOX
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.7793330902104797,1.3437249620441822,0.17647058823529413,1.0,1.0,3/6,8.29%,FGF10;OPRK1;SGK1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.5963214300218527,-1.343621571561837,0.08771929824561403,0.982570340963955,1.0,11/94,3.78%,PARP2;LDHC;AURKA;GSTM3;CCT6B;PCSK4;RPL39L;CDKN3;PEBP1;NCAPH;MEP1B
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.662385304374827,1.3429360362663088,0.06818181818181818,1.0,1.0,11/30,15.05%,LTK;PIK3R5;IRS1;NYAP2;IGF1R;PIK3C2B;PIK3C2G;PIK3CA;EDN1;PIK3R1;CD160
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.653028362383368,1.3424024793842289,0.08163265306122448,1.0,1.0,12/37,10.41%,B4GALNT2;EFNA5;SMAD7;PKHD1;MEGF10;PTPRG;EPHA7;FUT9;ADA;ZDHHC2;JAG1;TENM3
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7417504582135481,-1.3419500248122886,0.11538461538461539,0.9889873934180227,1.0,2/15,4.99%,AZGP1;HLA-DRA
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.864737835629265,1.3418554813500747,0.12244897959183673,1.0,1.0,1/5,3.52%,CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.8238090973051475,1.3410790450636145,0.041666666666666664,1.0,1.0,3/8,12.96%,ITGAX;PARD3;MYRF
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.8786742121842176,-1.3406219631872553,0.1568627450980392,0.9950804812135868,1.0,2/5,8.13%,SARDH;DMGDH
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8335810785527255,-1.3405996110203326,0.14583333333333334,0.9916442038061155,1.0,1/5,1.16%,CD9
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6910576742214896,-1.3405433240092723,0.12195121951219512,0.9884165574626401,1.0,2/20,6.50%,BUD23;GAR1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.7165486699737483,1.3399004373349834,0.10204081632653061,1.0,1.0,10/19,19.58%,CX3CR1;TOX;SMARCD3;DISP3;MDK;CTNNB1;VEGFA;DISC1;PROX1;DCT
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.5832751125844612,1.3398870792782067,0.07142857142857142,1.0,1.0,16/69,12.66%,SLC12A1;SLC12A3;HCN1;SLC5A12;SLC8A1;SLC6A13;SLC23A1;KCNK1;SLC5A8;SCNN1B;SGK1;SLC4A4;ASIC4;FGF13;ASIC2;SLC24A2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.7748306955704707,1.3394097945585257,0.08,1.0,1.0,5/16,11.91%,FZD1;FRAT2;DVL2;CTNNB1;WNT8A
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.8001673882707455,-1.3391929974427574,0.12962962962962962,0.9938652962355456,1.0,2/9,4.73%,CGAS;B2M
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.7813445316513707,-1.3391450716570064,0.11320754716981132,0.9907745797587422,1.0,1/10,2.31%,NOG
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5689634924302674,1.339074662093424,0.17142857142857143,1.0,1.0,35/109,15.03%,GUCY1A2;LRRC4C;NLGN1;SEMA6D;PCDH17;GFAP;ADGRB3;SLIT2;SLC35F1;PDZRN3;MEGF10;PTPRD;FBXL7;ADGRL3;NPAS3;GLI3;GPM6B;LRP4;NOVA1;ASXL3;PDGFD;LRRC3B;FAT3;ANK2;ZNF536;PPFIA2;RGS7BP;GRIA2;EFS;NOTCH3;RUNX1T1;CSRNP3;MAP2;TMEM178A;MAPK4
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7635603403746483,1.338771069208965,0.2127659574468085,1.0,1.0,2/9,2.39%,MYRFL;HJV
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7518619294423896,1.3386536637245325,0.16,1.0,1.0,6/12,18.14%,STK26;TNIK;RAP2A;RAPGEF6;RAP1A;MAP4K4
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7518619294423896,1.3386536637245325,0.16,1.0,1.0,6/12,18.14%,STK26;TNIK;RAP2A;RAPGEF6;RAP1A;MAP4K4
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8617488448341681,1.3380758950109957,0.14634146341463414,1.0,1.0,1/6,1.71%,RFWD3
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.7824255466150857,1.3380266270347818,0.06666666666666667,1.0,1.0,3/13,6.79%,AP1AR;RAB29;SNCA
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.8091765527890924,1.337836564760333,0.10204081632653061,1.0,1.0,2/10,11.86%,PLA2G10;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.8230089864297803,-1.3376591446651904,0.17647058823529413,0.9981892622015204,1.0,5/9,14.70%,NUPR1;IL10RB;ISCU;PINK1;PRELID1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7987773293570852,1.3372339384358647,0.1276595744680851,1.0,1.0,5/10,17.61%,THRSP;PRKAB2;ACACA;CPT2;SLC25A20
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.6407302016101072,-1.3368315538709787,0.06557377049180328,1.0,1.0,1/44,0.06%,PM20D1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.8066165521532946,1.3366262641371975,0.08771929824561403,1.0,1.0,2/8,9.99%,CCNH;CDK12
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.6125190926354542,1.3363113883895716,0.09090909090909091,1.0,1.0,15/42,17.43%,LOXL2;FGFR2;WNT5A;TGFBR1;HGF;RANBP3L;HIF1A;CTNNB1;FGFR1;MEF2C;TGFBR3;FBXL17;TGFBR3L;LIMS1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.6773876872396543,1.3362191308614695,0.16666666666666666,1.0,1.0,3/23,7.04%,IFI16;HEY1;ZNF675
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.7706391170187232,1.3361972046270698,0.23076923076923078,1.0,1.0,4/12,8.71%,HEY1;SMAD5;BMPR1A;SMAD1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.7030407154544619,1.3354601195195048,0.14285714285714285,1.0,1.0,6/21,9.92%,HEY1;ROBO1;SLIT2;ROBO2;TWIST1;JAG1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.7308570381567928,1.3354146047008548,0.19230769230769232,1.0,1.0,4/14,12.46%,CALCR;ADGRV1;FSHR;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.867840011022152,-1.3352905328389224,0.09090909090909091,1.0,1.0,1/8,0.51%,APOBEC3H
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6203030385852089,1.3349588981136344,0.1276595744680851,1.0,1.0,8/45,6.34%,ACE2;IL1RAPL1;NLGN1;NRXN1;NRP1;GRID2;CNTNAP2;PTPRD
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.8243428909259363,-1.3346478769788541,0.11764705882352941,1.0,1.0,1/6,0.61%,NUPR1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.5225031178608166,-1.3345711114737797,0.05660377358490566,1.0,1.0,66/181,25.91%,SURF6;SBDS;UTP11;DDX27;EXOSC10;RPF2;RPLP1;PDCD11;NOP14;RPL37A;RPL28;LAS1L;NOLC1;NOP16;RPS15;RPL4;RPL12;RPL34;NOP56;RPL31;RPS27;EMG1;RPL8;NVL;RPL19;RPL23;RPL5;MRTO4;RPL7A;MPHOSPH10;RPL38;PAK1IP1;RPL24;RPS24;RPL6;DDX54;RRP1B;RBIS;RPL29;FBL;POP5;NOM1;RPL13;NOL8;EXOSC4;RPL11;EIF6;RPL35A;RPL10A;RPL37;RPLP2;RPS14;RPS25;DHX29;RPS6;WDR75;NOP58;RRP1;RAN;KRR1;PELP1;UTP14A;RPL27A;NPM1;SDAD1;RPL18
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.7744228371501497,1.334261195165325,0.12727272727272726,1.0,1.0,5/12,18.60%,ZFP36;UBP1;MID2;IFITM3;TRIM32
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.619593223185758,1.3340422625683381,0.11627906976744186,1.0,1.0,6/29,8.64%,NLGN1;CEL;SYNJ2;SYT1;SNCA;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.8091841755352297,-1.3339917140433384,0.16071428571428573,1.0,1.0,4/10,14.70%,CYP19A1;TRIAP1;DBI;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.6052080861142988,-1.3338836657911395,0.06451612903225806,1.0,1.0,19/75,18.79%,PLK4;DDX11;AURKA;CXCR5;KIF20B;GIPC1;NUDT16;DRD3;NSFL1C;BTC;SOX15;INO80;XRCC3;RANBP1;CEP295;E2F7;WIZ;NPM2;GPSM2
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.8919237225873057,-1.3337714509192826,0.08928571428571429,1.0,1.0,1/5,1.12%,RTF1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5638856854397719,-1.3336143072348383,0.061224489795918366,0.9993342467843822,1.0,13/67,9.89%,CLDN4;CBLC;SH3RF2;CD9;EPAS1;HEBP2;ADIRF;DUOXA1;DNPH1;CLDN1;LTBR;PKP1;GYPC
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.8558044505258704,1.3335240650226248,0.061224489795918366,1.0,1.0,2/6,7.48%,PTPRD;FRS2
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),0.8380750400858572,1.333433570255829,0.09090909090909091,1.0,1.0,2/6,11.01%,ABHD4;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.7343140332191267,1.3328889013904575,0.075,1.0,1.0,7/19,13.04%,ELAPOR2;SULF1;ACVR2A;BMPR1A;CRB2;SMAD2;SOX11
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.6161451882553511,-1.3327264101813114,0.08163265306122448,1.0,1.0,3/55,6.10%,STING1;ATG14;UBC
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.776240515391396,1.3326362938205352,0.1,1.0,1.0,7/18,11.89%,HS6ST3;CSGALNACT1;HS3ST5;HS2ST1;HS3ST3B1;UGDH;EXT1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.7400955987405884,1.3325903179037468,0.125,1.0,1.0,1/14,1.11%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.7599082646054901,-1.3325395802952307,0.1320754716981132,0.999765672601881,1.0,1/8,1.73%,CLU
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.9046333970747701,1.3325177724843291,0.13043478260869565,1.0,1.0,1/7,3.94%,WNT5A
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.801172469378907,-1.3321430445153497,0.12727272727272726,0.9990394953538609,1.0,3/13,0.74%,NCKAP1L;INHA;SFRP1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.764672793233455,-1.3314505394260037,0.11538461538461539,0.9997816204753518,1.0,1/9,2.10%,HK2
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.7390137150081089,1.331170869443521,0.2033898305084746,1.0,1.0,7/11,22.45%,WNT5A;SMAD2;CHD7;WNT8A;TGFBR3;SMAD4;TGFB3
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5891842009404161,1.3309721900175933,0.16666666666666666,1.0,1.0,20/79,13.54%,FAT4;SSC5D;MXRA5;SULF1;POSTN;HMCN1;SLIT2;PRRX1;NID2;SYNPO2;PRKG1;ACTA2;ADAMTSL1;PDGFRB;COL5A2;CXCL12;ABI3BP;FLNC;ITGA11;RUNX1T1
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.9026950783844483,-1.3307170082703084,0.05555555555555555,1.0,1.0,1/5,3.79%,GOLGA2
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.9104431742410323,1.330603797000618,0.061224489795918366,1.0,1.0,2/5,7.13%,FAS;GLI3
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.8909558416138399,1.3306032688283218,0.05660377358490566,1.0,1.0,2/6,5.02%,PHACTR1;NRP1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.7951945345255671,1.3305656241453625,0.11627906976744186,1.0,1.0,3/8,13.93%,CCL5;SYK;PREX1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.8577975030053457,1.3305181051310666,0.04878048780487805,1.0,1.0,4/7,10.96%,CALCR;GRM6;PDGFRB;CXCL12
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.6513967380499515,1.3299999041110313,0.0851063829787234,1.0,1.0,9/27,20.29%,PRELP;CHST6;B4GALT1;GLB1;B3GNT2;HEXB;GNS;ST3GAL6;ST3GAL4
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.8514902737286212,-1.3297198174292941,0.10869565217391304,1.0,1.0,1/6,3.23%,RAC1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.6764620705729917,-1.3297169536572535,0.08888888888888889,1.0,1.0,5/28,7.36%,CLDN4;DUOX1;SERPINE1;ADRA2A;CLDN1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.6424642459190473,1.3292728578169366,0.0784313725490196,1.0,1.0,4/32,5.02%,SEMA3C;SEMA5A;SEMA6D;NRP1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.7461531717221843,-1.3291541452762479,0.10526315789473684,1.0,1.0,2/14,9.00%,PLK4;PLK2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),-0.862875652402571,-1.3290424244160404,0.12,0.9983808331744461,1.0,1/5,0.91%,MYB
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.6941557090909444,1.3277696362368323,0.14583333333333334,1.0,1.0,6/18,10.68%,ZFP36;PTPRK;FGFR2;FGF10;PRKD1;MDK
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.5850672662076353,-1.3268682402333627,0.09230769230769231,1.0,1.0,8/68,9.56%,CBLC;SPRY4;UCHL1;SPRY1;LATS2;GADD45A;RGS2;INCA1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.5752280310305643,1.3259442542153719,0.15555555555555556,1.0,1.0,37/131,14.51%,RUNX1;IRS1;PPARG;MAGI2;SMAD7;NRP1;SYNJ2;ATP2B4;SPOP;ACVR2A;NR3C1;CELF2;ATXN1;NR1D2;PTGFR;LDLR;BMPR1A;MMP16;DDAH1;IGF1R;TOGARAM1;DYRK1A;PRKCA;ADGRL2;PDGFRB;PLCB4;PHF3;PTPRM;COL5A2;INPP4B;NFIB;TFPI;F3;SCAF8;BCKDHB;TGFBR3;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.6681793320268792,1.3258190758165307,0.11363636363636363,1.0,1.0,5/24,8.37%,PLCB1;EGFR;UBE2E2;FGF10;ANKRD17
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.8358635012108694,1.3257725296496505,0.14285714285714285,1.0,1.0,3/7,10.56%,ITGAV;DISP3;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.7246040963411408,1.325746870545276,0.14,1.0,1.0,4/15,12.70%,KLKB1;BAG2;LPCAT3;ADAM8
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7703653101481371,-1.3257100072834243,0.14814814814814814,1.0,1.0,7/16,10.49%,CLDN4;HRNR;FLG;FLG2;CLDN1;STMN1;ALOXE3
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7703653101481371,-1.3257100072834243,0.14814814814814814,1.0,1.0,7/16,10.49%,CLDN4;HRNR;FLG;FLG2;CLDN1;STMN1;ALOXE3
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6033765264630171,-1.3255371512175889,0.03636363636363636,1.0,1.0,9/74,6.53%,CD44;SFRP1;FGF1;GTF2F1;FGF20;SHCBP1;SPRED2;POLR2I;FGF7
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.7535622216559204,1.3254173219693248,0.13636363636363635,1.0,1.0,3/16,9.07%,IFI16;XAF1;AIM2
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.7271704148626462,1.3252208554119693,0.16666666666666666,1.0,1.0,2/22,4.37%,ZDHHC11;ZDHHC14
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.7271704148626462,1.3252208554119693,0.16666666666666666,1.0,1.0,2/22,4.37%,ZDHHC11;ZDHHC14
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6119527033192655,1.324882312748054,0.15217391304347827,1.0,1.0,6/30,13.07%,RUNX1;H3-3A;LATS1;NCOA2;KCTD6;EP300
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.6515131694646309,-1.324562160013511,0.1774193548387097,1.0,1.0,8/31,14.81%,NCKAP1L;C2;SPACA3;RAB31;APOA1;AZU1;MYO18A;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.8088860006448684,-1.3245208854071373,0.06521739130434782,1.0,1.0,1/12,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.6939720866400729,-1.324081836573147,0.18181818181818182,1.0,1.0,5/19,11.93%,NEMP1;DCTN1;NSFL1C;AKAP8L;EMD
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.8316985861061291,1.3240144194137669,0.11538461538461539,1.0,1.0,1/8,1.86%,SPX
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.7731883548159354,-1.3239848622512356,0.08928571428571429,1.0,1.0,1/16,0.51%,APOBEC3H
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.7309678690587198,1.3239654378921863,0.13636363636363635,1.0,1.0,2/15,7.30%,KCNC2;MAT2A
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8691742123343784,1.3236965482698047,0.13043478260869565,1.0,1.0,1/5,5.25%,AK3
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8081485859755617,-1.323473640947582,0.13953488372093023,1.0,1.0,2/11,7.06%,DDX11;DTX3L
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.8781527480472918,1.3234243697740415,0.08888888888888889,1.0,1.0,1/5,2.22%,NLGN1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.7274640951524224,1.3233867452087864,0.11363636363636363,1.0,1.0,4/14,17.27%,CCL5;ACKR3;CXCL12;THPO
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7316635392504924,-1.3230277486815631,0.11538461538461539,1.0,1.0,4/10,17.45%,B2M;UBC;ENO1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.7147698699561541,1.3228916150477439,0.125,1.0,1.0,4/17,12.75%,MAP3K11;DVL2;EDN1;SASH1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.6618085942572489,1.322851599123787,0.09302325581395349,1.0,1.0,13/30,19.18%,SNCA;SERF1A;PEX2;RNF139;FBXL3;BTRC;SIRT1;EP300;ISOC2;PLK1;MDM2;CUL3;DERL1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.8186155539438402,1.322655503352041,0.1956521739130435,1.0,1.0,2/7,9.92%,HEY1;JAG1
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.8116400339275384,-1.3225851715744688,0.08333333333333333,1.0,1.0,2/9,7.36%,CLDN4;CLDN1
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.8660568738049366,1.3224470101404489,0.1509433962264151,1.0,1.0,2/5,5.90%,TMEM86B;AGMO
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.7281148514518604,-1.32235728463641,0.15517241379310345,1.0,1.0,4/12,17.38%,NFKBIB;TMSB4X;NFKBIA;PSMD10
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.7362758414402155,1.3223442012284947,0.20930232558139536,1.0,1.0,2/7,7.35%,TWIST1;UBR5
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8405644550557785,-1.321825326818302,0.2033898305084746,1.0,1.0,4/8,13.04%,PDXDC1;ENPP2;CYP1B1;PPT1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.5419629241445243,1.3217333366095765,0.038461538461538464,1.0,1.0,32/122,13.63%,CADM2;RIT2;LRRC4C;KCNC2;LSAMP;OLFM3;GABRB1;LRRTM3;NEGR1;NRXN1;GFAP;ADGRB3;NXPH1;GRM5;AMER2;GRIA4;CA10;ELAVL4;ATXN1;RAB3C;SH3GL2;SYNPR;MRTFB;RBFOX1;LRRC3B;NPY;ASIC2;ZNF536;PPFIA2;RGS7BP;GRIA2;CSRNP3
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.5444698147130386,-1.3210851728882207,0.08,1.0,1.0,74/150,30.94%,SBDS;UTP11;DDX27;EXOSC10;RPLP1;PDCD11;NOP14;RPL37A;RPL28;LAS1L;NOLC1;RPS15;RPL4;RPL12;RPL34;NOP56;RPL31;RPS27;EMG1;RPL8;NVL;DIS3L;RPL19;RPL23;RPL5;MRTO4;RPL7A;MPHOSPH10;RPL38;RPL24;RPS24;RPL6;DDX54;RRP1B;RPL29;FBL;POP5;RPL13;NOL8;EXOSC4;RPL11;RPL35A;RPL10A;RPL37;RPLP2;RPS14;RPS25;RPS6;WDR75;NOP58;RRP1;KRR1;PELP1;UTP14A;RPL27A;NIFK;RPL18;WDR46;RPS2;RRP7A;SNU13;RPL14;UTP15;DHX37;EXOSC6;TBL3;NOC4L;NOB1;RPL3;RPL32;LYAR;NOL6;EXOSC7;RPS16
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.7830694204224824,1.3209452102701458,0.1568627450980392,1.0,1.0,4/12,14.77%,PLA2G10;ABHD4;LPCAT3;PLA2G4C
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.7955999509018493,1.320501598629437,0.19230769230769232,1.0,1.0,3/5,16.53%,FLRT3;PDGFRB;DCHS1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.6867690917238889,1.3204871593040977,0.16279069767441862,1.0,1.0,3/13,12.91%,SLIT2;MDK;MTUS1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.8139805065555525,-1.3204484225934552,0.13114754098360656,1.0,1.0,2/5,10.28%,NOP14;NOP9
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.8139805065555525,-1.3204484225934552,0.13114754098360656,1.0,1.0,2/5,10.28%,NOP14;NOP9
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.8139805065555525,-1.3204484225934552,0.13114754098360656,1.0,1.0,2/5,10.28%,NOP14;NOP9
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6388020384995984,-1.3198216503524582,0.1346153846153846,1.0,1.0,4/27,13.56%,TERF2IP;GAR1;WRAP53;PIF1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.8184888254949871,-1.3195365969981478,0.11764705882352941,1.0,1.0,3/9,14.35%,PARP2;PARP14;PARP1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.7803507956474928,1.3195307200909203,0.11764705882352941,1.0,1.0,1/6,1.16%,SLC26A3
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.7582132301601628,1.318875147691418,0.14893617021276595,1.0,1.0,2/11,5.29%,INPP1;SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7582132301601628,1.318875147691418,0.14893617021276595,1.0,1.0,2/11,5.29%,INPP1;SYNJ2
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.7494075723628818,1.318389494405398,0.13636363636363635,1.0,1.0,6/15,16.55%,TAFA1;CX3CR1;SMARCD3;CTNNB1;VEGFA;DISC1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.7625081121306354,1.318094433329843,0.14893617021276595,1.0,1.0,4/8,14.51%,TGFBR1;RORA;SMAD2;INSIG1
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.7431296285801874,-1.3177297781162864,0.22641509433962265,1.0,1.0,4/14,15.02%,NUPR1;COX7A1;PINK1;UQCC2
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.6524987186780644,1.3171214641008946,0.11904761904761904,1.0,1.0,11/41,11.57%,GALNT3;GALNT8;C1GALT1;GALNT13;MUC20;C1GALT1C1;GALNT7;GXYLT1;MUC6;GCNT3;ST6GALNAC4
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.8753855316496254,-1.3168965368772996,0.125,1.0,1.0,1/6,1.83%,WNT7B
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.7097993950283249,-1.3166291017162928,0.14545454545454545,1.0,1.0,1/17,0.21%,SELP
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.7606786735561679,-1.3165803809933327,0.17543859649122806,1.0,1.0,3/8,4.25%,RTP5;GNAT3;AZGP1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.8455160375448032,1.3163362938089682,0.06666666666666667,1.0,1.0,1/5,3.51%,IMMP2L
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.8604580891334341,1.3160582153830511,0.09803921568627451,1.0,1.0,1/5,1.59%,GRM7
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.7563583686398989,1.3157950888388177,0.1206896551724138,1.0,1.0,4/13,8.76%,NDNF;KCNC2;DDAH1;DDAH2
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.7396608648536063,1.3154998826132955,0.19148936170212766,1.0,1.0,1/10,5.02%,NRP1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.8172707615079206,-1.3150432667531606,0.15384615384615385,1.0,1.0,2/8,9.02%,NCKAP1L;RAB31
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.7511795795506045,1.3144118510880534,0.14814814814814814,1.0,1.0,4/13,8.75%,TMEM86B;PLA2G7;AGMO;DHRS7B
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.9083431203125296,-1.313977443250323,0.10344827586206896,1.0,1.0,2/5,0.74%,INHA;SFRP1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7377750726546672,1.3138066507711113,0.09090909090909091,1.0,1.0,8/14,23.53%,ZFP36;ZFP36L2;CPEB3;NANOS1;TNRC6C;ZFP36L1;CNOT7;TOB1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7377750726546672,1.3138066507711113,0.09090909090909091,1.0,1.0,8/14,23.53%,ZFP36;ZFP36L2;CPEB3;NANOS1;TNRC6C;ZFP36L1;CNOT7;TOB1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.6016719438892825,-1.3137227214237643,0.1864406779661017,1.0,1.0,13/62,14.58%,GOLGA8B;ABRAXAS1;HAUS8;GOLGA2;TUBGCP5;GOLGA8A;TUBGCP2;TPX2;GOLGA8N;TOGARAM2;WRAP73;GOLGA8M;INO80
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.8880923860148241,1.3136435472808472,0.13333333333333333,1.0,1.0,3/5,9.92%,ZFPM2;BMPR1A;JAG1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.7567329598729876,-1.3135524266246212,0.14814814814814814,1.0,1.0,3/6,12.30%,DHX58;UFD1;C1QBP
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7908475568776225,1.3134071642973153,0.1282051282051282,1.0,1.0,2/7,5.02%,RIT2;NRP1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7594658463266203,1.312892499752446,0.06818181818181818,1.0,1.0,8/14,15.18%,SLC12A1;SLC12A3;SLC8A1;SCNN1B;ATP12A;SLC12A2;SLC9A1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.7960050244678818,-1.3128138841063304,0.11290322580645161,1.0,1.0,1/11,0.51%,APOBEC3H
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.8042217451130815,-1.3124336484116434,0.20930232558139536,1.0,1.0,3/7,10.89%,HLA-DRA;CR1;IL4I1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.5995697382926896,1.3117356696385623,0.15555555555555556,1.0,1.0,3/49,4.20%,VAPB;IFI16;CCL5
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.75955655961302,-1.3116564140049396,0.13559322033898305,1.0,1.0,3/14,9.46%,AOAH;CALM1;MGAM
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.6994127212362207,1.3114820339459028,0.2222222222222222,1.0,1.0,8/14,16.40%,NTF3;VEGFC;IL16;VEGFD;CDH13;CXCL12;F3;VEGFA
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.587775680228469,1.3111732491581911,0.10204081632653061,1.0,1.0,14/68,12.66%,VAPB;CCL5;SLC8A1;PKHD1;ATP2B4;SNCA;TRDN;TMTC2;TMEM203;NPTN;CXCL12;ANK2;EDN1;SLC24A2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7038935893593653,-1.3110964584124407,0.12962962962962962,1.0,1.0,4/14,17.65%,DECR2;CRAT;ACOX3;ACOX2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6406623005866697,1.3110307713304505,0.1276595744680851,1.0,1.0,9/24,19.68%,CHSY3;CSGALNACT1;CHSY1;UGDH;CHST7;CSGALNACT2;CHST11;VCAN;CHST15
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8341326591284368,1.3109655622033936,0.1694915254237288,1.0,1.0,2/5,11.76%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8341326591284368,1.3109655622033936,0.1694915254237288,1.0,1.0,2/5,11.76%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.7253867578422091,-1.310572460017928,0.1509433962264151,1.0,1.0,2/17,1.83%,GSTM5;GSTM3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.7253867578422091,-1.310572460017928,0.1509433962264151,1.0,1.0,2/17,1.83%,GSTM5;GSTM3
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.7031611233527055,-1.3103775804935773,0.16363636363636364,1.0,1.0,3/10,14.73%,SLX4;ERCC1;XRCC3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.7031611233527055,-1.3103775804935773,0.16363636363636364,1.0,1.0,3/10,14.73%,SLX4;ERCC1;XRCC3
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.7031611233527055,-1.3103775804935773,0.16363636363636364,1.0,1.0,3/10,14.73%,SLX4;ERCC1;XRCC3
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8228097691935113,-1.3098443243882667,0.12280701754385964,1.0,1.0,2/7,6.10%,B2M;UBC
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8228097691935113,-1.3098443243882667,0.12280701754385964,1.0,1.0,2/7,6.10%,B2M;UBC
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5813803302090137,-1.309609301502683,0.15384615384615385,1.0,1.0,9/55,8.23%,CLDN4;CBLC;TMEM184A;SH3RF2;ANO1;GPR39;PRLR;CLDN1;BTN3A1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.7380440364532994,1.3095822946220765,0.125,1.0,1.0,6/14,16.05%,FGFR2;GLI3;SOX11;RARB;SALL1;PKDCC
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.5090141539905878,1.3095149219477145,0.13333333333333333,1.0,1.0,38/163,15.03%,PMP2;SGK2;SGK3;FGFR2;CREB5;LRRTM3;NRXN1;PEX5L;GFAP;ANLN;KIF6;SLC39A12;TMEM63A;GRM5;ENPP6;AMER2;CA10;SLC1A2;DLG2;MBP;MYO1D;GPM6B;SYNPR;ST18;TF;RGS7BP;TSPAN15;MYRF;GRIA2;OLIG1;SORBS1;FASN;MOBP;SLCO1C1;GABRG1;SLC25A38;TMEM178A;MAPK4
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6396390030591457,-1.3086815559963119,0.1509433962264151,1.0,1.0,4/26,13.56%,TERF2IP;GAR1;WRAP53;PIF1
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.8496045291030523,-1.3086600366658951,0.0851063829787234,1.0,1.0,1/5,0.38%,SLC19A3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.7521938453015009,1.3084787371355668,0.15384615384615385,1.0,1.0,2/8,3.37%,SPX;SPHK1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.8239937437731291,1.3084776030805476,0.19672131147540983,1.0,1.0,2/5,13.82%,PPARG;ABHD5
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.8693632100852715,-1.3074818466141054,0.09615384615384616,1.0,1.0,3/6,10.91%,ARR3;DRD3;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.8143124194294105,1.3074224308751112,0.14,1.0,1.0,2/8,6.53%,ENPP1;ERRFI1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.9220879610044435,-1.3068316101888735,0.10638297872340426,1.0,1.0,1/5,0.74%,SFRP1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.8486221296594061,-1.3066782267997201,0.06976744186046512,1.0,1.0,1/7,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7291306555358724,1.3064970813813392,0.16326530612244897,1.0,1.0,3/12,8.32%,IRS1;IRS2;SOCS2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7291306555358724,1.3064970813813392,0.16326530612244897,1.0,1.0,3/12,8.32%,IRS1;IRS2;SOCS2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.7171917038334569,-1.306383760509558,0.21052631578947367,1.0,1.0,2/18,6.25%,CYP19A1;CYP21A2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.7591968981112804,-1.3058480816965332,0.125,1.0,1.0,3/12,6.17%,FIP1L1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5870434832429587,-1.3055340115752154,0.12244897959183673,1.0,1.0,1/77,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.7527389108984199,-1.3053747305557242,0.1282051282051282,1.0,1.0,2/9,9.44%,CCN3;HDAC5
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.7122061470202116,-1.3053648963565783,0.10638297872340426,0.9988776883716067,1.0,4/27,4.47%,HLA-DPB1;TNFSF18;FGL1;CD4
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.8479105796651701,-1.3052035648154752,0.1875,0.9971032352645408,1.0,2/6,6.67%,CRH;ADRA2A
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.6966133534304888,1.3048945643343448,0.14285714285714285,1.0,1.0,3/11,10.55%,DGAT2;ZNF516;ARID5B
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.7326682567696015,-1.3047227343377716,0.171875,0.997636173177699,1.0,2/14,2.31%,SFRP1;NOG
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6059296461530211,-1.304347575613129,0.08333333333333333,0.9971314493765863,1.0,5/47,3.96%,P2RY10;CD9;SPAG4;CD74;CD37
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.8176903209550921,1.3043181881575034,0.14583333333333334,1.0,1.0,2/6,13.91%,KANK1;ARHGAP24
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.8555373810424931,1.30412644078178,0.14893617021276595,1.0,1.0,4/5,10.35%,RUNX1;HMGB1;GLI3;ZBTB7B
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.7665701344635296,-1.3037586982184677,0.16666666666666666,0.9981772739399307,1.0,4/11,15.70%,SPRED3;SPRED2;HIC1;SPRED1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.6945010742750815,-1.3033830902285781,0.20408163265306123,0.9978453413093298,1.0,2/23,5.06%,TERF2IP;ERCC1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.6592212062626674,1.3033103955664929,0.06818181818181818,1.0,1.0,9/34,14.98%,SLC12A1;KCNJ3;SLC12A3;KCNJ16;KCNJ6;KCNK9;KCNJ2;ATP12A;SLC12A2
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.7411386634704956,1.302940597479356,0.20454545454545456,1.0,1.0,3/11,9.49%,CXXC4;COBL;SMAD2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.6672130693161711,-1.3026509970893494,0.15789473684210525,0.9997629939956385,1.0,4/31,5.99%,ACOT1;ACOT11;ACOT4;ACOT12
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.8193811223522276,1.302197849827862,0.20454545454545456,1.0,1.0,4/5,17.12%,CDK6;CDH2;DLL1;BMP6
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.7466893495626346,-1.3018238146016456,0.20754716981132076,1.0,1.0,4/16,6.17%,C2ORF49;TRPT1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7108183031325593,1.3017851492771253,0.18518518518518517,1.0,1.0,1/9,3.68%,NEDD4
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5224359007712598,1.301739005709325,0.11428571428571428,1.0,1.0,48/165,18.77%,DACH1;ENPEP;LOXL2;LRIG3;FAT4;KANK1;MAGI2;EGFR;SULF1;AIF1L;SH2D4A;SNX7;CCN2;RASAL2;PTPRG;MYO1D;CRB2;DDAH1;PLCE1;THSD7A;ADGRL2;CDH13;PARD3B;BCAR1;LIFR;ENAH;NFIB;AMOTL2;PRICKLE2;THSD4;GPRC5A;ARHGAP24;ADAMTS13;NEBL;QKI;MAGI1;TDRD5;VEGFA;WWTR1;DST;PROS1;MID1;PTPRO;SH3BP4;LGR4;GNG12;DOCK5;PHLDB1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.7037025100174347,1.301354959517183,0.12727272727272726,1.0,1.0,5/15,15.51%,IRS1;IRS2;TWIST1;ABHD5;AKT2
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.887316353565867,-1.3011343592872622,0.125,1.0,1.0,3/5,10.68%,OAS3;OAS2;HMGB2
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.8945324320290039,1.3011144811280868,0.14545454545454545,1.0,1.0,2/5,3.76%,CX3CR1;CSF1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.8309194477270037,-1.3009107940096982,0.11320754716981132,1.0,1.0,1/7,2.31%,NOG
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.8477951486095023,-1.3008819316434739,0.14814814814814814,0.9972412390734589,1.0,2/5,4.47%,CD74;CD4
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.8477951486095023,-1.3008819316434739,0.14814814814814814,0.9972412390734589,1.0,2/5,4.47%,CD74;CD4
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.7303948289948597,1.3007456687838168,0.13043478260869565,1.0,1.0,5/12,15.08%,KCNJ3;CACNB2;ANK2;GJC1;KCNA5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.7625915567953171,-1.3004953237764432,0.19148936170212766,0.9964855123735703,1.0,1/15,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.7962725873077692,-1.2993925943740265,0.13636363636363635,1.0,1.0,3/7,10.77%,PLK5;SPI1;DLEC1
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7509025926890003,-1.2989447410365393,0.17777777777777778,0.9971751579419815,1.0,2/8,6.91%,CHTF18;DSCC1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7509025926890003,-1.2989447410365393,0.17777777777777778,0.9971751579419815,1.0,2/8,6.91%,CHTF18;DSCC1
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.7528666483434996,1.2985253106474353,0.20833333333333334,1.0,1.0,4/13,11.18%,DSCAM;CNTN4;NPTN;EMB
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.7889523147359628,-1.2982978858985388,0.14285714285714285,0.9990194186476871,1.0,2/10,4.73%,CGAS;B2M
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.8803675582519439,-1.2981370890597816,0.1864406779661017,0.9971307906670445,1.0,3/5,6.67%,WNT7B;FGF1;PAX8
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.6772857250238672,-1.2970674755326936,0.1276595744680851,0.9986672516956816,1.0,6/18,15.33%,ERCC1;RBX1;GTF2H2;DDB1;PARP1;ERCC2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.6772857250238672,-1.2970674755326936,0.1276595744680851,0.9986672516956816,1.0,6/18,15.33%,ERCC1;RBX1;GTF2H2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5250597279294879,-1.2969884848450437,0.11940298507462686,0.9964181892497472,1.0,28/146,15.15%,SELP;CD9;F8;CLU;F5;SERPINE1;ANXA5;TMSB4X;PCYOX1L;SYT6;CDK5;CFD;CD63;CALM1;SCG3;RAB31;F13A1;SPARC;SELENOP;APOA1;MAGED2;SERPINF2;ITIH4;SYT12;ITGA2B;PDGFA;RAB3A;SRGN
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.7933961993549977,1.2969659299123384,0.22727272727272727,1.0,1.0,3/8,10.67%,PTAR1;RCE1;PGGT1B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.583815368533544,1.2961328256668996,0.14583333333333334,1.0,1.0,22/57,19.50%,SEMA5A;HMGB1;WNT5A;TGFBR1;NRP1;VEGFC;PRKD1;HIF1A;PRKCA;VEGFD;CDH13;MDK;SIRT1;FGFR1;F3;THBS4;PDCL3;VEGFA;PROX1;VASH2;ARNT;AKT3
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.8829223194316401,-1.2960993843002424,0.14285714285714285,0.9995070382880102,1.0,1/5,3.31%,ACOT4
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.7731443024923423,1.2959251450523084,0.16326530612244897,1.0,1.0,2/9,9.44%,CEP120;PCM1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.8035979021018728,1.2958806483224037,0.13725490196078433,1.0,1.0,2/8,10.56%,PPARG;NR1H3
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.6116595782122932,-1.2955058043995216,0.11864406779661017,1.0,1.0,16/52,17.04%,PLK4;HK2;MAP3K6;RABEPK;SORD;LAS1L;NOLC1;NOP16;MCM5;DDX18;PA2G4;NOP56;SUPV3L1;MRTO4;MPHOSPH10;TCOF1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.5427846785853878,-1.295425815206069,0.08333333333333333,0.9985175337293494,1.0,75/163,29.95%,SBDS;UTP11;RRP15;DDX27;EXOSC10;RPLP1;PDCD11;NOP14;RPL37A;RPL28;LAS1L;NOLC1;RSL1D1;RPS15;RPL4;RPL12;RPL34;NOP56;RPL31;RPS27;EMG1;RPL8;NVL;RPL19;RPL23;NAT10;RPL5;MRTO4;RPL7A;MPHOSPH10;RPL38;RPL24;RPS24;RPL6;DDX54;RRP1B;RPL29;FBL;POP5;RPL13;NOL8;EXOSC4;RPL11;EIF6;RPL35A;RPL10A;RPL37;RPLP2;NSA2;RPS14;RPS25;RPS6;WDR75;NOP58;RRP1;KRR1;PELP1;UTP14A;RPL27A;RPL18;LSM6;WDR46;RPS2;RRP7A;SNU13;RPL14;NHP2;UTP15;DHX37;EXOSC6;TBL3;NOC4L;NOB1;RPL3;RPL32
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.739729677334113,1.2952351359112488,0.19148936170212766,1.0,1.0,3/12,17.89%,CSGALNACT1;CSGALNACT2;VCAN
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6192486452919524,1.2949757494339627,0.22727272727272727,1.0,1.0,10/35,12.38%,TRPV2;PDYN;OR3A2;ADGRV1;PCDH15;OPRK1;PTGES;MYO7A;USH2A;TMEM150C
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7749266155542909,1.2947864579408372,0.12280701754385964,1.0,1.0,4/14,9.89%,PPARG;ADIPOR2;ADIPOR1;PRKAB2
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7969266987816103,1.2946373031983898,0.1836734693877551,1.0,1.0,3/6,12.42%,UHRF2;HELLS;ZNF445
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.610516737520938,1.2945191439067048,0.11538461538461539,1.0,1.0,6/30,8.13%,RUNX1;PNP;ZFP36;NAV3;PDE4B;PDE4D
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.7079785169272022,-1.2945181869334959,0.12244897959183673,1.0,1.0,5/21,10.28%,SH3RF2;PPP1R17;ZCCHC9;PPP1R35;PTPA
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.7895120047909386,1.294456895697047,0.22916666666666666,1.0,1.0,1/6,1.90%,NFKBIZ
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.807865321874557,-1.2944194143668104,0.17647058823529413,0.9992564429093375,1.0,2/7,1.87%,SFRP1;ATRAID
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5269794604527909,-1.2934214484146642,0.08771929824561403,1.0,1.0,65/180,26.64%,SDHC;ATP6V1E1;SLC25A3;HSD17B10;PDHX;VDAC2;NDUFC1;ETFB;ATP6V1D;HADHA;ATP1B1;UQCRH;NDUFA1;UQCRC1;ISCU;COX4I1;SLC25A5;NDUFA3;ATP5F1A;ATP5F1B;CYB5A;COX6C;SUPV3L1;NDUFS6;NDUFAB1;TIMM17A;PDHA1;PRDX3;NDUFS2;TIMM50;ATP5F1D;LDHA;ETFDH;RETSAT;NDUFA5;GOT2;AFG3L2;ATP5MC1;PHYH;UQCR10;ATP6V1F;FH;OAT;ATP5MC2;ATP5F1E;MRPS22;COX7B;CYB5R3;TIMM13;SLC25A11;NDUFS8;COX6B1;COX5B;ATP5PD;COX7C;COX7A2;ATP5F1C;MRPS11;MGST3;IDH3G;SUCLA2;UQCRQ;HSPA9;COX5A;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.8063975190458911,1.2932372851869836,0.06779661016949153,1.0,1.0,3/9,7.07%,IRS1;IRS2;TWIST1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6245529651882012,1.293187311506356,0.125,1.0,1.0,10/22,22.48%,PDE4D;RIMS2;PDE3A;PDE2A;AKAP6;EPHA5;CAP1;ADCY2;PDE7B;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.4631405257538501,-1.2928660562259422,0.06349206349206349,1.0,1.0,84/572,14.04%,CD44;APIP;NCKAP1L;NUPR1;SFRP1;TNFSF18;SH3RF2;HMGN5;IL31RA;USP27X;SPDEF;CLU;HCK;PLK3;CIDEB;ASCL1;NTRK1;PLK5;OBSCN;CASP6;CD74;RASGRF2;ANXA5;VAV3;ITGA6;BEX2;FGD3;PDCD5;UTP11;LATS2;AHI1;UBC;DNAJA3;GADD45A;CDK5;PRR7;HTATIP2;DUSP6;PAX8;PRLR;VIP;ANKLE2;BCL2L2;PTMA;DAXX;RFPL1;ANP32E;ATF4;TRIAP1;PLK2;TAF9B;PRAME;TCIM;LRP8;PTPA;RSL1D1;FHL2;NR1H4;PROC;PA2G4;ITGB3BP;PINK1;PIDD1;CRYAB;DDRGK1;IGFBP3;TNFAIP8;CYP1B1;C1QBP;DNM1L;CTSH;PPT1;AZU1;SUPV3L1;IFI6;SFRP4;RACK1;APH1B;MYO18A;CBX4;PIP5KL1;PNMA2;SAP18;IFIT2
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.8810767915171732,1.2920979964003565,0.12244897959183673,1.0,1.0,1/6,4.04%,H6PD
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.8408338214619341,-1.2920444445994956,0.16326530612244897,1.0,1.0,3/5,5.05%,SPRED3;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.7798547931807747,-1.2919967309431095,0.16363636363636364,1.0,1.0,2/7,8.29%,WNT7B;ATF4
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.7870276267261742,-1.291677097440424,0.21739130434782608,1.0,1.0,1/7,4.09%,MAN2B2
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.699340490270549,-1.2913635098022909,0.11764705882352941,1.0,1.0,4/15,12.63%,H1-4;H1-0;CHAF1A;H1-2
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.8129576605772408,1.2904298551495945,0.19230769230769232,1.0,1.0,2/6,4.99%,ITGAM;HPRT1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7508716894851375,1.290008950167507,0.15789473684210525,1.0,1.0,4/12,7.07%,IRS1;PPARGC1A;IRS2;TWIST1
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7499994269598876,1.2899836090764083,0.14285714285714285,1.0,1.0,2/12,5.29%,INPP1;SYNJ2
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.8429704661907891,-1.2895734760618829,0.125,1.0,1.0,1/7,3.79%,GOLGA2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6355041486984193,1.2889763952130622,0.14583333333333334,1.0,1.0,4/28,7.22%,CD151;PTPRK;TRIP6;LAMC2
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.7349158690408126,-1.2879413145289391,0.10416666666666667,1.0,1.0,2/13,6.96%,CYP19A1;HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.7463212212163692,1.287407488566992,0.125,1.0,1.0,2/13,1.24%,EIF3E;C8ORF88
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.6611369966365302,1.2873541693723032,0.1836734693877551,1.0,1.0,6/17,16.81%,NRG1;SLC8A1;ACVR1;MEF2C;VEGFA;ALPK2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7331117584304565,1.2867691602349076,0.14893617021276595,1.0,1.0,5/15,9.72%,CHRM3;SPHK1;CHRM2;PLCE1;KCNB2
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5342968843329174,1.2866874591241928,0.12244897959183673,1.0,1.0,56/150,19.87%,CADM2;TAFA1;EFNA5;GUCY1A2;LRRC4C;LSAMP;OLFM3;TSHZ1;NRXN1;PCDH17;ADGRB3;KCTD16;CYB561;CA10;ELAVL4;ADGRL3;HMGCLL1;TOX;FILIP1;PLCE1;FBXO7;CNTN1;NOVA1;ZDHHC2;ASXL3;RBFOX1;ANK2;PIK3CA;ASIC2;ZNF536;PLEKHA5;PPFIA2;RGS7BP;AKAP6;GRIA2;CSRNP3;TUB;PCLO;HIVEP3;MAP2;MAPK4;FSTL5;ATRNL1;DCLK1;SLC10A4;GFRA2;BRINP1;SLC7A14;ST8SIA3;TMEM59L;LRCH2;PAK5;ADGRA1;STXBP5;CPE;MAPK10
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.7969217502743116,1.2866009748510991,0.24489795918367346,1.0,1.0,1/7,1.31%,RUNX1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.6496774045518455,1.2865866836467443,0.16326530612244897,1.0,1.0,1/24,0.23%,DACH1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7047361115442955,1.2861082707370504,0.14583333333333334,1.0,1.0,4/18,9.69%,PLCB1;CHRM3;CHRM2;GNAQ
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.7261792825076556,-1.2859898030202386,0.14285714285714285,1.0,1.0,4/13,13.77%,MYH14;PVALEF;CCDC78;STAC
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.6453225820692026,-1.2858315747625069,0.22641509433962265,1.0,1.0,6/31,12.84%,TRMO;HSD17B10;DALRD3;TARBP1;METTL6;TRMT112
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.7429678403312875,1.2857653588083053,0.16326530612244897,1.0,1.0,5/10,14.93%,GABRG3;GABRB2;GABRA4;GABRA2;GABRG1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6695930909825858,-1.2857045792323452,0.2,1.0,1.0,2/36,0.56%,NCKAP1L;INHA
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6360802852474341,1.285648929120025,0.1875,1.0,1.0,10/24,16.53%,FAT4;TEAD2;LATS1;DVL2;SAV1;WWC1;MOB1B;AMOTL2;WWTR1;DCHS1
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.7639516241559665,1.285609769206198,0.18181818181818182,1.0,1.0,2/9,6.05%,GLYAT;RIDA
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.9000904100720546,1.2854790347633616,0.11320754716981132,1.0,1.0,1/5,8.48%,MSTN
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.8157866588147348,1.2853583731581595,0.21153846153846154,1.0,1.0,3/6,13.04%,FGFR2;FGFR3;FGFR1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.8639664647629228,-1.2853262893007737,0.10714285714285714,1.0,1.0,4/5,12.62%,SORD;CRYL1;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.8639664647629228,-1.2853262893007737,0.10714285714285714,1.0,1.0,4/5,12.62%,SORD;CRYL1;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.8639664647629228,-1.2853262893007737,0.10714285714285714,1.0,1.0,4/5,12.62%,SORD;CRYL1;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.7640138983994755,-1.2851992329551358,0.23728813559322035,1.0,1.0,2/7,9.26%,GNAT3;ASIC3
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5192862588209728,1.2848779328400521,0.07894736842105263,1.0,1.0,38/155,12.49%,LOXL2;MARVELD3;IL17RD;ALDH1A1;SPX;HS3ST5;IL18R1;CIDEA;ZNF706;ELAPOR2;AGER;EGFR;SMAD7;HEY1;ROBO1;RPS6KA4;HDAC9;PLCL1;ATP2B4;TWSG1;CHSY1;ARRDC3;PTPRG;TLE3;LRP4;NOVA1;ADIPOR1;WWC1;HMGCR;TIMP1;NR1H3;MDK;NPTN;CRHBP;MAP2K6;USF3;RPS6KA6;NFIB
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.8570373699682395,-1.2848698796388522,0.19148936170212766,1.0,1.0,2/5,12.93%,STX1B;BAIAP3
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5585092537252991,-1.2843734459275933,0.16363636363636364,1.0,1.0,8/65,9.53%,STING1;DDX41;CGAS;DHX58;OAS3;POLR3A;OAS2;POLR3E
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.8426335981103961,1.2843711429415372,0.2,1.0,1.0,3/6,14.25%,MEGF10;MSTN;THBS4
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7472145125152597,1.2841590408858627,0.2127659574468085,1.0,1.0,4/8,16.91%,PPP3CA;NFATC2;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7472145125152597,1.2841590408858627,0.2127659574468085,1.0,1.0,4/8,16.91%,PPP3CA;NFATC2;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.8030562400832841,1.2840919513739837,0.17777777777777778,1.0,1.0,2/7,12.46%,LRRC38;AKAP6
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6512276235278461,1.2838017560063801,0.2127659574468085,1.0,1.0,8/15,24.24%,SLC23A1;SLC1A2;ABCC2;SLC12A2;ABCG2;SLC1A3;SLC26A6;CXADR
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.646914750021505,1.2835173128904735,0.125,1.0,1.0,7/25,16.05%,FGFR2;GLI3;COBL;NPY;RARB;SALL1;PKDCC
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.6107597243417837,1.2833774896191454,0.12727272727272726,1.0,1.0,8/30,16.70%,NKAIN2;NEDD4;FGF12;ATP2B4;NKAIN3;ANK3;P2RX7;SLMAP
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.7820503016968975,-1.2831956520910632,0.18518518518518517,1.0,1.0,1/8,0.53%,DDX11
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5821580682273907,1.2827840240711028,0.16666666666666666,1.0,1.0,22/82,15.78%,GALNT3;GALNT8;C1GALT1;GALNT13;GALNTL6;MUC20;C1GALT1C1;ST8SIA6;CRPPA;GALNT7;TMTC2;GXYLT1;MUC6;GCNT3;POMGNT2;ST6GALNAC4;B3GLCT;TET2;MUC16;OGT;B3GNT2;GALNT12
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.7585324957413092,1.2826397760811172,0.1568627450980392,1.0,1.0,2/11,9.07%,IFI16;AIM2
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.8379814299141286,-1.2822278761331114,0.16071428571428573,1.0,1.0,1/6,0.63%,CCN3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.7702785161298353,-1.2819224719462694,0.16666666666666666,1.0,1.0,4/7,16.76%,ENPP2;VIL1;CORO1B;SRC
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.6713999696155819,-1.2818422306569808,0.2459016393442623,1.0,1.0,2/21,0.83%,PARP2;TERF2IP
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.8593338503375652,1.2818009615429744,0.08888888888888889,1.0,1.0,1/5,1.45%,TYR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.5337626329772535,1.2813071477381184,0.17777777777777778,1.0,1.0,21/119,7.67%,PIK3R5;NRG1;CALCR;SEMA5A;ERBB4;IRS1;CASS4;FGFR2;CX3CR1;EGFR;TGFBR1;FGF10;IRS2;GAB1;MYORG;FGFR3;MFHAS1;FRS2;FGF17;FGF5;HGF
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.700992704539878,-1.2812012262583135,0.12727272727272726,1.0,1.0,4/19,8.16%,NCKAP1L;TNFSF18;MADCAM1;ZP3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.7521943973410896,1.2811195794248917,0.2,1.0,1.0,2/20,4.72%,NLRP2B;OTUD4
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.828162098992256,1.2808937213884668,0.21428571428571427,1.0,1.0,1/5,4.72%,OTUD4
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.6620442006691104,1.2808733447473168,0.2222222222222222,1.0,1.0,3/17,10.04%,PLA2G10;SLC15A2;SLC29A2
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.6676240307825961,-1.2808295075240237,0.24074074074074073,1.0,1.0,2/18,4.44%,EEF1AKMT2;KMT2B
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.7940390874973877,-1.2807574614095756,0.2037037037037037,1.0,1.0,2/8,6.67%,NOG;PAX8
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.7940390874973877,-1.2807574614095756,0.2037037037037037,1.0,1.0,2/8,6.67%,NOG;PAX8
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7465834951638393,-1.2807465377640213,0.20833333333333334,1.0,1.0,4/13,13.36%,SFRP1;GPC3;RNF213;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.8504306341526324,1.2801930904544332,0.1590909090909091,1.0,1.0,2/6,7.73%,SPX;RNLS
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.6745633043680369,-1.2800507509827328,0.14634146341463414,1.0,1.0,1/19,0.56%,BUD23
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8218246442278043,-1.2790917116446152,0.2,1.0,1.0,1/6,4.44%,KMT2B
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.7002079472552115,1.2785794416717475,0.17777777777777778,1.0,1.0,3/13,15.05%,KLRD1;CADM1;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7002079472552115,1.2785794416717475,0.17777777777777778,1.0,1.0,3/13,15.05%,KLRD1;CADM1;CD160
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.6163953457126019,-1.278478316709705,0.14285714285714285,1.0,1.0,16/37,27.67%,RPS27L;SURF6;NOP14;RPS15;RPS27;EMG1;RPS24;NOM1;RPS14;RPS25;RPS6;MRPS11;NPM1;LSM6;RRP7A;SNU13
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5688516591935353,1.2784146427126521,0.15555555555555556,1.0,1.0,29/100,13.63%,GUCY1A2;RGMA;LSAMP;MAGI2;NRXN1;PCDH17;ADGRB3;UNC5D;SLC35F1;GRID2;ROBO2;GRIA4;PTPRD;ADGRL3;RAB3C;CTNNA2;GPM6B;SH3GL2;CNTN1;NOVA1;ASXL3;RBFOX1;CPT1C;FAT3;ANK2;GJC1;GRIA2;RUNX1T1;CSRNP3
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.6202084002887622,1.2783580846688265,0.16071428571428573,1.0,1.0,9/29,13.68%,THRSP;ADIPOR2;ZBTB20;ADIPOR1;C3;ASXL3;PRKAB2;CREB1;SORBS1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.7585571256335074,1.2781887245935595,0.17543859649122806,1.0,1.0,1/10,1.86%,SPX
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.8239803633863236,1.278148111973113,0.16071428571428573,1.0,1.0,3/6,14.33%,PPP3CA;MSTN;EYS
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5662777111852225,-1.2778687490540495,0.1206896551724138,1.0,1.0,7/56,4.26%,CLDN4;CBLC;TMEM184A;CD9;SPDEF;CD74;CEBPD
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.7073614045955188,1.2777033488729996,0.12727272727272726,1.0,1.0,4/14,13.82%,PPARG;ITGAV;NR1H3;ABHD5
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.8520629875116839,1.2774135223584038,0.1509433962264151,1.0,1.0,2/6,9.25%,MFHAS1;TLR1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8988363130967495,1.2772925235706787,0.10869565217391304,1.0,1.0,3/5,5.02%,SEMA5A;DSCAM;NRP1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7009258741747182,1.277223366873781,0.17777777777777778,1.0,1.0,4/14,11.75%,HDAC9;HDAC3;HDAC2;SIRT1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6998367275895938,1.276816804037302,0.17647058823529413,1.0,1.0,3/10,10.81%,KCNC2;PDE3A;PDE2A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6260356627037151,1.276491663088311,0.11627906976744186,1.0,1.0,5/29,8.37%,PLCB1;EGFR;UBE2E2;FGF10;ANKRD17
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.669258840442091,1.2757221735185829,0.1276595744680851,1.0,1.0,2/19,2.22%,KANK1;NLGN1
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),0.8421852139606498,1.2756334091757184,0.20833333333333334,1.0,1.0,1/5,4.20%,SULF1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.721096393685994,1.2751602716064316,0.14285714285714285,1.0,1.0,8/15,18.53%,ENPP6;GDPD3;PRDX6;PLA2G4C;SMPD4;GPCPD1;PNPLA6;ABHD12
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.8627824255856895,-1.2750140823860074,0.16,1.0,1.0,1/6,0.74%,SFRP1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.7476901636376114,1.2749602888392053,0.2727272727272727,1.0,1.0,1/8,2.81%,LAMB4
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.7482687714550524,-1.2746126566126126,0.18461538461538463,1.0,1.0,1/8,2.49%,CACNG5
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.7482687714550524,-1.2746126566126126,0.18461538461538463,1.0,1.0,1/8,2.49%,CACNG5
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.6459365162184774,1.2745737662585301,0.21153846153846154,1.0,1.0,11/26,16.48%,ZFPM2;ENPP1;WNT5A;ZFP36L2;RORA;SIRT1;FOXO1;RUNX1T1;ASXL1;SMAD3;WWTR1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.544081421648871,1.274423761739344,0.10256410256410256,1.0,1.0,25/79,14.14%,ESRRG;FRK;ERBB4;ATP6V0A4;CYP4Z1;HYDIN;MUC20;SLC5A8;RP1;BBOX1;SCNN1B;ATP6V0D2;TMEM213;EXPH5;PROM2;KCNJ16;JAG1;CFAP65;ITGB8;PPIL6;PACRG;DCDC1;TMEM150C;AVPR1A;SLC22A6
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.684909660245325,1.2740697168378337,0.2,1.0,1.0,2/17,7.08%,CHMP6;PDCD6IP
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.6505406952601903,-1.2737823426066475,0.10416666666666667,1.0,1.0,4/17,11.69%,HK2;SKP1;CHCHD10;PINK1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.6069239430294825,-1.2737754146337825,0.12,1.0,1.0,4/31,13.56%,TERF2IP;GAR1;WRAP53;PIF1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7723454620434034,-1.2733838832549844,0.18181818181818182,1.0,1.0,4/9,14.70%,TRIAP1;APOA1;DBI;PRELID1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7292994869071232,1.2733388690134835,0.22,1.0,1.0,2/9,3.36%,P3H2;EGLN3
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.6222727160003504,-1.2729248965922486,0.14814814814814814,1.0,1.0,3/32,10.27%,TERF2IP;LEMD2;TPP1
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.847963244656935,-1.2724121299584121,0.2037037037037037,1.0,1.0,3/5,15.17%,STMN1;PBXIP1;MET
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.8298396333071181,-1.2722185972632012,0.14,1.0,1.0,2/6,3.04%,TEKT3;TEKT5
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.6285478820297431,-1.2720464723872973,0.26666666666666666,1.0,1.0,3/27,4.01%,RTF1;COL6A1;NODAL
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.8196614297722831,1.2719497167809373,0.2553191489361702,1.0,1.0,2/6,8.11%,SULF1;EIF2AK3
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8271902556023089,1.2716363667392356,0.1590909090909091,1.0,1.0,2/7,5.81%,CHRM3;ATP2B4
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.7387232980303262,1.2714846525640422,0.2391304347826087,1.0,1.0,2/9,1.54%,B4GALNT2;CSGALNACT1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.5858512063627904,-1.2712419096533982,0.14285714285714285,1.0,1.0,19/51,22.65%,SURF6;RRP15;RPF2;TRAF7;LAS1L;NOP16;RSL1D1;NVL;RPL5;MRTO4;RPL7A;PAK1IP1;RPL24;RPL6;RPL11;EIF6;RPL35A;RPL10A;NSA2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.7909010205815613,1.2710905698875523,0.2127659574468085,1.0,1.0,1/8,3.98%,ROBO1
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.8186189819152097,1.2707205225108738,0.2,1.0,1.0,2/5,10.34%,CDK6;DLL1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.7429749306693489,-1.270522153534453,0.17543859649122806,1.0,1.0,8/13,23.10%,C1QBP;SAP18;SRSF7;RBMX;SRSF10;RNPS1;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7381327146044854,-1.2704719623694005,0.14285714285714285,1.0,1.0,5/9,23.54%,EIF2S2;MCTS1;EIF2S3;EIF4H;DHX29
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.7979690340240759,1.2702703060538358,0.22033898305084745,1.0,1.0,2/7,10.58%,MDGA2;ZC4H2
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.6813781118440162,1.2702443542376483,0.24,1.0,1.0,4/16,8.28%,SLC39A12;SLC30A8;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.5069025498651789,-1.2702428176114717,0.08333333333333333,1.0,1.0,15/169,9.61%,TLCD2;GOLGA8B;SUN3;DYSF;SPAG4;GOLGA2;ZFP69B;TANGO2;GOLGA8A;REEP6;ATP8B4;LEMD2;CR1;NSFL1C;GOLGA8N
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.7060776243840847,1.2699663640007657,0.1590909090909091,1.0,1.0,3/16,7.59%,NLGN1;DOC2B;RAB27A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.666594087640578,1.2693998559874375,0.20833333333333334,1.0,1.0,3/15,8.12%,NLRP2B;CX3CR1;SERPINB1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.7549669000726601,1.2691834935202335,0.24489795918367346,1.0,1.0,3/12,6.79%,LOXL2;MT1M;SNCA
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.7222241333180602,1.2690306571647747,0.2653061224489796,1.0,1.0,6/11,21.50%,ELOVL6;HACD2;TECR;ELOVL7;HACD4;ELOVL2
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.753446424549133,-1.2687987005815198,0.25,1.0,1.0,1/11,0.56%,INHA
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6811571181130098,1.2687774961761322,0.19607843137254902,1.0,1.0,6/22,4.35%,MYBPC3;NRG1;ZFPM2;FGFR2;SMAD7;TGFBR1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.5422152955986086,-1.2684402449332952,0.12962962962962962,1.0,1.0,7/65,9.00%,AURKA;RPS27L;PLK3;FOXM1;GADD45A;TRIAP1;PLK2
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.5530573799807776,1.2682911406540445,0.08163265306122448,1.0,1.0,9/63,12.99%,VAPB;TRDN;EIF2AK3;TRAM1L1;REEP1;TOR1AIP2;LPCAT3;STX18;ALDH3A2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.8962905497396074,1.2682872069377613,0.12,1.0,1.0,2/5,9.25%,MFHAS1;TLR1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.551612948496793,-1.2681367093093066,0.1509433962264151,1.0,1.0,32/96,22.46%,DDX11;NEMP1;DDX12P;INCENP;UCP3;ILF3;PDCD11;NOP14;DHX16;CHAF1A;MCM2;DDB1;GART;ORC1;NCAPD2;HNRNPL;PABPC4;NAT10;GLE1;GTF3C2;EFTUD2;FTSJ3;POLG;DHX38;DDX21;DARS2;EIF3A;ZDHHC5;EIF4G1;SNRNP200;NUP85;TBRG4
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.5009256346074749,1.2672541573538976,0.1111111111111111,1.0,1.0,9/85,7.94%,U2AF1;ZFP36;DXO;PPARGC1A;ZFP36L2;RIDA;NUDT16L1;ERN1;PCBP2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.6010916733518525,-1.266967100519168,0.16071428571428573,1.0,1.0,12/66,10.26%,PLK4;AURKA;CXCR5;PLK3;PLK5;KIF20B;GIPC1;DRD3;CALM1;PLK2;ANKRD53;CETN2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6143373548713101,-1.266616630620337,0.14545454545454545,1.0,1.0,8/47,8.81%,TERF2IP;CGAS;H1-4;PARPBP;H1-0;POLR2I;DAXX;POLR2J
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.7942133485628666,-1.2662454065162076,0.22,1.0,1.0,4/7,17.38%,NFKBIB;TMSB4X;NFKBIA;PSMD10
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.8213448353712519,1.2660685725981071,0.13636363636363635,1.0,1.0,2/7,10.34%,DOCK10;DLL1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.5899670264161258,-1.265130233177941,0.17307692307692307,1.0,1.0,9/52,7.36%,HLA-DPB1;NCKAP1L;SIGLEC1;HCK;AOAH;CD74;HLA-DRA;SPI1;CLDN1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.6479579727606973,1.264885468993364,0.08163265306122448,1.0,1.0,3/23,8.00%,PRELP;CHST6;B4GALT1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.6198370902592144,1.2647015769173529,0.0851063829787234,1.0,1.0,8/35,11.88%,LOXL2;KANK1;ANLN;ZEB2;NRP1;CDH13;PIK3CA;PRSS3
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.7125455037232308,-1.264627026006063,0.24,1.0,1.0,6/20,13.43%,SFRP1;WARS1;ETS1;HTATIP2;TSPAN12;LEP
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.7893466113903483,1.2643814235693989,0.16,1.0,1.0,5/8,15.18%,LEPROTL1;GPM6B;PICALM;COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.7183687596602366,1.2642337435821402,0.2978723404255319,1.0,1.0,2/6,14.31%,MDK;SALL1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.7186885659906666,1.2639071588782338,0.24,1.0,1.0,7/18,17.61%,THRSP;PRKAB2;ACACA;ABCD3;CPT2;SLC2A1;SLC25A20
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.708835884253068,-1.2637339732217432,0.15384615384615385,1.0,1.0,3/21,8.29%,DDX11;NCL;ATF4
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.5305525244061053,-1.263429507341541,0.061224489795918366,1.0,1.0,16/101,6.92%,SLC28A2;CDHR5;TREH;GSTM3;AQP8;BEST4;CASP6;SLC51A;FABP6;CDH17;PLIN2;A1CF;DEGS2;VIL1;COL18A1;CDHR2
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.7574733863405302,-1.2629149977494656,0.21818181818181817,1.0,1.0,2/6,6.56%,REC8;XRCC1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.8530449457925686,1.26276059769876,0.11764705882352941,1.0,1.0,2/5,6.13%,ROBO1;ROBO2
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.8038018599598566,1.2626340654423787,0.27586206896551724,1.0,1.0,2/6,7.43%,PPARGC1A;ZNF516
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.7817539415217766,1.2622592285150338,0.16981132075471697,1.0,1.0,3/6,14.98%,DLG2;CRHBP;SLC12A2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.7817539415217766,1.2622592285150338,0.16981132075471697,1.0,1.0,3/6,14.98%,DLG2;CRHBP;SLC12A2
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5433761773836279,1.262206310025032,0.12244897959183673,1.0,1.0,12/55,14.51%,HMGCS1;CEL;SULT2B1;SULT2A1;FDFT1;HMGCR;LBR;MSMO1;PLPP6;LDLRAP1;INSIG2;INSIG1
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.8409917178734141,-1.2621993333222246,0.25,1.0,1.0,1/5,4.72%,ANO1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.8277114582626606,1.2612256763765974,0.25,1.0,1.0,2/6,5.92%,ERBB4;LATS1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.7682032082961843,-1.2610387281210087,0.19607843137254902,1.0,1.0,5/9,18.36%,H1-4;H1-0;H1-2;CTCF;SMARCA5
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6973862877638877,1.2605527519877366,0.24444444444444444,1.0,1.0,10/13,25.58%,SLC8A1;CDH2;CTNNB1;PIK3CA;DMD;SLC9A1;PTK2;TCAP;RYR2;CAV3
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.7554646119927287,1.2605014752233767,0.1875,1.0,1.0,1/7,1.32%,PNP
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.5679850296638688,-1.2601047095698519,0.1320754716981132,1.0,1.0,13/71,16.68%,STING1;DDX11;B2M;DTX3L;STMN1;HMGB2;PIN1;TXN;KDM4D;NVL;MET;TAF1;VTN
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.6608310185349979,-1.2597228447311248,0.21052631578947367,1.0,1.0,6/17,15.94%,MYB;HLA-DRA;DHX58;MYO18A;PTPRC;LBP
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.594042132397478,1.2595137525034474,0.1111111111111111,1.0,1.0,12/39,17.43%,LOXL2;HEY1;WNT5A;TGFBR1;HGF;HIF1A;CTNNB1;FGFR1;TGFBR3;TGFBR3L;LIMS1;ROCK2
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.6589085988464803,1.2588297396738446,0.18,1.0,1.0,11/22,14.32%,ZFPM2;SMAD7;HEY1;ROBO1;TGFBR1;SLIT2;ROBO2;BMPR1A;SOX11;ACVR1;TGFBR3
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.8219545886617866,-1.258560158222368,0.2909090909090909,1.0,1.0,3/5,14.70%,TRIAP1;DBI;PRELID1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.8054548499789369,1.258343386918682,0.22448979591836735,1.0,1.0,4/6,19.28%,SLC30A10;RELA;ROCK2;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.7831762885228617,1.2580604168173433,0.10869565217391304,1.0,1.0,5/9,14.85%,SYK;MC4R;PRKCA;ADAM8;PLEKHM1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.676663952412223,1.2579050829839529,0.12195121951219512,1.0,1.0,3/13,16.38%,ITPKB;IP6K2;IPPK
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6683119802938192,1.2578785086508486,0.16279069767441862,1.0,1.0,6/15,8.18%,ZFPM2;RUNX1;ERBB4;FGFR2;TGFBR1;BMPR1A
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.7901418899983045,-1.257058292294013,0.17777777777777778,1.0,1.0,5/9,19.82%,MAP1LC3B2;MAP1LC3A;NPRL2;MAP1LC3B;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.7901418899983045,-1.257058292294013,0.17777777777777778,1.0,1.0,5/9,19.82%,MAP1LC3B2;MAP1LC3A;NPRL2;MAP1LC3B;GABARAPL2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6063315049666204,1.2570254309605726,0.1956521739130435,1.0,1.0,8/32,11.68%,CERS3;SCEL;WNT5A;HDAC2;ACER1;JAG1;USH2A;CTNNB1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.7043640707013934,1.2565797867493993,0.22448979591836735,1.0,1.0,6/11,19.39%,RP1;CRB2;MYO7A;VEGFA;BBS4;RPGRIP1L
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.857525648592205,1.2561097841649898,0.16666666666666666,1.0,1.0,5/6,14.26%,SLIT2;NRP1;ROBO2;PTPRM;ALCAM
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.7487331803673878,-1.2560461354242285,0.2608695652173913,1.0,1.0,1/8,6.09%,HENMT1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.796177759391544,-1.255459260446151,0.1568627450980392,1.0,1.0,2/6,4.20%,ST6GALNAC2;ST6GAL1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.8369223147040072,1.255078125127914,0.30612244897959184,1.0,1.0,2/5,9.14%,ADIPOR2;ADIPOR1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6313322774357405,-1.254968877333654,0.17543859649122806,1.0,1.0,3/27,11.71%,HLA-C;B2M;ACE
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4861146143607734,-1.2547751545693335,0.07142857142857142,1.0,1.0,14/286,4.74%,CD44;INHA;TERF2IP;TEC;FGF1;NTRK1;RAC1;CD74;ENPP2;FGF20;NODAL;CD4;ATG14;IL11
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.7973532611563121,-1.2539623301632803,0.19642857142857142,1.0,1.0,3/6,13.46%,HK2;PINK1;TOMM7
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7948499507894589,-1.2538749119760906,0.17307692307692307,1.0,1.0,1/5,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.7532454608020055,1.2538587760852151,0.1111111111111111,1.0,1.0,1/6,2.56%,FGFR2
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.769194898314532,-1.2525138905365165,0.34146341463414637,1.0,1.0,2/6,15.28%,PNPO;PSAT1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6988606842570972,1.2524410377689688,0.15,1.0,1.0,4/18,9.69%,PLCB1;CHRM3;CHRM2;GNAQ
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.7962826990022717,-1.2519041007866263,0.1875,1.0,1.0,1/6,4.79%,TESMIN
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.6330151201874815,1.2517794629246013,0.14893617021276595,1.0,1.0,7/21,11.89%,HS6ST3;HS3ST5;SULF1;HS2ST1;HS3ST3B1;UGDH;EXT1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.7726532150602878,1.251421699517086,0.24444444444444444,1.0,1.0,3/5,20.83%,TWSG1;CD274;CD55
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.6992096560410976,-1.2511890035922333,0.19607843137254902,1.0,1.0,2/18,1.16%,CELA2A;CD9
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.6249147723056019,-1.2511420142044098,0.15789473684210525,1.0,1.0,2/27,1.83%,SFRP1;GSTM3
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.5707725281828031,-1.2507978307671015,0.13793103448275862,1.0,1.0,12/64,9.81%,SELP;CD9;TSPAN32;HCK;AOAH;PLK3;MAFG;SPI1;PRAM1;PDE6B;F13A1;PARVG
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.8298359000665778,1.250652939034964,0.23404255319148937,1.0,1.0,2/5,10.34%,DOCK10;DLL1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6666786235260707,1.2502387676284592,0.20408163265306123,1.0,1.0,1/15,1.31%,RUNX1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.47349619879000193,-1.2500780751093832,0.03636363636363636,1.0,1.0,93/276,25.26%,INHA;TYMS;SARS1;WARS1;NFKBIB;ABCF1;TICRR;POLR2I;PAX8;MRPL23;PTMA;RPLP1;POLR3A;RPL37A;POLR2J;RPL28;ORC3;MRPS18B;MCM5;RPS15;MRPL55;RPL4;RPL12;RPL34;RPL31;NT5M;MCM2;MRPS21;POLL;HUS1;PIF1;ORC1;RPS27;RPL8;MRPL9;POLR2G;TOP3A;DRG1;RPS8;RPL19;PABPC4;RPL23;POLR2C;MRPL27;RPL5;RBBP8;RPL7A;KAT5;RPL38;RRBP1;RMI1;KIN;RPL24;RPS24;MRPL51;MRPS18C;RPS3;DTX1;RPL6;RNPS1;CHEK1;CDC6;MRPL37;RPL29;RPL13;RPA3;RPS20;RPL11;RPL35A;RPL10A;EIF4G1;RPL37;ORC6;RPLP2;RPS14;RPS4X;RPS25;GTPBP1;POLE3;ORC2;EEF2;FARSB;IGHMBP2;RPS6;EEFSEC;MRPS11;PTMS;POLR2L;MCM4;EEF2K;SET;CDC7;RPL27A
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.7665714504242463,1.2499545584685043,0.2978723404255319,1.0,1.0,2/6,9.83%,NTF3;TMEM108
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.8345070428038299,1.2498264179540284,0.20833333333333334,1.0,1.0,2/6,7.13%,PNP;GLI3
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7159793252271812,1.2496672765298367,0.14035087719298245,1.0,1.0,8/14,16.49%,IRS1;FOXO3;SCD;FOXO1;PID1;GLDC;LPL;PDK4
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.631067879074507,1.2495177588896564,0.2682926829268293,1.0,1.0,3/14,13.78%,HMGCS1;ACACA;ACSS1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.6362032238656031,1.249145000489264,0.24,1.0,1.0,3/18,8.12%,NLRP2B;CX3CR1;SERPINB1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.5746428208019452,1.249041662274465,0.1590909090909091,1.0,1.0,8/30,10.00%,PBX1;ITGAM;MEIS1;PBX3;CPAMD8;C3;ATF6;MEIS2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.7416288364356869,1.248771321057628,0.23809523809523808,1.0,1.0,3/8,6.13%,FGFR2;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7558956453846274,1.248716555670514,0.2222222222222222,1.0,1.0,6/7,23.87%,ANO7;PLSCR5;PLSCR2;P2RX7;PLSCR4;PLSCR1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.8130550681074447,-1.2485587398157068,0.2,1.0,1.0,1/6,8.17%,RNF213
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8025471917248501,1.248219154820429,0.2653061224489796,1.0,1.0,2/5,12.30%,MTHFS;QDPR
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.7269917811210229,1.2480320961658968,0.2857142857142857,1.0,1.0,3/7,18.95%,CCL5;ANK3;DMTN
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7771183035029894,1.2480287832176709,0.21818181818181817,1.0,1.0,3/8,6.19%,HSPB1;GAB1;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.7521841373889341,-1.2478527509881259,0.2222222222222222,1.0,1.0,1/12,0.61%,NUPR1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.736962872370554,1.2477843691876545,0.2653061224489796,1.0,1.0,1/9,0.45%,FAS
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.6643316357076161,1.2477376209673372,0.23529411764705882,1.0,1.0,5/17,13.68%,PPARG;ZBTB20;DISP3;CREB1;SORBS1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.7894973006801609,1.2477245071762169,0.19047619047619047,1.0,1.0,3/6,11.49%,BATF3;HMGB1;CAMK4
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.775072434010071,1.247193398509237,0.25,1.0,1.0,2/6,19.71%,FHIT;MACROD2
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.8033598621871072,1.246964688736302,0.19148936170212766,1.0,1.0,3/6,6.13%,FGFR2;WNT5A;ROBO2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.7275561370898327,1.2464756331170304,0.21568627450980393,1.0,1.0,4/12,4.78%,MYBPC3;FGFR2;SMAD7;ADAMTS9
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.6500513253097668,-1.2464456036054956,0.125,1.0,1.0,4/29,12.69%,DYSF;NSFL1C;DNM1;DNM1L
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.7987644774494429,1.2462721259091725,0.1590909090909091,1.0,1.0,1/6,1.73%,ALDH1A1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.7911310332425392,1.2462677104655666,0.22448979591836735,1.0,1.0,3/7,13.10%,TGFBR1;JAG1;ACVR1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.685695338624486,-1.2460076740424342,0.21568627450980393,1.0,1.0,4/16,3.03%,P2RY10;CD5;KLRB1;TRBC2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7429585855942399,1.2458820908697137,0.22807017543859648,1.0,1.0,3/7,15.86%,RFX3;FOXO1;BAD
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.6306277684901678,1.2455438945438395,0.11363636363636363,1.0,1.0,11/31,16.54%,SOCS6;ITPKB;PIP4K2A;SOCS2;IP6K2;PIK3C2B;PIK3C2G;PIK3CA;PIK3R1;SOCS4;SMG1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.6895187527029328,-1.245450011073544,0.25,1.0,1.0,1/11,1.67%,EEF1AKMT2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.7177721249434625,-1.245323479389412,0.23728813559322035,1.0,1.0,3/14,2.72%,TXK;TEC;NTRK1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.6764128311209597,-1.2453197164360899,0.16981132075471697,1.0,1.0,5/19,8.00%,CLDN4;DUOX1;ADRA2A;CLDN1;SCARF1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5749919860670146,-1.2452390650654603,0.10638297872340426,1.0,1.0,8/34,15.33%,ERCC1;UBC;RBX1;NTHL1;GTF2H2;DDB1;PARP1;ERCC2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.7868732376707142,1.2451630809229388,0.21568627450980393,1.0,1.0,3/6,5.86%,RUNX1;HMGB1;TWSG1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6623256023512736,1.244929044285852,0.17647058823529413,1.0,1.0,4/12,19.50%,HMGB1;MDK;FGFR1;AKT3
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.6906783326835636,1.2447584624383907,0.23404255319148937,1.0,1.0,4/18,8.80%,SLC22A2;SLC15A2;ABCC2;ABCC11
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5978129392008683,1.2446532175995808,0.14285714285714285,1.0,1.0,10/24,18.35%,PLA2G10;PLCB1;LHFPL2;PDE3A;SMURF2;ACVR1B;TACR1;VEGFA;INHBA;TACR3
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.7077273327480655,1.2445145780739972,0.17307692307692307,1.0,1.0,4/12,11.75%,SLC30A10;CDK6;TWIST1;SIRT1
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.8506974640887663,-1.2444504864786163,0.12962962962962962,1.0,1.0,2/6,3.48%,LCP1;CD74
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.7065700530935135,-1.244074108071367,0.2727272727272727,1.0,1.0,3/16,12.84%,BUD23;NUDT16;TRMT112
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5267455581148125,1.2440500002858002,0.13043478260869565,1.0,1.0,20/75,17.66%,VAPB;CCL5;SLC8A1;PKHD1;ATP2B4;TRDN;TMEM203;NPTN;CXCL12;ANK2;EDN1;SLC24A2;KCNJ2;ATP12A;SLC12A2;SLC9A1;NEDD4L;SLC24A4;STIM1;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.62152181601863,1.2437415984138267,0.18867924528301888,1.0,1.0,9/32,15.20%,RUNX1;CCL5;ZBTB20;HDAC2;RAB27A;CREB1;SCX;SORBS1;VIM
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5802807806399108,1.2433639158260792,0.1111111111111111,1.0,1.0,20/64,15.05%,LTK;PIK3R5;PLCB1;IRS1;IRS2;NYAP2;PLCL1;PLCE1;IGF1R;CSF1R;PDGFRB;PLCB4;PIK3C2B;PIK3C2G;PIK3CA;EDN1;FGFR1;PIK3R1;OGT;CD160
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.6579796273072946,-1.2433420611932229,0.2,1.0,1.0,2/11,6.67%,PACSIN3;ADRA2A
prerank,PanglaoDB_Augmented_2021__Macrophages,0.550236741240663,1.2430552136424187,0.13636363636363635,1.0,1.0,14/97,4.52%,CHIT1;SAMSN1;PIK3R5;ITGAX;HPGDS;MARCHF1;PPARG;STAB1;EGLN3;CX3CR1;CCL5;TGFBR1;ITGAM;SYK
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.6887544621551953,1.242939730871678,0.1896551724137931,1.0,1.0,3/13,16.09%,PPARG;NR1H3;LPL
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.6755140431000655,-1.242933755020131,0.24561403508771928,1.0,1.0,6/15,16.06%,NCL;RBM3;CELF3;CIRBP;SNW1;RBMX
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.6441332069601041,-1.242696668453891,0.2153846153846154,1.0,1.0,6/20,16.06%,NCL;RBM3;CELF3;CIRBP;SNW1;RBMX
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7585872420161135,1.24247605986264,0.13333333333333333,1.0,1.0,4/10,14.32%,SMAD7;TGFBR1;ACVR1;TGFBR3
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.6020958846032372,1.2421343659430433,0.23404255319148937,1.0,1.0,4/23,6.34%,PLD6;JAM2;SYCP3;CCDC63
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.6381172392625151,-1.2420466523903084,0.21153846153846154,1.0,1.0,3/25,1.25%,P2RY10;TYMS;KLRB1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5317289309342118,1.2418593873044252,0.15,1.0,1.0,27/109,10.78%,LTK;FZD1;NDNF;RIT2;IL1RAPL1;MAGI2;WNT5A;ROBO1;ROR1;SLIT2;EPHA3;ZNF804A;GRIP1;ROBO2;PRKD1;PTPRD;TOX;ABL2;FUT9;PROM2;RETREG3;DVL2;STYXL1;LRRC7;TENM3;MDK;NPTN
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7978393584264254,1.2417825179338404,0.19607843137254902,1.0,1.0,2/6,8.42%,GRM5;TCAF2
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7805598093849158,-1.241310110893639,0.32,1.0,1.0,1/6,0.56%,BUD23
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.5814068783483344,1.2411259059006639,0.23076923076923078,1.0,1.0,6/41,8.52%,HEMGN;PRSS57;TOR2A;FAM117A;B9D2;RASSF1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.5002112241966176,1.2404849281198842,0.12962962962962962,1.0,1.0,21/77,14.30%,PPARG;THRSP;HMGCS1;IRS2;ELOVL6;SCD;NCOA2;TBL1XR1;HDAC3;FDFT1;RORA;NR1D2;SMARCD3;ADIPOR1;HMGCR;ACACA;DISP3;PLPP1;NFYC;FASN;CCDC3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.7792011250562882,1.240474477282289,0.2,1.0,1.0,2/7,6.10%,MCU;MICU1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.6408693749410536,1.2403429370879482,0.1956521739130435,1.0,1.0,4/15,18.55%,TEX14;PLK1;BUB1B;ZNF207
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.6408693749410536,1.2403429370879482,0.1956521739130435,1.0,1.0,4/15,18.55%,TEX14;PLK1;BUB1B;ZNF207
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.6408693749410536,1.2403429370879482,0.1956521739130435,1.0,1.0,4/15,18.55%,TEX14;PLK1;BUB1B;ZNF207
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.734587744172764,1.240232103433606,0.2708333333333333,1.0,1.0,3/9,8.56%,SPX;SLC2A5;DDAH1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.6210726472847926,-1.2398255935342886,0.1875,1.0,1.0,9/42,4.51%,P2RY10;NCKAP1L;CD5;CXCR5;AOAH;TRAF3IP3;CD37;CD4;SLA
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.7374639250161362,1.2398152896569334,0.2549019607843137,1.0,1.0,3/9,11.45%,HPGDS;PTGES;PTGS2
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.8109689970137507,1.2397402799019366,0.22727272727272727,1.0,1.0,2/5,11.75%,AUTS2;SIRT1
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7163864372869446,1.2395789863445237,0.22641509433962265,1.0,1.0,3/8,14.78%,HPRT1;DPYD;GMPS
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.746000560105341,-1.2395754175910019,0.26785714285714285,1.0,1.0,4/12,10.31%,ADRA2A;DRD3;ADRA1D;DRD1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6593065596499934,1.2395332968581882,0.14285714285714285,1.0,1.0,5/19,14.77%,PLA2G10;TMEM86B;NR1H3;LPCAT3;PLA2G4C
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.7979679683248821,1.239435492880841,0.2727272727272727,1.0,1.0,2/7,11.25%,ZFP36;DCP1B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.6368070105490857,1.2389993055972368,0.23255813953488372,1.0,1.0,5/14,10.68%,CCL5;NRP1;DOCK4;PDGFRB;MDK
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.7677626780882111,1.2389965714066438,0.20408163265306123,1.0,1.0,1/9,0.64%,STK26
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.7172966020805238,1.2388659245293654,0.25,1.0,1.0,2/9,4.52%,ITGAM;SYK
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.7588971850539589,-1.2386347479076631,0.2777777777777778,1.0,1.0,1/8,2.01%,ENTPD2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7050832648846599,1.2385749562965718,0.2631578947368421,1.0,1.0,4/11,9.16%,PLCB1;IRS1;EIF2AK3;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.7649211497014783,1.2385657759704252,0.16,1.0,1.0,3/12,4.87%,IRS1;PPARG;IRS2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.7559852312380066,-1.237901835580411,0.26,1.0,1.0,1/11,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.7665730686962507,-1.2370627661722629,0.22,1.0,1.0,3/7,4.25%,RTP5;GNAT3;AZGP1
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.7665730686962507,-1.2370627661722629,0.22,1.0,1.0,3/7,4.25%,RTP5;GNAT3;AZGP1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.49364765703945945,1.2360307766560767,0.2222222222222222,1.0,1.0,33/155,13.04%,PIK3R5;NRG1;CALCR;SEMA5A;ERBB4;IRS1;CASS4;FGFR2;MAGI2;CX3CR1;EGFR;TGFBR1;PKHD1;FGF10;IRS2;GAB1;MYORG;FGFR3;MFHAS1;FRS2;FGF17;FGF5;HGF;MSTN;IGF1R;PHLPP2;PHLPP1;PDGFRB;SIRT1;PIK3CA;ADAM8;NRG2;FGFR1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.6359369084468918,1.235734235238752,0.15,1.0,1.0,7/27,15.51%,IRS1;ENPP1;IRS2;PID1;SORBS1;PIK3R1;AKT2
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.49777538789193776,-1.2356903298664774,0.13333333333333333,1.0,1.0,15/232,5.25%,CD44;LOXL4;MMP26;LCP1;COL6A2;COL6A1;COL4A3;ADAM12;ADAMTS15;SERPINE1;COL9A1;ADAMTS12;MMP21;ITGA6;ADAM19
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6831855337735665,1.2351909729715365,0.16,1.0,1.0,13/29,19.36%,PARD3;SYNE4;PDCD6IP;DLG2;CRB2;LRRC7;RAP2A;PARD3B;ERBIN;MTCL1;LIN7A;WDR1;CRB1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.5525462191843962,1.2349214772341384,0.2,1.0,1.0,16/30,26.76%,HMGCS1;FDFT1;HMGCR;LBR;MSMO1;PLPP6;INSIG2;INSIG1;DHCR24;FDPS;SC5D;ACAA2;NSDHL;HSD17B7;MVD;LSS
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.606918591755899,-1.2346532421748988,0.22807017543859648,1.0,1.0,7/38,9.48%,GNAT3;HCK;AOAH;CDHR2;SPI1;DRD3;RGS2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5473422573780101,1.2344549080604306,0.21428571428571427,1.0,1.0,27/100,12.40%,GRM7;LRRC4C;NTF3;NLGN1;CEL;CX3CR1;NRG3;AGER;GRM5;GRID2;GRM8;SYT1;MCTP1;GRIK2;PXK;CDH2;NLGN4X;CHRNB4;GRM6;TMEM108;RIMS2;GRIK1;GRM1;DLGAP1;BTBD9;SYN3;SNCAIP
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.8255717827002547,1.2342567373004636,0.1951219512195122,1.0,1.0,3/5,13.99%,HMGB1;AGER;LGALS1
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.6389389965408259,1.2341955420449788,0.1956521739130435,1.0,1.0,4/16,18.55%,TEX14;PLK1;BUB1B;ZNF207
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7975345780105958,1.234010804587825,0.2549019607843137,1.0,1.0,2/6,6.79%,SLC22A2;SNCA
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.5501294769233525,-1.2339950800650092,0.2,1.0,1.0,25/72,20.53%,AURKA;PSMA7;ANAPC15;ECRG4;PSMD7;UBC;PSMB4;PSMC3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;ANAPC2;PSMA8;FZR1;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7076636228280894,1.2339079027655069,0.20454545454545456,1.0,1.0,3/14,4.00%,ENPP1;SULT2B1;SULT2A1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),0.8664014093955205,1.233502216649066,0.125,1.0,1.0,1/5,3.79%,SMAD7
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.8031613226252758,-1.2333290284045761,0.21052631578947367,1.0,1.0,4/5,18.43%,APOA1;COLEC12;NOTCH4;FLOT1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.6709827343988758,1.2331095294518815,0.18867924528301888,1.0,1.0,5/19,20.05%,PLA2G10;LPCAT3;PLA2G15;ABHD12;SERINC5
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7119829709026768,-1.2329811281559087,0.22807017543859648,1.0,1.0,3/14,6.28%,DUOX1;TRPC3;RYR1
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.6192677373771281,-1.2328314233418463,0.21428571428571427,1.0,1.0,9/34,7.09%,CBLC;DUOX1;CYP2B7P;DUOXA1;AZGP1;C11ORF97;MYH14;SCGB1A1;ZBTB7C
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.7313344199641666,1.2328042520073734,0.21739130434782608,1.0,1.0,2/10,3.94%,FGFR2;WNT5A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.5382729728658634,-1.2325568375941554,0.1320754716981132,1.0,1.0,21/60,20.53%,HLA-C;PSMA7;B2M;PSMD7;PSMB4;PSMC3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),-0.7765908907535208,-1.23247378096394,0.24561403508771928,1.0,1.0,3/5,18.58%,PKP1;NEFL;PKP2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6268935440646317,1.2323905473892212,0.19148936170212766,1.0,1.0,1/21,0.76%,MED17
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.5419991441068298,1.2319163827101718,0.1702127659574468,1.0,1.0,19/124,7.36%,HEMGN;LTK;RUNX1;NTF3;NLGN1;FGFR2;CSF1;SMAD7;HEY1;MOSMO;TRPS1;TGFBR1;EPHA3;RUNX2;CCN2;MEGF10;CDK6;NREP;NR1D2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6068365846227317,1.2317110673966791,0.09302325581395349,1.0,1.0,3/34,4.59%,SKA3;EFNA5;EPHA3
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7592503718158216,-1.2316516531864092,0.23636363636363636,1.0,1.0,1/9,0.61%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.8173048382828518,-1.2308704098839152,0.1702127659574468,1.0,1.0,2/7,9.02%,NCKAP1L;RAB31
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.8173048382828518,-1.2308704098839152,0.1702127659574468,1.0,1.0,2/7,9.02%,NCKAP1L;RAB31
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.7846872690837209,-1.2305131282816937,0.2553191489361702,1.0,1.0,2/6,10.53%,RAB17;NOS2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5711438422403126,1.23048338384459,0.23809523809523808,1.0,1.0,14/35,16.60%,HMGB1;CSF1;CCL5;VEGFC;PLA2G7;MSTN;CSF1R;VEGFD;MDK;CXCL12;CMKLR1;CREB3;VEGFA;IL34
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.7374836142848057,1.2302051341402782,0.28,1.0,1.0,6/11,19.58%,CX3CR1;SMARCD3;CTNNB1;VEGFA;DISC1;DCT
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.6262483680276218,1.229021638110972,0.2222222222222222,1.0,1.0,5/17,16.07%,CYSLTR2;PRKACB;CREB1;CRY1;ADCY2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5772822781197745,1.2288694705962246,0.14893617021276595,1.0,1.0,7/40,9.34%,ACE2;CORIN;SLC8A1;ATP2B4;NPR2;TRDN;ITPR1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.582120897523351,-1.228808620480216,0.2542372881355932,1.0,1.0,1/48,0.28%,STING1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.8041895161175991,-1.2283601975693361,0.20408163265306123,1.0,1.0,1/5,6.22%,SRP54
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.47328921678899033,1.2282516370824512,0.1320754716981132,1.0,1.0,29/218,10.92%,SLC12A1;NOX5;KCND2;KCNH7;TRPV2;KCNC2;KCNQ5;KCNS3;ATP6V0A4;SLC12A3;HCN1;SLC8A1;SLC6A13;SLC30A8;KCNK1;ATP2B4;LRRC38;KCNG3;SLC30A10;SCNN1B;SLC39A8;KCNJ16;TRPC4;SLC4A4;KCNB2;ITGAV;ASIC4;SLC40A1;KCNG1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.5407521730639206,1.228215779134851,0.1276595744680851,1.0,1.0,14/55,12.46%,NDNF;CHRM3;SPHK1;CX3CR1;ACKR3;MCU;MCTP1;ACKR2;EIF2AK3;DDAH1;DDAH2;PLCE1;LAT2;EDN1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6291848465082243,-1.227951363591932,0.22413793103448276,1.0,1.0,6/32,9.27%,CCN3;SFRP1;ADRA2A;RHBDF2;DRD3;MIDN
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.7115268630265238,-1.2274728253591904,0.20754716981132076,1.0,1.0,1/14,0.74%,SFRP1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.5943863460540648,1.227371986071752,0.16666666666666666,1.0,1.0,20/61,18.53%,PLA2G10;PLCB1;PIGP;ENPP6;PLA2G7;PIGA;GDPD3;CSF1R;PRDX6;PDGFRB;PIGV;PLA2G15;PIGW;PLA2G4C;PIGQ;SMPD4;GPCPD1;LCAT;PNPLA6;ABHD12
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.8014318179909067,1.2273283487459827,0.1875,1.0,1.0,3/6,10.87%,PKHD1;PARD3;PARD3B
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.7496398860497023,1.2273231842900254,0.2222222222222222,1.0,1.0,3/6,17.12%,PRKCA;SASH1;BMP6
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.7603202211259494,1.2273043345234027,0.27450980392156865,1.0,1.0,1/8,4.52%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.7603202211259494,1.2273043345234027,0.27450980392156865,1.0,1.0,1/8,4.52%,SYK
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7793219930482614,-1.2272377382588338,0.2777777777777778,1.0,1.0,2/7,9.90%,AQP8;AQP7
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.8782281215896947,1.2271505686646247,0.23076923076923078,1.0,1.0,2/5,10.84%,SLC22A2;SLC7A2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.6057535637350152,-1.2271284001574987,0.20754716981132076,1.0,1.0,5/33,8.23%,HLA-DPB1;TXK;IL1R1;ZP3;BTN3A1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.48989492917858146,1.227062681591676,0.18604651162790697,1.0,1.0,45/218,14.31%,SEMA3C;PLA2G10;EFNA5;SEMA5A;SEMA6D;FGFR2;GFRA1;UNC5C;NRXN1;DSCAM;WNT5A;ROBO1;CNTN4;UNC5D;SLIT2;EPHA3;IRS2;NRP1;PARD3;NRXN3;GAB1;ROBO2;RYK;DOK6;FRS2;EPHA7;CTNNA2;AUTS2;PSPN;PRKCA;NCAM1;NPTN;CXCL12;EMB;PIK3CA;LGR6;SLITRK5;SEMA3B;ENAH;EPHA5;ANK3;NOTCH3;KLF7;LRTM2;PIK3R1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7390568052536037,-1.2270049231291984,0.23076923076923078,1.0,1.0,3/9,17.58%,PGP;TKFC;GK5
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.7306099221933509,1.226977713654268,0.27450980392156865,1.0,1.0,4/11,18.60%,TRIM8;TRIM5;MID2;TRIM32
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.7254691917825412,-1.2267030925385254,0.25925925925925924,1.0,1.0,2/10,5.21%,CACNG5;NPTXR
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.4928266338990621,1.226624752479602,0.11320754716981132,1.0,1.0,31/149,13.29%,CADM2;RIT2;OLFM3;LRRTM3;TSHZ1;NRXN1;ADGRB3;HCN1;NXPH1;GRM5;HIVEP2;PPM1E;GRID2;CNTNAP2;AMER2;GRIA4;CA10;ELAVL4;RAB3C;PRKG1;CTNNA2;SYNPR;PRKCA;RBFOX1;LRRC3B;DLGAP1;PDE1A;ASIC2;SLC24A2;CBLN1;GRIA2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.6893974197369586,-1.2266087670236074,0.20833333333333334,1.0,1.0,2/11,5.49%,SLC25A10;SLC25A3
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.6893974197369586,-1.2266087670236074,0.20833333333333334,1.0,1.0,2/11,5.49%,SLC25A10;SLC25A3
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),-0.8275465917646911,-1.2264361322234532,0.2222222222222222,1.0,1.0,1/5,6.67%,ADRA2A
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.7415702196520159,-1.2263611507756473,0.2916666666666667,1.0,1.0,1/11,0.88%,CSRP2
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.7980378194816486,1.2263177102912914,0.3541666666666667,1.0,1.0,3/6,13.69%,DGAT2;PLCE1;PLA2G15
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6946007574718067,1.2261846796621847,0.2826086956521739,1.0,1.0,2/10,13.06%,PLD6;PID1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.7708308469696943,1.2261041687880883,0.1875,1.0,1.0,3/6,15.95%,SLC22A2;ABCC2;ABCG2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5670612866531923,-1.2260474161981734,0.16071428571428573,1.0,1.0,23/53,23.13%,SDHC;NDUFC1;NDUFB9;NDUFS5;UQCRH;NDUFA1;UQCRC1;COX4I1;NDUFA3;COX6C;NDUFS6;NDUFAB1;NDUFS2;NDUFA5;NDUFA10;UQCR10;NDUFB10;NDUFA12;COX7B;NDUFS8;COX6B1;COX5B;COX7C
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7169952992949016,-1.2257795004012213,0.19607843137254902,1.0,1.0,10/18,23.30%,SPRED3;SPRED2;EIF5A;RPS15;HIC1;RPL23;SPRED1;RPS20;RPL37;UBB
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6266912941138115,1.2255838850531895,0.18604651162790697,1.0,1.0,5/22,10.81%,PNP;NUDT10;HPRT1;PDE4D;PDE2A
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.5591170195157156,1.2254568428757593,0.20930232558139536,1.0,1.0,16/28,26.76%,HMGCS1;FDFT1;HMGCR;LBR;MSMO1;PLPP6;INSIG2;INSIG1;DHCR24;FDPS;SC5D;ACAA2;NSDHL;HSD17B7;MVD;LSS
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.7736316339967296,-1.2251453515677317,0.22,1.0,1.0,2/5,12.30%,SBDS;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.8464935241169721,1.224893686265802,0.2692307692307692,1.0,1.0,2/5,3.68%,SULT2B1;ELAPOR2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.639700226421881,-1.2247845200975294,0.25,1.0,1.0,4/22,14.81%,STX4;RBP4;HMCES;PTPRC
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5935394125285074,1.2244989858704374,0.11627906976744186,1.0,1.0,9/28,14.31%,NRG1;ERBB4;EGFR;GAB1;PRKCA;PIK3CA;ERBIN;NRG2;PIK3R1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.807660447375007,1.224390058731585,0.2222222222222222,1.0,1.0,2/6,5.55%,NRG1;HDAC9
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7032389405875852,1.2242956787214272,0.2558139534883721,1.0,1.0,2/12,11.75%,ATP2B4;SIRT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5298269243836699,-1.2242774804947187,0.11764705882352941,1.0,1.0,21/62,20.53%,HLA-C;PSMA7;B2M;PSMD7;PSMB4;PSMC3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.6804535142471161,1.223863839085238,0.3269230769230769,1.0,1.0,3/12,14.24%,CHST6;CHST7;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.737321875503637,1.2237777291760648,0.2765957446808511,1.0,1.0,3/11,18.94%,ESPL1;NSMCE2;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.737321875503637,1.2237777291760648,0.2765957446808511,1.0,1.0,3/11,18.94%,ESPL1;NSMCE2;CUL3
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.737321875503637,1.2237777291760648,0.2765957446808511,1.0,1.0,3/11,18.94%,ESPL1;NSMCE2;CUL3
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.7560404371900662,1.2234444985952304,0.2558139534883721,1.0,1.0,3/6,19.60%,HEY1;DCHS1;SMAD4
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6694067620730378,-1.2231703858373053,0.24074074074074073,1.0,1.0,11/15,31.18%,ATP5F1A;ATP5F1B;ATP5F1D;ATP5MC1;ATP5MC2;ATP5F1E;ATP5PD;ATP5F1C;ATP5PB;ATP5MC3;VPS9D1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.7707994626147728,-1.2231348671690012,0.24,1.0,1.0,1/7,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.7467562828023698,1.2230068484613015,0.22448979591836735,1.0,1.0,3/6,21.65%,SYK;GAB2;VAMP8
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.6757093427333041,1.2229938665304203,0.29411764705882354,1.0,1.0,3/13,6.77%,BCO1;AKR1C1;RDH10
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5675493788305283,1.222442117087042,0.1568627450980392,1.0,1.0,11/53,10.34%,CD151;RIT2;SPHK1;EPHA3;CD22;PRKD1;MCTP1;SNCA;ABL2;CDH13;DLL1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.7967344299054344,-1.2223583482382778,0.2222222222222222,1.0,1.0,3/6,19.37%,ALOX12B;ABCB11;GPLD1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.6213761438256122,1.2218717847303864,0.21818181818181817,1.0,1.0,7/18,21.44%,DXO;RIDA;FTO;ROCK2;MEX3D;PUM1;YTHDF3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8051297550496892,1.2217738249546757,0.25,1.0,1.0,2/5,10.01%,CHRM3;DOCK4
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.627449636097571,-1.2217187251148058,0.2545454545454545,1.0,1.0,9/32,14.37%,H1-4;INCENP;NCAPH;H1-0;SMC4;AKAP8L;NCAPD3;H1-2;NCAPD2
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.6556439309207867,1.2215627790827517,0.17391304347826086,1.0,1.0,6/10,16.40%,SLIT2;DDAH1;SH3GL2;PDE3A;PDE2A;VEGFA
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.7811399356843962,1.2210564754482736,0.23636363636363636,1.0,1.0,4/5,13.87%,AUTS2;SH3GL2;TMEM108;LLPH
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8308586684580921,1.220863253985859,0.24528301886792453,1.0,1.0,2/5,13.12%,CSGALNACT1;CSGALNACT2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6548541020759621,1.220826077463886,0.24528301886792453,1.0,1.0,4/14,13.35%,HORMAD1;KIF2C;RAD18;SMC5
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.681493136035346,1.2206523407782384,0.2857142857142857,1.0,1.0,2/11,3.17%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.7329995132889525,1.2204805911346561,0.30952380952380953,1.0,1.0,1/5,5.54%,RAB34
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.5322992898125497,-1.2203809284276517,0.20833333333333334,1.0,1.0,15/78,14.84%,INHA;NUPR1;TERF2IP;WARS1;ATG14;ANKLE2;MYADM;NIBAN1;TRAF3IP1;IGFBP3;PRKRIP1;NPRL2;BMP7;PIP5KL1;PRDX3
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.6282372514715917,-1.220349383719517,0.20408163265306123,1.0,1.0,3/28,3.35%,APOD;PLET1;SERPINE1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.7176798621303755,1.220343636338339,0.19607843137254902,1.0,1.0,2/11,11.49%,BATF3;CAMK4
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5248237581137419,1.220255081391794,0.17307692307692307,1.0,1.0,10/64,9.34%,ACE2;SMAD7;CORIN;SLC8A1;ATP2B4;CELF2;NPR2;TRDN;PDE4D;ITPR1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6763544075430958,-1.220215641683667,0.3103448275862069,1.0,1.0,8/14,24.16%,ATP5F1A;ATP5F1B;ATP5F1D;ATP5MC1;ATP5MC2;ATP5F1E;ATP5PD;ATP5F1C
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.5885378244049049,-1.2200201174265624,0.20754716981132076,1.0,1.0,10/25,22.65%,RRP15;RPF2;LAS1L;RSL1D1;DDX18;RPL7A;FTSJ3;EIF6;RPL10A;NSA2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.632330198635108,-1.219000825486925,0.25806451612903225,1.0,1.0,9/35,11.10%,NCKAP1L;LCP1;RAC1;RND3;LLGL2;TRPV4;RND2;RHOBTB2;RHOBTB1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.7075383379594821,-1.2187798286390836,0.2391304347826087,1.0,1.0,2/8,5.55%,BDH1;HMGCL
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.6186527014505646,-1.2184904648673505,0.16326530612244897,1.0,1.0,7/28,12.42%,TPPP3;GOLGA2;TUBGCP5;TRPV4;TUBGCP2;TPX2;PIN1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.5717912837573945,-1.218333049200112,0.18518518518518517,1.0,1.0,23/52,23.13%,SDHC;NDUFC1;NDUFB9;NDUFS5;UQCRH;NDUFA1;UQCRC1;COX4I1;NDUFA3;COX6C;NDUFS6;NDUFAB1;NDUFS2;NDUFA5;NDUFA10;UQCR10;NDUFB10;NDUFA12;COX7B;NDUFS8;COX6B1;COX5B;COX7C
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7492693016329081,1.2179942229365919,0.2549019607843137,1.0,1.0,1/7,0.45%,FAS
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5694523721286788,-1.217916238889281,0.1875,1.0,1.0,8/36,15.33%,ERCC1;UBC;RBX1;NTHL1;GTF2H2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.8219060063292507,-1.2176404424905976,0.2962962962962963,1.0,1.0,1/5,2.12%,FGF1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6498541849424563,1.2173267868882571,0.21428571428571427,1.0,1.0,6/19,8.98%,NLGN1;CEL;NRXN1;NLGN4X;LRP4;LHFPL4
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.6238427537348009,1.2166185764375337,0.2558139534883721,1.0,1.0,6/24,9.92%,CERS3;SCEL;WNT5A;ACER1;EXPH5;JAG1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.6779614339415455,1.2165903819027235,0.24074074074074073,1.0,1.0,2/12,6.80%,ZFP36;ELAVL4
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.686093412826744,-1.2165258288833067,0.2553191489361702,1.0,1.0,1/10,1.73%,CLU
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.7911414073284018,-1.2164622248659371,0.25,1.0,1.0,1/7,2.60%,COL4A3
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.8030501347193725,1.2158672146493736,0.19230769230769232,1.0,1.0,3/6,16.40%,PRKD1;MAPK8;VEGFA
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.801586701265735,-1.2157217311233497,0.29411764705882354,1.0,1.0,4/5,19.85%,CD74;ZP3;CARD9;CD27
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.5610354894174304,-1.2156155885705735,0.11320754716981132,1.0,1.0,25/52,20.53%,AURKA;PSMA7;SKP1;PSMD7;RBX1;PSMB4;PSMC3;RFPL1;PSMD8;GPR132;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;MACROH2A1;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.8198162110243471,-1.2154818508762903,0.25,1.0,1.0,2/6,6.67%,AMH;PAX8
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.5720552559822827,1.215373474542659,0.24444444444444444,1.0,1.0,4/20,6.43%,PNP;HPRT1;FHIT;PPAT
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.7248169245065047,1.2150853083196302,0.2641509433962264,1.0,1.0,1/8,5.80%,GLA
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.6320209902061729,-1.2148585989400749,0.2,1.0,1.0,2/21,7.97%,SFRP1;LTBR
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.6641921751899904,-1.214619132732137,0.19607843137254902,1.0,1.0,1/17,1.43%,DHFR2
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),-0.832190440928651,-1.2144654878615029,0.23529411764705882,1.0,1.0,1/5,1.05%,CYP19A1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.7862643158631213,-1.2144511036118897,0.18,1.0,1.0,1/6,1.83%,GSTM3
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.5958239166704092,1.2143064507687573,0.21739130434782608,1.0,1.0,13/30,24.77%,GABRG3;GRID2;GABRA4;INSYN2A;MEF2C;GABRA2;GABRG1;GRIN2A;MPP2;GABRG2;GABRA5;LRRK2;GRIN2B
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6186465985305788,-1.2142770546383874,0.22033898305084745,1.0,1.0,1/18,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.7332300407617528,1.2142248972216478,0.3018867924528302,1.0,1.0,2/6,11.75%,BAHD1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.5425900924399903,1.2139288768450103,0.19047619047619047,1.0,1.0,23/64,21.34%,IL1RAPL1;CX3CR1;ROBO1;SLIT2;ROBO2;PTPRD;FAIM;SMARCD3;NPTN;CTNNB1;LIG4;SOX11;RGS14;TIAM2;CAPRIN1;SERPINF1;VEGFA;DISC1;PLXNB2;TRIM32;DCT;CUL7;NTRK2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.7332091796153868,1.21386595031589,0.3111111111111111,1.0,1.0,5/9,10.96%,NTF3;VEGFC;IL16;VEGFD;CXCL12
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.541523752354218,1.2138236013756012,0.15555555555555556,1.0,1.0,18/56,16.78%,SLC12A1;GABRR1;GABRB1;SLC12A3;GABRG3;GLRA2;GABRB2;ANO7;GLRB;GABRA4;ANO5;GABRA2;GABRG1;SLC12A2;GABRB3;SLC20A1;SLC37A4;SLC25A30
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.7070147366876636,1.2137700882410645,0.225,1.0,1.0,3/11,7.09%,B4GALNT2;CSGALNACT1;GMDS
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.671355932310119,1.2135700887560799,0.23404255319148937,1.0,1.0,3/13,12.61%,SHISA9;GRIK2;PPFIA3
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.6701682609051567,-1.2134991389869587,0.22448979591836735,1.0,1.0,3/19,5.66%,TEKT3;TEKT5;DNAH2
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.7155827087396386,1.2133810638380549,0.2391304347826087,1.0,1.0,1/5,3.48%,HMGB1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.6171743596817381,-1.2132936554986793,0.24242424242424243,1.0,1.0,5/25,9.40%,KIF25;DCTN1;LLGL2;SPDL1;NSFL1C
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.7140275200480364,-1.2129174501630202,0.22916666666666666,1.0,1.0,5/16,9.27%,CCN3;SFRP1;CRH;ADRA2A;MIDN
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.7398967755374413,-1.2129078435090566,0.23529411764705882,1.0,1.0,5/6,21.49%,CD74;CD70;CARD9;CD27;SLA2
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6283261135773197,1.2125743965590416,0.24528301886792453,1.0,1.0,10/23,18.60%,CX3CR1;RFX3;FAIM;PDE3A;LIG4;SOX11;RGS14;SERPINF1;BAD;TRIM32
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.7366241495060928,-1.2125610213164046,0.19642857142857142,1.0,1.0,2/7,5.06%,TERF2IP;ERCC1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.796782033642675,-1.2120037793484586,0.27450980392156865,1.0,1.0,3/5,17.36%,HSD17B10;SUPV3L1;TRMT10C
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.47608088774104895,1.2118099986380229,0.11363636363636363,1.0,1.0,31/114,10.06%,NDNF;PDZRN4;CADM2;LSAMP;SEMA6D;OLFM3;MAGI2;NRXN1;ADGRB3;CNTN4;SULF1;UNC5D;FGF10;KCTD16;FGF14;ZNF385D;PDZRN3;ROBO2;GRIA4;PTPRD;HFM1;GMPPA;NREP;RAB3C;RAB27A;PCSK2;PRKG1;RSPO2;NOVA1;ASXL3;RBFOX1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),-0.7992417066321832,-1.2116845289570393,0.20754716981132076,1.0,1.0,1/5,0.61%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5343684443246525,-1.2115455601794871,0.21818181818181817,1.0,1.0,13/71,14.37%,DDX11;CYP2D6;AURKA;GTF2F1;GOLGA2;TMC8;IFIT1;LRPAP1;PIN1;TTBK1;RACK1;IFIT2;ACTB
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),-0.8006743225114958,-1.2112357209052682,0.26,1.0,1.0,3/6,14.93%,ALOXE3;ALOX12B;GSTP1
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),-0.8006743225114958,-1.2112357209052682,0.26,1.0,1.0,3/6,14.93%,ALOXE3;ALOX12B;GSTP1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.6896782476509102,-1.2110872092158658,0.2553191489361702,1.0,1.0,3/17,10.72%,DDX11;DAXX;NR1H4
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6339934719835463,1.2109891305178144,0.22727272727272727,1.0,1.0,7/23,15.87%,IRS1;IRS2;C3;SORBS1;PIK3R1;AKT2;BRAF
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6403966522859819,1.2108549946346097,0.16666666666666666,1.0,1.0,8/23,11.47%,ENPP1;MOSMO;KCTD21;GLI3;TULP3;GLIS2;KCTD6;BTRC
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7736060782613645,1.2101620197568574,0.1956521739130435,1.0,1.0,2/8,6.79%,RAB29;SNCA
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.5303287293886672,1.2101415589650228,0.24528301886792453,1.0,1.0,23/67,17.81%,MARVELD3;CADM2;CDH8;CDH20;NECTIN3;PKHD1;CDH18;CDH10;CDH2;NLGN4X;CDH6;CSF1R;CADM1;CDH13;GJC1;CTNND2;PARD6B;AFDN;SMAD3;DCHS1;LIMS2;LIMS1;TJP3
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.6268240775506029,1.2099120918830402,0.16666666666666666,1.0,1.0,1/20,0.27%,ENPEP
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.655097389236395,1.2098297621216747,0.21739130434782608,1.0,1.0,5/14,16.99%,ITGAX;PARD3;RIMS2;MYRF;ATPSCKMT
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.6627215314517905,-1.2090487743975342,0.14814814814814814,1.0,1.0,6/22,16.76%,ANKLE2;CALM1;PTPA;PIN1;CALM3;SRC
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7937108498758156,1.208773223934232,0.23404255319148937,1.0,1.0,1/5,2.63%,ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.7137419993339653,1.2085326153886105,0.2653061224489796,1.0,1.0,5/10,22.89%,ZFP36L2;JAG1;N4BP2L2;HNRNPU;NELFB
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.7185993059103308,-1.2085265724905956,0.2711864406779661,1.0,1.0,3/8,8.00%,APOBEC3H;A1CF;NUDT16
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6072438609105982,-1.2083864279452097,0.22413793103448276,1.0,1.0,10/34,17.38%,CLU;CIDEB;PDCD5;TRIAP1;PINK1;DNM1L;PRELID1;HRK;GHITM;PSMD10
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6816135538619135,-1.2072637073582815,0.1864406779661017,1.0,1.0,3/14,15.08%,ENTPD2;AK8;ENTPD5
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7505896709376793,1.2071607489411302,0.20833333333333334,1.0,1.0,2/5,18.93%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6826871232578882,1.2071296043557573,0.36363636363636365,1.0,1.0,3/18,4.00%,ENPP1;SULT2B1;SULT2A1
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.7792870660730171,1.207020235739307,0.25,1.0,1.0,2/5,12.07%,TIMP1;TIMP3
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.5776515136590846,-1.2069325313962802,0.18867924528301888,1.0,1.0,3/37,1.83%,CLDN4;TMEM184A;WNT7B
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.7418117937414328,1.206872624392977,0.3137254901960784,1.0,1.0,2/8,6.06%,FGFR2;FGFR3
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.7124922354978275,1.2066141643312245,0.29411764705882354,1.0,1.0,3/8,10.95%,PGM5;TMOD1;TMOD4
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.7650796481570004,1.2065122427261143,0.3148148148148148,1.0,1.0,1/6,8.70%,CDO1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.7466697884509006,-1.206326209101634,0.32,1.0,1.0,1/8,0.63%,CCN3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.8048801701536294,-1.2062330488456554,0.2702702702702703,1.0,1.0,2/5,16.93%,POLR3H;BRF1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6700581280236908,1.206091660281266,0.14634146341463414,1.0,1.0,3/15,13.63%,NRG1;SORT1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.611301079651759,1.2060610489349792,0.2619047619047619,1.0,1.0,7/22,21.29%,SPHK1;PRKCA;MEIS2;PPP1R10;MDM2;CUL3;RPS6KB1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.808921348308142,-1.2059133372468769,0.23076923076923078,1.0,1.0,1/5,4.07%,ETS1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7094050192120451,1.2058886805079454,0.28888888888888886,1.0,1.0,2/8,12.44%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7780016507238591,-1.2058748871505984,0.22448979591836735,1.0,1.0,1/5,9.85%,LRPAP1
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.7920399040879126,-1.205378540689379,0.2222222222222222,1.0,1.0,1/5,1.02%,SLC25A10
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.7920399040879126,-1.205378540689379,0.2222222222222222,1.0,1.0,1/5,1.02%,SLC25A10
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.7604799606229754,1.2053081669886672,0.21568627450980393,1.0,1.0,1/5,10.67%,PGGT1B
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7192767536435728,-1.2050282122340221,0.2727272727272727,1.0,1.0,4/11,17.85%,CLU;LIPC;APOA1;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.7071182291715726,-1.2048617580093683,0.2631578947368421,1.0,1.0,2/8,12.13%,SERPINE1;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.6688517487798653,-1.2047864658749479,0.2545454545454545,1.0,1.0,2/16,3.23%,SFRP1;RAC1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.5204980650042169,-1.2045074717899933,0.16417910447761194,1.0,1.0,7/93,5.86%,SELP;TRABD2A;CLU;HCK;WARS1;STX1B;TMC8
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5469339897073644,-1.204417907616665,0.19607843137254902,1.0,1.0,25/57,20.53%,AURKA;PSMA7;SKP1;PSMD7;RBX1;PSMB4;PSMC3;RFPL1;PSMD8;GPR132;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;CHEK1;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.6228000421756806,-1.20400192610828,0.24444444444444444,1.0,1.0,4/23,6.62%,P2RY10;RAC1;PRAG1;SYNPO2L
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7277416321029184,1.2036796879733693,0.34782608695652173,1.0,1.0,4/7,20.84%,NEDD4;COMMD1;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6901312811412017,1.2030059580329504,0.21951219512195122,1.0,1.0,2/10,4.52%,ITGAM;SYK
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.698212835596044,-1.202914773995181,0.35294117647058826,1.0,1.0,3/12,6.25%,NUPR1;CLU;MBTPS2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.48783025928135343,-1.2027439265700286,0.15625,1.0,1.0,9/204,4.47%,TLCD2;EPN1;RTP5;SUN3;DYSF;SPAG4;NEMP1;M6PR;CD4
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.7106569358708332,1.2026578395802214,0.22641509433962265,1.0,1.0,2/9,12.44%,RNF139;STX18
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5432187589485249,1.202476907099087,0.16279069767441862,1.0,1.0,17/55,17.16%,PLA2G10;AKR1C1;ACSM1;HDAC9;CYP39A1;DGAT2;RORA;LDLR;DISP3;NR1H3;SIRT1;CYP7B1;TMEM97;LDLRAP1;INSIG1;LPL;LCAT
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.7958607222207689,1.2024705027052316,0.2,1.0,1.0,1/5,2.21%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.7958607222207689,1.2024705027052316,0.2,1.0,1.0,1/5,2.21%,ENPP1
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.7840389782348738,-1.20220356567927,0.2830188679245283,1.0,1.0,1/5,3.60%,PDZD7
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.7348693536551272,1.2021276020337779,0.3125,1.0,1.0,1/6,0.98%,CALCR
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.803318114772205,-1.20210333228017,0.20930232558139536,1.0,1.0,1/5,5.59%,PNPO
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.7049360091836385,-1.2019838202846163,0.17857142857142858,1.0,1.0,6/10,22.26%,STX4;ANO1;BAIAP3;TRPM4;GPLD1;CFTR
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.8080396330445649,-1.2019256289401679,0.23333333333333334,1.0,1.0,2/5,8.01%,SLC51A;DRD3
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.7027184420594433,1.2018938186371875,0.2391304347826087,1.0,1.0,6/15,16.09%,PLA2G10;C3;ITGAV;SIRT1;FTO;LPL
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.7753545134622024,-1.201720450699961,0.22,1.0,1.0,1/6,5.80%,AHI1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6492456506609217,1.2015951908045808,0.1836734693877551,1.0,1.0,8/17,23.04%,SCD;DGAT2;ACSL4;ACACA;FASN;SLC25A1;FAR2;FITM2
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.7430485353969074,-1.2015019173463444,0.2692307692307692,1.0,1.0,2/8,8.02%,SLC7A7;SLC3A1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5281336220509445,-1.201285509164316,0.14814814814814814,1.0,1.0,4/59,4.18%,NCKAP1L;HCK;RAC1;VAV3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.5281336220509445,-1.201285509164316,0.14814814814814814,1.0,1.0,4/59,4.18%,NCKAP1L;HCK;RAC1;VAV3
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6244083917780358,-1.2005638479536884,0.2857142857142857,1.0,1.0,10/29,21.09%,MAP1LC3B2;ATG14;CALM1;WIPI2;MAP1LC3A;VPS16;RUBCNL;MAP1LC3B;GABARAPL2;VIPAS39
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.732284761254953,-1.2005138382448044,0.2708333333333333,1.0,1.0,1/6,3.68%,STX1B
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.8121772916494373,-1.2003302144268055,0.32142857142857145,1.0,1.0,2/5,12.37%,SF3A2;SF3A1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.8231486323998185,1.2001581465386288,0.3275862068965517,1.0,1.0,1/5,3.76%,CSF1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.757014105815183,1.2000756698604012,0.30952380952380953,1.0,1.0,1/5,5.17%,RPS6KA4
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.6279284763921176,-1.1998249364393039,0.19230769230769232,1.0,1.0,5/28,13.62%,TYMS;BACH1;CDK5;CCNE1;ORC1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.7411164753339733,1.1997322353449786,0.3404255319148936,1.0,1.0,4/9,18.51%,CSF1;CSF1R;IL34;PTK2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.6541888854151583,1.1994558807447746,0.21428571428571427,1.0,1.0,9/24,14.32%,MYBPC3;FGFR2;SMAD7;HEY1;BMPR1A;JAG1;SOX11;MEF2C;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.6577510542557453,1.199263309255948,0.2708333333333333,1.0,1.0,3/12,7.13%,PNP;SYK;GLI3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.4748007570324201,-1.1991902995493282,0.11475409836065574,1.0,1.0,36/358,11.90%,TEKT3;STING1;GOLGA8B;PLK4;MAP1LC3B2;TEKT5;HAUS8;PATL2;GOLGA2;RAB17;ATG14;TUBGCP5;CFAP221;UBXN10;HPS4;RILP;WIPI1;TXNDC15;AHI1;VPS25;LIMD1;TRAPPC6A;GOLGA8A;TUBGCP2;ATP6V1D;DBNL;NSFL1C;GOLGA8N;CIRBP;WIPI2;MAP1LC3A;CFAP52;TRAF3IP1;B9D1;TCTN1;DZIP1L
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.7504832287594531,1.1990306321156043,0.3125,1.0,1.0,3/6,10.56%,PPARG;ARG1;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.7504832287594531,1.1990306321156043,0.3125,1.0,1.0,3/6,10.56%,PPARG;ARG1;NR1H3
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.6651864857964043,1.1989975299967892,0.2777777777777778,1.0,1.0,4/14,15.20%,RUNX1;HDAC2;SCX;VIM
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.6495877654135633,1.1989727731342825,0.25,1.0,1.0,5/16,15.02%,CSF1;ZNF675;CAMK4;GPR137B;TMEM178A
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.6835355171593988,1.1985354911670345,0.3333333333333333,1.0,1.0,6/12,21.50%,ELOVL6;HACD2;TECR;ELOVL7;HACD4;ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6792375698894482,-1.1984314082171523,0.2037037037037037,1.0,1.0,1/13,2.70%,APOD
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.6649142488847267,1.1983822528267525,0.32142857142857145,1.0,1.0,3/11,8.82%,PNP;HPRT1;ADA
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.7780378528255026,-1.198347205022149,0.27450980392156865,1.0,1.0,2/5,14.54%,CRH;AIMP1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5317515836981481,-1.198337512133915,0.2,1.0,1.0,5/60,3.35%,EPN1;ISM1;SARS1;COL4A3;SERPINE1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.6056870366172582,-1.1982819192993897,0.21818181818181817,1.0,1.0,12/33,12.65%,PAH;FGL1;SARDH;ACOT12;CDHR2;AMBP;RBP4;NR1H4;PROC;HPX;TTBK1;APOA1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.6604114078945433,-1.1981028543165593,0.2711864406779661,1.0,1.0,5/16,12.72%,PLK3;PLK5;ZWILCH;PLK2;WEE2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5410071347783334,1.197915605072159,0.18421052631578946,1.0,1.0,9/39,11.50%,ALDH1A1;IL18R1;CIDEA;PLCL1;ARRDC3;TLE3;NOVA1;NR1H3;MAP2K6
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),0.7437815369548151,1.1977167349418163,0.2909090909090909,1.0,1.0,1/5,1.57%,KCNJ3
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),0.7437815369548151,1.1977167349418163,0.2909090909090909,1.0,1.0,1/5,1.57%,KCNJ3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.7640253517902305,-1.1976113991236317,0.23076923076923078,1.0,1.0,1/5,5.83%,MRLN
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.7067899311099277,-1.1975727577938224,0.2982456140350877,1.0,1.0,4/7,17.29%,AGBL3;FOLH1;AGBL1;AGBL2
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.5705907663908812,1.1975505866010667,0.20833333333333334,1.0,1.0,8/27,13.63%,FGFR2;HDAC9;MEGF10;CTNNA2;CDH2;CTNNB1;MEF2A;MEF2C
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.636847281212264,1.1969969502748161,0.2564102564102564,1.0,1.0,6/15,16.91%,PPP3CA;PLCE1;EDN1;NFATC2;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5231073140308237,-1.1966870768450146,0.20408163265306123,1.0,1.0,12/74,12.42%,STING1;DDX41;CGAS;UBE2L6;DHX58;POLR3A;POLR3E;NLRX1;UFD1;POLR3D;TRAF3IP1;PIN1
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.687659991428813,-1.1966125734325246,0.28846153846153844,1.0,1.0,1/11,1.29%,LCP1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.6461095593295535,1.1964999667955987,0.16326530612244897,1.0,1.0,3/13,18.35%,ELP4;MOCS3;DPH3
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.7402257551051868,-1.1964960541623655,0.25925925925925924,1.0,1.0,4/7,22.46%,SUPV3L1;TRMT10C;TRMT10B;TBRG4
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.6721473375901015,-1.1964742192519873,0.23529411764705882,1.0,1.0,4/22,6.74%,CYP19A1;DHRS11;CYP21A2;PRLR
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.7406612004619652,-1.1964327593444413,0.25,1.0,1.0,2/7,15.92%,MTIF3;MCTS1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5424402328015163,1.1962238133144754,0.21818181818181817,1.0,1.0,15/46,14.84%,PLCB1;IRS1;IRS2;PLCL1;PLCE1;IGF1R;CSF1R;PDGFRB;PLCB4;PIK3C2B;PIK3C2G;PIK3CA;FGFR1;PIK3R1;OGT
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.6153527491445269,1.1962152360070306,0.21951219512195122,1.0,1.0,9/20,25.83%,KLRG1;CX3CR1;VEZF1;RELA;GNLY;ADORA2B;C5AR1;ITGB1;ZNF148
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.6763624618399346,-1.195361017082091,0.2558139534883721,1.0,1.0,4/11,8.67%,DCTN1;CLDN1;MYADM;CHCHD10
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.7628435782055322,1.1952132876918176,0.21739130434782608,1.0,1.0,2/6,13.93%,CCL5;PREX1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.5134047432678234,1.1947373503133172,0.15217391304347827,1.0,1.0,24/120,10.18%,ROGDI;PBX1;DDIT4;CX3CR1;SHROOM2;AFF2;CNTN4;SLC23A1;SYNJ2;KLHL17;MEIS1;CNTNAP2;ROBO2;PBX3;CA10;SCTR;ATXN1;ADGRL3;EPHA7;CTNNA2;CDH2;SHROOM4;MEIS2;ADGRL2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5278899783846706,-1.1946607054897496,0.1694915254237288,1.0,1.0,8/67,10.68%,SELP;NLRP1;GBP6;SERPINE1;OAS3;OAS2;NOS2;HMGB2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5470511174226935,-1.1938042351568554,0.19298245614035087,1.0,1.0,4/42,6.55%,TERF2IP;CGAS;PARPBP;RAD51AP1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.5283342390506689,1.19377410309857,0.15517241379310345,1.0,1.0,18/69,17.66%,SLC12A1;SLC12A3;HCN1;SLC8A1;SLC6A13;KCNK1;SCNN1B;SLC4A4;ASIC4;ASIC2;SLC24A2;ATP12A;SLC12A2;SLC9A1;SCNN1D;SLC9A2;SLC24A4;ATP1A2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.7232404022939016,1.193773826765805,0.3090909090909091,1.0,1.0,3/6,11.75%,PPARG;CTBP2;SIRT1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.6872747913618356,-1.193571043001555,0.22448979591836735,1.0,1.0,2/8,9.40%,KIF25;NSFL1C
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.6373433156088254,1.1935569772273318,0.19230769230769232,1.0,1.0,5/17,14.78%,HPRT1;AK3;PPAT;IMPDH1;GMPS
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7707326431621273,-1.1935194329255137,0.2631578947368421,1.0,1.0,2/7,9.90%,AQP8;AQP7
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.696766594453754,-1.1934950245620266,0.28846153846153844,1.0,1.0,1/7,7.44%,SEC62
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.6561175434740392,1.1932521831538423,0.20833333333333334,1.0,1.0,5/18,8.28%,SLC39A12;SLC30A8;SLC30A10;MT1M;SLC39A8
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.8135118370043075,1.1930612736673765,0.26666666666666666,1.0,1.0,2/5,8.28%,SLC39A12;SLC39A8
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5185125952213915,-1.1929837745399368,0.18032786885245902,1.0,1.0,10/73,4.47%,P2RY10;CD5;GEM;TXK;MYB;KLRB1;TRAF3IP3;TRBC2;MAFF;CD4
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),0.8228104111202135,1.1927730464265038,0.1702127659574468,1.0,1.0,1/5,3.37%,SPHK1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.8042366598062547,1.1927396469415257,0.3,1.0,1.0,1/6,8.48%,MSTN
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.7835511719140522,-1.1926666268544783,0.2807017543859649,1.0,1.0,2/6,10.89%,PAH;IL4I1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6889083291399458,-1.1926474233088122,0.32,1.0,1.0,1/10,0.48%,CLDN4
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.659708727697592,1.1922479884006365,0.25,1.0,1.0,4/15,10.48%,NFIL3;PBX1;TOX;IL21R
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.6582469064936036,-1.1913144291076623,0.2641509433962264,1.0,1.0,4/18,13.59%,INHA;ANKLE2;PRKRIP1;BMP7
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.7754571822823126,-1.191184226738907,0.2857142857142857,1.0,1.0,2/6,19.19%,PRPSAP1;PRPSAP2
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.7105574427886535,-1.1910656102763642,0.24444444444444444,1.0,1.0,1/13,0.78%,PARP2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.5087087882165755,1.1904733778975023,0.19047619047619047,1.0,1.0,35/135,13.63%,NKAIN2;CADM2;GDAP1;LSAMP;OLFM3;LRRTM3;MAGI2;NRXN1;ADGRB3;KCTD16;GRM5;AMER2;GRIA4;CA10;PTPRD;LRFN5;ELAVL4;RAB3C;CLGN;DLG2;SH3GL2;NOVA1;SYNPR;ZDHHC2;ASXL3;RBFOX1;FGF13;ANK2;ASIC2;ZNF536;PPFIA2;RGS7BP;ERC2;GRIA2;CSRNP3
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.7512239164721277,-1.1904659367497448,0.30612244897959184,1.0,1.0,1/7,5.42%,PCCB
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.7866796542270792,1.1901837487575433,0.21428571428571427,1.0,1.0,1/5,0.66%,HORMAD1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.7347304008594722,-1.190168132364521,0.35294117647058826,1.0,1.0,1/7,5.06%,ERCC1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.4993085948221335,1.1900934316567238,0.175,1.0,1.0,35/113,17.96%,GUCY1A2;SEMA6D;GFRA1;LDB2;PBX1;SLIT2;CCN2;PDZRN3;MEGF10;PTPRD;LRFN5;FBXL7;ADGRL3;PRKG1;CDO1;LRP4;PRDX6;ASXL3;ADGRL2;ANK2;LIFR;RGS7BP;PRICKLE2;EFS;RUNX1T1;CSRNP3;CCDC3;MAP2;TMEM178A;MAPK4;KCNT2;DCLK1;STOX2;VCAN;BRINP1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.6779966057768867,-1.1898066188416399,0.16666666666666666,1.0,1.0,1/19,0.18%,NOSTRIN
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.7186813009143416,-1.1897619633530516,0.32142857142857145,1.0,1.0,3/10,12.63%,H1-4;H1-0;H1-2
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6914446921482846,1.1897526000619,0.27906976744186046,1.0,1.0,3/9,16.02%,NRXN1;NEUROD2;YWHAZ
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.763305711190995,1.1896321055586976,0.3023255813953488,1.0,1.0,1/8,1.82%,SSC5D
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.5870544338018551,-1.1895868963515608,0.23333333333333334,1.0,1.0,10/40,15.70%,DUSP4;SPRED3;SPRY1;SPRED2;DUSP6;PIN1;CAMK2N1;PTPRC;GSTP1;SPRED1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5038329784193524,1.1895631065881576,0.18421052631578946,1.0,1.0,10/45,9.96%,RALA;IL1RAPL1;RAB9A;CHMP6;SYT1;SNCA;RAB3C;RAB27A;EXPH5;RIMS2
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.5589757060895241,-1.1890668221249479,0.2,1.0,1.0,5/43,5.32%,TEKT3;SPA17;TEKT5;CFAP61;ODAD1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.5564985243742206,1.1889378047957662,0.20512820512820512,1.0,1.0,8/27,14.51%,HMGCS1;FDFT1;HMGCR;LBR;MSMO1;PLPP6;INSIG2;INSIG1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.7010659006736961,1.188862143458286,0.3111111111111111,1.0,1.0,1/8,11.75%,SIRT1
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.7441716704539605,1.1888333727507536,0.28,1.0,1.0,2/6,13.04%,FGFR2;SOX11
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6581355884271575,1.1886292766820246,0.29508196721311475,1.0,1.0,6/11,16.49%,IRS1;AKR1C1;DGAT2;PID1;LPL;PDK4
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6578390069005037,-1.1883391780688275,0.21818181818181817,1.0,1.0,13/25,24.16%,SPG7;MICOS13;DNAJC11;ATP5F1A;ATP5F1B;ATP5F1D;AFG3L2;ATP5MC1;APOO;ATP5MC2;ATP5F1E;ATP5PD;ATP5F1C
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5882813531958739,-1.1882539221411106,0.22413793103448276,1.0,1.0,5/32,7.92%,CSRP2;OBSCN;TPM1;SYNPO2L;ACTC1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5390430524583056,1.1880184388504964,0.1590909090909091,1.0,1.0,17/56,17.16%,PLA2G10;AKR1C1;ACSM1;HDAC9;CYP39A1;DGAT2;RORA;LDLR;DISP3;NR1H3;SIRT1;CYP7B1;TMEM97;LDLRAP1;INSIG1;LPL;LCAT
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.5307309597666499,-1.1876066038979545,0.19607843137254902,1.0,1.0,9/77,9.17%,HLA-DPB1;CD74;KIF4A;HLA-DRA;DCTN1;RILP;KIF5A;ARF1;AP1S1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.6115104507232957,-1.1874491587467144,0.22448979591836735,1.0,1.0,1/25,0.61%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7880861623523493,-1.1873832197328016,0.3269230769230769,1.0,1.0,1/6,0.74%,SFRP1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.7294857599278737,-1.1873477121031932,0.23529411764705882,1.0,1.0,2/6,15.34%,SLC6A20;SLC6A7
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.527400908165161,-1.1870400115958146,0.2127659574468085,1.0,1.0,4/42,6.51%,DDX11;CACNB1;NTRK1;CDK5
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.5731115835141911,1.1869826810502297,0.1891891891891892,1.0,1.0,6/24,14.98%,ESAM;JAM2;MBP;CLDN12;DMD;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.6483907790579462,1.1868912905577358,0.23333333333333334,1.0,1.0,6/18,19.16%,IRS1;IRS2;SORBS1;PIK3R1;AKT2;INSR
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6995089373433652,-1.1864668205882805,0.3076923076923077,1.0,1.0,2/10,6.74%,GHR;PRLR
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.6132095835182414,1.1864229023882844,0.24489795918367346,1.0,1.0,4/18,15.61%,PTPRK;TRIP6;SORBS1;THSD1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.6308313460370584,-1.1864078221844925,0.27450980392156865,1.0,1.0,6/25,5.46%,P2RY10;CD5;KLRB1;TRAF3IP3;TRBC2;ZNF831
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.7810384655118294,-1.1863767077534577,0.3333333333333333,1.0,1.0,1/5,0.81%,TYMS
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7964567881062138,-1.1862499383947904,0.32,1.0,1.0,2/5,17.13%,SLX4;MUS81
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.6360125260994198,-1.186067338552463,0.30357142857142855,1.0,1.0,3/17,3.60%,WNT7B;DACT2;PDZD7
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.4922334456430252,-1.1858235239967048,0.18032786885245902,1.0,1.0,22/98,15.60%,UVSSA;XPC;SLX4;ERCC1;UBC;POLR2I;FANCC;XRCC1;RBX1;PRPF19;POLR2J;COPS6;CETN2;GTF2H2;DDB1;POLL;HUS1;COPS7A;POLR2G;PARP1;ERCC2;POLR2C
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.5388677908940628,-1.1851886431492162,0.16,1.0,1.0,2/53,2.59%,TLCD2;RBP1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.5730423471770623,-1.1849174173040158,0.2037037037037037,1.0,1.0,11/38,19.82%,MAP1LC3B2;ATG14;WIPI1;WIPI2;MAP1LC3A;PINK1;SPATA18;FIS1;CISD2;MAP1LC3B;GABARAPL2
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.7849596127380665,1.1849161158222485,0.3269230769230769,1.0,1.0,3/6,17.87%,GLI3;CHD7;PROX1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.690672238416013,-1.1847043500739434,0.28846153846153844,1.0,1.0,4/8,15.75%,ZNF593;TMSB4X;DDRGK1;TAF1
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.7549675006230915,-1.1846058690463843,0.30612244897959184,1.0,1.0,4/5,24.05%,NOS2;LEP;ABCC4;SLCO2A1
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.46382494743686065,-1.184525062539114,0.15384615384615385,1.0,1.0,34/178,18.38%,PLK4;DEPDC1;AURKA;CDKN3;HMGB3;GINS3;KIF4A;SMC4;RAD51AP1;DSCC1;ILF3;STMN1;ANP32E;NOLC1;KPNA2;MCM5;HMGB2;PA2G4;SPC25;NOP56;CDCA3;CCNE1;MCM2;HUS1;NCAPD2;RANBP1;USP1;CENPE;CKS1B;CTCF;POP7;XRCC6;CSE1L;CBX5
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.6357016888874212,1.1843827554093325,0.2558139534883721,1.0,1.0,4/19,13.63%,NRG1;EDN1;AKAP6;MEF2C
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5786268623249836,-1.1843666067519618,0.18,1.0,1.0,10/46,17.45%,LDHC;HK2;SLC16A8;PDHX;PDHA1;ENO1;GAPDHS;LDHA;NR4A3;PGK1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.703129120084947,1.1843259601988894,0.37735849056603776,1.0,1.0,5/9,20.00%,SELPLG;PID1;RELA;NFKB1;ST3GAL6
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.5264837670119706,-1.1842532286567788,0.1568627450980392,1.0,1.0,9/81,9.17%,HLA-DPB1;CD74;KIF4A;HLA-DRA;DCTN1;RILP;KIF5A;ARF1;AP1S1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.7177443361743354,-1.1839661903364702,0.3333333333333333,1.0,1.0,3/10,10.31%,PAH;DRD3;DRD1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.7440718052163773,-1.1838375631393865,0.3333333333333333,1.0,1.0,5/11,19.35%,PORCN;WIPI1;WIPI2;ALOX12B;ATG10
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.7870223365106268,1.1836231443879004,0.22807017543859648,1.0,1.0,2/5,7.86%,RNF128;LDLR
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7638619363742171,1.1835019907107858,0.34,1.0,1.0,1/7,1.11%,PLA2G10
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6998898360282184,1.1829478001441156,0.34615384615384615,1.0,1.0,3/7,21.48%,MSRA;SMS;ADI1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.7376311615168551,1.1824907232546922,0.36363636363636365,1.0,1.0,3/7,12.49%,CCL5;IDO1;CD274
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.7026409573913056,1.1822226444073984,0.33962264150943394,1.0,1.0,1/7,7.35%,UBR5
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.7826080000979101,-1.1820147773347232,0.26666666666666666,1.0,1.0,3/5,14.47%,NLRP3;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.7826080000979101,-1.1820147773347232,0.26666666666666666,1.0,1.0,3/5,14.47%,NLRP3;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7006666461678216,1.18197528402721,0.27450980392156865,1.0,1.0,3/11,9.92%,CD8A;KLRD1;JAG1
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.7368944293158826,-1.181944679555398,0.22,1.0,1.0,2/6,18.85%,LLGL2;SLC7A5
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.7260839394730263,1.1817575631439092,0.27450980392156865,1.0,1.0,2/8,4.75%,SMAD7;KLF2
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.7752814115069486,-1.181488096915427,0.22916666666666666,1.0,1.0,4/8,19.63%,FBXO43;TOM1L1;BMP7;CHEK1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.5361993101129626,-1.181286721015507,0.20408163265306123,1.0,1.0,2/53,2.59%,TLCD2;RBP1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.619321346220327,-1.181198734088355,0.26666666666666666,1.0,1.0,5/24,13.56%,DDX11;HMGB3;HMGB2;SUPV3L1;PIF1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.6218236422758001,-1.1811444661272,0.2641509433962264,1.0,1.0,2/19,3.19%,NUPR1;CDC37
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.45357866408112024,-1.1810130964507246,0.17307692307692307,1.0,1.0,42/394,9.35%,CD44;HLA-DPB1;TNFSF18;DUOX1;LCP1;IL31RA;TEC;HCK;HLA-C;STX4;PSMA7;TMSB4X;CEBPD;CD4;SLA;B2M;IL11;HLA-DRA;GHR;SKP1;PSMD7;OAS3;UBC;RBX1;PSMB4;PRLR;CCND1;IL3RA;SPI1;PSMC3;EIF5A;IL1R1;LTB;LTBR;IL10RB;IFIT1;EDAR;OAS2;IFI27;ARF1;IFNGR2;F13A1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.7430011069486658,-1.1806744836358076,0.32,1.0,1.0,1/8,0.74%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.6564963996165458,-1.1803717651533479,0.22413793103448276,1.0,1.0,1/13,0.91%,MYB
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.495448941275338,1.1802454983579007,0.20930232558139536,1.0,1.0,16/120,8.84%,SGK2;SGK3;RIT2;SPHK1;NRG3;NEDD4;GFAP;CHPT1;WNT5A;CD22;MLLT3;LATS1;ABL2;SGK1;SOCS2;PLCE1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.5887758378578187,-1.1801943000828476,0.2553191489361702,1.0,1.0,1/37,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.6888440341663753,-1.1801604339682812,0.32653061224489793,1.0,1.0,1/5,4.55%,ATG14
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.7319092981936355,1.1799942141621398,0.25,1.0,1.0,1/7,4.04%,H6PD
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.6756637535429095,1.179992286979858,0.23809523809523808,1.0,1.0,4/16,13.32%,TRPS1;SOX5;MDK;SCX
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.7574493376346948,1.1799835249778883,0.3275862068965517,1.0,1.0,1/5,3.05%,SLC22A2
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.7574493376346948,1.1799835249778883,0.3275862068965517,1.0,1.0,1/5,3.05%,SLC22A2
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6595830160544569,-1.1797427087165595,0.25,1.0,1.0,4/12,15.79%,AHI1;TRAF3IP1;ACTB;FUZ
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.7042971040432351,1.179655949961498,0.2909090909090909,1.0,1.0,2/14,6.54%,AGMO;DGAT2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.49803367100914636,1.1796303902870235,0.1794871794871795,1.0,1.0,25/102,18.03%,KCND2;KCNJ3;KCNH7;KCNC2;KCNQ5;KCNS3;HCN1;KCNK1;LRRC38;KCNG3;KCNJ16;KCNJ6;KCNB2;KCNG1;SLC24A2;KCNK9;KCNJ2;KCNA5;SLC9A1;KCNN1;KCNV1;SLC9A2;SLC24A4;ATP1A2;SLC1A3
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6267990148254309,1.1796091767817933,0.2926829268292683,1.0,1.0,3/16,5.02%,ROBO1;SLIT2;NRP1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6813482054467043,-1.1794615849056298,0.25,1.0,1.0,5/9,21.15%,DHX58;UFD1;C1QBP;TKFC;NPLOC4
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4952472969579038,1.1793443559721593,0.16216216216216217,1.0,1.0,42/162,15.72%,DACH1;NRG1;NDNF;CADM2;KCNH7;NLGN1;GALNT13;OLFM3;FLRT3;ADGRB3;SLC35F1;GRID2;CNTNAP2;MEGF10;SYT1;ADGRL3;FAM171B;HMGCLL1;EPHA7;FUT9;GPM6B;SMAD1;LINGO2;SH3GL2;NOL4;NOVA1;GNL3L;TMEM170B;FAT3;ANK2;SLITRK5;ZNF536;INSYN2A;PPFIA2;ERC2;GRIA2;CSRNP3;MAPK8;MAP2;MAPK4;PLPPR5;ATRNL1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.559595780171958,1.1793332296991876,0.23529411764705882,1.0,1.0,15/42,21.44%,ZFP36;ZFP36L2;RIDA;BTG2;FTO;CPEB3;ROCK2;NANOS1;MEX3D;TNRC6C;ZFP36L1;PUM1;CNOT7;CNOT8;YTHDF3
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.8062950633629016,-1.1793185131309334,0.26666666666666666,1.0,1.0,2/5,8.64%,KIF17;KIF5A
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.8062950633629016,-1.1793185131309334,0.26666666666666666,1.0,1.0,2/5,8.64%,KIF17;KIF5A
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.6718493601479447,-1.1792811171487907,0.33962264150943394,1.0,1.0,2/12,7.89%,TERF2IP;DAXX
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.7761717923295964,1.1789840141025651,0.2653061224489796,1.0,1.0,1/5,3.79%,SMAD7
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.49601998776118195,1.1788437664458933,0.15384615384615385,1.0,1.0,18/68,16.09%,CALCR;PLCB1;KCTD8;GUCY2F;CCL5;RGS6;CAMKMT;TULP3;PLCE1;C3;EDN1;PDE6A;RGS14;CNGB1;METAP1;CNGA1;CRY1;KLK14
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.7901585479625084,-1.1788316333912954,0.3018867924528302,1.0,1.0,1/5,0.74%,SFRP1
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.811915575610435,1.1787488075499255,0.2830188679245283,1.0,1.0,2/6,10.84%,SLC22A2;SLC7A2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6811142732789425,1.1786011597062358,0.20833333333333334,1.0,1.0,3/10,16.40%,DSCAM;MYO7A;VEGFA
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.757375207490226,-1.1785771485516676,0.33962264150943394,1.0,1.0,2/6,17.36%,HSD17B10;TRMT10C
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5905962782829205,-1.1784352797218043,0.24,1.0,1.0,10/47,8.19%,CLDN4;CBLC;PAH;FGL1;FOXM1;RAB17;A1CF;CLDN1;HNF4A;AMBP
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.717128735188893,-1.1782598694090867,0.34545454545454546,1.0,1.0,3/6,20.40%,PINK1;SYAP1;PRR5L
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.7575638647915692,1.1782508741090307,0.2916666666666667,1.0,1.0,3/5,23.30%,MDK;IL34;PTPRZ1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.6694101509301271,1.1780084764880638,0.3148148148148148,1.0,1.0,4/13,15.20%,RUNX1;HDAC2;SCX;VIM
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.6694101509301271,1.1780084764880638,0.3148148148148148,1.0,1.0,4/13,15.20%,RUNX1;HDAC2;SCX;VIM
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.5594943666305174,-1.1779772617189204,0.2826086956521739,1.0,1.0,5/24,14.12%,LDB1;TCEA2;SUPT5H;SUPT16H;CCNT1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.5247251995828007,-1.17790880323134,0.20689655172413793,1.0,1.0,9/77,8.59%,CAMK1G;GEM;KIF1A;UCHL1;SEZ6L2;SPRED2;SST;SLC22A8;VWA1
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.7233512222518237,-1.17779625840738,0.34,1.0,1.0,3/8,12.63%,H1-4;H1-0;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.7233512222518237,-1.17779625840738,0.34,1.0,1.0,3/8,12.63%,H1-4;H1-0;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.7233512222518237,-1.17779625840738,0.34,1.0,1.0,3/8,12.63%,H1-4;H1-0;H1-2
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.7991563603448448,1.1777653042755958,0.22448979591836735,1.0,1.0,1/5,9.25%,TLR1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.7279154404544022,1.1777477463269803,0.2916666666666667,1.0,1.0,4/9,18.73%,SHROOM2;TENM3;VEGFA;C12ORF57
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.5833955379640432,1.1772347824197908,0.3,1.0,1.0,3/25,14.10%,UBE2E2;UBE2E3;UBE2D3
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.6772769700304955,-1.17629154764784,0.34,1.0,1.0,2/9,7.89%,TERF2IP;DAXX
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.6772769700304955,-1.17629154764784,0.34,1.0,1.0,2/9,7.89%,TERF2IP;DAXX
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.6239082096061735,-1.1762444785623982,0.20754716981132076,1.0,1.0,1/17,1.73%,CLU
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.5102154922667571,1.1759075726159636,0.21052631578947367,1.0,1.0,20/69,16.94%,PTPRK;SMAD7;NLK;TGFBR1;PARD3;TWSG1;SMAD5;BMPR1A;SMAD1;SMAD2;SMAD9;SIRT1;SMURF1;ACVR1;GDF10;TGFBR3;LTBP2;SMAD3;TGFBR3L;DUSP22
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.5401997408211558,-1.1758908342588603,0.2391304347826087,1.0,1.0,2/71,1.73%,PM20D1;CLU
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.6351491443881666,1.1757805404786024,0.28,1.0,1.0,4/10,14.98%,CCL5;ADAM8;CYP7B1;SLC12A2
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5192899724425051,-1.1757527349266317,0.1509433962264151,1.0,1.0,4/61,4.18%,NCKAP1L;HCK;RAC1;VAV3
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5653163032464054,1.1753441303197234,0.20454545454545456,1.0,1.0,6/28,10.68%,PLCB1;HMGB1;AGER;SYK;IL16;MDK
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.5217882387385325,-1.1752981106857188,0.19642857142857142,1.0,1.0,14/88,10.64%,PLK4;SFRP1;AURKA;PLK3;PLK5;ANKK1;KIF20B;KNSTRN;NUDT16;IHO1;CALM1;PLK2;CETN2;FBXO43
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.7990322073015332,1.1746105715641013,0.30434782608695654,1.0,1.0,3/5,18.51%,CSF1R;IL34;PTK2
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.7990322073015332,1.1746105715641013,0.30434782608695654,1.0,1.0,3/5,18.51%,CSF1R;IL34;PTK2
prerank,MSigDB_Hallmark_2020__Apical Surface,0.5674473549532665,1.174586810573231,0.22,1.0,1.0,7/34,8.00%,EFNA5;ATP6V0A4;ADIPOR2;SHROOM2;PKHD1;HSPB1;B4GALT1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6856189648844275,1.1745336381397,0.2857142857142857,1.0,1.0,2/9,7.22%,CD151;LAMC2
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.7000417933912051,1.174398683860586,0.3333333333333333,1.0,1.0,8/17,18.51%,CSF1;CCL5;MSTN;CSF1R;MDK;CMKLR1;IL34;PTK2
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7174328495451519,1.174114206653563,0.2777777777777778,1.0,1.0,6/9,23.83%,DNAJB2;SNCAIP;SACS;HSPA1A;BAG5;DNAJB1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6972084966637063,1.17392034779181,0.3333333333333333,1.0,1.0,3/6,19.39%,RP1;BBS4;RPGRIP1L
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.7601495680715351,1.1735373486057838,0.24,1.0,1.0,2/8,2.51%,NDNF;ADIPOR2
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.6020695731375344,-1.1732921373693745,0.3018867924528302,1.0,1.0,3/20,7.46%,DUSP4;DUSP6;DUSP5
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.7797359112807781,1.1728751620311202,0.37254901960784315,1.0,1.0,1/5,3.05%,SLC22A2
prerank,GO_Biological_Process_2021__norepinephrine transport (GO:0015874),0.7797359112807781,1.1728751620311202,0.37254901960784315,1.0,1.0,1/5,3.05%,SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.7321292706787913,1.1728103062909756,0.23404255319148937,1.0,1.0,8/14,18.51%,CSF1;CCL5;MSTN;CSF1R;MDK;CMKLR1;IL34;PTK2
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.7278188495005438,-1.1721818134083963,0.23214285714285715,1.0,1.0,2/7,13.37%,SERPINE1;SERPINF2
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.7838712839451921,-1.1721190326072968,0.26229508196721313,1.0,1.0,2/5,14.78%,PDHX;PDHA1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.6927127839242326,-1.1719436038777638,0.29310344827586204,1.0,1.0,2/5,18.93%,WRAP53;CCT2
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.6927127839242326,-1.1719436038777638,0.29310344827586204,1.0,1.0,2/5,18.93%,WRAP53;CCT2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.760218182949715,1.1717947821240415,0.1951219512195122,1.0,1.0,5/8,20.84%,NEDD4;NEDD4L;HECW2;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.4975000597574638,-1.1716701766788298,0.18867924528301888,1.0,1.0,38/134,20.53%,PLK4;AURKA;HAUS8;PSMA7;DCTN1;SKP1;PSMD7;RBX1;PSMB4;CCND1;PSMC3;RFPL1;SSNA1;TPX2;PRKACA;CETN2;ODF2;TUBB4B;PSMD8;GPR132;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;HAUS5;RAB11A;CKAP5;PSMA8;TUBG1;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.8035606761353534,1.1716495341517708,0.34615384615384615,1.0,1.0,3/5,15.51%,DOC2B;SNCA;AKT2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.7218121850588279,1.171617946103446,0.36363636363636365,1.0,1.0,1/7,3.36%,CIDEA
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.6813822251288193,-1.1716019066024577,0.36,1.0,1.0,3/6,27.28%,MAP1S;UBB;UXT
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.727144959739074,-1.1714169652337352,0.32,1.0,1.0,3/6,26.07%,IRF1;PTPN22;MAPK8IP1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.6661964691060337,1.171167212528101,0.3333333333333333,1.0,1.0,3/13,5.81%,TRPV2;SLC8A1;ATP2B4
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.6661964691060337,1.171167212528101,0.3333333333333333,1.0,1.0,3/13,5.81%,TRPV2;SLC8A1;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.6614622664731269,-1.1709375323073026,0.225,1.0,1.0,1/12,0.63%,CCN3
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.7888439259420138,1.1707227036768482,0.3125,1.0,1.0,3/6,6.79%,GLA;ATP2B4;SNCA
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.6039357775528749,-1.170276756469275,0.19607843137254902,1.0,1.0,4/27,7.33%,NUPR1;CLU;KCNE2;PSMC3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.619837427864776,1.1702155820250553,0.29411764705882354,1.0,1.0,2/24,6.44%,FAS;FAIM
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.7016699994595473,1.1699520994026023,0.35,1.0,1.0,6/6,29.86%,KCNJ2;DMD;C12ORF57;SLC8A3;CAV3;DMPK
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.6110393297960711,1.1698208887353765,0.35,1.0,1.0,3/18,5.02%,ROBO1;SLIT2;NRP1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.5037384467842752,-1.1693173401943373,0.1875,1.0,1.0,5/79,2.99%,SELP;CYP19A1;WNT9B;ASCL1;PAQR7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7268450348898252,1.1692537891042338,0.2926829268292683,1.0,1.0,2/7,3.52%,KLRD1;CX3CR1
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.7306375227391797,1.1692421426770572,0.36065573770491804,1.0,1.0,3/8,14.58%,LMO3;SIRT1;ASXL1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.7782769275372798,-1.169131513642446,0.2777777777777778,1.0,1.0,1/5,14.47%,RSAD2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.617845027092979,1.169093848752088,0.23809523809523808,1.0,1.0,2/15,8.34%,CYSLTR2;PRKACB
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.7740742738896957,-1.1689460051705105,0.36363636363636365,1.0,1.0,1/5,7.33%,PSMC3
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.7604535113776226,1.168813540254199,0.2978723404255319,1.0,1.0,2/7,3.37%,DOC2B;SPHK1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.48431789148026383,1.1688058662651126,0.13157894736842105,1.0,1.0,24/111,16.81%,MYBPC3;FLRT2;ZFPM2;ERBB4;FLRT3;FGF12;TGFBR1;SGCZ;HDAC9;BCOR;TAB2;PLCE1;DVL2;CHD7;MEF2A;ACVR1;MEF2C;SALL1;TGFBR3;KAT2B;TBX19;VEGFA;PDLIM1;ALPK2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.5243942223756364,1.1687891942149562,0.23529411764705882,1.0,1.0,21/72,17.31%,RALA;NLGN1;ANLN;GPM6A;NRP1;TENM2;CEP120;AUTS2;MSTN;PLCE1;WASF2;TENM1;PIK3CA;FNBP1L;PIK3R1;ACTR3;PLEKHM1;P2RX7;PLPPR5;BBS4;EPS8
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.7069803005546209,1.1685451322700602,0.36,1.0,1.0,4/8,19.08%,PPARG;PRKCB;VMP1;ZDHHC17
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6736334532297491,1.1684327086612945,0.3333333333333333,1.0,1.0,6/10,24.31%,SLC8A1;JAG1;VEGFA;ALPK2;CXADR;TCAP
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5372893101782719,1.1683581876057285,0.2391304347826087,1.0,1.0,5/32,8.46%,RAB9A;SNCA;PDCD6IP;RAB27A;EXPH5
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.6746585191218476,-1.1683377825331707,0.30357142857142855,1.0,1.0,1/14,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.737712157296116,-1.1682618545804548,0.3488372093023256,1.0,1.0,2/6,8.01%,RYR1;DRD3
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.44778717698279796,1.1682003995829744,0.24390243902439024,1.0,1.0,52/255,13.29%,KCND2;GABRR1;RIT2;GRM7;CHRM3;PCDHB3;NLGN1;PDYN;GABRB1;CEL;GPR176;CDH8;NRXN1;PTCHD1;CHRNA10;CHRM2;GABRG3;GLRA2;GRM5;GABRB2;OPRK1;GRID2;CACNB2;GRIA4;SYT1;SLC1A2;SYPL1;GRIK2;SNCA;DLG2;MBP;GLRB;PRKACB;NLGN4X;APBA1;NOVA1;CHRNB4;GABRA4;ZACN;NPY;CRHBP;GRIK1;CAMK4;GRM1;DLGAP1;ASIC2;HTR1E;SYN3;PPFIA3;ERC2;CBLN1;GRIA2
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.7626161129101323,1.1679976790484299,0.3333333333333333,1.0,1.0,1/5,11.25%,DCP1B
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.6953954446806592,-1.1678987399120158,0.2765957446808511,1.0,1.0,2/8,11.52%,SPI1;TAF7
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.7604388112978204,-1.1678109667828205,0.30434782608695654,1.0,1.0,6/9,20.35%,DRD3;NOS2;ACE;LEP;ABCC4;DRD4
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.5076640003319565,1.1676801758058553,0.2631578947368421,1.0,1.0,10/61,7.52%,GALNT3;FLRT2;HNRNPH1;FGFR2;FLRT3;FGF10;FGFR3;FRS2;FGF17;FGF5
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.6803190985997383,-1.1669077585631897,0.3111111111111111,1.0,1.0,2/9,5.55%,BDH1;HMGCL
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5510456305808511,-1.1667638185293965,0.2222222222222222,1.0,1.0,5/54,5.17%,NCKAP1L;HCK;TPPP3;RAC1;DCTN1
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.6311331583994952,-1.1666634068803687,0.2692307692307692,1.0,1.0,3/8,15.92%,SRP54;MET;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.8135822925282699,-1.1665326851470985,0.3023255813953488,1.0,1.0,1/5,5.68%,BEX4
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6885945945945946,-1.1664495112999453,0.3492063492063492,1.0,1.0,9/9,31.18%,ATP5F1A;ATP5F1D;ATP5MC1;ATP5MC2;ATP5PD;ATP5F1C;ATP5PB;ATP5MC3;VPS9D1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.5220959529838972,1.1663854443184236,0.2641509433962264,1.0,1.0,4/37,5.83%,STK26;ECT2;RHOB;CAT
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.47810208627353673,1.1661946926682492,0.20930232558139536,1.0,1.0,28/119,10.48%,CADM2;EFNA5;LRRC4C;CXXC4;LSAMP;NRXN1;PCDH17;ADGRB3;FGF12;CNTN4;UNC5D;SLC30A8;ROBO2;GRIA4;CA10;ELAVL4;HMGCLL1;RAB3C;PCSK2;SH3GL2;NOL4;CNTN1;NOVA1;KCNB2;ASXL3;RBFOX1;SMAD9;NPY
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.6465071460305544,-1.166059254131864,0.34615384615384615,1.0,1.0,3/11,20.14%,SERPINE1;CHEK1;MME
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.5587304897446435,1.1659381381370975,0.18604651162790697,1.0,1.0,9/33,15.67%,NLGN1;CEL;SYNJ2;SYT1;SNCA;NLGN4X;DNAJC6;PICALM;SYT2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.7961820389865957,-1.165910475357253,0.3157894736842105,1.0,1.0,1/5,5.39%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.7961820389865957,-1.165910475357253,0.3157894736842105,1.0,1.0,1/5,5.39%,PAPSS2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.7435244119586526,-1.165862809046927,0.29411764705882354,1.0,1.0,4/7,24.56%,SECISBP2;DIO2;SEPSECS;EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.7435244119586526,-1.165862809046927,0.29411764705882354,1.0,1.0,4/7,24.56%,SECISBP2;DIO2;SEPSECS;EEFSEC
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5092858745757763,1.165406358195657,0.20754716981132076,1.0,1.0,41/126,14.21%,CADM2;LRRC4C;LSAMP;OLFM3;LRRTM3;NRXN1;ADGRB3;ROBO1;NXPH1;EPHA3;HIVEP2;SLC35F1;AMER2;ROBO2;GRIA4;ELAVL4;ADGRL3;NPAS3;RAB3C;EPHA7;CTNNA2;FUT9;GPM6B;NOL4;SOX5;NOVA1;SYNPR;RBFOX1;UNC79;FAT3;ANK2;ZNF536;PPFIA2;CREB1;ERC2;BCL2;GRIA2;NOTCH3;CSRNP3;CTNND2;PCLO
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.4855376788445806,1.165193054804597,0.1702127659574468,1.0,1.0,29/125,15.40%,MED17;ESRRG;CCNH;PPARG;HNF4G;NR3C2;PPARGC1A;NR2E1;TEAD2;CCN2;HDAC9;NR3C1;TBL1XR1;HDAC3;MAML2;RORA;NR1D2;MAML3;NR5A2;TAF3;NR1H3;MNAT1;NOTCH3;RARB;GTF2F2;TAF2;TAF4B;DR1;KAT2B
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.5812739115638452,-1.1650483065550261,0.22413793103448276,1.0,1.0,10/40,14.32%,AURKA;KIF20B;ANAPC15;DRD3;BTC;FBXO43;TOM1L1;PIN1;BMP7;CUL9
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.780834702812218,1.1648731693425192,0.3333333333333333,1.0,1.0,2/5,5.81%,EGFR;ATP2B4
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7452219351139411,-1.164160526865959,0.2857142857142857,1.0,1.0,4/11,21.82%,CDC37;IFNGR2;STAT1;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7294929060427513,-1.1641243924794658,0.3023255813953488,1.0,1.0,2/5,22.76%,DDRGK1;UFL1
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.5967108002715765,1.164066758044855,0.2553191489361702,1.0,1.0,11/24,18.51%,POSTN;NRP1;ITGAV;JAG1;TIMP1;COL5A2;FGFR1;LPL;VEGFA;VCAN;PTK2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.6525809779314593,1.164054570324877,0.3695652173913043,1.0,1.0,4/20,11.91%,HEY1;TGFBR1;SMAD2;WNT8A
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.6551810850137673,1.1636250701172948,0.2692307692307692,1.0,1.0,7/15,15.40%,PBX1;MAML2;MAML3;WWC1;EP300;NOTCH3;KAT2B
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.6765760217685733,-1.1635567457781293,0.3137254901960784,1.0,1.0,4/15,9.27%,CCN3;SFRP1;ADRA2A;MIDN
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7611917452703872,1.1633769012342559,0.23809523809523808,1.0,1.0,5/8,20.84%,NEDD4;COMMD1;NEDD4L;HECW2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7112403181846896,1.1632165188783035,0.34615384615384615,1.0,1.0,3/9,6.79%,IRS1;IRS2;SNCA
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.5175391432351463,-1.1632010027947868,0.27941176470588236,1.0,1.0,10/75,12.08%,PLK4;AURKA;HAUS8;DCTN1;SSNA1;TPX2;PRKACA;CETN2;ODF2;TUBB4B
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6035311050832857,-1.1630542413434664,0.26229508196721313,1.0,1.0,2/26,3.04%,PARP2;ART4
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6690245714690053,1.1629706482827797,0.34,1.0,1.0,5/12,15.51%,IRS1;PPARGC1A;IRS2;SIRT1;AKT2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.6212944546807743,1.1626226307463092,0.37735849056603776,1.0,1.0,3/18,8.77%,TRIM22;HS3ST5;TRIM5
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.6728987659812434,-1.1626106593542047,0.3404255319148936,1.0,1.0,4/12,20.34%,OAS2;CANX;STAT3;STAT1
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.608852891853296,-1.162298381556393,0.2549019607843137,1.0,1.0,4/26,8.01%,CXCR5;KIF20B;GIPC1;DRD3
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.6597444545860669,-1.1621849265221718,0.24528301886792453,1.0,1.0,2/11,8.95%,ATOX1;ARF1
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.7351926170105152,1.1619653910660996,0.375,1.0,1.0,4/6,25.79%,ELOVL6;ELOVL7;ELOVL2;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.7351926170105152,1.1619653910660996,0.375,1.0,1.0,4/6,25.79%,ELOVL6;ELOVL7;ELOVL2;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.7351926170105152,1.1619653910660996,0.375,1.0,1.0,4/6,25.79%,ELOVL6;ELOVL7;ELOVL2;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.7351926170105152,1.1619653910660996,0.375,1.0,1.0,4/6,25.79%,ELOVL6;ELOVL7;ELOVL2;ELOVL5
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.7408408558993641,1.1618469710744672,0.39215686274509803,1.0,1.0,1/5,3.52%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.7990671599389683,-1.161846624080684,0.29508196721311475,1.0,1.0,1/5,13.04%,RAP1GAP
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.6098035966711965,1.1616415749349827,0.36585365853658536,1.0,1.0,7/25,9.51%,NLGN1;MAGI2;NRXN1;DLG2;LRP4;SAV1;LRRC7
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7437687186037489,1.1612946217511215,0.3333333333333333,1.0,1.0,2/6,11.72%,SNCA;NDFIP2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.7135765227692026,-1.1612474495561624,0.3584905660377358,1.0,1.0,1/8,0.74%,SFRP1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.6647350658941353,1.161111758379565,0.37142857142857144,1.0,1.0,6/10,19.09%,SDHAF3;OGT;GNMT;PDK2;FBP1;ZNF692
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.6816442006706962,1.1610366634655473,0.3111111111111111,1.0,1.0,2/9,11.75%,DGAT2;SIRT1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.7666019121097103,-1.1603974041342955,0.32,1.0,1.0,1/7,8.17%,RNF213
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.6308899154077362,1.160167072371624,0.32,1.0,1.0,5/15,14.99%,PIGP;PIGA;PIGV;PIGW;PIGQ
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4863495584133069,1.1599225845882404,0.2777777777777778,1.0,1.0,28/107,13.86%,GPC6;FIGN;IL17RD;SEMA6D;GFRA1;PBX1;PCDH7;SLIT2;PDZRN3;FBXL7;ADGRL3;PTPRG;LRP4;GULP1;ADGRL2;TENM3;TMEM98;TUSC3;ANK2;LIFR;SEMA3B;ENAH;AMOTL2;PRICKLE2;EFS;RUNX1T1;CSRNP3;MEIS3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.5898563649078564,-1.1596073161035518,0.22807017543859648,1.0,1.0,4/24,4.96%,NCKAP1L;TEC;VAV3;SH2B2
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.7288225374423138,-1.15943027478973,0.39622641509433965,1.0,1.0,3/5,17.29%,AGBL3;AGBL1;AGBL2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.5575545698126096,-1.1594131881231444,0.2222222222222222,1.0,1.0,8/43,16.37%,SELP;FOXP1;NOS2;HMGB2;CD24;PRDX3;LBP;IRAK1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.7124897755790425,1.159228674143329,0.3,1.0,1.0,2/8,13.04%,FGFR2;SOX11
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.7390415967047979,1.1591244693581724,0.35555555555555557,1.0,1.0,3/5,25.78%,HTR1E;HTR1F;HTR5A
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5812859552151901,1.158890129685484,0.27450980392156865,1.0,1.0,7/25,13.63%,PPARG;HMGB1;SLIT2;ADAMTS9;ATP2B4;PTPRM;MEF2C
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.6227438339290413,1.1584132547713222,0.30612244897959184,1.0,1.0,2/13,5.93%,KPTN;RNF128
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.5209966594999139,-1.157926941559058,0.2641509433962264,1.0,1.0,7/57,11.44%,F8;F5;GOLGA2;TRAPPC2L;TRAPPC6A;TRAPPC4;CNIH3
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.5209966594999139,-1.157926941559058,0.2641509433962264,1.0,1.0,7/57,11.44%,F8;F5;GOLGA2;TRAPPC2L;TRAPPC6A;TRAPPC4;CNIH3
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.5209966594999139,-1.157926941559058,0.2641509433962264,1.0,1.0,7/57,11.44%,F8;F5;GOLGA2;TRAPPC2L;TRAPPC6A;TRAPPC4;CNIH3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.7758663180443921,1.1578807492693974,0.25,1.0,1.0,2/5,13.10%,TGFBR1;ACVR1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.749140247879615,-1.157838933946211,0.2857142857142857,1.0,1.0,1/5,5.95%,OAS3
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.6066192940855138,-1.1573667761130058,0.2962962962962963,1.0,1.0,3/18,7.47%,RFLNA;B2M;PAX6
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.7202563058280708,1.1570118335170472,0.30612244897959184,1.0,1.0,1/5,4.99%,HPRT1
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.7619257925587472,-1.1569813075887372,0.4,1.0,1.0,3/5,16.42%,CALM1;RACK1;CALM3
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.7520269591598345,1.1565879890930764,0.34782608695652173,1.0,1.0,1/5,2.21%,ENPP1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5626880896077658,-1.1564605274911026,0.23529411764705882,1.0,1.0,3/38,0.98%,HLA-DPB1;NCKAP1L;TNFSF18
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7393890961280046,-1.156354436006466,0.3137254901960784,1.0,1.0,1/5,7.24%,SPI1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5393520317185077,-1.156137745597042,0.23728813559322035,1.0,1.0,11/58,11.39%,P2RY10;TRHR;ANO1;P2RY11;ADRA2A;VIP;DRD3;FPR3;ADRA1D;DRD1;F2RL2
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7534618490195667,1.1558040428647471,0.3269230769230769,1.0,1.0,1/6,2.14%,BTLA
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8098560341937182,-1.1555850206454998,0.30357142857142855,1.0,1.0,3/6,11.86%,CLDN4;SVBP;DDRGK1
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.6154102030517508,1.155563408892219,0.23076923076923078,1.0,1.0,3/13,18.35%,ELP4;MOCS3;DPH3
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.754445529483222,1.1553554154013994,0.3269230769230769,1.0,1.0,3/7,20.84%,PRKD1;VEGFA;CAMK2D
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.7546043106544815,-1.1553036550968727,0.41509433962264153,1.0,1.0,1/5,3.61%,PRKCH
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.531396184162803,-1.1542965710622954,0.23529411764705882,1.0,1.0,2/40,1.58%,SUN3;SPAG4
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5680252224614855,1.1539898382748512,0.30952380952380953,1.0,1.0,6/19,12.48%,NTF3;MAGI2;DDIT4;FRS2;BCAR1;SORT1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.6117699161857558,1.153338786742799,0.2826086956521739,1.0,1.0,9/31,14.26%,SEMA5A;FLRT3;NRP1;AUTS2;SH3GL2;TMEM108;CTNNB1;LLPH;ALCAM
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.704317442200641,1.1532772721858322,0.3076923076923077,1.0,1.0,4/9,13.04%,FGFR2;FGFR3;SNCA;FGFR1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.6995093687271676,-1.1530255322905394,0.2909090909090909,1.0,1.0,3/10,17.25%,SCARA3;COLEC12;RFTN1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6861536052086902,-1.1529458253267637,0.3064516129032258,1.0,1.0,4/13,18.62%,PRPF6;PRPF19;USP4;SRSF10
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.46611300123286353,1.152853266878364,0.2553191489361702,1.0,1.0,33/140,15.26%,PMP2;CADM2;LRRTM3;NRXN1;CDH20;GFAP;ADGRB3;SLC39A12;GRM5;PLA2G7;AMER2;FGFR3;CA10;SLC1A2;LUZP2;GPM6B;RLBP1;SYNPR;SLC4A4;RBFOX1;LRRC3B;SRR;RGS7BP;AANAT;GRIA2;SORBS1;SLCO1C1;GABRG1;NFATC3;TMEM178A;MAPK4;VIM;BYSL
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.780660072152846,-1.1526915918903655,0.28888888888888886,1.0,1.0,2/7,13.53%,NMNAT3;KYNU
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5440496211438386,1.152325701606915,0.28846153846153844,1.0,1.0,2/36,0.55%,ACE2;UTS2R
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.750386379855053,-1.15219825550469,0.3191489361702128,1.0,1.0,1/7,4.44%,KMT2B
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.7011069093850977,-1.152172351232914,0.32558139534883723,1.0,1.0,1/6,1.08%,NLRP1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.6293701519273041,-1.152086740915469,0.2857142857142857,1.0,1.0,4/11,14.58%,XPC;ERCC1;DDB1;INO80
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6804596864537964,1.1520866733047475,0.3,1.0,1.0,3/9,14.77%,CHPT1;DHRS7B;PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.6295338334632273,-1.1520018775763385,0.3018867924528302,1.0,1.0,2/21,3.23%,SFRP1;RAC1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.6812883094005109,1.1517581319973709,0.23809523809523808,1.0,1.0,4/6,19.60%,HIF1A;BMPR1A;SMAD3;SMAD4
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.7128822646037635,-1.1515963711828316,0.35185185185185186,1.0,1.0,2/5,20.14%,STK11;MME
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.6720607582087775,1.1515424698251355,0.29545454545454547,1.0,1.0,1/9,5.25%,AK3
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.6777914810188529,-1.1513668889080109,0.3269230769230769,1.0,1.0,4/11,7.07%,RPS27L;PLK3;PLK5;CCND1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5175260860930588,1.151017869380012,0.1956521739130435,1.0,1.0,12/56,13.04%,MAP3K11;PIK3R5;EGFR;ROBO1;DVL2;PDGFD;PDGFRB;TENM1;EDN1;ADAM8;SASH1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.7461345351333522,1.150965152715038,0.3333333333333333,1.0,1.0,4/7,12.70%,CCL5;IDO1;CD274;ADAM8
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.6478605556620505,-1.1509149573021584,0.35,1.0,1.0,2/14,6.45%,KIF25;LLGL2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.5589194057923572,-1.1506904652934777,0.29411764705882354,1.0,1.0,8/48,9.56%,SIGLEC1;HCK;AOAH;PLET1;NLRP3;KLHDC4;SPI1;ADGRE2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7395025168039517,1.1506127856562383,0.32653061224489793,1.0,1.0,3/5,20.03%,HIF1A;VEGFA;NFE2L2
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.674677814691128,-1.1505214357569902,0.27450980392156865,1.0,1.0,1/12,0.78%,PARP2
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6856375945911701,-1.1500961395648825,0.37777777777777777,1.0,1.0,2/11,11.00%,CD9;CEACAM1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.6110203474034919,1.1500476853983959,0.2916666666666667,1.0,1.0,6/12,14.33%,GNAT2;RP1;GRM6;GNAQ;CNGB1;EYS
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.6018894396370684,-1.149876081461798,0.3191489361702128,1.0,1.0,5/24,10.28%,SH3RF2;PPP1R15A;ZCCHC9;PPP1R35;PTPA
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5310663293502367,1.1498439910845328,0.2972972972972973,1.0,1.0,9/37,22.62%,RFWD3;RADX;NSMCE1;CASP9;CRY1;SMG1;ANKLE1;ABL1;NPAS2
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.7221992804237822,1.1494356774903773,0.35185185185185186,1.0,1.0,1/5,10.56%,NR1H3
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.7563287990653503,-1.1492139569900333,0.35294117647058826,1.0,1.0,4/5,24.38%,SERPINE1;SERPINF2;USF1;THBS1
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),0.7837841210193973,1.1492002167962119,0.30952380952380953,1.0,1.0,2/6,5.50%,SPX;TBXA2R
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.7107361309095803,-1.1488855525966115,0.3181818181818182,1.0,1.0,4/7,19.80%,WARS1;XRCC1;PUM3;HPF1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.7426582024771959,1.1488350554253506,0.3404255319148936,1.0,1.0,3/5,12.49%,TWSG1;GLI3;CD274
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7671633662301709,1.1487145278647002,0.358974358974359,1.0,1.0,2/5,12.80%,CNTNAP2;ANK3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.547496624741795,-1.1485977187339929,0.36538461538461536,1.0,1.0,6/33,12.82%,DUSP4;DUSP6;DUSP5;PGP;PTPN9;PTPRB
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.47556283378972225,1.1483762670052187,0.23404255319148937,1.0,1.0,25/121,15.86%,TRIM22;IRS1;HMGB1;DXO;TFEB;IRS2;FOXO3;ZBTB20;PRKD1;SNCA;TWIST1;TRIM8;HIF1A;TRIM5;ATF6;SLC4A4;TP53INP1;ZSWIM8;FOXO1;ADAM8;ABHD5;P2RX7;AKT2;MID2;BAD
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7008225899528465,1.1483535625111632,0.36,1.0,1.0,3/8,14.74%,DNAJB2;SACS;HSPA1A
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.6053466725068495,-1.1483446833883486,0.2777777777777778,1.0,1.0,5/16,21.20%,TSPYL5;CRYAB;XRCC6;YAP1;TMEM109
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7142934799199305,-1.1480954055981638,0.36363636363636365,1.0,1.0,1/7,0.74%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.7356489495608234,-1.1480662773793282,0.37037037037037035,1.0,1.0,4/9,14.47%,CD74;NLRP3;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.6989495652074705,1.1480271332126324,0.3333333333333333,1.0,1.0,3/8,5.80%,NLGN1;WNT5A;GRID2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.5033999384542935,-1.1476851972445206,0.25,1.0,1.0,11/103,13.52%,STING1;ATP6V1E2;UCHL1;ATP6V1E1;CDK5;ATP6V1D;PRKACA;PINK1;SUPT5H;ATP6V0A2;SNX6
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.6179373435951947,1.1476637749387295,0.36585365853658536,1.0,1.0,3/10,8.82%,HPRT1;PPAT;ADA
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.6576064561600792,1.147309876426689,0.3,1.0,1.0,4/13,9.15%,ENPP1;AK3;DCTPP1;SMPDL3A
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.6560015984268045,-1.1472806227042132,0.2909090909090909,1.0,1.0,3/18,5.40%,SFRP1;TTC23;TXNDC15
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6325586766038088,1.1472486397134063,0.28,1.0,1.0,3/16,9.38%,PLA2G10;CIDEA;C3
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6783795771197009,1.1470920908288345,0.3,1.0,1.0,5/14,17.18%,CEL;FAH;PLA2G15;FAAH;LDHD
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5842747318673814,1.1470648066528448,0.30612244897959184,1.0,1.0,4/27,9.16%,AGER;ZBTB20;ERN1;IGF1R
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.7489988291266412,-1.1467733521270282,0.2916666666666667,1.0,1.0,4/5,25.09%,CTNNA3;DSC2;PKP2;JUP
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.7489988291266412,-1.1467733521270282,0.2916666666666667,1.0,1.0,4/5,25.09%,CTNNA3;DSC2;PKP2;JUP
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.7197227308894498,-1.146159662549678,0.47619047619047616,1.0,1.0,3/7,14.70%,HEBP2;PIP5KL1;PRELID1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.5278117366358847,1.1457005921975727,0.2727272727272727,1.0,1.0,13/54,19.51%,MED17;RUNX2;TWIST1;MITF;CSF1R;CTNNB1;ZNF45;RELA;CBFB;MECP2;MED24;NFKB1;TNRC6C
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.6463429269017699,1.1456887576197934,0.3269230769230769,1.0,1.0,3/15,8.89%,WNT5A;GRIP1;DVL2
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.740913517148261,1.1450887922881186,0.33962264150943394,1.0,1.0,3/5,24.42%,CDO1;MPST;GCLC
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.6358036249746362,1.1450682068252844,0.2653061224489796,1.0,1.0,6/10,24.85%,ZNF675;GPR137B;TMEM178A;FBXW7;GPR137;FBN1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5151820052154675,-1.1449952483421704,0.21739130434782608,1.0,1.0,24/61,20.64%,MYB;LDB1;PSMA7;PSMD7;PSMB4;SPI1;PSMC3;METTL3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6;YAP1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.5888937932371698,1.1448779105177211,0.32653061224489793,1.0,1.0,4/15,19.52%,NEDD1;PCM1;BBS4;KIAA0753
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.8048793975555633,-1.1447015627494417,0.3469387755102041,1.0,1.0,3/6,12.73%,SPI1;TRPV4;METTL3
prerank,GO_Biological_Process_2021__vascular wound healing (GO:0061042),0.799676295840327,1.1445412293989579,0.38,1.0,1.0,2/5,2.51%,NDNF;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6715520552878665,1.1444966328456352,0.3793103448275862,1.0,1.0,3/14,7.07%,IRS1;IRS2;TWIST1
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.7155847840744383,-1.1442725953702206,0.3617021276595745,1.0,1.0,3/6,19.03%,DIRAS3;CTCF;PRMT7
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.7544393507160885,1.1439396072908228,0.33962264150943394,1.0,1.0,1/5,3.94%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7307627998659383,-1.1439149955085808,0.3392857142857143,1.0,1.0,3/7,16.35%,PINK1;TOMM7;HDAC6
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.5928278641083186,-1.1436346031889455,0.32727272727272727,1.0,1.0,6/16,16.85%,TOMM40;TIMM17B;TOMM20;TIMM17A;TIMM50;TIMM44
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5812668737051234,1.143559162620743,0.3181818181818182,1.0,1.0,6/23,11.21%,SLC8A1;MCU;MICU1;CACNB2;TRPC4;MAIP1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6212360631887355,1.1433806151456747,0.3333333333333333,1.0,1.0,3/14,10.56%,PPARG;PPARGC1A;NR1H3
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.45383207471978276,1.1433679301174822,0.20512820512820512,1.0,1.0,44/202,12.08%,KCND2;GABRR1;RIT2;GRM7;CHRM3;PCDHB3;NLGN1;PDYN;GABRB1;CEL;GPR176;NRXN1;PTCHD1;CHRNA10;CHRM2;GABRG3;GLRA2;GRM5;GABRB2;OPRK1;CACNB2;GRIA4;SYT1;SLC1A2;SYPL1;GRIK2;SNCA;DLG2;MBP;GLRB;PRKACB;NLGN4X;APBA1;NOVA1;CHRNB4;GABRA4;ZACN;NPY;GRIK1;CAMK4;GRM1;DLGAP1;ASIC2;HTR1E
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.7164465401085597,1.1433012031188572,0.3103448275862069,1.0,1.0,1/7,5.81%,ATP2B4
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5417117007490843,1.143169550377871,0.30434782608695654,1.0,1.0,4/20,11.75%,BAHD1;H3-3A;HELLS;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6152219739262201,-1.1430577784673293,0.25862068965517243,1.0,1.0,1/13,0.70%,DYSF
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.601014078186142,-1.1430255913948024,0.4166666666666667,1.0,1.0,7/24,21.80%,HK2;ENO1;GAPDHS;LDHA;PGK1;ENO2;ALDOB
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.6410112259020162,-1.1429867069422137,0.2962962962962963,1.0,1.0,2/17,6.25%,FGF1;MBTPS2
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.5777425478374786,1.1429232190493037,0.3333333333333333,1.0,1.0,4/17,19.52%,NEDD1;PCM1;BBS4;KIAA0753
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.5067828262595182,-1.1427563055993915,0.22413793103448276,1.0,1.0,4/58,3.79%,NUPR1;KIF25;ATRAID;GOLGA2
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5487069471873153,-1.142679495768084,0.2833333333333333,1.0,1.0,20/44,26.15%,SPG7;MICOS13;DNAJC11;ATP5F1A;ATP5F1B;MTX1;ATP5F1D;GHITM;AFG3L2;ATP5MC1;APOO;TMEM11;TIMM29;ATP5MC2;ATP5F1E;TIMM13;ATP5PD;ATP5F1C;TIMM8A;HSPA9
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.7416869369475995,1.1426189279502776,0.26666666666666666,1.0,1.0,1/5,5.68%,OPRK1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6386587261201393,1.142467576872015,0.37735849056603776,1.0,1.0,6/16,15.13%,NRG1;CDH2;WNT8A;SOX11;MEF2C;FBXL17
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.4709132932850061,1.1423919513361205,0.22727272727272727,1.0,1.0,18/90,13.19%,LRIG3;FIGN;EGFR;WNT5A;SLIT2;SNX7;ERRFI1;PTPRG;CDR2L;DDAH1;LRP4;ADGRL2;TENM3;BCAR1;FLNC;LIFR;ENAH;AMOTL2
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.7622210632601956,-1.142307847357735,0.3191489361702128,1.0,1.0,3/7,19.63%,TOM1L1;BMP7;CHEK1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.465479679911581,-1.1421855351849213,0.18032786885245902,1.0,1.0,12/119,8.59%,INHA;TMEM184A;AARD;COL6A1;CLU;EPAS1;AMH;DOCK6;COL18A1;PRLR;RBP4;VWA1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.600570074512279,-1.142181153433049,0.3018867924528302,1.0,1.0,3/24,7.22%,LCP1;LLGL2;RHBDF2
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6306847688998255,-1.1419144805953005,0.25,1.0,1.0,2/26,3.35%,NCKAP1L;SERPINE1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7019969670866424,1.1417022554545535,0.3389830508474576,1.0,1.0,3/7,25.78%,LIG4;MSH2;MSH6
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.4952484154608578,-1.1414145458613352,0.23529411764705882,1.0,1.0,6/62,6.62%,NCKAP1L;PLK4;HCK;CDK5;VIL1;SYNPO2L
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.6465258531977196,1.141403716739989,0.2857142857142857,1.0,1.0,2/7,8.41%,ITGAM;SETMAR
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.7068322714918731,1.1413896637851226,0.33962264150943394,1.0,1.0,1/7,1.86%,SPX
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.52759910028304,-1.1413635236921165,0.1875,1.0,1.0,20/45,20.53%,PSMA7;PSMD7;PSMB4;PSMC3;BCKDK;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.6643588784508745,-1.141153754763208,0.28846153846153844,1.0,1.0,2/16,4.85%,SFRP1;FTH1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.49195768454674654,1.1411377124420388,0.25,1.0,1.0,9/44,11.50%,ALDH1A1;IL18R1;CIDEA;PLCL1;ARRDC3;TLE3;NOVA1;NR1H3;MAP2K6
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7102273918495032,1.1411198030777026,0.3090909090909091,1.0,1.0,3/7,24.69%,BOK;TP53BP2;TP53
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.531448996182342,1.141060402216855,0.21739130434782608,1.0,1.0,7/44,7.04%,NLRP2B;PPARG;ROBO1;SLIT2;OTUD4;ARG1;ZNF675
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.6438964088480533,-1.1404055976850331,0.32727272727272727,1.0,1.0,4/19,9.23%,GOLGA2;TUBGCP5;TUBGCP2;TPX2
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.6615858254384772,1.1402890748014378,0.3404255319148936,1.0,1.0,1/8,3.81%,HEY1
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.706956223895147,1.1401602760355558,0.3829787234042553,1.0,1.0,2/5,4.60%,FGFR2;FGF10
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.7472112855268301,-1.140153363430598,0.3442622950819672,1.0,1.0,2/8,6.67%,FGF1;PAX8
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.7101877736283913,1.140124687557331,0.2727272727272727,1.0,1.0,1/7,4.97%,MLLT3
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7093680130227027,1.1400374568559677,0.3,1.0,1.0,6/11,27.28%,CIDEA;BOK;TP53BP2;BCL2L1;TP53;FZD3
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.6792658481390104,-1.1398218495695074,0.3148148148148148,1.0,1.0,3/10,7.58%,DYSF;SPACA3;FOXP1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.5935168638153766,1.1397690380078764,0.26666666666666666,1.0,1.0,5/17,17.28%,RUNX1;WNT5A;LIFR;ELF1;CBFB
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.7861266792788607,-1.139718620066749,0.35294117647058826,1.0,1.0,1/5,3.23%,RAC1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5669696272410986,-1.139712391945884,0.32653061224489793,1.0,1.0,8/50,10.72%,HLA-DPB1;INHA;TXK;IL1R1;ZP3;BTN3A1;CR1;NR1H4
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.7069290593109683,-1.1393796675957921,0.29411764705882354,1.0,1.0,4/8,23.66%,DNAH1;CFAP100;CCDC39;CCDC40
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.7510919027137467,-1.1392532229933103,0.3877551020408163,1.0,1.0,2/5,20.68%,TRMT112;FBL
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.5280938300733787,1.1391461087437584,0.3023255813953488,1.0,1.0,9/39,13.86%,PBX1;SHROOM2;MEIS1;PBX3;CPAMD8;ATF6;MEIS2;COL5A2;MEIS3
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.7101854973098762,-1.1390701685020475,0.3870967741935484,1.0,1.0,4/9,16.75%,ZWILCH;PLK2;WEE2;PRCC
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.4922072992771537,1.1390616000191427,0.21621621621621623,1.0,1.0,18/87,15.40%,ZFPM2;ERBB4;FLRT3;HEY1;FGF12;TGFBR1;HDAC9;CRB2;BCOR;TAB2;PLCE1;DVL2;PIK3CA;MEF2A;ACVR1;MEF2C;SALL1;KAT2B
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.5672737516590116,1.1389816061204827,0.27450980392156865,1.0,1.0,6/33,7.08%,MARVELD3;ESAM;FRMPD2;PARD3;ECT2;PDCD6IP
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.6922769050446693,1.1388939906989062,0.3541666666666667,1.0,1.0,4/9,19.08%,PPARG;PRKCB;VMP1;ZDHHC17
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.6316438079379951,1.1386121536306686,0.34210526315789475,1.0,1.0,3/15,5.02%,SEMA5A;FGF10;NRP1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.7124410880241817,1.1382404262704529,0.35714285714285715,1.0,1.0,2/6,11.76%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.6863878633116559,-1.1379750243690891,0.37209302325581395,1.0,1.0,2/9,11.00%,CD9;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.586027086831567,1.137800137679186,0.22916666666666666,1.0,1.0,5/17,5.71%,HMGB1;JAM2;AGER;CCL5;PLA2G7
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.6603690507738248,1.137730957486616,0.4166666666666667,1.0,1.0,2/10,3.94%,RUNX1;WNT5A
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5340893349677727,1.1375476560948747,0.2558139534883721,1.0,1.0,9/34,16.16%,FAS;PDE2A;TMEM150C;MAP3K1;MAPK8;SLC9A1;CASP2;BAD;CRADD
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.6679914111953376,-1.1373974123157653,0.2909090909090909,1.0,1.0,2/12,6.77%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.6012894054569585,-1.137370575037272,0.34782608695652173,1.0,1.0,6/21,21.80%,HK2;ENO1;GAPDHS;PGK1;ENO2;ALDOB
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.6012894054569585,-1.137370575037272,0.34782608695652173,1.0,1.0,6/21,21.80%,HK2;ENO1;GAPDHS;PGK1;ENO2;ALDOB
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.6745033016824484,1.1371526681495117,0.35294117647058826,1.0,1.0,6/9,29.10%,SHQ1;RUVBL2;NAF1;RUVBL1;PIH1D1;NUFIP1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.7177489942526736,1.1367711522238293,0.3673469387755102,1.0,1.0,2/6,5.52%,GABRB1;GABRB2
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.727379424640076,1.136680899961794,0.3673469387755102,1.0,1.0,1/6,2.28%,IL18R1
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.727379424640076,1.136680899961794,0.3673469387755102,1.0,1.0,1/6,2.28%,IL18R1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.7480880650139206,-1.136534177057295,0.2916666666666667,1.0,1.0,1/5,5.64%,BCAT2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6422320345326976,1.1365114768111768,0.32608695652173914,1.0,1.0,6/18,15.69%,FAS;ITGAV;BOK;BCL2;CASP9;CASP2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.5492854474086252,1.1363820760473422,0.3409090909090909,1.0,1.0,6/24,13.27%,PTPRK;FGF10;CTNNB1;ANK2;SMURF1;PIGU
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.5230196460027936,1.1361152921883224,0.19230769230769232,1.0,1.0,6/40,13.86%,INF2;PPARGC1A;PDE2A;PID1;EP300;MARCHF5
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.6424144901246335,-1.1358039399956097,0.3617021276595745,1.0,1.0,1/9,0.99%,PAH
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.4487915747300101,-1.1358016352515714,0.23880597014925373,1.0,1.0,55/233,19.26%,SNRNP27;FIP1L1;DDX41;ZCRB1;GTF2F1;RBM4;RBM8A;UPF3B;CWC25;CPSF1;PRPF6;RNF113A;SYF2;CPSF4;POLR2I;LSM7;PRPF19;POLR2J;DNAJC8;WBP4;PDCD7;NONO;SF3B2;DHX16;RBM19;RNPC3;ZRSR2;SF3A2;SF3A1;MFAP1;METTL3;SNW1;RBM22;POLR2G;HNRNPL;SF3B6;RBMX2;SRSF7;DHX8;GPATCH1;CPSF3;PRPF4;POLR2C;RBM4B;RBMX;PRCC;SNIP1;SNRPD2;EFTUD2;HNRNPH2;PPIL3;SRSF10;ALYREF;IK;HNRNPM
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.713225547472433,1.135659002128527,0.375,1.0,1.0,3/6,19.28%,ZSWIM8;RELA;NFKB1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.7091935487762322,1.1353617327982233,0.2692307692307692,1.0,1.0,4/8,23.16%,GRIA2;CPEB4;GRIN3A;CLN3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5556239953692637,1.1351003192052775,0.3181818181818182,1.0,1.0,6/23,17.28%,RUNX1;ZBTB1;MDK;CAMK4;NFATC2;CBFB
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.6059802475258748,1.1345622908668158,0.3,1.0,1.0,2/18,2.07%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.7369639827859443,-1.1345589181754208,0.3269230769230769,1.0,1.0,4/6,18.23%,RAD51AP1;MEIOSIN;PRDM7;NPM2
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.5077502958584751,1.1345566567702,0.2619047619047619,1.0,1.0,17/60,19.40%,NLGN1;ITPKB;ADGRV1;WNT5A;ECT2;SYT1;ACER1;CRHBP;SYT15;MEF2A;NEUROD2;MEF2C;SYT2;BRAF;SYT17;DMTN;SLC25A24
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.6159127800767448,1.1343009184620172,0.38,1.0,1.0,5/16,12.46%,CALCR;CACNB2;SNCA;ANK2;AKAP6
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.5319486986465729,1.134188075485544,0.2777777777777778,1.0,1.0,11/36,16.81%,MYBPC3;FLRT2;HEY1;TGFBR1;BMPR1A;CHD7;ACVR1;TGFBR3;TBX19;VEGFA;ALPK2
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.7568236880906783,1.1341878445586862,0.3902439024390244,1.0,1.0,2/5,8.13%,PDE4B;PDE4D
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.673569560302841,1.133931711491723,0.27450980392156865,1.0,1.0,4/6,30.51%,SIRT1;TP53;MAPK14;WNT16
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5160837829827315,1.133816320746023,0.25,1.0,1.0,12/55,19.51%,MED17;RUNX2;CSF1R;CTNNB1;ZNF45;RELA;ATF7IP;CBFB;MECP2;MED24;NFKB1;TNRC6C
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.6026818601508558,1.133804504167091,0.3,1.0,1.0,2/12,3.73%,HMGB1;AGER
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7046679418688038,1.133784324737176,0.43137254901960786,1.0,1.0,2/5,11.01%,GDPD3;NAPEPLD
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7046679418688038,1.133784324737176,0.43137254901960786,1.0,1.0,2/5,11.01%,GDPD3;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.5206467149814399,-1.1337426548227303,0.2826086956521739,1.0,1.0,5/51,6.62%,P2RY10;NTRK1;RAC1;PRAG1;SYNPO2L
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.5170413683250827,-1.1337238352914767,0.30158730158730157,1.0,1.0,7/38,11.39%,ARR3;CD9;DRD3;RAB31;GTF2H2;CEACAM1;DNM1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4888146375612509,1.133634889421609,0.2558139534883721,1.0,1.0,43/182,14.31%,SEMA3C;PLA2G10;EFNA5;SEMA5A;SEMA6D;GFRA1;UNC5C;NRXN1;DSCAM;WNT5A;ROBO1;CNTN4;UNC5D;SLIT2;EPHA3;IRS2;NRP1;NRXN3;GAB1;ROBO2;RYK;LAMC2;DOK6;FRS2;EPHA7;PSPN;PRKCA;NCAM1;PTPRM;NPTN;CXCL12;EMB;PIK3CA;LGR6;SEMA3B;ENAH;NFIB;EPHA5;NOTCH3;KLF7;LRTM2;ALCAM;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.5605371242511252,-1.133624781626167,0.23076923076923078,1.0,1.0,4/20,4.74%,NCKAP1L;CD74;VAV3;BST1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7033206422169844,-1.1334878574992557,0.3148148148148148,1.0,1.0,1/5,8.41%,RAB7B
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.739383780253895,-1.1332656476971796,0.35294117647058826,1.0,1.0,2/5,13.25%,FGF1;FGF18
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.6391226674411721,1.1332099416980845,0.40425531914893614,1.0,1.0,4/13,17.56%,SCEL;NR5A2;FGFR1;STOX2
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.762122417425624,-1.1330571503209077,0.3728813559322034,1.0,1.0,2/6,8.01%,NOG;DRD3
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.7155590317712857,-1.1330206839968708,0.37254901960784315,1.0,1.0,2/7,4.74%,NMB;IL11
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.6302218947850797,1.1329548190676233,0.3269230769230769,1.0,1.0,5/21,13.36%,LEPR;PPARGC1A;ACSM1;PID1;ACADVL
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.5467210813545587,1.1329408407027233,0.3,1.0,1.0,6/36,7.08%,MARVELD3;ESAM;FRMPD2;PARD3;ECT2;PDCD6IP
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5680013579826494,1.132903918557215,0.32,1.0,1.0,3/18,3.30%,IFI16;PPARG;BATF3
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.735211112825373,-1.1325962921916917,0.3877551020408163,1.0,1.0,2/5,16.25%,CD63;RAB32
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.735211112825373,-1.1325962921916917,0.3877551020408163,1.0,1.0,2/5,16.25%,CD63;RAB32
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6134046899133107,1.1324054439069828,0.34146341463414637,1.0,1.0,3/21,7.07%,ENPP1;HEY1;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.5947029343746199,-1.1323294109938256,0.3333333333333333,1.0,1.0,8/25,18.17%,GTF2F1;POLR2I;POLR2J;SUPT5H;CCNT1;POLR2G;POLR2C;NELFA
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.7434570066649306,-1.1319823323309561,0.3469387755102041,1.0,1.0,3/8,13.53%,PAH;IL4I1;KYNU
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.7421701239567882,1.131963195894694,0.40816326530612246,1.0,1.0,2/6,19.49%,ELAVL4;TENT4B
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.6531939320038942,-1.1310967627016397,0.36363636363636365,1.0,1.0,2/11,13.40%,SEC62;SGTB
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7105638081813315,-1.130973535365908,0.4166666666666667,1.0,1.0,1/7,4.73%,B2M
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6664431209879751,1.130759229457386,0.3148148148148148,1.0,1.0,6/12,28.99%,REEP1;RAB10;TMEM33;ATL1;ATL2;REEP2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.6985441053759425,1.1306911084291387,0.3333333333333333,1.0,1.0,2/9,6.79%,THRSP;SNCA
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6109169854367769,1.1305097924520544,0.23684210526315788,1.0,1.0,7/32,8.71%,NRG1;HEY1;ADAMTS9;SGCZ;SMAD5;BMPR1A;SMAD1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5915555828839848,1.1303986355373539,0.2857142857142857,1.0,1.0,2/27,1.24%,SLC26A3;SLC26A7
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.5431232128112176,1.1303206545450721,0.3076923076923077,1.0,1.0,11/40,12.78%,UTS2R;CYSLTR2;PDYN;GLRA2;OPRK1;MCHR2;NXPH4;GLRB;NPY;SORT1;GPR149
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.5857747281356526,-1.1295772289628971,0.26,1.0,1.0,8/26,17.38%,CLU;TRIAP1;PINK1;SLC25A5;ADCK1;PRELID1;GHITM;PSMD10
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.5437985256043287,-1.1293315509048958,0.2459016393442623,1.0,1.0,2/30,1.83%,GSTM5;GSTM3
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.7454311215899961,-1.1288312321393794,0.34545454545454546,1.0,1.0,2/7,2.83%,SFRP1;MEOX1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6644910522994989,-1.1287330801105266,0.3469387755102041,1.0,1.0,4/10,21.78%,ART4;PRMT7;NDUFAF5;PADI4
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.6054288728302459,1.1286152843476385,0.24444444444444444,1.0,1.0,9/30,17.19%,IL1RAPL1;NEDD4;ADGRB3;TNIK;PTPRD;RAP2A;CAPRIN1;NEDD4L;HECW2
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.6382028610167366,1.1285351501096224,0.2826086956521739,1.0,1.0,9/19,18.51%,CSF1;CCL5;SLIT2;MSTN;CSF1R;MDK;CMKLR1;IL34;PTK2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.5937501091289626,1.128285668675189,0.32075471698113206,1.0,1.0,5/19,18.06%,SLC22A2;SLC6A13;SLC25A38;SLC1A3;SH3BP4
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.7428982365935041,-1.128177389964755,0.3389830508474576,1.0,1.0,1/5,5.59%,PNPO
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.598809167961825,1.1280305481256114,0.26666666666666666,1.0,1.0,5/12,19.56%,ZBTB7B;NAPEPLD;PTGS2;PIM1;HNRNPU
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.6398167830269508,1.1279625838380583,0.32558139534883723,1.0,1.0,3/9,15.80%,SMPDL3A;SGMS1;SMPD4
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.45957534932168004,1.1278567702536901,0.175,1.0,1.0,9/91,5.96%,ACE2;NOX5;IFI16;S100A13;CIDEA;RPS6KA4;HDAC9;TWSG1;DTX4
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.6684559441238379,-1.1276441225797627,0.34545454545454546,1.0,1.0,1/14,2.85%,PPP1R17
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.613537574273967,1.1273847361832026,0.3137254901960784,1.0,1.0,2/8,5.75%,SLC23A1;SLC2A5
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.6135501275578884,-1.1271565812481577,0.3191489361702128,1.0,1.0,1/17,0.63%,CCN3
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.769223220382242,-1.1271491270006424,0.38181818181818183,1.0,1.0,3/5,17.46%,PTGR1;LTC4S;HPGD
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.6294108274832231,1.1270997648215964,0.26,1.0,1.0,4/11,20.36%,NLGN1;PLEKHM1;EPS8;EPS8L2
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.6453032084614443,1.1266812082253261,0.32653061224489793,1.0,1.0,1/11,0.17%,ZDHHC11
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.49476466624370724,1.1266255237520042,0.2545454545454545,1.0,1.0,6/56,8.83%,MAP3K11;ZFP36;TAB3;CUL1;DUSP9;TAB2
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.6908512745642759,-1.1265761979133166,0.391304347826087,1.0,1.0,2/8,8.95%,SARDH;CHAC1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.6014298121598722,1.1265572566503033,0.30434782608695654,1.0,1.0,4/18,8.13%,RUNX1;PNP;PDE4B;PDE4D
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.4769398952483289,1.1265288992591551,0.2391304347826087,1.0,1.0,21/70,22.04%,LOXL2;CHRM3;MSRA;ABL2;YES1;ST8SIA4;FBXO11;QPCT;UBE2D3;FBXL2;AKT2;PHKA2;STK38;CSNK1G3;GNMT;CPE;ST3GAL6;TGM1;ABL1;PPP4R2;PLAT
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),-0.7436640008259456,-1.1265245367085532,0.36666666666666664,1.0,1.0,3/6,10.31%,GNAS;DRD3;DRD1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5329660020416527,-1.1262349581531006,0.23636363636363636,1.0,1.0,9/37,4.51%,P2RY10;CD5;KLRB1;AOAH;TRAF3IP3;TRBC2;CD37;CD4;SLA
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.7194903691558582,1.1259180930599115,0.3404255319148936,1.0,1.0,2/5,15.53%,LMO3;CRY1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5045524517398091,1.1258413927713533,0.2830188679245283,1.0,1.0,27/85,20.21%,CYSLTR2;IRS1;PPARG;ENPP1;IRS2;HDAC9;SLC30A10;PRKACB;FER;CRHBP;FOXO1;SORBS1;INSIG2;PIK3R1;INSIG1;CPEB2;TBC1D4;KAT2B;AKT2;ADCY2;RELA;RAB10;INSR;NFKB1;ZFP36L1;GCK;ADCY3
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.608077943103823,-1.125543628058081,0.30158730158730157,1.0,1.0,6/21,20.24%,CIDEB;PDCD5;PINK1;DNM1L;HRK;BIK
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.7471131684879837,1.1254760106672101,0.4074074074074074,1.0,1.0,1/5,0.66%,HORMAD1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6083541274802767,-1.1251870273549045,0.3888888888888889,1.0,1.0,8/18,23.10%,C1QBP;SAP18;SRSF7;RBMX;SRSF10;RNPS1;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.564413857157858,-1.1249967718603862,0.29411764705882354,1.0,1.0,2/40,1.29%,PLK4;LCP1
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.6767305602988929,1.1249861592251613,0.3137254901960784,1.0,1.0,2/5,21.32%,RPE;RPEL1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.5452473974159329,-1.1249468527980424,0.30357142857142855,1.0,1.0,11/39,19.80%,TERF2IP;TICRR;KPNA2;TOM1L1;PIF1;PDGFA;NUCKS1;USP1;SUB1;ALYREF;MPV17
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6943826243564754,-1.124930540832087,0.4230769230769231,1.0,1.0,1/6,2.34%,XG
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.7128933374028319,-1.1248723742582925,0.37037037037037035,1.0,1.0,2/5,24.43%,KYNU;CDKN2D
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5473833404288975,1.1248601796383026,0.22857142857142856,1.0,1.0,6/35,4.11%,ACE2;SLC26A3;BCO1;HNF4G;GOLT1A;TOX3
prerank,MSigDB_Hallmark_2020__Coagulation,-0.5081909124681616,-1.1248022446724153,0.2909090909090909,1.0,1.0,21/89,12.76%,CD9;F8;CLU;C2;RAC1;SERPINE1;MAFF;SH2B2;CPQ;DUSP6;CFD;HNF4A;SPARC;USP11;PROC;ISCU;F2RL2;CTSO;PRSS23;APOA1;CTSH
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.6829248256155903,-1.1247123657945215,0.3137254901960784,1.0,1.0,3/7,20.34%,IFIT1;DDB1;STAT1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.6279780392912835,-1.1245785844860015,0.25862068965517243,1.0,1.0,3/11,6.67%,TMIE;NOG;PAX8
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.6075764595777002,1.124540478683911,0.3404255319148936,1.0,1.0,4/13,8.29%,NRG1;FGF10;OPRK1;SGK1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.638055584854537,-1.1244891885024135,0.3620689655172414,1.0,1.0,2/12,6.77%,PATL2;LIMD1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.706198925475094,-1.1244100822342578,0.44680851063829785,1.0,1.0,3/8,17.09%,ST6GAL1;PARP1;ST3GAL1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.6310471447765393,-1.1243818375973764,0.3157894736842105,1.0,1.0,1/11,0.70%,DYSF
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.627760859458207,1.1243446750971127,0.3333333333333333,1.0,1.0,6/13,13.10%,MAGI2;SMAD7;ACVR2A;FST;ACVR1B;ACVR1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.6454543234586302,1.124265769283942,0.4098360655737705,1.0,1.0,3/8,8.77%,APOLD1;ZEB1;ATOH8
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7748962117837863,1.1241879590530652,0.40816326530612246,1.0,1.0,2/5,19.49%,ELAVL4;TENT4B
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.4873429994933536,-1.1241495581966765,0.2692307692307692,1.0,1.0,13/89,10.32%,DYSF;SIGLEC1;HCK;RASSF4;RNASE1;CEBPD;SLC7A7;RAB3B;IL1R1;FPR3;F13A1;MMP19;THRA
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.6687097433884904,-1.123593110574371,0.37037037037037035,1.0,1.0,3/7,22.15%,HSD17B10;TRMT10C;TRMT10B
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6550752405968503,-1.1234805028018242,0.3148148148148148,1.0,1.0,1/8,3.85%,TMSB4X
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.5224758329892784,-1.1234460846872991,0.26785714285714285,1.0,1.0,6/47,9.84%,SLC25A10;SLC1A7;SLC16A8;SLC6A9;LLGL2;SLC6A20
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.6562514696289095,1.1234417033358792,0.32608695652173914,1.0,1.0,1/8,2.78%,KLRD1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.5405935111124349,-1.1232364392851222,0.3,1.0,1.0,5/45,6.56%,DDX11;ABRAXAS1;FOXM1;RNF8;XRCC1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6972368957215168,1.1231273358350238,0.36363636363636365,1.0,1.0,4/13,16.20%,GLA;ACER1;ASAH2;HEXB
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.7412140861188651,1.1230678468408264,0.4583333333333333,1.0,1.0,1/5,5.80%,GLA
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.5348613428481955,1.1229902406225847,0.3125,1.0,1.0,8/47,9.07%,NLRP2B;IFI16;CX3CR1;AGER;WNT5A;HSPB1;SERPINB1;AIM2
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.6457214322125485,-1.1228018848611863,0.28846153846153844,1.0,1.0,1/17,1.87%,ATRAID
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.6079797367851745,1.1227553218908854,0.3333333333333333,1.0,1.0,3/13,9.61%,PPP1R15B;PPP3CA;NCK1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5197126054997031,-1.1227377654385666,0.3018867924528302,1.0,1.0,6/43,8.16%,MYB;CD74;STX4;NLRP3;HLA-DRA;ZP3
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.6854223507572648,-1.1225876162278194,0.36,1.0,1.0,3/6,21.82%,CD24;CDH3;HSP90AB1
prerank,PanglaoDB_Augmented_2021__B Cells,-0.49788094387610105,-1.1222710641217368,0.35294117647058826,1.0,1.0,10/88,5.86%,P2RY10;NCKAP1L;CD5;SP140;TRAF3IP3;CD74;CD37;BST1;HLA-DRA;TMC8
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.6087145457481786,1.1220851087102428,0.3181818181818182,1.0,1.0,3/16,8.71%,ENPP1;HEY1;BCOR
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.5917359224405793,-1.121842912298006,0.2711864406779661,1.0,1.0,4/28,8.88%,LCP1;PLK3;KIF20B;IFI27
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.583852818292601,1.1217271035276095,0.34615384615384615,1.0,1.0,6/22,13.63%,NRG1;CTNNA2;CDH2;CTNNB1;MEF2A;MEF2C
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.7272106980394385,1.1214990538669134,0.3617021276595745,1.0,1.0,2/7,16.20%,GLA;HEXB
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.4378678510908517,-1.1213284224773234,0.2647058823529412,1.0,1.0,56/256,19.26%,SNRNP27;FIP1L1;DDX41;ZCRB1;GTF2F1;RBM4;RBM8A;UPF3B;CWC25;CPSF1;PRPF6;RNF113A;SYF2;CPSF4;POLR2I;LSM7;PRPF19;POLR2J;DNAJC8;WBP4;PDCD7;NONO;SF3B2;DHX16;RBM19;RNPC3;ZRSR2;SF3A2;SF3A1;MFAP1;METTL3;SNW1;RBM22;POLR2G;HNRNPL;SF3B6;RBMX2;SRSF7;DHX8;GPATCH1;CPSF3;PRPF4;POLR2C;RBM4B;RBMX;PRCC;SNIP1;SNRPD2;EFTUD2;HNRNPH2;PPIL3;SRSF10;ALYREF;IK;PRMT7;HNRNPM
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.7032417100310172,-1.1210361000380047,0.3584905660377358,1.0,1.0,4/7,28.18%,AARS2;GARS1;DARS2;TARS2
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.5144630353686312,-1.1209886904822495,0.2698412698412698,1.0,1.0,17/38,20.34%,HLA-C;OAS3;IFIT1;OAS2;IFI27;IFI6;IFIT2;RSAD2;STAT2;IRAK1;IFIT5;GBP2;PSMB8;IRF1;RNASEL;ISG15;STAT1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.5144630353686312,-1.1209886904822495,0.2698412698412698,1.0,1.0,17/38,20.34%,HLA-C;OAS3;IFIT1;OAS2;IFI27;IFI6;IFIT2;RSAD2;STAT2;IRAK1;IFIT5;GBP2;PSMB8;IRF1;RNASEL;ISG15;STAT1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.5122390904119334,1.120728610095864,0.26666666666666666,1.0,1.0,10/80,6.75%,ENPEP;SGK2;CALCR;COL22A1;OIT3;PPARGC1A;CORIN;OPRK1;RNF128;C6
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.584877034379241,1.120566021032528,0.3023255813953488,1.0,1.0,7/28,21.30%,KLF2;GLRA2;CPEB4;VEGFA;CPEB3;SH3BP4;IPO5
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),-0.7311086396695203,-1.1205291844614729,0.37777777777777777,1.0,1.0,2/5,15.99%,CEMIP;HAS3
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.734461860410278,-1.1203322996701122,0.34545454545454546,1.0,1.0,1/5,2.46%,ST6GALNAC2
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.734993870732705,-1.1199789471490134,0.391304347826087,1.0,1.0,2/5,16.72%,VPS25;VPS28
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.734993870732705,-1.1199789471490134,0.391304347826087,1.0,1.0,2/5,16.72%,VPS25;VPS28
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.6124126202363839,1.119769837433912,0.2653061224489796,1.0,1.0,6/27,8.79%,ARHGAP25;ITGAM;XKR6;IGLL1;MEGF10;GULP1
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.696612889416384,1.1194559217378506,0.45454545454545453,1.0,1.0,1/5,1.15%,COL22A1
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),-0.7578079126465335,-1.1193087401508637,0.36363636363636365,1.0,1.0,1/5,3.60%,PDZD7
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),-0.7578079126465335,-1.1193087401508637,0.36363636363636365,1.0,1.0,1/5,3.60%,PDZD7
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5004853921791388,-1.1192826105191094,0.2826086956521739,1.0,1.0,23/58,20.64%,MYB;LDB1;PSMA7;PSMD7;PSMB4;PSMC3;METTL3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6;YAP1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.6310521298220099,-1.118633935369228,0.34615384615384615,1.0,1.0,4/19,11.39%,P2RY10;DRD3;DRD1;F2RL2
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.5884387059981675,-1.1184945742581478,0.3157894736842105,1.0,1.0,2/20,3.67%,CLU;M6PR
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.6552508416519547,1.1183002481045312,0.425531914893617,1.0,1.0,4/10,25.43%,TRDN;ANK2;DIAPH1;RYR2
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5877847917107251,-1.1180777819652385,0.4222222222222222,1.0,1.0,6/22,21.80%,HK2;ENO1;GAPDHS;PGK1;ENO2;ALDOB
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5594245055676992,1.117957513593138,0.3404255319148936,1.0,1.0,7/15,19.56%,ZBTB7B;NAPEPLD;PTGS2;SIRT1;FTO;PIM1;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.6968307717734803,1.1177237677833025,0.34146341463414637,1.0,1.0,2/9,1.86%,NRG1;SPX
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.651242607947065,1.1172286515240957,0.3953488372093023,1.0,1.0,2/12,10.61%,SYNE4;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.6966514321512871,-1.117200121985586,0.4523809523809524,1.0,1.0,3/8,14.70%,HEBP2;PIP5KL1;PRELID1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.5902353737568559,1.1163457389020268,0.3125,1.0,1.0,5/19,10.56%,PLA2G10;PPARG;CSF1;ITGAV;NR1H3
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.6099064224642075,1.1160367013451562,0.28,1.0,1.0,3/16,8.28%,SLC30A8;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.610681672746098,1.1159398969428758,0.3617021276595745,1.0,1.0,6/19,21.48%,AHCY;MSRA;CDO1;MPST;SMS;ADI1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.6958046783068923,-1.1155664491349118,0.32786885245901637,1.0,1.0,1/9,0.99%,PAH
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.6304430570093595,-1.1154927002966608,0.34782608695652173,1.0,1.0,3/9,12.65%,METAP2;METAP1D;APOA1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6995875360863052,1.1154761942545843,0.4375,1.0,1.0,3/9,10.56%,PPARG;ITGAV;NR1H3
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5638590400971332,1.1154035417341333,0.2564102564102564,1.0,1.0,10/42,14.32%,NRG1;FGFR2;ZBTB1;TGFBR1;FGF10;COBL;ARID5B;MDK;SALL1;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.7072194807655029,1.1150304356371634,0.41818181818181815,1.0,1.0,1/6,3.98%,ROBO1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.6816901416132677,-1.1148521849289084,0.37735849056603776,1.0,1.0,3/9,11.35%,DBNL;LRP8;CUX2
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.7024976573189359,-1.1144589890525547,0.375,1.0,1.0,1/5,7.38%,TRPV4
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.6755108808142049,-1.1144371605630072,0.35555555555555557,1.0,1.0,3/15,13.64%,RPS27L;RPS15;RPS27
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.6779106302123777,1.114146822364833,0.425531914893617,1.0,1.0,2/6,9.92%,MAGI2;JAG1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.6779106302123777,1.114146822364833,0.425531914893617,1.0,1.0,2/6,9.92%,MAGI2;JAG1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.7327260036534655,1.1140028693295878,0.38461538461538464,1.0,1.0,4/5,25.92%,CAP1;MAPK8;MAPK14;CAP2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.7069000675953093,1.113927567166554,0.4186046511627907,1.0,1.0,1/7,3.52%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6315189856237784,1.1135877621695411,0.3508771929824561,1.0,1.0,7/15,23.53%,ZFP36;BTG2;CPEB3;TENT4B;TNRC6C;CNOT7;TOB1
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.5572673055145311,1.1134930585330662,0.30434782608695654,1.0,1.0,6/39,7.08%,MARVELD3;ESAM;FRMPD2;PARD3;ECT2;PDCD6IP
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5983802143299319,1.1128205811110214,0.3125,1.0,1.0,2/16,11.98%,SLC22A2;SLC25A26
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.6583097836709048,-1.1127066919018023,0.391304347826087,1.0,1.0,7/15,29.56%,WBP4;RBM22;SNRNP200;SFSWAP;DCPS;CACTIN;SNRPC
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6488929234709035,1.11213733030755,0.43137254901960786,1.0,1.0,3/11,12.06%,PEX5L;PEX2;PEX13
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7281376259656437,1.1120136864070174,0.4791666666666667,1.0,1.0,2/6,17.66%,TSHZ3;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6986472312595554,-1.11193483735252,0.38,1.0,1.0,1/9,1.87%,ATRAID
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.7090561635760462,-1.1119014320015348,0.3620689655172414,1.0,1.0,4/8,25.19%,INO80;WIZ;NUGGC;CDC7
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.6696894331552617,-1.1117235684292284,0.3673469387755102,1.0,1.0,2/6,13.98%,SHANK3;NECAB2
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.6379534826793344,-1.1115148859389836,0.31746031746031744,1.0,1.0,2/13,1.87%,SFRP1;ATRAID
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.5080975248784243,1.1113872968910161,0.2857142857142857,1.0,1.0,7/68,11.22%,RGPD5;RGPD3;RGPD4;SYK;RGPD2;CBLB;PRICKLE1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.7504912227060487,-1.1112188101518297,0.38,1.0,1.0,2/5,13.37%,SERPINE1;SERPINF2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.44670562052917967,1.111213251990916,0.22727272727272727,1.0,1.0,31/153,14.35%,MED17;ESRRG;CCNH;PPARG;HNF4G;NR3C2;CAVIN1;PPARGC1A;NR2E1;TEAD2;CCN2;HDAC9;NR3C1;TBL1XR1;HDAC3;MAML2;RORA;NR1D2;MAML3;NR5A2;TAF3;TAF1A;NR1H3;TFB2M;MNAT1;NOTCH3;RARB;GTF2F2;TAF2;TAF1B;TAF4B
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.7040662623863062,-1.1111339495247767,0.40425531914893614,1.0,1.0,1/7,0.53%,DDX11
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6397081715670884,-1.1110158849621945,0.37777777777777777,1.0,1.0,1/13,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.672511200573144,-1.1106381718474907,0.3888888888888889,1.0,1.0,3/12,14.92%,PTCD2;SAFB;CDK11B
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6285409737001495,1.1104161265016854,0.35714285714285715,1.0,1.0,6/13,23.53%,ZFP36;BTG2;CPEB3;TNRC6C;CNOT7;TOB1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.6276623751188983,-1.1101007318255707,0.3620689655172414,1.0,1.0,8/14,23.10%,C1QBP;SAP18;SRSF7;RBMX;SRSF10;RNPS1;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.5237452912781692,1.1100696632451934,0.2682926829268293,1.0,1.0,14/64,15.66%,SGK2;CD151;DOC2B;SNCA;ZNF205;RAB27A;SGK1;DLL1;NR1H3;BOK;TUB;NEDD4L;AKT2;IL15RA
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.6904235799700934,1.1099421178328588,0.40816326530612246,1.0,1.0,3/5,28.60%,SETMAR;SETD3;ASH1L
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.5291949032520209,1.1094562459644557,0.25,1.0,1.0,5/30,17.16%,SULT2B1;SULT2A1;LDLRAP1;IDH1;LCAT
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.7448335118645804,1.1091219950220725,0.3958333333333333,1.0,1.0,2/5,15.07%,BOK;CASP9
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6028713866725515,1.1089823199590336,0.3617021276595745,1.0,1.0,3/12,10.86%,B4GALNT2;UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.7562073864420122,1.1089789967864072,0.4166666666666667,1.0,1.0,3/5,17.87%,GRID2;CBLN1;PROX1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6882999063425406,1.108839600217851,0.37254901960784315,1.0,1.0,3/8,9.83%,NLGN1;NRXN1;TMEM108
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.6891367799994852,1.1087437636306339,0.3409090909090909,1.0,1.0,4/7,14.33%,GNAT2;GRM6;CNGB1;EYS
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.6891367799994852,1.1087437636306339,0.3409090909090909,1.0,1.0,4/7,14.33%,GNAT2;GRM6;CNGB1;EYS
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6560791934176152,1.1087127888679968,0.4,1.0,1.0,1/9,1.22%,DAPK2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.5187270369196216,1.108508505655901,0.26666666666666666,1.0,1.0,7/43,11.76%,FAS;AGER;EGFR;IGF1R;PHLPP1;RAP2A;FOXO1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.7154938909479446,1.1084449968419143,0.3404255319148936,1.0,1.0,3/7,15.51%,IRS2;PRKCB;AKT2
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.4810263986241091,-1.1080705620039033,0.2545454545454545,1.0,1.0,8/73,7.38%,NCKAP1L;CLU;HCK;RAC1;DCTN1;VIL1;SYNPO2L;TRPV4
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.6585083310957491,1.1079806560112047,0.38596491228070173,1.0,1.0,6/10,22.10%,KLF2;HDAC3;MEF2C;NFE2L2;SREBF2;PKD2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.7382474097082636,1.1079441320722716,0.42592592592592593,1.0,1.0,3/5,16.40%,HSPB1;PRKD1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.6203658361106325,-1.1072892821626632,0.32,1.0,1.0,5/17,15.12%,CD74;CD4;KPNA2;DDB1;TYRO3
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.4953138011697149,-1.1072442652472783,0.2653061224489796,1.0,1.0,4/64,5.59%,SLC19A3;DHFR2;PCCB;PNPO
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.4845086447593544,1.1071909852095307,0.21951219512195122,1.0,1.0,29/102,19.40%,NLGN1;ITPKB;EGFR;ADGRV1;WNT5A;GLRA2;ECT2;SYT1;MT1M;SNCA;ACER1;DLG2;CRHBP;SYT15;TF;MEF2A;NEUROD2;ANK3;MEF2C;MAPK8;SLC12A2;SYT2;BRAF;BMP6;ZNF658;FBP1;SYT17;DMTN;SLC25A24
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.5826963477266058,1.1071859511885849,0.3541666666666667,1.0,1.0,2/19,3.79%,MYBPC3;SMAD7
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.7358566711898329,-1.106912448797369,0.40350877192982454,1.0,1.0,2/5,19.66%,NLRP9;GBP5
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.6450516429245999,-1.1067532736199317,0.3492063492063492,1.0,1.0,3/11,19.37%,FOLH1;AGBL1;GPLD1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5945244045487836,-1.1065454969728343,0.3404255319148936,1.0,1.0,13/18,27.88%,PSMA7;PSMB4;PSMB5;PSMB2;PSMA1;PSMB8;PSMA8;PSMB3;PSMB7;PSMB1;PSMA5;PSMA4;PSMB6
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5646671340901454,-1.106079194545498,0.3409090909090909,1.0,1.0,1/24,0.41%,RTP5
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.6250201059202897,-1.1060060190591607,0.3,1.0,1.0,4/19,7.57%,CCN3;NODAL;PBLD;RBPMS
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.46584330807577373,-1.105580262483157,0.24528301886792453,1.0,1.0,45/166,20.53%,PLK4;AURKA;PLK5;XPC;HAUS8;PSMA7;DCTN1;ANAPC15;SKP1;PSMD7;UBC;PSMB4;PSMC3;SSNA1;TPX2;PRKACA;CETN2;ODF2;TUBB4B;DDB1;PSMD8;PSMB5;INO80;PSMC1;ERCC2;PSMB2;PSMC4;PSMD2;PSMA1;CENPE;PSMB8;PSME1;PSMD10;HAUS5;NPM2;CKAP5;ANAPC2;PSMA8;TUBG1;FZR1;CDC6;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.46412710035730415,-1.1055723211448574,0.27586206896551724,1.0,1.0,13/85,19.88%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;MRPS21;TRMT112;MRPL9;MRPL19;MRPL27;MRPL51;MRPS18C;MRPL37
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6510905509305928,-1.1055050934434123,0.29310344827586204,1.0,1.0,1/10,1.08%,NLRP1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6988336710069578,1.1053805033838657,0.37037037037037035,1.0,1.0,4/10,18.03%,SLC1A2;PRAF2;SLC25A12;SLC1A3
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5319832637095119,1.1053442194960792,0.3541666666666667,1.0,1.0,9/31,18.97%,NECTIN3;RAB34;BLZF1;ANK3;KIF13A;AFDN;SPTBN1;GGA1;RAB10
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5484155990908751,1.105338724528555,0.35294117647058826,1.0,1.0,4/25,5.81%,PPARG;HMGB1;TBXA2R;ATP2B4
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.48788028783342063,1.1051721191498396,0.3,1.0,1.0,21/72,21.39%,GRM7;SEMA5A;FGFR2;CNTN4;PARD3;RYK;NREP;CTNNA2;SLITRK5;ANK3;KLF7;PARD6B;NTNG1;PLP1;VASH2;RAB10;ZDHHC17;PAK3;BAIAP2;LLGL1;RTN4RL1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6170133905997489,1.105146340347164,0.3181818181818182,1.0,1.0,8/28,17.61%,SPX;PPARG;THRSP;PRKAB2;ACACA;ABCD3;CPT2;SLC25A20
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.7707863210082403,-1.105053254472654,0.34146341463414637,1.0,1.0,1/5,5.30%,D2HGDH
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.5233523267320906,-1.105035592527708,0.32142857142857145,1.0,1.0,4/57,5.99%,ACOT1;ACOT11;ACOT4;ACOT12
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.5769930357072554,1.1049333723132315,0.3269230769230769,1.0,1.0,6/19,19.16%,ZBTB20;HIF1A;SLC4A4;P2RX7;ARNT;INSR
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.5769930357072554,1.1049333723132315,0.3269230769230769,1.0,1.0,6/19,19.16%,ZBTB20;HIF1A;SLC4A4;P2RX7;ARNT;INSR
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6286057430035619,1.1048823483917323,0.32653061224489793,1.0,1.0,3/10,12.42%,PCBP2;NOVA1;ZNF445
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.48164236696242513,1.104837913802012,0.2708333333333333,1.0,1.0,13/56,13.91%,NDNF;NTF3;CX3CR1;PPARGC1A;TOX3;SLC30A10;HIF1A;MDK;LIG4;ADAM8;BCL2;MEF2C;CPEB4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.4647092696960026,1.104766908932451,0.16666666666666666,1.0,1.0,11/73,9.25%,ZFP36;CIDEA;HMGB1;CX3CR1;AGER;WNT5A;SYK;HSPB1;TWIST1;PTPN6;TLR1
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.6883452809605548,1.104572533317725,0.4117647058823529,1.0,1.0,1/6,8.80%,ABCC11
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7091754202508247,-1.1038667369093014,0.3333333333333333,1.0,1.0,2/5,24.25%,TAF7;NLRC5
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.6796769292456479,1.103823923435348,0.47619047619047616,1.0,1.0,2/7,9.38%,ALDH1A1;NPL
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6936074099084567,1.1038192520991779,0.32558139534883723,1.0,1.0,1/9,1.91%,ERBB4
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5251113992882813,1.1036157194505234,0.32727272727272727,1.0,1.0,4/36,8.83%,MAP3K11;TAB3;DUSP9;TAB2
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6399739482608495,1.1033124969189902,0.35714285714285715,1.0,1.0,7/15,18.90%,ERN1;NCK1;BOK;PIK3R1;RNFT1;USP13;RNF185
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6181093155138343,1.103274679293952,0.38181818181818183,1.0,1.0,4/18,12.70%,RUNX1;BAG2;RNF139;ADAM8
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.6767938824421813,1.1026320644399628,0.3902439024390244,1.0,1.0,4/11,11.23%,HPGDS;AKR1C1;PTGES;CES2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.6902924168386011,1.1020076514913573,0.3673469387755102,1.0,1.0,3/7,16.79%,CPEB4;CPEB2;CPEB3
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4148828152421303,1.1019725519843087,0.21052631578947367,1.0,1.0,55/331,10.43%,GALNT3;LTK;FLRT2;NRG1;FRK;EFNA5;PLCB1;NTF3;ERBB4;IRS1;HNRNPH1;CASS4;ATP6V0A4;CD8A;FGFR2;MUC20;FLRT3;DDIT4;EGFR;CSF1;ROR1;SULF1;SYK;EPHA3;FGF10;IRS2;NRP1;VEGFC;CNKSR1;GAB1;NUS1;FGFR3;PRKD1;RYK;ATP6V0D2;FRS2;FGF17;FGF5;HGF;PTPRG;EPHA7;COL4A6;EIF2AK3;SOCS2;FER;YES1;IGF1R;BLNK;CSF1R;NCK1;ITGAV;PDGFD;VEGFD;PDGFRB;WASF2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5672495346871601,-1.101729112919465,0.3090909090909091,1.0,1.0,1/30,0.18%,NOSTRIN
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.6319347438599353,1.1016929300382918,0.41304347826086957,1.0,1.0,1/10,4.75%,KLF2
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6736439817810246,-1.1016175068871088,0.3898305084745763,1.0,1.0,3/7,20.53%,PSMC3;PSMC4;PSMC6
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6332680872223777,1.101346705941133,0.3684210526315789,1.0,1.0,3/12,13.04%,NRG1;CDH2;SOX11
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.5486795677277349,1.1011595310293412,0.275,1.0,1.0,3/25,0.75%,CHIT1;GPC5;GPC6
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.5779483387286992,1.1010148543468816,0.3617021276595745,1.0,1.0,5/30,12.56%,ZDHHC11;ZDHHC14;ZDHHC2;HHAT;ZDHHC11B
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.4609871650500433,1.1009407398430104,0.325,1.0,1.0,22/107,14.88%,LRIG3;CALCR;RUNX1;KCNS3;EGFR;SNX7;ERRFI1;MSTN;DDAH1;NCAM1;COL5A2;PARD3B;BCAR1;FLNC;TIMP3;LIFR;CDCP1;ENAH;AMOTL2;NOTCH3;DMD;NFATC2
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.4999716639596926,-1.1008443796012435,0.3333333333333333,1.0,1.0,18/50,25.22%,NDUFC1;NDUFB9;NDUFS5;NDUFAF3;NDUFA1;NDUFA3;NDUFS6;NDUFAB1;TMEM126B;NDUFS2;NDUFA5;NDUFA10;NDUFB10;NDUFA12;NDUFAF5;NDUFS8;NUBPL;TMEM126A
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4999716639596926,-1.1008443796012435,0.3333333333333333,1.0,1.0,18/50,25.22%,NDUFC1;NDUFB9;NDUFS5;NDUFAF3;NDUFA1;NDUFA3;NDUFS6;NDUFAB1;TMEM126B;NDUFS2;NDUFA5;NDUFA10;NDUFB10;NDUFA12;NDUFAF5;NDUFS8;NUBPL;TMEM126A
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7084593878290978,-1.1008314652236069,0.375,1.0,1.0,3/5,24.87%,RPF2;NOL8;RAN
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.7108197270294431,-1.1005674215007244,0.3541666666666667,1.0,1.0,3/5,20.65%,SBDS;PTPRC;LRRC17
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.703273360318766,-1.1004817150476078,0.4074074074074074,1.0,1.0,4/9,25.19%,INO80;E2F7;WIZ;CDC7
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.5560161102810202,1.1004240120032374,0.3695652173913043,1.0,1.0,4/22,8.82%,PNP;HPRT1;PPAT;ADA
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.59902276102862,-1.1004091075270412,0.38,1.0,1.0,5/15,16.83%,SVBP;PINK1;CSTB;CTSH;PSMB8
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6061047544230206,1.0998701162800792,0.3958333333333333,1.0,1.0,3/17,9.07%,IFI16;EPHA7;AIM2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7172018875558519,-1.0997247357966073,0.41818181818181815,1.0,1.0,4/7,21.13%,SIGIRR;ITIH4;LBP;IL6R
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.5071133639651254,-1.0989970688934603,0.3584905660377358,1.0,1.0,10/74,7.99%,NUPR1;SH3RF2;CLU;TRIB2;ARIH2;RBX1;DDA1;KCNE2;PSMC3;RFPL1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.6322034759186489,-1.0987182266143523,0.3695652173913043,1.0,1.0,4/13,5.94%,CD9;ADAM12;ADAMTS15;ERVW-1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.46844722567277397,-1.0984724716284098,0.36,1.0,1.0,24/93,21.02%,TRABD2A;LCP1;CLU;TPPP3;WARS1;ERCC1;RBX1;PSMC3;GTF2H2;TTBK1;DDB1;RACK1;PARP1;ERCC2;PSMC4;HRK;SRC;BAK1;RPS3;GBP5;BIK;ISG15;PSMC6;RPA3
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.7603890296629228,-1.0983807164096129,0.4318181818181818,1.0,1.0,1/5,3.35%,SERPINE1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.5032576438253938,-1.0974783210683803,0.34615384615384615,1.0,1.0,10/77,8.88%,STING1;APOBEC3H;NLRP1;CGAS;RNASE1;OAS3;NLRP9;IFIT1;OAS2;IFI27
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.6635352518415407,-1.0973759825846785,0.4074074074074074,1.0,1.0,8/9,30.13%,DRD3;CALM1;GNB5;CALM3;DRD4;CBARP;GPR35;DRD2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.7415222003893237,1.0972534789808748,0.41304347826086957,1.0,1.0,2/6,15.16%,TRDN;SLC9A1
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.737603004931577,-1.0972394532162224,0.4418604651162791,1.0,1.0,1/5,0.52%,CELA2A
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.4793833523279849,1.097015989004565,0.26,1.0,1.0,10/33,23.50%,GFAP;LATS1;SPTY2D1;SNCAIP;ROCK2;RAP1A;HSPA8;BAG5;RAPGEF2;BBS10
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5828547569896342,1.0970027044021808,0.3770491803278688,1.0,1.0,7/19,20.37%,EIF2AK3;NCK1;BOK;SYVN1;HSPA1A;CREB3;BCL2L1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.70228288718891,-1.0969581761792198,0.42592592592592593,1.0,1.0,2/7,9.84%,SLC6A9;SLC6A20
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.7308365937370527,-1.0968904202788343,0.3877551020408163,1.0,1.0,3/6,20.35%,DRD3;ACE;DRD4
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.7308365937370527,-1.0968904202788343,0.3877551020408163,1.0,1.0,3/6,20.35%,DRD3;ACE;DRD4
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.6534877297295052,-1.096711754552389,0.4,1.0,1.0,2/9,11.49%,CLU;PRX
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7446887593982414,-1.0965653146273706,0.48214285714285715,1.0,1.0,3/5,19.69%,NLRP3;PRKCZ;IL18
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.7446887593982414,-1.0965653146273706,0.48214285714285715,1.0,1.0,3/5,19.69%,NLRP3;PRKCZ;IL18
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4819130121178774,1.0964310069926149,0.32608695652173914,1.0,1.0,14/62,17.02%,B4GALNT2;UBE2J1;MGAT4C;OSTC;B4GALT1;SLC39A8;TUSC3;MOGS;ALG13;ALG10;MGAT3;UGGT1;FUT8;DPM1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7326468151213921,1.0962178585769593,0.38636363636363635,1.0,1.0,3/6,25.22%,CNOT2;CNOT6L;CNOT6
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.7142220594614496,-1.0956847318885223,0.3953488372093023,1.0,1.0,1/7,4.46%,SLX4
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.7371861667253142,1.0956805426619658,0.3584905660377358,1.0,1.0,1/6,3.08%,S100A13
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.7109704891193873,-1.0954483778273594,0.4074074074074074,1.0,1.0,1/6,3.18%,PLET1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.44283846505068514,1.0953152201395537,0.29545454545454547,1.0,1.0,14/93,10.38%,LTK;ERBB4;FGFR2;EGFR;CSF1;ROR1;EPHA3;FGFR3;RYK;EPHA7;TAB2;IGF1R;CSF1R;PDGFRB
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.7481112902411493,1.0953109621612245,0.49122807017543857,1.0,1.0,1/5,6.10%,MICU1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.44043355606289686,-1.0952199866358716,0.27450980392156865,1.0,1.0,61/189,25.26%,SARS1;TRPT1;SBDS;UTP11;INTS5;DDX27;EXOSC10;RPLP1;PDCD11;NOP14;RPL37A;RPL28;LAS1L;NOLC1;RPS15;RPL4;RPL12;RPL34;NOP56;RPL31;METTL3;RPS27;EMG1;RPL8;POP1;NVL;RPL19;RPL23;RPL5;MRTO4;RPL7A;MPHOSPH10;RPL38;POP7;RPL24;RPS24;DGCR8;RPL6;DDX54;RRP1B;RPL29;FBL;POP5;RPL13;NOL8;EXOSC4;RPL11;RPL35A;RPL10A;RPL37;RPLP2;RPS14;RPS25;RPS6;WDR75;NOP58;RRP1;KRR1;PELP1;UTP14A;RPL27A
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.6698715428205582,-1.095112206910679,0.4166666666666667,1.0,1.0,2/7,18.94%,NR1H4;HTR2A
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.688356107776497,1.0950885403325257,0.28205128205128205,1.0,1.0,3/9,16.38%,ITPKB;IP6K2;IPPK
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.4658402000070657,1.0948620286124098,0.23404255319148937,1.0,1.0,24/98,18.33%,VAPB;CERS3;PPM1L;SPHK1;ELOVL6;GLA;PRKD1;ACER1;ASAH2;GLB1;HACD2;PLPP1;ALDH3A2;PLA2G15;ESYT3;SGMS1;CERS5;SMPD4;TECR;HEXB;ELOVL7;TEX2;ESYT2;CERS6
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.465067219166602,1.09485388620019,0.22727272727272727,1.0,1.0,24/112,10.61%,DACH1;MARVELD3;STK26;KANK1;PTPRK;MAGI2;SMAD7;ROBO1;SULF1;NAV3;SLIT2;FOXO3;RHOB;MCTP1;PTPRG;BMPR1A;SRGAP2B;ADIPOR1;MITF;TP53INP1;JAG1;TIMP1;TMEFF2;RAP2A
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.7379300006728546,1.0948447806582666,0.38181818181818183,1.0,1.0,1/5,5.80%,GLA
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.46170719727674575,1.0944657127555413,0.2777777777777778,1.0,1.0,29/101,17.35%,RGMA;PTPRK;HJV;SMAD7;NLK;TGFBR1;RUNX2;PARD3;TWSG1;ACVR2A;SMAD5;BMPR1A;SMAD1;SMAD2;SMAD9;SMURF2;ACVR1B;SIRT1;SMURF1;ACVR1;SCX;GDF10;TGFBR3;LTBP2;SMAD3;TGFBR3L;DUSP22;BMP6;INHBA
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.624592942645143,-1.0943356150669041,0.44680851063829785,1.0,1.0,2/12,14.73%,ANAPC15;XRCC3
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.5219292967356828,1.0940729368318696,0.2608695652173913,1.0,1.0,6/33,10.68%,ESAM;NTF3;NRP1;ABL2;CSF1R;MDK
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5132317871638619,-1.0940090940572211,0.2608695652173913,1.0,1.0,27/43,27.88%,PSMA7;PSMD7;PSMB4;PSMC3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6;AZIN1;PSMB1;PSMA5;PSME2;PSMA4;PSMD3;PSMD11;PSMB6
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.634056604172388,1.0938481919886456,0.3191489361702128,1.0,1.0,2/7,11.81%,CXCL12;PIK3CA
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.5717450213222542,1.0938404515318783,0.30434782608695654,1.0,1.0,8/22,17.48%,HORMAD1;DMC1;FSHR;MDK;MEI4;M1AP;DIAPH2;NANOS1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.6134770882246945,-1.0938143077712406,0.36,1.0,1.0,1/14,0.53%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.6225569809564133,1.093710054324255,0.40425531914893614,1.0,1.0,2/13,8.16%,NUS1;HIF1A
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6508501802716057,1.0936648452255546,0.4583333333333333,1.0,1.0,1/8,6.79%,SNCA
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6478371261644219,1.0936519108641956,0.3617021276595745,1.0,1.0,5/10,19.31%,RUNX1;ELF1;ELF2;CBFB;PAX5
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.5129428355403174,1.0934647078024589,0.27450980392156865,1.0,1.0,7/34,18.51%,B4GALNT2;EPCAM;MBP;JAG1;VEGFA;BMP6;PTK2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.6205971360725442,1.0933119779690932,0.3333333333333333,1.0,1.0,3/12,12.98%,NR3C2;NR3C1;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.4817312590497966,1.0932753371707535,0.2857142857142857,1.0,1.0,20/80,10.78%,LTK;FZD1;NDNF;RIT2;MAGI2;WNT5A;ROR1;EPHA3;ZNF804A;PRKD1;TOX;ABL2;COBL;FUT9;RETREG3;STYXL1;LRRC7;TENM3;MDK;NPTN
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.7504812248155905,-1.0932161100586157,0.34615384615384615,1.0,1.0,1/5,0.63%,CCN3
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5831010330660328,1.0930834267274128,0.36363636363636365,1.0,1.0,11/16,25.91%,NRP1;FER;PDGFD;PDGFRB;BCAR1;RGS14;PDGFC;ABL1;PLAT;PDGFB;PDGFRA
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.7541803473477932,1.0927383455081419,0.36363636363636365,1.0,1.0,1/5,3.08%,S100A13
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.7541803473477932,1.0927383455081419,0.36363636363636365,1.0,1.0,1/5,3.08%,S100A13
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5509567154328673,1.0926240624381114,0.3404255319148936,1.0,1.0,4/24,11.86%,PPARG;NR1H3;SIRT1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5826788453162375,1.0922113286135668,0.4,1.0,1.0,3/16,15.05%,KLRD1;CADM1;CD160
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6201948324441059,1.0921603256632804,0.4230769230769231,1.0,1.0,7/15,26.44%,GRID2;MEF2C;GRIN2A;MPP2;LRRK2;GRIN2B;ARRB2
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.5507723511795571,-1.0920705258150627,0.33962264150943394,1.0,1.0,4/22,8.19%,WNT7B;FGF1;FGF7;RBP4
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.5954766019773763,1.0920640012584317,0.4,1.0,1.0,8/25,13.63%,SLIT2;PKHD1;FGF10;RHOB;CSF1R;CTNNB1;ACVR1;MEF2C
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6141235859529883,1.091931564296364,0.38181818181818183,1.0,1.0,4/14,14.25%,RUNX1;LEPR;MDK;THBS4
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.6925872482014488,1.0917369569514745,0.41935483870967744,1.0,1.0,1/5,8.43%,LMO3
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.6827616528438281,1.0916084318550499,0.4146341463414634,1.0,1.0,3/7,21.24%,AGER;EPHA4;ABL1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.49603860038748226,-1.0913042335877627,0.2857142857142857,1.0,1.0,3/77,3.94%,PM20D1;NTRK1;FGF20
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.6022898008045884,1.0911092912465692,0.375,1.0,1.0,2/11,12.38%,NLGN1;SYN3
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6905090562790254,1.0911060810320579,0.39655172413793105,1.0,1.0,2/6,10.22%,WNT5A;CHD7
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.6531515863469753,-1.0910487011589398,0.4098360655737705,1.0,1.0,1/9,0.61%,NUPR1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5642634307726756,1.0910402485766628,0.375,1.0,1.0,3/25,3.66%,KLKB1;IFI16;HGFAC
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5517738027857207,-1.0906536490865242,0.36666666666666664,1.0,1.0,7/29,8.48%,SELP;PCDHB6;PCDHB10;PCDHB9;CDH17;PCDHB4;CDH24
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.46606155151856604,1.0905697921179776,0.3409090909090909,1.0,1.0,21/98,16.62%,SGK2;FGFR2;TOX3;CAPN13;ABLIM1;FGFR3;ZSWIM5;COBL;PPP1R13B;PIK3C2B;ZDHHC11B;ANK3;MTUS1;SORBS1;PPP1R9A;MAPK4;MYO5C;NEBL;HLF;SLC22A23;FAAH
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.6215719823581437,1.0895803072071162,0.3617021276595745,1.0,1.0,2/8,11.75%,HDAC9;SIRT1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5680496945636092,1.0894266823686312,0.36,1.0,1.0,3/25,10.37%,RUNX1;LATS1;KCTD6
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.6934272842010687,1.0890858952258997,0.39215686274509803,1.0,1.0,3/9,16.60%,CSF1;PRKCA;IL34
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.5632717372313091,1.0890256684250073,0.32,1.0,1.0,7/22,19.28%,ZBTB20;HIF1A;SLC4A4;P2RX7;ARNT;INSR;NFKB1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.5007983681844039,1.0889155612176125,0.2765957446808511,1.0,1.0,2/46,3.20%,ACE2;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5624636992711215,1.0888217516149368,0.32653061224489793,1.0,1.0,5/18,15.54%,HMGB1;MFHAS1;TLR1;NR1H3;IFI35
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.5255691300082569,1.0884435233527934,0.3469387755102041,1.0,1.0,11/25,21.50%,ELOVL6;SCD;ACSL4;ACACA;HACD2;FASN;TECR;ELOVL7;SLC25A1;ACSBG1;ELOVL2
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.7355762785943494,-1.0884132593050933,0.391304347826087,1.0,1.0,2/7,7.58%,PRKCH;FOXP1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.6305722845421919,-1.087988875181109,0.425531914893617,1.0,1.0,2/12,11.78%,CLU;CRYAB
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.39445462805949894,-1.0877480643220634,0.21818181818181817,1.0,1.0,56/306,19.20%,DDX11;PARP2;CGAS;PLK3;BACH1;CIDEB;CBX1;PLK5;XPC;VAV3;SLX4;ERCC1;REXO4;RNF8;PPP1R15A;TICRR;PWWP3A;GADD45A;FANCC;RAD51AP1;BCL2L2;NUDT1;DTX3L;CCND1;FOXP1;XRCC2;HMCES;STK11;HIC1;PIDD1;METTL3;DDB1;HUS1;PARP1;INO80;RPAIN;XRCC3;SPATA18;MORC2;TAF1;RBBP8;MBD4;FBXO6;MUS81;ZRANB3;USP10;NRDE2;KIN;BAK1;SLFN11;XIAP;CBX5;RPS3;RECQL;FANCG;TDP1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6428082692784383,1.0876802724023598,0.38181818181818183,1.0,1.0,4/10,23.83%,NCK1;HSPA1A;VHL;DNAJB1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.5153460044441928,-1.0875424315925486,0.3050847457627119,1.0,1.0,10/46,19.22%,DHFR2;ACOT4;D2HGDH;MDH1B;NIT2;GOT2;L2HGDH;PHYH;ASS1;FH
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.5724308017507749,-1.0874647452374302,0.3442622950819672,1.0,1.0,2/27,5.06%,SLX4;ERCC1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.4814599682350079,1.0870203333772077,0.28205128205128205,1.0,1.0,13/69,10.34%,IFI16;RUNX1;SELPLG;FGFR2;WNT5A;ZFP36L2;RUNX2;MEIS1;TOX;FST;CSF1R;JAG1;DLL1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.6069991112780628,-1.0868317281776396,0.37735849056603776,1.0,1.0,2/7,19.22%,MDH1B;FH
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6523928967068631,1.0867362532482092,0.4418604651162791,1.0,1.0,3/8,19.39%,RP1;BBS4;RPGRIP1L
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.6394075645678937,-1.0866315014458563,0.4230769230769231,1.0,1.0,2/10,18.69%,ATF4;KDR
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.5687690942847781,1.0866144621719516,0.3111111111111111,1.0,1.0,10/26,14.47%,FZD1;WNT5A;CUL1;DTX4;MAML2;PRKCA;JAG1;DLL1;NOTCH3;WNT2
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.439576230941103,-1.0865955597966228,0.31666666666666665,1.0,1.0,12/111,10.39%,GOLGA8B;PLK3;STX16;PLK5;GOLGA2;ZFP69B;TANGO2;GOLGA8A;ATP8B4;NSFL1C;GOLGA8N;GAK
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.7026303847344735,1.0865136732828857,0.4,1.0,1.0,1/6,6.38%,DENND4A
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.5124013535952164,-1.0863462307364002,0.33962264150943394,1.0,1.0,10/55,5.86%,P2RY10;CD5;KLRB1;ARHGAP15;TRAF3IP3;TRBC2;EPSTI1;CD4;SLA;TMC8
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.591608524456839,-1.0862059780509743,0.40350877192982454,1.0,1.0,8/14,25.85%,NAXE;MYADM;PPT1;RFTN1;FLOT1;NPC1;EMP2;ANXA2
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.5210430438903396,1.0861490591277414,0.34615384615384615,1.0,1.0,3/24,10.96%,ESAM;LATS1;CXCL12
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.6614097302615067,1.0859087202223476,0.37735849056603776,1.0,1.0,2/6,8.76%,DDAH1;DDAH2
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4005699502828342,1.0858038278151574,0.25,1.0,1.0,15/158,9.67%,GALNT3;SGK2;SGK3;NDNF;GALNT13;TGFBR1;RPS6KA4;LATS1;DYRK3;PRKD1;CLSPN;EIF2AK3;SGK1;DYRK1A;PRKCA
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5041475231756273,1.0853593546958837,0.27906976744186046,1.0,1.0,11/42,11.73%,GRM7;NLGN1;NRXN1;TSHZ3;GRM5;GRM8;SYT1;CDH2;GRM6;GRIK1;GRM1
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.7237467179760664,-1.0849187929200272,0.3958333333333333,1.0,1.0,1/5,13.94%,DERA
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.6985645691503767,-1.0844681784241808,0.49122807017543857,1.0,1.0,3/6,25.19%,INO80;WIZ;CDC7
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5137051485153298,-1.0843237278442048,0.2926829268292683,1.0,1.0,35/57,27.26%,PSMA7;PSMD7;UBC;PSMB4;PSMC3;ORC3;MCM5;MCM2;PSMD8;ORC1;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;CDC6;PSMD12;PSMB3;PSMB7;PSMC6;ORC6;UBB;ORC2;PSMB1;MCM4;PSMA5;PSME2;PSMA4;PSMD3;PSMD11
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.5580727520235456,-1.0842070968087962,0.38596491228070173,1.0,1.0,1/25,0.81%,TYMS
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.7201771353563029,1.0830936322731188,0.425531914893617,1.0,1.0,4/5,25.73%,CLASP1;PHLDB1;CLASP2;DAG1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.7201771353563029,1.0830936322731188,0.425531914893617,1.0,1.0,4/5,25.73%,CLASP1;PHLDB1;CLASP2;DAG1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.5717850742827411,1.0830820174272486,0.38,1.0,1.0,4/14,12.30%,IDO1;HPD;FAH;QDPR
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4253530833933136,1.0829818284905526,0.2619047619047619,1.0,1.0,39/206,10.78%,FAS;LTK;EFNA5;ERBB4;FGFR2;LEPR;DSCAM;AGER;EGFR;ROR1;CCL5;EPHA3;FGF10;PELI2;TNIK;NRP1;VEGFC;ZBTB20;ACVR2A;FGFR3;HDAC3;RYK;LIMK2;FGF17;FGF5;HGF;EPHA7;HIF1A;PROM2;DVL2;P2RY1;IGF1R;C3;CSF1R;SLC4A4;VEGFD;PDGFRB;RAP2A;NPTN
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.6948368952563173,-1.0827737515556972,0.48,1.0,1.0,3/7,12.65%,METAP2;METAP1D;APOA1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.5744578435483998,-1.0826526272620154,0.2909090909090909,1.0,1.0,1/17,0.91%,MYB
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.6947883189531256,-1.082633338093285,0.46153846153846156,1.0,1.0,3/8,10.87%,TPM1;MYL5;PVALEF
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.6579728174857927,1.0823906470596178,0.38636363636363635,1.0,1.0,1/7,9.54%,ZDHHC2
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.7259561701103945,1.0822802058791738,0.44680851063829785,1.0,1.0,3/6,17.81%,SH3GL2;VEGFA;TJP3
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6988557311615732,-1.0821996706780312,0.4,1.0,1.0,2/5,19.78%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.4998391975306148,1.081923128880924,0.34782608695652173,1.0,1.0,8/33,10.68%,SEMA5A;DSCAM;NRP1;HSPB1;PRKD1;CDH13;PDGFRB;MDK
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.659327281727813,1.0816703067794173,0.40350877192982454,1.0,1.0,1/10,0.64%,STK26
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.4447239854231235,1.0815885176384743,0.2727272727272727,1.0,1.0,16/81,10.38%,LTK;ERBB4;FGFR2;LDB2;EGFR;ROR1;EPHA3;IRS2;ECT2;FGFR3;RYK;EPHA7;PLCE1;IGF1R;CSF1R;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.6620002879456071,1.0815819376652651,0.4,1.0,1.0,2/9,12.70%,BAG2;ADAM8
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.5305941973256472,1.0814502203317915,0.23809523809523808,1.0,1.0,8/28,9.51%,HMGB1;AGER;WNT5A;SYK;TWIST1;MBP;HIF1A;CSF1R
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.7759273943279904,1.0813850267737142,0.4489795918367347,1.0,1.0,4/5,21.34%,SH3GL2;TMEM108;WASF1;NTRK2
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.4721827976970747,-1.081301888617917,0.37254901960784315,1.0,1.0,15/95,12.65%,CPXM2;TAGLN;COL6A1;GSTM3;FBLN2;RNASE1;TPM1;TPM4;CALD1;ADAM33;ADAMTS5;COX7A1;CRYAB;CYP1B1;APOA1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.5793572754246993,-1.0809987263764844,0.39622641509433965,1.0,1.0,7/17,22.65%,RRP15;EXOSC10;LAS1L;FTSJ3;EXOSC4;EIF6;NSA2
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.6688570147531983,-1.0805593775553544,0.3898305084745763,1.0,1.0,1/8,0.63%,CCN3
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.590305705871788,1.0804085774374375,0.3125,1.0,1.0,4/18,16.72%,PARD3;SYNE4;RAP2A;CLASP1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.5359613414593779,1.0803225089120476,0.34,1.0,1.0,8/25,11.75%,ADIPOR2;CX3CR1;CCL5;ADIPOR1;MITF;C3;PRKAB2;SIRT1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.5470264665676376,-1.0802105788120353,0.34545454545454546,1.0,1.0,3/31,6.17%,FIP1L1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.5428482026263388,1.0798555908956664,0.40476190476190477,1.0,1.0,3/21,4.82%,HMGB1;AGER;IDO1
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.5390278314401421,-1.0796098596698893,0.3584905660377358,1.0,1.0,3/29,6.54%,USP27X;ABRAXAS1;USP20
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.41354636547649026,1.0795839289270523,0.32432432432432434,1.0,1.0,80/394,14.88%,MED17;FZD1;MYRFL;ESRRG;RUNX1;PLCB1;NFIL3;ERBB4;PPARG;CREB5;FANK1;TFEB;EGFR;HEY1;PPARGC1A;WNT5A;ARID1A;TGFBR1;ARID1B;RUNX2;KLF2;TEAD2;RFX3;MLLT3;FOXO3;SP3;PSRC1;TP63;SMAD5;RFPL2;TBL1XR1;SPIN1;NPAS3;TCF4;GLI3;RORA;NR1D2;ZNF516;HDAC2;SUPT3H;SMARCD3;HINFP;HIF1A;NR5A2;MSTN;GLIS2;ACTA2;ATOH8;MITF;SMAD2;TP53INP1;DYRK1A;SNX5;NR1H3;ING1;RYBP;CD38;BTRC;CAMK4;CTNNB1;FOXO1;EPC1;NFIB;YAF2;PPM1A;CREB1;MYRF;SOX11;EP300;ACVR1;SCX;MEF2C;FLI1;PICALM;SALL1;HNRNPD;TRERF1;HIVEP3;ZXDC;NFATC2
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.6776382071369886,-1.0793307350373205,0.4909090909090909,1.0,1.0,2/6,5.72%,CGAS;PDE11A
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6109767449138942,1.078729472949182,0.4444444444444444,1.0,1.0,2/9,16.92%,PIP4K2A;ELAPOR1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.6152792014503818,-1.0784594452936715,0.39215686274509803,1.0,1.0,1/10,2.08%,SPA17
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.6439311544973918,1.0779785239872621,0.38,1.0,1.0,3/9,14.54%,ENPP1;PID1;PRKCB
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.6719206924029166,-1.0779343806825514,0.46,1.0,1.0,2/6,20.38%,LIMD1;PTHLH
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.5262473478558594,1.0776318346840463,0.2826086956521739,1.0,1.0,14/49,23.01%,LRRC4C;ROBO1;SLIT2;ROBO2;CDH2;LRP4;TIAM2;SIPA1L1;PLXNB2;EPHA4;PAK3;NTRK2;PLXNB1;CHODL
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.6721142428055956,-1.077218119139061,0.42592592592592593,1.0,1.0,2/9,7.42%,B3GNT9;B3GALT5
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.4783702036501356,-1.0770561613538667,0.3090909090909091,1.0,1.0,2/37,0.46%,HLA-DPB1;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.502698527745201,1.0769305249657957,0.2708333333333333,1.0,1.0,5/35,9.79%,MYBPC3;FGF10;SETMAR;TOR1AIP2;DNAJB2
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.7083079648177609,1.0768489301769095,0.40425531914893614,1.0,1.0,1/6,2.19%,PPARG
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.5453299529910955,-1.076600751047715,0.33962264150943394,1.0,1.0,2/34,3.54%,TLCD2;STX4
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.7129267859309518,1.0761772000338865,0.44680851063829785,1.0,1.0,2/5,10.34%,CDK6;DLL1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.5152527141789214,-1.0760794914906788,0.3617021276595745,1.0,1.0,3/40,4.06%,HLA-DPB1;NCKAP1L;DOCK8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.6743363312525421,1.0760061927854103,0.4166666666666667,1.0,1.0,1/6,10.05%,BICD1
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.6934426035907377,-1.0759993968674122,0.38636363636363635,1.0,1.0,4/6,28.92%,SLC27A1;TAMM41;CDS2;PLA2G6
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.6720687826622572,-1.0759311517600374,0.4482758620689655,1.0,1.0,3/8,17.70%,PHAX;PKP1;NRDE2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.49917663082943226,-1.0759098140209034,0.3181818181818182,1.0,1.0,17/42,25.55%,RPS27L;SBDS;RPF2;TRAF7;RPS15;C1QBP;RPS27;RPL5;RPL24;RPL6;RPL11;EIF6;RPS14;MPV17L2;DHX29;MRPS11;NPM1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6028851283554663,1.0756888044318826,0.36363636363636365,1.0,1.0,4/16,16.40%,RPS6KA4;PRKD1;EPHA5;VEGFA
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7125151710785306,1.0753622859303789,0.45652173913043476,1.0,1.0,1/5,1.73%,ALDH1A1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.6199230321077823,-1.0751405973396517,0.4426229508196721,1.0,1.0,8/15,30.80%,CAMLG;EMC8;EMC4;EMC3;EMC1;BAG6;EMC10;GET3
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6516020415193958,1.075107955998395,0.35294117647058826,1.0,1.0,2/6,24.66%,ARFIP1;LRRK2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.5981422611162216,1.0747065848329882,0.2972972972972973,1.0,1.0,5/15,22.52%,HEY1;BMPR1A;ACVR1;SMAD4;SLIT3
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6619956631140415,1.0746002099859475,0.375,1.0,1.0,4/8,16.40%,TGFBR1;NRP1;TGFBR3;VEGFA
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.6789965134273815,1.0745644982802876,0.3958333333333333,1.0,1.0,3/6,23.29%,PIK3R1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.6789965134273815,1.0745644982802876,0.3958333333333333,1.0,1.0,3/6,23.29%,PIK3R1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.47549895717197077,1.0743320609758922,0.3170731707317073,1.0,1.0,16/62,8.64%,FZD1;PCDHB3;NLGN1;LRRTM3;NRXN1;DSCAM;FLRT3;WNT5A;GPM6A;RAB29;GABRB2;GRID2;RYK;ADGRL3;CDH2;NLGN4X
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.5317004205311111,-1.0741673743177025,0.34545454545454546,1.0,1.0,6/46,8.14%,TPPP3;CATIP;RAC1;VIL1;TRPV4;WASHC3
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.48246991972343073,1.074120994357328,0.3333333333333333,1.0,1.0,10/62,11.09%,EIF3E;C8ORF88;CCL5;PPP1R15B;HSPB1;DNAJC3;EIF3H;EIF2AK3;NCK1;ATF3
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.4652072067900062,-1.074014674502133,0.2830188679245283,1.0,1.0,8/50,7.97%,CLDN4;TMEM184A;SERPINE1;MAFF;CD4;ADAM19;IL1R1;LTBR
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5811956708403745,-1.0739401698681093,0.4426229508196721,1.0,1.0,2/12,7.70%,TK2;PUDP
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.45622572970248587,-1.0738685586863843,0.2692307692307692,1.0,1.0,15/83,12.65%,CCN3;MMP26;AOAH;SIGIRR;SERPINE1;NLRP3;DHX58;DRD3;DRD1;NR1H4;PROC;TRAF3IP1;C1QBP;CERS2;APOA1
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6099218085192636,1.0737210925125455,0.4222222222222222,1.0,1.0,3/9,6.13%,FGFR2;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.6247533478253483,-1.0733206655339234,0.46,1.0,1.0,2/14,10.89%,FGL1;IL4I1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.5662582821834025,1.0731968365133515,0.4186046511627907,1.0,1.0,5/21,10.68%,LOXL2;TRPS1;TGFBR1;SOX5;MDK
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.7000831657113791,1.0727333382570714,0.39622641509433965,1.0,1.0,2/6,15.51%,IRS2;AKT2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6009176143284207,1.0723503711631606,0.38461538461538464,1.0,1.0,4/14,17.27%,C3;PRKCB;BRAF;SLC2A1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.6737239998701243,1.0722309459952333,0.36,1.0,1.0,2/9,10.61%,SYNE4;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.5698746281195828,-1.0721244818573639,0.37254901960784315,1.0,1.0,5/18,10.28%,SH3RF2;PPP1R15A;ZCCHC9;PPP1R35;PTPA
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5233155144522554,1.0716031185090518,0.3076923076923077,1.0,1.0,4/26,8.43%,CALCR;LGR5;RXFP2;FSHR
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.552236072174714,-1.071397488285736,0.32142857142857145,1.0,1.0,3/26,7.58%,SFRP1;NODAL;FOXP1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.48647984653835613,1.0710715814885752,0.3111111111111111,1.0,1.0,11/53,15.40%,RUNX1;H3-3A;MEIS1;CDK6;CNOT4;RBBP5;MEIS2;EP300;MEF2C;PRKCB;KAT2B
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6690178738844718,-1.0706439702227943,0.44680851063829785,1.0,1.0,1/11,0.56%,INHA
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.6564546235227243,1.0706348122461888,0.42857142857142855,1.0,1.0,4/8,24.52%,ANK3;AKT2;BAD;GLRX
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5870759390344092,1.069912373080121,0.36363636363636365,1.0,1.0,3/14,7.23%,C12ORF50;NXF1;NXF5
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.45189621453322193,-1.0690892752771777,0.32142857142857145,1.0,1.0,10/75,9.00%,TYMS;PLK3;BACH1;CDKN3;LATS2;CDK5;CCND1;ZNF324;MAX;PLK2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.5903929612579013,-1.0690244650743692,0.4067796610169492,1.0,1.0,1/16,0.56%,INHA
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5047370461340122,1.0689071187751638,0.2826086956521739,1.0,1.0,8/30,16.07%,PDE4D;RIMS2;PDE3A;PDE2A;AKAP6;EPHA5;CAP1;ADCY2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.47093711526400306,-1.0685920493484855,0.3620689655172414,1.0,1.0,8/98,7.68%,ACOT1;AOAH;ACOT11;ACOT4;MECR;ACOT12;LIPC;ACSBG2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6111736379158337,-1.0685475634085924,0.4426229508196721,1.0,1.0,3/10,23.08%,COPS6;COPS7A;COPS7B
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.7013395823685089,-1.0684449998769587,0.4444444444444444,1.0,1.0,1/5,7.06%,DTX3L
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.4571988592830584,-1.0682824557075297,0.24489795918367346,1.0,1.0,20/57,25.80%,SURF6;RPF2;NOP14;NOP16;RPS15;EMG1;NVL;RPL5;MRTO4;RPL38;PAK1IP1;RPS24;RBIS;NOM1;RPL11;RPL35A;RPS25;RPS6;NPM1;SDAD1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.4946099641516825,-1.0681723873093096,0.32075471698113206,1.0,1.0,11/51,8.88%,ETV5;SIGLEC1;C2;DUOXA1;RNASE1;CEBPD;NRN1;SCGB1A1;IL1R1;FPR3;IFI27
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.7347929080335246,1.067978347823993,0.43478260869565216,1.0,1.0,1/5,2.10%,ZFP36
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5303727362438397,-1.0677038619842598,0.3877551020408163,1.0,1.0,9/30,19.07%,RAC1;VAV3;PPP1R15A;RAB3B;RIN3;PEX11B;PEX11G;PPP1CA;MTPN
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.45576507736108196,-1.067517758116241,0.3387096774193548,1.0,1.0,15/70,15.60%,UVSSA;ERCC1;UBC;POLR2I;XRCC1;RBX1;PRPF19;POLR2J;COPS6;GTF2H2;DDB1;COPS7A;POLR2G;ERCC2;POLR2C
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.5625962281430715,1.067049565342342,0.375,1.0,1.0,9/29,21.00%,PLCB1;TDG;CRB2;RPS6KA6;CLASP1;PHLDB1;INSR;CLASP2;NIPBL
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.6671976826358067,1.0664048411057188,0.5172413793103449,1.0,1.0,1/6,3.72%,MTERF3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.6860569484113169,-1.0661360634365686,0.37254901960784315,1.0,1.0,3/6,26.86%,CEACAM1;PVR;IL12A
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.7163603907704376,1.066099135631879,0.45098039215686275,1.0,1.0,4/6,20.85%,GLA;ATP2B4;ROCK2;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.7163603907704376,1.066099135631879,0.45098039215686275,1.0,1.0,4/6,20.85%,GLA;ATP2B4;ROCK2;SIRPA
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.7251360009195811,1.066050694178132,0.44776119402985076,1.0,1.0,3/5,9.15%,ENPP1;DCTPP1;SMPDL3A
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6473542205752228,-1.0659559584927614,0.45098039215686275,1.0,1.0,3/8,22.54%,ATG14;MAP1LC3B;SQSTM1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),0.7285313689063587,1.065904136112747,0.4528301886792453,1.0,1.0,1/5,10.78%,NPTN
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.42987253797724023,1.0658796930616932,0.23529411764705882,1.0,1.0,22/118,8.74%,GPC6;LRRC4C;PCDHB3;NLGN1;NRXN1;DSCAM;FLRT3;CX3CR1;NEDD4;GPM6A;GRM5;RAB29;PDZRN3;CACNB2;PTPRD;LRFN5;SNCA;RYK;ADGRL3;CDH2;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.6116102619614837,-1.0654683834649215,0.43137254901960786,1.0,1.0,2/10,16.76%,CDH17;SRC
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5134674307378753,-1.0654518299390625,0.2833333333333333,1.0,1.0,9/45,5.86%,P2RY10;NCKAP1L;CD5;AOAH;TRAF3IP3;CD37;CD4;SLA;TMC8
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4190727760188703,1.065422388993091,0.275,1.0,1.0,58/367,12.59%,DACH1;LOXL2;NRG1;IFI16;ZFPM2;NAB1;PLCB1;NFIL3;PPARG;PTPRK;ID3;ZNF706;BAHD1;MTERF3;ZEB1;HEY1;WNT5A;TSHZ3;RUNX2;RFX3;FOXP2;HDAC9;KCTD1;SP3;NR3C1;TP63;ATXN1;HDAC3;TWIST1;GLI3;NR1D2;SPINDOC;HDAC2;TLE1;HINFP;PHC2;CTBP2;GLIS2;BCOR;ATOH8;SMAD2;SMARCE1;POU2F1;SMURF2;NPAS1;ARID5B;HIC2;PRICKLE1;BRMS1;CD38;BTRC;CTNNB1;SIRT1;FOXO1;EPC1;DPF3;YAF2;FOXN3
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.618278711421485,-1.0650920126812693,0.4807692307692308,1.0,1.0,3/13,4.48%,WNT9A;ADAMTS12;RFLNA
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.6894338591727309,-1.065074116528934,0.45098039215686275,1.0,1.0,1/6,2.43%,FOXM1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.5974078688825216,-1.0650611920792479,0.42592592592592593,1.0,1.0,5/14,21.16%,SIGIRR;ITIH4;LBP;IL6R;MYLK3
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.6700551069173895,-1.0648423589302343,0.4528301886792453,1.0,1.0,2/7,10.16%,RAB3B;RIN3
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.6823068278053401,1.064791893641882,0.5319148936170213,1.0,1.0,1/5,3.62%,JAM2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.6333495928500179,1.0645760554974755,0.509090909090909,1.0,1.0,5/6,34.19%,FYN;GRIN2B;PRNP;APOE;HOMER1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.609513343914517,1.0644756132412276,0.39655172413793105,1.0,1.0,5/10,28.56%,NDFIP2;TERF1;WWP2;SNX3;CORO2B
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.6791444163848942,1.0644450063536095,0.5294117647058824,1.0,1.0,1/6,4.52%,SYK
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.509221166314784,-1.0641097478858017,0.4107142857142857,1.0,1.0,18/48,24.18%,NUPR1;KCNE2;PSMC3;GLMN;PRKACA;PINK1;DDRGK1;LAMP3;PSME1;DESI1;NUDT15;GABARAPL2;PSMC6;ARAF;HSP90AB1;UFL1;UBB;DAB2IP
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.5579948427312726,1.0639783371432168,0.3695652173913043,1.0,1.0,6/18,21.00%,SHROOM2;TENM3;COL5A2;VEGFA;C12ORF57;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.6394417077086316,-1.0639339454525547,0.44,1.0,1.0,3/12,13.37%,SERPINE1;CHAC1;SERPINF2
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.5753718302786983,1.0637850938669142,0.42105263157894735,1.0,1.0,3/12,6.43%,MSH4;EME2;HFM1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6444212375841847,1.063724832085731,0.45454545454545453,1.0,1.0,8/11,34.98%,PICALM;ROCK2;PRNP;FLOT2;ABCA2;APOE;CHRNA7;RANBP9
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.7261567990251507,-1.0635868305358922,0.44642857142857145,1.0,1.0,1/5,1.62%,AMDHD1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.7261567990251507,-1.0635868305358922,0.44642857142857145,1.0,1.0,1/5,1.62%,AMDHD1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.7142878613984335,-1.0633958282116687,0.48936170212765956,1.0,1.0,4/6,26.53%,SETDB1;BEND3;SUV39H1;PRDM5
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6815016915405273,1.063292429410124,0.45161290322580644,1.0,1.0,2/5,17.06%,SLC39A8;SLC11A2
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6815016915405273,1.063292429410124,0.45161290322580644,1.0,1.0,2/5,17.06%,SLC39A8;SLC11A2
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6814409445998659,1.0632569619042478,0.3877551020408163,1.0,1.0,4/9,25.87%,GBE1;UGP2;PPP1R3C;PYGL
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.591248349295155,-1.0629524705504354,0.325,1.0,1.0,2/11,3.23%,NTN5;RAC1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.5478476261168979,1.0628638033321742,0.325,1.0,1.0,7/20,10.38%,SMAD7;TGFBR1;ADAMTS9;NRP1;BMPR1A;JAG1;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.6514142387729228,1.0627360682237388,0.4444444444444444,1.0,1.0,1/6,11.49%,CAMK4
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.5999139513436649,-1.062645500182211,0.40425531914893614,1.0,1.0,2/18,11.17%,DHFR2;GGH
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5175771326976776,1.0623779491010883,0.35714285714285715,1.0,1.0,9/39,15.45%,RALA;NLGN1;GPM6A;NRP1;TENM2;TENM1;FNBP1L;PIK3R1;PLPPR5
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.6230187514732883,-1.062152837503269,0.45652173913043476,1.0,1.0,4/14,17.48%,CD9;CEACAM1;PDGFA;ADAMTS18
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.6866523883965144,-1.0618676287816915,0.4444444444444444,1.0,1.0,1/5,6.67%,ADRA2A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.5769268220278718,-1.0614104198705168,0.4642857142857143,1.0,1.0,1/14,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5627450047692806,1.0610156378208673,0.4418604651162791,1.0,1.0,6/17,25.07%,HELLS;TEX15;ATF7IP;KMT2E;PPM1D;GATAD2A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5627450047692806,1.0610156378208673,0.4418604651162791,1.0,1.0,6/17,25.07%,HELLS;TEX15;ATF7IP;KMT2E;PPM1D;GATAD2A
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.4780683796316732,-1.0610001766181867,0.38461538461538464,1.0,1.0,7/56,9.00%,AURKA;RPS27L;PLK3;GADD45A;CCND1;TRIAP1;PLK2
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.7389568055336896,-1.0608427884091611,0.41818181818181815,1.0,1.0,1/5,6.80%,VIP
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.621097302893481,1.0608228938970803,0.38636363636363635,1.0,1.0,2/9,11.68%,SMAD7;CTNNB1
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.6323395440123859,-1.0606044307168114,0.4583333333333333,1.0,1.0,1/10,2.83%,MEOX1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.604150238194346,1.060290806914926,0.45098039215686275,1.0,1.0,2/12,3.36%,PPARG;CIDEA
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.5228266060344646,1.0601253941433095,0.35714285714285715,1.0,1.0,5/24,15.52%,ECT2;HDAC3;UBR5;PIK3R1;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.48413618231599154,-1.059967408042364,0.3269230769230769,1.0,1.0,7/59,4.30%,NCKAP1L;TNFSF18;FBLN2;RAC1;STX4;NODAL;TPM1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.5322264621408531,-1.0597591025362574,0.3617021276595745,1.0,1.0,8/20,22.63%,RPF2;TRAF7;RPL5;RPL24;RPL6;DDX28;RPL11;DHX30
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.45733442184144923,-1.0597037554761384,0.36538461538461536,1.0,1.0,28/80,20.53%,AURKA;PSMA7;SKP1;PSMD7;RBX1;PSMB4;PSMC3;RFPL1;PSMD8;BRD7;GPR132;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;E2F7;PSME1;PSMD10;SLFN11;PSMA8;PSMD12;PSMB3;PSMB7;CDKN2B;PSMC6
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.5681800735861139,-1.0592715953038387,0.391304347826087,1.0,1.0,3/21,5.16%,GSTM3;GFRA3;GPC1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.44949475185047166,1.0590665795492782,0.3488372093023256,1.0,1.0,9/66,12.39%,AEN;IFI16;RFWD3;ECT2;RHOB;IKBIP;SIRT1;LIG4;RAD9B
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.6780900329624027,-1.0588424412219235,0.43478260869565216,1.0,1.0,1/6,9.51%,PCARE
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5538999224160966,1.0588295997825987,0.3541666666666667,1.0,1.0,4/16,9.72%,MYBPC3;CHRM2;PLCE1;KCNB2
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.6826853059866713,-1.0586758063714783,0.5,1.0,1.0,1/5,7.38%,TRPV4
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7080560286871693,-1.0586277970189264,0.39622641509433965,1.0,1.0,2/8,8.15%,SFRP1;PLEKHA4
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6450010674515709,-1.0583044699558686,0.46,1.0,1.0,3/7,22.98%,OAS3;TRIM25;CLPB
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.47239334609012823,1.058237050209517,0.34285714285714286,1.0,1.0,22/88,10.61%,DACH1;STK26;KANK1;PTPRK;MAGI2;SMAD7;ROBO1;SULF1;NAV3;SLIT2;FRMD5;FOXO3;RHOB;MCTP1;SPOCK3;SRGAP2B;MITF;TP53INP1;JAG1;TMEFF2;CCDC125;RAP2A
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5502639492058289,-1.0579912785146786,0.4074074074074074,1.0,1.0,8/29,18.36%,TBPL2;TCEA2;TTF1;TAF7;TAF6;TAF10;BRF1;SMARCA5
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6185258200804276,-1.0579704353284654,0.46551724137931033,1.0,1.0,3/13,19.90%,ZRANB3;SLFN11;ZNF830
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6558571963332249,1.0579342485087093,0.41509433962264153,1.0,1.0,4/7,18.92%,AGER;PICALM;ROCK2;EPHA4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.43865430636723307,-1.0575984572763726,0.3333333333333333,1.0,1.0,39/104,24.53%,RBM8A;UPF3B;UPF3A;RPLP1;RPL37A;RPL28;RPS15;RPL4;RPL12;RPL34;RPL31;RPS27;RPL8;RPS8;RPL19;RPL23;RPL5;RPL7A;RPL38;RPL24;RPS24;RPS3;RPL6;RNPS1;RPL29;RPL13;RPS20;RPL11;RPL35A;RPL10A;EIF4G1;RPL37;RPLP2;RPS14;RPS4X;RPS25;MAGOHB;SMG6;RPS6
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.455595240644096,1.0575784541380109,0.42,1.0,1.0,23/65,16.09%,ANTXR2;NFIL3;PPARG;HMGCS1;SCD;ERRFI1;FDFT1;LDLR;TP53INP1;JAG1;HMGCR;STARD4;GNAI1;ATF3;CTNNB1;SEMA3B;AVPR1A;TMEM97;FASN;ALCAM;CPEB2;GLDC;LPL
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.6518081321220408,1.057425623602922,0.45098039215686275,1.0,1.0,2/7,4.87%,CCL5;IRS2
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.7214168584686442,1.0573768499224536,0.4915254237288136,1.0,1.0,4/5,24.66%,FGF13;PEX13;EFHC1;LRRK2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5967010283862408,1.0573024726263542,0.38461538461538464,1.0,1.0,3/10,11.21%,MCU;MICU1;MAIP1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.550546245590197,-1.057292609588745,0.4074074074074074,1.0,1.0,2/24,4.15%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.550546245590197,-1.057292609588745,0.4074074074074074,1.0,1.0,2/24,4.15%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.551942892808204,1.057289845387989,0.3392857142857143,1.0,1.0,11/31,13.97%,AEN;IFI16;DDIT4;FHIT;ZNF385B;DYRK2;PPP1R13B;SIRT1;BOK;EP300;TP53BP2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.5364544105380391,1.0567181860120556,0.2916666666666667,1.0,1.0,5/28,11.21%,SLC8A1;MCU;JPH1;MICU1;MAIP1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.46071050445727413,-1.056692019294615,0.38181818181818183,1.0,1.0,13/79,21.78%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;MRPS21;MRPL9;MRPL19;MRPL27;MRPL51;MRPS18C;MRPL37;MRPS22
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.44515155259413297,-1.056597265174121,0.375,1.0,1.0,11/199,5.80%,TEKT3;PLK4;CATIP;TEKT5;CFAP61;RAB17;CFAP221;UBXN10;RILP;TXNDC15;AHI1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.49820167689455197,-1.056418331932839,0.39215686274509803,1.0,1.0,11/36,19.22%,SLC25A10;SORD;RBP4;ATF4;G6PC3;PER2;ENO1;GAPDHS;GOT2;PGK1;ENO2
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.5821549800217865,1.056404364469457,0.4146341463414634,1.0,1.0,3/14,13.89%,LDLR;STARD4;LDLRAP1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6288816109364764,-1.0562790532893542,0.41818181818181815,1.0,1.0,2/11,3.61%,ETV4;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.6727660666792035,1.0562627345661122,0.5116279069767442,1.0,1.0,1/6,8.39%,AUTS2
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5552151316481873,-1.056186861532503,0.39215686274509803,1.0,1.0,6/23,15.25%,RAC1;SHANK3;VIL1;SYNPO2L;ASAP3;SHANK1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.5421396738208121,-1.0561042624054147,0.3076923076923077,1.0,1.0,9/34,19.82%,MAP1LC3B2;WIPI1;WIPI2;MAP1LC3A;PINK1;FIS1;CISD2;MAP1LC3B;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5533197366492627,-1.055972970582671,0.3877551020408163,1.0,1.0,5/31,8.01%,CXCR5;FGF1;KIF20B;GIPC1;DRD3
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5713078432801661,-1.0559083899590866,0.3793103448275862,1.0,1.0,1/15,1.48%,HSF2BP
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.5755385834268223,-1.055896168973263,0.36,1.0,1.0,7/12,25.80%,NOP9;RPS15;EIF6;NMD3;RAN;NPM1;SDAD1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6002947491176689,-1.0556416469071401,0.4107142857142857,1.0,1.0,4/16,3.48%,NCKAP1L;XG;RAC1;CD74
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.49443161232701216,-1.055479089614866,0.3392857142857143,1.0,1.0,9/61,10.26%,PLK4;AURKA;PLK3;FGF1;PLK5;RFPL1;CALM1;PLK2;CETN2
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.7005184223941492,-1.0552487921990972,0.5510204081632653,1.0,1.0,1/7,2.91%,DIRAS3
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.6186709913889638,-1.0551243343607333,0.3958333333333333,1.0,1.0,1/12,0.21%,SELP
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5491669090106666,-1.054956886187161,0.4,1.0,1.0,1/19,1.73%,CLU
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.6406512981240889,1.0547085983662885,0.4634146341463415,1.0,1.0,4/7,24.25%,NFATC2;NFATC3;PDCD4;PDGFB
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.5480429664241908,-1.0545766372740861,0.3508771929824561,1.0,1.0,2/22,6.54%,USP27X;USP20
prerank,PanglaoDB_Augmented_2021__Interneurons,0.41462358943075533,1.0545740595967514,0.34210526315789475,1.0,1.0,69/274,16.12%,NDNF;CADM2;RIT2;KCNC2;KCNQ5;RGMA;OLFM3;SHISA9;LRRTM3;NRXN1;ADGRB3;FGF12;NXPH1;NCALD;GRM5;HIVEP2;CCN2;SLC35F1;TRIM9;AMER2;GRIA4;SYT1;CA10;ELAVL4;RPRML;NXPH4;RAB3C;RORA;SPOCK3;PCSK2;CTNNA2;CALN1;LMO3;ACSL4;SH3GL2;NOL4;SPTY2D1;SYNPR;GABRA4;RBFOX1;VEGFD;ADGRL2;PLCB4;NPY;DNAJC6;TMEM132D;CAMK4;GRM1;DLGAP1;PDE1A;PPFIA2;PCF11;RGS7BP;FBXO11;ERC2;GRIA2;KCNK9;CSRNP3;CTNND2;OXR1;PRKCB;DEPTOR;MAP2;PVALB;MAPK4;PLPPR5;HLF;NTNG1;TACR1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.6753818454560543,-1.0542438931501306,0.5227272727272727,1.0,1.0,3/6,30.03%,ATP5F1D;ATPAF1;OXA1L
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.5963849693216174,-1.0540339412958053,0.46808510638297873,1.0,1.0,1/15,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.5901586529884418,-1.053934057821023,0.4153846153846154,1.0,1.0,2/19,4.04%,MYO15A;MYO7B
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.4763883319980048,1.0538383524932227,0.2978723404255319,1.0,1.0,15/81,11.89%,GPC5;GPC6;PRELP;CHSY3;CSGALNACT1;HS3ST5;HS2ST1;CHSY1;CHST6;B4GALT1;HS3ST3B1;UGDH;CHST7;HS3ST1;EXT1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.4676722375337655,-1.0535462028612201,0.3269230769230769,1.0,1.0,5/46,4.74%,HLA-DPB1;NCKAP1L;CD74;VAV3;BST1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.5073833286997582,-1.0532370919504885,0.4,1.0,1.0,10/49,17.65%,DECR2;MECR;HSD17B10;ECHDC2;ETFB;HADHA;CRAT;ACOX3;ETFDH;ACOX2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.5978934884623823,1.0532330539106796,0.47058823529411764,1.0,1.0,3/13,9.92%,CD8A;CADM1;JAG1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4399735872737338,1.0531725563635514,0.3,1.0,1.0,12/70,8.18%,HEMGN;PPARG;FGFR2;RUNX2;ACVR2A;PRKD1;TP63;CDK6;TWIST1;HGF;RANBP3L;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.5454762870527738,-1.0530286401771536,0.36,1.0,1.0,2/23,4.07%,NCKAP1L;ETS1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.6355081456427265,1.0529552743681987,0.46938775510204084,1.0,1.0,3/6,30.48%,SLC38A2;SLC38A3;SLC38A5
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.6221558570408412,1.0528547279866658,0.3877551020408163,1.0,1.0,4/8,12.46%,ROBO1;SLIT2;HIF1A;EDN1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.490616987990496,1.0527996419505687,0.2978723404255319,1.0,1.0,6/39,13.53%,SLC22A2;SLC6A13;SLC7A13;SLC38A11;SLC38A2;SLC25A12
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.4304658686626729,1.052755626372039,0.36538461538461536,1.0,1.0,18/95,12.45%,LRIG3;CXXC4;HNF4G;FLRT3;TOX3;AIF1L;FGFR3;JPH1;C1ORF226;CKMT1A;COBL;DDAH1;LRP4;WWC1;SLC7A2;BCAR1;CTNNB1;ENAH
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.6097007757525195,-1.0527117528909944,0.4666666666666667,1.0,1.0,2/10,10.40%,FOXM1;RSL1D1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.6527006369785942,-1.0525955042083195,0.46938775510204084,1.0,1.0,1/7,8.17%,RNF213
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.43423068941419113,-1.0524730070717556,0.2962962962962963,1.0,1.0,35/142,17.38%,HLA-DPB1;NCKAP1L;TXK;TEC;PSMA7;VAV3;CD4;SH2B2;HLA-DRA;SKP1;PSMD7;PSMB4;PSMC3;PRAM1;BTN3A1;BTNL2;BTN2A1;THEMIS;RBCK1;CARD11;EIF2B4;PSMD8;PSMB5;PIK3CB;PSMC1;PTPRC;PSMB2;PSMC4;PSMD2;PSMA1;EIF2B3;PSMB8;RFTN1;PSME1;PSMD10
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.48778161958046745,-1.0524373454864273,0.36538461538461536,1.0,1.0,12/49,17.45%,SLC25A10;APOD;SORD;RBP4;ATF4;G6PC3;AKR1A1;PER2;ENO1;GAPDHS;GOT2;PGK1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.4717929026430765,1.052130844167875,0.40425531914893614,1.0,1.0,22/68,19.50%,SEMA5A;WNT5A;SULF1;TGFBR1;NRP1;VEGFC;PRKD1;HIF1A;ATOH8;PRKCA;VEGFD;CDH13;PTPRM;SIRT1;F3;THBS4;PDCL3;VEGFA;PROX1;VASH2;ARNT;AKT3
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5786329680730734,1.0517269310192316,0.3877551020408163,1.0,1.0,5/19,6.53%,ACE2;CALCR;PPARG;CHMP6;ERRFI1
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.510882646319862,-1.051661196307755,0.36538461538461536,1.0,1.0,13/51,13.45%,HCK;AOAH;NLRP3;DOCK8;BST1;OAS3;SPI1;PRAM1;CR1;CEACAM1;CD24;AZU1;PILRA
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.6247378745822791,-1.0514524628262834,0.32727272727272727,1.0,1.0,2/13,5.15%,RAB17;FGD3
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.4340005130439282,-1.0512002502223194,0.36363636363636365,1.0,1.0,21/97,12.91%,CLDN4;CBLC;TMEM184A;F5;EMILIN2;INCENP;KIF20B;ST6GAL1;DLX5;SCGB1A1;CKAP2;CLDN1;STAP2;IL1R1;CRYBA1;HIRIP3;CEACAM1;ATP2C2;SELENBP1;APOA1;CD24
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.6404544912725282,-1.0510797442110165,0.43859649122807015,1.0,1.0,1/8,3.79%,KIF20B
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.48109319986033416,1.0510026975618065,0.38461538461538464,1.0,1.0,14/59,17.35%,FAS;FGFR3;ITGAV;ACVR1B;SORT1;BOK;BCL2;P2RX7;CASP9;SMAD3;CASP2;BAD;CRADD;INHBA
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5947405229278541,1.0509678369417992,0.43243243243243246,1.0,1.0,3/11,10.59%,FRMD5;SPOCK3;CCDC125
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.6475529288018216,-1.0506275256463617,0.43478260869565216,1.0,1.0,1/12,1.02%,SLC25A10
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.6903373502031244,1.0503986003972678,0.45652173913043476,1.0,1.0,2/6,16.21%,TMED9;TMED2
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.6903373502031244,1.0503986003972678,0.45652173913043476,1.0,1.0,2/6,16.21%,TMED9;TMED2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.6903373502031244,1.0503986003972678,0.45652173913043476,1.0,1.0,2/6,16.21%,TMED9;TMED2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.6509817386762733,1.0500538052326978,0.45098039215686275,1.0,1.0,2/8,3.52%,ZFP36;CX3CR1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.6220417496468258,1.0499303896855712,0.425,1.0,1.0,1/6,12.35%,SLC38A2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.6108415391816729,1.049583530702359,0.49019607843137253,1.0,1.0,2/9,19.16%,IGF1R;INSR
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.6118862054956842,-1.049473256787087,0.39655172413793105,1.0,1.0,1/12,0.52%,CELA2A
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.6649896437299934,1.0494023786821107,0.4444444444444444,1.0,1.0,2/8,10.70%,GLI3;COL5A2
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.5763519768179113,1.0493601500753076,0.40816326530612246,1.0,1.0,3/11,12.35%,DYRK3;CRHBP;SLC38A2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.4301231958486512,-1.0492767086252202,0.33962264150943394,1.0,1.0,22/86,16.01%,GEM;LDB1;XPC;UBC;PWWP3A;RBX1;CENPH;COPS6;HDAC5;SAFB;CETN2;GATAD1;HMGB2;NUP133;SOX15;DDB1;COPS7A;PARP1;NUCKS1;FAM50A;NUP155;HDAC11
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.6329383658323727,1.049138350352014,0.3953488372093023,1.0,1.0,3/7,11.81%,PIK3C2B;PIK3C2G;PIK3CA
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.70709630492955,1.048861558376553,0.4666666666666667,1.0,1.0,2/5,10.50%,HMGB1;TMEM98
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.43128705680072316,1.0487672581438638,0.3148148148148148,1.0,1.0,29/151,10.78%,LTK;FZD1;NDNF;RIT2;LRRC4C;KANK1;IL1RAPL1;MAGI2;WNT5A;ROR1;EPHA3;ZNF804A;RAB29;MINAR1;CSMD3;PRKD1;TOX;HDAC2;ABL2;CTNNA2;FUT9;CDH2;RETREG3;FBXO7;STYXL1;LRRC7;TENM3;MDK;NPTN
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.4295482610723605,-1.0487253007852877,0.35714285714285715,1.0,1.0,12/160,8.19%,CYP1A2;HSD11B1;UPB1;CYP2E1;CASP6;SERPINE1;PAPSS2;NMT1;IL1R1;HNF4A;BLVRB;RBP4
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.43864109923487415,1.0485963258368092,0.30612244897959184,1.0,1.0,35/139,14.47%,FZD1;NDNF;RUNX1;TAFA1;IL1RAPL1;DDIT4;CX3CR1;HEY1;WNT5A;RUNX2;GPM6A;NRP1;PTPRD;CDK6;RYK;ADGRL3;FUT9;AUTS2;NLGN4X;ATOH8;ACSL4;DLL1;POMGNT2;FGF13;CTNNB1;WNT8A;PEX13;ADNP2;NEUROD2;SOX11;FGFR1;OLIG1;MEF2C;LRP12;WNT2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5412382641823705,-1.0482719075489955,0.4444444444444444,1.0,1.0,9/33,15.19%,ENTPD2;RNASET2;DNASE1L1;NUDT1;NUDT16;NUDT18;SUPV3L1;ENTPD5;PABPC4
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.6390221512719783,-1.0476287196474403,0.4791666666666667,1.0,1.0,1/7,3.35%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.6390221512719783,-1.0476287196474403,0.4791666666666667,1.0,1.0,1/7,3.35%,SERPINE1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.45708186727352373,-1.047385850976647,0.3333333333333333,1.0,1.0,12/95,7.24%,P2RY10;HLA-DPB1;HCK;AOAH;HLA-C;CD74;SLA;HLA-DRA;ADAM19;RYR1;PPP1R14A;SPI1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.5017216770267416,-1.0472430586323482,0.375,1.0,1.0,5/60,6.17%,SARS1;C2ORF49;TRPT1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.5998299274949489,1.0472376241280843,0.5416666666666666,1.0,1.0,4/6,28.81%,CXCL12;EPS8;WAS;ARHGAP35
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.6044869218690656,-1.0472002935011568,0.4603174603174603,1.0,1.0,1/9,4.74%,IL11
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.43678141853823094,-1.047002316851249,0.3148148148148148,1.0,1.0,40/124,20.53%,HLA-DPB1;TXK;TEC;PSMA7;CD4;HLA-DRA;SKP1;PSMD7;PSMB4;PSMC3;PRAM1;BTN3A1;BTNL2;BTN2A1;THEMIS;RBCK1;CARD11;EIF2B4;PSMD8;PSMB5;PIK3CB;PSMC1;PTPRC;PSMB2;PSMC4;PSMD2;PSMA1;EIF2B3;PSMB8;RFTN1;PSME1;PSMD10;BTN2A2;PSMA8;PSMD12;PSMB3;PTPN22;PSMB7;HHLA2;PSMC6
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.608459176033043,1.04672756642016,0.41509433962264153,1.0,1.0,3/8,10.99%,NRXN1;PCDH15;MYO7A
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.6974054631797283,-1.046617849073561,0.4716981132075472,1.0,1.0,2/5,13.43%,SVIP;DBI
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5734276871685225,1.0465330479879695,0.3877551020408163,1.0,1.0,3/18,11.75%,PPARG;NR1H3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.48204462783246904,1.0465120648401305,0.36538461538461536,1.0,1.0,8/43,9.77%,HMGB1;AGER;WNT5A;SYK;TWIST1;MBP;TLR1;IL16
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.6269505103499644,1.0462510907193874,0.4489795918367347,1.0,1.0,3/8,20.41%,RNF2;PCGF5;BMI1
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.5936026479883064,-1.0461010502681323,0.46551724137931033,1.0,1.0,2/15,3.36%,SARS1;TRPT1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.38903009429909835,-1.0459879606765436,0.3559322033898305,1.0,1.0,90/322,23.16%,FIP1L1;TSPAN32;SARS1;WARS1;RBM4;RBM8A;NFKBIB;LMF2;ABCF1;UPF3B;CPSF1;RBM3;RBMS2;CPSF4;POLR2I;PAX8;MRPL23;PTMA;RBPMS;RPLP1;POLR3A;RPL37A;POLR2J;RPL28;MRPS18B;RPS15;MRPL55;NUP133;RPL4;RPL12;RPL34;RPL31;LMF1;MRPS21;NUP43;RPS27;RPL8;MRPL9;POLR2G;HNRNPL;DRG1;RPS8;SRSF7;DHX8;RPL19;PABPC4;NUP155;RPL23;CPSF3;GALNT2;PRPF4;POLR2C;MRPL27;RPL5;GLE1;RPL7A;CHTOP;MPHOSPH10;RPL38;RRBP1;ALKBH5;RPL24;RPS24;MRPL51;MRPS18C;RPS3;DTX1;ALYREF;RPL6;DDX54;RNASEL;RNPS1;MRPL37;RPL29;DHX38;SLBP;RPL13;HSPD1;RPS20;RPL11;RPL35A;RPL10A;EIF4G1;RPL37;NUP85;RPLP2;RPS14;RPS4X;CPSF2;RPS25
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.4588329042559819,-1.0458797998683576,0.35384615384615387,1.0,1.0,11/87,12.08%,PLK4;HAUS8;DCTN1;AHI1;SSNA1;PRKACA;CETN2;ODF2;B9D1;TCTN1;TUBB4B
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6635347672229825,1.0458361148329827,0.5576923076923077,1.0,1.0,3/8,14.26%,SLIT2;NRP1;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6635347672229825,1.0458361148329827,0.5576923076923077,1.0,1.0,3/8,14.26%,SLIT2;NRP1;ALCAM
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.48020889297048336,-1.0457161415998326,0.37254901960784315,1.0,1.0,6/48,11.70%,AURKA;PLK3;GADD45A;TRIAP1;PLK2;PIDD1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.5680868257613195,-1.0453605038077667,0.4444444444444444,1.0,1.0,5/24,14.03%,ADRA2A;BTC;BCAR3;DGKD;SHKBP1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.515963329729063,-1.0453198494971425,0.4444444444444444,1.0,1.0,3/34,2.97%,DYSF;HCK;SPACA3
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5242737422229616,1.0453114627674067,0.3409090909090909,1.0,1.0,11/27,15.77%,SMAD7;TWSG1;LATS1;NREP;FST;SMAD2;SMURF2;SOX11;TGFBR3;SMAD3;TGFBR3L
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.5519920055212872,1.0452714393595985,0.37777777777777777,1.0,1.0,5/15,25.58%,SMAD7;NEDD4L;CAMK2D;LRRK2;CAV3
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.4712015237752062,-1.0452653289479852,0.3620689655172414,1.0,1.0,7/76,7.30%,CPXM2;TSPAN32;PCSK4;LMF2;ADAM19;METAP2;PHEX
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.666390305379011,-1.045250610743143,0.5,1.0,1.0,3/6,18.23%,FBXO43;WEE2;NPM2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.6476064009333682,-1.0452310825798696,0.4807692307692308,1.0,1.0,3/6,29.89%,NDUFS2;NDUFA12;COA6
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.6596963385917385,-1.0451428517114816,0.49056603773584906,1.0,1.0,3/6,21.01%,CORO1B;SYAP1;MARS1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.5194654890562359,-1.045137992990398,0.41379310344827586,1.0,1.0,5/39,7.24%,SIGLEC1;HCK;AOAH;SLC7A7;SPI1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.6520963106937585,-1.0447685905469057,0.4666666666666667,1.0,1.0,2/8,14.73%,SLX4;XRCC3
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.5511814481567767,1.0447128434287851,0.4166666666666667,1.0,1.0,5/20,8.28%,SLC39A12;SLC30A8;SLC30A10;MT1M;SLC39A8
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.5962389512521471,-1.0443555079437736,0.43859649122807015,1.0,1.0,1/12,0.71%,TCHH
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.5080351764463834,-1.0442918876764937,0.4716981132075472,1.0,1.0,9/40,16.85%,TOMM40;TIMM17B;SRP54;SEC62;TOMM20;TIMM17A;PEX1;TIMM50;TIMM44
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.5622787711069296,1.0438307634745405,0.4339622641509434,1.0,1.0,2/15,9.40%,CHRNA10;CHRNB4
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.5209594213312074,1.043618466693573,0.32432432432432434,1.0,1.0,11/22,20.04%,PPARGC1A;SDHAF3;SIRT1;EP300;OGT;CRY1;GNMT;PDK2;FBP1;ZNF692;GCK
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.6869654374619457,1.0435550211366782,0.4375,1.0,1.0,1/6,4.55%,PKHD1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.4363665402272957,-1.0435537245947757,0.37254901960784315,1.0,1.0,10/61,12.65%,CCN3;MMP26;AOAH;NLRP3;DHX58;NR1H4;PROC;TRAF3IP1;C1QBP;APOA1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5575281972039853,1.0432852453117023,0.3389830508474576,1.0,1.0,6/23,16.55%,IL1RAPL1;ZNF804A;CTNNA2;FBXO7;NTNG1;DISC1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.7069535433461385,1.0430365436938327,0.475,1.0,1.0,2/5,13.07%,PPARG;EP300
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.7069535433461385,1.0430365436938327,0.475,1.0,1.0,2/5,13.07%,PPARG;EP300
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.7221443542350362,-1.0428990656859658,0.5,1.0,1.0,2/5,12.86%,RGS2;KCNQ1
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6307711659416937,1.0428880396293028,0.44,1.0,1.0,4/9,18.92%,AGER;PICALM;ROCK2;EPHA4
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.5308165993449988,-1.0428586436403091,0.4642857142857143,1.0,1.0,1/18,0.84%,OSTN
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.682909850398419,-1.0428081611129782,0.475,1.0,1.0,3/8,12.57%,GPR37;PDE8A;TXN
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.6505050219742496,-1.04275627998741,0.46,1.0,1.0,2/7,28.36%,ADCK1;BNIP3
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.6021166826834978,1.0423320392387134,0.43902439024390244,1.0,1.0,3/10,22.52%,BMPR1A;ACVR1;SLIT3
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6595902596292288,1.0420569935307973,0.3902439024390244,1.0,1.0,1/6,4.67%,ATP10A
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.5829102429556667,-1.0420284477121289,0.45652173913043476,1.0,1.0,2/19,6.77%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),0.6767130097061329,1.0419512824416584,0.48936170212765956,1.0,1.0,2/5,10.81%,PDE3A;PDE2A
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),0.6767130097061329,1.0419512824416584,0.48936170212765956,1.0,1.0,2/5,10.81%,PDE3A;PDE2A
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.4634914648818719,1.0409420087252548,0.3137254901960784,1.0,1.0,18/69,17.81%,MARVELD3;PKHD1;GRM5;SNCA;NLGN4X;LRP4;FBLIM1;FLNC;PPFIA2;PPFIA3;CBLN1;CTNND2;VMP1;SMAD3;LIMS2;LIMS1;VASP;TJP3
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.6408934407520251,-1.0409070595276584,0.4583333333333333,1.0,1.0,2/9,11.78%,CLU;CRYAB
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.504855703526503,-1.040586420663266,0.4074074074074074,1.0,1.0,6/50,7.36%,DYSF;AHNAK2;FGF1;NOG;TPM1;CLDN1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.6749800499691186,1.0401698632373526,0.6037735849056604,1.0,1.0,1/5,3.52%,CX3CR1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.6992018343672781,-1.0399460086294094,0.4727272727272727,1.0,1.0,2/7,9.77%,LCP1;PRKACA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.5256349142820598,-1.0399280758360707,0.3508771929824561,1.0,1.0,4/23,8.16%,AZGP1;B2M;HLA-DRA;ZP3
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.6722562687970125,-1.0392862765815385,0.5094339622641509,1.0,1.0,1/5,10.52%,LAGE3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5211423646396166,1.0387462753084598,0.3953488372093023,1.0,1.0,3/25,6.22%,DCUN1D1;SMAD7;ARRDC3
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.5138791870555505,-1.0387007913501358,0.38596491228070173,1.0,1.0,4/28,4.74%,NCKAP1L;CD74;VAV3;BST1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5737216024358957,1.0386392143631273,0.42105263157894735,1.0,1.0,6/16,15.72%,RIT2;CD22;ITPR1;CDH13;NEUROD2;CMKLR1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5694859057965951,1.0385319952978047,0.3953488372093023,1.0,1.0,2/18,3.50%,LOXL2;ZNF706
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.7101013127106386,-1.038293166533693,0.46296296296296297,1.0,1.0,1/5,3.54%,STX4
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.5263781311452881,1.0382778719784755,0.28888888888888886,1.0,1.0,6/28,17.89%,PRELP;GLB1;MPST;HEXB;GNS;VCAN
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.5664541083063498,-1.0379346073558333,0.423728813559322,1.0,1.0,3/22,3.92%,SFRP1;MEOX1;SBDS
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5300567547666761,1.0379027303544768,0.41304347826086957,1.0,1.0,6/23,20.84%,SLC30A8;SLC4A4;SLC4A7;NEDD4L;KLHL3;CAMK2D
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.5860050099439285,1.0378238201521555,0.4166666666666667,1.0,1.0,2/10,9.20%,H3-3A;ASF1A
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.45769880662083706,-1.0372802674762698,0.35185185185185186,1.0,1.0,29/53,27.88%,PSMA7;PSMD7;PSMB4;PSMC3;NR1H4;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6;AZIN1;FGFR4;PSMB1;PSMA5;PSME2;PSMA4;PSMD3;PSMD11;PSMB6
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.5008491337970697,1.0372018452147478,0.36538461538461536,1.0,1.0,14/47,16.55%,NDNF;DDIT4;GPM6A;NRP1;ADGRL3;AUTS2;POMGNT2;FGF13;PEX13;FGFR1;MEF2C;LRP12;VEGFA;DISC1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.6763865163589603,1.0371835485675545,0.5238095238095238,1.0,1.0,1/7,2.22%,NLGN1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.5607640294223639,-1.036624282179414,0.45098039215686275,1.0,1.0,8/23,24.53%,RHEBL1;PINK1;CARD11;SYAP1;MEAK7;PRR5L;MTOR;RPS6
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6064867576936636,1.0362223789745861,0.48936170212765956,1.0,1.0,1/10,1.54%,CSGALNACT1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6784625461521959,1.0362052893612703,0.43103448275862066,1.0,1.0,5/7,27.35%,IGF1R;INSR;FYN;PRNP;MTMR2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.634995714173305,-1.036153042220509,0.4528301886792453,1.0,1.0,2/7,19.78%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.6201660020403101,1.0361520649308331,0.5,1.0,1.0,2/13,4.41%,ZFP36;NAV3
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.4596824143146053,-1.035908804759229,0.4444444444444444,1.0,1.0,22/63,20.53%,PSMA7;SKP1;PSMD7;PSMB4;PSMC3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;IRAK1;PSMB8;PSME1;PSMD10;CARD14;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.521799829294634,-1.0358855346671099,0.39622641509433965,1.0,1.0,6/23,18.85%,SLC6A9;LLGL2;SLC6A20;SLC6A7;CTNS;SLC7A5
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.661421510378476,-1.0357849647488593,0.5,1.0,1.0,2/6,23.52%,COX7A1;COX7A2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.44843501225464694,1.0357833551236653,0.2894736842105263,1.0,1.0,36/117,13.39%,LTK;FRK;NTF3;ERBB4;CASS4;GUCY2F;CD8A;FGFR2;EGFR;CSF1;ROR1;SYK;EPHA3;CNKSR1;GP6;ACVR2A;FGFR3;PTPRD;NPR2;RYK;FRS2;PTPRG;EPHA7;FER;YES1;IGF1R;BLNK;CSF1R;PDGFRB;ACVR1B;BCAR1;MPZL1;LIFR;EPHA5;FGFR1;EFS
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.49531028063213023,1.0357172724204005,0.375,1.0,1.0,17/52,20.04%,IRS1;PPARG;ADIPOR2;LEPR;SLC30A8;MCU;ADIPOR1;IGF1R;KLF7;CRY1;BAD;PDK4;MBD5;PDK2;INSR;TENT4B;GCK
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.6611619835996764,-1.0357001547426936,0.5,1.0,1.0,1/6,6.30%,EXOSC10
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5662287755730107,-1.035569991031006,0.4126984126984127,1.0,1.0,2/14,6.67%,TMIE;PAX8
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.4559917475919393,1.0349009443593515,0.2553191489361702,1.0,1.0,14/88,11.63%,MARVELD3;MAP3K11;PLCB1;HMGB1;AGER;EGFR;CCN2;HDAC3;ZNF675;MFHAS1;IGF1R;PHLPP1;RAP2A;GADD45B
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.6938772107843697,1.0347184482243843,0.4909090909090909,1.0,1.0,2/5,18.53%,FAAH;ABHD12
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.6612360221905955,1.0344748231521732,0.44,1.0,1.0,1/6,5.98%,NUS1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.6612360221905955,1.0344748231521732,0.44,1.0,1.0,1/6,5.98%,NUS1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.41501741620549065,1.0344396933560727,0.275,1.0,1.0,33/149,17.47%,TBC1D3L;ARHGAP25;ARHGAP42;NTF3;CCL5;RGS6;ECT2;TBC1D12;SNX18;TBC1D8B;DOCK10;RGS7;CCDC125;RABGAP1L;GRTP1;RUNDC1;SYDE2;ARHGAP27;TBC1D1;TIAM2;ARHGAP24;PICALM;USP6NL;EVI5;RSU1;TBC1D4;AFDN;TBC1D5;RAPGEF6;SIPA1L1;LIMS1;ABR;RAP1A
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.682962791461387,-1.0342910885800705,0.42,1.0,1.0,2/5,21.80%,TMEM9;ALDOB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.6713473226686115,1.0341522878529243,0.5106382978723404,1.0,1.0,2/6,15.86%,AKT2;BAD
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.40941883788266153,1.0340011722599598,0.35714285714285715,1.0,1.0,75/371,13.14%,IL1RAPL2;NRG1;FAT4;NAB1;EFNA5;CHRM3;PCDHB3;SEMA5A;NTF3;ERBB4;NLGN1;LSAMP;ROGDI;GFRA1;LDB2;NRXN1;DSCAM;FLRT3;IRF2BPL;ADGRV1;FGF12;SNTG2;ROBO1;CHRM2;CNTN4;NR2E1;BTBD3;TGFBR1;NAV3;ZEB2;GPM6A;RAB29;ECT2;ROBO2;ATXN1;RYK;ADGRL3;POU6F2;FGF17;FGF5;MBNL1;TBX6;MBP;GLRB;CDH2;GPM6B;GLIS2;SH3GL2;APBA1;PSPN;SERF1A;DYRK1A;JAG1;HMGCR;RBFOX1;CHD7;NPAS1;ZC4H2;MDK;GRIK1;ACVR1B;FGF13;TENM1;ATXN10;ASIC2;RPS6KA6;ACTL6A;DPF3;LIG4;NEUROD2;ST8SIA4;ALDH3A2;EP300;CBLN1;PAFAH1B3
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5544489979651818,1.033665336041629,0.3541666666666667,1.0,1.0,1/15,1.62%,GDAP1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.43591811630998534,-1.0333311720897924,0.32786885245901637,1.0,1.0,32/89,20.53%,TNFSF18;PSMA7;TMSB4X;PSMD7;PSMB4;PSMC3;EIF5A;LTB;LTBR;EDAR;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;CD70;PSMD2;NFKBIA;BAG4;PSMA1;PSMB8;PSME1;PSMD10;CARD14;TNFSF9;PSMA8;CD27;PSMD12;PSMB3;PSMB7;STAT1;PSMC6
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.6153226421943606,1.032899832760296,0.44,1.0,1.0,2/9,10.68%,FUT9;MDK
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.46495096960516025,1.0327609461674283,0.40476190476190477,1.0,1.0,8/61,14.71%,DDIT4;PKHD1;MINAR1;DYRK3;HDAC3;SIRT1;PIK3CA;DEPTOR
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.6633842521466395,1.032690819387718,0.5121951219512195,1.0,1.0,1/7,5.36%,RAB29
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5162609576226052,-1.0323330536135402,0.4117647058823529,1.0,1.0,7/45,9.64%,CYP19A1;HSD11B1;DHRS11;CYP21A2;PRLR;HSD17B10;TM7SF2
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4927317679237885,1.0323316093615382,0.41304347826086957,1.0,1.0,9/32,16.17%,PPARG;FOXO3;NR3C1;HIF1A;ATOH8;NFIB;NFATC3;SMAD3;RELA
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5403905423905475,1.0322949993171957,0.4,1.0,1.0,5/13,15.19%,ARID1A;SMARCD3;SMARCE1;ARID2;SMARCD2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5403905423905475,1.0322949993171957,0.4,1.0,1.0,5/13,15.19%,ARID1A;SMARCD3;SMARCE1;ARID2;SMARCD2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5957493440462751,-1.0319761096586626,0.40425531914893614,1.0,1.0,1/13,0.21%,SELP
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.5266824983992209,1.0317348164346267,0.40425531914893614,1.0,1.0,8/23,20.62%,ADIPOR2;ADIPOR1;PRKAB2;NR1H3;ACADVL;PDK4;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5809830420946688,1.0317022517674337,0.45454545454545453,1.0,1.0,4/12,27.30%,DLL1;SOX11;PKD2;PKD1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.5404118270500291,1.031595564984539,0.38181818181818183,1.0,1.0,6/20,15.75%,CSGALNACT1;HS2ST1;FUT9;EXT1;CSGALNACT2;B3GNT2
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.6008028316604487,1.0314645416839512,0.4222222222222222,1.0,1.0,2/7,12.17%,SIRT1;LIG4
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.46605886580790545,1.0314595217553453,0.4098360655737705,1.0,1.0,19/62,16.41%,FAS;CASP12;PPARG;SLC22A2;EGLN3;ROBO1;SNCA;EIF2AK3;IFT57;CASP10;BOK;F3;CASP9;SMAD3;CASP2;BAD;CRADD;SENP1;NOD1
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.6821026345749552,-1.031229917665502,0.5106382978723404,1.0,1.0,2/5,11.78%,MRLN;CRYAB
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.4417357020772925,1.0308362594209433,0.3333333333333333,1.0,1.0,16/97,14.77%,PIK3R5;PLA2G10;PLCB1;PIP4K2A;SYNJ2;PTPN13;CSF1R;PDGFRB;INPP4B;PIK3C2B;PIK3C2G;PIK3CA;PIGW;MTMR12;PIK3R1;PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6417567913865594,-1.030569728112253,0.4897959183673469,1.0,1.0,5/10,31.60%,WRAP53;CCT2;CCT6A;CCT8;DKC1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.6022197701859899,-1.030461450079371,0.47619047619047616,1.0,1.0,4/11,18.53%,D2HGDH;GOT2;L2HGDH;PHYH
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.467028939685679,1.0303615443182057,0.3695652173913043,1.0,1.0,19/66,16.07%,CADM2;LRP1B;RGMA;PTCHD1;CMYA5;SLC35F1;CACNB2;HFM1;TRDN;FILIP1;RBFOX1;ANO5;FGF13;KBTBD12;SORBS1;PREX2;FAM110D;DTNA;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.6611729418374778,1.0303564981508735,0.4888888888888889,1.0,1.0,1/5,3.48%,HMGB1
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.5489930381201229,-1.0303232805441964,0.425531914893617,1.0,1.0,1/22,0.86%,TXK
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.6755056121338268,1.0301511595158663,0.4523809523809524,1.0,1.0,4/7,16.08%,CRB2;SMAD2;SCX;TBX19
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6817298675893733,-1.0300099542821035,0.39622641509433965,1.0,1.0,4/5,28.40%,CPSF3;SLBP;CPSF2;LSM11
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.39289658279750955,-1.0296445190742147,0.35294117647058826,1.0,1.0,19/231,9.20%,STING1;NCKAP1L;F8;F5;CD74;HGSNAT;GOLGA2;SPG7;SKP1;TRAPPC2L;FANCC;VIL1;RBX1;CLDN1;TRAPPC6A;CHCHD10;TUBGCP2;DBNL;TRAPPC4
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.6401975899413457,-1.0295484876177352,0.47368421052631576,1.0,1.0,5/10,17.75%,ACOT4;BCKDK;IL4I1;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.6929446184740896,-1.029183510557516,0.5454545454545454,1.0,1.0,2/5,15.58%,KCNE1;GDI1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.5396615161163262,-1.0291793215961356,0.40350877192982454,1.0,1.0,3/20,9.08%,ATP6V1E2;ATP6V1E1;ATP6V1D
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.649627788242702,1.029139897389397,0.5087719298245614,1.0,1.0,1/5,14.68%,KIF13A
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6394320603486314,-1.0291336948756635,0.5454545454545454,1.0,1.0,1/6,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.5792981980184364,1.0291308464496343,0.43636363636363634,1.0,1.0,4/16,17.08%,LEPR;GBE1;PID1;UGP2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.5622380910628606,1.029014023616605,0.49056603773584906,1.0,1.0,4/15,12.30%,SPHK1;ACER1;ASAH2;QDPR
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.5056023732318473,1.0288453545548957,0.46,1.0,1.0,10/28,14.81%,MDGA2;GRID2;RYK;TOX;NPY;ZC4H2;CTNNB1;CBLN1;WNT2;MAP2
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.42988520654698426,1.0287679237831033,0.2926829268292683,1.0,1.0,36/105,19.41%,PMP2;KCNC2;NRXN1;HCN1;AMER2;CACNB2;GRIA4;NR3C1;SLC1A2;ZNF493;PCSK2;CTNNA2;KCNJ6;SYNPR;ST18;RUNDC3A;FGF13;CNTNAP5;SLC24A2;C4ORF50;GRIA2;UNC13C;MOBP;PRKCB;P2RX7;ADCY2;TAS1R1;TNR;SLC24A4;PROX1;SEZ6L;SLC7A14;ST8SIA3;CATSPER2;ASPA;CACNB4
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.4614274848432467,-1.0285263545624304,0.39655172413793105,1.0,1.0,6/80,6.97%,TYMS;CLU;RBM4;NCL;PATL2;ILF3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.5945981341862248,1.0283941703062809,0.5102040816326531,1.0,1.0,3/12,12.49%,HMGB1;SYK;CD274
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.401116234996111,-1.0283618502565075,0.4074074074074074,1.0,1.0,21/174,11.68%,PLK4;AURKA;CBX1;MARCKS;CDKN3;HMGB3;INCENP;NCL;KIF20B;KIF4A;SMC4;FANCC;ILF3;CCND1;STMN1;TPX2;NOLC1;KPNA2;MCM5;ODF2;CHAF1A
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.5623837010978479,1.028324516953601,0.4583333333333333,1.0,1.0,4/15,7.79%,SULF1;SLIT2;TWSG1;FST
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.43469904325326597,-1.028300100177609,0.35294117647058826,1.0,1.0,18/78,24.72%,ARF3;COPE;KIF4A;KIF5A;KDELR1;COPG2;KDELR3;CENPE;RER1;KIF4B;ATP9B;KLC1;USE1;COG4;KIF23;KIF1C;KIF11;ARCN1
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.5761076609374314,-1.0278518484728396,0.4782608695652174,1.0,1.0,5/15,16.09%,FABP6;FABP5;LIPC;LIPI;PNPLA4
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.6542023069603344,-1.0276489481008337,0.45098039215686275,1.0,1.0,1/6,7.06%,DTX3L
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.6702200256892682,1.0275385341290577,0.5283018867924528,1.0,1.0,1/5,18.43%,MECP2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.6361890338669024,1.0270882947500517,0.4888888888888889,1.0,1.0,1/8,5.11%,PELI1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.6143894805047483,1.0268909377939617,0.41818181818181815,1.0,1.0,4/8,18.92%,AGER;PICALM;ROCK2;EPHA4
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.7028627349501348,-1.0267439807660623,0.5166666666666667,1.0,1.0,3/5,27.06%,SLC25A5;VDAC1;SLC25A4
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.5960340276275051,-1.0267387820770286,0.43137254901960786,1.0,1.0,2/15,6.34%,OR2M4;GNAS
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.46404147282941394,-1.0264779171553085,0.42592592592592593,1.0,1.0,8/66,7.99%,SH3RF2;CLU;PLK3;TRIB2;ARIH2;RBX1;DDA1;RFPL1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.672422080232095,-1.0263558197481009,0.6363636363636364,1.0,1.0,3/5,22.98%,OAS3;TRIM25;CLPB
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.6065283936228172,-1.0257029433967533,0.46511627906976744,1.0,1.0,4/7,26.86%,DCAF15;LEP;PTPN22;IL12A
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4361283146321318,-1.0256474166950993,0.38596491228070173,1.0,1.0,9/131,8.00%,SLC28A2;SERPINE1;NLRP3;ADRM1;GPC3;RGS16;VIP;IL1R1;SCARF1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.5586681347698454,1.0252967004973044,0.4375,1.0,1.0,10/20,20.04%,IRS1;ENPP1;IRS2;PPP1R3B;DYRK2;SORBS1;AKT2;INSR;EPM2AIP1;GCK
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.6507854113763578,-1.0252871897315459,0.5,1.0,1.0,1/6,7.24%,SPI1
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.633493437324717,1.0251954750405166,0.5434782608695652,1.0,1.0,3/8,23.82%,TSFM;NSUN3;SHMT2
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5460678344306229,1.0248776538001725,0.43902439024390244,1.0,1.0,6/19,25.07%,HELLS;TEX15;ATF7IP;KMT2E;PPM1D;GATAD2A
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.6838598190876976,-1.02482619226631,0.5121951219512195,1.0,1.0,3/5,30.03%,ATP5F1D;ATPAF1;OXA1L
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.6545764871443891,1.0248214778108542,0.48936170212765956,1.0,1.0,3/5,25.58%,DEPTOR;PTEN;CAV3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.6196018516027066,-1.0247627911397983,0.44,1.0,1.0,3/7,18.43%,ADAM19;SERPINF2;FLOT1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.39501927767434475,-1.0245052620393855,0.3880597014925373,1.0,1.0,66/276,19.73%,SNRNP27;FIP1L1;DDX41;ZCRB1;GTF2F1;RBM4;RBM8A;UPF3B;CWC25;CPSF1;PRPF6;RNF113A;SYF2;CPSF4;POLR2I;CMTR1;LSM7;PRPF19;POLR2J;DNAJC8;WBP4;PDCD7;NONO;PRKACA;SF3B2;DHX16;RBM19;RNPC3;GTF2H2;AKAP8L;ZRSR2;SF3A2;SUPT5H;SF3A1;MFAP1;METTL3;SNW1;RBM22;POLR2G;HNRNPL;SF3B6;RBMX2;SRSF7;DHX8;GPATCH1;ERCC2;CPSF3;PRPF4;POLR2C;RBM4B;RBMX;CHTOP;PRCC;SNIP1;ALKBH5;SNRPD2;KIN;EFTUD2;HNRNPH2;PPIL3;SRSF10;ALYREF;IK;HNRNPM;RNPS1;RNMT
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.524210443709076,-1.0242311408402467,0.39622641509433965,1.0,1.0,2/30,2.80%,PLK3;PLK5
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.5243532756088478,1.0240955081465237,0.40816326530612246,1.0,1.0,7/25,15.40%,SPHK1;NAA50;SIRT1;FOXO1;AANAT;EP300;KAT2B
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.6360263369097826,-1.0239605218137167,0.509090909090909,1.0,1.0,2/8,16.12%,DRD3;RGS8
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5878570214058527,1.0239353394109687,0.48214285714285715,1.0,1.0,4/17,10.68%,TAFA1;TOX;DISP3;MDK
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.5275146450535144,1.023817796375278,0.44,1.0,1.0,1/25,0.68%,SKA3
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.42557874534453155,-1.0237997667378043,0.3684210526315789,1.0,1.0,13/83,10.86%,TAGLN;WNT7B;UPK1B;MEOX1;CASP6;DNPH1;AHI1;VIL1;PAX8;CDHR2;GSTK1;TPP1;NDRG4
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.5850963308612404,-1.0236101946963558,0.4782608695652174,1.0,1.0,3/10,26.28%,GNB3;MFSD2A;MTMR4
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.6423122599379024,1.0235968837518035,0.48936170212765956,1.0,1.0,5/7,25.58%,CDH2;CTNNB1;PTK2;TCAP;CAV3
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.5902040784457879,-1.0232964159661981,0.4528301886792453,1.0,1.0,2/11,4.06%,APOD;DOCK8
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.5241862809193119,1.0232571434796516,0.3877551020408163,1.0,1.0,2/21,5.05%,GDAP1;PEX11A
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.48322182496663246,1.0231387085578656,0.40425531914893614,1.0,1.0,12/31,17.12%,ADGRV1;WNT5A;SLC8A1;ACVR2A;BMPR1A;GPM6B;SOX11;ACVR1;MEF2C;P2RX7;PKDCC;BMP6
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.6024320864429815,-1.0229876416310466,0.38181818181818183,1.0,1.0,2/9,7.70%,TK2;PUDP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.6024320864429815,-1.0229876416310466,0.38181818181818183,1.0,1.0,2/9,7.70%,TK2;PUDP
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.5134177019293454,-1.0228085148927468,0.38181818181818183,1.0,1.0,4/30,10.68%,NCKAP1L;ETS1;RAB7B;HMGB2
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.5025592700366729,-1.0226518493901784,0.4230769230769231,1.0,1.0,4/25,8.19%,WNT7B;FGF1;FGF7;RBP4
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.6632242683934456,1.0221601460508973,0.4074074074074074,1.0,1.0,1/5,7.08%,PDCD6IP
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5295839788354691,1.022055106823129,0.46511627906976744,1.0,1.0,2/24,1.84%,SAMSN1;NTF3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.6216546653775249,1.0220363986030474,0.5434782608695652,1.0,1.0,1/5,2.28%,IL18R1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.6684389466682941,-1.021993594906681,0.5087719298245614,1.0,1.0,4/6,28.96%,PRDX1;SOD1;NOS3;MT3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.5589491944478872,-1.0219252738970355,0.5098039215686274,1.0,1.0,4/21,9.99%,CBLC;VPS25;ADRA2A;BTC
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.6405231663884974,-1.0217277038272055,0.5333333333333333,1.0,1.0,4/6,25.09%,CTNNA3;DSC2;PKP2;JUP
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5116168121114877,-1.0216246940813498,0.44642857142857145,1.0,1.0,11/31,19.15%,SPG7;MICOS13;RCC1L;DNAJC11;SLC25A5;MTX1;TIMM50;GHITM;BAK1;APOO;TMEM11
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.6144276045826866,1.0216234504288173,0.5192307692307693,1.0,1.0,2/8,14.85%,PIP4K2A;PLEKHM1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5595825000944163,-1.0216126559923056,0.4666666666666667,1.0,1.0,4/14,14.32%,KIF20B;FBXO43;PIN1;CUL9
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.6011416143864154,-1.021569973726696,0.4791666666666667,1.0,1.0,2/10,5.87%,GOLGA2;SKP1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5309734544716662,-1.021463849620556,0.45614035087719296,1.0,1.0,4/16,17.27%,AOAH;DERA;FBXO6;FBXO2
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.5989751043816514,-1.0214213228812479,0.5,1.0,1.0,2/7,16.68%,GTF2H2;CHTOP
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.5669575950595835,1.0213449821925853,0.5106382978723404,1.0,1.0,4/24,8.39%,SEMA5A;SLIT2;NRP1;AUTS2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.4610354795452978,1.0211681197929339,0.4528301886792453,1.0,1.0,8/39,10.34%,CERS3;FGFR2;SCEL;CCN2;LAMC2;HDAC2;ACER1;DLL1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6502643400453143,-1.0208805397215244,0.43859649122807015,1.0,1.0,2/8,19.90%,ZRANB3;ZNF830
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.6213771044001554,1.0208269505821967,0.42,1.0,1.0,2/7,8.80%,ABCC2;ABCC11
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-0.7187927783349813,-1.0208179527542736,0.56,1.0,1.0,2/6,10.31%,DRD3;DRD1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5650128519118256,-1.0205919456109036,0.48,1.0,1.0,1/19,1.73%,CLU
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.5879152819394826,-1.0205679593373822,0.4339622641509434,1.0,1.0,2/12,2.72%,ASCL1;NTRK1
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.6547802553708724,-1.0204970481503743,0.5531914893617021,1.0,1.0,3/6,25.96%,CDHR2;YAP1;PTPRJ
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5873829554482373,1.0204636371621438,0.49056603773584906,1.0,1.0,2/17,14.77%,CIDEA;PLA2G4C
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.4567532319968139,-1.0204483885761624,0.35185185185185186,1.0,1.0,10/68,10.08%,B3GALT4;ST6GALNAC2;CHST8;GOLGA2;ALG1L2;ST8SIA2;B3GNT9;B3GALT5;CHST10;MPI
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4812958568575819,-1.0203790107015074,0.43137254901960786,1.0,1.0,6/41,6.62%,SFRP1;RAC1;TPM1;EPHA1;VIL1;SYNPO2L
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.5563977213328393,1.0202850342834018,0.425531914893617,1.0,1.0,11/20,18.53%,PLA2G10;ENPP6;PLA2G7;GDPD3;PRDX6;PLA2G15;PLA2G4C;SMPD4;GPCPD1;PNPLA6;ABHD12
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.5416033722418636,1.0200371893688425,0.38095238095238093,1.0,1.0,6/15,26.64%,TGFBR1;SMAD2;GRAMD1C;GRAMD1A;LRP6;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.6388073106697462,-1.019748597180172,0.46153846153846156,1.0,1.0,1/8,1.42%,IL31RA
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6099218270001505,-1.0196947545858557,0.46511627906976744,1.0,1.0,2/10,6.67%,PACSIN3;ADRA2A
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.6282238762490209,-1.0196601535158751,0.47619047619047616,1.0,1.0,3/9,6.80%,CCN3;SCN11A;VIP
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.6083819483086677,-1.0195889396944293,0.5208333333333334,1.0,1.0,5/14,17.38%,CLU;TRIAP1;PRELID1;GHITM;PSMD10
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6105386406067792,1.019570339174731,0.5,1.0,1.0,5/10,19.69%,PUS10;SMAD1;SMAD2;SMAD3;HNRNPA2B1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.46617117365379873,-1.0195557267900806,0.38461538461538464,1.0,1.0,26/77,21.70%,HLA-C;WARS1;CD74;EPSTI1;B2M;UBE2L6;DHX58;CMTR1;IFI27;PARP14;PROCR;GMPR;TMEM140;LAMP3;IFIT2;RSAD2;STAT2;GBP2;PSMB8;PSME1;IRF1;TRIM25;LY6E;ISG15;OGFR;DDX60
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.4921561586221561,1.019429013950449,0.3829787234042553,1.0,1.0,6/34,11.10%,IFI16;NUAK2;FOXO3;KPTN;EIF2AK3;NIM1K
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.6064731537788024,1.0193809632491773,0.43636363636363634,1.0,1.0,3/11,16.18%,HMGB1;LIG4;RAG1
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.6451962094662009,1.018656527309174,0.52,1.0,1.0,1/5,17.27%,THPO
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.4127061460268838,1.0185412658294148,0.37209302325581395,1.0,1.0,27/149,13.87%,PLCB1;RALA;PLD6;NLGN1;NRXN1;ELAPOR2;WNT5A;GRIP1;CCN2;MCU;FST;COBL;BMPR1A;DVL2;SOX5;SMURF2;MDK;ACVR1B;SIRT1;SHLD1;NEUROD2;FGFR1;ACVR1;FOXO6;SCX;MARCHF5;LLPH
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.5155284079020042,-1.017831785059799,0.39655172413793105,1.0,1.0,2/32,5.09%,NUPR1;TCHP
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.6592663538361347,-1.0173866879449083,0.4888888888888889,1.0,1.0,2/6,26.38%,SVIP;UBXN1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.6153980754425998,1.0173296442558402,0.46511627906976744,1.0,1.0,2/6,11.75%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6111568368425383,-1.0173022311187363,0.45614035087719296,1.0,1.0,1/12,1.78%,HCK
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.5724485660718494,1.0166985539643136,0.5,1.0,1.0,2/15,7.59%,GLI3;MBNL1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.589502671477099,1.0166470618022816,0.4772727272727273,1.0,1.0,2/8,8.09%,FGFR2;COBL
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.6949340112198487,1.0165275426205254,0.5263157894736842,1.0,1.0,3/5,6.62%,ZFP36;ZFP36L2;NPR2
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.6949340112198487,1.0165275426205254,0.5263157894736842,1.0,1.0,3/5,6.62%,ZFP36;ZFP36L2;NPR2
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5897477344669018,1.0164922312300522,0.425531914893617,1.0,1.0,1/8,1.40%,DCUN1D1
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.6533651977939265,1.0164308394353347,0.4318181818181818,1.0,1.0,3/6,25.91%,SOX5;SOX6;PDGFRA
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.5248432062350973,1.0163778697488373,0.46938775510204084,1.0,1.0,3/27,3.94%,NRG1;NTF3;WNT5A
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4036057224833423,1.016254906341373,0.38461538461538464,1.0,1.0,14/84,10.24%,RIT2;RALA;SPHK1;SYK;CD22;NRP1;SLC30A8;SYT1;RAB3C;ABL2;ITGAV;RIMS2;RNF139;CDH13
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.4448687903208603,1.0159978281677289,0.38095238095238093,1.0,1.0,2/59,4.20%,VAPB;CCL5
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.7239253126093897,-1.0157293096354973,0.4791666666666667,1.0,1.0,3/5,22.84%,FABP5;MFSD2A;SLC27A1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.4481996484451339,-1.0155568525603713,0.41509433962264153,1.0,1.0,13/79,21.78%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;MRPS21;MRPL9;MRPL19;MRPL27;MRPL51;MRPS18C;MRPL37;MRPS22
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.4344675918176687,1.015514029002623,0.40540540540540543,1.0,1.0,33/117,15.03%,GUCY1A2;LSAMP;SEMA6D;NRXN1;DOC2B;PCDH17;ADGRB3;UNC5D;KCTD16;GRIA4;PTPRD;ELAVL4;FAM171B;RAB3C;LRP4;P2RY1;CNTN1;SYNPR;ASXL3;RBFOX1;NPY;TTLL7;ANK2;ASIC2;LIFR;RGS7BP;ERC2;GRIA2;CSRNP3;PCLO;MAP2;SLC12A2;MAPK4
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6059926047144141,-1.0149899844234773,0.4444444444444444,1.0,1.0,4/10,31.22%,TIMM29;TIMM13;TIMM8A;ROMO1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.4285981065178932,-1.014949515276118,0.42857142857142855,1.0,1.0,25/151,13.02%,NOSTRIN;EMCN;CD9;F8;EPAS1;MEOX1;ADIRF;PRKCH;ARAP3;ETS1;RNASE1;CYYR1;MADCAM1;SCARF1;VWA1;IFI27;SPARC;AQP7;MCAM;FHL2;PROCR;COX7A1;CYP1B1;PTPRB;PCDH12
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.6451200006127239,1.0149224240411991,0.5217391304347826,1.0,1.0,1/6,1.32%,PNP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5903303997893536,1.0147734785806426,0.4716981132075472,1.0,1.0,3/19,3.42%,AEN;IFI16;DDIT4
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.46252519751255056,1.014605304714757,0.3404255319148936,1.0,1.0,18/57,14.10%,PPARG;VWC2L;ELAPOR2;SMAD7;SULF1;TWSG1;ACVR2A;SMAD5;FST;BMPR1A;CRB2;SMAD1;SMAD2;SMAD9;SMURF2;SOX11;SMURF1;UBE2D3
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.6254848982500717,-1.0140144331328547,0.47540983606557374,1.0,1.0,1/5,6.27%,SHANK3
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5791424398485796,1.013864285557577,0.48717948717948717,1.0,1.0,6/12,26.39%,RORA;INSIG2;INSIG1;GRAMD1C;GRAMD1A;LRP6
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.6664342000976298,-1.0138632985386455,0.5192307692307693,1.0,1.0,3/6,24.15%,RFT1;CPTP;PLTP
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.6528042056012231,-1.013809477811404,0.5434782608695652,1.0,1.0,2/5,28.87%,HDAC6;TRIM37
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.4842953354029761,-1.0137653411829712,0.48148148148148145,1.0,1.0,11/50,8.19%,CLDN4;CBLC;TMEM184A;RAB17;AZGP1;ANO1;MYH14;GPR39;CLDN1;SLC3A1;AMBP
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5597029528730751,-1.013498171377749,0.46938775510204084,1.0,1.0,3/19,6.88%,CBLC;VPS25;SH3BP5
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.440602772566958,-1.0132004271846793,0.43636363636363634,1.0,1.0,28/82,20.53%,XPC;PSMA7;ANAPC15;SKP1;PSMD7;PSMB4;PSMC3;TCIM;DDB1;PSMD8;PSMB5;PSMC1;ERCC2;PSMB2;PSMC4;TAF1;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;ANAPC2;PSMA8;FZR1;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5153872992483042,1.0131321229025267,0.3953488372093023,1.0,1.0,5/17,17.66%,SLC8A1;CACNB2;ANK2;KCNJ2;ATP1A2
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.4625137554906717,1.0129561639031475,0.49019607843137253,1.0,1.0,5/25,15.23%,AKR1C1;CYP39A1;CYP7B1;OSBPL6;OSBPL3
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.3774827131891902,1.012755587672901,0.425,1.0,1.0,76/419,13.08%,PIK3R5;NRG1;CALCR;RIT2;SEMA5A;NTF3;ERBB4;TRIM22;IRS1;NLGN1;CASS4;FGFR2;NR3C2;S100A13;SPHK1;HMGB1;CX3CR1;TRIP6;TAB3;NEDD4;AGER;EGFR;ADGRV1;WNT5A;ROR1;CCL5;TGFBR1;IQCJ-SCHIP1;FGF10;PELI2;IRS2;PELI1;GAB1;ECT2;LITAF;MYORG;FGFR3;PRKD1;SCTR;HDAC3;RYK;MFHAS1;FRS2;FGF17;FGF5;HGF;TRIM8;PTPN6;ANKRD17;FSHR;TRIM5;TAB2;STYXL1;IGF1R;LRRC19;ITGAV;WWC1;PDGFD;CDH13;PDGFRB;CASP10;RUNDC3A;NDFIP2;SIRT1;PIK3CA;NEUROD2;PPM1A;BOK;ADAM8;SASH1;NRG2;BCL2;SOX11;FGFR1;EP300;ALPK1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5873549615571592,-1.0127363950110317,0.5434782608695652,1.0,1.0,3/10,12.83%,CACNB1;CACNG1;CACNG6
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.5187661326985038,1.0126663980522266,0.4186046511627907,1.0,1.0,5/25,13.63%,PLCB1;RANBP3L;MSTN;DLL1;MEF2C
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.6090056352039144,-1.0125067880431393,0.45652173913043476,1.0,1.0,3/9,11.29%,ACOT4;PCCB;CRAT
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.4412335659365265,-1.0124008142372338,0.42,1.0,1.0,28/81,20.60%,PSMA7;FBXO48;SKP1;PSMD7;RBX1;PSMB4;PSMC3;PSMD8;PSMB5;PSMC1;FBXL13;PSMB2;PSMC4;PSMD2;PSMA1;FBXO6;PSMB8;FBXO2;PSME1;PSMD10;PSMA8;PSMD12;FBXL18;PSMB3;PSMB7;FBXL16;PSMC6;FBXL12
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.6007475937489377,1.0120102858068198,0.5333333333333333,1.0,1.0,4/9,18.95%,SLC23A1;GSTO2;SLC2A1;RGN
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.415025118751904,1.0119865350609918,0.37209302325581395,1.0,1.0,30/115,13.63%,FZD1;RUNX1;IL1RAPL1;PBX1;DDIT4;WNT5A;TGFBR1;RUNX2;TENM2;MANF;PBX3;PTPRD;RYK;FUT9;NLGN4X;ATOH8;ACSL4;UGDH;TENM3;MYO7A;USH2A;TENM1;CTNNB1;WNT8A;ADNP2;NEUROD2;EPHA5;SOX11;OLIG1;MEF2C
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.5028915987944157,1.011871988923625,0.54,1.0,1.0,5/19,19.18%,KLHL15;UGGT1;RNF185;CUL3;DERL1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5481105341799637,1.011730552305669,0.391304347826087,1.0,1.0,4/18,18.69%,NEDD4;HIF1A;PRKCB;ARNT
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.6003749663098532,-1.0115837468803428,0.45454545454545453,1.0,1.0,5/10,29.97%,EMC8;EMC4;EMC3;EMC1;EMC10
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6446112315443603,-1.011266570678316,0.5689655172413793,1.0,1.0,2/5,23.49%,NUCKS1;PPIB
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.5204179230878399,1.011133318237985,0.4444444444444444,1.0,1.0,3/22,5.08%,PNP;REXO2;FHIT
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.4446080368022443,-1.0110463311760154,0.4727272727272727,1.0,1.0,8/83,6.09%,GEM;TAGLN;COL6A2;COL6A1;FBLN2;MXRA8;ADAMTS12;CALD1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.5803129458007232,-1.0110194454744035,0.54,1.0,1.0,5/13,23.21%,RCC1L;C1QBP;UQCC2;TRMT10C;MPV17L2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.5524019882576252,-1.0106162498399156,0.42105263157894735,1.0,1.0,4/25,8.14%,CATIP;RAC1;VIL1;WASHC3
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.5550197491895592,1.0104877740058271,0.48214285714285715,1.0,1.0,4/16,13.34%,KANK1;ABL2;CCDC125;KCTD10
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6001269891124084,-1.0104053097551995,0.5094339622641509,1.0,1.0,4/7,38.72%,CTPS2;UMPS;CTPS1;CAD
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.40334187391719517,-1.0103932546544225,0.2857142857142857,1.0,1.0,21/135,13.64%,AURKA;ABRAXAS1;INCENP;GOLGA2;SBDS;KIF4A;ZWILCH;ERCC6L;CENPH;STMN1;SPDL1;PLK2;TPX2;PTPA;NUP133;SPC25;ITGB3BP;TOGARAM2;WRAP73;NUP43;RPS27
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.6594717510129293,-1.0103708294933325,0.5094339622641509,1.0,1.0,4/7,28.96%,PRDX1;SOD1;NOS3;MT3
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.6055229382508602,1.0103223381280733,0.5,1.0,1.0,1/9,0.30%,NOX5
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.6443322727065067,1.0103011592216518,0.5,1.0,1.0,2/7,13.06%,ENPP1;PID1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.5834927193029011,-1.0102130690759112,0.42105263157894735,1.0,1.0,3/13,3.48%,NCKAP1L;RAC1;CD74
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.5834927193029011,-1.0102130690759112,0.42105263157894735,1.0,1.0,3/13,3.48%,NCKAP1L;RAC1;CD74
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.5310502768721157,1.010207219310552,0.43137254901960786,1.0,1.0,5/18,10.34%,RUNX1;ZFP36;SULT2B1;ERRFI1;DLL1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.4625592462956083,1.0101065533503109,0.40384615384615385,1.0,1.0,8/48,10.22%,NFIL3;LEPR;PBX1;HDAC9;TOX;TPD52;BLNK;CHD7
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.5909051905112506,1.0100512369057002,0.5227272727272727,1.0,1.0,6/12,19.60%,HIF1A;ITGAV;ITGB8;PTGS2;SMAD3;SMAD4
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.42341921447144665,1.010044671160173,0.41304347826086957,1.0,1.0,30/150,14.81%,GRM7;NTF3;NLGN1;FLRT3;GPRIN1;HMGB1;NEDD4;AGER;ADGRV1;CNTN4;TNIK;GPM6A;NYAP2;MANF;CNTNAP2;RYK;SGK1;GPM6B;DOCK10;SH3GL2;TMEM108;NPY;PTPRM;ATXN10;BTG2;NCDN;CTNND2;LRP12;PPP1R9A;MAP2
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.6740685873344201,1.0099917244452998,0.4772727272727273,1.0,1.0,2/5,19.99%,BBOX1;ACADM
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.6740685873344201,1.0099917244452998,0.4772727272727273,1.0,1.0,2/5,19.99%,BBOX1;ACADM
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.5593924145802966,1.009754007642993,0.4722222222222222,1.0,1.0,5/14,17.62%,SCD;ACACA;ACSS1;FASN;SLC25A1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.5941125087400011,1.0095827721302617,0.45098039215686275,1.0,1.0,5/12,27.13%,SYNE4;RAP2A;RAB10;CAMSAP3;OPHN1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.49472218216173264,1.0095468559898824,0.4489795918367347,1.0,1.0,6/27,13.97%,IFI16;FHIT;ZNF385B;PPP1R13B;BOK;TP53BP2
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.49097248089694406,-1.0094731988457126,0.46296296296296297,1.0,1.0,5/36,6.62%,SFRP1;RAC1;TPM1;EPHA1;SYNPO2L
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.6029455772319046,1.0092744868824308,0.5217391304347826,1.0,1.0,3/9,12.70%,TOX;CAMK4;ADAM8
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.7281023796187578,-1.0092626559503501,0.6222222222222222,1.0,1.0,2/5,23.11%,SLC6A20;SLC25A29
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.6696749854672821,1.0092405428598141,0.5,1.0,1.0,2/5,16.40%,TGFBR1;VEGFA
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.6438011881708661,1.009004019860298,0.46511627906976744,1.0,1.0,3/5,24.43%,CHD7;SALL1;CHRNB2
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5157575750235274,1.0086437004296387,0.3958333333333333,1.0,1.0,9/21,15.77%,SMAD7;LATS1;NREP;SMAD2;SMURF2;SOX11;TGFBR3;SMAD3;TGFBR3L
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.5716944566790388,1.0086384131469364,0.48,1.0,1.0,4/8,23.77%,MAP2K6;CRY1;ABL1;CHEK2
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.5935775533400083,-1.0085328358280112,0.5192307692307693,1.0,1.0,2/10,3.65%,MYB;NLRP3
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.6004268140286712,-1.0084674930578665,0.5272727272727272,1.0,1.0,4/15,10.31%,ADRA2A;DRD3;ADRA1D;DRD1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.5205655000746447,-1.008228424739518,0.39215686274509803,1.0,1.0,5/28,12.30%,CLU;C2;HLA-DRA;CR1;C1QBP
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.5319405800305395,-1.0081992080179218,0.5,1.0,1.0,8/29,14.25%,CLU;RAC1;SERPINE1;B2M;ARF1;LRPAP1;PPT1;PIK3CB
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),0.6551776616936407,1.007899657257426,0.48,1.0,1.0,1/6,12.46%,EDN1
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.6837973586439214,1.0077917371913703,0.49019607843137253,1.0,1.0,2/5,10.68%,GLI3;MDK
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.5972124138137113,-1.0077885882264186,0.45901639344262296,1.0,1.0,2/17,4.04%,MYO15A;MYO7B
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.5189064893554622,1.0076084318606326,0.4166666666666667,1.0,1.0,6/28,14.14%,CHMP6;PDCD6IP;RAB27A;VPS37D;VPS37B;CHMP1A
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.5089069693677156,-1.007551738692224,0.4716981132075472,1.0,1.0,5/27,13.31%,ATP6V1E2;ATP6V1E1;ATP6V1D;TMEM9;ATP6V0A2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.5128025109416507,1.0074553768159449,0.4727272727272727,1.0,1.0,2/26,1.83%,NDNF;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.6393987253448525,1.0072756853916085,0.52,1.0,1.0,2/5,10.56%,ITGAV;NR1H3
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.5298651886542265,1.00716154375868,0.4186046511627907,1.0,1.0,9/17,25.58%,GRM6;PDGFRB;CXCL12;CTNNB1;FYN;PKD2;PDGFB;PRNP;CAV3
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.653059480644014,-1.0070553431018734,0.54,1.0,1.0,2/7,8.51%,ATG14;CALM1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5772872754241091,1.0066861569755623,0.4878048780487805,1.0,1.0,3/8,16.53%,BMPR1A;ACVR1;DCHS1
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.6431827571316131,-1.006388865110944,0.5348837209302325,1.0,1.0,1/5,12.95%,KCNE3
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.4487636059690295,1.0058509931580562,0.4117647058823529,1.0,1.0,24/97,13.54%,FAT4;GUCY1A2;SEMA6D;GFRA1;MXRA5;SULF1;POSTN;SLIT2;ADAMTS9;PDZRN3;PRRX1;FBXL7;PRKG1;LRP4;ADGRL2;COL5A2;PARD3B;CXCL12;ANK2;TIMP3;LIFR;AMOTL2;EFS;RUNX1T1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.45308672021947977,1.0052041266387366,0.3611111111111111,1.0,1.0,30/92,17.20%,PTPRK;SMAD7;WNT5A;NLK;TGFBR1;ZFP36L2;WWOX;PARD3;TWSG1;NR3C1;SMAD5;BMPR1A;SMAD1;SOX5;SMAD2;SMAD9;PDE3A;PDE2A;SIRT1;SMURF1;ACVR1;GDF10;MEF2C;TGFBR3;WNT2;LTBP2;SMAD3;TGFBR3L;DUSP22;LIMS1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.46523685386833874,1.0046249474063795,0.48936170212765956,1.0,1.0,14/41,17.12%,ENPP1;ADGRV1;SLC8A1;ACVR2A;TWIST1;BMPR1A;GPM6B;BCOR;ACVR1;MEF2C;P2RX7;PKDCC;ANKH;BMP6
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.6377836054029501,-1.0040887149882989,0.5306122448979592,1.0,1.0,1/7,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.6358402009211461,-1.0040454661325378,0.5238095238095238,1.0,1.0,7/11,32.60%,AKAP8L;HPF1;NNMT;PARG;CDK9;PARK7;MTHFR
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.676791059229501,1.0039351230856626,0.5,1.0,1.0,1/5,3.05%,SLC22A2
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.5969584548562614,1.0037428558346386,0.54,1.0,1.0,5/12,17.27%,SLC2A5;SLC2A11;SLC2A14;SORT1;SLC2A1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.41180909752888234,1.0037245694173416,0.43243243243243246,1.0,1.0,35/128,11.66%,GPC6;FAT4;LRRC4C;PCDHB3;IL1RAPL1;NLGN1;CDH8;DSCAM;FLRT3;CDH20;ROBO1;CNTN4;UNC5D;NECTIN3;ITGAM;HMCN1;CDH18;TENM2;GRID2;ROBO2;PTPRD;LRFN5;ADGRL3;CDH10;CRB2;CDH2;CDH6;CADM1;CLDN12;CDH13;TENM3;PTPRM;NPTN;EMB;TENM1
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.6013006307370841,-1.0034305598332693,0.5087719298245614,1.0,1.0,4/11,13.20%,HIRIP3;CHAF1A;MTA2;SUPT16H
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.4781773088930715,-1.00332133228874,0.453125,1.0,1.0,9/51,7.86%,CLDN4;HRNR;DACT2;FLG;FLG2;ITGA6;RYR1;CLDN1;STMN1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.44826978273811274,1.0032447992726512,0.40425531914893614,1.0,1.0,20/84,10.49%,ESRRG;TRPV2;OXTR;ADIPOR2;LEPR;PPARGC1A;SYK;ELOVL6;SCD;HDAC3;ZNF516;PIGA;ADIPOR1;IGF1R;IL4R;PRKAB2;ACACA;ZBTB7B;DISP3;PLAC8
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.45618856662404256,-1.003176862118282,0.40384615384615385,1.0,1.0,3/54,3.79%,NUPR1;KIF25;GOLGA2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.48744469884873337,-1.0026634178499223,0.46153846153846156,1.0,1.0,10/33,19.22%,SLC25A10;RBP4;ATF4;G6PC3;PER2;ENO1;GAPDHS;GOT2;PGK1;ENO2
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.5318780254548083,1.0026593300324647,0.48148148148148145,1.0,1.0,2/16,5.79%,PPARG;SLC5A8
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.6404944809692843,-1.0025478641847618,0.5471698113207547,1.0,1.0,1/6,2.00%,CGAS
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.5338184818353715,1.0024636455567577,0.49019607843137253,1.0,1.0,3/20,6.08%,SLC8A1;ATP2B4;JPH1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.6059424004551806,1.0024601743826418,0.43478260869565216,1.0,1.0,2/7,16.47%,ATG9A;ATG2B
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.5003838151360145,1.0024588707856645,0.45098039215686275,1.0,1.0,4/21,9.83%,NTF3;MAGI2;SH3GL2;TMEM108
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.5373823760588802,1.002282755418039,0.45098039215686275,1.0,1.0,3/17,3.79%,MYBPC3;FGFR2;SMAD7
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.47942037491760714,1.0022683027523456,0.41304347826086957,1.0,1.0,3/28,4.74%,B4GALNT2;UBE2J1;OSTC
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.46040690544019264,1.0011088780668869,0.39473684210526316,1.0,1.0,7/59,8.37%,PLCB1;EGFR;UBE2E2;FGF10;CDK6;PTPN6;ANKRD17
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.3789112731890742,-1.000974029461608,0.47058823529411764,1.0,1.0,53/246,19.84%,PARP2;TYMS;TERF2IP;BACH1;HMGB3;XPC;DNASE1L1;SLX4;ERCC1;REXO4;TICRR;UBC;PWWP3A;GADD45A;FANCC;RAD51AP1;XRCC1;NUDT1;NTHL1;XRCC2;ORC3;KPNA2;MCM5;HMGB2;MCM2;DDB1;POLL;SUPV3L1;HUS1;ORC1;PARP1;TOP3A;INO80;RPAIN;XRCC3;UHRF1;RBBP8;GLRX2;MBD4;FBXO6;KAT5;MUS81;ZRANB3;XRCC6;SMUG1;STN1;RECQL;FANCG;TDP1;NUDT15;CHEK1;CDC6;POLG
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.4536694547620884,1.000912197095166,0.3958333333333333,1.0,1.0,8/62,9.54%,ZDHHC11;EGFR;ZDHHC14;NECTIN3;PARD3;VPS37D;REEP1;ZDHHC2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.47519351555942846,-1.0008993501840988,0.4666666666666667,1.0,1.0,3/32,5.17%,KIF1A;KIF4A;DCTN1
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.6545309624845335,-1.0008912524547138,0.4878048780487805,1.0,1.0,3/6,25.26%,BRSK2;FUZ;CELSR1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.5473730260832272,1.0008334898208495,0.4883720930232558,1.0,1.0,1/13,0.66%,HORMAD1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5895966748913907,1.0004766496524427,0.5217391304347826,1.0,1.0,1/13,0.25%,SAMSN1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.45007882451351466,1.0004272201765438,0.4146341463414634,1.0,1.0,30/135,13.19%,LRIG3;FZD1;PRTG;IL17RD;L1TD1;ARHGAP42;ROR1;TEAD2;PARD3;SMAD5;PTPRG;EPCAM;COL4A6;SMAD1;LRP4;GULP1;FBLIM1;YES1;SMAD2;SMAD9;ADGRL2;CD59;TENM3;PTPN14;CTNNB1;LIFR;FNBP1L;ENAH;GJC1;AMOTL2
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.646294748705627,1.0003204156790921,0.5208333333333334,1.0,1.0,2/6,28.72%,EZH2;RIF1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.42360870413571383,1.0001284904071701,0.4,1.0,1.0,14/99,9.01%,SAMSN1;CALCR;IFI16;CYSLTR2;GPR176;SYK;SCTR;RXFP2;MC4R;PCBP2;PRKACB;FSHR;FER;YES1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5977762877385391,1.000084018550086,0.46938775510204084,1.0,1.0,2/12,6.29%,DOC2B;SYT1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.47237284615622144,1.000026492247931,0.4583333333333333,1.0,1.0,6/33,13.90%,CHRM3;CHRM2;NPY;CNR2;HTR1E;CALCRL
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.5928228462196451,-0.9998853806366319,0.5833333333333334,1.0,1.0,2/7,8.64%,KIF1A;KIF5A
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.5243180571583683,0.9998690560600083,0.5106382978723404,1.0,1.0,10/23,22.19%,IRS1;FGFR3;PRKD1;PDGFRB;PTK2;DGKZ;FLT1;AMBRA1;EPHA8;TNFAIP8L3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.6476244674071143,-0.9997202108167123,0.5849056603773585,1.0,1.0,1/9,0.63%,CCN3
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.6515070934416295,-0.9997097702592627,0.5102040816326531,1.0,1.0,4/6,24.81%,TMEM9;PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5008384973631672,0.9992940532728404,0.4791666666666667,1.0,1.0,8/35,9.77%,IFI16;S100A13;HMGB1;AGER;WNT5A;HSPB1;AIM2;IL16
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.6502744156338744,-0.9992623166396374,0.5660377358490566,1.0,1.0,2/7,2.62%,WNT7B;ASCL1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.5937301905724399,-0.9991481939838185,0.5116279069767442,1.0,1.0,7/11,26.31%,COX4I1;COX6C;COX7B;COX6B1;COX5B;COX7C;COX5A
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.5498407219212347,0.9990433757158997,0.4339622641509434,1.0,1.0,5/11,20.33%,BBOX1;CPT1C;CPT2;ACADM;ACADL
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.47478423114218493,0.9989857625574022,0.41304347826086957,1.0,1.0,4/29,7.15%,MYBPC3;SLC8A1;SGCZ;TRDN
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.5567033175249708,-0.9989838712805195,0.46551724137931033,1.0,1.0,6/13,20.70%,RPP25;HSD17B10;POP1;POP7;TRMT10C;POP5
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.461050566484465,0.9989822844993353,0.4489795918367347,1.0,1.0,10/55,17.12%,DOC2B;IRS2;SLC30A8;MCU;EXPH5;ACSL4;ADAM8;FRMD4A;BAD;BMP6
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.5023551649349567,0.9989800937327228,0.5102040816326531,1.0,1.0,7/33,21.30%,GLRA2;CPEB4;SESN1;CPEB3;SH3BP4;FYN;IPO5
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.6683732445450415,0.9989091586293727,0.52,1.0,1.0,1/6,14.52%,MPST
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.44881109511369666,0.9987556324883947,0.325,1.0,1.0,18/58,18.52%,NRG1;ERBB4;EGFR;FAM83A;GAB1;SLC30A10;PLCE1;PRKCA;BCAR1;PIK3CA;ERBIN;NRG2;PIK3R1;BRAF;PTPN12;SOS1;PTK2;TGFA
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.5825474240364664,0.9982464750235344,0.5,1.0,1.0,2/7,10.55%,RAB34;SNX5
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.6432262200404182,0.9979498921616288,0.5217391304347826,1.0,1.0,2/7,3.79%,KLRD1;SMAD7
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.41299862361741363,-0.9976665118296326,0.47058823529411764,1.0,1.0,31/120,24.60%,RPS27L;EIF2S2;PRPF6;CELF3;RPF2;TRAF7;PRPF19;RPS15;ZRSR2;SF3A2;RPS27;RPL5;MCTS1;RPL38;SNRPD2;RPL24;EIF2S3;SRSF10;PRMT7;RPL6;EIF4H;EIF3A;RPL11;EIF6;HSP90AB1;SNRNP200;RPS14;DHX29;GEMIN4;MRPS11;COIL
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.48143064907535293,-0.9976197413543095,0.45,1.0,1.0,14/33,27.30%,UBE2L6;DHX58;NLRX1;UFD1;TRAF3IP1;PIN1;TRIM25;ISG15;NPLOC4;OTUD5;NLRC5;CACTIN;HAVCR2;HERC5
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.4734573820965242,-0.9975745808410825,0.4727272727272727,1.0,1.0,12/37,27.71%,PHAX;NUP133;NUP43;XPOT;NUP155;NUP85;NUP214;RAN;NPM1;NUP50;SEC13;TPR
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.5765028501442249,0.9973783907647246,0.5094339622641509,1.0,1.0,3/12,8.67%,SPHK1;ACER1;ASAH2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.5765028501442249,0.9973783907647246,0.5094339622641509,1.0,1.0,3/12,8.67%,SPHK1;ACER1;ASAH2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.44593443461888826,-0.9973645492157389,0.46,1.0,1.0,9/79,9.17%,HLA-DPB1;CD74;KIF4A;HLA-DRA;DCTN1;RILP;KIF5A;ARF1;AP1S1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.449413067309153,0.9971995402828733,0.42857142857142855,1.0,1.0,7/51,15.73%,PLA2G10;PRELID2;ATP10A;LDLR;ATP8B3;ATP8A2;ATP11C
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.45177242149925706,0.996897955857611,0.41025641025641024,1.0,1.0,5/64,10.06%,U2AF1;ZFP36;NXF1;NXF5;RBFOX1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.4761006738036157,0.9968971749784101,0.4489795918367347,1.0,1.0,3/29,4.74%,B4GALNT2;UBE2J1;OSTC
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.4234107777375933,0.9964265903488643,0.3076923076923077,1.0,1.0,15/76,10.17%,SLC26A3;SEMA5A;AFP;LSAMP;SEMA6D;PPARGC1A;CNTN4;FGF14;GIPC2;CNTN3;PTPRD;SLC38A11;SLC4A4;FREM1;PDE3A
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.5070957659273077,0.9960288872449465,0.4418604651162791,1.0,1.0,2/23,4.45%,MYBPC3;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5046325689919844,-0.9959862111985008,0.5,1.0,1.0,7/23,18.22%,SLX4;EXOSC10;PIF1;PARP1;NAT10;SRC;STN1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.49173987583804235,0.9959135781631631,0.4666666666666667,1.0,1.0,9/33,19.73%,MAGI2;PKHD1;MSTN;PHLPP2;PHLPP1;SIRT1;PHLDA3;PLEKHA1;BANK1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.634612763221967,0.9958608563890395,0.5625,1.0,1.0,4/7,29.10%,RUVBL2;RUVBL1;PIH1D1;NUFIP1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.5669807373534533,0.9957611046516531,0.4074074074074074,1.0,1.0,8/12,20.04%,IRS1;IRS2;DYRK2;SORBS1;AKT2;INSR;EPM2AIP1;GCK
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.4224847810745404,-0.9955938648911261,0.4583333333333333,1.0,1.0,16/88,15.35%,KLRB1;FGL1;HLA-C;B2M;HLA-DRA;DHX58;MADCAM1;FOXP1;AMBP;LRP8;IL4I1;PILRA;COLEC12;RSAD2;TKFC;CLEC2D
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.4293492074342458,0.9948836283518597,0.4146341463414634,1.0,1.0,10/75,7.13%,LRIG3;PPARG;STAB1;EGFR;SLIT2;FGF10;TEAD2;PRRX1;TWIST1;GLI3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.6435904748181943,0.9946352110423694,0.6,1.0,1.0,3/5,31.07%,ZNF274;PIH1D1;ZNF304
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.5789264067648112,0.9944849820272278,0.5102040816326531,1.0,1.0,2/9,7.07%,RPS6KA4;TWIST1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.6223760989524941,0.9944180463175322,0.5106382978723404,1.0,1.0,4/6,26.75%,MYRF;PLP1;B4GALT6;B4GALT5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.45609476893846707,0.9943640363383314,0.36363636363636365,1.0,1.0,14/51,22.14%,PNLDC1;ZFP36;CNOT4;DCP1B;PATL1;DIS3;PAN3;CNOT2;PDE12;EXOSC8;CNOT7;CNOT8;CNOT6L;TUT7
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.48107435970823476,0.9943140110265813,0.4,1.0,1.0,9/27,25.28%,PUS10;SMAD1;SMAD2;SMAD3;HNRNPA2B1;PUM1;TUT7;PRKRA;PUM2
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.4773418743685694,-0.9942480623038429,0.47368421052631576,1.0,1.0,2/26,5.79%,LDB1;RNF8
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.5997673024381308,-0.9941299566261694,0.5094339622641509,1.0,1.0,1/7,9.27%,CR1
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.5997673024381308,-0.9941299566261694,0.5094339622641509,1.0,1.0,1/7,9.27%,CR1
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.5997673024381308,-0.9941299566261694,0.5094339622641509,1.0,1.0,1/7,9.27%,CR1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.42874707265014705,-0.9939488873473471,0.484375,1.0,1.0,18/114,12.62%,CNGA3;GNAT3;GFRA3;TMEM179;KIF1A;VWA5B2;ENPP2;FABP5;CELF3;SST;PAX6;NKX2-2;SCG3;TCEAL5;LRRTM1;CHGB;TAGLN3;TTBK1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.656903849617605,-0.9937486182421793,0.5161290322580645,1.0,1.0,4/6,27.10%,HDAC6;SAT2;SAT1;SRM
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.41552310012180255,0.9936624296900349,0.4807692307692308,1.0,1.0,25/107,15.61%,NLGN1;FLRT3;GPRIN1;HMGB1;NEDD4;AGER;CNTN4;GPM6A;MANF;CNTNAP2;RYK;GPM6B;SH3GL2;CSF1R;TMEM108;NPY;PTPRM;TTC29;ATXN10;BTG2;NCDN;LRP12;PPP1R9A;MAP2;HDGFL3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.54461672728743,-0.9931679921425794,0.4807692307692308,1.0,1.0,1/15,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5839333756500321,-0.9931551227632429,0.48936170212765956,1.0,1.0,2/11,6.44%,CBLC;VPS25
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.5728045740299308,-0.9926819492781958,0.4909090909090909,1.0,1.0,4/12,28.66%,AASS;CRYM;ALDH7A1;AADAT
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.5728045740299308,-0.9926819492781958,0.4909090909090909,1.0,1.0,4/12,28.66%,AASS;CRYM;ALDH7A1;AADAT
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.6261934023353022,0.9925749942670132,0.5,1.0,1.0,2/6,4.55%,ROBO1;SLIT2
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.5215949888567407,-0.9925405582478873,0.5306122448979592,1.0,1.0,2/21,6.22%,NCKAP1L;SRP54
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.6488694125646266,0.9924523563364207,0.5652173913043478,1.0,1.0,2/6,14.24%,LDLR;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4915793407166346,0.9924441053274273,0.45652173913043476,1.0,1.0,5/24,8.77%,PPARG;FOXO3;NR3C1;HIF1A;ATOH8
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.4185394871595104,-0.9922449334960181,0.38181818181818183,1.0,1.0,14/94,19.88%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;MRPS21;MTIF3;MRPL9;MRPL19;IARS2;MRPL27;MRPL51;MRPS18C;MRPL37
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.622603369766731,0.9922031040375849,0.5384615384615384,1.0,1.0,1/7,14.52%,MPST
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.6210301554327129,-0.9921329927482478,0.46511627906976744,1.0,1.0,4/7,25.55%,NOP9;RPS15;RAN;NPM1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.5834552459023188,0.992009553121599,0.5294117647058824,1.0,1.0,3/7,28.92%,YWHAZ;ARHGAP21;RIPOR1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.562503794511276,-0.9918365170814873,0.4791666666666667,1.0,1.0,5/19,7.14%,SPRY4;NOG;SPRY1;GPC1;LRIT3
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.5780012911439542,0.9917212171767698,0.5227272727272727,1.0,1.0,2/9,3.10%,NTF3;MAGI2
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.584136228447804,0.9916788863231619,0.4666666666666667,1.0,1.0,3/7,16.40%,CDH13;F3;VEGFA
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.6308296010589767,0.9916040455012414,0.5208333333333334,1.0,1.0,4/8,17.53%,PDCD6IP;CRB2;LIN7A;WDR1
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.6308296010589767,0.9916040455012414,0.5208333333333334,1.0,1.0,4/8,17.53%,PDCD6IP;CRB2;LIN7A;WDR1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.5292766226609819,-0.9915189476343743,0.44642857142857145,1.0,1.0,5/13,23.49%,GHR;GHRHR;MFSD2A;SOD1;PPIB
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.6194843458574546,-0.9913640496064609,0.5102040816326531,1.0,1.0,1/5,9.14%,HADHA
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.44599953669675324,-0.9912896672024071,0.42,1.0,1.0,12/72,7.24%,P2RY10;NCKAP1L;HCK;AOAH;TRAF3IP3;CD37;DOCK8;CD4;SLA;HLA-DRA;IL3RA;SPI1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.4649587676390298,0.9911939139410654,0.4523809523809524,1.0,1.0,12/47,16.87%,PPARG;STEAP4;PPARGC1A;ZNF516;CTBP2;BBS9;SIRT1;FOXO1;PID1;EP300;AKT2;BBS4
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.6276484389519184,0.9910546083431943,0.46808510638297873,1.0,1.0,3/7,15.56%,COL4A6;ITGA11;ITGA2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.474935052008026,0.9909283961438218,0.5,1.0,1.0,11/38,19.64%,CHMP6;KLF2;SPOP;LDLR;ODC1;ZDHHC2;MAPK8;NEDD4L;ROCK2;MDM2;SPOPL
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.5328429629691964,-0.9907672581136078,0.4375,1.0,1.0,2/19,6.22%,NCKAP1L;SRP54
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.4346234551128563,0.9907573751799281,0.4,1.0,1.0,24/135,9.69%,SAMSN1;NLRP2B;NTF3;ENPP1;PPEF2;DDIT4;SMAD7;SLIT2;PPP1R15B;PARD3;HSPB1;PPM1E;ERRFI1;DNAJC3;SNCA;TWIST1;PTPN13;FKBP8;PTPN6;PDE4D;SH3GL2;CEP85;NCK1;GNAQ
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.4565448866566944,0.9905318724443046,0.4791666666666667,1.0,1.0,7/52,9.91%,LOXL2;NEDD4;SLC30A8;PPP3CA;SNCA;HIF1A;ZACN
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.5973308292768952,0.9904566519174217,0.4897959183673469,1.0,1.0,5/8,25.73%,SMAD3;CLASP1;PHLDB1;CLASP2;DAG1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.5099058104459938,0.9903559118596587,0.5306122448979592,1.0,1.0,6/17,18.51%,TLE1;BRMS1;PIK3CA;BCL2;PDK4;PTK2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.5804181910129742,-0.9902467715540585,0.5172413793103449,1.0,1.0,3/9,23.30%,UBC;ISG15;UBB
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.5783822583200542,0.9902358365100675,0.5365853658536586,1.0,1.0,4/21,9.16%,ZBTB20;SLC2A5;ERN1;IGF1R
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.4561302929582953,0.9901908003993374,0.4857142857142857,1.0,1.0,22/104,16.36%,GPC6;FLRT3;EGFR;SHROOM2;TOX3;PDZRN3;RNF128;FGFR3;COBL;DDAH1;ADGRL2;TMEM98;PARD3B;BCAR1;AMOTL2;PRICKLE2;EFS;NOTCH3;CHMP1A;TMEM178A;MAGI1;SLC31A1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.47003541617819206,-0.9901411304122507,0.42857142857142855,1.0,1.0,9/60,14.58%,KIF25;ABRAXAS1;GOLGA2;KNSTRN;SMC4;TPX2;TOGARAM2;WRAP73;INO80
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.58768918390627,-0.9900831032517103,0.543859649122807,1.0,1.0,3/9,15.75%,TAF7;TAF11;TAF1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),0.6097607641321798,0.9899824005835627,0.5384615384615384,1.0,1.0,2/6,5.71%,PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.635953126712259,-0.9898707825653233,0.5714285714285714,1.0,1.0,1/5,5.11%,HPS4
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.5848168986632826,-0.9896740040106361,0.5106382978723404,1.0,1.0,4/16,12.30%,INHA;CR1;NR1H4;C1QBP
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.5193307213701451,-0.9895837708941603,0.49056603773584906,1.0,1.0,1/26,0.79%,SIGLEC1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.6357746810076791,0.9895500270083146,0.5416666666666666,1.0,1.0,3/11,3.05%,ERBB4;OXTR;SLC22A2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.47511994654889905,0.9893441816446124,0.42592592592592593,1.0,1.0,6/29,13.89%,PPARG;ERN1;PRKG1;BMPR1A;MEF2C;LDLRAP1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5700048896806709,0.9892973410439335,0.44,1.0,1.0,8/12,26.99%,SAXO2;PCM1;BICD1;CLASP1;CLASP2;BCCIP;DAG1;CAMSAP3
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.46680311481335013,-0.9892378167036492,0.4666666666666667,1.0,1.0,8/82,6.63%,SFRP1;WNT7B;WNT9B;WNT9A;PORCN;SKP1;UBC;RBX1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.5294221887961312,0.9890696725700977,0.4666666666666667,1.0,1.0,1/11,4.35%,PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5186087615118693,-0.9889960816151329,0.5192307692307693,1.0,1.0,1/23,0.91%,MYB
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.47204402101217147,0.9887958879760104,0.4222222222222222,1.0,1.0,9/48,7.92%,NRG1;ERBB4;EGFR;TGFBR1;PKHD1;CDK6;ZSWIM6;ZSWIM5;ABL2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.6977884632920928,-0.9886977541503327,0.6041666666666666,1.0,1.0,3/5,24.28%,RFPL1;RPS3;RFFL
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.49784470818572335,0.9886292785284602,0.5319148936170213,1.0,1.0,6/24,18.80%,DOC2B;SYT1;RIMS2;SYT15;SYT2;SYT17
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.45601302398390875,0.9884861261150005,0.38461538461538464,1.0,1.0,2/39,3.48%,NLRP2B;HMGB1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.5142399116981694,-0.9881297441271528,0.5185185185185185,1.0,1.0,7/29,10.31%,KCNE1;ADRA2A;VIP;KCNE2;DRD3;CD63;DRD1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6391339292959418,-0.9880311754543913,0.5535714285714286,1.0,1.0,5/7,30.37%,PIK3CB;SPRY2;DAB2IP;IL12A;CADM4
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5401387808325949,-0.9868858133976188,0.49019607843137253,1.0,1.0,6/12,16.76%,GPR37;PDE8A;TXN;RACK1;MET;NR4A3
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.5899703521266436,-0.9868642921802397,0.5409836065573771,1.0,1.0,1/11,1.29%,LCP1
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.6844448845011848,0.9868235832500101,0.5833333333333334,1.0,1.0,2/7,2.08%,ERBB4;OXTR
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.6243218654327549,0.9866470923468537,0.4727272727272727,1.0,1.0,2/5,24.13%,PTPN12;HIP1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5368792486634231,0.9864761999430394,0.5,1.0,1.0,4/27,11.75%,PLA2G10;PPARG;NR1H3;SIRT1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.43930130471564327,0.9856467183313092,0.39215686274509803,1.0,1.0,22/79,18.99%,IL17RD;L1TD1;FGFR2;TOX3;UNC5D;GRID2;CNTNAP2;EPHA7;EPCAM;NLGN4X;CXCL12;CRABP1;SOX11;CBLN1;GABRB3;DPYSL5;FRAS1;IGDCC3;BCL11A;VASH2;ADAMTS19;GAL3ST3
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.415774061623551,0.985303677362222,0.43478260869565216,1.0,1.0,22/103,14.29%,LRIG3;FZD1;MXRA5;FAM114A1;EGFR;SULF1;POSTN;ACKR3;IL17RE;TWSG1;COBLL1;COL5A2;PARD3B;CXCL12;PTGS2;FLNC;TIMP3;LURAP1L;AMOTL2;PRICKLE2;F3;MUC16
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5587727025031886,-0.9851196976766583,0.5,1.0,1.0,2/24,1.05%,SFRP1;CYP19A1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.6121862305032056,-0.9850521868848431,0.5510204081632653,1.0,1.0,1/6,12.84%,TRMT112
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.4615503788842319,0.9850313256922598,0.41304347826086957,1.0,1.0,17/65,15.67%,NKAIN2;KCNJ3;NEDD4;SYT1;SNCA;PXK;KCNJ16;KCNJ6;NKAIN3;SYT15;TF;ANK3;KCNJ2;P2RX7;KCNA5;NEDD4L;SYT2
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.5219793063057835,0.98495290494159,0.48,1.0,1.0,10/18,18.53%,ENPP6;GDPD3;SMPDL3A;PRDX6;PLBD2;PLA2G4C;SMPD4;GPCPD1;PNPLA6;ABHD12
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.4612085384828725,0.9848752120934827,0.4666666666666667,1.0,1.0,6/41,15.52%,NEDD4;ECT2;HDAC3;UBR5;PIK3R1;SMAD3
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.5021227742725018,0.9846350117243291,0.5405405405405406,1.0,1.0,14/30,19.09%,IRS1;IRS2;RORA;SDHAF3;ADIPOR1;SIRT1;OGT;AKT2;PDK4;GNMT;PDK2;FBP1;PDK1;ZNF692
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),-0.6179580617702589,-0.9845275470484411,0.5,1.0,1.0,3/6,23.50%,KIF4A;KIF4B;KIF23
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),-0.6179580617702589,-0.9845275470484411,0.5,1.0,1.0,3/6,23.50%,KIF4A;KIF4B;KIF23
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4247190606176777,0.9843142984136938,0.3829787234042553,1.0,1.0,12/67,8.88%,LRIG3;MXRA5;SPHK1;FAM114A1;TNC;EGFR;POSTN;TP63;LAMC2;FST;ACTA2;FBLIM1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6476709208838,0.9841473694302716,0.5581395348837209,1.0,1.0,1/6,4.48%,ZFP36L2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.4361693614998079,-0.9841338405093735,0.5098039215686274,1.0,1.0,13/81,14.35%,PLK4;HK2;NCL;FANCI;ERCC6L;TICRR;KNOP1;CENPH;CHAF1A;SUPT16H;PIF1;ORC1;PARP1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.5777231445973146,-0.9839190475734397,0.5263157894736842,1.0,1.0,3/8,28.58%,AK8;AK7;AK1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),0.6224954252865018,0.983838547447341,0.5531914893617021,1.0,1.0,3/6,23.16%,SCTR;NEDD4L;CLN3
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.646726530164409,0.9837923129104515,0.574468085106383,1.0,1.0,1/5,5.17%,RPS6KA4
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.5875658288681735,-0.9837783800595981,0.5535714285714286,1.0,1.0,4/11,20.04%,CTSH;BRD8;CTSL;CTSB
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5762406587015705,0.9836606804463572,0.4909090909090909,1.0,1.0,4/11,14.31%,ERN1;ATF6;BOK;PIK3R1
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6495277696712078,0.9832226690216584,0.5625,1.0,1.0,3/5,26.90%,RELA;NFKB1;RC3H1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.4968060955641808,-0.9831175755364825,0.5,1.0,1.0,11/36,19.62%,NFKBIB;POLR2I;PAX8;PTMA;POLR3A;POLR2J;POLR2G;DRG1;POLR2C;DTX1;RNPS1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.5662299677000103,-0.983043398858416,0.4909090909090909,1.0,1.0,2/11,4.11%,WNT9A;ADAMTS12
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.4916780092864586,-0.9827572983714419,0.48214285714285715,1.0,1.0,2/20,10.04%,EEF1AKMT2;METTL22
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.5967308070041326,0.9827079308145166,0.5142857142857142,1.0,1.0,4/8,12.80%,SLC8A1;TRDN;PDE4D;ANK3
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.5713741791014881,-0.9826220186063107,0.4444444444444444,1.0,1.0,5/10,24.85%,RNF8;DTX3L;RNF20;CTR9;PAF1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.5974167332284789,-0.9824473617688516,0.5434782608695652,1.0,1.0,1/7,3.88%,ENPP2
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.5128557880502782,-0.9824189622145517,0.4897959183673469,1.0,1.0,4/18,10.16%,RAC1;WDR54;LRPAP1;RIN3
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.46501694455373793,0.9823419285664599,0.5277777777777778,1.0,1.0,16/46,15.40%,PBX1;HEY1;DTX4;GMDS;MAML2;MAML3;NLE1;JAG1;WWC1;DLL1;MDK;SUSD5;EP300;NOTCH3;MIB1;KAT2B
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.47074462633881536,0.9820351000936667,0.4444444444444444,1.0,1.0,8/40,16.02%,NRXN1;SYT1;SNCA;RIMS2;SYN3;PPFIA3;PCLO;LIN7A
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.5547689128436882,-0.9820196079418468,0.5471698113207547,1.0,1.0,2/19,5.21%,CACNG5;NPTXR
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.504196494275363,-0.9818181850007526,0.4528301886792453,1.0,1.0,5/29,12.30%,CLU;C2;ZP3;CR1;C1QBP
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.540451833320765,0.981646084805908,0.5,1.0,1.0,8/24,15.38%,SGCZ;MRTFA;MEGF10;RORA;MRTFB;MEF2C;DMD;NEBL
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.4528743312364338,0.9811281598903097,0.3958333333333333,1.0,1.0,18/65,17.29%,IRS1;PPARG;ADIPOR2;LEPR;PPARGC1A;SLC30A8;MCU;HIF1A;ADIPOR1;IGF1R;SIRT1;FOXO1;KLF7;PIK3R1;CRY1;BAD;PDK4;MBD5
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.6095940851885461,-0.9810693452994129,0.5370370370370371,1.0,1.0,2/10,7.42%,B3GNT9;B3GALT5
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5044268011963359,0.9810258302556711,0.44642857142857145,1.0,1.0,5/27,13.07%,TLE1;TLE3;RBBP5;CTNNB1;EP300
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5153359422113806,0.9805369200784079,0.48214285714285715,1.0,1.0,3/26,8.43%,LHFPL2;WNT5A;FSHR
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.478586903044516,-0.9805270471810038,0.44642857142857145,1.0,1.0,1/40,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5420848638522751,0.9803011268929803,0.5192307692307693,1.0,1.0,2/12,14.39%,AK3;GNAI3
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.48736171416303853,0.9796942199297469,0.4375,1.0,1.0,9/33,16.40%,UNC5C;HEY1;NRP1;CDK6;TLE1;TLE3;RTN1;ADGRG1;VEGFA
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.5416494460224115,0.9796021126948973,0.4791666666666667,1.0,1.0,2/11,3.94%,ADGRV1;WNT5A
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.5826061288589731,0.9792461887074336,0.5686274509803921,1.0,1.0,3/9,16.87%,LEPR;SIRT1;BBS4
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.4726712816862342,0.9788603298643395,0.5,1.0,1.0,9/19,24.77%,TGFBR1;SLIT2;SMAD2;TGFBR3;GRIN3A;GRIN2A;SLIT3;CHRNB2;GRIN2B
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.5472184212781448,-0.9788528337702658,0.5,1.0,1.0,4/19,9.83%,BCAT2;HSD17B10;BCKDK;SLC25A44
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.5472184212781448,-0.9788528337702658,0.5,1.0,1.0,4/19,9.83%,BCAT2;HSD17B10;BCKDK;SLC25A44
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.4284260655819349,0.9788449987728441,0.42857142857142855,1.0,1.0,10/52,16.06%,KCNJ3;NEDD4;KCNIP4;KCNJ16;KCNJ6;DPP10;AKAP6;KCNJ2;NEDD4L;KCNN1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.49147998635762086,0.9787549535694813,0.43636363636363634,1.0,1.0,10/28,16.18%,SLIT2;AUTS2;MSTN;FER;PLCE1;WASF2;PIK3CA;PIK3R1;ACTR3;TWF1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.6460436654231739,0.9786801864541307,0.5625,1.0,1.0,2/5,14.54%,PRKCA;PRKCB
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5633519240904997,0.9786718246117073,0.5476190476190477,1.0,1.0,6/10,17.66%,SLC8A1;ATP12A;SLC12A2;SLC9A1;NEDD4L;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.5360245487148899,0.9785576511407351,0.5306122448979592,1.0,1.0,2/17,8.16%,NUS1;HIF1A
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.4408141125374704,-0.9784746931615801,0.4915254237288136,1.0,1.0,13/98,11.10%,RAC1;WTIP;RND3;ARAP3;TPM1;FGD3;PACSIN3;LIMD1;ZMYM6;RND2;PAK6;RHOBTB2;RHOBTB1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.46059163166606115,-0.9784594107456411,0.43636363636363634,1.0,1.0,7/40,7.97%,CLDN4;CBLC;ST6GALNAC2;CRH;CEBPD;LLGL2;LTBR
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3962973905149515,0.9783489038365965,0.4418604651162791,1.0,1.0,45/243,13.33%,NOX5;LOXL2;IFI16;ESRRG;ITGAX;TRPV2;PLCB1;OXTR;NLGN1;ADIPOR2;LEPR;S100A13;PPARGC1A;WNT5A;TGFBR1;SYK;RFX3;ELOVL6;TBXA2R;SCD;HDAC3;TWIST1;ZNF516;FST;BMPR1A;CRB2;SOX5;ADIPOR1;IGF1R;IL4R;SMAD2;CADM1;PRKAB2;ZBTB7B;SMURF2;PLAC8;MDK;ACVR1B;CTNNB1;SIRT1;SHLD1;SOX11;ACVR1;SCX;AVPR1A
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4160002662281338,0.9781370868270404,0.42857142857142855,1.0,1.0,57/321,10.96%,DACH1;SGK3;CD151;STK26;SEMA3C;ITGAX;SEMA5A;NTF3;ERBB4;KANK1;CASS4;PTPRK;FAM83H;SEMA6D;PHACTR1;LDB2;MAGI2;SPHK1;TRIP6;EGFR;CSF1;SMAD7;ROBO1;SULF1;CCL5;TGFBR1;NAV3;SLIT2;FGF10;FRMD5;FOXO3;RHOB;PPP3CA;MCTP1;LAMC2;FGF17;FGF5;HGF;CTNNA2;SGK1;TCAF2;FER;SRGAP2B;DOCK10;IGF1R;MITF;CSF1R;TP53INP1;PRKCA;JAG1;PDGFD;TMEFF2;CDH13;PDGFRB;RAP2A;MDK;CXCL12
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.5580906010070387,-0.9781057852977258,0.5306122448979592,1.0,1.0,2/14,8.95%,DCTN1;ARF1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.5717736727404908,0.9779527187145131,0.6122448979591837,1.0,1.0,2/9,7.86%,SPHK1;LDLR
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.42895700076554905,-0.9779130273033396,0.42857142857142855,1.0,1.0,19/120,12.65%,NCKAP1L;INHA;SARS1;SIGIRR;APOD;RAC1;TMSB4X;TRIB2;UBE2L6;DHX58;CR1;NLRX1;UFD1;NR1H4;CEACAM1;TRAF3IP1;C1QBP;PIN1;APOA1
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.591995215947481,0.9775652253731387,0.46511627906976744,1.0,1.0,2/6,11.68%,USH2A;CTNNB1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.5023003462044469,0.9774849973690533,0.5121951219512195,1.0,1.0,4/13,16.58%,CHRNB4;ERC2;DTNA;ERC1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.49170273583913704,-0.9773382683480392,0.45454545454545453,1.0,1.0,5/28,12.71%,GPC2;EVC2;DISP2;B9D1;IFT27
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5273012725840972,0.977231136032912,0.4909090909090909,1.0,1.0,4/20,10.84%,SLC22A2;SLC6A13;SLC1A2;SLC7A2
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.5929886182563767,0.9770258304693,0.5625,1.0,1.0,1/8,0.90%,KLKB1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.5078634355873234,0.9768466194048587,0.5102040816326531,1.0,1.0,6/21,12.46%,HPGDS;AKR1C1;PTGES;CES2;PTGS2;EDN1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.5676143902527209,0.9768440641062196,0.4727272727272727,1.0,1.0,8/11,20.04%,IRS1;IRS2;DYRK2;SORBS1;AKT2;INSR;EPM2AIP1;GCK
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.49349017239048404,-0.9767405572343608,0.48148148148148145,1.0,1.0,3/21,13.54%,KIF1A;KIF5A;TUBA1B
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.5620285301055415,0.9765687632737149,0.5526315789473685,1.0,1.0,2/9,10.96%,UBE2J1;YOD1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5744272044242393,0.976435342116973,0.5333333333333333,1.0,1.0,1/9,4.52%,SYK
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6379408959895904,-0.9762059197182047,0.5192307692307693,1.0,1.0,2/7,9.99%,ADRA2A;BTC
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.6462441356033151,0.976008280616462,0.58,1.0,1.0,4/5,34.91%,ATP8A2;ATP8A1;TMEM30A;ATP11B
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.4697396001203672,-0.975941655081401,0.4583333333333333,1.0,1.0,5/56,3.24%,SFRP1;WNT7B;WNT9B;WNT9A;PORCN
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.5599184673054732,0.9756849598734194,0.5319148936170213,1.0,1.0,1/8,3.62%,JAM2
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.49651372165445024,-0.9756150451954314,0.49056603773584906,1.0,1.0,7/25,20.14%,DHX58;FOXP1;LRP8;TKFC;XIAP;IRF1;PTPN22
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.5969389714396568,0.9755903221320005,0.6,1.0,1.0,1/7,5.02%,NRP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.4967966221040845,0.975500327849133,0.5106382978723404,1.0,1.0,3/25,6.08%,INF2;RALA;MCU
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.43001003317124387,-0.9753166012361021,0.5,1.0,1.0,15/79,14.93%,CBLC;SPRY4;FGF1;UCHL1;TRIB2;SPRY1;ADRA2A;RGS2;CD24;FGF18;BMP7;DIRAS1;PIK3CB;PDGFA;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.6265448124741959,-0.9752476403755617,0.5813953488372093,1.0,1.0,1/7,11.04%,PARP14
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.5215105404313563,-0.9752005583693115,0.5,1.0,1.0,2/15,5.13%,TRPC3;P2RY11
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.5962768507732201,-0.9751124973399761,0.543859649122807,1.0,1.0,1/7,3.24%,DECR2
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5554792382809661,-0.9750653261966644,0.5306122448979592,1.0,1.0,3/12,13.94%,UPB1;NT5M;DERA
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4164976926203729,0.9748955731212325,0.4583333333333333,1.0,1.0,14/59,22.41%,FAS;TGFBR1;FAIM;ITGAV;BCL2;ACVR1;HSPA1A;RELA;EYA3;PHIP;BCL2L1;EYA2;ZMYND11;ICAM1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.4876710000079383,-0.9747729211841125,0.47368421052631576,1.0,1.0,9/45,17.34%,SERPINB8;SERPINE1;TIMP4;SERPINF2;APH1B;PRELID1;VTN;PSMB8;PSME1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.40317350027942145,0.9747220896979419,0.3684210526315789,1.0,1.0,21/111,20.03%,LRP1B;SLC22A2;SLC25A48;SLC6A13;SLC19A2;SLC23A1;ARRDC3;SLC15A2;ABCC2;SLC7A2;SLC38A2;EDN1;CALCRL;CHMP1A;SLC12A2;ABCG2;SLC16A10;SLC7A14;SLC7A9;TCN2;SLC43A1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.45434606893386825,0.9745208812527965,0.4444444444444444,1.0,1.0,5/46,9.14%,MARVELD3;FGF10;PTPRG;HIF1A;ADIPOR1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.5550085453913838,-0.9743877592986459,0.5686274509803921,1.0,1.0,2/14,8.82%,DUOX1;PRDX1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.5490983383009574,0.9743554931971354,0.5333333333333333,1.0,1.0,8/18,18.51%,CSF1;CCL5;MSTN;CSF1R;MDK;CMKLR1;IL34;PTK2
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.6426833541663479,-0.9741522146353239,0.5535714285714286,1.0,1.0,4/5,31.49%,EIF4G1;COL5A1;SLC11A1;EIF4G2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.41462003634075956,-0.9740723981082089,0.5,1.0,1.0,7/97,7.88%,CCN3;SFRP1;OSTN;TSPYL2;TCHP;CDHR2;HNF4A
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5475098353353699,0.9740148904708713,0.5625,1.0,1.0,3/14,14.39%,AK3;IMPDH1;GNAI3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.5872468938327104,0.9738303002547601,0.5106382978723404,1.0,1.0,2/6,15.68%,SIRT1;DIPK2A
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5464392181256187,0.973555247845323,0.5614035087719298,1.0,1.0,3/19,7.59%,SLC30A10;SNCA;RAB27A
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.6115985457962456,0.9735029141792355,0.5333333333333333,1.0,1.0,1/7,2.00%,HS3ST5
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.5178857480434842,0.9733339126661796,0.54,1.0,1.0,8/21,26.44%,GRID2;INSYN2A;MEF2C;GRIN2A;MPP2;LRRK2;GRIN2B;ARRB2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.441929448178084,-0.9733081495813535,0.45614035087719296,1.0,1.0,11/69,17.13%,GTF2F1;INTS5;PHAX;POLR2I;POLR2J;TAF11;TAF6;CCNT1;POLR2G;POLR2C;SNAPC5
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.37899868506418743,0.9732901576296976,0.4473684210526316,1.0,1.0,64/436,12.59%,DACH1;LOXL2;NRG1;IFI16;ZFPM2;NAB1;PLCB1;NFIL3;PPARG;ENPP1;PTPRK;ID3;ZNF706;BAHD1;MTERF3;ZEB1;HEY1;WNT5A;TSHZ3;RUNX2;RFX3;FOXP2;HDAC9;KCTD1;SP3;RIDA;NR3C1;TP63;ATXN1;HDAC3;TWIST1;GLI3;SYNCRIP;NR1D2;SPINDOC;HDAC2;TLE1;HINFP;EIF2AK3;PHC2;CTBP2;GLIS2;BCOR;ATOH8;SMAD2;SMARCE1;RNF139;POU2F1;SMURF2;NPAS1;ARID5B;HIC2;PRICKLE1;BRMS1;CD38;BTRC;CTNNB1;SIRT1;FOXO1;EPC1;DPF3;BTG2;YAF2;FOXN3
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.47528279532161477,-0.9729543779370591,0.4716981132075472,1.0,1.0,4/32,7.24%,NCKAP1L;LDB1;ETS1;SPI1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.49539289347292775,-0.9729239793684161,0.47058823529411764,1.0,1.0,4/34,8.23%,SFRP1;RAC1;EPHA1;GFUS
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.4540896169434007,-0.9726540034343967,0.4925373134328358,1.0,1.0,5/35,8.77%,APOBEC3H;OAS3;ILF3;IFIT1;OAS2
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.6067429298516271,0.9723322377775604,0.5636363636363636,1.0,1.0,1/5,8.75%,DHRS7B
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.6067429298516271,0.9723322377775604,0.5636363636363636,1.0,1.0,1/5,8.75%,DHRS7B
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.3985876202159507,0.9715875539970077,0.5121951219512195,1.0,1.0,19/105,13.90%,SLC12A1;DACH1;SLC12A3;LDB2;MXRA5;FAM114A1;POSTN;PLA2G7;SMARCD3;CDH6;C3;SHROOM4;JAG1;CXCL12;PTGS2;TIMP3;SASH1;PRICKLE2;CALCRL
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.4550320125911225,-0.9715874550408065,0.4418604651162791,1.0,1.0,4/23,8.49%,KANK3;TMSB4X;VIL1;MYADM
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.5154703364503375,-0.9713501578414949,0.5,1.0,1.0,2/14,8.95%,ATOX1;ARF1
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),-0.6147557854187806,-0.9712550351801309,0.576271186440678,1.0,1.0,3/5,13.59%,FGF1;PAX8;BMP7
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.4737119987136417,0.9712488116785669,0.4,1.0,1.0,1/23,0.66%,HORMAD1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.5591677048314857,-0.97100564379377,0.5833333333333334,1.0,1.0,4/9,28.92%,HADHA;SLC27A1;TAMM41;PLA2G6
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.5281325619291188,-0.97037520320206,0.5,1.0,1.0,3/25,6.22%,KIF25;KNSTRN;SMC4
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5745871660200905,0.9702918077919802,0.5777777777777777,1.0,1.0,1/11,3.74%,EGFR
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),0.6287029996738924,0.9702891324204832,0.5,1.0,1.0,3/5,29.63%,WWC1;PTEN;SLC6A4
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.5170014871586759,0.9699296198501967,0.5,1.0,1.0,2/12,4.35%,HEY1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.5492783615987097,-0.9698723461024288,0.44642857142857145,1.0,1.0,4/18,4.74%,NCKAP1L;RAC1;CD74;BST1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.5518165803885783,0.9694025235547127,0.5306122448979592,1.0,1.0,2/15,1.83%,NDNF;SEMA5A
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.49719447006911166,-0.9693861996463913,0.5818181818181818,1.0,1.0,3/28,0.62%,CLDN4;CBLC;TMEM184A
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.618108040519066,0.9693090527174737,0.5714285714285714,1.0,1.0,1/6,14.68%,KIF13A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5171357692126156,0.9692421601065366,0.4222222222222222,1.0,1.0,2/18,5.17%,PPARGC1A;RPS6KA4
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.5875045735752449,0.9684759533921793,0.5581395348837209,1.0,1.0,2/11,6.72%,GLRA2;MT1M
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.552227007913952,0.968323397040604,0.6666666666666666,1.0,1.0,4/14,15.56%,NRP1;VEGFC;ITGA11;ITGA2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.5903804495373688,-0.9682460873259368,0.5098039215686274,1.0,1.0,3/11,21.17%,SRC;DENND10;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.42262184191562047,0.9681857689419454,0.4722222222222222,1.0,1.0,9/41,19.21%,KCNJ3;KCNJ16;KCNJ6;ANK2;AKAP6;KCNJ2;KCNN1;GNG2;KCNN4
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.5867558317679745,0.9681007690547332,0.5416666666666666,1.0,1.0,2/6,8.98%,NLGN1;LHFPL4
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.44210288524804675,-0.9680933715046317,0.47368421052631576,1.0,1.0,11/68,17.13%,GTF2F1;INTS5;PHAX;POLR2I;POLR2J;TAF11;TAF6;CCNT1;POLR2G;POLR2C;SNAPC5
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.5122354904392581,-0.9679825443705762,0.48333333333333334,1.0,1.0,3/35,4.04%,MYO15A;KIF1A;MYO7B
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.5024629109132703,-0.9679456670227616,0.509090909090909,1.0,1.0,7/30,17.73%,ADAM19;MBTPS2;CTSH;APH1B;HM13;RBMX;AFG3L2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.5923579610970204,0.9675543326165358,0.5777777777777777,1.0,1.0,2/7,11.68%,RHOB;CTNNB1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.620836513927556,-0.9672847372762093,0.6037735849056604,1.0,1.0,4/6,30.30%,STAT3;STAT1;STAT5A;JAK3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.620836513927556,-0.9672847372762093,0.6037735849056604,1.0,1.0,4/6,30.30%,STAT3;STAT1;STAT5A;JAK3
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.57106663457508,-0.9669477620498704,0.5254237288135594,1.0,1.0,2/13,9.46%,CALM1;MGAM
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.41153200634843046,-0.9667520337596063,0.4915254237288136,1.0,1.0,8/70,9.00%,PLK3;ASB9;RILP;GPC3;PACSIN3;ADRA2A;VIP;PLK2
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6619181245694301,0.9666240263474026,0.5686274509803921,1.0,1.0,2/5,21.57%,PIGU;GPAA1
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.4144402982635678,0.9666147038439425,0.4418604651162791,1.0,1.0,25/79,13.46%,IL17RD;EFNA5;SERTAD4;P3H2;CNN3;TNC;WNT5A;ROR1;SLIT2;VEGFC;SNX7;FBXL7;GLI3;CDR2L;FST;COL4A6;FBLIM1;ADGRL2;TENM3;MDK;PTPN14;FLNC;ENAH;AMOTL2;NOTCH3
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.5015791076472166,0.9665049681363321,0.425531914893617,1.0,1.0,2/13,5.25%,PNP;AK3
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5780837491444647,0.9664736947396592,0.5319148936170213,1.0,1.0,5/8,14.47%,FZD1;WNT5A;RYK;CTNNB1;WNT2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.4477871758761106,0.9654368597128733,0.4716981132075472,1.0,1.0,11/53,14.77%,PLA2G10;ABHD4;CHPT1;TMEM86B;PLA2G7;SLC44A5;NR1H3;LPCAT3;PCYT1B;PLA2G15;PLA2G4C
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.45750925663125336,-0.9652104360210032,0.5625,1.0,1.0,5/39,12.24%,SH3RF2;ZCCHC9;GMIP;PPP1R35;CSTB
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),0.6101686110903152,0.9650834792801545,0.5609756097560976,1.0,1.0,1/5,6.14%,CACNB2
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.5825622904228125,0.9650792571866458,0.4897959183673469,1.0,1.0,3/9,20.21%,GNAI1;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.5825622904228125,0.9650792571866458,0.4897959183673469,1.0,1.0,3/9,20.21%,GNAI1;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.40067351390854733,0.9650689484117017,0.4222222222222222,1.0,1.0,35/190,13.10%,LOXL2;PLA2G10;PLCB1;ZFP36;PPARG;CSF1;ZEB1;TGFBR1;RUNX2;CCN2;ECT2;ACVR2A;PRKD1;TP63;TWIST1;TCF4;BRINP3;HGF;RANBP3L;CTNNA2;BMPR1A;CRB2;CDH2;LMO3;SOX5;SMAD2;ZC4H2;MDK;CTNNB1;MEF2A;NEUROD2;CREB1;SOX11;FGFR1;ACVR1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.528418599652185,-0.9650597420931369,0.5098039215686274,1.0,1.0,4/18,11.04%,TXK;CDC37;IFNGR2;PARP14
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.6176134435203298,-0.9650151176785065,0.5098039215686274,1.0,1.0,1/6,15.40%,ITM2C
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.51365177933338,-0.9646105305945237,0.5087719298245614,1.0,1.0,4/11,13.98%,WDR54;LRPAP1;RIN3;NECAB2
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.4753546731413978,-0.9644672909902456,0.5081967213114754,1.0,1.0,1/33,0.61%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.6071320557885458,0.9644416129638318,0.6666666666666666,1.0,1.0,2/7,12.70%,PTGS2;ADAM8
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.6566214964470235,-0.964369711102186,0.5862068965517241,1.0,1.0,1/5,2.62%,ASCL1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.42134944431486215,0.9641067106193226,0.5192307692307693,1.0,1.0,11/56,13.10%,MAP3K11;CCNH;CCNA2;CUL1;LATS1;CDK6;HINFP;CCNE2;ACVR1B;MNAT1;ACVR1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.5639784468764133,0.9639704477952648,0.5357142857142857,1.0,1.0,4/14,9.92%,NRG1;MBNL1;HINFP;JAG1
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6356512563970614,0.9639688680165653,0.6216216216216216,1.0,1.0,4/7,19.28%,SLC30A10;RELA;CA2;NFKB1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.5698326170059691,-0.9639476276329775,0.49122807017543857,1.0,1.0,2/9,6.52%,STX1B;GRIPAP1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5706485670045727,0.9639249488827877,0.5660377358490566,1.0,1.0,1/10,2.19%,PPARG
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.4061434044107365,-0.9639043995113988,0.5102040816326531,1.0,1.0,25/153,12.01%,ETV5;ETV4;LCP1;HSD11B1;APOD;PTCD2;RBM4;CD37;TRIB2;ETS1;ST6GAL1;ANO1;PPP1R15A;RGS16;DUSP6;TMEM158;RBP4;SCG3;F13A1;GYPC;BTC;NR1H4;PRKG2;ACE;IGFBP3
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4531759481052069,-0.9638639617862812,0.5106382978723404,1.0,1.0,3/25,6.51%,CACNB1;NTRK1;CDK5
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.5534965103866688,-0.9634883979034707,0.48936170212765956,1.0,1.0,2/15,2.72%,ASCL1;NTRK1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.5234929635447185,-0.9632723538059745,0.45614035087719296,1.0,1.0,3/19,14.03%,BCAR3;DGKD;SHKBP1
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.40757597728001915,0.9632586812184899,0.5217391304347826,1.0,1.0,28/106,15.86%,SEMA6D;LEPR;NRXN1;PCDH17;PPARGC1A;TOX3;CNTN4;UNC5D;LCORL;PTPRD;ELAVL4;HMGCLL1;RAB3C;PCSK2;NOL4;CNTN1;KCNB2;ASXL3;ASIC2;BCHE;RGS7BP;CBLN1;GRIA2;CSRNP3;SORBS1;MAPK4;GABRB3;KCNT2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.5382584043476951,0.9632297820479602,0.5405405405405406,1.0,1.0,1/11,2.63%,ZBTB1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6328679913759144,0.9628967390204464,0.5740740740740741,1.0,1.0,1/5,10.03%,PRIMPOL
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.41655443122712005,-0.9628897496319659,0.5076923076923077,1.0,1.0,11/72,9.58%,TMIE;COL4A3;PDZD7;MYO7B;KCNE1;TSPEAR;MYH14;CEMIP;TBL1X;NDUFB9;GRXCR1
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.6308816886591092,-0.9626336959695839,0.5918367346938775,1.0,1.0,4/5,25.85%,RFTN1;FLOT1;EMP2;ANXA2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.5128564938267925,-0.9625379839143455,0.509090909090909,1.0,1.0,2/15,12.57%,UPB1;NT5M
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5694521787316663,0.9625220592984615,0.543859649122807,1.0,1.0,3/10,17.12%,EPCAM;VEGFA;BMP6
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5066552193893739,-0.9623972828027209,0.49056603773584906,1.0,1.0,4/21,5.05%,SFRP1;SPRED3;SPRY1;SPRED2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.4196284310022089,0.9623746336280813,0.35714285714285715,1.0,1.0,18/93,13.54%,FLRT2;FIGN;IL17RD;GUCY1A2;SEMA6D;SLIT2;ADAMTS9;FBXL7;PTPRG;BMPR1A;ADGRL2;TENM3;PTPN14;ANK2;LIFR;ENAH;GJC1;RUNX1T1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5427230967996458,0.9619538666608031,0.46,1.0,1.0,2/13,4.09%,LEPROTL1;CHMP6
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3662063201923758,-0.9619347713863974,0.5166666666666667,1.0,1.0,51/433,13.59%,APOBEC3H;SINHCAF;INHA;NUPR1;CCN3;DYSF;SFRP1;CD9;CLU;FOXM1;DACT2;COL4A3;WNT9A;NTRK1;CDKN3;WARS1;ETS1;AZGP1;TSPYL2;FABP6;FTH1;TCHP;PDCD5;TPTE2;DNAJA3;SST;COL18A1;ZBTB7C;HNF4A;RFPL1;ZP3;GLMN;CR1;PRAME;INCA1;LRPAP1;MNT;BTG1;STK11;CRYAB;PDE8A;IGFBP3;CYP1B1;NR4A1;APOA1;PPT1;DUS2;SFRP4;BRD7;RACK1;BMP7
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.4182664769307953,-0.9618663334612166,0.5666666666666667,1.0,1.0,11/69,9.58%,TMIE;COL4A3;PDZD7;MYO7B;KCNE1;TSPEAR;MYH14;CEMIP;TBL1X;NDUFB9;GRXCR1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.525268003969745,0.9618515697157325,0.5,1.0,1.0,4/15,22.35%,HSPB1;SIRT1;NFE2L2;BAG5
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.5452370828715687,0.961783780247172,0.5098039215686274,1.0,1.0,2/10,9.38%,ADGRB3;C3
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.5570061068680063,0.9614549273482669,0.5,1.0,1.0,2/9,6.14%,PDE4B;CACNB2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5596103578580761,-0.9614089621829186,0.6086956521739131,1.0,1.0,5/10,25.09%,CTNNA3;DSC2;PKP2;TRPM4;JUP
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5176612768582856,0.9613256738702314,0.5116279069767442,1.0,1.0,3/16,13.89%,ERN1;BMPR1A;LDLRAP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.4410350388954655,-0.9610775865313094,0.45614035087719296,1.0,1.0,7/81,6.97%,TYMS;ATRAID;RBM4;NCL;PATL2;CDK5;ILF3
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.48550832930447907,0.9609629049131859,0.45652173913043476,1.0,1.0,6/31,21.30%,GLRA2;GLRB;CPEB4;CPEB3;SH3BP4;IPO5
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.6436398006606608,-0.960916868666312,0.6346153846153846,1.0,1.0,1/5,6.08%,TICRR
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.6121081987046869,-0.9603201461707913,0.6727272727272727,1.0,1.0,4/5,38.72%,CTPS2;UMPS;CTPS1;CAD
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.6307958848073916,-0.9602825269533276,0.5217391304347826,1.0,1.0,2/6,12.60%,GINS3;MCM2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.6307958848073916,-0.9602825269533276,0.5217391304347826,1.0,1.0,2/6,12.60%,GINS3;MCM2
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.547029398595814,0.9601928410025353,0.49019607843137253,1.0,1.0,1/13,3.37%,SPHK1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.4680272619754558,-0.9601161909516033,0.4909090909090909,1.0,1.0,7/46,7.97%,P2RY10;CD5;KLRB1;TRAF3IP3;CD4;LTB;LTBR
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.47700844658215974,-0.9600970042705524,0.4827586206896552,1.0,1.0,4/28,9.08%,ATP6V1E2;ATP6V1E1;RAB31;ATP6V1D
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.5587861130169386,0.9596331817092812,0.5333333333333333,1.0,1.0,1/12,0.66%,HORMAD1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.5587861130169386,0.9596331817092812,0.5333333333333333,1.0,1.0,1/12,0.66%,HORMAD1
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.6119725235930148,0.9592789169063567,0.6046511627906976,1.0,1.0,3/7,32.34%,GRIN2A;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.43707484264696456,0.959262715412781,0.5,1.0,1.0,13/48,11.18%,DSCAM;ROBO1;CNTN4;NECTIN3;HMCN1;ROBO2;CDH2;CADM1;CDH13;TENM3;PTPRM;NPTN;EMB
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.6289833002942703,-0.9589879087810722,0.5909090909090909,1.0,1.0,3/5,22.76%,DDRGK1;UFC1;UFL1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.6289833002942703,-0.9589879087810722,0.5909090909090909,1.0,1.0,3/5,22.76%,DDRGK1;UFC1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.6289833002942703,-0.9589879087810722,0.5909090909090909,1.0,1.0,3/5,22.76%,DDRGK1;UFC1;UFL1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.45791990004010563,0.9586565858243092,0.4418604651162791,1.0,1.0,3/26,4.48%,ZFP36;EGFR;ZFP36L2
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.5807850567444163,-0.958377310630317,0.660377358490566,1.0,1.0,1/10,8.19%,AMBP
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.6440980419115349,-0.9582872798203088,0.6166666666666667,1.0,1.0,1/7,13.53%,KYNU
prerank,MSigDB_Hallmark_2020__Androgen Response,0.40058791294657947,0.9582466893821585,0.4358974358974359,1.0,1.0,26/95,17.21%,HERC3;UBE2J1;HMGCS1;ZBTB10;STEAP4;SCD;UAP1;CDK6;B4GALT1;TPD52;SGK1;ITGAV;HMGCR;ARID5B;INPP4B;LIFR;SLC38A2;PLPP1;TSC22D1;GNAI3;INSIG1;KRT8;MAP7;ANKH;GUCY1A1;FKBP5
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.5415323436540768,-0.9581273574481517,0.5510204081632653,1.0,1.0,4/21,16.14%,APOD;KCNE1;GDI1;BAG4
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.4578014843342326,-0.9580119557447119,0.5357142857142857,1.0,1.0,11/42,21.75%,FOXM1;GNB3;ARF1;PINK1;CYP1B1;ABCB11;FLOT1;BTN2A2;MPV17;STK17A;EIF6
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6223407165882341,0.957868091253265,0.5952380952380952,1.0,1.0,1/8,3.74%,EGFR
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5202246500351505,0.9578424728468689,0.5,1.0,1.0,3/11,3.71%,EFNA5;KANK1;AP1AR
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5202246500351505,0.9578424728468689,0.5,1.0,1.0,3/11,3.71%,EFNA5;KANK1;AP1AR
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.586308919873374,0.9575863598885217,0.6052631578947368,1.0,1.0,3/9,17.90%,TRIM5;MID2;IFITM3
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.5968985309385836,0.9575282427064824,0.5102040816326531,1.0,1.0,2/8,8.91%,SULF1;TBC1D8B
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.44846705766220246,0.9574516116724555,0.5102040816326531,1.0,1.0,14/36,18.60%,ZEB1;ECT2;TCF4;BRINP3;ZC4H2;NEUROD2;SOX11;FGFR1;MEF2C;KCTD11;VWC2;PROX1;BRINP1;TRIM32
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5646562993628124,-0.9574106764214286,0.5102040816326531,1.0,1.0,1/12,0.63%,CCN3
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.5096725865286196,0.9573141671355152,0.6122448979591837,1.0,1.0,2/13,4.55%,COL22A1;PKHD1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.5593209849268479,0.9572592437284402,0.5925925925925926,1.0,1.0,3/14,13.04%,NRG1;CDH2;SOX11
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4646754420473346,0.9570801375571617,0.4772727272727273,1.0,1.0,6/32,5.58%,ACE2;REP15;PLA2G10;SLC26A3;CAPN13;MANF
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.511213864089797,0.9570167117955866,0.49019607843137253,1.0,1.0,3/21,13.06%,NEDD4;ZNRF3;SMURF1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.4654920104722039,0.956970567551742,0.5,1.0,1.0,7/38,14.19%,PLA2G10;PLD6;ABHD4;LIPH;AGPAT5;ABHD5;DGKB
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.521425915391555,0.9569552165162949,0.5,1.0,1.0,4/13,19.50%,HDAC9;PTGS2;VEGFA;AKT3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.48725208857854263,0.9567841313137376,0.55,1.0,1.0,9/34,14.81%,PHACTR1;BTBD3;CTNNA2;LRP4;DOCK10;MEF2A;KLF7;CTNND2;MAP2
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.6082970442644198,-0.9567617446016383,0.62,1.0,1.0,1/10,5.74%,XYLT2
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5698760338038916,0.9567004349761443,0.574468085106383,1.0,1.0,3/13,13.63%,PLCB1;RANBP3L;MEF2C
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.5275331278750017,0.956554522802616,0.5116279069767442,1.0,1.0,3/17,9.89%,ZFP36L2;FGF10;ITGAV
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.614845801780342,0.9564523868867555,0.5434782608695652,1.0,1.0,2/7,23.69%,CXCL12;FERMT2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.5001319794385315,0.9563973433993532,0.5416666666666666,1.0,1.0,3/13,10.96%,WNT5A;CCL5;CXCL12
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.5086687034003914,-0.9560975426401254,0.4583333333333333,1.0,1.0,3/21,9.56%,NCKAP1L;SRP54;ADGRE2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5055565433164686,-0.9560276432451753,0.5094339622641509,1.0,1.0,5/26,13.46%,HPS4;PDCD5;ARIH2;PINK1;TOMM7
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.44302118817565794,0.9560044870858704,0.47619047619047616,1.0,1.0,8/44,8.18%,FGFR2;PBX1;HEY1;TEAD2;PBX3;GLI3;COBL;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.41619263337446966,-0.9557701860064043,0.5849056603773585,1.0,1.0,21/105,16.81%,SFRP1;NTRK1;DOCK8;ITGA6;AGRN;RGS16;CALM1;BCAR3;HMGB2;PINK1;PIN1;APOA1;CTSH;RAP1GAP;GNB5;RACK1;RTN4R;ASAP3;RGS8;CALM3;ZC3H15
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.42683275644984603,0.9552371438724809,0.38461538461538464,1.0,1.0,12/95,12.06%,SEMA3C;ALDH1A1;CEL;SULT2B1;PEX11A;CAT;ATXN1;ACSL4;CADM1;PEX2;CRABP1;PEX13
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.6524389665521007,-0.955041841962097,0.5892857142857143,1.0,1.0,1/6,0.63%,CCN3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5309194776935408,0.9549779352851598,0.5333333333333333,1.0,1.0,11/21,20.03%,RUNX2;SMAD5;HIF1A;SMAD1;SMAD9;EP300;RELA;CREB3;VEGFA;SMAD4;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.5158897613805042,0.9546876856419914,0.5128205128205128,1.0,1.0,3/22,7.07%,PPARG;HMGB1;TWIST1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.4588270387790267,-0.9543312145898114,0.5636363636363636,1.0,1.0,6/21,19.10%,ATXN7L3;RNF8;DTX3L;UHRF1;USP22;RNF20
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.5811691313069721,0.9542780310909035,0.5714285714285714,1.0,1.0,3/10,11.22%,MSTN;DLL1;PRICKLE1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.49034536188720396,-0.9542288458075517,0.56,1.0,1.0,6/27,15.33%,RAD51AP1;HMCES;PRDM7;WRAP53;PARP1;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.496973163005461,0.9541935692706318,0.5294117647058824,1.0,1.0,4/21,10.38%,IRS1;FGFR3;PRKD1;PDGFRB
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.586946191663805,-0.9540495120282444,0.5384615384615384,1.0,1.0,1/8,3.79%,KIF20B
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.5131845839777944,-0.954016634289528,0.5769230769230769,1.0,1.0,2/11,15.40%,NECAB2;ITM2C
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4631425017625382,-0.953983335004397,0.54,1.0,1.0,5/32,15.53%,NUPR1;EIF5A;DNM1L;RACK1;FIS1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.5653324933495633,0.9539683780336665,0.4909090909090909,1.0,1.0,3/17,2.08%,NRG1;ERBB4;OXTR
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.39643884035466187,0.9538334924324426,0.4807692307692308,1.0,1.0,26/129,13.46%,FAS;RRAD;LDB2;MXRA5;SULF1;POSTN;ACKR3;PRRX1;NID2;LMO7;FBXL7;SYNPO2;PRKG1;SLC38A11;ACTA2;ADAMTSL1;PDGFD;PDGFRB;COL5A2;CXCL12;LGR6;CRABP1;TIMP3;ZBTB44;GJC1;NOTCH3
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.5311033229716813,-0.9537017139967088,0.5102040816326531,1.0,1.0,4/14,14.81%,STX4;RBP4;CR1;PTPRC
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.5515069853878591,0.9536657737843179,0.5217391304347826,1.0,1.0,1/8,6.48%,GGTA1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4759482963690843,0.9533494831138014,0.5102040816326531,1.0,1.0,15/33,22.55%,GLA;ATP2B4;EP300;ACADVL;CRY1;ROCK2;PROX1;NFKB1;FYN;GCK;ACADL;ERLIN1;SIRPA;RAPGEF2;FBXW7
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.5385385621171261,0.9532847118219271,0.5,1.0,1.0,2/10,2.19%,IFI16;PPARG
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.590471731584489,-0.9531268453680484,0.5178571428571429,1.0,1.0,4/7,35.61%,VIPAS39;P3H4;PLOD1;PLOD3
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5264885778296016,0.9531251917941774,0.5217391304347826,1.0,1.0,3/13,6.88%,TDG;DCTPP1;DUT
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.41848100870494787,-0.9531159371373406,0.4583333333333333,1.0,1.0,23/71,20.64%,MYB;LDB1;PSMA7;PSMD7;PSMB4;PSMC3;METTL3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6;YAP1
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.5781526591111916,0.9529861837908612,0.5686274509803921,1.0,1.0,2/7,12.70%,CCL5;ADAM8
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.5243188430030903,-0.9529616794442175,0.5172413793103449,1.0,1.0,3/21,6.38%,NMNAT3;NUDT12;NAXE
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.47964003553675194,0.9528245670188289,0.4528301886792453,1.0,1.0,8/23,15.40%,FGF10;GLI3;RSPO2;LRP4;ZNRF3;CHD7;SALL1;KAT2B
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.573721433688434,-0.9528112410462332,0.509090909090909,1.0,1.0,3/11,14.77%,VIL1;ARF1;CORO1B
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.4886756002782639,0.9527879456468308,0.5283018867924528,1.0,1.0,7/21,18.51%,EFNA5;EPHA3;GPM6B;SLC9A1;CLASP1;ROCK2;PTK2
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.5605557013833272,0.952095605946651,0.5957446808510638,1.0,1.0,2/9,10.06%,NXF5;RBFOX1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.42036193425291307,0.952093554518107,0.4375,1.0,1.0,16/52,22.10%,PTPRK;EGFR;ECT2;RHOB;FER;SIRT1;AGAP3;MAPK8;RELA;MAP3K5;PDK2;PLEKHA1;NFE2L2;SIRPA;ABL1;PKD2
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.5877776186407951,0.951758571925892,0.6111111111111112,1.0,1.0,1/6,2.63%,ZBTB1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.48937475371468364,0.9515408094599244,0.45652173913043476,1.0,1.0,5/16,19.56%,PDCD6IP;CHMP1A;HSPA1A;PLK1;HNRNPU
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.5372442231123166,0.9514243910220693,0.574468085106383,1.0,1.0,3/11,19.71%,PAPOLA;BARD1;ZFP36L1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.5538328167205282,-0.9511766302261692,0.5344827586206896,1.0,1.0,5/12,24.96%,CTSH;BRD8;CTSL;CTSB;HPN
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.4925619096546751,0.950937879489595,0.56,1.0,1.0,9/29,17.16%,SPHK1;AGER;RELL1;MFHAS1;PHLPP1;GADD45B;SASH1;VEGFA;GADD45G
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.6360536850943852,0.9507379412723517,0.525,1.0,1.0,1/5,6.19%,DYRK3
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.46096427472732865,0.9506913021245622,0.49056603773584906,1.0,1.0,5/35,12.66%,TRPV2;SLC8A1;ATP2B4;ITPR1;SLC24A2
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.5447253924390958,-0.9505067181258521,0.5483870967741935,1.0,1.0,1/9,0.70%,DYSF
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.42394797867019873,-0.9504278033346197,0.5263157894736842,1.0,1.0,7/61,13.08%,TRMO;TARBP1;AARS2;PUSL1;METTL6;TRMT112;DUS2
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.4826330471361209,-0.9504132420106123,0.5555555555555556,1.0,1.0,5/24,16.09%,FABP6;FABP5;LIPC;LIPI;PNPLA4
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.5562280513909788,-0.9502788913581658,0.5208333333333334,1.0,1.0,2/8,16.76%,FOXP1;SRC
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.5180020158096885,-0.950252678555576,0.4727272727272727,1.0,1.0,1/10,3.77%,PATL2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.4569168776901116,0.9501443133233649,0.5,1.0,1.0,6/41,7.45%,ZFP36;DXO;ZFP36L2;RIDA;NUDT16L1;ERN1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.5618069738580094,0.9500137420312809,0.5471698113207547,1.0,1.0,3/7,15.08%,ANK2;GJC1;KCNA5
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.4206108924173053,-0.9497594249422818,0.5185185185185185,1.0,1.0,21/93,25.95%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;MRPS21;RACK1;MRPL9;MRPL19;MRPL27;MRPL51;MRPS18C;MRPL37;MRPS22;GTPBP1;EEF2;EEFSEC;MRPS11;EEF2K;EEF1B2;MRPS33
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5994354636062132,0.9493518255383568,0.6428571428571429,1.0,1.0,2/10,3.76%,PLA2G10;CSF1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.4604648222819857,-0.9491352488449598,0.576271186440678,1.0,1.0,2/28,3.85%,NUPR1;TMSB4X
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.47838361837893983,0.9490935814530418,0.5652173913043478,1.0,1.0,4/17,14.98%,CCL5;ACKR3;CXCL12;SLC12A2
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.46199990431070664,0.9489768830530169,0.48148148148148145,1.0,1.0,7/39,14.19%,PLA2G10;PLD6;ABHD4;LIPH;AGPAT5;ABHD5;DGKB
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.4656550607781647,0.9486638403885418,0.5306122448979592,1.0,1.0,6/27,14.14%,PKHD1;TMEM67;PDCD6IP;CEP120;SIRT1;CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.5369271041803414,-0.9485343612625781,0.576271186440678,1.0,1.0,3/17,9.99%,AURKA;DRD3;BTC
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.5700872240483603,-0.9484932816930529,0.5272727272727272,1.0,1.0,3/8,23.66%,TNFRSF1A;TGFB1;CST3
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.433614443978723,0.9484824661208007,0.5641025641025641,1.0,1.0,7/29,15.73%,ATP10A;ATP8B3;PLSCR5;PLSCR2;P2RX7;ATP8A2;ATP11C
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.4309330072133788,0.9483927495435106,0.4772727272727273,1.0,1.0,4/33,9.20%,CENPI;H3-3A;KNL1;ASF1A
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.3733617328973645,-0.948052225249029,0.576271186440678,1.0,1.0,37/284,12.51%,NUPR1;CCN3;SFRP1;ATRAID;NOG;COL4A3;WNT9A;APOD;NTRK1;CDKN3;WARS1;NODAL;ETS1;AZGP1;FABP6;B2M;FTH1;PDCD5;TPTE2;DNAJA3;SST;COL18A1;VIP;ZBTB7C;HNF4A;RFPL1;RBP4;GLMN;INCA1;MNT;NDRG4;BTG1;STK11;EMD;IGFBP3;CYP1B1;PER2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.4204648722891826,0.9479267110137564,0.4444444444444444,1.0,1.0,27/98,17.81%,PMP2;ALDH1A1;NRXN1;PCDH17;GFAP;INTS6;MEGF10;PTPRD;ADGRL3;GPM6B;CNTN1;FREM1;CRTAC1;ANK2;ZNF536;RGS7BP;EFS;SORBS1;CHL1;CCDC3;SLCO1C1;MAPK4;DCLK1;ACKR1;IL34;ATP1A2;PLP1
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.6197980864906444,0.9478916800090004,0.5882352941176471,1.0,1.0,1/6,3.52%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.4370855765620779,-0.9477824934568111,0.5294117647058824,1.0,1.0,4/44,5.76%,GPC2;LCP1;GPC1;GPC3
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.4115413949749529,-0.9474951628310804,0.4642857142857143,1.0,1.0,13/75,13.89%,TERF2IP;WARS1;ATG14;BEX4;PPP1R15A;XRCC1;MYADM;NIBAN1;PTPA;TRAF3IP1;IGFBP3;DBI;PIP5KL1
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.5815875607481485,0.9474734827564606,0.5434782608695652,1.0,1.0,1/9,2.56%,FGFR2
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4131844045932884,-0.9474557703002281,0.559322033898305,1.0,1.0,9/97,8.17%,APIP;KIF25;UPB1;GOLGA2;B2M;SCARA5;RYR1;HSD17B10;RNF213
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.5363766744975194,0.9472324804639841,0.5952380952380952,1.0,1.0,7/16,22.10%,COBL;ARID5B;TGFBR3;PROX1;CEBPG;NIPBL;PKD2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5482669526772866,0.9472316890175184,0.4423076923076923,1.0,1.0,4/9,30.19%,SIRT1;KLF15;PRKAA2;DIP2A
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.42317210544600353,-0.9471044258997215,0.5813953488372093,1.0,1.0,7/59,9.09%,NCKAP1L;HCK;KANK3;VIL1;ABITRAM;MYADM;DBNL
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.4214506340792122,0.9469450049923888,0.5208333333333334,1.0,1.0,14/56,16.09%,NFKBIZ;WNT5A;CCL5;PLA2G7;SNCA;IL16;MDK;PDE2A;NAPEPLD;ADAM8;MEF2C;IFI35;AKIRIN2;LPL
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5656853545234907,-0.9468761768079402,0.5869565217391305,1.0,1.0,2/8,10.86%,APOD;NDRG4
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.5676420675631638,0.9467170312936574,0.5208333333333334,1.0,1.0,2/9,8.80%,ABCC2;ABCC11
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.6445991027829564,0.9466477605143052,0.6382978723404256,1.0,1.0,1/5,8.43%,LMO3
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.4400921544650702,0.9464635341570874,0.41304347826086957,1.0,1.0,17/74,10.49%,ESRRG;TRPV2;OXTR;ADIPOR2;LEPR;PPARGC1A;SYK;ELOVL6;SCD;HDAC3;ZNF516;ADIPOR1;IGF1R;IL4R;PRKAB2;ZBTB7B;PLAC8
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.3940620234191045,-0.94632252509848,0.5882352941176471,1.0,1.0,42/117,25.19%,GINS3;PSMA7;PSMD7;UBC;PSMB4;PSMC3;TWNK;ORC3;MCM5;MCM2;PSMD8;ORC1;PSMB5;RPAIN;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;RECQL;PSMA8;CDC6;POLG;PSMD12;PSMB3;PSMB7;PSMC6;DDX21;WDHD1;RPA3;ORC6;POLE4;UBB;POLE3;ORC2;PSMB1;MCM4;PSMA5;CDC7
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.44560091800999846,-0.946062977000795,0.5573770491803278,1.0,1.0,3/40,5.39%,GUCY2C;DCAKD;PAPSS2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.49754284530079196,0.9460239587245912,0.5636363636363636,1.0,1.0,2/17,7.46%,ATP6V0A4;ATP6V0D2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.47720760172243437,-0.945850729273034,0.5294117647058824,1.0,1.0,1/27,0.84%,OSTN
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.3810601244677737,-0.9456853681976156,0.5254237288135594,1.0,1.0,45/196,18.72%,RTF1;HSF2BP;GTF2F1;NFKBIB;CEBPD;TBPL2;POLR2I;PAX8;DRAP1;TCEA2;PTMA;TTF1;ATF4;POLR3A;POLR2J;TAF9B;NFX1;TWNK;ETV7;THRA;MNT;GTF2H2;TAF7;TAF11;SUPT5H;SUPT16H;TAF6;TAF10;CCNT1;POLR2G;POLR3H;PARP1;DRG1;ERCC2;POLR2C;TAF1;RBMX;BRF1;POLRMT;GTF3C2;BTF3;ELOB;NELFA;SMARCA5;DTX1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.6091639769768228,-0.9456788193076576,0.6274509803921569,1.0,1.0,2/5,26.86%,PVR;IL12A
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.6091639769768228,-0.9456788193076576,0.6274509803921569,1.0,1.0,2/5,26.86%,PVR;IL12A
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.4045865245376748,-0.9454906136690852,0.6,1.0,1.0,13/90,13.68%,SARDH;TMEM179;DACT2;KIF1A;ARVCF;CELF3;CDHR2;REEP6;LRRTM1;TTBK1;APOA1;RAP1GAP;CALY
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.5343753279753253,0.9450067837805161,0.4666666666666667,1.0,1.0,2/12,9.96%,SLC30A8;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5937517758062043,-0.9449942945521971,0.5333333333333333,1.0,1.0,3/5,28.15%,RNF20;CTR9;CDK9
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3653421679303813,0.9449281186112668,0.5434782608695652,1.0,1.0,23/142,13.99%,FAS;STK26;DAPK2;NTF3;FANK1;CIDEA;TOX3;MAGED1;TP63;PTPN6;SGK1;TP53INP1;PHLPP1;IFT57;CASP10;PPP1R13B;BCAR1;BRMS1;SIRT1;FBXO11;AIFM2;TP53BP2;LGALS1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.6472739747119888,0.9447749488636112,0.62,1.0,1.0,4/5,32.15%,SOX11;RNF10;SKI;DICER1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.44819573730999257,-0.9446886075789788,0.5423728813559322,1.0,1.0,7/34,17.17%,PPP1R15A;ANKLE2;CALM1;PTPA;PIN1;CALM3;YWHAB
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.4964567924365171,-0.9446481419836904,0.5106382978723404,1.0,1.0,1/23,1.67%,EEF1AKMT2
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5138953838113374,-0.9439813324228885,0.5416666666666666,1.0,1.0,5/13,24.18%,DDRGK1;BAK1;UFL1;BCL2L11;DAB2IP
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.4528052331302339,-0.9439801449452625,0.53125,1.0,1.0,3/63,1.83%,GSTM5;CPXM2;GSTM3
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.5468041140127676,0.9438858617036573,0.5,1.0,1.0,1/7,4.20%,CCL5
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.5665076164064208,0.9436512160453187,0.631578947368421,1.0,1.0,5/11,15.14%,RP1;GNAQ;PDE6A;CNGB1;CNGA1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.5209792533056025,-0.9433732120644339,0.5357142857142857,1.0,1.0,2/16,5.44%,APOD;LATS2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.6191035545276493,-0.9433543468779713,0.5833333333333334,1.0,1.0,3/5,28.15%,RNF20;CTR9;CDK9
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.40721161637120645,0.9433291661771929,0.47619047619047616,1.0,1.0,17/108,13.03%,VAPB;CCL5;SLC8A1;PKHD1;ATP2B4;MCU;MICU1;TRDN;TRPC4;TMEM203;NPTN;CXCL12;MAIP1;ANK2;EDN1;SLC24A2;BCL2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.49368201060696104,-0.9432453368298779,0.5740740740740741,1.0,1.0,6/21,16.42%,SLC6A9;DRD3;CALM1;KCNE3;GNB5;CALM3
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.5924099295410629,0.943226305577708,0.5869565217391305,1.0,1.0,1/6,14.93%,P2RX7
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.47818212200385546,0.9430621375540524,0.6216216216216216,1.0,1.0,3/16,12.92%,PLD6;TDRD9;TEX15
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.6071205189981055,0.9428832115856838,0.575,1.0,1.0,3/5,34.01%,MAPK14;PIEZO1;ATP11A
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.5371820309547087,0.9426581962631194,0.5,1.0,1.0,1/9,4.00%,BAG2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.43445143038259165,0.9426345380596647,0.43478260869565216,1.0,1.0,7/44,13.75%,PLA2G10;CSF1;FOXO3;GRM5;NR1H3;EDN1;METAP1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.3754364560454284,-0.9425321640764045,0.582089552238806,1.0,1.0,27/275,12.08%,TEKT3;PLK4;TEKT5;HAUS8;RAB17;KIF17;CFAP221;UBXN10;DCTN1;RILP;TXNDC15;AHI1;SSNA1;ATP6V1D;CFAP46;PRKACA;CETN2;BBOF1;RSPH4A;ODF2;CFAP52;TBC1D32;TRAF3IP1;B9D1;TCTN1;DZIP1L;TUBB4B
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.4130351489620049,-0.9424053078799118,0.5,1.0,1.0,8/91,5.82%,INHA;CYP19A1;ADAMTS15;AMH;RND3;SEZ6L2;GPC1;PACSIN3
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.5602587157520842,0.94236270965235,0.5,1.0,1.0,2/9,5.50%,OXTR;TBXA2R
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.5456009551174016,0.9422662712621953,0.5777777777777777,1.0,1.0,5/13,18.51%,TLE1;PIK3CA;BCL2;PDK4;PTK2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.5210477532883756,0.9421837862356125,0.5909090909090909,1.0,1.0,3/16,6.43%,PNP;HPRT1;PPAT
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.4604734418168021,-0.9418837193500589,0.4444444444444444,1.0,1.0,6/37,12.96%,ABRAXAS1;GOLGA2;KIF4A;TPX2;TOGARAM2;WRAP73
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.5518066613847407,0.9418573515735541,0.5370370370370371,1.0,1.0,4/12,20.03%,RNFT1;USP13;RNF185;NFE2L2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.49084248755471044,0.9418303461034704,0.5471698113207547,1.0,1.0,5/16,13.63%,PPARG;HMGB1;MDK;FGFR1;MEF2C
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.3971759217244085,0.9418097925982606,0.5333333333333333,1.0,1.0,17/88,15.87%,NLGN1;ITPKB;NEDD4;ADGRV1;WNT5A;ECT2;PPP3CA;SYT1;ACER1;CRHBP;SYT15;MEF2A;NEUROD2;SLC25A12;MEF2C;SYT2;BRAF
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.5837440820228226,-0.9415388411232376,0.6545454545454545,1.0,1.0,1/8,2.12%,FGF1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5147946453975002,0.9413797931259318,0.5576923076923077,1.0,1.0,10/21,22.96%,ELOVL6;DGAT2;ACSL4;HACD2;TECR;ELOVL7;ACSBG1;ELOVL2;FAR2;ACOT7
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.5041580760451146,0.9412541267444359,0.5106382978723404,1.0,1.0,5/17,8.26%,B4GALNT2;ST8SIA6;ABO;B4GALT1;FUT9
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.5598043072614294,0.9410847446178131,0.6129032258064516,1.0,1.0,1/11,2.38%,CYP4Z1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.6192132849810037,-0.9410790459429733,0.5573770491803278,1.0,1.0,1/7,2.31%,NOG
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.5134625118767221,-0.9409434051780398,0.52,1.0,1.0,3/20,9.07%,MYH14;RYR1;LEMD2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.5877633692916318,0.9406463300081559,0.6122448979591837,1.0,1.0,1/7,6.61%,NUDT16L1
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.628398731800308,-0.9406010352498876,0.58,1.0,1.0,1/5,6.30%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.628398731800308,-0.9406010352498876,0.58,1.0,1.0,1/5,6.30%,EXOSC10
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.628398731800308,-0.9406010352498876,0.58,1.0,1.0,1/5,6.30%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.628398731800308,-0.9406010352498876,0.58,1.0,1.0,1/5,6.30%,EXOSC10
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.39577801433349513,0.9404196305509107,0.4772727272727273,1.0,1.0,26/112,13.30%,LOXL2;TYR;BNC2;PPARG;ENPP1;FAM114A1;TNC;EGFR;POSTN;MLANA;HMCN1;HSPB1;PRRX1;TP63;RASAL2;GLI3;MITF;PRKCA;ITGAV;COL5A2;PTPN14;CRABP1;TIMP3;SASH1;AMOTL2;PRICKLE2
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.5946842117510887,0.9404094684144565,0.5689655172413793,1.0,1.0,3/6,22.05%,KLF2;NFE2L2;SREBF2
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.547943606760399,0.9404039374752476,0.54,1.0,1.0,2/9,5.52%,GABRB1;GABRB2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.4068526501665557,-0.9395466411831713,0.5531914893617021,1.0,1.0,9/79,7.97%,HLA-C;ANXA5;CEBPD;FABP5;OAS3;DTX3L;RHBDF2;IL1R1;LTBR
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.45380362335419694,-0.939473499749118,0.5370370370370371,1.0,1.0,1/46,0.83%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.6308612327995727,-0.9392475541896724,0.6440677966101694,1.0,1.0,3/5,32.81%,YBX3;PKM;CNBP
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.4970401994311266,0.9388682051364954,0.56,1.0,1.0,1/12,4.97%,MLLT3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.5208255112006315,0.9388045901797744,0.5918367346938775,1.0,1.0,4/18,12.98%,SPHK1;ACER1;ASAH2;PLPP1
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),-0.6102983808356809,-0.9387069862409955,0.5294117647058824,1.0,1.0,2/5,16.76%,DRD1;NR4A3
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),-0.6102983808356809,-0.9387069862409955,0.5294117647058824,1.0,1.0,2/5,16.76%,DRD1;NR4A3
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5234917895229396,0.9385707244893398,0.5961538461538461,1.0,1.0,5/13,16.79%,LDLR;SGK1;CAMK4;RGS14;CPEB3
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.5264911599745956,-0.9384131106079393,0.5370370370370371,1.0,1.0,5/13,26.20%,COX7A1;PINK1;UQCC2;COX7A2;ABCD1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.4584356818791063,0.9383386105283398,0.48214285714285715,1.0,1.0,10/31,19.71%,CD8A;LEPR;ZFP36L2;GLI3;CHD7;LIG4;RAG1;GPR89A;GPR89B;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.4700559982695944,-0.9380860450158047,0.5172413793103449,1.0,1.0,4/50,3.23%,SFRP1;LDB1;APOD;RAC1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.49618026148737826,0.9380484097850611,0.4883720930232558,1.0,1.0,5/14,15.19%,ARID1A;SMARCD3;SMARCE1;ARID2;SMARCD2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.36458202703352727,0.9379086757436855,0.44680851063829785,1.0,1.0,23/158,14.77%,PIK3R5;PLA2G10;PLD6;ABHD4;CHPT1;PIP4K2A;SYNJ2;PTPN13;LIPH;SLC44A5;INPP4B;PIK3C2B;PIK3C2G;AGPAT5;PIK3CA;LPCAT3;SELENOI;PCYT1B;ABHD5;DGKB;MTMR12;PIK3R1;PLA2G4C
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.6608230761843137,-0.9378841925466987,0.6833333333333333,1.0,1.0,1/5,4.01%,NODAL
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.482990628528993,-0.9377130683847722,0.5961538461538461,1.0,1.0,7/28,16.85%,TOMM40;TIMM17B;TOMM20;TIMM17A;PEX1;TIMM50;TIMM44
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.6060101860361283,0.9376660872441599,0.5882352941176471,1.0,1.0,1/10,9.09%,SOX5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.5577695106917387,-0.9376091576733258,0.5490196078431373,1.0,1.0,5/16,18.00%,HEBP2;SPG7;SLC25A5;CAMK2A;BAK1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.5807191608336318,-0.9375724191056893,0.5625,1.0,1.0,2/5,29.56%,SFSWAP;SNRPC
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4673414151684123,0.9374380211976118,0.46153846153846156,1.0,1.0,5/34,7.35%,NR3C2;NEDD4;ARID1A;NR3C1;UBR5
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.40181440185391776,-0.9373891529935019,0.5344827586206896,1.0,1.0,14/50,19.06%,FANCI;SLX4;ERCC1;RNF8;UBC;FANCC;RAD51AP1;CENPX;XRCC3;NUCKS1;USP1;MUS81;FAAP24;FANCG
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.5580954511506754,-0.9371508492949131,0.5686274509803921,1.0,1.0,1/11,2.08%,SPA17
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.49817878982149744,0.9368752463198027,0.56,1.0,1.0,6/18,13.63%,PDE4B;PPM1E;AIM2;RAP2A;CRHBP;MEF2C
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.49044219292380586,-0.936784210350975,0.5660377358490566,1.0,1.0,4/31,5.86%,SFRP1;SERPINE1;STX4;TMC8
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.5586198548633242,0.936600191716921,0.673469387755102,1.0,1.0,2/13,8.55%,SLC8A1;ACTA2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.3977232275465926,0.9365541201124185,0.38636363636363635,1.0,1.0,33/170,12.46%,CD151;SEMA3C;ITGAX;SEMA5A;NTF3;CASS4;FAM83H;SEMA6D;SPHK1;CAVIN1;TRIP6;EGFR;CSF1;CCL5;TGFBR1;PPP3CA;TWIST1;LAMC2;HGF;TCAF2;FER;IGF1R;CSF1R;PRKCA;PDGFD;CDH13;PDGFRB;MDK;CXCL12;BCAR1;LGR6;SEMA3B;EDN1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5335245930592355,-0.9363986977161916,0.5818181818181818,1.0,1.0,9/13,33.35%,RNF8;SUPT5H;NELFA;NELFE;LARP7;NELFCD;TCERG1;RECQL5;EAPP
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.4302662719519503,0.9363718366030243,0.5909090909090909,1.0,1.0,8/64,8.59%,NOX5;ANLN;ECT2;RHOB;PDCD6IP;SEPTIN11;SNX18;ESPL1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.371551490850564,-0.9361849473096344,0.5423728813559322,1.0,1.0,7/136,6.57%,GSTM5;INHA;PAH;GSTM3;PCYT1A;SPTLC3;DEGS2
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.6126500266653677,0.9361778438403351,0.5882352941176471,1.0,1.0,2/5,20.03%,TCAF2;SLC43A1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.3675328374941708,0.9360629759531982,0.4878048780487805,1.0,1.0,46/206,14.58%,FAS;NTF3;KANK1;IRS1;NLGN1;FGFR2;NRXN1;ROBO1;SULF1;TGFBR1;KLF2;NRP1;RAB34;MYORG;TP63;SPIN1;MAML2;CDKN2AIP;MN1;ERN1;MAML3;RSPO2;HIF1A;LMO3;CTBP2;STK36;C3;PRKCA;TMEM108;ITGAV;JAG1;RIMS2;DLL1;ZBTB7B;SNX5;NPTN;SIRT1;LGR6;SASH1;EP300;SORBS1;F3;PIK3R1;SALL1;PRKCB;ASXL1
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.605419610769744,0.9360370947434651,0.5531914893617021,1.0,1.0,2/7,8.91%,SULF1;TBC1D8B
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.5921772215358108,0.9358815341454826,0.6078431372549019,1.0,1.0,1/6,3.36%,EGLN3
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5167333264016617,-0.9357782007005228,0.5357142857142857,1.0,1.0,1/11,4.06%,DOCK8
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5944934039625256,0.9355123333557323,0.6,1.0,1.0,3/8,6.79%,PDE4B;ATP2B4;SNCA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5944934039625256,0.9355123333557323,0.6,1.0,1.0,3/8,6.79%,PDE4B;ATP2B4;SNCA
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.4002167690236231,-0.9354921949972812,0.5370370370370371,1.0,1.0,7/70,6.62%,TRABD2A;CLU;WARS1;SLX4;ERCC1;VIL1;SYNPO2L
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.4307987632932024,0.9351624647348479,0.5,1.0,1.0,15/60,13.58%,TYR;GNAT2;GUCY2F;ADGRV1;PCDH15;ABLIM1;GRM8;RDH10;POU6F2;ATF6;CRYZ;MYO7A;USH2A;RP2;CNGB1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5433890213552621,-0.9346277370716191,0.5416666666666666,1.0,1.0,4/13,15.53%,MYH14;DNM1L;SUPV3L1;FIS1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.5460086731417764,-0.9346031829211496,0.5714285714285714,1.0,1.0,1/9,2.31%,NOG
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.5060639560286796,0.9344420887884306,0.52,1.0,1.0,4/15,17.28%,RUNX1;MDK;NFATC2;CBFB
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.6311670931645136,-0.934308979400796,0.5625,1.0,1.0,3/5,32.34%,ATP6V0A2;ATP6AP1;ATP6V1G1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5057508331629709,-0.9339752646872593,0.49056603773584906,1.0,1.0,6/15,26.59%,OAS3;METTL3;STAT2;ISG15;NLRC5;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.5221802588672138,0.9339020737331043,0.5357142857142857,1.0,1.0,1/11,1.82%,SSC5D
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.5837850989210002,-0.9337751822236232,0.6470588235294118,1.0,1.0,3/8,22.62%,NR1H4;PRMT7;COPRS
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5416387720897448,0.9337534476294848,0.5625,1.0,1.0,4/14,8.18%,NRG1;HEY1;TGFBR1;BMPR1A
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),0.5806953885601142,0.9337316040274017,0.5777777777777777,1.0,1.0,2/7,15.08%,ANK2;KCNA5
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),-0.6176360019147509,-0.9336281990257072,0.6428571428571429,1.0,1.0,2/6,8.90%,TPM1;ADRA1D
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.522795494610395,-0.9333203254681601,0.5645161290322581,1.0,1.0,4/12,27.71%,AKAP8L;NRDE2;SUPT6H;TPR
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.6327361126814801,0.9330448731961077,0.6923076923076923,1.0,1.0,1/5,3.48%,HMGB1
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.6239614310621047,-0.9325908865706742,0.671875,1.0,1.0,2/5,19.34%,OPALIN;SLC45A3
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.4736175474988821,0.9324193189584739,0.4791666666666667,1.0,1.0,5/27,14.14%,CHMP6;PDCD6IP;VPS37D;VPS37B;CHMP1A
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.5550571675587319,-0.9320410294255235,0.5789473684210527,1.0,1.0,3/9,11.19%,PBLD;RBP4;VSIG1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.4749316639786523,0.9320183585654463,0.5,1.0,1.0,2/21,2.07%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.5401251553486541,0.9319527047223746,0.6170212765957447,1.0,1.0,1/10,1.83%,SEMA5A
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.3936534078495873,0.9317017191535645,0.46153846153846156,1.0,1.0,27/122,20.56%,GRAP2;RIT2;RALA;CCNA2;CNKSR1;RHOB;PRKD1;RASSF1;PLCE1;CDH13;RAP2A;GNA13;RGL2;ARHGAP5;ADGRG1;RAPGEF6;PHACTR4;EPS8;ROCK2;RAP1A;SOS1;ARHGEF3;RRAS2;WASF1;RERG;EPS8L2;G3BP1
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.38367425986752857,-0.9316659847541143,0.6481481481481481,1.0,1.0,26/136,15.60%,TYMS;TK2;XPC;GTF2F1;ADRM1;UPF3B;ERCC1;POLR2I;RBX1;ITPA;POLR2J;NFX1;APRT;USP11;CETN2;EIF1B;SUPT5H;DDB1;POLL;ZNF707;NME4;TAF6;TAF10;POLR2G;ERCC2;POLR2C
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.5518434338335514,-0.931659992367184,0.6458333333333334,1.0,1.0,4/9,26.18%,PCCB;PDZD11;BTD;MCCC2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.5655286926645919,0.9306386742420917,0.4772727272727273,1.0,1.0,2/8,9.67%,ERN1;DYRK1A
prerank,GO_Biological_Process_2021__negative regulation of muscle cell differentiation (GO:0051148),-0.6429513162685576,-0.9304565886403552,0.6226415094339622,1.0,1.0,3/5,32.32%,FOXO4;EREG;ID2
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.6040967421941057,-0.930436897494028,0.6363636363636364,1.0,1.0,2/7,14.84%,NOS2;PRDX3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.38020120035974175,-0.9296839459862926,0.5,1.0,1.0,19/125,10.77%,CCN3;MMP26;HCK;AOAH;CRH;NLRP3;P2RY11;GPR39;GPR83;VIP;RHBDF2;CRHR2;HRH2;PLK2;PTH2R;PRKACA;DRD1;NR1H4;PROC
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.5012374403973486,-0.9292275304040499,0.5681818181818182,1.0,1.0,8/20,19.19%,TPPP3;TRPV4;STMN1;PIN1;STMN3;STMN2;CKAP5;KATNB1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4615282304476819,0.9291887005011357,0.45714285714285713,1.0,1.0,7/19,16.09%,CCL5;SNCA;ADA;BICD1;RGS14;CRY1;KLK14
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.5958673066228376,-0.9291285118534908,0.6440677966101694,1.0,1.0,4/7,24.85%,RFPL1;E2F7;ORC6;TXNIP
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.4620225866177087,0.9290018407321106,0.6153846153846154,1.0,1.0,10/36,17.87%,SMAD7;TGFBR1;SYK;NRP1;CDH2;ITGB8;TGFBR3;TGFBR3L;VEGFA;PROX1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.4742240202748803,0.9289908946061161,0.6,1.0,1.0,6/34,10.61%,ENPP1;ERRFI1;EPHA7;PDGFD;MOB1B;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4735722946642068,-0.9288685968013125,0.574468085106383,1.0,1.0,4/29,7.54%,TNFSF18;IL31RA;GHR;STAP2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.5375427852293406,0.9288077023947102,0.5925925925925926,1.0,1.0,5/16,18.03%,SLC6A13;SLC1A2;PRAF2;SLC25A12;SLC1A3
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.6107089116097307,-0.9285691411793328,0.6086956521739131,1.0,1.0,1/6,3.10%,DGAT2L6
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.4202188066549777,0.9283885239838593,0.5581395348837209,1.0,1.0,7/46,9.25%,HMGB1;AGER;WNT5A;SYK;HSPB1;TWIST1;TLR1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.574855342312161,-0.9282134330520002,0.58,1.0,1.0,2/7,4.47%,CD74;CD4
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3338210821980946,0.9281187482003069,0.6097560975609756,1.0,1.0,126/752,14.14%,DACH1;LOXL2;NRG1;IFI16;ZFPM2;NAB1;RUNX1;FRK;ZBTB2;PLCB1;NFIL3;TGIF1;ZFP36;PPARG;PTPRK;HJV;FGFR2;ZBTB1;LDB2;BATF3;ID3;NRIP1;HMGB1;ZNF706;BAHD1;IRF2BPL;MTERF3;ZEB1;SMAD7;HEY1;WNT5A;TRPS1;NR2E1;ZEB2;TSHZ3;RUNX2;KLF2;ZBTB5;RFX3;WWOX;FOXO3;TENM2;FOXP2;ZNF202;HDAC9;KCTD1;SP3;NR3C1;TP63;MIER2;TBL1XR1;SNCA;ATXN1;HDAC3;ZNF675;ZGLP1;TWIST1;GLI3;NR1D2;ZNF205;SPINDOC;HDAC2;JAZF1;PHF21A;TBX6;FST;TLE1;HINFP;PHC2;CTBP2;GLIS2;BCOR;ZNF20;ATOH8;MYPOP;TAF3;MITF;MXD4;KLF12;SMAD2;PEX2;RNF2;SMARCE1;WWC1;MEIS2;NCOA5;POU2F1;ZBTB7B;SMURF2;NPAS1;ARID5B;NR1H3;HIC2;PDE2A;ZNF582;ATF3;PRICKLE1;BRMS1;CD38;BTRC;CTNNB1;SIRT1;FOXO1;ZNF175;THAP11;ZNF536;EPC1;DPF3;MEF2A;EDN1;YAF2;PPM1A;FOXN3;CREB1;SOX11;EP300;ETV6;NACC2;RUNX1T1;MEF2C;RARB;KLF7;CREM;ZNF19;UBE2D3;CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5604934790705527,0.9279038769803438,0.6046511627906976,1.0,1.0,1/8,1.72%,PLCB1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.4540073085695371,0.9278239507736852,0.5306122448979592,1.0,1.0,7/40,15.28%,CHMP6;KIF2C;PSRC1;PDCD6IP;CEP55;CHMP1A;MIS12
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4807168977150055,0.9276252055451837,0.5,1.0,1.0,7/19,17.66%,SLC8A1;TRDN;PDE4D;ANK2;AKAP6;DMD;ATP1A2
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.4558403576255886,0.9274646025112611,0.4772727272727273,1.0,1.0,3/28,5.93%,NEDD4;KPTN;RNF128
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.39554793289709306,0.9274139711450152,0.631578947368421,1.0,1.0,11/98,11.02%,GRAP2;RIT2;RALA;RRAD;CCNA2;CNKSR1;PRKD1;RASSF1;PLCE1;ARHGAP30;RUNDC3A
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.418798891334524,0.9273956900962806,0.543859649122807,1.0,1.0,13/53,19.85%,TRIM22;RAB9A;BORA;TRIM5;RABGAP1L;PICALM;MAPK8;MAP2;AFDN;TRIML2;KIAA0586;OOEP;TESK1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.4322896391988186,-0.9271784505581699,0.5789473684210527,1.0,1.0,11/50,19.42%,CELA2A;PRPF19;TPP1;CEACAM1;DDB1;PPT1;FBXO6;FBXO2;RAB12;LRSAM1;PSMA8
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.3753167165715197,-0.9268301350407488,0.6507936507936508,1.0,1.0,9/118,5.15%,ARHGAP15;FOXM1;ARHGAP22;OBSCN;RAC1;RASGRF2;ARAP3;VAV3;FGD3
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.5820014944117415,0.9267122816826655,0.6486486486486487,1.0,1.0,3/10,17.90%,TRIM5;MID2;IFITM3
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.539424271088596,0.926575960447841,0.54,1.0,1.0,2/9,15.28%,KIF2C;MIS12
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.5256921103926985,0.9265696223541977,0.5581395348837209,1.0,1.0,6/17,18.80%,SYT1;RIMS2;SMURF1;NEDD4L;SYT2;SYT17
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.3773330158494943,-0.9265614825243332,0.5517241379310345,1.0,1.0,28/110,22.33%,AURKA;INCENP;SBDS;KIF4A;ZWILCH;ERCC6L;CENPH;STMN1;SPDL1;PLK2;PTPA;NUP133;SPC25;ITGB3BP;NUP43;RPS27;CENPE;KIF4B;EFHC2;CKAP5;GPSM2;TUBG1;NUDC;TUBG2;PAFAH1B1;PCNT;DYNLL1;NUP85
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.5586336792265982,0.9264129399990454,0.5652173913043478,1.0,1.0,5/10,29.37%,ABL2;EDN1;ABL1;SIRT3;PDP2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.33880424831208655,-0.926410699781471,0.6551724137931034,1.0,1.0,50/266,19.80%,PARP2;BACH1;ABRAXAS1;XPC;FANCI;SLX4;ERCC1;REXO4;RNF8;TICRR;UBC;PWWP3A;GADD45A;FANCC;RAD51AP1;XRCC1;NUDT1;DTX3L;ALKBH2;XRCC2;CENPX;KPNA2;CETN2;GTF2H2;MDC1;DDB1;POLL;HUS1;PARP1;INO80;RPAIN;XRCC3;NUCKS1;ERCC2;USP1;RBBP8;MBD4;FBXO6;KAT5;MUS81;ZRANB3;ALKBH5;SMUG1;SMARCA5;FAAP24;RECQL;FANCG;TDP1;CHEK1;HPF1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.5491112931855544,-0.9263082340203075,0.6190476190476191,1.0,1.0,2/10,4.47%,IL31RA;CD4
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.4284318725217481,-0.9261651806462914,0.5636363636363636,1.0,1.0,11/72,11.02%,AMDHD1;SARDH;HMGCL;BCAT2;HSD17B10;BCKDK;AASS;SLC25A44;NOS2;IL4I1;ABAT
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.507724523929372,0.9259836998798902,0.4878048780487805,1.0,1.0,1/21,0.30%,NOX5
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.5615798991023375,-0.9259688499441622,0.5689655172413793,1.0,1.0,3/9,16.68%,SERPINE1;PROC;VTN
prerank,PanglaoDB_Augmented_2021__Neurons,0.35986810848352274,0.9259604170965638,0.5625,1.0,1.0,50/265,14.40%,SHISA2;CADM2;RIT2;PPP1R14C;OLFM3;LRRTM3;NRXN1;ADGRB3;NXPH1;NCALD;GPR162;ZCCHC7;GRM5;KCNK1;RNF220;CNTNAP2;AMER2;GRIA4;CA10;ELAVL4;RAB3C;RORA;SPOCK3;PCSK2;CTNNA2;LUZP2;ACSL4;LHFPL4;SH3GL2;NOL4;AIM2;SYNPR;RBFOX1;NPY;GNAI1;GNL3L;UNC79;DLGAP1;PDE1A;PPFIA2;RGS7BP;ZNF445;ERC2;GRIA2;CSRNP3;SACS;DGKB;CCDC28B;PCLO;PPP1R9A
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.493226536441899,-0.9259404503534763,0.5576923076923077,1.0,1.0,3/17,13.64%,RAC1;DBNL;GARRE1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4330818351677934,0.9258053368176955,0.6222222222222222,1.0,1.0,15/38,23.17%,PTCHD1;GRM5;SOBP;LINS1;SHROOM4;CHD7;TUSC3;MGAT3;BBS4;C12ORF57;ST3GAL4;NIPBL;MAGT1;METTL23;C5AR1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.5044008665333705,0.9254015882998701,0.5294117647058824,1.0,1.0,4/15,6.79%,CX3CR1;AGER;ITGAM;SNCA
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.38290850651878017,0.9252450526988312,0.525,1.0,1.0,20/124,14.85%,LTK;DCUN1D1;ERBB4;FGFR2;EGFR;ROR1;EPHA3;FGFR3;ARRDC3;RYK;EPHA7;IGF1R;CSF1R;PDGFRB;CTNNB1;EPHA5;FGFR1;RFC5;HNRNPD;PLK1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.4005164494980837,0.9249130594328736,0.5,1.0,1.0,20/70,20.69%,FGFR2;CNTN4;BTBD3;PARD3;RYK;CTNNA2;LRP4;SLITRK5;MEF2A;ANK3;MEF2C;KLF7;MAP2;PARD6B;NTNG1;RAB10;ZDHHC17;PAK3;BAIAP2;LLGL1
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.6161072327355595,0.9245620018158225,0.6341463414634146,1.0,1.0,1/6,4.57%,PUS10
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.49583016607901853,-0.9243252781864092,0.4827586206896552,1.0,1.0,2/17,4.84%,CGAS;PARPBP
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.4011053790059001,0.92403268300945,0.5897435897435898,1.0,1.0,45/220,13.14%,IL1RAPL2;ROGDI;PBX1;DDIT4;CX3CR1;SHROOM2;AFF2;SNTG2;CNTN4;ITGAM;SLC23A1;SYNJ2;KLHL17;MEIS1;CNTNAP2;ROBO2;PBX3;CA10;SCTR;ATXN1;ADGRL3;POU6F2;TBX6;EPHA7;MBP;CDH2;GLIS2;SH3GL2;PSPN;C3;SHROOM4;MEIS2;ADGRL2;CHD7;DLL1;NPAS1;GRIK1;ASIC2;RPS6KA6;LIG4;NFIB;MYRF;ALDH3A2;SOX11;PAFAH1B3
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.5870964187670202,-0.9237901072707463,0.5614035087719298,1.0,1.0,1/6,1.05%,CYP19A1
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.5788886188955681,-0.9237016663602914,0.6271186440677966,1.0,1.0,3/8,11.19%,PBLD;RBP4;VSIG1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.48937290236788444,0.923500985637549,0.543859649122807,1.0,1.0,2/13,7.59%,NLGN1;RAB27A
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.4768940021239784,0.9233281830614162,0.6181818181818182,1.0,1.0,3/22,11.04%,ITGAX;ITGAV;IZUMO1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.4445420516032519,0.9232732059203842,0.5535714285714286,1.0,1.0,7/39,16.02%,NRXN1;SYT1;SNCA;SYN3;PPFIA3;PCLO;LIN7A
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.5911317796169542,0.9228523710139358,0.5882352941176471,1.0,1.0,3/5,16.40%,VEGFC;VEGFD;VEGFA
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.42539505889489815,-0.9226921700238734,0.5172413793103449,1.0,1.0,14/80,10.92%,HLA-DPB1;LDHC;C2;TMEM220;CD74;RASSF4;HLA-DRA;KCNE1;C11ORF97;IL1R1;CCDC170;FPR3;TEX26;ANKUB1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.5424893365306946,-0.9226125524196348,0.5416666666666666,1.0,1.0,4/9,20.75%,DCTN1;CKAP5;RANGRF;EML2
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.531494985440351,-0.9225657569240017,0.6170212765957447,1.0,1.0,5/15,26.20%,ALOXE3;ALOX12B;GSTP1;FADS1;ABCD1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.4264271565040874,-0.9222277594736276,0.5303030303030303,1.0,1.0,6/64,7.35%,TXK;TEC;HCK;CDH17;MADCAM1;PRAM1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.6202329461361011,-0.9219461068830865,0.5925925925925926,1.0,1.0,1/5,15.65%,GREM1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.496504126943257,0.9219223382323534,0.5892857142857143,1.0,1.0,3/11,14.58%,KLF2;CTBP2;ASXL1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.42227006991824206,0.9218350680097783,0.5217391304347826,1.0,1.0,19/99,11.90%,MYBPC3;ZFPM2;RRAD;ADIPOR2;ADPRHL1;CMYA5;CKM;CCN2;SYNPO2;TRDN;XIRP2;PRKG1;PDE4D;FILIP1;ADIPOR1;MITF;FLNC;CTNNB1;PDE1A
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.6199539381167267,-0.9217717786576699,0.6363636363636364,1.0,1.0,1/5,8.01%,DRD3
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.5648703993492118,0.9213902144418225,0.5555555555555556,1.0,1.0,4/8,24.13%,ABHD17B;LYPLAL1;LYPLA1;ABHD17C
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.5648703993492118,0.9213902144418225,0.5555555555555556,1.0,1.0,4/8,24.13%,ABHD17B;LYPLAL1;LYPLA1;ABHD17C
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.44592465996424047,0.9213891624314889,0.54,1.0,1.0,6/43,8.74%,C1GALT1;SULF1;TGFBR1;FGF10;ROBO2;LRP4
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.42027826515201083,-0.9212373218779993,0.543859649122807,1.0,1.0,17/59,12.52%,TMEM212;VWA3A;SNTN;PPP1R42;C11ORF97;CAPS;SCGB1A1;CFAP77;DRC1;TEX26;RSPH4A;LRRC23;ANKUB1;CFAP52;ATP5MK;TUBB4B;CCDC60
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.6277704079283456,-0.9211520786277662,0.6666666666666666,1.0,1.0,2/5,6.52%,CDK5;GRIPAP1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4475989032062699,0.9211371221833096,0.5128205128205128,1.0,1.0,12/57,11.68%,LOXL2;IL17RD;SMAD7;TGFBR1;EPHA3;TWIST1;CRB2;ADIPOR1;SMAD2;MDK;USF3;CTNNB1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.645583337626056,0.9211019605505706,0.6444444444444445,1.0,1.0,2/5,5.91%,NRXN1;CNTNAP2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.645583337626056,0.9211019605505706,0.6444444444444445,1.0,1.0,2/5,5.91%,NRXN1;CNTNAP2
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.5663505552615268,-0.9210364339092816,0.5319148936170213,1.0,1.0,4/11,15.53%,MYH14;DNM1L;SUPV3L1;FIS1
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.5738199144165764,-0.9209416861810246,0.54,1.0,1.0,1/7,0.73%,GUCY2C
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.5026800866245125,0.9208353286953137,0.6410256410256411,1.0,1.0,9/17,27.79%,CDH2;CTNNB1;PTK2;PKD2;TCAP;PKD1L3;CAV3;PKD1;PIEZO1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.5259253864019853,0.9207672427801292,0.5357142857142857,1.0,1.0,3/13,10.56%,LDLR;C3;NR1H3
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5049264837657563,-0.9198971866787317,0.6382978723404256,1.0,1.0,1/12,0.98%,TNFSF18
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.4832535963571928,-0.919658773109993,0.5714285714285714,1.0,1.0,5/16,19.48%,TAF11;SNW1;CCNT1;NUCKS1;RRP1B
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.3506006768512225,-0.9194734726605499,0.6538461538461539,1.0,1.0,42/360,13.28%,GOLGA8B;GEM;KIF25;CATIP;HPS6;CFAP61;PTCD2;WTIP;STX4;GOLGA2;ARAP3;TPM1;KIF4A;FGD3;PACSIN3;ZFP69B;DNAJA3;LIMD1;ZMYM6;HSD17B10;TANGO2;GOLGA8A;REEP6;CHCHD10;ATP8B4;RAB31;NSFL1C;GOLGA8N;TWNK;PAK6;GAK;ODF2;PINK1;DOP1B;ATP5F1B;KIF9;DNM1L;MTX1;ADCK1;PEX11B;CHCHD2;GOLGA8M
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.37665613976956724,0.9189887694424033,0.5348837209302325,1.0,1.0,26/164,13.19%,RUNX1;PLCB1;SEMA5A;KCTD8;FGFR2;SULF1;RFNG;RGS6;PRKD1;CDKN2AIP;RORA;TULP3;SOCS2;TRIM5;PLCE1;NCK1;KIF26A;TMEM108;NCAM1;TIMP1;DLL1;SIRT1;LIFR;TSPAN15;ACVR1;RGS14
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.5571165273304446,-0.9186678641807563,0.5454545454545454,1.0,1.0,1/11,2.31%,NOG
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.4149082965100775,0.9186268130292318,0.4791666666666667,1.0,1.0,9/44,15.80%,CERS3;TLCD3B;ACER1;ASAH2;PLPP1;PLA2G15;SGMS1;CERS5;SMPD4
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5009333675104404,0.9178348861936565,0.4473684210526316,1.0,1.0,3/22,7.10%,KANK1;SLIT2;LIMK2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.5106804173612252,-0.9177628419291476,0.5454545454545454,1.0,1.0,6/18,27.69%,ADAM19;HM13;RBMX;ADAM9;ADAM17;NCSTN
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.4512733862401834,-0.9175165562663176,0.5185185185185185,1.0,1.0,4/37,4.74%,NCKAP1L;CD74;VAV3;BST1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4420428056632393,0.917375154639556,0.5675675675675675,1.0,1.0,7/39,7.45%,ZFP36;DXO;ZFP36L2;RIDA;NUDT16L1;PPP1R8;ERN1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.49651693706319006,0.9173255498498137,0.5128205128205128,1.0,1.0,7/27,16.40%,SLIT2;PKHD1;FGF10;NRP1;CTNNB1;SALL1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.4967339473830368,-0.9173133134042242,0.5416666666666666,1.0,1.0,5/36,13.37%,SERPINB8;SERPINE1;TIMP4;CSTB;SERPINF2
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.5750575374575707,-0.9172244035054844,0.5961538461538461,1.0,1.0,4/8,24.81%,TMEM9;PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.41832140052258965,0.9169407719178027,0.5625,1.0,1.0,12/36,22.14%,ZFP36;ZFP36L2;RIDA;FTO;CPEB3;ROCK2;MEX3D;PDE12;ZFP36L1;PUM1;YTHDF3;TUT7
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.6124483430408586,-0.9169206648118925,0.6808510638297872,1.0,1.0,3/5,38.48%,SSU72;CTDP1;RPAP2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5202894939807726,-0.9167949811464795,0.5833333333333334,1.0,1.0,3/12,12.72%,NOP14;NOP9;KRI1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.5827539345485587,-0.9166897421018165,0.5471698113207547,1.0,1.0,3/5,28.07%,LRP8;PAFAH1B1;STAT5A
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.5915184043789491,0.9166676215145291,0.576271186440678,1.0,1.0,4/7,30.91%,WASHC1;CDC42EP3;CDC42EP1;CDC42EP4
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.5915184043789491,0.9166676215145291,0.576271186440678,1.0,1.0,4/7,30.91%,WASHC1;CDC42EP3;CDC42EP1;CDC42EP4
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.6344737771557054,-0.9164898342643746,0.6818181818181818,1.0,1.0,1/6,21.25%,TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.5281506763864805,0.9164364860142402,0.5769230769230769,1.0,1.0,8/18,17.16%,SPHK1;AGER;RELL1;MFHAS1;GADD45B;SASH1;VEGFA;GADD45G
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.4892411142731844,-0.9161895961075844,0.5283018867924528,1.0,1.0,6/20,20.14%,STX4;LACC1;RBP4;PTPRC;SLC7A5;PTPN22
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.6069915684140271,0.9161668814833142,0.6296296296296297,1.0,1.0,3/6,29.99%,SLC25A12;SLC25A18;SLC25A13
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.33438978378853446,0.9161660926000187,0.6363636363636364,1.0,1.0,95/539,14.10%,DACH1;LOXL2;IFI16;ZFPM2;RUNX1;FRK;ZBTB2;NFIL3;TGIF1;ZFP36;PPARG;HJV;FGFR2;ZBTB1;LDB2;BATF3;ID3;NRIP1;HMGB1;IRF2BPL;NEDD4;ZEB1;SMAD7;HEY1;TRPS1;NR2E1;ZEB2;KLF2;ZBTB5;WWOX;FOXO3;TENM2;FOXP2;ZNF202;HDAC9;KCTD1;NR3C1;MIER2;TBL1XR1;SNCA;ATXN1;HDAC3;ZNF675;ZGLP1;TWIST1;GLI3;NR1D2;ZNF205;HDAC2;JAZF1;PHF21A;TBX6;FST;CTBP2;GLIS2;BCOR;ZNF20;MYPOP;TAF3;MITF;MXD4;KLF12;SMAD2;PEX2;RNF2;WWC1;MEIS2;NCOA5;ZBTB7B;SMURF2;ARID5B;NR1H3;PDE2A;ZNF582;ATF3;BRMS1;SIRT1;ZNF175;THAP11;ZNF536;EPC1;MEF2A;EDN1;NFIB;PPM1A;SOX11;EP300;ETV6;NACC2;MEF2C;RARB;KLF7;CREM;ZNF19;UBE2D3
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.5204485491375804,-0.9157271780462634,0.6190476190476191,1.0,1.0,3/8,28.58%,AK8;AK7;AK1
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.36563223832484615,-0.9157077615777531,0.6,1.0,1.0,28/137,19.70%,TCHH;PARP2;NPTXR;PDAP1;MRPL23;PSMC3;PRKACA;BTG1;GGH;NR4A1;CCNE1;PPT1;FGF18;YKT6;RXRB;TYRO3;NPTX2;NFKBIA;RPN1;CLTB;WIZ;BAK1;EIF2S3;ATP6V1F;IRF1;EPHX1;ENO2;SIGMAR1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.45103302620478647,-0.9156803517982345,0.5789473684210527,1.0,1.0,6/26,18.50%,GBP6;HMGB2;LBP;GBP2;PGLYRP2;GBP7
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.5736619352373212,-0.9156611028860628,0.56,1.0,1.0,2/6,28.94%,CPTP;TTPA
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.4029313173543563,-0.9155471294833385,0.6428571428571429,1.0,1.0,4/74,5.01%,SPRY4;FOXM1;NTRK1;SPRY1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.49291081478912835,-0.9152857657824263,0.5918367346938775,1.0,1.0,8/15,24.85%,NLRP3;TXN;ENTPD5;IL18;ENTPD1;HSP90AB1;P2RX4;TXNIP
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.5666481828744416,0.9152546871919321,0.6792452830188679,1.0,1.0,2/7,8.58%,SYK;FER
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.5811731884486289,0.9152402205721204,0.6666666666666666,1.0,1.0,1/5,15.85%,NAA30
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5410673838773034,-0.9151134770374321,0.6170212765957447,1.0,1.0,2/11,12.57%,UPB1;NT5M
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.4363103479049758,-0.91502260073316,0.515625,1.0,1.0,1/42,0.74%,SFRP1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.48890048008844933,0.9150161094758812,0.52,1.0,1.0,4/15,12.46%,HPGDS;PTGES;PTGS2;EDN1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.551994980084384,0.9149984868740061,0.696969696969697,1.0,1.0,3/10,14.51%,UBE2J1;YOD1;INSIG1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.5210647852157696,0.9145459259395794,0.5897435897435898,1.0,1.0,4/9,18.27%,ATP6V0A4;SLC9A1;PDK4;PDK2
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.5371420654075107,-0.9145404321850196,0.5918367346938775,1.0,1.0,3/11,19.83%,TSPYL2;SLFN11;CDC6
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.44277498625687606,-0.9145343038753811,0.4727272727272727,1.0,1.0,2/27,6.08%,ABRAXAS1;TICRR
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.372712341198032,-0.9143434346890156,0.5081967213114754,1.0,1.0,7/120,6.09%,NOSTRIN;TAGLN;COL6A1;FGF1;TPM1;LATS2;CALD1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.46580883953764063,0.9142621778858857,0.5853658536585366,1.0,1.0,7/30,18.06%,DDIT4;MINAR1;KPTN;SIRT1;DEPTOR;SESN1;SH3BP4
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.5752444767597024,0.9139928589517118,0.625,1.0,1.0,5/8,14.47%,FZD1;WNT5A;RYK;CTNNB1;WNT2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.4502169826638419,0.9138242461493017,0.5681818181818182,1.0,1.0,5/27,11.68%,CX3CR1;ELAPOR2;HEY1;DLL1;CTNNB1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.4616323502802656,0.9136252337002807,0.5,1.0,1.0,2/25,6.79%,NLGN1;SNCA
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.452766424543608,0.9135068418825324,0.6,1.0,1.0,5/32,11.73%,CHRM3;NEDD4;FGF12;TCAF2;ANK2
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.39406998066393223,0.9134044472230252,0.62,1.0,1.0,10/54,14.46%,NLK;TGFBR1;DYRK3;PRKD1;DYRK1A;PRKCA;DYRK2;ACVR1B;ACVR1;MAPK8
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.40325204619921196,0.9130290481250318,0.6666666666666666,1.0,1.0,9/52,17.00%,FAS;TGFBR1;WWOX;ITGAV;FGFR1;ACVR1;DEPTOR;RELA;TRAF1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.4527965600171427,0.9129877196469228,0.5909090909090909,1.0,1.0,3/24,3.73%,CALCR;IRS1;AGER
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.5804225408914522,-0.9127150410289938,0.5892857142857143,1.0,1.0,1/6,12.62%,TTBK1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.5072195948918039,0.9123067292358426,0.5531914893617021,1.0,1.0,7/22,14.55%,FGFR2;TGFBR1;WWOX;FGFR3;SOX11;FGFR1;SPEF2
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.4354990055667979,0.9121373068988828,0.5348837209302325,1.0,1.0,3/34,6.14%,KCNE4;KCNJ3;CACNB2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.45930571245294083,0.9119614898420857,0.5217391304347826,1.0,1.0,5/24,18.32%,P3H2;CWC27;PPIL6;FKBP5;NTMT1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.5440922133791402,-0.911921350984317,0.5957446808510638,1.0,1.0,3/18,8.29%,NUPR1;CDK5;ATF4
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.47658022633575337,0.9117300599820144,0.5625,1.0,1.0,2/21,6.36%,MYBPC3;TMOD1
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.47658022633575337,0.9117300599820144,0.5625,1.0,1.0,2/21,6.36%,MYBPC3;TMOD1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.3201644443497615,0.9117135576472432,0.7441860465116279,1.0,1.0,168/904,14.95%,MED17;FZD1;MYRFL;IFI16;ESRRG;ZFPM2;ZNF300;RUNX1;PLCB1;NFIL3;ERBB4;RGMA;PPARG;HJV;FGFR2;CREB5;HNF4G;LDB2;PBX1;FANK1;NRIP1;HMGB1;TFEB;IRF2BPL;EGFR;SMAD7;HEY1;PPARGC1A;WNT5A;TOX3;ARID1A;TGFBR1;ZNF827;ZEB2;ARID1B;RUNX2;KLF2;TEAD2;RFX3;WWOX;MLLT3;FOXO3;RPS6KA4;NFIA;MEIS1;LITAF;SP3;ACVR2A;PSRC1;PPP3CA;MRTFA;NR3C1;PRKD1;LMO7;TP63;NCOA2;SSBP4;SMAD5;RFPL2;TBL1XR1;SPIN1;HDAC3;NPAS3;ZGLP1;TWIST1;TCF4;GLI3;MAML2;RORA;NR1D2;ZNF516;HDAC2;SUPT3H;MAML3;SMARCD3;HGF;EPCAM;IER5;HINFP;EIF2AK3;HIF1A;BMPR1A;UBP1;NR5A2;AUTS2;MSTN;SERTAD2;CTBP2;GLIS2;ACTA2;SMAD1;ATOH8;DVL2;ASF1A;MITF;SSBP2;RFXANK;ATF6;ST18;SMAD2;TP53INP1;NCK1;DYRK1A;ASXL3;MRTFB;JAG1;MEIS2;POU2F1;CDH13;DLL1;PLAC8;SNX5;NR1H3;ING1;RFXAP;ATF3;CSRNP2;RYBP;CD38;BTRC;CAMK4;CTNNB1;SIRT1;FOXO1;ZNF175;WNT8A;EPC1;DPF3;MEF2A;EDN1;NFIB;YAF2;PPM1A;CREB1;E2F5;GABPA;MYRF;SOX11;PID1;EP300;ACVR1;PTOV1;SCX;CSRNP3;MEF2C;RARB;KLF7;MEIS3;FLI1;TET2;SCAF8;VEZF1;PICALM;ZBTB17;PIK3R1;SALL1;WNT2;FOSL2;ASXL1;HNRNPD;ACTR3;TRERF1;HIVEP3;ZXDC;OGT;NFATC2;NFATC3;DR1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.40960156332162806,0.9115617037305362,0.5,1.0,1.0,12/77,12.79%,ESAM;EFNA5;EPHA3;RHOB;ABL2;GPM6B;CSF1R;PDGFRB;MDK;PIK3CA;EPHA5;RHOBTB3
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.5889133011971156,-0.9114646757748901,0.6470588235294118,1.0,1.0,1/7,0.74%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3683340628140719,-0.9114606616727662,0.6,1.0,1.0,34/134,20.53%,SFRP1;NOG;PSMA7;LATS2;PSMD7;RBX1;PSMB4;LIMD1;PSMC3;NOTUM;TLE2;IGFBP4;STK11;EMD;PSMD8;SFRP4;PSMB5;PSMC1;PSMB2;PSMC4;GREM1;FUZ;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;TMEM88;TLE5;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.5524327329713344,0.9114336799443299,0.6326530612244898,1.0,1.0,2/7,11.75%,RFX3;CFAP53
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.48222202660624647,0.9114080714921011,0.5769230769230769,1.0,1.0,5/18,13.41%,SLC8A1;SNCA;TMTC2;ANK3;CNNM2
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.48902864356569203,0.9113756020572679,0.6122448979591837,1.0,1.0,1/14,1.32%,PNP
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.6169254015206183,-0.9113552843617089,0.6785714285714286,1.0,1.0,2/5,20.14%,FLOT1;PTPN22
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.5887947160682274,-0.911299376000592,0.6666666666666666,1.0,1.0,3/7,17.42%,KDELR1;KDELR3;RER1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4200805873255928,-0.911180685685866,0.5714285714285714,1.0,1.0,8/64,4.51%,P2RY10;CD5;TXK;KLRB1;HSD11B1;AOAH;TRAF3IP3;SLA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.6363495588398227,-0.9109272573580327,0.5925925925925926,1.0,1.0,2/5,15.65%,GSTP1;GREM1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.5615171523282901,0.9107615708103552,0.6,1.0,1.0,1/8,3.48%,HMGB1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.5208577968980673,0.9106347659419067,0.56,1.0,1.0,2/9,17.89%,HEXB;VCAN
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.5032697136410534,0.9101466819817955,0.5609756097560976,1.0,1.0,5/18,18.39%,CHMP6;ODC1;ZDHHC2;NEDD4L;MDM2
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.48197247144752386,0.9101159162456791,0.6222222222222222,1.0,1.0,5/14,16.08%,CRB2;SMAD2;SCX;ITGA2;TBX19
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.45606526690249044,0.9099830989892734,0.5918367346938775,1.0,1.0,10/47,13.07%,IFI16;RUNX1;PPARG;BATF3;CSF1;CSF1R;CAMK4;SIRT1;OSTM1;EP300
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.46819387477913565,-0.9099523078753228,0.5957446808510638,1.0,1.0,2/25,1.73%,DYSF;CLU
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4710666293775115,0.9097033129916962,0.5818181818181818,1.0,1.0,2/17,6.01%,EGFR;PSRC1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.38257209273420273,0.9096740281309859,0.5609756097560976,1.0,1.0,40/198,13.50%,NLRP2B;SHISA2;KANK1;IRS1;CXXC4;ENPP1;DDIT4;CX3CR1;NEDD4;EGFR;HEY1;MOSMO;SULF1;CCL5;NLK;PIP4K2A;OTUD4;WWOX;KCTD21;SNCA;GLI3;TLE1;TULP3;GLIS2;NLGN4X;ASAH2;NCK1;KIF26A;DLL1;KCTD6;CRHBP;BTRC;TSPAN15;BCL2;PID1;ACVR1;CBLN1;RGS14;NOTCH3;GPR108
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.5659024902913602,-0.909508095563398,0.6122448979591837,1.0,1.0,3/7,18.84%,ARF1;PLK2;PRRT1
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.5562012759981216,0.9094106047241214,0.6326530612244898,1.0,1.0,3/6,35.31%,MSH2;MSH6;RMI2
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.5654962697468108,0.9093722011401776,0.575,1.0,1.0,4/5,17.12%,CDK6;CDH2;DLL1;BMP6
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.570933737322145,-0.9091007781403905,0.631578947368421,1.0,1.0,2/8,19.69%,PRKCZ;IL18
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.4394330979789588,-0.9088909542903164,0.6129032258064516,1.0,1.0,4/44,8.14%,CATIP;RAC1;VIL1;WASHC3
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5463194437539832,-0.9084042962223433,0.6666666666666666,1.0,1.0,3/10,15.04%,SCARF1;CERS2;RTN4R
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.5537908794394835,0.9082400095769891,0.6382978723404256,1.0,1.0,3/8,13.11%,AGER;GRID2;CBLN1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.4785541281350925,-0.9078524439050806,0.5686274509803921,1.0,1.0,4/27,12.30%,CLU;C2;CR1;C1QBP
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.5013460757851453,0.9077670873089324,0.6666666666666666,1.0,1.0,4/13,12.80%,KCNE4;KCNG1;AKAP6;ANK3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.5978366400090425,-0.9077271429454515,0.6607142857142857,1.0,1.0,1/6,9.83%,ATP1B1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.4523182833086278,0.9076934796058046,0.5652173913043478,1.0,1.0,9/26,13.63%,RUNX1;SULF1;RUNX2;FGFR3;EIF2AK3;SOX5;NFIB;SCX;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.527471722593299,-0.9075534884367482,0.5238095238095238,1.0,1.0,1/13,2.70%,APOD
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4928469404921272,-0.9075330961553556,0.6111111111111112,1.0,1.0,2/10,19.71%,EDEM2;SEC16A
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.37169653185487295,-0.9074878253034099,0.6229508196721312,1.0,1.0,9/105,7.69%,INHA;CPXM2;CYP19A1;EPAS1;SLC9A8;ANO1;CALD1;PRLR;CFD
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.4105633789923623,0.9072016467010173,0.5853658536585366,1.0,1.0,17/90,12.93%,CD151;NRG1;RUNX1;NRXN1;TGFBR1;SYK;ATP10A;FRMPD4;SNCA;PROM2;LRP4;IGF1R;DLL1;GNL3L;NEUROD2;TMED9;MPP7
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.33787758769359016,0.9070120138800329,0.6060606060606061,1.0,1.0,78/424,16.58%,SGK2;SGK3;LTK;MAP3K11;STK26;CCNH;DAPK2;FRK;ERBB4;FGFR2;NUAK2;CCNA2;EGFR;SMAD7;NLK;TGFBR1;SYK;EPHA3;TNIK;RPS6KA4;LATS1;ACVR2A;FGFR3;DYRK3;PRKD1;CDK6;RYK;LIMK2;ERN1;PXK;CLSPN;ABL2;PRKG1;PTPN6;EIF2AK3;BMPR1A;SGK1;PRKACB;FER;IGF1R;STK36;SMAD2;CSF1R;DYRK1A;PRKCA;CDK12;PDGFRB;DYRK2;ACVR1B;NIM1K;CAMK4;MAP2K6;MEX3B;RPS6KA6;STK33;MAP3K1;CREB1;FGFR1;ACVR1;PIM3;CDK18;TGFBR3;MAPK8;PRKCB;PIM1;PLK1;AKT2;CRY1;BRAF;DCLK3;YWHAZ;PKDCC;DCLK1;AURKC;PDK4;SMG1;ERC1;STK38
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4637869679651911,-0.9069781157380961,0.5777777777777777,1.0,1.0,4/35,7.54%,TNFSF18;IL31RA;GHR;STAP2
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.4332050056709171,0.9068873401900996,0.5681818181818182,1.0,1.0,12/44,21.48%,ST8SIA6;GLA;GLB1;ST6GALNAC4;PIGW;ESYT3;SMPD4;HEXB;ESYT2;ST3GAL6;ST3GAL4;GALC
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.5602256663210529,0.9068675955391674,0.6808510638297872,1.0,1.0,3/9,12.70%,KLKB1;PTGES;ADAM8
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.5418170008846038,-0.90685214192752,0.627906976744186,1.0,1.0,2/18,6.74%,MYH14;SCN11A
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.36103328902751014,0.9061910959038711,0.5111111111111111,1.0,1.0,16/88,9.37%,PCDHB3;NLGN1;CDH8;NRXN1;DSCAM;FLRT3;CDH20;CDH18;GPM6A;RAB29;RYK;ADGRL3;CDH10;CDH2;FBLIM1;CDH6
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.38606521378583275,0.9061734945183473,0.5272727272727272,1.0,1.0,23/91,16.41%,FAS;CASP12;PPARG;SLC22A2;EGLN3;HMGB1;ROBO1;SYK;SNCA;EIF2AK3;ST18;IFT57;CASP10;SIRT1;BOK;F3;CASP9;SMAD3;CASP2;BAD;CRADD;SENP1;NOD1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.4260660716531202,0.9061487853748372,0.5869565217391305,1.0,1.0,7/39,14.77%,KCND2;KCNE4;GNAQ;AKAP6;ANK3;KCNJ2;DMD
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.5181027361710316,0.9051492955535299,0.6086956521739131,1.0,1.0,8/13,28.89%,COMMD1;NEDD4L;ATP1A2;SLC43A1;CAMK2D;CAB39;CAV3;BIN1
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.4465268189178723,-0.905067007637573,0.6326530612244898,1.0,1.0,12/35,27.71%,TOMM20;NUP133;NUP43;XPOT;NUP155;NUP85;NUP214;RAN;NUP50;YBX1;SEC13;TPR
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5156489807965786,-0.9049222901599128,0.6,1.0,1.0,1/9,6.67%,ADRA2A
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.42217727039789926,0.9047750284065892,0.5405405405405406,1.0,1.0,14/57,20.11%,HMGB1;EGFR;FGF10;OTUD4;TOX;HGF;PDGFRB;SIRT1;PPP1R10;MECP2;EYA3;TMEM161A;BABAM2;CEBPG
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.5718674447562857,0.9047726493323431,0.6785714285714286,1.0,1.0,2/6,8.58%,SYK;FER
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4619375676941324,0.9042510910237053,0.6666666666666666,1.0,1.0,4/23,12.58%,TAB3;TAB2;TLR1;MAP3K1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.3851955070910587,0.9040775062200838,0.5897435897435898,1.0,1.0,8/69,4.86%,SLC12A1;ADAM28;ARHGAP25;FRK;GPR174;BTLA;TMEM156;CD22
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.5716705994885776,-0.9040762552781684,0.5869565217391305,1.0,1.0,2/6,5.64%,PAH;BCAT2
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.5261258212724886,-0.9040307498041392,0.6545454545454545,1.0,1.0,4/10,17.75%,ST6GAL1;AMDHD2;ST3GAL1;GNPDA1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.575244366834805,0.9038704652618715,0.6744186046511628,1.0,1.0,3/5,16.40%,SMURF2;ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.408757239102263,0.9038066926298376,0.5740740740740741,1.0,1.0,11/45,13.63%,PPARG;HMGB1;HSPB1;ATP2B4;NUS1;PRKD1;HIF1A;PRKCA;SIRT1;FGFR1;MEF2C
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.48071804617417857,0.903445370800987,0.5535714285714286,1.0,1.0,4/18,15.16%,ATP2B4;DYRK2;AKAP6;SLC9A1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.4970959599376447,-0.9033410794180528,0.6363636363636364,1.0,1.0,7/22,28.45%,UBC;UFD1;RPA3;NPLOC4;UBB;RFC2;RPA1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.509782323749818,-0.9032541369561415,0.6153846153846154,1.0,1.0,2/8,14.82%,GNPTG;TKFC
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.4702359072472375,-0.9032428792134638,0.6037735849056604,1.0,1.0,5/21,21.20%,TSPYL5;CRYAB;XRCC6;YAP1;TMEM109
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.47208825306074076,-0.9032211986347143,0.5869565217391305,1.0,1.0,2/26,3.48%,TXK;CD74
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.595080959121382,-0.9032198394087545,0.6530612244897959,1.0,1.0,2/5,13.73%,HLA-DRA;HLA-DMA
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.43043087886382564,-0.9031690134402433,0.6226415094339622,1.0,1.0,10/41,17.16%,TXNRD2;ATOX1;PRDX1;PTPA;TXN;SBNO2;NDUFS2;ERCC2;GLRX2;SELENOS
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.46492336784761157,0.9029373216918009,0.5227272727272727,1.0,1.0,9/19,17.86%,FGFR2;TGFBR1;MBNL1;HINFP;CHD7;LIG4;FUT8;VEGFA;ZNF568
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5198568403137078,0.902925923035945,0.6296296296296297,1.0,1.0,3/12,14.78%,PPAT;IMPDH1;GMPS
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.527300850817638,-0.9028631326292426,0.6557377049180327,1.0,1.0,2/9,20.30%,IFIT1;ISG15
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.44976249772913784,-0.9028104395887663,0.6296296296296297,1.0,1.0,15/36,31.04%,PRPF6;PRPF19;USP4;SNRPD2;SRSF10;PRMT7;GEMIN4;COIL;WDR77;SNRPD1;PRPF3;SNRPC;LSM4;SMN1;SNRPB
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.40375634997720133,0.9025358005113617,0.5555555555555556,1.0,1.0,18/49,17.73%,TGIF1;ID3;SMAD7;TGFBR1;BMPR1A;SMAD1;SMURF2;CTNNB1;PPM1A;SMURF1;ACVR1;UBE2D3;LTBP2;SMAD3;SLC20A1;WWTR1;SKIL;SPTBN1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.40350890356688374,0.902132589265295,0.5789473684210527,1.0,1.0,6/61,10.68%,B4GALNT2;SEMA5A;DSCAM;JAG1;CDH13;MDK
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.5662955325666131,0.9020400729256957,0.6739130434782609,1.0,1.0,3/7,10.96%,JAM2;CCL5;CXCL12
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.5437579745660356,0.901718518617583,0.6304347826086957,1.0,1.0,1/8,5.41%,CYP2C8
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.49004221392455505,0.9013942780814697,0.52,1.0,1.0,1/14,1.00%,IFI16
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.3891591049483653,-0.9013803190639691,0.6271186440677966,1.0,1.0,21/94,12.55%,MYB;CATIP;TMEM212;CFAP47;VWA3A;CFAP61;SNTN;PPP1R42;CFAP221;DNAH2;C11ORF97;SCGB1A1;CFAP77;DRC1;CFAP99;TEX26;RSPH4A;LRRC23;CFAP52;CCDC60;AK8
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.36349894962098017,0.901198259001829,0.6097560975609756,1.0,1.0,38/217,11.09%,FAS;EFNA5;ERBB4;LEPR;AGER;EGFR;SLIT2;FGF10;PELI2;PPP1R15B;TNIK;VEGFC;GRM5;HSPB1;ECT2;ACVR2A;HDAC3;LIMK2;FGF17;FGF5;PTPN13;HGF;EPHA7;FKBP8;EIF2AK3;FER;PROM2;PLCE1;DVL2;P2RY1;SH3GL2;C3;CSF1R;MOB1B;VEGFD;RAP2A;NPTN;ATF3
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.5492757366123786,0.9010080045371899,0.6170212765957447,1.0,1.0,3/8,28.11%,GALC;GAL3ST1;B3GALT1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.35950129067345143,0.9008504441141759,0.6136363636363636,1.0,1.0,55/227,18.27%,LTK;SLC26A3;KCNC2;IRS1;ZFP36;PTPRK;NRIP1;HMGB1;CX3CR1;EGFR;HCN1;WNT5A;SLIT2;EPHA3;GLRA2;PDE4B;ATP2B4;PRKD1;RORA;BRINP3;ABL2;FER;P2RY1;IP6K2;PDE3A;NR1H3;PDE2A;CRHBP;FOXO1;ADNP2;AKAP6;AANAT;CD274;CREB1;AGAP3;PID1;MEF2C;CPEB4;MAPK8;WNT2;INSIG1;P2RX7;VIM;LPL;RELA;PDK4;NLRP7;CPEB3;ROCK2;RAP1A;BRINP1;SH3BP4;RUVBL2;GNG2;PDK2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.5450147493223823,0.900777046161496,0.6363636363636364,1.0,1.0,1/9,3.79%,SMAD7
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.5589162338141902,0.9005966049717624,0.5535714285714286,1.0,1.0,2/8,10.92%,ATP2B4;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5589162338141902,0.9005966049717624,0.5535714285714286,1.0,1.0,2/8,10.92%,ATP2B4;DYRK2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.39331001183526454,-0.9004667019036046,0.6229508196721312,1.0,1.0,11/64,15.64%,SFRP1;RAC1;TPM1;EPHA1;SYNPO2L;STMN1;APOA1;SERPINF2;MET;ASAP3;ARHGEF10L
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.4724144728243681,-0.900260877669335,0.6206896551724138,1.0,1.0,4/30,9.82%,DND1;PHAX;VIP;CIRBP
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.4235218819448512,0.9002226324966877,0.5405405405405406,1.0,1.0,13/71,8.70%,ACE2;FZD1;PHACTR1;TMEM229A;NR3C2;PELI2;CAPN13;SCNN1B;EPCAM;PTGES;COBL;PROM2;CDO1
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5117604162487097,0.9001495589442712,0.6595744680851063,1.0,1.0,4/11,22.46%,C3;PRKCA;KLK14;PRMT5
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.3570869644689649,0.9000832400049349,0.5681818181818182,1.0,1.0,71/306,16.93%,PTPN20;IL20RB;IFI16;GRAP2;ITGAX;SELPLG;SOCS6;ZFP36;IL1RAPL1;IL18R1;LEPR;GBP4;CSF1;ZEB1;WNT5A;CCL5;ITGAM;ZFP36L2;SYK;FOXO3;NPR2;ZNF675;TWIST1;GREM2;RORA;SYNCRIP;PTPN13;HGF;ABL2;PTPN6;HIF1A;SOCS2;CSF2RA;FER;ASAH2;AIM2;IL4R;CSF1R;IL16;TIMP1;POU2F1;PDE2A;CRHBP;PTPN14;CXCL12;PTGS2;SIRT1;FOXO1;PIK3CA;ERBIN;LIFR;AKAP6;BCL2;PID1;LDLRAP1;F3;PIK3R1;MAPK8;PIM1;SLC12A2;VIM;SMAD3;SMPD4;IL12RB2;YWHAZ;RELA;VEGFA;IL34;NLRP7;NFAT5;PTPN12
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.6053444179606697,0.8996661916527373,0.6410256410256411,1.0,1.0,2/5,13.10%,BMPR1A;ACVR1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.6074446189407854,0.8994707965732579,0.6956521739130435,1.0,1.0,2/6,13.06%,FNBP1L;SMURF1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4976067643793056,0.8993069411324094,0.5777777777777777,1.0,1.0,4/16,5.03%,PPEF2;DDIT4;SMAD7;PARD3
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.49190968970787785,0.8993042911653087,0.5636363636363636,1.0,1.0,2/11,9.80%,PNP;DPYD
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.5845885364665433,-0.8992882957401055,0.6,1.0,1.0,1/7,5.68%,BEX4
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.3558837196741593,-0.8990863581581136,0.7407407407407407,1.0,1.0,82/186,27.11%,TYMS;EIF2S2;PSMA7;HDDC2;SLC25A3;PSMD7;MRPL23;LSM7;NOLC1;NOP16;MRPS18B;KPNA2;MCM5;RSL1D1;DDX18;PA2G4;RPL34;NOP56;C1QBP;SF3A1;MCM2;PSMD8;RACK1;NDUFAB1;PPM1G;MRPL9;XPOT;SRSF7;PRDX3;RANBP1;PABPC4;PSMB2;PSMC4;USP1;PSMA1;LDHA;GOT2;PGK1;XRCC6;SNRPD2;EPRS1;ACP1;EIF3J;RPS3;CCT2;RPL6;CANX;RNPS1;PSMB3;EIF4H;IMPDH2;IARS1;PSMC6;SERBP1;FBL;DDX21;HSPD1;PCBP1;HSP90AB1;SNRPA1;DEK;APEX1;TARDBP;SF3B3;POLE3;ORC2;RPS6;MCM4;HDGF;RAN;SET;TFDP1;NPM1;EEF1B2;RPL18;SNRPD1;COX5A;VDAC1;RPS2;PSMA4;SRM;PSMD3
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5291050366877386,0.8990824628029473,0.6170212765957447,1.0,1.0,5/9,28.43%,ADCY2;ADCY10;ADCY3;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.45449333486744187,0.8987145582229068,0.4666666666666667,1.0,1.0,9/46,14.20%,REP15;NEDD4;SYK;ACKR3;SNCA;SMURF1;LDLRAP1;CALCRL;PICALM
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.5659600588301015,-0.8986799121146195,0.5833333333333334,1.0,1.0,2/9,12.60%,GINS3;MCM2
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.5732825365352028,0.8983620538466343,0.6226415094339622,1.0,1.0,1/6,6.79%,SNCA
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.4842028465979947,0.8983170528622165,0.5581395348837209,1.0,1.0,4/10,21.00%,LRWD1;RUVBL2;ACD;NIPBL
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.5653150479003727,0.8981956499007318,0.6346153846153846,1.0,1.0,3/6,29.30%,TENT4B;SND1;LIN28B
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.4274997594991844,0.8980639941283692,0.6046511627906976,1.0,1.0,10/29,17.12%,ADGRV1;SLC8A1;ACVR2A;BMPR1A;GPM6B;ACVR1;MEF2C;P2RX7;PKDCC;BMP6
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.5516577035136316,0.8978276605531743,0.6122448979591837,1.0,1.0,5/10,20.14%,CRB2;SCX;CLASP1;PHLDB1;CLASP2
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.4593767699569692,0.8977351623439173,0.5348837209302325,1.0,1.0,2/15,8.46%,INTS6;INTS11
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.44902176773494185,-0.8976668491213294,0.5918367346938775,1.0,1.0,5/36,8.29%,NUPR1;CLU;CDK5;DAXX;ATF4
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.547617687357253,-0.8976469824071982,0.625,1.0,1.0,1/12,3.23%,RAC1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.49865923543310386,-0.8974916870351932,0.6140350877192983,1.0,1.0,3/15,17.36%,CMTR1;METTL3;TRMT10C
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.44525212244576545,0.8970971195518569,0.6666666666666666,1.0,1.0,4/22,11.73%,PDE4B;PDE4D;FGF13;ANK2
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5109373587506989,0.896984812187308,0.5813953488372093,1.0,1.0,5/11,24.67%,PDE4D;ADCY2;ADCY10;ADCY3;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.45984871670974936,0.8968307406161931,0.6037735849056604,1.0,1.0,3/27,4.87%,ZFP36;SMAD7;IRS2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.5152298507542493,0.8967069699038498,0.6808510638297872,1.0,1.0,4/10,10.96%,HMGB1;CCL5;PLA2G7;CXCL12
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.5759305547285671,0.8966242976679996,0.6470588235294118,1.0,1.0,3/6,11.76%,DNAJC3;EIF2AK3;FOXO1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.5004826121098302,0.8962006295180173,0.627906976744186,1.0,1.0,4/16,10.00%,ZFP36;MEIS1;CDK6;MEIS2
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.5936409864876419,-0.8961612643867636,0.5892857142857143,1.0,1.0,1/5,2.34%,XG
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.5936409864876419,-0.8961612643867636,0.5892857142857143,1.0,1.0,1/5,2.34%,XG
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.5521980343210526,-0.8959763376786274,0.6595744680851063,1.0,1.0,3/8,5.05%,SPRED3;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.5456470465838588,-0.8958936729698589,0.6818181818181818,1.0,1.0,3/7,23.23%,RGS2;MLIP;P2RX4
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.5586955285387853,-0.8957330870313505,0.6349206349206349,1.0,1.0,3/7,12.72%,NOP14;NOP9;KRI1
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.437252494739939,-0.8955460056358536,0.627906976744186,1.0,1.0,1/24,1.73%,CLU
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.37696556953946475,-0.8953761799589908,0.6851851851851852,1.0,1.0,14/131,7.69%,TAGLN;NMB;COL6A2;COL6A1;HSD11B1;PXMP2;EPAS1;ADAM12;EPSTI1;AZGP1;BCAT2;FGF7;IL1R1;CFD
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5305161471499087,-0.8952132381877755,0.5882352941176471,1.0,1.0,1/15,2.70%,APOD
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5305161471499087,-0.8952132381877755,0.5882352941176471,1.0,1.0,1/15,2.70%,APOD
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.5287502986291456,0.8944757010770374,0.5384615384615384,1.0,1.0,1/8,5.25%,AK3
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.5897858198621112,0.8943535513159894,0.6938775510204082,1.0,1.0,2/6,10.50%,HMGB1;TMEM98
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.5645069503355682,0.8942675800593524,0.75,1.0,1.0,2/5,15.88%,CPT1C;CPT2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.5674644510757082,-0.8941938379769065,0.6346153846153846,1.0,1.0,3/6,27.71%,AKAP8L;SUPT6H;TPR
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.5674644510757082,-0.8941938379769065,0.6346153846153846,1.0,1.0,3/6,27.71%,AKAP8L;SUPT6H;TPR
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.5882797127507771,-0.8939020474330036,0.6595744680851063,1.0,1.0,1/5,17.58%,GK5
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),-0.5860451649442732,-0.8935761779051125,0.6521739130434783,1.0,1.0,2/5,18.94%,PDGFA;HTR2A
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.35474721030100037,0.8933994578021929,0.625,1.0,1.0,23/142,13.44%,MAP3K11;STK26;DAPK2;ERBB4;FGFR2;EGFR;TNIK;FGFR3;PRKD1;ERN1;EIF2AK3;FER;IGF1R;CSF1R;DYRK1A;CDK12;PDGFRB;ACVR1B;CAMK4;MEX3B;STK33;FGFR1;PIM3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.4735199889981081,0.893378612317484,0.6170212765957447,1.0,1.0,2/14,4.48%,ZFP36;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.3997350238677073,-0.8931007403737041,0.5777777777777777,1.0,1.0,25/66,20.53%,BACH1;EPAS1;PSMA7;PSMD7;UBC;RBX1;PSMB4;LIMD1;PSMC3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;ELOB;PSMA8;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3746754521281126,-0.8930387940279721,0.6166666666666667,1.0,1.0,38/126,20.53%,SFRP1;TNFSF18;PSMA7;TMSB4X;ADAMTS12;PSMD7;PSMB4;PSMC3;EIF5A;LTB;LTBR;EDAR;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;CD70;PSMD2;NFKBIA;BAG4;PSMA1;GBP2;PSMB8;PSME1;PSMD10;ASAH1;RPS3;CARD14;TNFSF9;PSMA8;YBX3;CD27;PSMD12;PSMB3;PSMB7;STAT1;PSMC6
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.4548637878395537,0.8929718755130728,0.7169811320754716,1.0,1.0,4/27,9.94%,GRM7;IL1RAPL1;SNCA;HMGCR
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.526012186454093,0.8928441688649953,0.65,1.0,1.0,2/11,9.42%,PARP8;TIPARP
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.4906953643505453,-0.8928271089209951,0.5849056603773585,1.0,1.0,4/14,19.82%,PPP1R15A;DDRGK1;SEC16A;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.44137428400508,0.8927344119809542,0.6,1.0,1.0,10/26,17.12%,ADGRV1;SLC8A1;ACVR2A;BMPR1A;GPM6B;ACVR1;MEF2C;P2RX7;PKDCC;BMP6
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.4536829810850092,-0.8926732420818353,0.5961538461538461,1.0,1.0,7/28,16.06%,NCL;RBM3;CELF3;CIRBP;SNW1;RBM22;RBMX
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),-0.5793671050799444,-0.89266559196169,0.6481481481481481,1.0,1.0,2/5,29.39%,SHH;ENG
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.6411250416186556,-0.8925943408879919,0.6538461538461539,1.0,1.0,1/5,8.01%,DRD3
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.4406790893754047,-0.8924735173935395,0.5737704918032787,1.0,1.0,14/33,31.28%,NGDN;NOP14;TSR2;RPS8;NAT10;RPS14;MRPS11;LSM6;WDR46;SNU13;DHX37;NOB1;RPS16;BMS1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.36888583845352435,-0.8924224114247387,0.7058823529411765,1.0,1.0,13/107,11.78%,TAGLN;COL6A2;COL6A1;HSD11B1;FBLN2;MXRA8;PDE5A;SPARC;MCAM;ADAM33;ADAMTS5;COX7A1;CRYAB
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.39426651829760284,-0.8920987183063086,0.5882352941176471,1.0,1.0,10/84,8.88%,STING1;APOBEC3H;NLRP1;CGAS;RNASE1;OAS3;NLRP9;IFIT1;OAS2;IFI27
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.40446042109418917,0.8919438849420571,0.6097560975609756,1.0,1.0,7/48,9.25%,HMGB1;AGER;WNT5A;SYK;HSPB1;TWIST1;TLR1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4543540874560966,0.8914975368592685,0.6415094339622641,1.0,1.0,4/26,9.14%,ERBB4;CCL5;NLK;ADIPOR1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3658937575961396,0.8914146446996363,0.5405405405405406,1.0,1.0,23/104,12.08%,CALCR;GNAT2;ADGRB3;CHRM2;TBXA2R;OPRK1;LGR5;GRM8;SCTR;RXFP2;ADGRL3;PTGFR;MC4R;PRKACB;FSHR;GNAQ;ADGRL2;WASF2;CNR2;GNAI1;PDE2A;GNA13;HTR1E
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.4335059433423082,-0.8913682815929876,0.5555555555555556,1.0,1.0,4/25,8.19%,WNT7B;FGF1;FGF7;RBP4
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.4079227617678402,-0.8911106861701831,0.6153846153846154,1.0,1.0,9/72,4.06%,P2RY10;NCKAP1L;SP140;CXCR5;PSG2;TRAF3IP3;CD74;CD37;DOCK8
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.4405250024607041,0.8910607506930847,0.6222222222222222,1.0,1.0,5/35,6.92%,FAT4;ROGDI;BTBD3;CDK6;RYK
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.4402496843970247,0.890744662576622,0.5714285714285714,1.0,1.0,12/50,15.88%,ADIPOR2;PPARGC1A;ACSM1;ADIPOR1;PEX2;CYP4V2;PEX13;ECHDC1;ALDH3A2;ACADVL;ABCD3;CPT2
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.5220754054810065,0.8900295730312449,0.6585365853658537,1.0,1.0,1/11,1.72%,PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.5220754054810065,0.8900295730312449,0.6585365853658537,1.0,1.0,1/11,1.72%,PLCB1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.40521785135031224,0.8896728649077932,0.6444444444444445,1.0,1.0,17/105,12.36%,NLRP2B;PLA2G10;ID3;SMAD7;PKHD1;ZNF675;HDAC2;TBX6;GLIS2;AIM2;TAF3;RNF2;BRMS1;BTRC;SIRT1;ERBIN;SETD6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.3720567898617116,0.8896565262034524,0.5625,1.0,1.0,10/57,10.63%,MARVELD3;PTPRK;FGFR2;ROBO1;SULF1;MAGED1;CDK6;ATOH8;PEX2;PTPRM
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6065529192922348,0.8896389992788163,0.6666666666666666,1.0,1.0,1/5,14.85%,PLEKHM1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),0.6209384901562748,0.8895045839276435,0.64,1.0,1.0,1/5,10.84%,SLC7A2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.5830966048752689,0.8894161916179384,0.6444444444444445,1.0,1.0,2/6,21.17%,MOCS3;GPHN
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.5404122472490847,0.8894060273534133,0.5869565217391305,1.0,1.0,2/8,5.71%,PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.45125452564034946,0.8891132464262965,0.625,1.0,1.0,7/33,13.89%,CCL5;ERN1;BMPR1A;CDH13;PDGFRB;EDN1;LDLRAP1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.48532083787185193,-0.8888738726293313,0.6326530612244898,1.0,1.0,5/17,24.10%,SRP54;SRP14;SRPRA;SPCS1;SEC61G
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4168113261304416,0.8888370308996474,0.6097560975609756,1.0,1.0,13/43,21.24%,IL1RAPL1;CASS4;NRP1;PTPRD;MDK;CAPRIN1;LIMS2;LIMS1;DOCK5;DMTN;TESK1;CUL7;ABL1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.48847875217281433,0.8886652430751717,0.5106382978723404,1.0,1.0,2/18,3.10%,NTF3;MAGI2
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.5904774560877846,-0.8885675045895132,0.6415094339622641,1.0,1.0,2/6,18.91%,SLC18A2;SLC29A4
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.5599334703880312,-0.8885483459945411,0.6346153846153846,1.0,1.0,2/5,19.69%,CARD9;IL18
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5599334703880312,-0.8885483459945411,0.6346153846153846,1.0,1.0,2/5,19.69%,CARD9;IL18
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.48405297579945605,-0.8884613302458435,0.7068965517241379,1.0,1.0,3/13,14.94%,REC8;DSCC1;MAU2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.38461993968458397,0.8883448499098964,0.6326530612244898,1.0,1.0,17/74,13.91%,NDNF;NTF3;EGLN3;PPARGC1A;TOX3;FOXO3;GRID2;SLC30A10;EPHA7;MDK;CTNNB1;LANCL1;LIG4;ADAM8;BCL2;MEF2C;CPEB4
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.516478589083299,-0.8880513269170117,0.6326530612244898,1.0,1.0,3/12,17.22%,ACOT4;ACSF3;GOT2
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.4217521812049091,0.8880317923551208,0.5909090909090909,1.0,1.0,1/49,0.50%,SNX31
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.30684994764328233,0.8880202080044834,0.926829268292683,1.0,1.0,262/1686,14.23%,DACH1;LOXL2;MED17;FZD1;TSHZ2;MYRFL;NRG1;IFI16;ESRRG;ZFPM2;CCNH;TPRX1;NAB1;ZNF300;RUNX1;ZBTB2;PKNOX1;ZNF600;PLCB1;NFIL3;TGIF1;ERBB4;TRIM22;BNC2;PPARG;PTPRK;ZNF792;ZBTB1;CREB5;ZBTB10;HNF4G;NR3C2;TSHZ1;ZSCAN20;PBX1;FANK1;ZNF697;BATF3;ID3;BBX;HMGB1;ZNF706;BAHD1;TFEB;IRF2BPL;MTERF3;EGFR;ZEB1;SMAD7;HEY1;PPARGC1A;WNT5A;TRPS1;TOX3;ARID1A;NR2E1;FOXD4L5;MAGED1;NLK;TGFBR1;ZEB2;TSHZ3;ARID1B;RUNX2;ZNF408;KLF2;TEAD2;ZBTB5;RFX3;MLLT3;FOXO3;TBL1Y;ELP4;FOXP2;RPS6KA4;ZNF202;NFIA;HIVEP2;MEIS1;HDAC9;ZBTB20;KCTD1;LCORL;PRRX1;LITAF;ATP2B4;SP3;PSRC1;ZNF114;NR3C1;IKZF2;PBX3;TP63;DENND4A;ZNF433;NCOA2;ZNF493;ZBTB9;SMAD5;RFPL2;TBL1XR1;SPIN1;ATXN1;HDAC3;MKX;NPAS3;ZNF613;JMJD1C;ZNF675;ZGLP1;TWIST1;TCF4;GLI3;SRCAP;DACH2;POU6F2;TOX;RORA;NR1D2;ZNF518A;ZNF205;SPINDOC;ZNF516;HDAC2;SUPT3H;SMARCD3;TBX6;ZNF283;ZNF782;TLE1;HINFP;ZBTB34;ZNF165;PHC2;HIF1A;TULP3;SLC39A8;UBP1;NR5A2;MSTN;CTBP2;GLIS2;ACTA2;SMAD1;BCOR;ZNF20;ATOH8;ZNF677;DMTF1;DVL2;SPTY2D1;MYPOP;SOX5;MITF;MXD4;SSBP2;RFXANK;ZNF211;ATF6;KLF12;ST18;SMAD2;ZFHX4;TP53INP1;DYRK1A;SMARCE1;WWC1;ZSCAN22;MEIS2;SMAD9;POU2F1;TFCP2L1;ZNF732;CHD7;ZBTB7B;SMURF2;NPAS1;BAZ2B;SNX5;ARID5B;NR1H3;HIC2;ING1;ZNF582;ZSCAN25;ACVR1B;RFXAP;ATF3;ZBTB40;MED13L;PRICKLE1;CSRNP2;GPBP1L1;ZNF630;BRMS1;MLF1;RYBP;CD38;BTRC;CAMK4;ZNF396;TENM1;CTNNB1;SIRT1;FOXO1;ZNF175;ZNF607;THAP11;ZNF536;EPC1;ZNF189;ACTL6A;DPF3;ZNF273;ZNF142;ZNF526;MEF2A;ZNF445;NEUROD2;NFIB;YAF2;PPM1A;FOXN3;CREB1;ZBTB26;ZNF212;E2F5;GABPA;ZBTB37;ZNF320;MYRF;SOX11;EP300;MNAT1;ACVR1;ZNF835;ETV6;RGS14;FOXO6;SCX;NFYC;NACC2;ZNF45;RUNX1T1;OLIG1;CSRNP3;MEF2C;CDK18;KLF7;ZNF341;SP4;CREM;MEIS3;SLC2A4RG;FLI1;ZNF19;CHMP1A;VEZF1;ZNF570;ZFP62;PICALM;ZBTB17
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5697381077936458,-0.8878835395444282,0.6545454545454545,1.0,1.0,2/5,11.52%,SPI1;TAF7
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.38260507164506047,0.8876791377542211,0.5106382978723404,1.0,1.0,21/101,15.03%,CADM2;LRRC4C;GALNT13;NR2E1;UNC5D;SLC35F1;LGR5;MEGF10;ADGRL3;LRP4;LHFPL4;NOL4;ANK2;ZNF536;CRABP1;ERC2;GRIA2;CSRNP3;CTNND2;PCLO;MAPK4
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.5515384217384657,-0.8871782007203695,0.6595744680851063,1.0,1.0,2/7,15.52%,PPP1R3E;PPP1R3D
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.497032576871463,-0.8871234407896854,0.6666666666666666,1.0,1.0,1/17,0.73%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.4712195768472269,0.8870914502947164,0.6875,1.0,1.0,7/19,21.76%,BCL2;FGFR1;HSPA1A;INHBA;EYA3;BCL2L1;EYA2
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.5715400739170735,0.8867813593311477,0.5641025641025641,1.0,1.0,3/5,34.76%,MVD;MVK;IDI2
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.552899162688099,0.8865935991708294,0.6097560975609756,1.0,1.0,4/8,27.85%,YOD1;VCPIP1;OTUD7B;USP30
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5233241276001729,-0.8865014328051699,0.6122448979591837,1.0,1.0,1/8,5.79%,RNF8
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.3729364367204944,0.8862856367993526,0.6274509803921569,1.0,1.0,1/47,0.18%,VAPB
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.37504589269016037,-0.8861068106144425,0.6590909090909091,1.0,1.0,29/76,20.53%,BACH1;EPAS1;PSMA7;PSMD7;UBC;RBX1;PSMB4;LIMD1;PSMC3;ATF4;PSMD8;PSMB5;INO80;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;ANKRD2;PSMB8;PSME1;PSMD10;ELOB;PSMA8;CHEK1;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.43820812570124656,0.8859549288718188,0.5853658536585366,1.0,1.0,5/35,5.03%,PPEF2;SPHK1;DDIT4;SMAD7;PARD3
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5071213086103777,0.8859087912351593,0.6181818181818182,1.0,1.0,6/15,29.03%,SOX11;PROX1;PKD2;ZNF358;PKD1;ALDH1A2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.5952138307352557,0.8859068192722893,0.68,1.0,1.0,2/5,22.05%,LPL;SREBF2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.46497342206991715,-0.8859025951167956,0.5689655172413793,1.0,1.0,2/22,8.64%,KIF1A;KIF5A
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.418815646265049,0.8856084719547115,0.5777777777777777,1.0,1.0,6/36,10.61%,NEDD4;ADGRB3;TNIK;CSMD3;COBL;RAP2A
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.37619707670380836,-0.8855881199704445,0.6363636363636364,1.0,1.0,10/105,8.53%,CNGA3;LOXL4;TMEM179;CELF3;SST;PCDHB4;PAX6;PRRG2;ID4;NKX2-2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.5394493423217248,-0.8852884175601464,0.6481481481481481,1.0,1.0,1/9,0.73%,GUCY2C
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.40980440860802064,0.8850871617743566,0.6122448979591837,1.0,1.0,13/36,17.20%,NR3C2;SPHK1;TRIP6;AGER;EGFR;LRRC19;SASH1;EP300;IFI35;RELA;NOD1;NFAT5;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.47745460056382466,0.885014551447061,0.5686274509803921,1.0,1.0,6/16,28.11%,PID1;PICALM;BCL2L1;LZTFL1;PPP2R5A;RHOQ
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.42293218837637286,-0.8845496324557981,0.6538461538461539,1.0,1.0,3/30,6.77%,WTIP;RBM4;LIMD1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.5533794272873882,-0.884537311615709,0.5636363636363636,1.0,1.0,6/8,28.15%,SUPT5H;CCNT1;RNF20;CTR9;NELFE;CDK9
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.44977865379850634,-0.8845285787825773,0.6111111111111112,1.0,1.0,4/26,12.16%,SLC9A8;LACC1;SLC9B1;ATP5F1B
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5432738585080249,0.8842935820506159,0.6785714285714286,1.0,1.0,3/10,14.78%,PPAT;IMPDH1;GMPS
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.4622345510394896,0.8842572634717837,0.5517241379310345,1.0,1.0,1/14,1.94%,KANK1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.4401572762557317,-0.8839903244551865,0.6363636363636364,1.0,1.0,6/19,22.95%,ATXN7L3;TAF10;USP22;USP21;USP51;ENY2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.3905271139313602,0.883785252007992,0.5238095238095238,1.0,1.0,12/49,10.38%,ERBB4;FGFR2;EGFR;SYK;EPHA3;FGFR3;ABL2;PTPN6;FER;CSF1R;DYRK1A;PDGFRB
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.5359726302834493,0.8835936660754876,0.631578947368421,1.0,1.0,1/8,3.94%,WNT5A
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.4159876928570393,0.8835800067262788,0.5714285714285714,1.0,1.0,5/31,14.32%,CCNH;CAVIN1;TAF1A;MNAT1;TAF1B
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.49171314600016774,-0.8832762661657102,0.660377358490566,1.0,1.0,3/16,8.78%,PACSIN3;ADRA2A;TIMP4
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.5365546558690011,-0.8832258055649379,0.6808510638297872,1.0,1.0,1/13,2.12%,FGF1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.4987132856633576,0.8831788298603492,0.5660377358490566,1.0,1.0,1/11,5.03%,PARD3
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.5775653448053705,-0.8831573076289794,0.68,1.0,1.0,2/5,17.79%,NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.398743640094637,0.8831002987723385,0.5681818181818182,1.0,1.0,23/87,14.97%,RUNX1;ITGAX;SEMA5A;SPHK1;WNT5A;VEGFC;HSPB1;GAB1;RHOB;PRKD1;TWIST1;HIF1A;SMAD1;PRKCA;VEGFD;DLL1;MDK;ITGB8;SIRT1;SASH1;F3;PRKCB;PDCL3
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.42407126803501527,0.8826600381945956,0.5416666666666666,1.0,1.0,3/24,4.94%,SLC26A7;SLC6A13;SLC19A2
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.42390521025858885,0.8825255001478518,0.52,1.0,1.0,5/39,9.47%,NEDD4;UBE2E2;PELI1;TRIM5;UBE2E3
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.48887170413059833,0.8819830065650038,0.5945945945945946,1.0,1.0,3/15,4.50%,NLGN1;NRXN1;TSHZ3
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.3795587841691347,-0.8817703033641328,0.6842105263157895,1.0,1.0,12/115,10.95%,PLK4;AURKA;PLK3;BACH1;FOXM1;HAUS8;DCTN1;SKP1;SSNA1;PRKACA;CETN2;ODF2
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.5565899126919576,0.8817271128759605,0.6382978723404256,1.0,1.0,1/5,3.83%,FGF12
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.6018639820288034,-0.8816339709982914,0.7027027027027027,1.0,1.0,1/5,2.65%,HEBP2
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.42601065185493625,-0.881523331729316,0.7288135593220338,1.0,1.0,12/37,25.63%,ABRAXAS1;TICRR;HUS1;ORC1;FZR1;CHEK1;CDC6;ZNF830;HMGA2;TAOK1;TAOK3;TAOK2
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.6084077424992071,-0.8814259538525453,0.6956521739130435,1.0,1.0,4/6,33.34%,RPUSD2;DKC1;TSR3;RPUSD3
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.5581245824481105,0.8813572287249546,0.7551020408163265,1.0,1.0,3/6,16.58%,ERC2;PCLO;ERC1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.5448957328663951,-0.881272037912,0.6363636363636364,1.0,1.0,2/8,10.31%,ATF4;DRD1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.5448957328663951,-0.881272037912,0.6363636363636364,1.0,1.0,2/8,10.31%,ATF4;DRD1
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.6267321957175199,0.8812692388612,0.7441860465116279,1.0,1.0,1/6,0.64%,STK26
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.5764594519499611,0.8811569054661871,0.7297297297297297,1.0,1.0,4/6,19.60%,SMAD1;SMAD2;SMAD3;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.43964077833285503,0.8809803959623125,0.5849056603773585,1.0,1.0,5/28,13.68%,ZBTB20;LDLR;NR1H3;CREB1;SORBS1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.4363341038337824,-0.8809803133886225,0.6111111111111112,1.0,1.0,13/43,19.80%,SPRED3;WARS1;ATG14;SPRED2;ASPSCR1;PIN1;KDM4D;STAT2;PUM3;SPRED1;ATG10;ROPN1L;HPF1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.5622876673120871,-0.8809488142410625,0.6481481481481481,1.0,1.0,1/7,9.83%,ATP1B1
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.5387637927891369,0.8809194428968353,0.62,1.0,1.0,2/5,18.16%,MSRA;MSRB3
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.5776604576337445,0.8808017752576225,0.7142857142857143,1.0,1.0,3/5,22.93%,SLC2A5;KHK;SLC26A6
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.4439695312960362,0.8802888358953154,0.5531914893617021,1.0,1.0,2/15,8.46%,INTS6;INTS11
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.48415387066705257,-0.8802382658581581,0.5333333333333333,1.0,1.0,3/16,8.19%,NOG;WNT9A;RBP4
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.5705747998070723,-0.8801076179602219,0.7045454545454546,1.0,1.0,1/10,6.50%,GAR1
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),0.5510570131914564,0.8801064014516716,0.625,1.0,1.0,1/7,6.97%,ARG1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.4630681940078465,-0.8799207631706939,0.6666666666666666,1.0,1.0,2/23,2.00%,STING1;CGAS
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.40423698887551035,0.8797569239152003,0.54,1.0,1.0,15/47,15.52%,RGMA;HJV;SMAD7;RUNX2;ACVR2A;SMAD5;BMPR1A;SMAD1;SMAD2;SMAD9;SMURF1;ACVR1;SCX;TGFBR3;SMAD3
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.41521677191520356,0.879737801405839,0.6530612244897959,1.0,1.0,6/29,10.47%,LEPR;NRP1;SLC30A8;SNCA;WWC1;DISP3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.46201173674963286,0.8797253530658263,0.6521739130434783,1.0,1.0,5/17,20.31%,P2RX7;AFDN;BAD;ADAM10;AHCTF1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5212610568567775,0.8797139865243969,0.574468085106383,1.0,1.0,6/9,17.12%,SNCA;HIF1A;TF;BCL2;SLC11A2;BMP6
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.5179618114119552,0.8795850106081602,0.6304347826086957,1.0,1.0,2/11,14.39%,ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.5179618114119552,0.8795850106081602,0.6304347826086957,1.0,1.0,2/11,14.39%,ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.4467318208342639,0.8795601223488819,0.5208333333333334,1.0,1.0,12/53,18.53%,PLA2G10;PIP4K2A;FDFT1;AGPAT5;PLPP1;PLA2G15;PLBD2;PLA2G4C;PLPPR5;LPL;LCAT;ABHD12
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.5299952515228954,-0.8795488365822907,0.631578947368421,1.0,1.0,5/11,25.74%,NOS2;ISCU;ORAI1;NOS3;NOS1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.5036997849443348,-0.8791861904301049,0.6181818181818182,1.0,1.0,8/12,33.35%,RNF8;NELFA;NELFE;LARP7;NELFCD;TCERG1;RECQL5;EAPP
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.4720754213960644,-0.8791431772937596,0.6170212765957447,1.0,1.0,2/12,13.37%,SERPINE1;SERPINF2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.37955204126060627,-0.8791373824266693,0.660377358490566,1.0,1.0,4/89,3.65%,SELP;SERPINE1;NFKBIB;NLRP3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.3751956425675357,0.8787315065924974,0.6521739130434783,1.0,1.0,5/73,8.86%,U2AF1;NXF1;ATXN1;RANBP3L;WASHC4
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.49271136202338917,0.8786424365187333,0.6818181818181818,1.0,1.0,5/12,22.22%,H6PD;RPE;PGD;RPEL1;PGM2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.556938788053804,-0.8783748284131578,0.6730769230769231,1.0,1.0,4/10,24.15%,LIPC;APOA1;ABCA5;PLTP
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.5809679384732519,-0.8783339302014478,0.6590909090909091,1.0,1.0,2/7,5.64%,HMGCL;BCAT2
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),0.6172107954766473,0.8780150831492906,0.7358490566037735,1.0,1.0,1/5,10.84%,SLC7A2
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.46704657621754325,0.8779771862803722,0.5952380952380952,1.0,1.0,7/20,16.02%,TP63;PPP1R13B;BCL2;TP53BP2;MAPK8;BAD;YWHAZ
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.46704657621754325,0.8779771862803722,0.5952380952380952,1.0,1.0,7/20,16.02%,TP63;PPP1R13B;BCL2;TP53BP2;MAPK8;BAD;YWHAZ
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4054744676930339,-0.8779084337873588,0.6607142857142857,1.0,1.0,14/64,15.60%,RTF1;GTF2F1;ADRM1;POLR2I;TCEA2;POLR2J;ELOF1;GTF2H2;SUPT5H;SUPT16H;CCNT1;POLR2G;ERCC2;POLR2C
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4335634477491995,-0.8777135987560147,0.7254901960784313,1.0,1.0,3/35,6.67%,NUPR1;RILP;ADRA2A
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.5702894579634108,0.8773260723398586,0.6730769230769231,1.0,1.0,1/5,7.88%,COL4A6
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.5087180237105655,0.8770929004276737,0.64,1.0,1.0,1/11,1.32%,PNP
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.47995362084995713,-0.8770632249028923,0.625,1.0,1.0,3/14,14.35%,RAD51AP1;WRAP53;PARP1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.4687007543988885,-0.8770191247023852,0.6078431372549019,1.0,1.0,4/25,9.82%,DND1;VIP;PKP1;CIRBP
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.42264028009525517,0.8768821634234898,0.7021276595744681,1.0,1.0,4/27,10.34%,PLCB1;LATS1;FGFR3;DLL1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.5594538153138997,-0.8766502730258023,0.660377358490566,1.0,1.0,1/5,25.55%,NPM1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.5343565405959955,0.8766246970440331,0.6382978723404256,1.0,1.0,2/5,13.63%,SIRT1;MEF2C
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.5282816123661701,0.8764567814120425,0.6346153846153846,1.0,1.0,1/8,4.82%,IDO1
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.5339800266125707,0.8763109756523915,0.6739130434782609,1.0,1.0,5/12,19.71%,ZFP36L2;GLI3;LIG4;RAG1;ZFP36L1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.47905864808191073,0.8758843820149923,0.6785714285714286,1.0,1.0,7/16,21.50%,ELOVL6;ACSL4;HACD2;TECR;ELOVL7;ACSBG1;ELOVL2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3863830144895114,-0.8758819240354452,0.625,1.0,1.0,13/79,16.06%,RBM4;RBM8A;NCL;RBM3;CELF3;RBM11;CIRBP;C1QBP;SNW1;SAP18;HNRNPL;SRSF7;RBMX
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.3243262901652514,0.8758391945731347,0.7073170731707317,1.0,1.0,51/347,14.85%,SGK2;SGK3;LTK;MAP3K11;STK26;DAPK2;FRK;NUAK2;SPHK1;NLK;TGFBR1;SYK;TNIK;RPS6KA4;LATS1;ACVR2A;DYRK3;PRKD1;CDK6;RYK;LIMK2;ERN1;PXK;EPHA7;PRKG1;EIF2AK3;BMPR1A;SGK1;PRKACB;FER;STK36;DYRK1A;PRKCA;CDK12;DYRK2;ACVR1B;NIM1K;CAMK4;MEX3B;PIK3CA;MAP3K1;CREB1;FGFR1;ACVR1;PIM3;CDK18;DGKB;MAPK8;PRKCB;PIM1;PLK1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3846394047187282,0.8750018484893671,0.5555555555555556,1.0,1.0,2/64,2.90%,VAPB;BET1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.538677228641144,-0.8748604657356636,0.625,1.0,1.0,1/10,0.63%,CCN3
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.4483358226717953,0.8747029617327609,0.6888888888888889,1.0,1.0,9/17,25.91%,SLC8A1;PDGFRB;VEGFA;ALPK2;SORBS2;FHOD3;CXADR;TCAP;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.43764877335221486,-0.8746817114741634,0.5217391304347826,1.0,1.0,4/29,8.49%,PLEKHH2;KANK3;SHANK3;MYADM
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.576502877766212,-0.8746537233871823,0.6271186440677966,1.0,1.0,2/6,19.69%,PRKCZ;IL18
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4485675914169728,-0.8743443074583629,0.65,1.0,1.0,6/27,14.60%,NGDN;NOP14;NOP9;KRI1;TSR2;RPS8
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.5383211822745498,-0.8741766196783359,0.5918367346938775,1.0,1.0,2/9,10.68%,RAB7B;HMGB2
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.363816824314376,0.8739643048145896,0.625,1.0,1.0,27/127,16.15%,NTF3;NLGN1;FGFR2;FLRT3;CNTN4;BTBD3;TNIK;GPM6A;PARD3;NYAP2;CNTNAP2;RYK;CTNNA2;SGK1;LRP4;DOCK10;CTNNB1;SLITRK5;MEF2A;ANK3;KLF7;CTNND2;ALCAM;MAP2;PARD6B;NTNG1;DCLK1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.33989094737449127,0.8739454327213257,0.6190476190476191,1.0,1.0,37/138,18.16%,LTK;IRS1;ZFP36;NRIP1;HMGB1;CX3CR1;EGFR;WNT5A;EPHA3;PDE4B;NR3C1;RORA;BRINP3;ABL2;NR1H3;GNAI1;CRHBP;ADNP2;CD274;CREB1;PID1;MEF2C;TFPI;MAPK8;WNT2;INSIG1;VIM;URI1;ADCY2;LPL;RELA;PDK4;NLRP7;ROCK2;ATP1A2;BRINP1;RUVBL2
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.3709590610975374,-0.8737512641997313,0.6666666666666666,1.0,1.0,5/92,4.11%,CNGA3;CBLN4;ENPP2;RASSF4;RNASE1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.4892983579127227,0.8736013593461052,0.5333333333333333,1.0,1.0,5/19,12.49%,HMGB1;AGER;SYK;DLL1;CD274
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.47545707106351326,0.8736009753627637,0.5853658536585366,1.0,1.0,5/12,17.41%,PXK;SIRT1;VCPKMT;PAM16;THADA
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.5348104761641416,0.8735760643557107,0.5957446808510638,1.0,1.0,1/8,2.73%,CEL
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.5348104761641416,0.8735760643557107,0.5957446808510638,1.0,1.0,1/8,2.73%,CEL
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.5348104761641416,0.8735760643557107,0.5957446808510638,1.0,1.0,1/8,2.73%,CEL
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.3626413497970639,0.8735112345356194,0.5319148936170213,1.0,1.0,18/103,9.51%,SGK3;NRG1;ERBB4;LDB2;CAVIN1;EGFR;FGF10;FRMD5;RHOB;CDK6;TWIST1;FGF17;FGF5;SPOCK3;ABL2;SGK1;DOCK10;CSF1R
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.5551097296262325,0.8733187205630167,0.7391304347826086,1.0,1.0,1/5,9.22%,MITF
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.44706586082088734,0.8732959038111406,0.6153846153846154,1.0,1.0,8/23,20.00%,SELPLG;FER;ST18;PID1;RELA;NFKB1;SMAD4;ST3GAL6
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.46456774642451837,0.8731898693510125,0.6190476190476191,1.0,1.0,2/24,3.57%,MSH4;TDG
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.5902332717471371,0.8731024487041883,0.723404255319149,1.0,1.0,1/5,6.39%,SLC15A2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.3833802422702231,-0.8729549507109607,0.7777777777777778,1.0,1.0,7/66,9.23%,PLEKHH2;CLU;KANK3;SHANK3;STMN1;MYADM;TPX2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.4946820482510794,-0.8727311908789955,0.64,1.0,1.0,1/13,3.79%,KIF20B
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3452080597785808,-0.8726907426889428,0.6461538461538462,1.0,1.0,30/282,8.80%,LOXL4;TCHH;COL6A2;MYO15A;COL6A1;TPPP3;PLK3;COL4A3;MARCKS;TNXB;RAC1;RND3;COL9A1;MYO7B;TPM1;ITGA6;B2M;TUBGCP5;TPM4;DCTN1;UBE2L6;UBC;COL18A1;TRPV4;STMN1;ACTC1;LOXL1;ERMN;RND2;TUBGCP2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.38624457780658095,0.8724853184206413,0.660377358490566,1.0,1.0,3/58,3.94%,ACE2;CASP12;WNT5A
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.551951281167871,-0.8724269347084623,0.6181818181818182,1.0,1.0,4/7,28.00%,POLL;POLQ;MCM3AP;PMS2
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5538717064343662,-0.8723841672523878,0.6122448979591837,1.0,1.0,2/7,4.88%,MAFF;MAFG
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4141617182246467,0.8723194171489899,0.6470588235294118,1.0,1.0,5/43,5.02%,EFNA5;KANK1;CASS4;AP1AR;NRP1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.366404440998894,-0.8721427721569283,0.7254901960784313,1.0,1.0,38/110,21.02%,XPC;PSMA7;PSMD7;UBC;RBX1;PSMB4;PSMC3;DAXX;ORC3;CETN2;MCM5;HMGB2;GTF2H2;CHAF1A;MCM2;DDB1;PSMD8;ORC1;PSMB5;PARP1;PSMC1;ERCC2;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10;SMARCA5;MACROH2A1;PSMA8;CDC6;PSMD12;PSMB3;PSMB7;PSMC6;RPA3
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.5723385193571082,0.8718971313572602,0.6530612244897959,1.0,1.0,2/5,12.04%,HPD;FAH
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3634626062014819,0.87187352470304,0.7083333333333334,1.0,1.0,16/97,10.96%,EFNA5;SEMA5A;DSCAM;CCL5;PKHD1;FRMD5;PPP3CA;EPHA7;ABL2;ZDHHC2;PRKCA;ITGAV;CDH13;DLL1;MDK;CXCL12
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.39002270835620456,0.8716462914811093,0.575,1.0,1.0,6/35,12.39%,IFI16;ECT2;RHOB;SIRT1;LIG4;RAD9B
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.41992684777003947,0.8714942862538674,0.6,1.0,1.0,7/29,15.18%,KCNE4;FGF12;ANK2;GJC1;KCNJ2;KCNA5;NEDD4L
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.5684586132832662,0.871358296702679,0.717391304347826,1.0,1.0,2/6,14.85%,GNAI1;PLK1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4208675721512284,0.8709339781440649,0.5957446808510638,1.0,1.0,12/40,26.31%,ROBO1;SLIT2;ROBO2;TIAM2;PLXNB2;NTRK2;PLXNB1;CHODL;SEMA4D;MAP3K13;RUFY3;MAP6
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.4155515309972729,-0.8708571914959607,0.5686274509803921,1.0,1.0,9/44,18.52%,SFRP1;ADAMTS12;IL1R1;RBMX;IRAK1;GBP2;SRC;USP10;TLE5
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.5053708174985098,-0.8707937668346498,0.6296296296296297,1.0,1.0,2/11,10.29%,WIPI1;WIPI2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),0.5917333025026619,0.87074344161493,0.7111111111111111,1.0,1.0,1/5,10.68%,MDK
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5181059190785219,-0.8706785150988585,0.6458333333333334,1.0,1.0,6/11,31.60%,EXOSC10;FBL;EXOSC4;LARP7;EXOSC6;DKC1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.49650911275240617,-0.870622650226202,0.6851851851851852,1.0,1.0,1/11,4.38%,DCAKD
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.49650911275240617,-0.870622650226202,0.6851851851851852,1.0,1.0,1/11,4.38%,DCAKD
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.49650911275240617,-0.870622650226202,0.6851851851851852,1.0,1.0,1/11,4.38%,DCAKD
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.5675215451233632,0.8703001928591875,0.6551724137931034,1.0,1.0,2/5,18.50%,TMEM39A;PHF23
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.4033280550194415,0.8702415014780082,0.5333333333333333,1.0,1.0,13/48,13.71%,SLIT2;MCTP1;SLC30A10;CDK6;TWIST1;DDAH1;KIF26A;NR1H3;SIRT1;LPCAT3;ACVR1;PIM3;KLF7
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.5393305932213186,-0.8702050237654781,0.6739130434782609,1.0,1.0,5/8,33.65%,RACK1;TNFRSF1A;SMPD3;PLA2G6;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.5393305932213186,-0.8702050237654781,0.6739130434782609,1.0,1.0,5/8,33.65%,RACK1;TNFRSF1A;SMPD3;PLA2G6;SPHK2
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5232429187465023,-0.8701196394667036,0.6222222222222222,1.0,1.0,1/9,3.10%,DGAT2L6
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.48670981719169737,0.8700223465054291,0.6666666666666666,1.0,1.0,2/15,4.00%,SMAD7;BAG2
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),0.5648802713482831,0.8698923703345598,0.6739130434782609,1.0,1.0,1/5,12.49%,CD274
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.5348370033535619,0.8698509299564546,0.6666666666666666,1.0,1.0,5/8,27.86%,CLASP1;CLASP2;FERMT2;PTEN;RREB1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.5176490507185054,-0.8695203330227682,0.673469387755102,1.0,1.0,1/10,1.42%,IL31RA
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4351352669099008,0.8689844304051902,0.6410256410256411,1.0,1.0,3/30,7.04%,MARVELD3;HDAC3;ZNF675
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4194227382653811,0.8689297278785811,0.6086956521739131,1.0,1.0,14/30,14.26%,FAT4;IL1RAPL1;NLGN1;NECTIN3;HMCN1;TENM2;GRID2;PTPRD;CRB2;CADM1;TENM3;TENM1;CBLN1;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.5288548052850343,0.86885489969402,0.6190476190476191,1.0,1.0,1/7,6.14%,CACNB2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.42002761501073926,-0.8688292109939738,0.6923076923076923,1.0,1.0,4/27,10.89%,NCKAP1L;HLA-DRA;CR1;IL4I1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.37844563622686517,0.8687355156369759,0.5740740740740741,1.0,1.0,33/114,22.21%,LRIG3;GPC6;EGFR;AIF1L;SNX7;ERRFI1;RORA;CDR2L;DDAH1;CLDN12;ADGRL2;SLC7A2;BCAR1;BOK;AMOTL2;PKDCC;MAGI1;FKBP5;SH3BP4;ZDHHC9;LGR4;GNG12;CPE;DHCR24;PC;ARHGEF17;GALNT18;ALDH4A1;BCAT1;PLS3;TSPAN9;PLXNB1;NR2F6
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.604428924577921,0.8686178009973823,0.7659574468085106,1.0,1.0,2/5,28.81%,HNRNPU;RCC2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.42432682147149137,0.868473858400164,0.64,1.0,1.0,7/25,18.97%,RAB34;BLZF1;ANK3;KIF13A;SPTBN1;GGA1;RAB10
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.46411978813547583,0.8683645015161029,0.6326530612244898,1.0,1.0,4/19,15.35%,MCU;MICU1;MAIP1;PDZD8
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.3383732349766802,0.868313861804428,0.6888888888888889,1.0,1.0,19/147,9.38%,ZDHHC11;FRK;TRIM22;PPARG;KLRD1;HMGB1;CX3CR1;AGER;COLEC11;SYK;IGLL1;SNCA;MFHAS1;TRIM8;ANKRD17;FER;TRIM5;YES1;C3
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.390917128693401,-0.8682306100102326,0.7142857142857143,1.0,1.0,12/90,8.51%,DYSF;MYL10;TPM1;TPM4;MYL7;CALD1;RYR1;MYL5;MYL12B;MYOM3;ACTC1;CALM1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.47667923241656324,0.8678710163699689,0.6818181818181818,1.0,1.0,5/21,17.02%,CRPPA;TMTC2;POMGNT2;TMTC3;DPM1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.43543721209651454,0.8678447024919612,0.574468085106383,1.0,1.0,7/26,19.37%,SLC1A2;SLC7A2;SLC38A2;PRAF2;SLC25A12;SLC1A3;SLC7A9
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.4994245221629806,0.8678266093385256,0.7142857142857143,1.0,1.0,4/8,22.05%,INSIG2;INSIG1;ERLIN1;SREBF2
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.4994245221629806,0.8678266093385256,0.7142857142857143,1.0,1.0,4/8,22.05%,INSIG2;INSIG1;ERLIN1;SREBF2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.48469735245119583,-0.8677836926666884,0.55,1.0,1.0,2/11,8.64%,CDK5;KIF5A
prerank,PanglaoDB_Augmented_2021__Microglia,-0.4037839429197469,-0.8674466072802131,0.7090909090909091,1.0,1.0,7/79,4.99%,STING1;SIGLEC1;HCK;AOAH;CD4;SLA;HLA-DRA
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3674289733730176,0.8672068356945027,0.575,1.0,1.0,19/89,11.81%,PIK3R5;NTF3;NEDD4;EGFR;ROR1;CCL5;PIP4K2A;IRS2;GAB1;TWIST1;PTPN13;HGF;PTPN6;FSHR;IGF1R;PDGFD;PDGFRB;SIRT1;PIK3CA
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5071039498893071,-0.8671689923918727,0.6428571428571429,1.0,1.0,3/10,7.58%,CD74;OAS3;FOXP1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.5243186961183228,-0.8671140889951549,0.7719298245614035,1.0,1.0,5/13,18.45%,CD9;METTL3;AZU1;NDUFS2;METRN
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.4097895984547171,0.8670994065977963,0.6666666666666666,1.0,1.0,7/31,12.12%,KLHL15;NUDT16L1;TWIST1;UBR5;RADX;HELB;SHLD1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5317961781173167,-0.8668009648034671,0.6666666666666666,1.0,1.0,2/8,4.99%,NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.475978762308954,-0.8667449268037624,0.660377358490566,1.0,1.0,2/17,17.33%,HENMT1;SNIP1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.540028638892113,0.8667372054116039,0.64,1.0,1.0,3/10,12.55%,PLA2G10;MFHAS1;GPR137B
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.5113182913175305,-0.8665861462904598,0.6136363636363636,1.0,1.0,1/8,0.61%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.455230656837924,0.8665641796041523,0.6296296296296297,1.0,1.0,5/21,14.47%,SPHK1;WNT5A;CDK6;LIG4;WNT2
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),0.5713118398340822,0.8662551175114834,0.7333333333333333,1.0,1.0,2/5,13.63%,DLL1;MEF2C
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.49802748197912705,0.8656433808447853,0.6595744680851063,1.0,1.0,3/10,14.85%,PRKCA;PRKCB;PLK1
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.44964196436034376,0.865537617829174,0.68,1.0,1.0,5/23,7.98%,IL1RAPL1;NEDD4;ABHD17B;WNT5A;CTNNA2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.4673767634589202,-0.8654690374846593,0.7,1.0,1.0,1/21,3.23%,RAC1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.41377757571830986,0.8653759127475835,0.7115384615384616,1.0,1.0,10/43,21.16%,HSPB1;ERN1;DNAJB2;HSPA1L;PACRG;HSPA1A;DNAJB4;DERL1;RHBDD1;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.4128868026317974,0.8651346733987976,0.6122448979591837,1.0,1.0,9/39,11.72%,NRG1;EPHA3;PRKD1;MCTP1;SNCA;PXK;ITGAV;NR1H3;NDFIP2
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.5405606864439444,0.8646489478518808,0.6607142857142857,1.0,1.0,2/5,11.75%,DGAT2;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.4764613076623888,-0.8646302052978404,0.7142857142857143,1.0,1.0,3/16,15.04%,SERPINE1;CERS2;RTN4R
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.5922581644144433,-0.8646050451797205,0.7291666666666666,1.0,1.0,2/5,16.66%,MIDN;GCKR
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4868895516029155,-0.8644542812272209,0.7017543859649122,1.0,1.0,5/16,25.11%,APOA1;ABCA5;ABCG5;ABCG4;NPC1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.5436354372863719,-0.8642001264359225,0.6666666666666666,1.0,1.0,1/8,5.17%,DCTN1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.41072296688448007,0.8641815431016916,0.6666666666666666,1.0,1.0,5/34,7.35%,ZFP36;TENT5C;ELAVL4;TENT5A;SYNCRIP
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4417897474088881,0.8640980824846424,0.6904761904761905,1.0,1.0,6/23,19.18%,KLHL15;UGGT1;FBXL17;RNF185;CUL3;DERL1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.5743783383824976,0.8640499434903709,0.6875,1.0,1.0,2/5,17.12%,VEGFA;BMP6
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.4837205658726192,0.8637975498314878,0.7,1.0,1.0,2/19,5.17%,PPARGC1A;RPS6KA4
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3958164079181803,0.863646133780331,0.6538461538461539,1.0,1.0,12/61,17.20%,NLRP2B;PKHD1;ZNF675;AIM2;BRMS1;SIRT1;ERBIN;SETD6;COMMD1;CMKLR1;OTULIN;NLRC3
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.3672229081061171,-0.8636232725176257,0.7358490566037735,1.0,1.0,18/88,21.45%,TMEM179;KIF1A;CELF3;ST8SIA2;STMN1;KIF5A;RND2;PCDH8;RGS8;TUBB2B;CACNG4;STMN2;CASKIN1;CCDC177;SCG2;GDAP1L1;MAGEL2;VGF
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.31247083006810705,0.8631558259193355,0.8,1.0,1.0,132/684,15.19%,MED17;IFI16;ZFPM2;ZNF300;RUNX1;RGMA;PPARG;HJV;FGFR2;HNF4G;LDB2;PBX1;NRIP1;HMGB1;TFEB;IRF2BPL;EGFR;SMAD7;HEY1;PPARGC1A;WNT5A;TOX3;ZNF827;ZEB2;RUNX2;KLF2;RFX3;WWOX;FOXO3;RPS6KA4;NFIA;MEIS1;LITAF;SP3;ACVR2A;PPP3CA;MRTFA;NR3C1;PRKD1;LMO7;TP63;NCOA2;SSBP4;SMAD5;TBL1XR1;HDAC3;ZGLP1;TWIST1;TCF4;GLI3;MAML2;RORA;NR1D2;HDAC2;MAML3;SMARCD3;HGF;EPCAM;IER5;HINFP;HIF1A;BMPR1A;UBP1;NR5A2;AUTS2;CTBP2;GLIS2;SMAD1;ATOH8;DVL2;MITF;SSBP2;RFXANK;ATF6;ST18;SMAD2;NCK1;ASXL3;MRTFB;JAG1;WWC1;CDK12;MEIS2;SMAD9;POU2F1;CDH13;DLL1;PLAC8;NR1H3;RFXAP;ATF3;CSRNP2;CTNNB1;SIRT1;FOXO1;ZNF175;WNT8A;EPC1;DPF3;MEF2A;EDN1;NFIB;CREB1;E2F5;GABPA;SOX11;PID1;EP300;ACVR1;PTOV1;SCX;NOTCH3;CSRNP3;MEF2C;RARB;KLF7;MEIS3;TET2;VEZF1;ZBTB17;PIK3R1;SALL1;WNT2;FOSL2;ASXL1;ACTR3;TRERF1;OGT;NFATC3;DR1;SLC9A1;SMARCD2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.3649374465821108,-0.8631457228046099,0.6666666666666666,1.0,1.0,14/109,13.59%,NCKAP1L;INHA;LDB1;ATG14;ITGA6;ANKLE2;GLMN;NUP133;PIN1;PRKRIP1;CD24;NUP43;KDM4D;BMP7
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5413677991011311,0.8623993932048006,0.7169811320754716,1.0,1.0,2/7,12.99%,PEX13;ALDH3A2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.3640344028405533,-0.8622659120315521,0.75,1.0,1.0,20/116,16.06%,DDX24;RNASET2;GTF2F1;RBM4;RNASE1;RBM3;RBMS2;POLR2I;RBPMS;POLR2J;LAGE3;METTL3;SUPV3L1;POLR2G;HNRNPL;DHX8;PABPC4;PRPF4;POLR2C;RBMX
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.47329089675873515,-0.8621135994551312,0.6346153846153846,1.0,1.0,4/14,13.59%,WNT7B;PAX8;CTSH;BMP7
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.4589123699298121,0.8618462059953018,0.5957446808510638,1.0,1.0,4/17,13.04%,HEY1;ZNF675;TWIST1;SOX11
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.426320417743319,0.8612537203041212,0.7321428571428571,1.0,1.0,6/27,11.76%,CX3CR1;HEY1;HDAC9;DLL1;CTNNB1;FOXO1
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.33319629451283583,0.8612283725640231,0.7692307692307693,1.0,1.0,40/166,20.65%,DCUN1D1;TYR;MARCHF8;FOXO3;TENT5C;CAT;NR3C1;SLC30A10;SNCA;KEL;MFHAS1;FBXO7;ADIPOR1;C3;BTRC;BTG2;RBM5;VEZF1;PICALM;GMPS;FECH;SLC25A38;PIGQ;KAT2B;ENDOD1;ABCG2;CDR2;LAMP2;ACKR1;SLC11A2;SLC2A1;BSG;ERMAP;CA2;DMTN;ARHGEF12;PC;BNIP3L;RNF19A;FBXO34
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4040563823484361,-0.8610200437955919,0.6111111111111112,1.0,1.0,7/55,10.05%,CCN3;TERF2IP;NLRP3;TMSB4X;SPI1;TCIM;PTP4A3
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.48940268573811196,0.8608699402766018,0.725,1.0,1.0,2/10,4.35%,FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.5453444843657731,0.8606533567309572,0.64,1.0,1.0,3/5,32.23%,PROX1;BMPR2;ACVR2B
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.40552842831313696,0.860649278339842,0.7142857142857143,1.0,1.0,5/25,15.95%,WNT5A;CCL5;ADAM8;IFI35;AKIRIN2
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.39863272911390396,0.8604660038438334,0.6829268292682927,1.0,1.0,11/49,20.29%,MAN2A1;ST8SIA6;ADAMTS9;HIF1A;ST8SIA4;ADAMTS13;FUT8;HPSE;ST8SIA3;ST8SIA1;ST3GAL4
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.47424277361733347,-0.8601639804408241,0.775,1.0,1.0,5/17,16.99%,RNF8;SKP1;DTX3L;DDB1;RING1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.5271173963510322,0.8601077444941329,0.6862745098039216,1.0,1.0,2/8,8.58%,SYK;FER
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.4821226946733333,-0.8599470099167182,0.6206896551724138,1.0,1.0,2/16,14.35%,SLX4;PARP1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5010120145867846,0.8593361484299175,0.6730769230769231,1.0,1.0,2/8,13.35%,RAD18;SMC5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5202302574941983,-0.859268651587848,0.6346153846153846,1.0,1.0,5/11,31.60%,CCT2;CCT6A;LARP7;CCT8;DKC1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5202302574941983,-0.859268651587848,0.6346153846153846,1.0,1.0,5/11,31.60%,CCT2;CCT6A;LARP7;CCT8;DKC1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.5459558422880684,-0.8590964141269605,0.7,1.0,1.0,1/9,6.25%,MBTPS2
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.36552735667728165,-0.8587325899279171,0.6491228070175439,1.0,1.0,5/95,4.72%,CNGA3;SLC25A10;SLC1A7;SLC9A8;ANO1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.46062823346510173,-0.8585451063300945,0.6379310344827587,1.0,1.0,2/13,3.79%,STX16;GOLGA2
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5922227391191293,-0.8585386975455869,0.6666666666666666,1.0,1.0,1/5,12.69%,DNM1L
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.4865191333112402,-0.8584106573335127,0.68,1.0,1.0,3/15,13.10%,JADE2;KANSL1;MEAF6
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.4865191333112402,-0.8584106573335127,0.68,1.0,1.0,3/15,13.10%,JADE2;KANSL1;MEAF6
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.5433556368305666,-0.8583577038026906,0.6666666666666666,1.0,1.0,3/7,10.31%,RAB3B;DRD3;DRD1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4731130124598511,0.8583124949801028,0.6341463414634146,1.0,1.0,4/11,11.33%,MUC20;NRP1;HGF;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.4298505189792906,0.858243989450143,0.6296296296296297,1.0,1.0,7/21,14.65%,AUTS2;MSTN;PLCE1;WASF2;PIK3CA;PIK3R1;ACTR3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3856809382975968,-0.8581225978701967,0.6507936507936508,1.0,1.0,4/59,11.76%,RAC1;RAB17;ABITRAM;TBC1D24
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.5471389077674913,-0.8581148996375444,0.6666666666666666,1.0,1.0,2/8,5.05%,SPRED3;SPRED2
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.43793995839566746,0.8579928873679882,0.6938775510204082,1.0,1.0,9/22,17.66%,KCNE4;ATP2B4;SLC4A4;SLC40A1;ATP12A;KCNA5;SLC9A1;KCNT2;ATP1A2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.38661992270775847,0.8579412748046605,0.675,1.0,1.0,7/77,4.35%,LOXL2;CD151;COL22A1;TLL1;P3H2;COL8A1;TGFBR1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.4795444630863236,0.8578965345851065,0.6190476190476191,1.0,1.0,4/17,18.73%,SHROOM2;TENM3;VEGFA;C12ORF57
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.37049758894851376,0.8571614742308811,0.575,1.0,1.0,34/170,15.52%,SGK2;SGK3;ENPP1;SPHK1;NRG3;EGFR;CHPT1;TGFBR1;SLIT2;H3-3A;MINAR1;PSRC1;CDKN2AIP;SGK1;SOCS2;SERTAD2;PLCE1;KIF26A;DNAJB2;IP6K2;ING1;ACVR1B;BCAR1;SIRT1;ADNP2;AKAP6;OSGIN2;BCL2;TMEM97;HSPA1A;NAIF1;URI1;DACT3;SMAD3
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.39581245188653935,0.8569978246559725,0.6,1.0,1.0,5/41,3.20%,GPC5;GPC6;ALDH1A1;BCO1;AKR1C1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.48862348615943646,-0.8569359399597647,0.625,1.0,1.0,2/13,4.30%,RAC1;TPM1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.4826381579552861,0.8567800695951266,0.6818181818181818,1.0,1.0,5/17,17.02%,CRPPA;TMTC2;POMGNT2;TMTC3;DPM1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.35530018858960477,0.8563213225896777,0.6785714285714286,1.0,1.0,14/92,13.75%,ACE2;CASP12;GUCY2F;WNT5A;CAMKMT;NR1D2;PTGES;TRIM5;LRRC19;PTGS2;SETD6;PDE6A;CNGB1;METAP1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.45259552948860204,0.8559261277139764,0.7446808510638298,1.0,1.0,5/22,13.46%,EGFR;HEY1;DLL1;TSPAN15;NOTCH3
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.5379330503350043,0.8555434482510292,0.627906976744186,1.0,1.0,2/7,9.88%,MEGF10;MRTFB
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.36080074964167036,0.8552529146036978,0.6818181818181818,1.0,1.0,19/125,10.83%,FAS;CD8A;STAB1;KLRD1;EGFR;CSF1;CCL5;HDAC9;ACVR2A;DYRK3;PTPN6;HIF1A;TPD52;IL4R;TLR1;NCK1;IL16;TIMP1;HLA-DMB
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4710465617107287,0.8546982357178733,0.5862068965517241,1.0,1.0,5/14,24.66%,SYVN1;HSPA1A;CREB3;BCL2L1;LRRK2
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.5537266716588076,-0.8546250452104673,0.6829268292682927,1.0,1.0,1/6,2.65%,HEBP2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.4636906262952243,0.8545967425683092,0.6739130434782609,1.0,1.0,7/23,19.48%,ITGAM;TCAF2;ANK3;MTCL1;AKT2;MIEF2;FYN
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.4219270741618443,-0.8544037105059397,0.6666666666666666,1.0,1.0,5/57,4.74%,SFRP1;LDB1;PLET1;EPHA1;BST1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.49809191883172177,0.8543050994953512,0.6458333333333334,1.0,1.0,2/8,5.17%,CCNA2;RPS6KA4
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.4695893208358765,0.8543027379167977,0.6739130434782609,1.0,1.0,6/15,22.56%,NEDD4;TCAF2;NEDD4L;HECW2;CAMK2D;CAB39
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.47316226133066125,0.854227880123583,0.6521739130434783,1.0,1.0,2/8,23.11%,BARD1;RNF6
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.47548168020478543,-0.8541416943677432,0.6470588235294118,1.0,1.0,2/14,10.44%,RPF2;DDX18
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5103950576307382,0.8539344307104664,0.6346153846153846,1.0,1.0,7/11,34.34%,TMEM39A;PHF23;CLN3;TBC1D25;UVRAG;RUBCN;CALCOCO2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.2899991372103572,0.8538044813707778,1.0,1.0,1.0,284/1645,15.68%,DACH1;LOXL2;MED17;TSHZ2;IFI16;ESRRG;ZFPM2;CCNH;TPRX1;ZNF300;RUNX1;FRK;ZBTB2;PKNOX1;ZNF600;NFIL3;TGIF1;ZFP36;RGMA;PPARG;HJV;ZNF792;FGFR2;ZBTB1;CREB5;ZBTB10;HNF4G;NR3C2;LDB2;TSHZ1;ZSCAN20;PBX1;ZNF697;BATF3;ID3;BBX;NRIP1;HMGB1;TFEB;IRF2BPL;EGFR;ZEB1;SMAD7;HEY1;PPARGC1A;WNT5A;TRPS1;TOX3;ARID1A;NR2E1;FOXD4L5;ZNF827;ZEB2;TSHZ3;ARID1B;RUNX2;ZNF408;KLF2;TEAD2;ZBTB5;RFX3;WWOX;FOXO3;TBL1Y;ELP4;TENM2;FOXP2;RPS6KA4;ZNF202;NFIA;HIVEP2;MEIS1;HDAC9;ZBTB20;KCTD1;LCORL;PRRX1;LITAF;ATP2B4;SP3;ACVR2A;PPP3CA;MRTFA;NR3C1;PRKD1;IKZF2;LMO7;PBX3;TP63;MIER2;ZNF433;NCOA2;ZNF493;ZBTB9;SSBP4;SMAD5;TBL1XR1;SNCA;ATXN1;HDAC3;MKX;NPAS3;ZNF613;JMJD1C;ZNF675;ZGLP1;TWIST1;TCF4;GLI3;SRCAP;MAML2;DACH2;POU6F2;TOX;RORA;NR1D2;ZNF518A;ZNF205;HDAC2;SUPT3H;JAZF1;MAML3;SMARCD3;PHF21A;HGF;TBX6;FST;ZNF283;EPCAM;ZNF782;IER5;HINFP;ZBTB34;ZNF165;HIF1A;BMPR1A;UBP1;NR5A2;AUTS2;CTBP2;GLIS2;SMAD1;BCOR;ZNF20;ATOH8;ZNF677;DMTF1;DVL2;MYPOP;SOX5;TAF3;MITF;MXD4;SSBP2;RFXANK;ZNF211;ATF6;KLF12;ST18;SMAD2;CSF1R;ZFHX4;NCK1;PEX2;RNF2;SMARCE1;ASXL3;MRTFB;JAG1;WWC1;ZSCAN22;CDK12;MEIS2;SMAD9;NCOA5;POU2F1;TFCP2L1;CDH13;DLL1;ZBTB7B;SMURF2;NPAS1;PLAC8;BAZ2B;ARID5B;NR1H3;HIC2;PDE2A;ZNF582;ZSCAN25;RFXAP;ATF3;ZBTB40;MED13L;CSRNP2;ZNF630;BRMS1;ZNF396;CTNNB1;SIRT1;FOXO1;ZNF175;ZNF607;THAP11;WNT8A;ZNF536;EPC1;ZNF189;ACTL6A;DPF3;ZNF142;ZNF526;MEF2A;ZNF445;NEUROD2;EDN1;NFIB;PPM1A;CREB1;ZBTB26;ZNF212;E2F5;GABPA;ZBTB37;ZNF320;SOX11;PID1;EP300;MNAT1;ACVR1;ZNF835;ETV6;FOXO6;PTOV1;SCX;NFYC;NACC2;ZNF45;OLIG1;CSRNP3;MEF2C;RARB;KLF7;SP4;CREM;MEIS3;SLC2A4RG;FLI1;TET2;ZNF19;UBE2D3;VEZF1;ZNF570;ZFP62;ZBTB17;PIK3R1;SALL1;WNT2;PRKCB;FOSL2;ASXL1;ACTR3;TRERF1;HIVEP3;ZXDC;OGT;PLK1;NFATC2;NFATC3;DR1;ZFP92;SLC9A1;NEDD4L;SMARCD2;URI1;ZNF850;KAT2B;SMAD3;CRY1;HDGFL3;ZNF616;ZXDA;ZNF30;ELF1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.3588536852306016,0.8536107124190752,0.660377358490566,1.0,1.0,8/43,11.75%,TBL1Y;HDAC9;MIER2;TBL1XR1;HDAC3;HDAC2;BRMS1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.5506585185705065,-0.8535582055639089,0.6964285714285714,1.0,1.0,1/6,3.61%,PRKCH
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.36500364417020603,-0.8535474202858172,0.6206896551724138,1.0,1.0,15/125,11.78%,TAGLN;GFRA3;FGF1;APOD;NTRK1;MPZ;NRN1;PCDHB4;STMN1;ID4;SCN4B;TCEAL6;NDRG4;PRX;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.34451537444162816,-0.853423797463883,0.75,1.0,1.0,13/190,6.25%,STING1;TERF2IP;TNFSF18;CLU;NTRK1;NFKBIB;PRKCH;NLRP3;NODAL;BEX1;RHEBL1;UBC;MBTPS2
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.5386807113635106,-0.8533482927766928,0.6170212765957447,1.0,1.0,1/5,12.20%,EDEM2
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.5386807113635106,-0.8533482927766928,0.6170212765957447,1.0,1.0,1/5,12.20%,EDEM2
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.5386807113635106,-0.8533482927766928,0.6170212765957447,1.0,1.0,1/5,12.20%,EDEM2
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.5178144449478018,-0.8532510632299701,0.7111111111111111,1.0,1.0,2/12,7.24%,SRP54;SPI1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3454640752420319,-0.8531949275424091,0.7037037037037037,1.0,1.0,18/219,9.81%,TLCD2;NCKAP1L;LCP1;RAC1;CD74;MYO7B;SPG7;SYCE2;REC8;CALD1;FANCC;VIL1;PARVB;CHCHD10;TUBGCP2;CFAP46;PKP1;PARVG
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.5289444869692589,-0.8531076730719618,0.673469387755102,1.0,1.0,1/6,5.17%,DCTN1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.5333543714751781,-0.8530480277970299,0.6595744680851063,1.0,1.0,1/6,5.17%,DCTN1
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.5884799189667569,0.8529491855680668,0.7222222222222222,1.0,1.0,1/5,8.62%,ABCC2
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.3922353374523196,-0.852728631986942,0.6842105263157895,1.0,1.0,14/50,28.81%,ADAMTS12;CTSO;CTSH;SPATA18;CLTA;CTSL;RAB12;CTSB;DAB2IP;AP2A1;AP2S1;CTSZ;BNIP3;DENND3
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.45692025520533613,0.8524469697380708,0.7209302325581395,1.0,1.0,1/18,0.45%,FAS
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.5248139351925073,-0.8522582662598497,0.6304347826086957,1.0,1.0,1/7,3.77%,PATL2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.4753999998163877,-0.8521765103109076,0.5869565217391305,1.0,1.0,5/10,16.76%,ATF4;NONO;PINK1;RACK1;NR4A3
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4856096448970399,0.8520417296228819,0.6153846153846154,1.0,1.0,1/13,5.21%,YAE1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.4680139103536505,0.8514116659064376,0.525,1.0,1.0,4/20,9.91%,GLRA2;SLC30A8;MT1M;ZACN
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.49823160480967976,-0.8512791600528405,0.6792452830188679,1.0,1.0,6/14,22.75%,HCK;LBP;IRAK1;IL18;PTPN22;TGFB1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.5614288677864349,-0.8512742780041859,0.6862745098039216,1.0,1.0,2/8,17.36%,HSD17B10;TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.4535837514144895,0.8512021497963965,0.6888888888888889,1.0,1.0,6/14,20.84%,PRKCA;MEF2A;EDN1;SLC9A1;ROCK2;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.5323018699465991,0.8510210802799015,0.6382978723404256,1.0,1.0,2/7,8.95%,SLC8A1;P2RY1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.4424132833810098,0.8508354989132122,0.5869565217391305,1.0,1.0,3/13,16.79%,CPEB4;CPEB2;CPEB3
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.38783321849333047,0.8508236288691111,0.65,1.0,1.0,10/46,11.89%,GPC5;GPC6;HS3ST5;HS2ST1;HPSE2;HS3ST3B1;UGDH;GLB1;HS3ST1;EXT1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.35315885606986586,0.8506025209325233,0.75,1.0,1.0,15/88,13.04%,PIK3R5;EGFR;WNT5A;ROBO1;ATP2B4;PSRC1;SNCA;CSF1R;PDGFD;PDGFRB;TENM1;SIRT1;EDN1;ADAM8;FGFR1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.49397922118359905,0.8505439444289239,0.6458333333333334,1.0,1.0,2/11,9.92%,MAGI2;JAG1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.49281313257359655,0.8504885479212684,0.6851851851851852,1.0,1.0,3/14,6.19%,SEMA5A;HSPB1;PRKD1
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.5176616076153003,-0.8504713469773785,0.6511627906976745,1.0,1.0,1/5,7.92%,ACTC1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3805949905694195,-0.8504323822856774,0.7358490566037735,1.0,1.0,3/55,4.18%,NCKAP1L;RAC1;VAV3
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.506974134165612,0.8503753573243856,0.6136363636363636,1.0,1.0,2/8,17.02%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3705200826706044,0.850149282142419,0.6590909090909091,1.0,1.0,14/114,8.19%,GPC5;SEMA5A;KANK1;FGFR2;SCEL;EGFR;ZEB2;FGF10;RNF220;LGR5;PSMD13;TBL1XR1;UBR5;TMEM198
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.5113754475820507,-0.8500038612911978,0.68,1.0,1.0,3/9,7.58%,CD74;CD4;FOXP1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.40210336952012204,0.84981166778251,0.6666666666666666,1.0,1.0,9/46,17.28%,RUNX1;H3-3A;CNOT4;RBBP5;EP300;MEF2C;KAT2B;THPO;CBFB
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.4526411600155673,-0.8498000241985718,0.6938775510204082,1.0,1.0,4/20,14.79%,HK2;G6PC3;DERA;PGLS
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.4371767963254019,0.8495824494374414,0.7115384615384616,1.0,1.0,5/29,8.80%,DOC2B;IRS2;SLC30A8;MCU;ACSL4
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.3386833619183667,-0.8493096254815875,0.7547169811320755,1.0,1.0,41/153,20.53%,SFRP1;TRABD2A;NOG;PSMA7;HMGXB4;LATS2;PSMD7;RBX1;PSMB4;LIMD1;PSMC3;RNF213;NOTUM;TLE2;IGFBP4;STK11;HIC1;EMD;PSMD8;SFRP4;RACK1;PSMB5;PSMC1;PSMB2;PSMC4;GREM1;FUZ;PSMD2;PSMA1;CBY1;PSMB8;PSME1;PSMD10;TMEM88;TLE5;PSMA8;WIF1;PSMD12;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.5057719880649565,-0.8489425054306001,0.6612903225806451,1.0,1.0,5/9,19.90%,TICRR;HUS1;ORC1;CDC6;ZNF830
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.34515039737622216,-0.8488839591781439,0.7049180327868853,1.0,1.0,23/143,16.81%,SFRP1;ARHGAP15;NTRK1;DOCK8;VAV3;EPHA1;ITGA6;FGD3;AGRN;RGS16;GMIP;BCAR3;PIN1;RAP1GAP;GNB5;RACK1;ARHGAP12;RTN4R;ASAP3;RGS8;STMN3;PLXNA1;ZC3H15
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.4584127171442567,0.8488451059189978,0.7,1.0,1.0,3/14,9.44%,ELAPOR2;ROBO2;PCM1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.3554913386587051,0.8485913033288117,0.6744186046511628,1.0,1.0,20/136,10.00%,FAS;RIT2;PPEF2;FGFR2;HMGB1;EGFR;ROR1;SYK;PKHD1;FGF10;PELI2;TNIK;FGFR3;RYK;EPHA7;PTPN6;TRIM5;IGF1R;WWC1;PHLPP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.3790832568139428,0.8485779654194086,0.6904761904761905,1.0,1.0,9/37,19.21%,KCNJ3;KCNJ16;KCNJ6;ANK2;AKAP6;KCNJ2;KCNN1;GNG2;KCNN4
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.45085107666804436,-0.8485567422904753,0.631578947368421,1.0,1.0,2/21,4.18%,RAC1;VAV3
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.4709647943358459,-0.8485054175044955,0.6078431372549019,1.0,1.0,1/17,2.04%,PLK3
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.5642145306853067,-0.8483157993706203,0.6875,1.0,1.0,2/6,24.49%,ULK2;EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5074879172897726,0.848188368592078,0.6862745098039216,1.0,1.0,2/11,19.39%,CD160;PDCD4
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.47062413369841005,0.8481825571043241,0.6792452830188679,1.0,1.0,9/15,34.10%,GPR137B;SIK3;GPR137;GPR137C;RRAGD;PIH1D1;KLHL22;PIP4P1;RRAGB
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.48662457927733854,-0.84803415997729,0.6808510638297872,1.0,1.0,4/12,19.30%,HEBP2;PINK1;ACOX2;MACROH2A1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.44809387611651513,0.8476391567987164,0.660377358490566,1.0,1.0,7/26,18.03%,SLC22A2;SLC1A2;SLC7A2;PRAF2;SLC25A12;SLC25A38;SLC1A3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3275768574623155,-0.8474362247798742,0.7894736842105263,1.0,1.0,23/227,8.55%,STING1;HLA-DPB1;TXK;DDX41;CGAS;SERPINE1;CD74;NLRP3;NODAL;CD4;DHX58;ADRA2A;FOXP1;LACC1;IL1R1;NLRP9;LTB;ZP3;BTN3A1;ATF4;POLR3A;RAB7B;GLMN
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.4180920335657344,-0.8474315964516993,0.6029411764705882,1.0,1.0,6/25,20.60%,RBM4;PDE6B;PER2;RBM4B;PPP1CA;FBXL12
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5253696441330568,0.8472803366489068,0.6792452830188679,1.0,1.0,1/10,1.12%,NDNF
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.460887319468178,0.8469686016781685,0.7333333333333333,1.0,1.0,2/18,6.34%,IL1RAPL1;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.47627543482708007,0.8468510135274275,0.66,1.0,1.0,3/8,22.99%,WASF2;WASF1;ABI2
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.3739612284408499,-0.8467302699453034,0.7213114754098361,1.0,1.0,6/65,7.92%,CSRP2;OBSCN;TPM1;MYH14;SYNPO2L;ACTC1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.3465535762855267,0.8464446982806422,0.7083333333333334,1.0,1.0,22/109,19.43%,HS6ST3;OLFM3;NRXN1;NXPH1;HMGCLL1;LHFPL4;NOL4;KCNJ6;KCNB2;TENM1;ERC2;GRIA2;CSRNP3;CTNND2;MAPK4;SMAD3;ATRNL1;DPYSL5;ST8SIA3;TMEM59L;PAK5;ADGRA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.3757056170331123,0.8463304936939141,0.7272727272727273,1.0,1.0,9/57,16.48%,ECT2;HDAC3;LIMK2;UBR5;EIF2AK3;PIK3R1;PLK1;SMAD3;WWTR1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.45300535608486225,-0.8460911245855272,0.717391304347826,1.0,1.0,1/14,1.73%,CLU
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.5387040824729802,-0.8460299707005078,0.6808510638297872,1.0,1.0,1/6,21.19%,VPS11
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.5342635908648302,0.8459753679829213,0.7333333333333333,1.0,1.0,2/6,17.74%,TIMP1;OPN5
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3493404214315143,0.8458767756404801,0.66,1.0,1.0,33/212,11.83%,GPC5;SEMA5A;KANK1;FGFR2;SCEL;EGFR;WNT5A;ZEB2;FGF10;MLLT3;RNF220;LGR5;PSMD13;LATS1;AMER2;TBL1XR1;GLI3;UBR5;TLE1;TMEM198;TLE3;LRP4;DVL2;ZNRF3;GNAQ;BICC1;SMURF2;MDK;PRICKLE1;TMEM170B;BTRC;CTNNB1;LGR6
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.3531385817922803,0.8457961132057368,0.7291666666666666,1.0,1.0,15/76,12.07%,LDB2;MXRA5;GFAP;SULF1;POSTN;PRRX1;FBXL7;PRKG1;ACTA2;ADAMTSL1;PDGFRB;COL5A2;CXCL12;FLNC;TIMP3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.48962485321042065,0.845787784693976,0.6938775510204082,1.0,1.0,5/12,15.86%,SULT2B1;RFX3;ATOH8;VEZF1;BAD
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.40530141512370255,-0.8457705770780415,0.6730769230769231,1.0,1.0,7/28,20.45%,APOD;NOS2;LEP;CARD9;GBP5;STAT3;ADCY7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.3523449337088646,-0.8457250003018915,0.8125,1.0,1.0,11/243,5.80%,TEKT3;PLK4;TEKT5;RAC1;RAB17;CFAP221;UBXN10;FGD3;RILP;TXNDC15;AHI1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.4779183792073466,-0.8455680350809202,0.6938775510204082,1.0,1.0,2/16,10.16%,RBP1;RBP2
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5363485909880294,-0.8455678915767864,0.7090909090909091,1.0,1.0,2/13,0.74%,INHA;SFRP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.5016684466596086,0.845240298787981,0.675,1.0,1.0,2/8,13.63%,FRS2;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.46373433008173137,-0.8449821417294952,0.671875,1.0,1.0,2/18,2.00%,STING1;CGAS
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.4457145065644527,-0.8448517689611225,0.6451612903225806,1.0,1.0,8/20,22.75%,WNT7B;GLMN;CCM2;SPRED1;SHH;KDR;EGFL7;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4343960077406568,-0.8448426130284061,0.6,1.0,1.0,9/24,19.19%,RAC1;DCTN1;TRPV4;ANKRD53;DRG1;MET;STMN2;RPS3;KATNB1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.4843623141654706,-0.8447818697030458,0.6545454545454545,1.0,1.0,2/11,8.85%,BCKDK;PGP
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.48887649442781966,0.8447803796287982,0.5961538461538461,1.0,1.0,2/14,9.92%,CD8A;JAG1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.49046430350160636,0.8447737364518095,0.7037037037037037,1.0,1.0,5/13,32.15%,TUT7;PRKRA;LIN28B;AGO3;DICER1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.4005551754259826,0.8447300136835219,0.6744186046511628,1.0,1.0,15/61,14.33%,TYR;GNAT2;GUCY2F;ADGRV1;ABLIM1;GRM8;RDH10;POU6F2;ATF6;CRYZ;GRM6;MYO7A;RP2;CNGB1;EYS
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.42076438772183344,0.8446117495157814,0.6226415094339622,1.0,1.0,18/64,16.48%,ZFPM2;ZFP36;PPARG;ENPP1;WNT5A;ZFP36L2;RORA;LMO3;SIRT1;FOXO1;CREB1;FTO;RUNX1T1;ASXL1;SMAD3;CMKLR1;LPL;WWTR1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.44475080424850366,-0.8444273792119249,0.6491228070175439,1.0,1.0,5/22,14.37%,NCAPH;SMC4;AKAP8L;NCAPD3;NCAPD2
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.4981401040769611,0.8443934125709867,0.6818181818181818,1.0,1.0,1/7,1.23%,KCNE4
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.4981401040769611,0.8443934125709867,0.6818181818181818,1.0,1.0,1/7,1.23%,KCNE4
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.4487198927342564,-0.8443742864651005,0.75,1.0,1.0,6/21,14.71%,FLG2;AHI1;PRKX;TRAF3IP1;ACTB;ARHGAP12
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.48833460089762043,0.8442312771787862,0.7777777777777778,1.0,1.0,1/14,1.31%,RUNX1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.35395756970011527,-0.844229762023017,0.8275862068965517,1.0,1.0,25/166,16.16%,TYMS;RPS27L;MIF4GD;RBM4;NCL;PATL2;UPF3B;RBM3;UPF3A;ILF3;EIF1;NIBAN1;NOLC1;CIRBP;ZNF540;EIF1B;EIF2B4;METTL3;EIF4A2;RACK1;PUM3;NAT10;RBM4B;RPL5;GLE1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.39223532814055745,0.8438119723032997,0.64,1.0,1.0,2/37,4.45%,MYBPC3;SLC8A1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5033462280449401,-0.8437861102919633,0.6938775510204082,1.0,1.0,3/11,22.68%,IRAK1;CARD14;CARD10
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.5134726958062057,0.8437441512423273,0.625,1.0,1.0,1/13,1.72%,PLCB1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.49055738289305373,0.8433981940677573,0.660377358490566,1.0,1.0,1/7,1.57%,KCNJ3
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.5579728438141158,0.8432437462419597,0.6818181818181818,1.0,1.0,1/6,11.73%,ANK2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.5641428545945105,-0.8430121345466998,0.7017543859649122,1.0,1.0,1/5,17.70%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.5641428545945105,-0.8430121345466998,0.7017543859649122,1.0,1.0,1/5,17.70%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.49497286217635605,-0.8428489647106078,0.6346153846153846,1.0,1.0,1/8,7.70%,VDAC2
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.3636167912411531,0.8427735122983957,0.7358490566037735,1.0,1.0,11/41,10.17%,ALDH1A1;LEPR;MUC20;STEAP4;SCEL;CAPN13;SCNN1B;ERN1;PROM2;SFTPC;TFCP2L1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.470898320015109,0.8426509292597417,0.6538461538461539,1.0,1.0,1/13,7.08%,PDCD6IP
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.5112595726561567,0.8424334582224895,0.717391304347826,1.0,1.0,3/9,32.15%,CLP1;AGO3;DICER1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.3623821114358913,0.8422550736184723,0.6944444444444444,1.0,1.0,29/89,19.50%,SEMA5A;FGFR2;EGFR;WNT5A;TGFBR1;PKHD1;FGF10;NRP1;VEGFC;PRKD1;HIF1A;PRKCA;VEGFD;CDH13;MDK;SIRT1;SOX11;F3;THBS4;PDCL3;BAD;VEGFA;BMP6;PROX1;TGFA;VASH2;ARNT;STXBP4;AKT3
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.4984800454239529,0.8421498486467284,0.68,1.0,1.0,1/9,7.59%,MBNL1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.5423633908549832,0.8417050039191127,0.7777777777777778,1.0,1.0,1/5,11.68%,CTNNB1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.5423633908549832,0.8417050039191127,0.7777777777777778,1.0,1.0,1/5,11.68%,CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.4949351978887838,0.8416241826045331,0.6956521739130435,1.0,1.0,2/7,11.45%,BMPR1A;PTGS2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.45521076055742704,-0.8416114200152663,0.6521739130434783,1.0,1.0,4/17,11.10%,ADAM12;ADAMTS15;ERVW-1;ADAMTS5
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.5175293436133387,0.841481452371244,0.6964285714285714,1.0,1.0,2/6,5.86%,AGER;TWSG1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.46204701322818587,-0.8414429529198758,0.6610169491525424,1.0,1.0,5/16,28.66%,AASS;GOT2;CRYM;ALDH7A1;AADAT
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.38897318563254296,0.8413768651340857,0.6578947368421053,1.0,1.0,13/54,19.33%,PTPRK;ZBTB1;NEDD4;PDE6A;EP300;CNGB1;EIF2S1;CASP9;CNGA1;BMF;OPN5;RUVBL2;TMEM161A
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.3156595641011227,-0.8409361081413,0.8,1.0,1.0,40/223,17.69%,USP27X;ABRAXAS1;UCHL1;PSMA7;NLRP3;ADRM1;ATXN7L3;USP40;MBD6;PSMD7;UBC;USP20;PSMB4;PSMC3;TAF9B;TOMM20;UFD1;USP11;PSMD8;USP35;PSMB5;TAF10;ACTB;INO80;PSMC1;PSMB2;PSMC4;USP1;PSMD2;NFKBIA;PSMA1;USP48;PSMB8;USP22;USP21;PSME1;PSMD10;USP10;USP4;SPATA2
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3516848869142614,0.8405267783429844,0.68,1.0,1.0,16/86,15.18%,NEDD4;GFAP;EGFR;WNT5A;BANP;CHMP6;ODC1;TIPARP;ZDHHC2;HMGCR;SMURF2;FOXO1;SEC22B;SMURF1;BARD1;NEDD4L
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.3896661909444841,-0.840317395516713,0.7068965517241379,1.0,1.0,5/59,6.74%,CYP19A1;DHRS11;CYP21A2;LIPC;PRLR
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4977647231777602,0.8395057471256989,0.6976744186046512,1.0,1.0,2/9,11.73%,LRRC38;ANK2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.47983885047064545,0.839298036790498,0.7222222222222222,1.0,1.0,5/19,18.60%,TRIM8;TRIM5;VPS37B;MID2;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.5052166331836534,0.839292596481159,0.7317073170731707,1.0,1.0,2/10,4.52%,ITGAM;SYK
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.41656914727844085,0.8391073935621335,0.64,1.0,1.0,5/21,19.56%,PDCD6IP;CHMP1A;HSPA1A;PLK1;HNRNPU
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.46279868407509783,0.8389909942238145,0.6938775510204082,1.0,1.0,7/21,20.00%,SPHK1;AGMO;ACER1;ST6GALNAC4;TECR;TEX2;ST3GAL6
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.3772321537188369,-0.8387016220857387,0.6964285714285714,1.0,1.0,6/77,9.66%,STING1;UPB1;HGSNAT;CLDN1;RNF213;TWNK
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.5063475615576519,-0.8386732910773803,0.6458333333333334,1.0,1.0,2/9,6.58%,PLEKHH2;VIL1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.5072217181066061,0.83864082918388,0.6666666666666666,1.0,1.0,2/7,17.02%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.5762569840578405,-0.8382011397027523,0.7407407407407407,1.0,1.0,1/6,0.73%,GUCY2C
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.34788766557574813,-0.8381862310410124,0.7916666666666666,1.0,1.0,18/181,9.64%,NUPR1;CD9;AURKA;HK2;WARS1;NFKBIB;EIF2S2;M6PR;TOMM40;SLA;NMT1;PPP1R15A;PDAP1;SORD;NIBAN1;PRDX1;ATP6V1D;TM7SF2
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4017194643741267,0.8378605255886157,0.75,1.0,1.0,10/42,13.04%,HMGB1;HSPB1;HDAC9;NUS1;PRKD1;HIF1A;PRKCA;PTGS2;SIRT1;FGFR1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.4385713349755714,-0.8378399755638465,0.7169811320754716,1.0,1.0,1/33,0.74%,SFRP1
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.38911817862207526,0.8374343337902204,0.6904761904761905,1.0,1.0,7/53,6.23%,ARHGAP25;PIK3R5;ITGAX;SELPLG;CCL5;ITGAM;IKZF2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3923898971582913,-0.8372218207490739,0.6981132075471698,1.0,1.0,7/68,7.99%,SH3RF2;CLU;TRIB2;ARIH2;RBX1;DDA1;RFPL1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.5526826974454158,-0.8371809479949058,0.75,1.0,1.0,1/5,6.56%,XRCC1
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.5125405312282965,0.836965512622324,0.7021276595744681,1.0,1.0,2/5,19.85%,LIMK2;TESK1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.47682241019245686,-0.8369552496755902,0.7037037037037037,1.0,1.0,2/16,10.29%,WIPI1;WIPI2
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.5302807807173879,0.8368509067980546,0.6833333333333333,1.0,1.0,2/8,11.75%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.3202209350819886,-0.836681268748751,0.8947368421052632,1.0,1.0,94/338,23.24%,F5;SARS1;MXRA8;WARS1;ABCF1;SPG7;PAPPA;D2HGDH;CKAP4;UBE2L6;GPC3;ST8SIA2;MRPL23;PHEX;RPLP1;TTF1;VWA1;RPL37A;RPL28;SCG3;NOTUM;SDC2;UBE2M;MRPS18B;RPS15;PROC;MRPL55;IGFBP4;NUCB1;RPL4;RPL12;CHGB;IGFBP3;RPL34;PRSS23;RPL31;APOA1;MRPS21;CTSH;CALU;APH1B;RPS27;RPL8;MRPL9;RPS8;RPL19;HM13;PABPC4;RPL23;MRPL27;RPL5;RPL7A;RPN1;ST3GAL1;RPL38;L2HGDH;RRBP1;FBXO2;AFG3L2;RAB12;RPL24;RPS24;MRPL51;LMCD1;MRPS18C;RPS3;RPL6;SCG2;MRPL37;RPL29;SPCS1;RPL13;ARAF;LTBP1;PCMT1;RPS20;VGF;RPL11;PADI4;RPL35A;RPL10A;EIF4G1;MSRB2;APLP2;RPL37;PAPPA2;RPLP2;SEC11C;UBL5;RPS14;RPS4X;FBXO22;RPS25;MAN2B1
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.5421884660268208,0.8365891605595096,0.7636363636363637,1.0,1.0,4/7,29.03%,NLRC3;SIRPA;REL;RELB
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.5557590219710306,0.8365500554778859,0.75,1.0,1.0,3/6,30.53%,ACVR1;TGFB2;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5052328327837966,0.8359610960877052,0.7692307692307693,1.0,1.0,2/10,10.56%,LDLR;NR1H3
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.42057887422724527,0.8357983830952324,0.7254901960784313,1.0,1.0,4/47,2.37%,SEMA3C;SEMA5A;ERBB4;SEMA6D
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.4011063175125486,0.8356709955201913,0.6585365853658537,1.0,1.0,5/29,14.32%,CCNH;CAVIN1;TAF1A;MNAT1;TAF1B
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.3905087052899558,-0.8356007426582394,0.7058823529411765,1.0,1.0,5/59,7.86%,P2RY10;RAC1;PRAG1;SYNPO2L;STMN1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.4554419971382123,-0.8349379326064964,0.6666666666666666,1.0,1.0,3/25,9.99%,AURKA;DRD3;BTC
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.5526638182868517,0.8348865380171094,0.6938775510204082,1.0,1.0,2/5,19.28%,PROX1;NFKB1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.4750033295848335,0.8345904697608617,0.6226415094339622,1.0,1.0,3/12,21.17%,MOCS3;NOXRED1;GPHN
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.44037146091317236,0.8345493614560915,0.7441860465116279,1.0,1.0,5/16,10.38%,CCL5;SLIT2;NRP1;BMPR1A;PDGFRB
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.2949223832861681,0.8345177237901333,1.0,1.0,1.0,97/864,11.82%,LOXL2;SGK2;SGK3;LTK;MAP3K11;STK26;DAPK2;DCUN1D1;FRK;ASB17;CHRM3;HS3ST5;SOCS6;AFP;KLHL21;PTPRK;PPEF2;PTAR1;CEL;RCE1;EVA1A;NUAK2;MAN2A1;PPM1L;EGLN3;TNC;CSF1;UBE2E2;ST8SIA6;NLK;TGFBR1;SYK;TNIK;RPS6KA4;CUL1;PPM1E;PSMD13;LATS1;NUS1;ACVR2A;PPP3CA;DYRK3;PRKD1;LMO7;PTPRD;DUSP9;DNAJC3;FBXL7;CDK6;PARP8;RYK;LIMK2;DCAF5;FBXO30;ERN1;PTPN13;PTPRG;FBXW9;PXK;MSRA;ABL2;PRKG1;PTPN6;EIF2AK3;HIF1A;BMPR1A;FUT9;SGK1;CDH2;SOCS2;PRKACB;RCN1;FER;RBBP5;FBXO7;YES1;STK36;C3;TIPARP;DYRK1A;PRKCA;CDK12;TIMP1;KCTD6;FBXL3;PTPRM;PGGT1B;DYRK2;PTPN14;ACVR1B;NIM1K;TF;BTRC;CAMK4;MEX3B;SIRT1;SENP8
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.4807338689479862,-0.8343879233431337,0.7391304347826086,1.0,1.0,1/14,2.23%,SIGIRR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.5506977629523224,0.8343138891546152,0.7659574468085106,1.0,1.0,2/5,3.94%,EGFR;WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.5506977629523224,0.8343138891546152,0.7659574468085106,1.0,1.0,2/5,3.94%,EGFR;WNT5A
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.40644174694890833,0.8342184705231268,0.6904761904761905,1.0,1.0,7/40,12.14%,ARID1A;ARID1B;SRCAP;HDAC2;SPTY2D1;SMARCE1;ACTL6A
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.4661631865259047,-0.8340215606764578,0.7142857142857143,1.0,1.0,5/14,17.45%,ADAMTS12;EDEM2;FBXO6;FBXO2;CTSL
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.4111139870969296,0.8336529445848857,0.6862745098039216,1.0,1.0,11/35,19.81%,SPHK1;ZDHHC14;ZDHHC2;HHAT;FOXO1;EP300;KAT2B;ZDHHC9;ZDHHC18;ZDHHC17;ZDHHC23
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4475920171370321,0.8336253976228187,0.7021276595744681,1.0,1.0,6/19,20.10%,MAN2A1;ST8SIA6;ST8SIA4;FUT8;ST8SIA3;ST8SIA1
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.5548735249324408,0.8333764103189327,0.6938775510204082,1.0,1.0,1/5,11.16%,MOCS3
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.49961602581119774,0.8332374442941164,0.6046511627906976,1.0,1.0,1/9,4.20%,CCL5
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.44728984937638944,0.8332106560009005,0.65,1.0,1.0,7/14,17.66%,SLC8A1;KCNJ2;ATP12A;SLC12A2;SLC9A1;NEDD4L;ATP1A2
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.49001702103990585,0.8329145342423866,0.72,1.0,1.0,3/12,8.64%,NYNRIN;ZC3H12C;RPP40
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.5664772519490027,-0.8328983715729829,0.7307692307692307,1.0,1.0,2/5,12.65%,LIPC;APOA1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.5664772519490027,-0.8328983715729829,0.7307692307692307,1.0,1.0,2/5,12.65%,LIPC;APOA1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.49025860289998624,-0.8328742863717123,0.7045454545454546,1.0,1.0,2/10,16.27%,CENPH;CENPE
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.43664063145570553,0.8328644359744054,0.7083333333333334,1.0,1.0,9/27,16.02%,TP63;ZNF205;PPP1R13B;BOK;BCL2;TP53BP2;MAPK8;BAD;YWHAZ
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.4925226330972475,-0.832166289494483,0.7272727272727273,1.0,1.0,1/10,5.82%,PACSIN3
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.4541882924474656,0.8320232650029507,0.6363636363636364,1.0,1.0,7/22,17.95%,TRIM22;HS3ST5;TRIM5;LGALS1;MID2;IFITM3;TRIML2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.47932005816198764,-0.8319144636742144,0.7021276595744681,1.0,1.0,2/15,17.70%,HENMT1;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.5511461156931393,0.8317413276543107,0.7608695652173914,1.0,1.0,2/5,28.16%,SMAD4;PIH1D1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.49935651678751664,-0.8317218112006546,0.723404255319149,1.0,1.0,1/8,4.34%,KNSTRN
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.32401587409526555,0.8316979965309445,0.7708333333333334,1.0,1.0,43/285,14.35%,MED17;ESRRG;CCNH;PKNOX1;PPARG;ZBTB1;HNF4G;NR3C2;PPARGC1A;NR2E1;TEAD2;MLLT3;ELP4;INTS6;CCN2;HDAC9;PRRX1;NR3C1;TBL1XR1;HDAC3;MAML2;RORA;NR1D2;MAML3;NR5A2;INTS11;SOX5;TAF3;CDK12;POU2F1;ZBTB7B;TAF1A;NR1H3;PAPOLA;PCF11;MNAT1;TSC22D1;NOTCH3;RARB;GTF2F2;SCAF8;TAF2;TAF4B
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.5335238003349464,-0.8316729767911997,0.6792452830188679,1.0,1.0,3/7,35.25%,ENG;EFEMP2;SOD2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4096345314528252,0.8311513163019169,0.6666666666666666,1.0,1.0,10/29,17.19%,NEDD4;FGF12;FGF14;FGF13;ANK3;NETO1;DMD;NEDD4L;SLMAP;HECW2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.46668127330977194,-0.8311087058311964,0.7413793103448276,1.0,1.0,2/16,3.35%,CCN3;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.4058827777674711,-0.8310086660916408,0.6666666666666666,1.0,1.0,4/34,9.27%,SERPINB8;SERPINE1;TIMP4;CR1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.43460017410042223,0.8309903187010704,0.7045454545454546,1.0,1.0,5/16,17.66%,NR3C1;TFPI;TRERF1;URI1;ATP1A2
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.46820997924476276,-0.8309581190440001,0.6458333333333334,1.0,1.0,2/16,6.45%,B3GALT4;ST8SIA2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.46387761667753746,-0.8308810896588481,0.6610169491525424,1.0,1.0,2/14,6.45%,B3GALT4;ST8SIA2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.44161466117403014,-0.830496154788696,0.6888888888888889,1.0,1.0,1/24,0.70%,DYSF
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.5318917812271529,-0.8303216722892949,0.6382978723404256,1.0,1.0,1/5,13.52%,SNX6
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.4513298463858355,0.8302326731679472,0.6363636363636364,1.0,1.0,4/16,8.26%,B4GALNT2;ABO;B4GALT1;FUT9
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.3569988028501111,-0.8300938224036188,0.7192982456140351,1.0,1.0,12/116,10.95%,PLK4;AURKA;PLK3;FOXM1;HAUS8;DCTN1;SKP1;SSNA1;PRKACA;CETN2;AKAP8L;ODF2
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.5073739809868579,0.8300666853189823,0.7735849056603774,1.0,1.0,2/8,16.72%,LIMK2;CLASP1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.536458379821038,-0.8298856845710654,0.74,1.0,1.0,2/10,18.96%,TICRR;NUGGC
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.41199065894949427,0.829560996430267,0.7,1.0,1.0,10/31,20.81%,NAV3;SNCA;DYRK1A;FGF13;MAP2;HDGFL3;CLASP1;APC2;CLASP2;ATXN7
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.405275322511082,0.8293732935531606,0.7674418604651163,1.0,1.0,8/29,17.12%,CCL5;ANKRD17;PRKCA;ADAM8;SASH1;IFI35;AKIRIN2;BMP6
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.4013379051378823,0.8293675925413879,0.6744186046511628,1.0,1.0,10/42,10.36%,PPARG;VWC2L;SMAD7;ACVR2A;SMAD5;GREM2;BMPR1A;SMAD1;SMAD9;SMURF2
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.49300140507764123,0.8290408036443627,0.6909090909090909,1.0,1.0,2/10,15.40%,TMEM67;KAT2B
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.39546621182266806,-0.8288868893722527,0.7169811320754716,1.0,1.0,7/58,6.74%,TXK;TEC;HCK;NTRK1;EPHA1;GHR;PRLR
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.3520044660486898,-0.8288690430748002,0.7692307692307693,1.0,1.0,29/124,20.37%,PLEKHH2;ASCL1;PPP1R17;KIF1A;RND3;RBM3;CELF3;DLX5;ID4;IFIT1;RND2;TMTC4;IGFBP3;TAGLN3;PCDH8;PCDH19;BRSK2;RGS8;TUBB2B;CACNG4;S100B;STMN2;GRIK3;CCDC177;HOPX;SRRM3;KLHDC8A;ISG15;ARNT2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.35995422436784197,0.828653223912719,0.7647058823529411,1.0,1.0,4/63,3.49%,HORMAD1;ENPP1;DNASE1L2;DXO
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.4016774350386266,0.8279519118629866,0.660377358490566,1.0,1.0,7/27,15.19%,TWIST1;GLI3;HDAC2;MBNL1;CTNNB1;SALL1;AFF3
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.48380968666319263,-0.8279352498389958,0.6666666666666666,1.0,1.0,1/12,1.02%,SLC25A10
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.36720979965076356,0.8279300209083883,0.7906976744186046,1.0,1.0,10/91,6.89%,ALDH1A1;SULT2B1;NR3C2;NEDD4;PEX11A;SLC23A1;CAT;CYP39A1;BBOX1;ATXN1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4197632378833361,-0.8276557503544528,0.6567164179104478,1.0,1.0,6/24,20.60%,RBM4;PDE6B;PER2;RBM4B;PPP1CA;FBXL12
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.5604622265517665,-0.8276064145317461,0.75,1.0,1.0,3/5,36.12%,COMT;MOXD1;MAOB
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.38765147100593667,0.8274596094012936,0.7551020408163265,1.0,1.0,3/34,3.71%,EFNA5;KANK1;AP1AR
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),0.5471286022650304,0.8271571433203913,0.7435897435897436,1.0,1.0,1/5,11.73%,ANK2
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.48139773576868367,-0.8269704782507052,0.6521739130434783,1.0,1.0,4/9,18.69%,IFI6;RACK1;SRC;KDR
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.5193850774711803,-0.826752166015924,0.7222222222222222,1.0,1.0,2/7,21.87%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.5193850774711803,-0.826752166015924,0.7222222222222222,1.0,1.0,2/7,21.87%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.39244357860154044,-0.8266498272404081,0.7924528301886793,1.0,1.0,13/62,15.60%,RTF1;GTF2F1;ADRM1;POLR2I;POLR2J;ELOF1;GTF2H2;SUPT5H;SUPT16H;CCNT1;POLR2G;ERCC2;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.41007174808351016,-0.8265581973217406,0.75,1.0,1.0,6/48,11.45%,ABRAXAS1;SPRED3;SPRED2;RNF8;HIC1;WRAP53
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.34234374904221054,-0.8265203569193731,0.8723404255319149,1.0,1.0,10/107,6.86%,CLDN4;SFRP1;WTIP;KIF1A;WARS1;ETS1;SHANK3;CDK5;HTATIP2;ZMYM6
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5056463426549536,0.8261314863254362,0.803921568627451,1.0,1.0,2/6,12.48%,HDAC9;SORT1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.5398853289952833,-0.8260312914987887,0.6724137931034483,1.0,1.0,1/5,16.22%,ABCC4
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.43676766262338734,0.8260192204339093,0.7446808510638298,1.0,1.0,4/18,9.79%,DCUN1D1;TGFBR1;HIF1A;DNAJB2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.35965244237389826,0.8259315715710617,0.6666666666666666,1.0,1.0,20/81,15.77%,IL17RD;CIDEA;SMAD7;TGFBR1;ZEB2;ADAMTSL2;LATS1;NREP;SMAD2;SMURF2;WFIKKN1;SIRT1;PPM1A;SOX11;SMURF1;EP300;TGFBR3;HSPA1A;SMAD3;TGFBR3L
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.35430643791501054,0.8258519018942321,0.6052631578947368,1.0,1.0,23/111,17.02%,PIK3R5;SOCS6;ITPKB;PIP4K2A;PIGP;SYNJ2;PTPN13;SOCS2;PIGA;IP6K2;INPP4B;PIK3C2B;PIK3C2G;PIK3CA;PIGV;PIGU;PIGW;MTMR12;PIK3R1;PIGQ;SOCS4;SMG1;DPM1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3156335986179234,0.8256313214195697,0.8529411764705882,1.0,1.0,41/174,19.55%,TRIM22;S100A13;TAB3;WNT5A;ROR1;PELI2;PELI1;HSPB1;ECT2;LITAF;PRKD1;RORA;TRIM8;TLE1;ANKRD17;TRIM5;TAB2;CASP10;NDFIP2;SIRT1;PPM1A;ALPK1;LGALS1;PRKCB;MID2;RELA;SLC20A1;NOD1;GPR89A;TRAF5;TRAF1;NLRC3;EEF1D;TFG;C18ORF32;TRIML2;ZFAND6;TRIM32;ZDHHC17;TSPAN6;TRAF4
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.3510949689617906,-0.8255625509590944,0.7627118644067796,1.0,1.0,14/146,6.59%,SFRP1;ISM1;SARS1;HK2;FGF1;COL4A3;ADAM12;SERPINE1;WARS1;NODAL;ETS1;EPHA1;NAXE;HTATIP2
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.47795862764523717,-0.8254543444966856,0.6530612244897959,1.0,1.0,6/12,27.11%,CALM1;PRKG2;PTS;GCHFR;NOS3;HSP90AA1
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.528896248292679,0.8254530164745947,0.7142857142857143,1.0,1.0,4/7,17.35%,ERBB4;ZSWIM6;SALL1;INHBA
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5431426531107555,0.8253264739768088,0.6610169491525424,1.0,1.0,1/5,8.56%,DDAH1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.48685931506041363,-0.8252913517486936,0.6724137931034483,1.0,1.0,4/11,24.49%,IFI27;NUCKS1;PPIB;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.3803644829315241,-0.8252577653304944,0.6949152542372882,1.0,1.0,7/57,11.49%,AHNAK2;AKAP17A;OAS3;AHNAK;OAS2;CLK3;PRX
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.4216547173670908,-0.82523428862996,0.7017543859649122,1.0,1.0,5/19,18.54%,SDHC;UQCRH;UQCRC1;ATP5F1D;UQCR10
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.4898760614181772,0.8252104535123523,0.7333333333333333,1.0,1.0,3/9,11.81%,ERRFI1;PDGFRB;PIK3CA
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.49068816303084023,0.8251536850366031,0.7446808510638298,1.0,1.0,1/10,1.31%,RUNX1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.4399123466278497,-0.8250699745165805,0.6935483870967742,1.0,1.0,5/20,13.77%,CACNB1;DRD3;AHNAK;GNB5;STAC
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4858450122917648,0.8250699699482368,0.7169811320754716,1.0,1.0,3/13,14.78%,PPAT;IMPDH1;GMPS
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5018928598445254,-0.8249894117475678,0.7551020408163265,1.0,1.0,3/13,5.16%,SPRY4;SPRY1;GPC1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.5077952491215482,0.8249757770362719,0.7954545454545454,1.0,1.0,3/5,23.87%,SETMAR;HNRNPU;PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.5077952491215482,0.8249757770362719,0.7954545454545454,1.0,1.0,3/5,23.87%,SETMAR;HNRNPU;PLSCR1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.41900448165309767,0.8248784586863833,0.673469387755102,1.0,1.0,11/42,15.69%,AEN;IFI16;DDIT4;DYRK2;SIRT1;BOK;BCL2;EP300;CASP9;PHLDA3;CASP2
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.40685367525264704,0.8248032379016301,0.6388888888888888,1.0,1.0,9/28,13.63%,ENPP1;WNT5A;CHSY1;TWIST1;LRP4;MDK;SOX11;ACVR1;MEF2C
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.34982550809123486,-0.8245974246929053,0.7833333333333333,1.0,1.0,19/151,12.01%,TAGLN;COL6A2;SPDEF;CLU;APOD;ADAM12;MYL7;AGRN;RYR1;CACNG1;CFD;ACTC1;HDAC5;SPARC;PTP4A3;CRAT;COX7A1;CRYAB;IGFBP3
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.3529440616717401,0.8245572654586691,0.6578947368421053,1.0,1.0,8/72,8.37%,KLKB1;MYRFL;HJV;RCE1;HGFAC;KEL;PCSK2;MMP16
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.39756404682401814,-0.8243678856295211,0.6785714285714286,1.0,1.0,8/35,18.19%,MRPL23;MRPL16;TWNK;MRPS18B;MRPS21;IARS2;POLRMT;MRPL51
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.3417676798412194,-0.8243651384923402,0.8,1.0,1.0,22/107,22.54%,MAP1LC3B2;TOMM40;ATG14;WIPI1;VPS25;TOMM20;WIPI2;MAP1LC3A;PINK1;TOMM7;VPS16;VPS28;SRC;RUBCNL;ATG10;ACBD5;MAP1LC3B;GABARAPL2;VIPAS39;CHMP2A;DYNLL1;SQSTM1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.40678279987680965,0.8242445226446325,0.7142857142857143,1.0,1.0,7/29,13.63%,NLGN1;GRIA4;DLG2;LRRC7;CRHBP;GRIA2;MEF2C
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.34069364663290935,-0.8242251715588499,0.7333333333333333,1.0,1.0,38/147,20.53%,XPC;PSMA7;KIF20B;ANAPC15;SKP1;PSMD7;PSMB4;PSMC3;RFPL1;DYNLT3;FBXO43;BTG1;PIN1;DDB1;PSMD8;PSMB5;CUL9;PSMC1;CDK11B;ERCC2;PSMB2;PSMC4;PSMD2;PSMA1;CKS1B;PSMB8;USP22;PSME1;PSMD10;ANAPC2;RNF20;PSMA8;FZR1;PSMD12;PSMB3;PSMB7;SDCBP;PSMC6
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.5047925732674678,0.824198173335238,0.7333333333333333,1.0,1.0,1/5,19.97%,TRIP11
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.38426751152407984,0.8239709871139501,0.6341463414634146,1.0,1.0,20/76,14.97%,RUNX1;ITGAX;SEMA5A;SPHK1;WNT5A;VEGFC;HSPB1;GAB1;RHOB;PRKD1;TWIST1;HIF1A;PRKCA;VEGFD;ITGB8;SIRT1;SASH1;F3;PRKCB;PDCL3
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.5057536780821904,0.8237200478072053,0.75,1.0,1.0,3/8,12.65%,PPP1R15B;NCK1;BOK
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.36955841926187466,0.823604710241214,0.6857142857142857,1.0,1.0,8/48,12.08%,GRM7;CHRM3;CHRM2;OPRK1;GRM8;GNAI1;PDE2A;HTR1E
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.45835697298265327,-0.8235846221055347,0.6511627906976745,1.0,1.0,2/13,6.28%,CASP6;RYR1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.39154367463296713,0.8235274548174096,0.7346938775510204,1.0,1.0,7/33,13.33%,NTF3;EGFR;ABL2;GNAQ;PDGFRB;FGFR1;AVPR1A
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.5520484683892678,-0.8235057363848837,0.7592592592592593,1.0,1.0,1/5,3.61%,PRKCH
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4176863030844763,-0.8231243358919608,0.7377049180327869,1.0,1.0,10/37,17.49%,INHA;NOG;NODAL;RBPMS;BMP3;PIN1;BMP7;GREM1;GDF5;GDF11
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.46278617625299184,0.8230370317244035,0.7111111111111111,1.0,1.0,5/12,32.15%,MDK;IL34;PTPRZ1;BIN1;DICER1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.35546135065134915,-0.822944235634695,0.7636363636363637,1.0,1.0,11/87,11.86%,SH3RF2;CLU;TRIB2;ARIH2;RBX1;DDA1;GIPC1;RFPL1;GLMN;CAMLG;DDRGK1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.36402632318830114,0.8226643572749957,0.7209302325581395,1.0,1.0,15/63,11.81%,PIK3R5;NTF3;NEDD4;ROR1;CCL5;IRS2;GAB1;HGF;PTPN6;FSHR;IGF1R;PDGFD;PDGFRB;SIRT1;PIK3CA
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3630919643246321,0.8225422851313576,0.7777777777777778,1.0,1.0,15/102,9.14%,CALCR;CHRNA10;HMGB1;CX3CR1;WNT5A;SLC8A1;ACKR3;TBXA2R;ATP2B4;ACKR2;PTGFR;ABL2;PLCE1;P2RY1;TRPC4
prerank,GO_Biological_Process_2021__photoreceptor cell outer segment organization (GO:0035845),-0.5591859727731266,-0.8224989612162628,0.7083333333333334,1.0,1.0,3/5,11.22%,AHI1;PCARE;CDHR1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4062206027800851,-0.8224290568020665,0.6792452830188679,1.0,1.0,8/50,10.97%,CLDN4;WNT7B;RND3;PACSIN3;CCND1;CRABP2;ALOXE3;TOM1L1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.5290815737676156,-0.8223260994105481,0.6981132075471698,1.0,1.0,3/7,14.80%,DCTN1;CHCHD10;RAB3A
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.5108766319185949,-0.8216261000165624,0.7,1.0,1.0,1/5,24.50%,UBE2S
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.45196750872377817,-0.8215685627522274,0.7037037037037037,1.0,1.0,2/21,3.54%,DUOX1;STX4
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.5236970539524216,-0.8207962877041917,0.75,1.0,1.0,1/7,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.3711389750442688,0.8206544298808607,0.7333333333333333,1.0,1.0,6/44,12.39%,IFI16;ECT2;RHOB;SIRT1;LIG4;RAD9B
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3412823918163841,-0.8205792434254027,0.75,1.0,1.0,9/116,6.10%,TERF2IP;TNFSF18;CLU;NTRK1;NFKBIB;PRKCH;NLRP3;RHEBL1;UBC
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5657596910035857,0.8205724739078945,0.7906976744186046,1.0,1.0,3/8,18.69%,HIF1A;PRKCB;ARNT
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.520090666085496,-0.8202005109718916,0.6875,1.0,1.0,3/7,31.41%,MAP1LC3B;SQSTM1;PEX5
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.546322327935398,0.8201909638367254,0.8,1.0,1.0,2/5,13.28%,TDG;FTO
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.32986733582017536,0.819717674108879,0.8461538461538461,1.0,1.0,23/126,12.36%,ACE2;CASP12;NFKBIZ;PPARG;SPHK1;WNT5A;CCL5;PLA2G7;LRFN5;SNCA;RORA;NR1D2;MFHAS1;PTGES;LRRC19;IL16;NR1H3;MDK;PDE2A;NAPEPLD;PTGS2;LPCAT3;SETD6
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3196760079263817,0.8195169227150764,0.9024390243902439,1.0,1.0,27/97,15.52%,PTPN20;IL1RAPL1;IL18R1;SPHK1;CCL5;TGFBR1;SLIT2;ACVR2A;ROBO2;NCOA2;PTPN13;PTPN6;BMPR1A;SOCS2;ASAH2;TIPARP;CSF1R;PTPN14;ACVR1B;CTNNB1;AKAP6;PID1;ACVR1;LDLRAP1;MAPK8;URI1;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.46450130874129014,0.8193705438274539,0.6981132075471698,1.0,1.0,3/19,9.67%,RUNX1;CSF1;PRKCA
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.44851262965861205,0.8191271444921219,0.7111111111111111,1.0,1.0,2/17,9.38%,ADGRB3;C3
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.47154406787336345,0.819028319871204,0.6904761904761905,1.0,1.0,1/7,0.90%,KLKB1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.3917796540893968,-0.8189932417364096,0.7222222222222222,1.0,1.0,3/32,7.86%,SPRY4;SPRY1;STMN1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.34040976362597275,0.8187322831366975,0.7027027027027027,1.0,1.0,8/71,13.35%,SEM1;RFWD3;TONSL;SWSAP1;RAD51B;NSMCE1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.4592029549023279,-0.8187216609517414,0.7222222222222222,1.0,1.0,3/14,13.41%,NLRP3;ZP3;PRKCZ
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.4783087069196511,-0.8180462105734058,0.7,1.0,1.0,1/10,0.99%,PAH
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.36760569703772417,-0.8180450396403952,0.7166666666666667,1.0,1.0,12/56,10.72%,PAH;UPB1;SPTLC3;A1CF;LIPC;PRLR;HNF4A;TTF1;SLC3A1;AQP7;TMEM45B;NR1H4
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.4844796127377783,-0.8175271890157053,0.6829268292682927,1.0,1.0,1/6,15.73%,USP1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.39275396719974337,0.8174711342141717,0.6444444444444445,1.0,1.0,4/25,7.77%,PPARG;CDK6;TWIST1;RANBP3L
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.4478107240049316,-0.8174411231152477,0.6808510638297872,1.0,1.0,2/23,3.88%,AOAH;ENPP2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.3871860475359181,-0.8174286770147071,0.7454545454545455,1.0,1.0,1/41,0.56%,BUD23
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.5052243311782463,-0.8174284602175274,0.6428571428571429,1.0,1.0,2/7,12.69%,DNM1;DNM1L
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.5052243311782463,-0.8174284602175274,0.6428571428571429,1.0,1.0,2/7,12.69%,DNM1;DNM1L
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.4373051575550339,0.8172961806987816,0.7692307692307693,1.0,1.0,6/22,21.98%,SLC19A2;SLC23A1;SLC2A14;ABCG2;TCN2;CUBN
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.5098629771011665,0.8172188253631607,0.75,1.0,1.0,3/11,18.90%,RNFT1;USP13;RNF185
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.5003037319558443,-0.8171078535130876,0.717391304347826,1.0,1.0,1/5,13.03%,ABHD1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.3817248353977836,0.8170407483302377,0.8823529411764706,1.0,1.0,14/41,23.16%,TM4SF20;SPOP;HDAC2;RNF139;BTRC;DNAJC1;OGT;PLK1;BAD;TRIM32;SPOPL;PLAT;TRAF3;CLN3
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.4842779850554325,0.8167019838174236,0.7391304347826086,1.0,1.0,1/7,7.98%,CTNNA2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.4521603305606561,-0.8166874523671768,0.72,1.0,1.0,6/22,11.00%,GUCY2C;WNT9B;CDH17;CFD;TMEM45B;CEACAM1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.5046384301405694,0.8162887464146243,0.6774193548387096,1.0,1.0,1/7,1.86%,SPX
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3787124852498062,0.8160543555723024,0.7307692307692307,1.0,1.0,6/57,7.47%,MAP3K11;PLCB1;HMGB1;AGER;CCN2;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.46429731889767656,0.8158206901840371,0.7291666666666666,1.0,1.0,2/13,14.39%,ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.44372732254961156,-0.8156751183527052,0.7254901960784313,1.0,1.0,1/17,6.07%,MYH14
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.35844532475620866,-0.8154779004314057,0.7446808510638298,1.0,1.0,1/65,0.61%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.42437497606660857,0.8154560110974451,0.7450980392156863,1.0,1.0,4/18,8.44%,NEDD4;SNCA;PXK;GPM6B
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.39662373261582395,-0.815359119939674,0.7391304347826086,1.0,1.0,7/49,7.89%,CLU;CIDEB;HEBP2;NTRK1;PRR7;HTATIP2;DAXX
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.5404090367911927,0.8148596470256207,0.8297872340425532,1.0,1.0,2/5,10.41%,PTPRG;TENM3
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.5138461104453155,0.8147140430178432,0.7307692307692307,1.0,1.0,3/8,15.98%,MAT2A;UGDH;SPAST
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.44355991441768416,0.8145908963344805,0.6511627906976745,1.0,1.0,3/18,14.46%,EGFR;MT1M;MAPK8
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.5128160538921585,-0.814519983709433,0.7073170731707317,1.0,1.0,3/14,14.70%,IL10RB;NOS2;PRELID1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.37914921501487636,0.8144959839377515,0.7446808510638298,1.0,1.0,9/62,13.07%,IFI16;DAPK2;PIP4K2A;HSPB1;ABL2;ITPR1;GPR137B;BOK;EP300
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5223850964619782,0.8142943601685678,0.7272727272727273,1.0,1.0,3/7,14.67%,NEDD4;UBR5;TRERF1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.5180079254600793,0.8142160906314088,0.7115384615384616,1.0,1.0,1/5,9.61%,NCK1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.34652508606842497,-0.814199694152492,0.7090909090909091,1.0,1.0,3/85,0.74%,CELA2A;CCN3;SFRP1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.4242691755406028,0.8141917288685401,0.6739130434782609,1.0,1.0,5/19,21.44%,BICD1;EIF2S1;LSM14A;G3BP1;YTHDF3
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.4209019136004317,-0.8141543974689731,0.7291666666666666,1.0,1.0,5/41,5.76%,NCKAP1L;CLU;SERPINE1;B2M;GPC3
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.3922377623332872,-0.8139900811369863,0.6730769230769231,1.0,1.0,8/26,23.30%,UBC;HDAC6;ACBD5;PCNT;DYNLL1;CFTR;SQSTM1;UBB
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3280176702903548,-0.8139273667086436,0.8596491228070176,1.0,1.0,13/181,8.17%,CBLC;AURKA;ADRM1;PCYOX1L;ANAPC15;UBE2L6;ARIH2;RNF8;UBC;UBL7;RBX1;DTX3L;RNF213
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.463099905660882,-0.8137096149799337,0.7254901960784313,1.0,1.0,1/14,4.38%,DCAKD
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.3878134825506122,0.8136061414878483,0.6739130434782609,1.0,1.0,13/53,16.40%,NDNF;KCND2;EGLN3;TWIST1;RORA;HIF1A;PTGS2;SIRT1;ADAM8;CPEB4;CPEB2;BAD;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.4490556951145331,-0.8134796060717472,0.6981132075471698,1.0,1.0,5/17,14.47%,NLRP3;B2M;IL1R1;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.42682282871375116,0.8126950644060847,0.74,1.0,1.0,10/26,23.15%,PHACTR1;CTNNA2;MDK;ADGRG1;NTNG1;PLXNB2;ZNF609;NIPBL;RAPGEF2;SRGAP2C
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.36698904005144856,0.8126799062970026,0.7954545454545454,1.0,1.0,13/40,18.52%,EGFR;FAM83A;GAB1;SLC30A10;PLCE1;BCAR1;PIK3CA;ERBIN;PIK3R1;BRAF;SOS1;PTK2;TGFA
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.4332117389256367,0.8122260708830491,0.7142857142857143,1.0,1.0,3/14,14.24%,CHST6;CHST7;MGAT3
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.5004112348981611,-0.8121691154213637,0.6818181818181818,1.0,1.0,1/8,1.72%,GBP6
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.3377857990958394,0.8120225825321221,0.7209302325581395,1.0,1.0,14/67,15.38%,FAM216B;LRRIQ1;HYDIN;DNAH5;CAPN13;SLC5A8;EXPH5;TFCP2L1;CFAP65;MUC16;ATP12A;SLC12A2;MYO5C;NEBL
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4515239561413749,-0.8119562161415421,0.574468085106383,1.0,1.0,2/9,10.86%,APOD;NDRG4
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.5113983720543475,0.8119308289069899,0.7708333333333334,1.0,1.0,1/7,6.39%,SLC15A2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.4480320467392511,-0.8119042236406293,0.7924528301886793,1.0,1.0,7/30,17.23%,SEPTIN5;STX1B;HCRT;BAIAP3;PREPL;PNKD;CAMK2A
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.4086258277491887,-0.8118768594423469,0.7169811320754716,1.0,1.0,4/28,19.82%,COPE;COPG2;NAPG;GABARAPL2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.4043308292766159,0.8118574389542449,0.6382978723404256,1.0,1.0,4/34,8.74%,C1GALT1;SULF1;TGFBR1;LRP4
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.45926280557689775,0.8118061651729209,0.7045454545454546,1.0,1.0,3/13,14.75%,GSTO2;ATF3;CPEB2
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.5292701170964844,-0.8117898853679175,0.7037037037037037,1.0,1.0,1/5,7.33%,SORD
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.49232057288302444,-0.8115305708662198,0.7111111111111111,1.0,1.0,1/7,7.92%,ACTC1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.501548345557469,-0.8113324253097807,0.74,1.0,1.0,6/10,27.11%,CALM1;PRKG2;PTS;GCHFR;NOS3;HSP90AA1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.4424223791822764,-0.8111416830183754,0.711864406779661,1.0,1.0,5/21,24.15%,SLC14A2;SLC14A1;CPTP;SLC27A1;PLTP
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.4192658892401898,0.8111401052126346,0.7021276595744681,1.0,1.0,7/24,14.93%,CCL5;CACNB2;GRM6;PDGFRB;CXCL12;ANK2;P2RX7
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.4473151582992257,-0.8111083730519398,0.7735849056603774,1.0,1.0,3/17,9.69%,WTIP;LIMD1;NEK8
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.39327430181847056,-0.8110506182824779,0.7222222222222222,1.0,1.0,10/54,19.63%,KIF25;MAX;FBXO43;TOM1L1;BMP7;RBBP8;E2F7;RING1;CBX5;CHEK1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.328933992182962,-0.8108829183750561,0.8813559322033898,1.0,1.0,32/149,19.80%,PARP2;ABRAXAS1;SLX4;ERCC1;RNF8;RAD51AP1;XRCC1;DTX3L;PRPF19;MORF4L1;XRCC2;KPNA2;HMGB2;MDC1;POLM;POLL;HUS1;KDM4D;PARP1;INO80;XRCC3;NUCKS1;RBBP8;KAT5;XRCC6;RMI1;CYREN;SMARCA5;RECQL;TDP1;ZSWIM7;HPF1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.36447756001785486,-0.8108663690991205,0.7454545454545455,1.0,1.0,10/49,22.33%,ANKLE2;LEMD2;NSFL1C;NUP133;EMD;NUP43;NUP155;VRK1;CHMP2A;NUP85
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.3349789047303875,-0.8106096738973524,0.8307692307692308,1.0,1.0,15/144,8.88%,SELP;GBP6;WARS1;CD74;EPSTI1;B2M;LATS2;UBE2L6;DHX58;OAS3;CMTR1;RNF213;IFIT1;OAS2;IFI27
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.38317445516218845,-0.8104148047209012,0.7192982456140351,1.0,1.0,4/37,8.49%,FBLN2;RAC1;BST1;MYADM
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5099282703344922,-0.8100802738806476,0.7916666666666666,1.0,1.0,1/15,0.74%,SFRP1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.4392994759486131,-0.8099772399619519,0.660377358490566,1.0,1.0,1/17,2.31%,UPB1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.4780384300672752,0.8098854720110558,0.6326530612244898,1.0,1.0,3/6,21.00%,LRWD1;RUVBL2;NIPBL
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),0.5424039839597509,0.8098818206685601,0.7209302325581395,1.0,1.0,2/5,16.82%,BAD;BMF
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.4118013059520015,0.8098771993281935,0.8235294117647058,1.0,1.0,5/28,13.07%,CX3CR1;CCL5;LRRC19;NAPEPLD;EP300
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5270425583109783,-0.8097954510805728,0.7659574468085106,1.0,1.0,1/6,5.79%,RNF8
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3121936927838657,0.8096506031970779,0.8947368421052632,1.0,1.0,17/148,12.12%,SGK2;SGK3;NLK;TGFBR1;RPS6KA4;LATS1;DYRK3;PRKD1;ERN1;CLSPN;EIF2AK3;SGK1;DYRK1A;PRKCA;DYRK2;CAMK4;RPS6KA6
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.31205788903656106,-0.8096034265186152,0.9807692307692307,1.0,1.0,40/231,17.67%,USP27X;ABRAXAS1;UCHL1;PSMA7;NLRP3;ADRM1;USP40;MBD6;PSMD7;UBC;USP20;PSMB4;PSMC3;TAF9B;TOMM20;COPS6;UFD1;USP11;PSMD8;USP35;PSMB5;COPS7A;TAF10;ACTB;INO80;PSMC1;PSMB2;PSMC4;USP1;PSMD2;NFKBIA;PSMA1;USP48;PSMB8;USP22;USP21;PSME1;PSMD10;USP10;USP4
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.4822105793262189,0.8095639674783158,0.7045454545454546,1.0,1.0,2/6,28.11%,GAL3ST1;B3GALT1
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.4822105793262189,0.8095639674783158,0.7045454545454546,1.0,1.0,2/6,28.11%,GAL3ST1;B3GALT1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.3605705817363479,-0.8090840429265242,0.7678571428571429,1.0,1.0,3/42,5.83%,MPZ;GPC1;MAL
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.4101078466978867,0.8090426756417612,0.6666666666666666,1.0,1.0,8/28,17.43%,LEPROTL1;LATS1;MFHAS1;GPM6B;PICALM;COMMD1;NEDD4L;ROCK2
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.5474602685436059,0.8089069513970818,0.782608695652174,1.0,1.0,2/5,7.98%,FRMPD4;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.3497273361361132,0.808745231601209,0.8157894736842105,1.0,1.0,17/133,8.19%,GPC5;SEMA5A;KANK1;FGFR2;SCEL;EGFR;SULF1;ZEB2;FGF10;RNF220;LGR5;PSMD13;TBL1XR1;SPIN1;UBR5;RSPO2;TMEM198
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.47122342700765374,-0.8085512000653272,0.7777777777777778,1.0,1.0,3/12,12.86%,TPM1;ADRA1D;KCNQ1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3893341011030214,-0.8085126004966745,0.8113207547169812,1.0,1.0,10/33,27.71%,NUP133;NUP43;XPOT;NUP155;NUP85;NUP214;RAN;NUP50;SEC13;TPR
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.3893341011030214,-0.8085126004966745,0.8113207547169812,1.0,1.0,10/33,27.71%,NUP133;NUP43;XPOT;NUP155;NUP85;NUP214;RAN;NUP50;SEC13;TPR
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.4831747177680069,0.8083868628262167,0.7241379310344828,1.0,1.0,1/8,4.66%,SLC25A48
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.36667521351466015,-0.8083054335044694,0.7962962962962963,1.0,1.0,14/76,15.70%,WARS1;TRIB2;EPHA1;GADD45A;SH3BP5;CEACAM1;TAF7;PRKRIP1;PTPRB;CAMK2N1;PTPRC;GSTP1;GSKIP;SPRED1
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.5082035174158333,0.8082364939588628,0.7884615384615384,1.0,1.0,4/7,26.30%,ASIC2;PKD2;ABCC8;ABCC9
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.3621375897911611,-0.8082271501490306,0.7368421052631579,1.0,1.0,21/74,13.66%,PAH;HSD11B1;AOAH;UPB1;CACNG5;SLC9A8;CYP2E1;GHR;A1CF;SORD;SLC22A8;HNF4A;AMBP;RBP4;CRYL1;NR1H4;SLC13A3;PPIC;NME4;SERPINF2;SLC5A2
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.5221850737006801,-0.8078726803230314,0.7166666666666667,1.0,1.0,2/7,17.89%,PAX8;SHH
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.4867878841245983,0.8078457983670222,0.717391304347826,1.0,1.0,1/7,6.19%,DYRK3
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.391336752967804,0.8076279470832183,0.6857142857142857,1.0,1.0,4/23,14.59%,ABHD17B;HDAC3;SIRT1;LYPLAL1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.44190996533897914,0.80747711405074,0.7317073170731707,1.0,1.0,3/12,14.31%,TGFBR1;MDK;SALL1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.3629377910102568,-0.8074142363068154,0.75,1.0,1.0,11/58,18.14%,ABRAXAS1;ERCC1;RNF8;PRPF19;HMGB2;MDC1;POLM;POLL;KAT5;XRCC6;CYREN
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.48679111731192176,-0.8072860443315053,0.7058823529411765,1.0,1.0,3/14,9.27%,SH2B2;FPR3;CR1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.45437130308440443,-0.8072027081951842,0.6808510638297872,1.0,1.0,2/11,7.79%,METAP2;METAP1D
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.539109056441864,0.8070459563682135,0.8,1.0,1.0,2/5,17.87%,VEGFA;PROX1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.45565024543598476,0.806870262319723,0.7818181818181819,1.0,1.0,3/13,13.63%,PPARG;PRKG1;MEF2C
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.43389324649765515,0.8066482487442368,0.7045454545454546,1.0,1.0,3/15,12.48%,AP1AR;CORO7;SORT1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.34538684915187345,0.8064555306182608,0.75,1.0,1.0,16/72,13.04%,SEMA5A;HMGB1;WNT5A;NRP1;HSPB1;RHOB;NUS1;PRKD1;HIF1A;ATOH8;PRKCA;BCAR1;SIRT1;EDN1;SASH1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5500681356141522,0.8061442541625305,0.7872340425531915,1.0,1.0,2/5,13.35%,NSMCE2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5500681356141522,0.8061442541625305,0.7872340425531915,1.0,1.0,2/5,13.35%,NSMCE2;SMC5
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5500681356141522,0.8061442541625305,0.7872340425531915,1.0,1.0,2/5,13.35%,NSMCE2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5081777169212864,-0.8061305792677247,0.7058823529411765,1.0,1.0,2/7,24.03%,PPT1;AXL
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.39599595614931976,0.8061171003837413,0.7727272727272727,1.0,1.0,6/22,10.81%,PEX5L;SCTR;PDE4D;PDE3A;GNAI1;PDE2A
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.43977701964542293,0.8060869045260972,0.6585365853658537,1.0,1.0,2/19,6.72%,EGFR;MT1M
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3081737825956749,0.80583644935281,0.926829268292683,1.0,1.0,29/133,17.95%,TRIM22;S100A13;TAB3;ROR1;PELI2;PELI1;ECT2;LITAF;PRKD1;TRIM8;ANKRD17;TRIM5;TAB2;CASP10;NDFIP2;PPM1A;ALPK1;LGALS1;PRKCB;MID2;RELA;SLC20A1;NOD1;GPR89A;TRAF5;EEF1D;TFG;C18ORF32;TRIML2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.3145292818974054,0.8057464698316626,0.875,1.0,1.0,57/286,19.66%,MARCHF1;TRIM22;UBE2J1;RNF217;NEDD4;MARCHF8;UBE2E2;PELI2;PELI1;UBE3D;UBE2U;CUL1;SPOP;PSMD13;LMO7;FBXL7;UBR5;FBXO30;FBXW9;TRIM5;FBXO7;UBE2E3;SMURF2;FBXL3;ARIH1;BTRC;CTNNB1;SHPRH;SASH1;FBXO11;BCL2;SMURF1;UBE2E1;SYVN1;MARCHF5;UBE2D3;PSME4;RNF144A;FBXL17;BARD1;NEDD4L;RNF19B;TRAF5;PSMF1;TRAF1;HECW2;CBFB;AKTIP;TRIML2;TTC3;MDM2;TRIM32;KLHL3;CUL3;FBXO10;WWP1;ZNRF2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.4306989558624533,0.8048221797465146,0.7115384615384616,1.0,1.0,6/17,28.11%,PID1;PICALM;PKDCC;BCL2L1;PPP2R5A;RHOQ
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.4383975824210926,0.8048085030362943,0.7435897435897436,1.0,1.0,4/18,17.55%,ADGRV1;GNAI3;CAP1;STIM1
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.5235439501123815,0.8047966079498752,0.6923076923076923,1.0,1.0,4/6,25.94%,TOR1AIP2;PLK1;NUP54;INTS13
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.5306975411328312,-0.8046372580476949,0.7777777777777778,1.0,1.0,1/8,2.70%,APOD
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.348669968347332,-0.8046225957133777,0.8333333333333334,1.0,1.0,9/65,10.27%,TAGLN;UPK1B;ASCL1;CASP6;DNPH1;VIL1;CDHR2;GSTK1;TPP1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.5386969943221191,0.8044413019718953,0.7555555555555555,1.0,1.0,2/5,11.75%,HDAC2;SIRT1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.33585057479584,0.8042619738583128,0.7551020408163265,1.0,1.0,18/114,10.10%,PPARG;HMGCS1;IRS2;ELOVL6;PSMD13;SCD;NCOA2;TBL1XR1;HDAC3;FDFT1;NR1D2;SMARCD3;LDLR;ODC1;ADIPOR1;PRKAB2;HMGCR;ACACA
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.4442081548953441,-0.8040819587141257,0.7454545454545455,1.0,1.0,2/14,14.16%,EMD;RBM22
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.43303401760452576,-0.8039115907812965,0.7592592592592593,1.0,1.0,3/22,17.36%,CMTR1;METTL3;TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3765621021974395,0.8033905506136545,0.7916666666666666,1.0,1.0,8/77,7.47%,MAP3K11;PLCB1;SPHK1;HMGB1;AGER;CCN2;RELL1;MFHAS1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.4352857317119896,0.8031782040385926,0.782608695652174,1.0,1.0,5/20,14.12%,DNAH5;DLL1;CFAP53;DNAH11;ODAD2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4066194670874496,-0.8030912808295396,0.7446808510638298,1.0,1.0,8/26,15.33%,XPC;UBC;RBX1;CETN2;GTF2H2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.5511323185496694,-0.8030708183401586,0.7407407407407407,1.0,1.0,1/6,2.31%,NOG
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.4509947031016759,-0.8030642646016346,0.7647058823529411,1.0,1.0,1/11,12.69%,DNM1L
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.5214215856092597,0.8030612825679536,0.7872340425531915,1.0,1.0,2/5,9.61%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.4201877166129492,-0.8030361142350689,0.7446808510638298,1.0,1.0,1/31,1.05%,CYP19A1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.45810099594936793,0.802994378241963,0.7441860465116279,1.0,1.0,3/9,10.81%,PDE4D;PDE3A;PDE2A
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.4235140565636845,0.8028652133920987,0.7272727272727273,1.0,1.0,9/19,18.69%,SULF1;RORA;EIF2AK3;HIF1A;C3;PTGS2;C5;HPSE;ARNT
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3958404611099172,-0.8026332356486096,0.6976744186046512,1.0,1.0,5/18,18.22%,EXOSC10;PIF1;NAT10;SRC;STN1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.5506099570313947,0.8025652778616559,0.8297872340425532,1.0,1.0,1/5,3.17%,NRXN1
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.5163388060132219,0.8025319862901504,0.7755102040816326,1.0,1.0,3/6,31.29%,CRLF2;PLSCR1;CD300LF
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.4821481778812643,0.8024893302151022,0.72,1.0,1.0,2/8,8.04%,HSPB1;DLG2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.4821481778812643,0.8024893302151022,0.72,1.0,1.0,2/8,8.04%,HSPB1;DLG2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.4821481778812643,0.8024893302151022,0.72,1.0,1.0,2/8,8.04%,HSPB1;DLG2
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.3336673963866395,0.8024716421036615,0.7857142857142857,1.0,1.0,37/215,12.46%,CD151;SEMA3C;ITGAX;SEMA5A;NTF3;CASS4;FAM83H;SEMA6D;SPHK1;TRIP6;EGFR;CSF1;CCL5;TGFBR1;FGF10;NRP1;GAB1;PPP3CA;LAMC2;HGF;HIF1A;TCAF2;FER;IGF1R;CSF1R;PRKCA;PDGFD;CDH13;SMURF2;PDGFRB;MDK;CXCL12;ACVR1B;BCAR1;LGR6;SEMA3B;EDN1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.44144255433712065,0.8024284684098025,0.7454545454545455,1.0,1.0,3/15,14.93%,OPRK1;PTGES;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4153859479346159,-0.8022289739910484,0.7068965517241379,1.0,1.0,4/29,9.41%,INHA;NODAL;RBPMS;BMP3
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.5021238998524059,0.8020389269947293,0.7551020408163265,1.0,1.0,3/11,19.26%,SLCO1C1;SLCO4A1;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.39827451005665565,0.8017124718746524,0.7441860465116279,1.0,1.0,4/26,11.85%,FGF10;IRS2;ITGAV;ERBIN
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.41148853189268925,0.8012674962881761,0.8235294117647058,1.0,1.0,7/28,17.63%,COBL;DVL2;PRICKLE1;PHACTR4;BBS4;PLXNB2;VASP
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.41148853189268925,0.8012674962881761,0.8235294117647058,1.0,1.0,7/28,17.63%,COBL;DVL2;PRICKLE1;PHACTR4;BBS4;PLXNB2;VASP
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.3756367292320708,0.8012473398494308,0.7272727272727273,1.0,1.0,13/43,17.87%,FGFR2;WNT5A;SULF1;TGFBR1;MBNL1;HINFP;CHD7;LIG4;FGFR1;FUT8;VEGFA;ZNF568;PROX1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.3947276643119443,0.8012415340286858,0.6176470588235294,1.0,1.0,7/26,17.57%,HJV;CYBRD1;SLC40A1;TF;PICALM;COMMD1;HMOX2
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.4845769773681027,0.8011842060450038,0.8035714285714286,1.0,1.0,2/11,8.56%,ARG1;DDAH1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.3760804787147748,-0.8010211955913679,0.7450980392156863,1.0,1.0,3/35,12.84%,EEF1AKMT2;METTL22;TRMT112
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.3409568121056266,0.801010453638002,0.7714285714285715,1.0,1.0,37/171,17.73%,NLGN1;MAGI2;NRXN1;TNIK;RAB29;RAB34;ARL5A;KCNIP4;CACNB2;RAB3C;DLG2;P2RY1;TSPAN17;SAV1;LRRC7;ZDHHC2;KCNB2;DPP10;RAP2A;FGF13;PACS1;ANK2;TSPAN15;ANK3;SMURF1;PIGW;ARL5B;MAP7;BRAF;LIN7A;TMED2;RAPGEF6;SLMAP;BSG;ROCK2;RAP1A;SPTBN1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.4713185829382681,0.800882948803081,0.7045454545454546,1.0,1.0,2/8,9.47%,CAT;PXDNL
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.42864873827866223,-0.8008691993573783,0.72,1.0,1.0,3/23,7.02%,SLC25A10;SLC1A7;GIPC1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.37046430967781774,0.8007114679476088,0.68,1.0,1.0,11/76,13.65%,ZDHHC11;GDAP1;ZDHHC14;PARD3;VPS37D;ZDHHC2;PEX2;PEX13;ZDHHC11B;ALDH3A2;VPS37B
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.49589471232772137,-0.8007049599488626,0.7333333333333333,1.0,1.0,4/10,17.46%,ALOXE3;ALOX12B;LTC4S;HPGD
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.5132986956177001,-0.8005685461584056,0.7674418604651163,1.0,1.0,1/5,11.77%,TCTN1
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),0.5201552758631843,0.8003371235234918,0.6666666666666666,1.0,1.0,2/5,14.32%,HEY1;TGFBR3
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.5290352620653674,0.8003343070290436,0.7674418604651163,1.0,1.0,1/8,3.02%,MAN2A1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.4580786202755487,0.8001103391229343,0.7254901960784313,1.0,1.0,2/13,6.82%,CAVIN1;SPIN1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.47468238706948584,-0.7998874846508927,0.7659574468085106,1.0,1.0,2/14,6.45%,B3GALT4;ST8SIA2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.4413158805998032,-0.7991414430450021,0.723404255319149,1.0,1.0,3/18,12.83%,CACNB1;CACNG1;CACNG6
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.3423195357825631,-0.7990663055669087,0.8548387096774194,1.0,1.0,7/109,4.11%,SFRP1;TAGLN;COL6A2;COL6A1;NOG;COL9A1;ADAMTS12
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.43156754359347416,0.7989288596503495,0.7441860465116279,1.0,1.0,2/13,10.96%,UBE2J1;YOD1
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.33446232430365647,0.7987277607336829,0.8372093023255814,1.0,1.0,15/77,15.14%,RCVRN;HCN1;GABRG3;MGAT4C;SLC2A11;KCNJ6;CHRNB4;GRM6;AANAT;PDE6A;SLC24A2;CNGB1;CREM;UNC13C;CNGA1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.41343930242288324,0.7983042820339722,0.76,1.0,1.0,5/31,9.07%,IFI16;AGER;WNT5A;HSPB1;AIM2
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.4578968029374132,-0.798302128591479,0.6363636363636364,1.0,1.0,2/10,5.08%,DNASE1L1;REXO4
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.4357577767941133,-0.7982777654811117,0.7708333333333334,1.0,1.0,9/16,25.01%,KIF1A;KIF5A;NEFL;MAP1A;SOD1;PAFAH1B1;MGARP;KIF1C;HAP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.42417735151716957,-0.7981567521380672,0.6938775510204082,1.0,1.0,3/23,4.74%,NUPR1;SERPINE1;IL11
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.5250884255654997,-0.7979283726657085,0.7391304347826086,1.0,1.0,1/6,4.74%,IL11
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.40318459226167025,0.7977007162548175,0.7307692307692307,1.0,1.0,3/11,22.99%,WASF2;WASF1;ABI2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3361837366280952,0.7976835770629127,0.7906976744186046,1.0,1.0,13/70,11.55%,CALCR;ADGRB3;TBXA2R;LGR5;RXFP2;ADGRL3;PTGFR;MC4R;FSHR;GNAQ;ADGRL2;CNR2;GNA13
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.3975940512022358,0.7976095576440989,0.7142857142857143,1.0,1.0,5/25,11.73%,SMAD7;SLC8A1;PDE4B;PDE4D;ANK2
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.39122374313496583,0.7975908081292897,0.8292682926829268,1.0,1.0,5/25,15.52%,ECT2;HDAC3;UBR5;PIK3R1;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3356437325379886,-0.7974574904095789,0.8103448275862069,1.0,1.0,11/139,5.05%,SINHCAF;SFRP1;MYB;NOG;WNT9A;ASCL1;SPRED3;TRIB2;ADAMTS12;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.4384686106541111,0.7974363908831081,0.7692307692307693,1.0,1.0,7/18,19.31%,RUNX1;CD22;PRKCB;ELF1;ELF2;CBFB;PAX5
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.3486214799858526,0.7973108818906633,0.7906976744186046,1.0,1.0,14/71,10.96%,FAT4;SSC5D;LDB2;MXRA5;POSTN;PRRX1;NID2;PRKG1;ACTA2;ADAMTSL1;CYBRD1;PDGFRB;COL5A2;CXCL12
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.3361726642817507,0.7972770818814391,0.8571428571428571,1.0,1.0,45/257,14.75%,NRG1;IL17RD;RIT2;ERBB4;IRS1;ZFP36;FGFR2;RCE1;GFRA1;EGFR;ABHD17B;CCL5;ZFP36L2;FGF10;IRS2;TNIK;CUL1;PSMD13;FGFR3;DUSP9;RASAL2;FRS2;FGF17;FGF5;HGF;DLG2;MBP;CSF2RA;PSPN;LRRC7;NCAM1;ITGAV;PDGFRB;FGF13;BTRC;PIK3CA;MEF2A;NRG2;FGFR1;RGL2;MEF2C;PIK3R1;MAPK8;PSME4;WDR83
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3682945689060251,0.7965928697755102,0.75,1.0,1.0,13/54,15.52%,IL17RD;CIDEA;SMAD7;TGFBR1;ADAMTSL2;SMAD2;SMURF2;WFIKKN1;SIRT1;PPM1A;SMURF1;HSPA1A;SMAD3
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.42167930897305783,-0.7964901718565129,0.75,1.0,1.0,6/19,24.33%,CDK5;EIF2B4;EIF2B3;SHH;EIF2B1;EIF2B2
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.47264136544098134,-0.7964237069521118,0.7868852459016393,1.0,1.0,1/8,2.04%,PLK3
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.39880879741070435,0.7963641852902156,0.74,1.0,1.0,5/35,10.28%,PIK3R5;ITGAX;ITGAM;IL4R;ARHGAP30
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.4821795414600868,0.7963113797026461,0.7551020408163265,1.0,1.0,4/7,37.49%,GAL3ST1;B3GALT1;UGCG;UGT8
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.39559916005866197,-0.7963093030542677,0.7115384615384616,1.0,1.0,1/33,0.53%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.4286085642537997,0.796274303134232,0.64,1.0,1.0,4/18,14.93%,CALCR;SNCA;AKAP6;P2RX7
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.5109495809888619,0.796243606120258,0.7142857142857143,1.0,1.0,1/6,3.73%,AGER
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.48379295209425127,0.7961606042094322,0.6875,1.0,1.0,3/9,17.13%,CYP2C8;CYP3A4;ALDH8A1
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.44267055257387294,0.7959712223063244,0.7254901960784313,1.0,1.0,1/11,2.10%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.44267055257387294,0.7959712223063244,0.7254901960784313,1.0,1.0,1/11,2.10%,ZFP36
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3197933204176948,-0.795621616854193,0.8125,1.0,1.0,27/140,18.01%,AURKA;PLK3;RPF2;CDK5;DAXX;TAF9B;TPX2;RPS15;STK11;TAF7;TAF11;MTA2;PIN1;MEAF6;SUPT16H;HUS1;BRD7;TAF6;TAF10;TOP3A;RPL23;TAF1;RPL5;RBBP8;KAT5;RMI1;PAK1IP1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.39360706662745465,0.7953014004456579,0.6470588235294118,1.0,1.0,5/37,9.16%,IRS2;SLC30A8;ZBTB20;ERN1;IGF1R
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.5869928676251366,0.7952124315860427,0.8285714285714286,1.0,1.0,2/5,13.63%,MEGF10;MEF2C
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.32100706288848635,-0.7951062042175742,0.8518518518518519,1.0,1.0,9/78,13.59%,CCN3;CLU;CIDEB;PRR7;LRPAP1;CRYAB;PDE8A;DUS2;BMP7
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.3965515900642985,0.7949569482943091,0.7,1.0,1.0,6/29,12.47%,SLC26A3;HCN1;PDE2A;CRHBP;AKAP6;AANAT
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.43059261153667583,-0.7949049867343605,0.8,1.0,1.0,5/24,9.77%,CACNB1;ADRA2A;AHNAK;CALM1;PRKACA
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.49500850561303766,-0.7948866429468555,0.7843137254901961,1.0,1.0,2/9,7.24%,STX4;SPI1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4177869171953444,0.7944654673022378,0.6923076923076923,1.0,1.0,5/22,16.82%,NEDD4;VPS37D;UBAP1L;VPS37B;UBAP1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.34211734241287933,-0.7944213194530982,0.8421052631578947,1.0,1.0,29/105,23.70%,TSPYL2;DCTN1;WIPI1;EXOSC10;ATF4;NOP14;NFYB;IFIT1;CHAC1;NOLC1;NOP56;EIF4A2;TUBB2A;XPOT;PSAT1;KDELR3;SLC30A5;CKS1B;SRPRA;SLC7A5;IARS1;SPCS1;EXOSC4;KHSRP;EIF4G1;RPS14;GEMIN4;MTHFD2;EEF2
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.48655203847515527,0.7943983464523511,0.7407407407407407,1.0,1.0,5/11,21.65%,KCNK1;KCNK9;KCNN4;KCNK2;KCNK12
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.3981661331306206,0.794291164084077,0.7142857142857143,1.0,1.0,6/27,15.18%,LEPROTL1;GPM6B;CTNNB1;PICALM;COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.3266339053150181,-0.7941747090833843,0.8444444444444444,1.0,1.0,18/103,17.29%,PARP2;SIN3B;INCENP;ATXN7L3;TBL1X;MORF4L1;HDAC5;MTA2;BRD8;TAF6;TAF10;MAP3K12;UHRF1;HDAC11;HDAC6;KAT5;USP22;USP21
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.474181489706239,-0.794084645897383,0.7777777777777778,1.0,1.0,4/7,38.72%,CTPS2;UMPS;CTPS1;CAD
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.5564688223159715,0.7940685019191872,0.8292682926829268,1.0,1.0,1/5,14.96%,IDH1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.5136726109861118,-0.7938467788507296,0.7954545454545454,1.0,1.0,3/9,18.17%,PPP1R3E;PPP1R3D;RUBCNL
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.44602922266095035,-0.7938403657909134,0.7111111111111111,1.0,1.0,5/21,12.01%,APOD;TPM1;VIP;NDRG4;IGFBP3
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.3222538850669073,0.7938109090882268,0.7804878048780488,1.0,1.0,37/272,15.29%,TBC1D3L;SNX31;ESAM;PTPRK;EGFR;WNT5A;FGF10;RABL2B;RAB29;ARL5A;GRID2;CNTNAP2;TBC1D12;SEPTIN11;TBC1D8B;REEP1;BICD1;RAP2A;MYO7A;ATG9A;RABGAP1L;GRTP1;RUNDC1;CTNNB1;ARFIP1;ANK2;TMED9;SMURF1;PIGU;TBC1D1;CNTLN;USP6NL;EVI5;KIF13A;DMD;TBC1D4;ARL5B
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.45178892906929286,-0.7935709846143453,0.7647058823529411,1.0,1.0,2/14,6.74%,GHR;PRLR
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.39117714273347126,-0.7935659366720187,0.7777777777777778,1.0,1.0,10/36,23.30%,HEBP2;PINK1;PIP5KL1;PRELID1;PRDX3;BAK1;TUSC2;ATP5IF1;SOD1;UBB
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.46053790053120625,0.7935041361131472,0.627906976744186,1.0,1.0,2/11,12.98%,ARID1A;PLPP1
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.4401627148352539,0.7931683742576285,0.6595744680851063,1.0,1.0,1/9,3.49%,DXO
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.3747489452405529,-0.793149077489291,0.803921568627451,1.0,1.0,13/56,15.70%,WARS1;TRIB2;EPHA1;CEACAM1;TAF7;PRKRIP1;NPRL2;CAMK2N1;PTPRC;PRDX3;GSTP1;GSKIP;SPRED1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5237703907965852,0.7930883492738797,0.7358490566037735,1.0,1.0,2/9,6.49%,STEAP4;SLC1A2
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5237703907965852,0.7930883492738797,0.7358490566037735,1.0,1.0,2/9,6.49%,STEAP4;SLC1A2
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.34375056210876354,0.7927974204926821,0.7,1.0,1.0,31/127,19.30%,ERBB4;TSHZ1;PBX1;EGFR;UNC5D;GRM5;SLC35F1;PPM1E;GRID2;ADGRL3;POU6F2;EPHA7;NOL4;NCAM1;B4GALNT4;SIRT1;PROKR2;ERC2;CBLN1;CSRNP3;MAPK4;PLPPR5;NTNG1;DPYSL5;PROS1;IGDCC3;TRIM32;TMEM59L;EPHA4;GAL3ST3;PAK5
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.38725451632502844,-0.7927356643625985,0.8,1.0,1.0,2/16,6.51%,HCK;CDK5
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.38005231860012945,0.7927076785917022,0.6938775510204082,1.0,1.0,14/37,20.29%,B4GALNT2;ST8SIA6;GLA;ABO;B4GALT1;FUT9;ST6GALNAC4;ST8SIA4;FUT8;ST8SIA3;GAL3ST3;ST3GAL6;ST8SIA1;ST3GAL4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.41185241830190666,-0.7925832542347623,0.7959183673469388,1.0,1.0,2/24,6.56%,UBC;XRCC1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.559010309383011,-0.7923483164723952,0.7954545454545454,1.0,1.0,2/5,20.50%,PPP1CA;PPP2CB
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.45540124751207056,-0.7920959573821599,0.7547169811320755,1.0,1.0,3/13,11.00%,APOD;ADRA2A;CEACAM1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.3650337717577805,0.7919186128639122,0.7441860465116279,1.0,1.0,5/32,15.28%,CENPI;KNL1;HELLS;CENPO;MIS12
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3388521346377134,-0.7916106492648267,0.835820895522388,1.0,1.0,6/121,5.20%,STING1;SFRP1;AQP8;CASP6;P2RY11;KCNE1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.4550392883820765,0.7913133270892749,0.8043478260869565,1.0,1.0,5/20,10.56%,HMGB1;XKR6;MEGF10;ITGAV;NR1H3
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4008867192157066,0.7912415724025563,0.8367346938775511,1.0,1.0,9/27,21.24%,ECT2;RHOB;SIRT1;RELA;MAP3K5;PLEKHA1;NFE2L2;SIRPA;ABL1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.45862243856368884,-0.791134767464241,0.7192982456140351,1.0,1.0,4/11,20.70%,RPP25;POP1;POP7;POP5
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.37141896248558925,-0.7909789026697422,0.8833333333333333,1.0,1.0,11/69,10.97%,SLC25A10;HMGB3;PACSIN3;AGRN;GIPC1;EIF5A;REEP6;KDELR1;LAS1L;CCDC86;TMEM52
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.5010636972269774,0.7907127829344878,0.68,1.0,1.0,1/5,10.70%,GNAI1
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.4823749905537077,-0.790332065560333,0.7241379310344828,1.0,1.0,4/8,25.32%,PER2;PIWIL2;SUV39H1;CRY2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.4608825972169792,0.7902800461814352,0.6909090909090909,1.0,1.0,4/10,22.48%,AFDN;RAPGEF6;TJP3;RAPGEF2
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.3979831722763882,0.7902490312390111,0.7,1.0,1.0,4/28,9.16%,CALCR;AGER;GRM5;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.4224417678902178,-0.7901112389059257,0.6530612244897959,1.0,1.0,4/23,5.58%,TERF2IP;H1-4;ERCC1;H1-0
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4513956128135106,0.7899826892422002,0.7924528301886793,1.0,1.0,2/15,4.20%,ERBB4;CCL5
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.42787625419588543,0.7896589118590628,0.82,1.0,1.0,3/17,11.75%,HSPB1;HIF1A;SIRT1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.4170044285669917,-0.7894802030031887,0.7254901960784313,1.0,1.0,2/27,3.52%,PIGO;PGAP2
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.34198261512364597,-0.7892663690832279,0.7777777777777778,1.0,1.0,17/91,16.27%,WARS1;TRIB2;TSPYL2;EPHA1;CD4;DAXX;CEACAM1;TAF7;PRKRIP1;AZU1;CAMK2N1;PTPRC;AGAP2;GSTP1;GSKIP;SPRED1;CENPE
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.33109102706828036,0.7892286137102417,0.75,1.0,1.0,39/298,16.21%,TBC1D3L;SNX31;REP15;LRP1B;PPARG;ATP6V0A4;TVP23B;RABL2B;RAB29;RAB34;ARL5A;TBC1D12;ARRDC3;RAB3C;ATP6V0D2;TBC1D8B;RABGAP1L;TF;GRTP1;RUNDC1;ARFIP1;BLZF1;TMED9;ANK3;TBC1D1;CALCRL;CHMP1A;USP6NL;EVI5;PRKCB;KIF13A;TBC1D4;VMP1;ARL5B;MIA2;LTBP2;TBC1D5;LAMP2;TMED2
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.5407074121983206,0.7889611997420799,0.72,1.0,1.0,1/5,4.60%,FGF10
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.35121417826390805,0.788777925818944,0.8333333333333334,1.0,1.0,17/81,14.75%,NOX5;FAS;PPARGC1A;FOXO3;CAT;PRKD1;SNCA;ERMP1;MSRA;PRDX6;FOXO1;PIK3CA;ADNP2;MGAT3;EIF2S1;HSPA1A;CPEB2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.42140618479386466,-0.7886394864576847,0.6538461538461539,1.0,1.0,2/19,5.62%,IL31RA;GHR
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.3277246344705098,0.788162742248836,0.6944444444444444,1.0,1.0,28/123,17.73%,TNIK;RAB29;RAB34;KCNIP4;CACNB2;RAB3C;P2RY1;TSPAN17;ZDHHC2;KCNB2;DPP10;RAP2A;FGF13;PACS1;ANK2;TSPAN15;ANK3;SMURF1;PIGW;MAP7;LIN7A;TMED2;RAPGEF6;SLMAP;BSG;ROCK2;RAP1A;SPTBN1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.4822450230761126,-0.7879065600341194,0.75,1.0,1.0,3/9,22.49%,HM13;SPCS1;SEC11C
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.48631747851353113,-0.7878378624715281,0.7272727272727273,1.0,1.0,1/5,23.81%,GPS2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4060451857104351,0.7876320034543216,0.7083333333333334,1.0,1.0,1/15,1.23%,KCNE4
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4262188618112437,-0.7874419574700635,0.7924528301886793,1.0,1.0,3/22,8.55%,NCKAP1L;ITGA6;GLMN
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.418150903754978,-0.7872266582502772,0.7307692307692307,1.0,1.0,3/38,4.85%,SFRP1;CD74;FTH1
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.4514229646386568,-0.7868405720284919,0.75,1.0,1.0,2/9,13.59%,PINK1;BMP7
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.3631026423516206,-0.7867893143319226,0.813953488372093,1.0,1.0,4/53,6.38%,ISM1;SARS1;COL4A3;NAXE
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.35490932987107066,-0.7867031185286343,0.8113207547169812,1.0,1.0,2/87,1.83%,GSTM5;GSTM3
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.41044234999028756,-0.7864383301016841,0.7333333333333333,1.0,1.0,7/24,19.10%,ATXN7L3;SKP1;DTX3L;DDB1;UHRF1;RING1;RNF20
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.40276591152040836,0.7862383107112747,0.7916666666666666,1.0,1.0,6/31,14.12%,DNAH5;RFX3;DLL1;CFAP53;DNAH11;ODAD2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.3118800953062939,0.7858986200090196,0.9148936170212766,1.0,1.0,23/146,12.46%,EIF3E;IRS1;PRR16;EGFR;PPARGC1A;CCL5;ZEB2;KLF2;IRS2;SNCA;ZNF205;HGF;LDLR;HIF1A;DDAH1;DDAH2;PDGFRB;STARD4;NR1H3;DYRK2;PTGS2;SIRT1;EDN1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.3836511754310672,0.78574063083911,0.7948717948717948,1.0,1.0,4/28,13.96%,CENPI;KNL1;HELLS;CENPO
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.44494903924370366,0.7856663775313356,0.7674418604651163,1.0,1.0,4/20,14.19%,DGAT2;PLCE1;PLA2G15;DGKB
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.4292389498944645,-0.7855867003682396,0.8043478260869565,1.0,1.0,1/13,3.60%,PDZD7
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.32952706192636333,0.7855444393832341,0.8541666666666666,1.0,1.0,17/82,16.09%,NFKBIZ;WNT5A;CCL5;PLA2G7;SNCA;ANKRD17;PRKCA;IL16;PDGFRB;MDK;PDE2A;NAPEPLD;ADAM8;SASH1;IFI35;AKIRIN2;LPL
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.46050891879669154,0.785416917654387,0.8888888888888888,1.0,1.0,6/13,26.99%,APBA1;DYNC1I2;ARHGAP21;DYNC1I1;BORCS5;CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.366582990714334,-0.785373622602364,0.84,1.0,1.0,3/51,4.07%,NUPR1;SERPINE1;ETS1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.40814641118988687,-0.7851895241331639,0.7719298245614035,1.0,1.0,2/32,2.83%,SFRP1;MEOX1
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.4869033368533105,-0.7851620491312157,0.7916666666666666,1.0,1.0,2/6,15.04%,CERS2;RTN4R
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.45144588420730797,0.785063096771508,0.7380952380952381,1.0,1.0,4/14,13.63%,MCTP1;CHRNB4;SNCAIP;MEF2C
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.37503396461698174,0.7849941437451267,0.7708333333333334,1.0,1.0,11/43,20.69%,RAB34;BLZF1;ANK3;KIF13A;COMMD1;SPTBN1;EXOC8;GGA1;RAB10;EXOC6B;LLGL1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.3705488213726694,-0.7849834731628946,0.7931034482758621,1.0,1.0,10/32,25.44%,CAMLG;EMD;EMC8;CYB5A;EMC4;EMC3;SEC61G;EMC1;OTOF;BAG6
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.393908166371736,-0.7844619397561918,0.7543859649122807,1.0,1.0,3/23,8.01%,FGF20;SYT6;DRD3
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.48252030595586487,0.7842963627299345,0.74,1.0,1.0,1/7,3.37%,SPHK1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2856328275196625,0.7842734825717456,1.0,1.0,1.0,63/381,13.90%,ESRRG;NAB1;NFIL3;TRIM22;BNC2;CCNA2;TFEB;PPARGC1A;MAGED1;NLK;TGFBR1;TEAD2;RFX3;FOXO3;GRM5;RPS6KA4;NFIA;SP3;ZNF114;NR3C1;DENND4A;NCOA2;SPIN1;ATXN1;JMJD1C;ZNF675;POU6F2;RORA;NR1D2;ZNF205;ZNF516;SUPT3H;HINFP;HIF1A;TULP3;SLC39A8;NR5A2;ANKRD17;DMTF1;DVL2;SPTY2D1;MITF;SSBP2;WWC1;ZNF732;CHD7;ACVR1B;GPBP1L1;MLF1;RYBP;ZNF536;ZNF273;YAF2;FOXN3;ZNF212;SOX11;EP300;NFYC;MEF2C;METAP1;ZNF341;CREM;SLC2A4RG
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.4548438702320017,-0.7841580585204346,0.6388888888888888,1.0,1.0,3/9,13.43%,ADRA2A;KCNQ1;LEP
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3429347847746557,0.7841254872062131,0.7352941176470589,1.0,1.0,32/120,20.14%,NECTIN3;TNIK;RAB34;KCNIP4;CACNB2;RAB3C;P2RY1;TSPAN17;ZDHHC2;KCNB2;DPP10;RAP2A;FGF13;PACS1;ANK2;TSPAN15;ANK3;SMURF1;PIGW;AFDN;MAP7;TMED2;RAPGEF6;SLMAP;BSG;ROCK2;RAP1A;SPTBN1;RAB10;ASB3;ZDHHC23;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.4772675462452475,-0.7838750895977942,0.7413793103448276,1.0,1.0,3/8,34.24%,ITM2C;JAK3;ACOT8
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.4614673547282353,0.7837604172791776,0.7636363636363637,1.0,1.0,1/10,4.20%,CCL5
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3895657273406844,0.7835666042363709,0.7021276595744681,1.0,1.0,2/16,12.72%,NUS1;ALG13
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.437876422476662,0.7835468344737213,0.6829268292682927,1.0,1.0,4/21,14.14%,LEPROTL1;CHMP6;SORT1;CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.4347356688302218,0.7833522643713278,0.7735849056603774,1.0,1.0,4/7,20.53%,FGF10;MDK;STXBP4;TGM1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.34466004158230235,0.7832389061991751,0.7659574468085106,1.0,1.0,30/108,20.26%,IRS1;PPARG;ENPP1;ATP6V0A4;IRS2;GAB1;HDAC9;ATP6V0D2;FER;IGF1R;BCAR1;FOXO1;SORBS1;INSIG2;PIK3R1;INSIG1;CPEB2;TBC1D4;KAT2B;AKT2;PDK4;SOS1;PDK2;RAB10;INSR;ZFP36L1;PHIP;GCK;IRS4;BAIAP2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.421850064213945,-0.7832030135293102,0.7358490566037735,1.0,1.0,4/18,18.00%,SELENOK;FIS1;TMCO1;BAK1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.31163048922293907,-0.7830922267582284,0.9107142857142857,1.0,1.0,17/187,10.95%,PLK4;AURKA;PLK3;FOXM1;CDKN3;HAUS8;DCTN1;LATS2;SKP1;CCND1;ZNF324;MAX;SSNA1;PLK2;PRKACA;CETN2;ODF2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.4700318711901781,0.7829540185972852,0.7592592592592593,1.0,1.0,3/8,23.23%,AKAP6;SLC9A1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4700318711901781,0.7829540185972852,0.7592592592592593,1.0,1.0,3/8,23.23%,AKAP6;SLC9A1;SPPL3
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.4153913503274509,-0.7827616996437614,0.7692307692307693,1.0,1.0,4/20,17.36%,RCC1L;C1QBP;UQCC2;TRMT10C
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.35263879077918764,0.7827248164117203,0.8269230769230769,1.0,1.0,12/52,23.37%,TAB3;FAIM;ZNF675;TAB2;RELA;ERC1;NLRC3;ROCK2;RIPK2;IRAK1BP1;TAB1;BIRC2
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.3017971109136264,0.7825288528020139,0.9523809523809523,1.0,1.0,81/559,13.56%,ACE2;SGK2;SGK3;LTK;NRG1;RUNX1;FRK;ITGAX;NTF3;ERBB4;IRS1;PTPRK;FGFR2;P3H2;SULT2B1;S100A13;MAGI2;EGLN3;CHRNA10;EGFR;CSF1;TGFBR1;PKHD1;FGF10;IRS2;VEGFC;MEIS1;MINAR1;FGFR3;BRICD5;CDK6;LAMC2;PTGFR;HDAC2;FGF17;FGF5;TBX6;EPCAM;IER5;PTPN6;BMPR1A;SGK1;CDCA7L;CTBP2;DDAH1;FER;IGF1R;ST18;CSF1R;TP53INP1;DNAJB2;ITGAV;JAG1;PDGFD;MEIS2;RNF139;TIMP1;VEGFD;CDH13;DLL1;PDGFRB;PTPN14;GML;TENM1;CTNNB1;SIRT1;MARCHF7;LIFR;BTG2;EDN1;ARID2;BOK;PLPP1;BCL2;SOX11;FGFR1;SCX;AVPR1A;GID8;NACC2;RBM5
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.3494686671096926,-0.7824625505455793,0.8076923076923077,1.0,1.0,2/76,2.04%,STING1;PLK3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.44529249971578333,-0.7821881202852382,0.7307692307692307,1.0,1.0,1/10,6.80%,VIP
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.3932804322128862,-0.7820336275020519,0.7924528301886793,1.0,1.0,2/23,7.77%,RAC1;PARVB
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4088849979760809,-0.7816097557792598,0.7407407407407407,1.0,1.0,5/22,16.42%,ADRA2A;DRD3;CALM1;GNB5;CALM3
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.4987285043859173,0.7815652490053056,0.7407407407407407,1.0,1.0,1/5,9.61%,NCK1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.41878193595050495,-0.7815472134363247,0.7962962962962963,1.0,1.0,2/24,3.52%,PIGO;PGAP2
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.33894835372779986,0.7814708874736896,0.8444444444444444,1.0,1.0,12/41,21.06%,SLC25A48;SLC7A13;SLC38A11;SLC7A2;SLC38A2;SLC16A10;SH3BP4;SLC7A14;SLC7A9;SLC43A1;SLC38A8;SLC38A10
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.4757155150812261,0.7813910906558869,0.6976744186046512,1.0,1.0,4/7,24.25%,NFATC2;NFATC3;PDCD4;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.3090523335559581,0.7813200812528424,0.8947368421052632,1.0,1.0,55/268,17.43%,CALCR;ITGAX;NTF3;SLC22A2;MAGI2;CSF1;HEY1;PPARGC1A;WNT5A;ROBO1;TGFBR1;FGF10;KLF2;ZNF804A;RAB29;SNCA;TWIST1;UBR5;FGF17;FGF5;RAB27A;TLE1;HINFP;EIF2AK3;HIF1A;ACTA2;SMAD1;MITF;RIMS2;ZBTB7B;ITGB8;PDE2A;ANK2;SLC38A2;ANK3;GABPA;SOX11;PID1;SCX;MEF2C;F3;MAPK8;HSPA1A;P2RX7;PDCL3;AFDN;SMAD3;TBC1D5;BRAF;ATF7IP;VEGFA;BMP6;LIMS1;INHBA;ROCK2
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.46261127607960073,-0.7810260623499153,0.6346153846153846,1.0,1.0,1/9,6.25%,MBTPS2
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.3409823018428334,-0.7807989416121454,0.8305084745762712,1.0,1.0,14/102,12.01%,MYB;TAGLN;COL6A2;COL6A1;RBP1;ADAMTS12;MEG3;CALD1;SPARC;ADAM33;NR1H4;ADAMTS5;CRYAB;IGFBP3
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.5355900217369287,-0.7807958559016215,0.8,1.0,1.0,3/7,19.37%,FPR3;CR1;GPLD1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.34247057634364725,0.7807682623490365,0.8431372549019608,1.0,1.0,8/44,11.75%,TBL1Y;HDAC9;MIER2;TBL1XR1;HDAC3;HDAC2;BRMS1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.40338365191920467,0.7806705972922415,0.7547169811320755,1.0,1.0,2/20,6.01%,EGFR;PSRC1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.47565804523405986,-0.7805897284681999,0.7346938775510204,1.0,1.0,3/9,29.37%,PIAS3;PIAS4;RASD2
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.32202821375880475,0.7804219270827911,0.8372093023255814,1.0,1.0,11/108,15.95%,LRP1B;SLC22A2;SLC19A2;SLC23A1;ARRDC3;ABCC11;CALCRL;CHMP1A;SLC22A6;ABCD3;ABCG2
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),0.5273885941346115,0.780266783172599,0.7948717948717948,1.0,1.0,1/5,11.73%,ANK2
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.4096526068798213,0.7801687768244326,0.7608695652173914,1.0,1.0,2/15,3.73%,KLRD1;AGER
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.4579436572073772,0.7799162385643597,0.7333333333333333,1.0,1.0,1/11,1.57%,KCNJ3
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.31132763664261276,0.7797299260347038,0.8780487804878049,1.0,1.0,60/352,15.52%,NOX5;EIF3E;CALCR;IFI16;ITGAX;SLC22A2;S100A13;PRR16;EGFR;CSF1;HEY1;PPARGC1A;SF3B1;WNT5A;ROBO1;TGFBR1;FGF10;ZNF804A;ELAVL4;TWIST1;UBR5;ERN1;FGF17;FGF5;RAB27A;TLE1;HINFP;EIF2AK3;HIF1A;ACTA2;SMAD1;MITF;CADM1;DYRK1A;RIMS2;ZBTB7B;TAF1A;ITGB8;PDE2A;ANK2;SLC38A2;ANK3;GABPA;SOX11;PID1;EP300;SCX;MEF2C;F3;PIK3R1;TAF1B;MAPK8;HNRNPD;HSPA1A;P2RX7;PDCL3;VIM;KAT2B;AFDN;SMAD3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3545221635147163,-0.7796408624845843,0.8269230769230769,1.0,1.0,2/48,3.79%,NCKAP1L;KIF20B
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.4751854435904566,-0.779525837050568,0.7068965517241379,1.0,1.0,4/8,38.57%,VPS11;VPS41;SAMD9;ANKFY1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.38416863104214466,-0.7793547667056183,0.76,1.0,1.0,10/38,22.76%,CLU;UBE3A;GLMN;RPL23;TAF1;RPL5;DESI1;ARAF;RPL11;UFL1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.4777849098134838,0.7793542706933646,0.8148148148148148,1.0,1.0,1/7,7.86%,LDLR
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.3372345645365779,-0.7787081202568138,0.7777777777777778,1.0,1.0,14/131,8.71%,LCP1;MYO15A;MARCKS;RAC1;RND3;MYO7B;TPM1;RFLNA;TPM4;VIL1;TRPV4;ACTC1;ERMN;RND2
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.37060793957894295,0.7784023493354206,0.7727272727272727,1.0,1.0,2/26,5.38%,CENPI;KNL1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.37060793957894295,0.7784023493354206,0.7727272727272727,1.0,1.0,2/26,5.38%,CENPI;KNL1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.38705222457151794,-0.7780512575677342,0.7454545454545455,1.0,1.0,1/37,0.53%,DDX11
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.45450042730329143,-0.7780333481137214,0.7446808510638298,1.0,1.0,2/7,15.31%,B2M;ATP2A3
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.3426838213428196,0.777879241050534,0.775,1.0,1.0,7/66,14.10%,HMGB1;TAB3;ITGAM;TAB2;TLR1;MAP3K1;UBE2D3
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.5027985409833481,0.7778620638329088,0.7735849056603774,1.0,1.0,2/8,10.56%,PROM2;NR1H3
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.3927587504043027,0.7778278651501098,0.7916666666666666,1.0,1.0,8/35,14.31%,PPARGC1A;ZBTB20;ERN1;HIF1A;IGF1R;SIRT1;FOXO1;PIK3R1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.47498445786725724,0.777471043769876,0.75,1.0,1.0,1/8,3.48%,HMGB1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.37381838466547224,-0.7773899170336774,0.7543859649122807,1.0,1.0,2/31,4.73%,CGAS;B2M
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.29194194231564385,-0.7772715099759997,0.9642857142857143,1.0,1.0,30/441,7.07%,SINHCAF;NUPR1;SFRP1;TNFSF18;HMGN5;IL31RA;HCK;FGF1;FOXM1;CIDEB;SPACA3;RAC1;STX4;KIF20B;FGF20;POFUT2;ETS1;TPM1;TRPC3;EPHA1;BST1;IL11;DNPH1;FGF7;PRR7;TSPYL5;ADRA2A;PRLR;VIP;CCND1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.36303338217343567,0.777130185359232,0.8085106382978723,1.0,1.0,4/27,9.81%,FGF12;ATP2B4;KCNIP4;DPP10
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.36638799265820643,0.7770989779535832,0.8,1.0,1.0,2/33,3.53%,CCNH;CAVIN1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.3990711689120946,-0.776932712753018,0.7755102040816326,1.0,1.0,3/26,10.40%,CGAS;B2M;RSL1D1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.4246604253442237,-0.7768776872340426,0.7719298245614035,1.0,1.0,3/20,10.72%,GNB3;MBTPS2;NR1H4
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.4668619842304276,-0.7767001359821121,0.7083333333333334,1.0,1.0,5/11,31.60%,WRAP53;CCT2;CCT6A;CCT8;DKC1
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.3040575063003784,-0.7763975525382846,0.8666666666666667,1.0,1.0,6/158,3.81%,DSC1;CLDN4;AMH;GTF2F1;STX4;COL9A1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.3698327859770232,-0.7762342940524194,0.7547169811320755,1.0,1.0,4/30,11.41%,APOD;SORD;GALK1;AKR1A1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.44133960536494876,0.7761757766245281,0.8,1.0,1.0,5/13,15.51%,ERBB4;LATS1;CSF1R;WNT2;AKT2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.46894309980655424,-0.7760146652614802,0.803921568627451,1.0,1.0,3/11,13.41%,NLRP3;ZP3;PRKCZ
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.39069020914509545,-0.775815511318149,0.7254901960784313,1.0,1.0,4/23,6.32%,CACNB1;DCTN1;AGRN;DNAJA3
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.37352873000034426,0.7757090098710767,0.7346938775510204,1.0,1.0,16/43,20.84%,ANLN;ECT2;RHOB;PDCD6IP;SNX18;ESPL1;CEP55;ANK3;PLK1;SPAST;BBS4;ROCK2;SPTBN1;EFHC1;CNTROB;CUL7
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.5218463597893066,0.7756455454027786,0.803921568627451,1.0,1.0,1/5,18.73%,PDE12
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.36474922108798236,-0.7756084009647863,0.8113207547169812,1.0,1.0,16/65,13.65%,CLDN4;CBLC;TPPP3;ENTPD2;AZGP1;MYH14;LLGL2;ADRA2A;TMEM45B;ATP2C2;SELENBP1;KCNQ1;CD24;PRKCZ;LEP;TMC4
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.3463938703261632,0.7754583847847183,0.696969696969697,1.0,1.0,16/68,20.43%,DCUN1D1;SPHK1;SMAD7;ARRDC3;HDAC3;PRICKLE1;NDFIP2;MARCHF7;PLK1;COMMD1;CRY1;PHF23;CUL3;DERL1;BMI1;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.35978888666333503,0.7753697281839064,0.7272727272727273,1.0,1.0,3/34,7.04%,MARVELD3;HDAC3;ZNF675
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.41516325618995004,-0.7748426476840192,0.71875,1.0,1.0,1/16,2.45%,LDB1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.4253375160695223,0.774798903163812,0.6862745098039216,1.0,1.0,6/17,14.20%,EPHA3;PRKD1;MCTP1;PROM2;NR1H3;PICALM
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.394682418465925,-0.7746646731040633,0.8363636363636363,1.0,1.0,6/30,11.35%,KIF1A;SHANK3;CDK5;DBNL;LRP8;CUX2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.3745743091030842,0.7746630422089337,0.7959183673469388,1.0,1.0,4/30,10.38%,MAGI2;PPP1R15B;STYXL1;PDGFRB
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.4608644670492145,0.774655414846767,0.7631578947368421,1.0,1.0,2/8,11.75%,H3-3A;SIRT1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.3248928933923259,-0.7746342118206225,0.86,1.0,1.0,19/129,14.62%,GPR3;SLC29A3;PLAG1;MYO15A;RYR1;SCGB1A1;KCNE2;CACNG1;PDE6B;ACTC1;EDAR;PKP1;NPHS1;STAG3;SELENOP;PROP1;RSAD2;P2RX6;ALOX12B
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.4921281260733046,-0.7745949816372861,0.7166666666666667,1.0,1.0,1/6,12.65%,APOA1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.3148175426467784,0.774253856044512,0.8863636363636364,1.0,1.0,30/206,13.07%,IFI16;DAPK2;TRIM22;LEPR;HMGB1;TAB3;TFEB;NEDD4;GFAP;PIP4K2A;FOXO3;HSPB1;PRKD1;ERN1;ATP6V0D2;HGF;TRIM8;ABL2;TRIM5;TAB2;ITPR1;ATF6;TP53INP1;PRKAB2;SNX5;FOXO1;GPR137B;BOK;BCL2;EP300
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.38390081183755376,-0.7742378591551864,0.8545454545454545,1.0,1.0,5/38,14.10%,LDB1;SPI1;JADE2;MEAF6;TAF10
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3224807762242512,0.7741132324479731,0.825,1.0,1.0,10/72,9.01%,CALCR;CYSLTR2;GPR176;SYK;SCTR;RXFP2;MC4R;PRKACB;FSHR;YES1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.45827399423675824,0.773428994909795,0.7857142857142857,1.0,1.0,1/10,3.36%,CIDEA
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.32062330878236844,-0.7730474077890408,0.8301886792452831,1.0,1.0,32/159,17.00%,HK2;PTCD2;TOMM40;SPG7;TIMM17B;MYH14;DNAJA3;HSD17B10;CHCHD10;TOMM20;TWNK;DNM1;COX7A1;PINK1;ATP5F1B;DNM1L;MTX1;ADCK1;CHCHD2;SUPV3L1;TOMM7;TIMM17A;IFIT2;PARP1;PRDX3;SPATA18;TIMM50;FIS1;ATP5F1D;RAB32;TIMM44;POLRMT
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.4094217914461568,0.7729150657649111,0.782608695652174,1.0,1.0,4/13,12.48%,DDIT4;FRS2;BCAR1;SORT1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.5259936549461466,-0.7728965048208626,0.7884615384615384,1.0,1.0,3/6,14.82%,DHX58;C1QBP;TKFC
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.453222618362667,0.7727382000867986,0.7872340425531915,1.0,1.0,3/11,16.40%,NRP1;CTNNB1;VEGFA
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.28052885784053205,0.7726185913870883,1.0,1.0,1.0,125/800,14.97%,ACE2;CALCR;IFI16;ESRRG;NAB1;RUNX1;ITGAX;NFIL3;NFKBIZ;TRIM22;HMG20B;HNRNPH1;BNC2;SLC22A2;TDG;TFEB;CSF1;HEY1;AFF2;PPARGC1A;WNT5A;ROBO1;MAGED1;NLK;TGFBR1;ZNF827;SLC8A1;FGF10;TEAD2;RFX3;ZNF804A;RPS6KA4;NFIA;ATP2B4;SP3;ZNF114;NR3C1;DENND4A;NCOA2;CDK6;SPIN1;ATXN1;JMJD1C;ZNF675;TWIST1;POU6F2;RORA;UBR5;NR1D2;ZNF205;ZNF516;FGF17;FGF5;SUPT3H;RAB27A;MBNL1;PCBP2;TLE1;HINFP;EIF2AK3;HIF1A;BMPR1A;TULP3;SLC39A8;NR5A2;ACTA2;ABCC2;SMAD1;ATOH8;TRIM5;DMTF1;DVL2;SH3GL2;SPTY2D1;NOVA1;MITF;SSBP2;RFXANK;TIPARP;LRRC19;WWC1;RIMS2;ZNF732;CHD7;ZBTB7B;ITGB8;PDE2A;ACVR1B;GPBP1L1;MLF1;RYBP;NDFIP2;ANK2;SIRT1;ZNF536;ZNF273;ADNP2;SLC38A2;MBNL2;SORT1;YAF2;FOXN3;ZNF212;ANK3;GABPA;ADNP;SOX11;PID1;EP300;SCX;NFYC;MEF2C;ZNF341;CREM;SLC2A4RG;F3;PICALM;CCDC3;MAPK8;HNRNPD;HSPA1A;SPIN2B;NFATC2;P2RX7;PDCL3
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3290778434826514,-0.7724687143467754,0.8333333333333334,1.0,1.0,4/93,5.09%,CCN3;SFRP1;TSPYL2;TCHP
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.4518452871557919,-0.7724587968870578,0.7678571428571429,1.0,1.0,2/10,7.70%,TK2;PUDP
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.41551470264839274,0.7719748896130674,0.7435897435897436,1.0,1.0,2/23,3.74%,ZFP36;EGFR
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.47751766799185397,0.7719408146613796,0.7735849056603774,1.0,1.0,1/7,6.53%,RP1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.4562218517445338,-0.7719089673250515,0.8076923076923077,1.0,1.0,1/9,2.31%,NOG
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.3176396952445333,0.7717384477222728,0.8936170212765957,1.0,1.0,45/282,19.34%,TBC1D3L;SNX31;NLGN1;SYK;RABL2B;RAB29;ARL5A;TBC1D12;RANBP3L;TBC1D8B;AP1M2;MAIP1;PRICKLE1;RABGAP1L;GRTP1;RUNDC1;ARFIP1;AKAP6;TMED9;SMURF1;TBC1D1;USP6NL;EVI5;PPP1R10;KIF13A;TBC1D4;ARL5B;LTBP2;AKT2;BCS1L;TBC1D5;LAMP2;TMED2;AP4B1;HERC2;ARL17A;NUP42;STX17;RAB21;GGA1;ACD;STX8;SNX17;IPO8;ANKLE1
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.49914400234022493,-0.7717187025777389,0.803921568627451,1.0,1.0,1/6,5.62%,GHR
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.40604124998282015,0.7716206584305939,0.7380952380952381,1.0,1.0,6/25,21.18%,TBXA2R;HDAC9;PTGS2;VEGFA;AKT3;MEOX2
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3562399188836122,-0.7709480909249101,0.8771929824561403,1.0,1.0,16/45,22.76%,SH3RF2;PRR7;SVBP;CAMLG;COPS9;PIAS3;PER2;RPL5;VPS28;USP4;RPS3;ISG15;RPL11;SPRY2;SQSTM1;UFL1
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.36328126823776286,0.7707724005643527,0.8297872340425532,1.0,1.0,19/44,28.92%,CNKSR1;RHOB;CDH13;GNA13;ARHGAP5;ADGRG1;PHACTR4;EPS8;ROCK2;ARHGEF3;EPS8L2;RHOU;CDC42EP3;WAS;CDC42EP1;RHOG;ARHGAP29;ARHGDIA;RIPOR1
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.5292024904803065,-0.7706236710403159,0.8085106382978723,1.0,1.0,1/5,31.85%,AKT1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.31112740136634504,0.7701667605463605,0.8421052631578947,1.0,1.0,27/170,11.75%,FAS;EFNA5;ERBB4;LEPR;AGER;EGFR;FGF10;PELI2;TNIK;VEGFC;ACVR2A;HDAC3;LIMK2;FGF17;FGF5;HGF;PROM2;DVL2;P2RY1;C3;CSF1R;DYRK1A;VEGFD;RAP2A;NPTN;BRMS1;SIRT1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.4535091904305693,0.7698232004293831,0.7368421052631579,1.0,1.0,6/11,32.34%,PKD2;GRIN2B;PKD1;CPSF6;CPSF7;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.5091450860868371,-0.7697912991120937,0.8113207547169812,1.0,1.0,1/8,6.67%,ADRA2A
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.37569745012373423,0.7695935978214582,0.813953488372093,1.0,1.0,10/39,23.64%,GLA;GLB1;ESYT3;SMPD4;HEXB;ESYT2;ST8SIA3;ST8SIA1;GALC;B4GALT6
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.4822601483023006,-0.7694711342229212,0.6888888888888889,1.0,1.0,4/6,25.80%,NMD3;RAN;NPM1;SDAD1
prerank,PanglaoDB_Augmented_2021__Platelets,0.3496101441295566,0.76934392034826,0.7692307692307693,1.0,1.0,10/110,4.84%,NOX5;ESAM;GRAP2;ITGAX;SELPLG;TUBB1;CYP2U1;CCL5;ITGAM;ACKR3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.3954091771060888,-0.7690220823342518,0.7857142857142857,1.0,1.0,3/27,6.09%,LCP1;RFLNA;CALD1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3196138479010263,0.7689677757814494,0.9148936170212766,1.0,1.0,21/84,22.58%,UBE2J1;TMEM67;DNAJB2;RNF139;YOD1;SYVN1;UGGT1;FAM8A1;JKAMP;SEL1L;RHBDD2;USP13;RNF185;RNF103-CHMP3;DERL1;ERLIN1;UBE4A;RHBDD1;EDEM1;RCN3;UBE2J2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.41023226257034345,0.7687944988894005,0.803921568627451,1.0,1.0,3/14,13.63%,HELLS;BCL2;MEF2C
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.3707011134617087,0.7687370870427547,0.8108108108108109,1.0,1.0,3/33,9.51%,CASS4;GRM5;CSF1R
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.3613480240778228,-0.7686299211049298,0.7777777777777778,1.0,1.0,6/56,10.29%,PIGO;PORCN;PGAP2;WIPI1;SELENOK;WIPI2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.44994330362128687,0.768495415868296,0.7391304347826086,1.0,1.0,3/9,15.40%,SIRT1;EP300;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3152924127496797,0.7683437923570084,0.9166666666666666,1.0,1.0,4/94,3.76%,EIF3E;PLA2G10;PRR16;CSF1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.31627872884422653,0.7682853103601898,0.8260869565217391,1.0,1.0,21/184,13.15%,NOX5;FAS;CASP12;DAPK2;EFNA5;EGLN3;DDIT4;RHOB;TP63;ESPL1;IFT57;CASP10;GML;CASP7;FOXO1;PIK3CA;LIG4;BOK;BCL2;EP300;AIFM2
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.40422038692011436,0.7682730532730019,0.8269230769230769,1.0,1.0,7/31,17.63%,COBL;DVL2;PRICKLE1;PHACTR4;BBS4;PLXNB2;VASP
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.4980708389285682,-0.7681672701383767,0.8333333333333334,1.0,1.0,1/8,2.31%,NOG
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3199842276030467,0.768022196761188,0.8918918918918919,1.0,1.0,10/71,9.01%,CALCR;CYSLTR2;GPR176;SYK;SCTR;RXFP2;MC4R;PRKACB;FSHR;YES1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.46488571814202573,-0.7679875891415778,0.74,1.0,1.0,2/6,10.08%,GFUS;MPI
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.5027791627348858,-0.7679122807041399,0.8076923076923077,1.0,1.0,2/6,16.99%,ACE;CARD9
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.3233038896854342,0.7676213807419516,0.8205128205128205,1.0,1.0,12/94,11.75%,CCNH;CCNB3;PPEF2;CCNA2;SLC8A1;CCNP;SNCA;CSF1R;CCNE2;CDK12;CCNG1;SIRT1
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.4987664815111953,0.7676072418627093,0.8305084745762712,1.0,1.0,2/5,31.37%,ABHD12;ABHD2
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.45715733512497536,0.7675710183971457,0.78,1.0,1.0,2/9,20.75%,ODC1;SMS
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.3429670279165012,-0.7675340983454547,0.864406779661017,1.0,1.0,18/86,18.28%,RPS27L;UPF3B;RBM3;UPF3A;EIF5A;RCC1L;NIBAN1;CIRBP;C1QBP;METTL3;POLR2G;UQCC2;NAT10;RPL5;BOLL;TRMT10C;PIWIL2;EIF2S3
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.5120352883016305,-0.7674520824568885,0.7647058823529411,1.0,1.0,2/6,30.44%,YBX1;DDX1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.4929279020887528,0.7674467481260397,0.84,1.0,1.0,2/7,8.56%,ARG1;DDAH1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.36479562596295634,-0.767414931457134,0.7884615384615384,1.0,1.0,10/33,25.01%,KIF1A;KIF4A;KIF5A;NEFL;MAP1A;MAPK8IP3;SOD1;MGARP;KIF1C;HAP1
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.5081910300386895,-0.7671218038597416,0.7894736842105263,1.0,1.0,1/5,6.67%,PAX8
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.45466893434357303,-0.7670014348113897,0.7659574468085106,1.0,1.0,2/11,8.29%,MBTPS2;ATF4
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.42209492383195224,-0.7665798508003646,0.7083333333333334,1.0,1.0,6/16,18.00%,CLU;DNM1L;IFI6;TIMM50;FIS1;BAK1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.32538222888754775,-0.7665319291954813,0.8214285714285714,1.0,1.0,11/108,7.33%,SFRP1;PLK3;BACH1;EPAS1;PSMA7;PSMD7;UBC;RBX1;PSMB4;LIMD1;PSMC3
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.37119553505169794,0.7664920693157304,0.8095238095238095,1.0,1.0,8/41,11.89%,GPC5;GPC6;HS3ST5;HS2ST1;HS3ST3B1;UGDH;HS3ST1;EXT1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.35493861861074577,-0.7664709782034625,0.8363636363636363,1.0,1.0,4/62,2.43%,SINHCAF;SFRP1;WNT9B;FOXM1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.556901827302338,0.7659225412390128,0.8,1.0,1.0,1/5,3.48%,HMGB1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.4284443269334434,0.7656905095705961,0.75,1.0,1.0,7/21,20.81%,NAV3;FGF13;HDGFL3;CLASP1;APC2;CLASP2;ATXN7
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3317697738928801,-0.7656218102554875,0.8833333333333333,1.0,1.0,9/87,8.87%,COL6A1;ADAM12;RND3;ADAMTS12;TPM1;GPC1;CALD1;ACTC1;SYNC
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.3969330595785592,-0.765614320164462,0.7735849056603774,1.0,1.0,8/33,22.67%,HPS4;ARIH2;PINK1;TOMM7;BAG4;ATP5IF1;VPS11;UBL5
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.5358871100898404,-0.7654477689411241,0.7872340425531915,1.0,1.0,2/5,15.37%,CRACR2A;ORAI1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.4458164295846963,0.7653624449625579,0.7906976744186046,1.0,1.0,4/10,20.62%,SIRT1;ACADVL;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.31118342118722014,-0.7648822251323678,0.8653846153846154,1.0,1.0,9/138,9.84%,CNGA3;KCNQ4;ANO1;SLC6A9;SCN11A;SCN4B;KCNC4;ATP1B1;SLC6A20
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.36686762243094573,0.7648349904167759,0.7916666666666666,1.0,1.0,4/28,11.73%,SLC8A1;TRDN;SOCS2;ANK2
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.46452413577161566,-0.7647479401175232,0.7547169811320755,1.0,1.0,1/8,2.62%,ASCL1
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.3904711536671396,0.7646509361021718,0.7115384615384616,1.0,1.0,11/26,27.30%,RANBP3L;SMURF1;NUP42;ANKLE1;STRADA;STYX;RANBP17;XPO1;XPO7;XPO4;PKD1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.38527926817585884,-0.7646123814087671,0.8823529411764706,1.0,1.0,5/43,9.08%,ATP6V1E2;ATP6V1E1;FTH1;SCARA5;ATP6V1D
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.4501989543491781,-0.7645435917275563,0.7142857142857143,1.0,1.0,3/9,12.04%,DLX5;TRPV4;COL13A1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.4845225614730931,0.7645234785180246,0.7708333333333334,1.0,1.0,1/6,7.98%,CTNNA2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.35861928262078446,0.7644829823948478,0.8043478260869565,1.0,1.0,2/45,1.79%,FZD1;FRAT2
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.48742865224221543,-0.7644550464172423,0.74,1.0,1.0,2/9,7.47%,ASCL1;PAX6
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.483176904737582,-0.7644361469560108,0.7446808510638298,1.0,1.0,3/7,18.69%,CEACAM1;TMEM100;KDR
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.41153578498466825,0.7644158023722313,0.7636363636363637,1.0,1.0,1/15,1.23%,KCNE4
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.441378571831943,0.7641234474200869,0.7692307692307693,1.0,1.0,5/16,20.33%,PPARGC1A;ACADVL;PDK4;TYSND1;ACADL
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.4473374152338408,0.7636997249763443,0.7674418604651163,1.0,1.0,2/13,6.91%,PUS10;PUS7L
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.42745566004540203,0.7636357902828166,0.7608695652173914,1.0,1.0,4/8,17.66%,SLC4A4;ATP12A;SLC9A1;ATP1A2
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.5163080420679542,0.7635089398963564,0.75,1.0,1.0,3/5,25.58%,EDN1;PROX1;CAV3
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4343041664287459,-0.7633199497808765,0.7346938775510204,1.0,1.0,2/6,12.65%,MYADM;APOA1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4343041664287459,-0.7633199497808765,0.7346938775510204,1.0,1.0,2/6,12.65%,MYADM;APOA1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.40821200977088995,-0.7631186427551826,0.8035714285714286,1.0,1.0,2/33,2.80%,SFRP1;PLK5
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),-0.5419215096924968,-0.7629706519113842,0.8260869565217391,1.0,1.0,2/5,17.89%,SPI1;SHH
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.46702351605717407,0.7628812838538913,0.6756756756756757,1.0,1.0,2/6,25.69%,NOP53;TANK
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.4919064641109577,0.7627647002181044,0.7777777777777778,1.0,1.0,3/6,19.46%,FGF13;PEX13;EFHC1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.43961563676963805,-0.7623045026321645,0.7962962962962963,1.0,1.0,2/10,17.78%,ALKBH2;ALKBH5
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.43961563676963805,-0.7623045026321645,0.7962962962962963,1.0,1.0,2/10,17.78%,ALKBH2;ALKBH5
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.41790761275301785,0.7622470988043729,0.7254901960784313,1.0,1.0,6/18,25.09%,BCS1L;COX19;COX10;SCO1;TIMM21;SCO2
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.39712874602341436,0.7622392039736856,0.7659574468085106,1.0,1.0,6/27,13.11%,NLGN1;NRXN1;NLGN4X;TMEM108;RIMS2;CBLN1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.30637732551879926,0.7621782967978392,0.926829268292683,1.0,1.0,63/332,14.47%,NRG1;ZFPM2;ITGAX;NTF3;ERBB4;IRS1;FGFR2;S100A13;SPHK1;EGFR;CSF1;WNT5A;CCL5;TGFBR1;PKHD1;FGF10;IRS2;VEGFC;MEIS1;FGFR3;MEGF10;CDK6;LAMC2;TOX;PTGFR;HDAC2;FGF17;FGF5;TBX6;EPCAM;PTPN6;BMPR1A;CDCA7L;FER;IGF1R;CSF1R;ITGAV;PDGFD;MEIS2;TIMP1;VEGFD;CDH13;DLL1;PDGFRB;DISP3;MDK;SIRT1;MARCHF7;LIG4;LIFR;EDN1;BCL2;SOX11;FGFR1;PID1;SCX;AVPR1A;GID8;MEF2C;MEIS3;SAAL1;TGFBR3;WNT2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.3835446828324369,-0.7619241800443028,0.7884615384615384,1.0,1.0,9/32,16.40%,SLC51A;SLC16A8;STARD5;RBP4;NR1H4;CEACAM1;SLC10A6;ABCC4;ABCB11
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.4414801437877507,0.7618647972207567,0.7272727272727273,1.0,1.0,1/7,9.67%,DYRK1A
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.40330263571774144,0.7617902119503693,0.8292682926829268,1.0,1.0,3/22,6.53%,RUNX1;ZFP36;ERRFI1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.35648546474364273,0.7617754796638182,0.8409090909090909,1.0,1.0,13/51,14.92%,CDH8;CDH20;SMAD7;CDH18;CDH10;CDH2;CDH6;PRKCA;CLDN12;CTNNB1;GJC1;CTNND2;PARD6B
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.45326566381031425,0.761737035611444,0.775,1.0,1.0,3/13,7.07%,FGFR2;TGFBR1;TWIST1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.38666317395412764,0.761719485582094,0.8085106382978723,1.0,1.0,1/24,4.21%,ST8SIA6
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.30082957520452475,-0.7615725787246452,0.9473684210526315,1.0,1.0,37/253,14.04%,NUPR1;SFRP1;USP27X;SPDEF;CLU;OBSCN;RASGRF2;VAV3;ITGA6;FGD3;PDCD5;UTP11;LATS2;UBC;GADD45A;CDK5;PRR7;DUSP6;TRAF7;RFPL1;ATF4;PTPA;BTG1;ITGB3BP;PIDD1;IGFBP3;TNFAIP8;CYP1B1;C1QBP;DNM1L;SFRP4;RACK1;APH1B;PIP5KL1;PNMA2;SAP18;IFIT2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.45865606215659505,-0.7614632010092972,0.8301886792452831,1.0,1.0,5/8,40.55%,RIOX1;KDM5C;RIOX2;KDM1A;KDM1B
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.42703710930857913,0.761424299302855,0.7291666666666666,1.0,1.0,5/11,32.20%,YWHAZ;ARHGAP21;RIPOR1;HOOK3;UVRAG
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.33705086259381334,0.7613661812494513,0.8260869565217391,1.0,1.0,8/94,8.34%,NRG1;NTF3;WNT5A;TNIK;ECT2;BORA;CLSPN;PRKACB
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.3849914935638879,-0.7609046539825435,0.873015873015873,1.0,1.0,3/34,5.20%,DUOX1;AQP8;KCNE1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.43637002317722884,0.7608506314164377,0.8787878787878788,1.0,1.0,1/10,3.10%,GGCT
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.4588879090442248,0.7608115086117898,0.8181818181818182,1.0,1.0,3/8,25.78%,HTR1E;HTR1F;HTR5A
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.3500155218026343,-0.7607527788672623,0.85,1.0,1.0,5/61,6.17%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.429504177008779,-0.7606916963877635,0.8,1.0,1.0,6/17,26.45%,SRC;DENND10;MAP2K1;VPS11;PTPN23;EZR
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.465803816023473,-0.760686409185854,0.7924528301886793,1.0,1.0,2/8,13.53%,CYP2E1;KYNU
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.3498398877964395,0.760192881502185,0.75,1.0,1.0,5/31,11.88%,LOXL2;NRP1;CDH13;PIK3CA;PRSS3
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.3309060789527656,0.7601508738399269,0.8125,1.0,1.0,8/43,18.52%,ZBTB1;PRIMPOL;NSMCE1;POLD3;RAD18;RFC5;WDR33;POLN
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4079889682596893,0.760040323766342,0.782608695652174,1.0,1.0,12/28,22.19%,IRS1;FGFR3;PRKD1;PDGFRB;PIK3R1;WDR81;PTK2;WASHC1;FLT1;AMBRA1;EPHA8;TNFAIP8L3
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.30796020267544805,-0.7599329576659433,0.9622641509433962,1.0,1.0,17/165,10.10%,INHA;CSRP2;LDHC;HK2;CASP6;SERPINE1;ETS1;MAFF;GPC1;PLIN2;GPC3;PPP1R15A;KIF5A;ANKZF1;SDC2;PKP1;GALK1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.43050919397238063,0.759679517306906,0.7391304347826086,1.0,1.0,2/13,5.12%,PPARGC1A;CYB561
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.48662409136201623,0.7596196664174028,0.8245614035087719,1.0,1.0,2/6,22.48%,CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.3995351453543923,-0.7595895048960992,0.8301886792452831,1.0,1.0,4/19,19.79%,RYR1;PTPRC;HTR2A;ITPR3
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.3645368231534919,-0.7594217639358096,0.7777777777777778,1.0,1.0,10/37,18.54%,SDHC;ETFB;UQCRH;UQCRC1;ETFRF1;ATP5F1D;ETFDH;NR4A3;NDUFA5;UQCR10
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.46762874650867226,0.7592165739781536,0.8085106382978723,1.0,1.0,2/6,12.07%,TIMP1;TIMP3
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.3307255696302407,0.7591893003823531,0.8297872340425532,1.0,1.0,18/85,12.07%,SSC5D;LDB2;MXRA5;TNC;SULF1;POSTN;PRRX1;LAMC2;ACTA2;TLR1;ADAMTSL1;CYBRD1;ITGAV;PDGFRB;COL5A2;CXCL12;ABI3BP;TIMP3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.41198918749602165,0.7591728142742945,0.8181818181818182,1.0,1.0,5/14,21.76%,BCL2;HSPA1A;EYA3;BCL2L1;EYA2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.41198918749602165,0.7591728142742945,0.8181818181818182,1.0,1.0,5/14,21.76%,BCL2;HSPA1A;EYA3;BCL2L1;EYA2
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.37010416102962185,-0.7588670761777823,0.7818181818181819,1.0,1.0,2/43,2.84%,SFRP1;ADIRF
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.43179093534519053,-0.7587920699232432,0.7872340425531915,1.0,1.0,1/10,3.73%,ADRM1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3446638849113115,0.758197882479801,0.8490566037735849,1.0,1.0,7/75,6.01%,CCNH;CCNB3;CCNA2;EGFR;CCNP;LATS1;PSRC1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.40561269807454353,0.7578477002302367,0.7391304347826086,1.0,1.0,3/20,13.10%,FGFR2;SOX11;ACVR1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.35769006834090306,-0.7575063997272543,0.8245614035087719,1.0,1.0,4/47,2.62%,WNT7B;WNT9B;WNT9A;ASCL1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.3589353567162643,0.7574631577469629,0.8571428571428571,1.0,1.0,5/35,7.35%,GBP4;WNT5A;CCL5;SNCA;SYNCRIP
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.3705159381544794,-0.7574624034117119,0.7966101694915254,1.0,1.0,2/36,7.22%,SLC25A10;SLC7A7
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.35815450346458183,0.7572784139136396,0.7755102040816326,1.0,1.0,6/52,8.74%,KANK1;NLGN1;RAB29;MINAR1;HDAC2;LRP4
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.5036727630170377,-0.7572612656351154,0.84,1.0,1.0,2/6,5.95%,APOD;OAS3
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.44151031931985935,0.7570175942260652,0.8611111111111112,1.0,1.0,1/9,3.10%,GGCT
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.38763382551736303,-0.7567299038001695,0.8333333333333334,1.0,1.0,1/20,1.74%,AURKA
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.3792745999299334,-0.7563332967617752,0.8823529411764706,1.0,1.0,4/26,6.51%,ARHGAP22;KIF1A;SHANK3;CDK5
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.4722020556644628,0.7562576680958972,0.8048780487804879,1.0,1.0,1/9,1.83%,SEMA5A
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.3749822670327864,0.755995302455733,0.7872340425531915,1.0,1.0,5/29,13.12%,CSGALNACT1;HS3ST3B1;UGDH;EXT1;CSGALNACT2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4012411717296503,0.755715611323163,0.7674418604651163,1.0,1.0,5/23,16.41%,TAB3;TAB2;MAP2K6;ALPK1;NOD1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.36106998154472714,-0.7555494967118624,0.873015873015873,1.0,1.0,5/49,6.07%,CLDN4;CBLC;RAB17;AZGP1;MYH14
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3679983697508826,0.7553333935070914,0.7631578947368421,1.0,1.0,14/64,10.36%,SHISA2;PPARG;VWC2L;NEDD4;SMAD7;SULF1;SLIT2;ATP2B4;ACVR2A;SMAD5;BMPR1A;SMAD1;SMAD9;SMURF2
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.475677251626955,0.7553207088657761,0.7916666666666666,1.0,1.0,1/6,11.75%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.32410901909570355,-0.755284663368751,0.9272727272727272,1.0,1.0,9/77,9.80%,FGF1;RAC1;ENPP2;ETS1;FGF7;VIL1;FOXP1;GFUS;SPARC
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.34577637442112685,-0.7552158232507176,0.85,1.0,1.0,7/66,8.11%,TAGLN;COL6A2;COL6A1;NOG;TPM1;CALD1;LOXL1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3494282196102691,-0.7549969555430133,0.84,1.0,1.0,7/40,16.76%,NUPR1;BCL2L2;PINK1;DNM1L;RACK1;FIS1;SRC
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.4002431189328227,-0.7549481060310823,0.8,1.0,1.0,1/25,0.36%,CYB5R2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3681259117990546,-0.7548981554993363,0.8070175438596491,1.0,1.0,8/30,19.07%,RBM3;NOLC1;NR1H4;EIF2B4;PUM3;RBM4B;TCOF1;MTPN
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.48265448152955726,-0.7547481695602773,0.7804878048780488,1.0,1.0,1/5,5.98%,GNB3
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.4620835204604894,0.7547148901640066,0.7291666666666666,1.0,1.0,2/9,6.79%,MT1M;SNCA
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.3753660906392699,0.7546904097939303,0.8148148148148148,1.0,1.0,3/20,8.93%,PPP1R8;MFHAS1;STYXL1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.4109262621651197,0.7546881718235958,0.7380952380952381,1.0,1.0,7/17,22.52%,SLIT2;NR1H3;CATSPERB;TGFBR3;CATSPER2;TGFB3;SLIT3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.28714713316047485,-0.7546765471786874,1.0,1.0,1.0,30/345,10.13%,TERF2IP;MYB;SKOR1;HMGN5;PLAG1;AKAP17A;ZIM2;BACH1;LDB1;ZNF100;WTIP;TESMIN;REXO4;SPIN2A;LIMD1;DRAP1;SPI1;CRABP2;DAXX;ZNF92;ZNF714;ATF4;NFYB;NFX1;NONO;ZNF648;PAK6;ZNF395;PTP4A3;ZNF98
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4130496020119927,-0.7544635227816279,0.7884615384615384,1.0,1.0,11/22,27.75%,UBE3A;PRKACA;PINK1;EFNA1;PSME1;NUDT15;ATP5IF1;UBB;GPX1;PSME2;NUB1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4554016616409331,-0.7539375294789362,0.7924528301886793,1.0,1.0,3/13,11.86%,H1-0;PAX6;DDRGK1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.3728995208747744,0.7538325817387321,0.7647058823529411,1.0,1.0,2/39,1.90%,PLCB1;RALA
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.34829208083369556,0.7538153977318932,0.8181818181818182,1.0,1.0,2/30,2.83%,CCNH;CMTR2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.34829208083369556,0.7538153977318932,0.8181818181818182,1.0,1.0,2/30,2.83%,CCNH;CMTR2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.4270246890804377,0.7535151160999624,0.8245614035087719,1.0,1.0,5/13,22.93%,C3;P2RX7;BRAF;CA2;SLC26A6
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.3238749562837779,0.7534649868531593,0.9318181818181818,1.0,1.0,12/59,16.67%,ZFP36;HMGB1;CX3CR1;WNT5A;PDE4B;NR1H3;CD274;MEF2C;MAPK8;VIM;RELA;NLRP7
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.3262884287591444,0.7532313812460116,0.925,1.0,1.0,12/60,17.12%,PLA2G10;RAB9A;SNCA;RAB27A;EXPH5;EDN1;ADAM8;SOX11;FRMD4A;SLC12A2;CLASP1;BMP6
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.4713949301095114,-0.7528211911643392,0.8541666666666666,1.0,1.0,1/7,5.79%,RNF8
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.36552488086916785,-0.7527937238210791,0.8148148148148148,1.0,1.0,2/26,7.77%,RAC1;PARVB
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.41627108814709174,-0.7524123423484537,0.8076923076923077,1.0,1.0,3/19,10.68%,H1-0;BLCAP;HMGB2
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.340800302794806,0.7523475547678226,0.8235294117647058,1.0,1.0,10/42,14.68%,CX3CR1;HEY1;FAIM;PCM1;DLL1;CTNNB1;LIG4;SOX11;RGS14;SERPINF1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.5278014868388179,0.7522827763853176,0.7959183673469388,1.0,1.0,2/5,25.13%,FGF13;DCC
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.45311593305033526,0.7522011851850008,0.8205128205128205,1.0,1.0,6/15,24.36%,SLC8A1;SLC12A2;SLC9A1;SLC9A2;SLC9A7;SLC9A5
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.32329344790679665,0.7520695361635196,0.8292682926829268,1.0,1.0,19/80,14.77%,NLGN1;SHISA9;FGF12;FGF14;JPH1;CACNB2;GRIA4;DLG2;PDE4D;LRRC7;KCNG1;CRHBP;FGF13;ANK2;ANK3;GRIA2;MEF2C;NETO1;DMD
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.3839832290554068,0.7518266296663835,0.7450980392156863,1.0,1.0,3/21,13.89%,POLE2;PRIMPOL;RFC5
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.42621662357815404,-0.7518180114796535,0.8,1.0,1.0,1/12,2.16%,NIPAL4
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.34633422163634564,0.7517014719537537,0.7678571428571429,1.0,1.0,19/72,15.51%,IRS1;PPARG;ENPP1;IRS2;HDAC9;FER;ZBTB7B;SIRT1;FOXO1;SORT1;SORBS1;INSIG2;PIK3R1;INSIG1;CPEB2;OGT;TBC1D4;KAT2B;AKT2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.32231179506359164,-0.7516438569987671,0.9090909090909091,1.0,1.0,31/108,20.53%,SFRP1;PSMA7;ADAMTS12;SKP1;PSMD7;UBC;RBX1;PSMB4;PSMC3;IL1R1;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;NFKBIA;RBMX;PSMA1;IRAK1;GBP2;PSMB8;PSME1;PSMD10;USP10;PSMA8;PSMD12;MAP3K8;PSMB3;PSMB7;PSMC6
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.41277896825128646,0.7516318908618604,0.7719298245614035,1.0,1.0,4/12,10.24%,PPARG;SYK;LDLR;CDH13
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.351353680017507,-0.751427838902624,0.8627450980392157,1.0,1.0,6/42,12.37%,PRPF6;CELF3;PRPF19;ZRSR2;SF3A2;SF3A1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.3806600361389715,0.7514139888345243,0.8695652173913043,1.0,1.0,3/56,4.44%,CHIT1;ITGAX;ITGAM
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.3955546317925758,0.7512796286605568,0.7916666666666666,1.0,1.0,9/25,22.70%,PDE4D;PDE2A;AFDN;RAPGEF6;RAP1A;TJP3;ICAM1;RAPGEF2;MARVELD2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.39977159862614164,0.7510927146451032,0.7441860465116279,1.0,1.0,2/18,3.17%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3161196903884404,0.7510353741798321,0.9142857142857143,1.0,1.0,14/93,8.95%,CALCR;GPR174;CHRNA10;HMGB1;CX3CR1;SLC8A1;ACKR3;TBXA2R;JPH1;ACKR2;PTGFR;ABL2;PLCE1;P2RY1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.43495155613327896,-0.7509435538381526,0.7719298245614035,1.0,1.0,3/9,15.94%,SPACA3;TTBK1;LBP
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.33482402079470164,0.7509090887457119,0.8636363636363636,1.0,1.0,20/61,20.26%,IRS1;ATP6V0A4;IRS2;GAB1;ATP6V0D2;FER;IGF1R;BCAR1;FOXO1;PIK3CA;SORBS1;PIK3R1;AKT2;PDK4;SOS1;PDK2;INSR;PHIP;IRS4;BAIAP2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.4375944680437827,0.7506980826460194,0.7872340425531915,1.0,1.0,3/10,19.39%,ZNF675;AIDA;PDCD4
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.430713505682921,0.7506001377872773,0.7346938775510204,1.0,1.0,4/11,20.14%,SPAST;CLASP1;EPS8;CLASP2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.38409569005679034,0.7505147243464472,0.7959183673469388,1.0,1.0,2/37,1.90%,PLCB1;RALA
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.35629927071545175,-0.7501546511343146,0.847457627118644,1.0,1.0,2/37,1.87%,WNT7B;ATRAID
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.352809971189621,-0.750095079542865,0.8245614035087719,1.0,1.0,8/42,19.07%,RBM3;ATG14;NOLC1;EIF2B4;PUM3;RBM4B;TCOF1;MTPN
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.4542351020081765,0.7500758875662679,0.7291666666666666,1.0,1.0,1/7,4.87%,IRS2
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.3905692299773834,0.7500399980985348,0.7714285714285715,1.0,1.0,2/18,10.79%,GGCT;MTHFS
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.5003564209059544,0.7498536194018041,0.8,1.0,1.0,3/6,17.29%,DNAH11;ODAD2;CFAP43
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.42584231010298546,-0.749710900990411,0.8333333333333334,1.0,1.0,7/22,19.05%,DRD3;ARF1;PLK2;TMEM25;PNKD;PRRT1;GRIK3
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.47316142686986185,0.7496203758919624,0.7777777777777778,1.0,1.0,1/6,4.48%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.47316142686986185,0.7496203758919624,0.7777777777777778,1.0,1.0,1/6,4.48%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.336496681033559,0.7495963592087045,0.8888888888888888,1.0,1.0,20/65,25.86%,DCUN1D1;SPHK1;SMAD7;HDAC3;PRICKLE1;NDFIP2;COMMD1;CRY1;PHF23;CUL3;DERL1;RIPK2;SAE1;DCUN1D5;FBXW7;BIRC2;LRRK2;AXIN1;TANK;UBE2D1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.35055483945402155,0.7492653409075603,0.8235294117647058,1.0,1.0,6/43,14.92%,EFNA5;FER;WWC1;EPHA5;MAP2;PARD6B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.38202866544194336,-0.7492487436937718,0.7254901960784313,1.0,1.0,7/21,18.70%,CALM1;CTNNA3;DSC2;CALM3;RANGRF;PKP2;TRPM4
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.31667787595168173,0.7491563703232124,0.9333333333333333,1.0,1.0,19/92,19.64%,TRPV2;CCL5;SLC8A1;ATP2B4;MICU1;CACNB2;TRPC4;ITPR1;ITGAV;ANK2;SLC24A2;CALCRL;P2RX7;SLC24A4;STIM1;TRPM6;KCNN4;FYN;STIM2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.35680188703434496,0.7490953700387976,0.8409090909090909,1.0,1.0,16/87,11.83%,SHISA2;RUNX1;KANK1;CXXC4;FGFR2;SULF1;NLK;WWOX;AMER2;SPIN1;TLE1;RSPO2;GNAQ;BTRC;CTNNB1;LGR6
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.3638521433537498,0.7490914794453783,0.7457627118644068,1.0,1.0,2/31,5.92%,ESAM;LATS1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.3413266972750042,0.7489789950307454,0.8913043478260869,1.0,1.0,3/44,4.91%,FAS;TGFBR1;WWOX
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.33889905969293754,0.7489452168296241,0.7894736842105263,1.0,1.0,9/70,6.70%,MARVELD3;ZFP36;FGFR2;EGFR;MAGED1;PKHD1;FGF10;PRKD1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.33146138671219266,-0.7489183025853623,0.9423076923076923,1.0,1.0,12/72,15.79%,CLU;RPS27L;UPF3B;RBM3;UPF3A;NIBAN1;CIRBP;METTL3;RACK1;NAT10;EFNA1;RPL5
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.4616272659769423,0.7487851971503058,0.7307692307692307,1.0,1.0,1/6,4.87%,IRS2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.40379999953144285,0.7486617728758763,0.7878787878787878,1.0,1.0,4/12,13.10%,HEY1;BMPR1A;SMAD2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.4256226981124147,0.7484754291419381,0.8461538461538461,1.0,1.0,1/17,4.20%,CCL5
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.4194646129995985,0.7484348127092483,0.8541666666666666,1.0,1.0,2/23,7.86%,PRELID2;LDLR
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.42927154464756645,0.7484061493176061,0.8333333333333334,1.0,1.0,3/13,19.04%,FOXO3;TFB2M;MTERF1
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.49053977282607847,-0.7483657174090879,0.7608695652173914,1.0,1.0,1/6,20.15%,STAT3
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.37241059891592826,-0.7481227257724389,0.7678571428571429,1.0,1.0,2/33,3.79%,PLK3;KIF20B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.3685149752667347,-0.7478413216399521,0.8793103448275862,1.0,1.0,4/56,4.46%,SFRP1;FBLN2;RAC1;EPHA1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.4295506907728358,-0.7476983277779747,0.7857142857142857,1.0,1.0,1/12,6.06%,EPHB6
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.38162252138760305,0.7476608777479371,0.8222222222222222,1.0,1.0,4/26,10.86%,ZSWIM6;ZSWIM5;PDGFRB;ZSWIM8
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.4585329784501033,-0.7475727164375136,0.7857142857142857,1.0,1.0,2/8,9.58%,PDZD7;GRXCR1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.49532604764572985,-0.7474790761104456,0.7636363636363637,1.0,1.0,1/5,13.45%,RACK1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.3725386546468685,-0.7468739889928993,0.8125,1.0,1.0,3/29,6.58%,RAC1;ENPP2;VIL1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.38702227599704525,0.7468567146968371,0.825,1.0,1.0,5/21,14.77%,JPH1;TRDN;PDE4D;AKAP6;DMD
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.43161991411026884,0.7467269110822187,0.72,1.0,1.0,1/10,0.32%,LOXL2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.3430860212184765,-0.7462526544515629,0.8775510204081632,1.0,1.0,5/48,8.77%,APOBEC3H;OAS3;ILF3;IFIT1;OAS2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.4208317950302688,0.746139439061069,0.8043478260869565,1.0,1.0,2/12,11.86%,H6PD;LPCAT3
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.42037738277624537,0.74613194480816,0.7857142857142857,1.0,1.0,3/19,5.75%,IRS2;SLC30A8;SLC2A5
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.46752482619668156,0.7459176915952944,0.7555555555555555,1.0,1.0,1/5,6.04%,MYORG
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.5026110109826234,-0.7458578108348227,0.8,1.0,1.0,3/5,13.18%,ADAMTS12;CD63;TSPAN12
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.40232606416639116,-0.7458491118219204,0.8275862068965517,1.0,1.0,1/22,1.74%,AURKA
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),-0.4607020811611153,-0.7457182357553668,0.7592592592592593,1.0,1.0,2/7,9.58%,PDZD7;GRXCR1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.421598056981672,0.7456864966739931,0.7708333333333334,1.0,1.0,1/10,3.49%,DXO
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.4528106422335626,-0.7455969465567214,0.82,1.0,1.0,2/7,15.04%,CERS2;RTN4R
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.472782994260715,0.7455823170152863,0.8103448275862069,1.0,1.0,1/8,2.73%,LEPR
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.4336861491561922,0.7454288140067945,0.8064516129032258,1.0,1.0,1/13,4.44%,ITGAM
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3293935786484872,0.7452858356417796,0.8409090909090909,1.0,1.0,21/89,13.10%,IL17RD;PPARG;VWC2L;MAGI2;CIDEA;SMAD7;TGFBR1;ADAMTSL2;ACVR2A;SMAD5;FST;BMPR1A;SMAD1;SMAD2;SMAD9;SMURF2;WFIKKN1;SIRT1;PPM1A;SMURF1;ACVR1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.2921639628315856,-0.7452620722588009,1.0,1.0,1.0,14/242,7.23%,INHA;NUPR1;SFRP1;FOXM1;ANKK1;CDKN3;KIF20B;TSPYL2;BEX2;PPP1R15A;GADD45A;CDK5;CCND1;RRP8
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.3471225547981429,-0.7449362857809511,0.8727272727272727,1.0,1.0,15/46,22.76%,SH3RF2;PRR7;DTX3L;SVBP;CAMLG;PER2;TAF1;VPS28;USP4;RPS3;ISG15;SPRY2;LIMK1;SQSTM1;UFL1
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.29911491627058434,0.7448478417037302,0.9183673469387755,1.0,1.0,21/152,13.29%,KCTD8;GALNTL6;OLFM3;YDJC;ADGRB3;FGF12;NXPH1;GRIP1;SLC35F1;CA10;POU6F2;SH3GL2;SYT16;PRKCA;DPP10;RBFOX1;NKAIN3;ASIC2;BTBD10;ERC2;GRIA2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.39926142637108086,-0.7447652559894448,0.8181818181818182,1.0,1.0,3/13,21.38%,EXOSC10;DIS3L;EXOSC4
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.36303954658348053,0.7444807256881069,0.8444444444444444,1.0,1.0,13/31,24.66%,SLC26A3;SLC4A4;SLC4A7;SLC9A1;GPR89A;SLC9A2;GPR89B;CA2;SLC9A7;SLC26A6;CLN3;SLC9A5;LRRK2
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.3326474992239044,-0.7444582294035282,0.8793103448275862,1.0,1.0,7/68,7.57%,CPXM2;TAGLN;TPM1;ANO1;CALD1;TRPV4;RBPMS
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.45962338740041675,0.744164520560632,0.717948717948718,1.0,1.0,2/6,17.43%,LDLR;ROCK2
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.37169583451081406,-0.7441518344280329,0.8181818181818182,1.0,1.0,6/19,21.55%,GOLGA2;SKP1;RPL23;RPL5;FZR1;RPL11
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.4748821101127364,-0.7440772609321314,0.7321428571428571,1.0,1.0,3/6,18.70%,RACK1;KDR;TRPM4
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.4527523716399334,0.7437219166230725,0.8,1.0,1.0,1/8,3.48%,HMGB1
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.37370928385022883,0.743332899954555,0.8367346938775511,1.0,1.0,4/19,10.86%,UAP1;SLC35D1;UGDH;GNPNAT1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3167518470375582,0.7430039350506151,0.8703703703703703,1.0,1.0,28/168,16.38%,PLA2G10;PLCB1;ENPP1;ITPKB;SPHK1;NUDT10;INPP1;PIP4K2A;PPP3CA;PTPRD;LIMK2;EPHA7;PLCE1;IP6K2;PLCB4;INPP4B;PIK3CA;DUSP18;PPM1A;PLPP1;GPD2;PLA2G15;PLA2G4C;PLPPR5;DUSP8;LPL;SLC20A1;IPPK
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.31884144193398595,-0.7429480105515377,0.8679245283018868,1.0,1.0,5/64,5.15%,ARHGAP15;PPP1R17;VAV3;EPHA1;FGD3
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.3982876000403344,0.7428545312996492,0.7413793103448276,1.0,1.0,2/16,9.78%,MCM7;MCMDC2
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.4815222538886148,0.7428292806561761,0.7954545454545454,1.0,1.0,3/6,17.66%,SLC8A1;SMAD3;ATP1A2
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.4978048349744972,0.7424252730849542,0.8367346938775511,1.0,1.0,1/5,5.08%,GRM5
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.43207805190720705,-0.7422855674904904,0.7894736842105263,1.0,1.0,2/11,8.74%,ZWILCH;SPDL1
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.4504780492792747,0.7422835052127532,0.7636363636363637,1.0,1.0,4/11,21.00%,PRKD1;ZBTB7B;VEGFA;NIPBL
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.3768636462618224,-0.7420935089814902,0.803921568627451,1.0,1.0,2/22,5.62%,IL31RA;GHR
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.4138427140067864,0.7420217176889736,0.7708333333333334,1.0,1.0,2/11,9.78%,MCM7;MCMDC2
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.4568517027560044,0.7419712185107229,0.717948717948718,1.0,1.0,2/6,20.74%,PDE4D;CRLF2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.4454072830608851,0.7419679799969833,0.8333333333333334,1.0,1.0,3/7,25.58%,FGF13;CAMK2D;CAV3
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.47642029222743,-0.7419261397051141,0.8181818181818182,1.0,1.0,3/7,27.69%,APH1B;ADAM17;NCSTN
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.4310001988036296,0.7419142682423371,0.8545454545454545,1.0,1.0,1/9,14.52%,MPST
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.5229115226822203,-0.7416226534958356,0.8367346938775511,1.0,1.0,1/5,3.23%,RAC1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4069526424199062,0.741403461439571,0.7692307692307693,1.0,1.0,2/17,4.20%,ERBB4;CCL5
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.3486227665925002,0.7413734697799808,0.7317073170731707,1.0,1.0,9/39,10.99%,PBX1;SHROOM2;MEIS1;PBX3;CPAMD8;ATF6;MEIS2;CHD7;MYO7A
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.37734057790023,-0.7413446146087522,0.8518518518518519,1.0,1.0,3/28,8.01%,FGF20;SYT6;DRD3
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.31461984628096595,0.7412765570919084,0.8125,1.0,1.0,10/89,13.35%,SEM1;RFWD3;MCM7;TONSL;SWSAP1;RAD51B;MCMDC2;NSMCE1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.3568324656728705,0.7412320907773059,0.8648648648648649,1.0,1.0,2/24,8.11%,CIDEA;PTPN6
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.398388313704602,0.7409980344325562,0.7777777777777778,1.0,1.0,2/26,0.75%,GPC5;GPC6
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.45942991845514247,0.7409840982208347,0.8108108108108109,1.0,1.0,2/9,10.13%,EGFR;TIMP1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.325837182334535,0.7408009466743399,0.9069767441860465,1.0,1.0,4/40,7.47%,IFI16;RUNX1;DYRK3;MFHAS1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.34094819293362716,-0.7407447233673067,0.85,1.0,1.0,5/70,6.17%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3055477480555297,0.7407141936703042,0.8085106382978723,1.0,1.0,10/129,8.11%,FAS;STK26;IFI16;NUAK2;TFEB;FOXO3;KPTN;PRKD1;ATP6V0D2;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.3874476674104338,-0.7405777494662261,0.85,1.0,1.0,6/21,16.42%,CALM1;TOM1L1;ACE;PDGFA;GREM1;CALM3
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.4376322145002981,0.7405375226726829,0.8235294117647058,1.0,1.0,1/9,4.82%,IDO1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.4376322145002981,0.7405375226726829,0.8235294117647058,1.0,1.0,1/9,4.82%,IDO1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.34677585340132266,-0.7402053794324471,0.8225806451612904,1.0,1.0,23/61,25.55%,H1-4;H1-0;RNF8;SMARCD1;DAXX;ANP32E;HMGB2;CHAF1A;H1-2;SUPT16H;INO80;CTCF;ZNHIT1;SMARCA5;MACROH2A1;PADI4;SUPT6H;POLE3;VPS72;CHAF1B;PAF1;SET;NPM1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.4298099466109201,-0.7401175629958431,0.7272727272727273,1.0,1.0,2/10,14.00%,DCTN1;CCDC68
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3850813138787792,0.7400980014274522,0.8444444444444444,1.0,1.0,1/18,1.23%,KCNE4
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.3672682709706493,0.7400800252147607,0.8431372549019608,1.0,1.0,6/30,18.36%,RAB29;TULP3;BBS9;TUB;BBS4;TCTN2
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.4323425949184831,0.7400732715778078,0.8431372549019608,1.0,1.0,1/10,4.82%,IDO1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.4779469562925645,0.7399948705930075,0.7916666666666666,1.0,1.0,1/6,2.22%,NLGN1
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4226826559588336,0.7399295367842443,0.7906976744186046,1.0,1.0,1/11,3.36%,CIDEA
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.4532337580632152,0.7398263920331395,0.8653846153846154,1.0,1.0,1/7,3.36%,CIDEA
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.3553318965456357,0.7395203701970472,0.8636363636363636,1.0,1.0,7/31,14.85%,PSRC1;PDCD6IP;BORA;GNAI1;CHMP1A;HSPA1A;PLK1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.4220605814035234,0.7394547553576827,0.7916666666666666,1.0,1.0,3/11,11.35%,DYRK1A;ZBTB7B;BRMS1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.3673519755116891,-0.7394352905359947,0.7758620689655172,1.0,1.0,6/32,16.41%,XG;GNAS;PIK3CB;ACTB;TYRO3;DSC2
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.3735132446744398,0.7394094211278349,0.875,1.0,1.0,3/18,12.71%,MCM7;MCMDC2;POLD3
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.3715497401484892,0.7392426063573774,0.782608695652174,1.0,1.0,5/32,7.92%,LTK;WNT5A;EPHA3;BRINP3;ABL2
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4001120232449241,0.7391131795023,0.825,1.0,1.0,4/12,13.10%,HEY1;BMPR1A;JAG1;ACVR1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3533797743579181,-0.7389966581602366,0.7924528301886793,1.0,1.0,13/47,19.76%,PORCN;VIP;RAB3B;TANGO2;SVBP;CAMK2G;COPG2;WLS;RAB3A;PDIA4;RAB12;CANX;SCG2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.4450862534314225,0.738871708719579,0.7555555555555555,1.0,1.0,1/8,3.57%,TDG
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.4743080790097015,-0.7386862272604864,0.8181818181818182,1.0,1.0,2/5,11.69%,NONO;PINK1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.43551358618974556,0.7386782675742716,0.7142857142857143,1.0,1.0,2/9,8.71%,ENPP1;BCOR
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.37221958251254694,0.7383738234914392,0.8367346938775511,1.0,1.0,1/30,1.00%,IFI16
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.3894683326758331,0.7379742867205022,0.8048780487804879,1.0,1.0,3/14,13.10%,AP1AR;KIF26A;ACVR1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.3595535680953496,0.7379549669264329,0.7959183673469388,1.0,1.0,6/21,21.00%,TDG;DUSP9;SCX;HPSE;INSR;NIPBL
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.40030472358246627,0.7378750182835921,0.8235294117647058,1.0,1.0,7/18,12.55%,PLA2G10;SPHK1;WNT5A;LRFN5;MFHAS1;NR1H3;GPR137B
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3032134497006107,0.7378180265365413,0.8888888888888888,1.0,1.0,7/91,9.99%,U2AF1;PPARGC1A;SF3B1;SYNCRIP;MBNL1;NOVA1;CDK12
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.36127434867954566,0.7377328095846587,0.8571428571428571,1.0,1.0,2/34,8.90%,PLD6;TDRD9
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.4367124565768844,0.7373178299181938,0.875,1.0,1.0,3/10,19.04%,FOXO3;TFB2M;MTERF1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.3586438853957068,0.7372608416298853,0.8571428571428571,1.0,1.0,4/25,7.77%,FGFR2;SULF1;FGFR3;RANBP3L
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.47343587123921516,-0.737111975289682,0.8372093023255814,1.0,1.0,1/8,6.30%,EXOSC10
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.47343587123921516,-0.737111975289682,0.8372093023255814,1.0,1.0,1/8,6.30%,EXOSC10
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.4330078999364646,-0.7369728643088809,0.84,1.0,1.0,4/12,21.79%,TAF7;TAF11;TAF1;POLR1E
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.40653860603543557,-0.7368899241199279,0.8103448275862069,1.0,1.0,3/23,7.73%,NMB;NMU;HCRT
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3508416382866583,0.7367627760940657,0.875,1.0,1.0,4/26,6.63%,SHROOM2;SHROOM1;AIF1L;FSCN3
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.31561753006914134,0.7367136138522089,0.7674418604651163,1.0,1.0,18/106,14.05%,LRIG3;SERTAD4;MXRA5;FAM114A1;AGER;EGFR;CCN2;SCNN1B;LAMC2;RADIL;FBLIM1;MEX3B;SEMA3B;AMOTL2;NOTCH3;THSD4;GPRC5A;F3
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.5047138020369749,0.7366662749884868,0.76,1.0,1.0,1/6,4.97%,MLLT3
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.3318300221499029,-0.7365348730183625,0.9375,1.0,1.0,17/51,22.86%,H1-4;POLR1G;H1-0;SMARCD1;ELOF1;ZMIZ2;TAF1D;H1-2;ACTB;SMARCA5;MACROH2A1;CHEK1;POLR1C;DDX21;POLR1E;DEK;POLR1A
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.4284703171184003,-0.7363825500617848,0.8064516129032258,1.0,1.0,2/9,16.76%,PIF1;SRC
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.4527235082454394,-0.7362207642341059,0.8235294117647058,1.0,1.0,3/7,32.52%,NECAB2;MT3;IGF1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.43789809744479846,-0.7357944280460633,0.7931034482758621,1.0,1.0,3/10,26.43%,METTL3;MACROH2A1;RBM15B
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.3495590631655834,0.7356911873178554,0.8297872340425532,1.0,1.0,2/35,2.21%,SLC26A7;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.3607472787564124,-0.7355614728328683,0.8846153846153846,1.0,1.0,5/30,17.17%,STX4;APOA1;AZIN2;CHTOP;YWHAB
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.36462591773027164,0.7354533721101923,0.8297872340425532,1.0,1.0,3/30,5.54%,S100A13;TFEB;RAB34
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.3438812659875946,-0.7352315828036864,0.8461538461538461,1.0,1.0,2/67,1.81%,SELP;CXCR5
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3076306650421106,0.7350480151614686,0.95,1.0,1.0,17/110,14.20%,LRP1B;STAB1;NEDD4;COLEC11;ITGAM;SYK;ACKR3;SNCA;LDLR;TMEM108;DLL1;DNAJC6;FNBP1L;ARHGAP27;LDLRAP1;CALCRL;PICALM
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.4263404621451214,-0.7349202642921435,0.8169014084507042,1.0,1.0,1/12,2.31%,NOG
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.42872334970576914,0.7346907437793144,0.8679245283018868,1.0,1.0,3/8,22.48%,SIRT1;MEF2C;RAPGEF2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.3868835420841702,-0.7346704990210751,0.8387096774193549,1.0,1.0,3/20,9.40%,DCTN1;SPDL1;NSFL1C
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4439953529026316,-0.7346149973514964,0.8181818181818182,1.0,1.0,2/11,3.85%,ZNF593;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3756550417112353,-0.7345426336094133,0.84375,1.0,1.0,10/34,16.68%,CLU;SERPINE1;B2M;AHI1;CD63;DGKD;PPT1;SFRP4;GREM1;VTN
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.4289315088017541,-0.7338567291017766,0.7846153846153846,1.0,1.0,1/12,2.31%,NOG
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.32389349834752534,0.7338467806894529,0.8888888888888888,1.0,1.0,21/92,18.06%,SLC26A3;GABRB1;HCN1;SLIT2;GLRA2;GABRB2;P2RY1;PDE3A;PDE2A;CRHBP;CTNNB1;AKAP6;AANAT;MEF2C;CPEB4;P2RX7;GABRB3;RELA;CPEB3;RAP1A;SH3BP4
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.44235089698791474,-0.7338269800354752,0.76,1.0,1.0,1/9,3.60%,PDZD7
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.34091640944641066,0.7337200642054726,0.803921568627451,1.0,1.0,6/65,8.11%,FAS;TFEB;KPTN;PRKD1;ATP6V0D2;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.41593433412680547,0.7334186531975168,0.8235294117647058,1.0,1.0,3/13,6.19%,SEMA5A;HSPB1;PRKD1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.3414874566802433,0.7331660394797904,0.8260869565217391,1.0,1.0,6/50,8.58%,STK26;PTPRK;EGFR;CAT;HIF1A;FER
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.44206150922082926,-0.7331392959806609,0.8113207547169812,1.0,1.0,3/15,13.39%,DTX3L;WRAP53;KDM4D
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.4434689831110301,0.7330048433584845,0.7843137254901961,1.0,1.0,4/9,14.46%,WNT5A;SYK;DVL2;MAPK8
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4071785781570578,0.7329238031825873,0.851063829787234,1.0,1.0,6/17,28.92%,MEF2A;ZBED3;TRAK2;LRRK2;BRAT1;MFN1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.4300928233053365,0.7329237039030748,0.8113207547169812,1.0,1.0,2/10,10.35%,SPHK1;ZBTB7B
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.4113619782619398,0.732404381345233,0.8627450980392157,1.0,1.0,4/18,13.69%,AGMO;DGAT2;PLCE1;PLA2G15
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.4359559413091226,0.7323788461430404,0.8333333333333334,1.0,1.0,5/11,17.81%,PDE3A;PDE2A;VEGFA;BMP6;TJP3
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.49480150858285776,0.7322437891114244,0.75,1.0,1.0,1/5,24.94%,ITGB1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.4137615838415174,-0.7321263527682416,0.8103448275862069,1.0,1.0,5/15,21.70%,DHX58;UFD1;C1QBP;NPLOC4;DDX60
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.31363438146447126,0.7320598586176394,0.8648648648648649,1.0,1.0,5/111,5.03%,ZDHHC11;GDAP1;NLGN1;ZDHHC14;PARD3
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.3878356115786206,-0.7319327015049748,0.875,1.0,1.0,4/20,19.79%,RYR1;PTPRC;HTR2A;ITPR3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.32997299717692485,-0.7316449000216275,0.8387096774193549,1.0,1.0,13/64,18.80%,CLU;PACSIN3;TMC8;NR1H4;TRAF3IP1;CRYAB;SVIP;APOA1;PRKCZ;HDAC6;SRC;CARMIL2;LRSAM1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.381144525596108,0.7316213773571147,0.7954545454545454,1.0,1.0,3/19,8.29%,ARHGAP25;SLIT2;LZTR1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.3859912832388007,-0.7315992572939738,0.8103448275862069,1.0,1.0,2/23,7.24%,ECRG4;SPI1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.4078158130321622,0.7313101531265238,0.8148148148148148,1.0,1.0,3/10,12.46%,HDAC2;TMEFF2;EDN1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.32328685426138115,0.7312932078631136,0.8695652173913043,1.0,1.0,5/41,13.89%,ZBTB1;POLE2;PRIMPOL;POLD3;RFC5
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.36408364060520243,0.7312855243958388,0.7627118644067796,1.0,1.0,1/16,1.94%,KANK1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.46261284644607026,0.7310635228659014,0.8292682926829268,1.0,1.0,2/6,27.61%,HSPA1A;LAPTM5
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.48764936508251877,-0.7308728173091473,0.74,1.0,1.0,2/6,24.75%,FBL;NOP58
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.4751565480353024,-0.7307676014199047,0.7547169811320755,1.0,1.0,2/6,13.10%,JADE2;MEAF6
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4058934172141734,-0.7302402896467903,0.8235294117647058,1.0,1.0,5/19,18.71%,PRKCH;FOXP1;CARD11;PTPRC;RPS3
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.41934204185651747,-0.7301511487024641,0.8032786885245902,1.0,1.0,1/15,0.74%,SFRP1
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.4699893204301223,0.7300246492881743,0.8478260869565217,1.0,1.0,2/5,12.46%,BCAR1;EDN1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.43767873879469976,-0.7299922014580676,0.7959183673469388,1.0,1.0,2/12,13.53%,ADAM19;APH1B
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.43907285905488513,0.7298745337177927,0.8043478260869565,1.0,1.0,2/12,6.19%,AFF2;DYRK3
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.45219221194028547,-0.7295726587063677,0.7627118644067796,1.0,1.0,2/12,12.01%,IL11;IGFBP3
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.4796115653784212,0.729553539034099,0.8297872340425532,1.0,1.0,1/6,9.06%,SPTY2D1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.2933619657080438,0.7293140837834358,0.9459459459459459,1.0,1.0,4/93,7.23%,U2AF1;ZFP36;NXF1;NXF5
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.36475844174514344,-0.7290300711286094,0.896551724137931,1.0,1.0,1/41,1.09%,TAGLN
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.36686846279341345,0.7290151887644918,0.8846153846153846,1.0,1.0,6/21,18.22%,PDE4B;ATP2B4;SNCA;GABPA;SLC9A1;GNG2
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.34021269533025916,0.7289424424690608,0.84,1.0,1.0,6/66,8.11%,FAS;TFEB;KPTN;PRKD1;ATP6V0D2;EIF2AK3
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.3382103231356737,0.7285625394773686,0.9347826086956522,1.0,1.0,2/44,3.57%,APEX2;TDG
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.2853005426928346,0.7283728083606021,0.972972972972973,1.0,1.0,24/168,11.28%,FAS;AEN;RRAD;SPHK1;DDIT4;ABHD4;SLC19A2;FOXO3;TP63;HDAC3;CDKN2AIP;SLC35D1;IER5;ADA;MXD4;IP6K2;CDH13;PTPN14;ACVR1B;ATF3;CCNG1;FGF13;CSRNP2;LDHB
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.40906665708478085,-0.7283616680538711,0.7857142857142857,1.0,1.0,3/12,11.10%,RAC1;RHOBTB2;RHOBTB1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.35447974796733595,0.72833801356423,0.851063829787234,1.0,1.0,5/39,13.08%,HMGB1;TAB3;TAB2;TLR1;ALPK1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.352101061657134,-0.728143695022808,0.8524590163934426,1.0,1.0,2/40,1.81%,CCN3;CXCR5
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.2929613152139393,0.728046310254208,0.972972972972973,1.0,1.0,39/187,21.24%,MAP3K11;SHROOM2;SHROOM1;ANLN;KIF2C;ECT2;KPTN;LATS1;ARHGAP10;RASAL2;ESPL1;PCM1;NCK1;DOCK4;WASF2;BCAR1;FGD4;ARHGAP27;PREX1;PLK1;ARHGAP5;SSH2;SAC3D1;RAPGEF6;CLASP1;DST;MID1;ABR;SPTBN1;SOS1;ARHGEF3;ARHGEF12;WASF1;CNTROB;PCGF5;LLGL1;LMNB1;CNTRL;ABL1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.4292735945621857,-0.7275955853807047,0.8166666666666667,1.0,1.0,3/10,16.76%,CD4;MET;SRC
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.3127754993894187,0.7275937024373359,0.9,1.0,1.0,33/118,19.48%,PMP2;LRRC4C;LRRTM3;GFAP;ADGRB3;NXPH1;PCDH15;SLC35F1;MEGF10;CA10;ADGRL3;CDO1;LRRC3B;ANK2;LHFPL3;ZNF536;GRIA2;OLIG1;CTNND2;MAP2;SLCO1C1;TMEM178A;MAPK4;DCLK1;TNR;ATP1A2;PLP1;VCAN;BRINP1;ST8SIA3;TMEM59L;ADGRA1;FYN
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3560588395321814,0.7274288539261053,0.8717948717948718,1.0,1.0,3/25,12.49%,CIDEA;PTPN6;CD274
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.4257735220807805,-0.7273282781647974,0.7924528301886793,1.0,1.0,5/12,31.46%,ACBD5;MAP1LC3B;SQSTM1;PEX5;PIK3C3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3643097836266381,-0.7267824359175172,0.8125,1.0,1.0,2/23,7.89%,SPI1;DAXX
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.3196267775866283,0.7267108150169668,0.8809523809523809,1.0,1.0,21/103,14.75%,NOX5;PTPRK;EGFR;PPARGC1A;FOXO3;CAT;PRKD1;SNCA;ERMP1;MSRA;HIF1A;FER;PRDX6;FOXO1;ADNP2;AGAP3;MGAT3;EIF2S1;MAPK8;HSPA1A;CPEB2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.41273900062953056,0.7266640520310896,0.76,1.0,1.0,3/12,19.21%,RAB29;RELA;KCNN4
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.3016874121325331,-0.7266411542616691,0.9622641509433962,1.0,1.0,7/89,6.80%,CLU;ASB9;LDB1;RILP;SLC6A9;GPC3;VIP
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.4507354213000414,0.7266031408032628,0.8461538461538461,1.0,1.0,2/6,21.00%,HPSE;NIPBL
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.44555109343732635,0.7263969944658173,0.8301886792452831,1.0,1.0,2/7,16.60%,KIF26A;PHACTR4
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.3696973365776762,0.7263939062128685,0.7804878048780488,1.0,1.0,7/21,16.79%,NLGN1;PPFIA2;FOXO6;MEF2C;LLPH;TANC2;CPEB3
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.30003678961000857,-0.7261049105036353,0.9555555555555556,1.0,1.0,15/97,19.83%,TMEM179;KIF1A;SLC6A9;CELF3;GNG3;KIF5A;NDRG4;TAGLN3;TTBK1;PCDH8;TUBB2B;STMN2;CASKIN1;CCDC177;SRRM3
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.3121831303235338,0.7259384124091484,0.8666666666666667,1.0,1.0,11/86,9.82%,FGFR2;PBX1;TOX3;CAPN13;PDZRN3;LRRN1;LGR5;AHCYL2;COBL;FREM1;ASXL3
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.42248310832171676,0.7258382640779606,0.8333333333333334,1.0,1.0,2/8,11.75%,HDAC2;SIRT1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.4676929953175007,-0.7257425255164087,0.76,1.0,1.0,1/6,10.10%,GALK1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.2918280305642442,-0.7257213763023793,0.9830508474576272,1.0,1.0,36/235,14.04%,SFRP1;USP27X;SPDEF;CLU;NTRK1;OBSCN;RASGRF2;VAV3;ITGA6;FGD3;PDCD5;UTP11;LATS2;UBC;GADD45A;PRR7;HTATIP2;DUSP6;RFPL1;ATF4;PTPA;NOS2;ITGB3BP;PIDD1;IGFBP3;TNFAIP8;CYP1B1;C1QBP;DNM1L;SFRP4;RACK1;APH1B;PIP5KL1;PNMA2;SAP18;IFIT2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.3408738329379013,-0.7255489892478063,0.9166666666666666,1.0,1.0,4/50,7.07%,RPS27L;ABRAXAS1;TICRR;CCND1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.31452692901877544,0.7254726930382553,0.8928571428571429,1.0,1.0,11/75,14.53%,FZD1;MAGI2;WNT5A;PSMD13;RYK;DVL2;SMURF2;PRICKLE1;SMURF1;PRICKLE2;PSME4
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.39597259805376206,0.7254140417817745,0.8431372549019608,1.0,1.0,1/17,5.93%,RNF128
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.4123539937647365,-0.7253342497188027,0.8769230769230769,1.0,1.0,7/17,27.69%,MBTPS2;APH1B;HM13;TGFB1;ADAM9;ADAM17;NCSTN
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.3937221851551149,-0.7252377677291403,0.7755102040816326,1.0,1.0,4/21,10.68%,DNASE1L1;REXO4;H1-0;HMGB2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.32636497304306683,0.7251637357874651,0.9318181818181818,1.0,1.0,16/68,17.57%,HJV;SLC39A12;CUL1;SLC30A8;SLC30A10;MT1M;SLC39A8;CYBRD1;SLC40A1;TF;ABCG2;SLC31A1;SLC11A2;BMP6;COX19;HMOX2
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.3299892411445595,-0.7250018314969443,0.8679245283018868,1.0,1.0,11/88,11.78%,TRIM55;LDB1;ADAM12;TPM1;MYH14;CACNG1;ACTC1;NPHS1;FHL2;COX7A1;CRYAB
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.36039709673310366,-0.7247249527709518,0.8846153846153846,1.0,1.0,1/40,0.52%,CELA2A
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.46972104262293957,0.7244525259426766,0.8627450980392157,1.0,1.0,3/10,8.49%,ARID1A;ARID1B;SERTAD2
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.4565636207436986,0.7244146472876599,0.7551020408163265,1.0,1.0,3/5,11.08%,ACVR2A;SMAD2;ACVR1B
prerank,MSigDB_Hallmark_2020__Complement,-0.30488133707518333,-0.724380879237746,0.9482758620689655,1.0,1.0,17/147,9.27%,F8;CLU;F5;C2;SERPINE1;STX4;ANXA5;MAFF;ATOX1;CPQ;DUSP6;PHEX;DUSP5;HNF4A;CALM1;SCG3;CR1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.4225562997444407,0.7243785250597502,0.7291666666666666,1.0,1.0,8/14,37.28%,AIFM2;COQ7;PDSS2;UBIAD1;COQ8B;COQ2;PDSS1;COQ3
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.43272530793906727,-0.7242908556010182,0.803921568627451,1.0,1.0,1/11,3.48%,CD74
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.47483083303214185,0.7242193477788159,0.7714285714285715,1.0,1.0,2/6,8.13%,TRDN;PDE4D
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4095674770408888,-0.7241684458393727,0.8,1.0,1.0,2/14,6.38%,NUDT12;NAXE
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3720517634408659,0.7240899444287822,0.8163265306122449,1.0,1.0,4/21,16.41%,TAB3;TAB2;MAP2K6;NOD1
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.3009166389424212,0.7239784177780407,0.9629629629629629,1.0,1.0,24/180,16.09%,CD151;PPARG;ADIPOR2;CIDEA;CAVIN1;PPP1R15B;ELOVL6;RAB34;CAT;DHRS7B;C3;DNAJC15;LPCAT3;FAH;LIFR;GBE1;QDPR;PIM3;GPD2;SORBS1;IDH1;MTARC2;CPT2;LPL
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.3662356140212767,0.7238925878777959,0.8695652173913043,1.0,1.0,4/33,11.64%,ITPKB;IP6K2;MOCS3;AGPAT5
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3355314320171261,-0.7237222689072002,0.8596491228070176,1.0,1.0,4/47,7.49%,RBM4;RBM8A;CELF3;RBM11
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.3582435244020506,0.7237135785190311,0.8378378378378378,1.0,1.0,4/51,6.05%,ENPEP;PLA2G10;PLA2G7;RIDA
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.418189630895958,0.7236932366618108,0.7619047619047619,1.0,1.0,1/14,3.20%,AKR1C1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.40073314175169705,0.7236010062805723,0.8461538461538461,1.0,1.0,1/12,4.89%,SLC6A13
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.4312950217646493,-0.7233764017478822,0.7916666666666666,1.0,1.0,2/16,13.53%,ADAM19;APH1B
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.32864017926645794,0.723195538768935,0.8936170212765957,1.0,1.0,13/70,16.73%,CA9;SLC26A7;SLC23A1;SLC39A8;ABCC11;SLC4A4;SLC2A14;SLC25A41;SLC22A6;SLC4A7;SLCO1C1;ABCG2;SLCO4A1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.44869369419669003,-0.7230938285330285,0.8269230769230769,1.0,1.0,5/11,14.77%,SERPINE1;TPM1;NDRG4;IGFBP3;CORO1B
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.41941239393533614,0.7228770601098923,0.7708333333333334,1.0,1.0,2/5,22.23%,FBP1;PFKP
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.43550773837825835,0.7228475227925861,0.7272727272727273,1.0,1.0,1/11,5.92%,LATS1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.4402648305608374,-0.7225963472520961,0.8936170212765957,1.0,1.0,2/11,19.63%,HDAC5;CHEK1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.38843110312516516,-0.7223976042784596,0.8596491228070176,1.0,1.0,8/23,21.82%,LAMP3;RPL23;EFNA1;TAF1;RPL5;GABARAPL2;RPL11;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.4878293268674859,0.722225539399026,0.9215686274509803,1.0,1.0,3/6,11.47%,NLGN1;RORA;BTRC
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.317418005415455,0.7222052471372905,0.9487179487179487,1.0,1.0,22/116,16.15%,GPC6;FIGN;GUCY1A2;SEMA6D;GFRA1;SLIT2;PDZRN3;FBXL7;LRP4;ADGRL2;TENM3;BCAR1;ANK2;LIFR;AMOTL2;PRICKLE2;KCNK9;MEIS3;VIM;PKDCC;MAGI1;DCLK1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.46333925966280975,0.7221256828642801,0.9111111111111111,1.0,1.0,3/6,15.41%,CDH2;FER;AFDN
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.3852973262355489,0.7219595947604496,0.8,1.0,1.0,1/14,1.23%,KCNE4
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.3575820105842108,-0.7219574930250579,0.8387096774193549,1.0,1.0,4/33,14.92%,PTCD2;CPSF4;SAFB;CDK11B
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.48954900288505215,-0.7219529952756829,0.8253968253968254,1.0,1.0,1/5,8.01%,DRD3
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.450861994575354,-0.7218846331173919,0.8372093023255814,1.0,1.0,1/8,8.95%,CHAC1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.34232613996394023,-0.7209064272382002,0.8727272727272727,1.0,1.0,8/45,13.71%,B2M;FTH1;SKP1;SCARA5;FRRS1;ISCU;ATP6V0A2;NUBP1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.37143554964926967,0.7207044958120271,0.82,1.0,1.0,4/17,14.32%,CAVIN1;SPIN1;GTF3C4;TAF1B
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.40348790235077336,0.720684243033394,0.8163265306122449,1.0,1.0,1/10,3.51%,IMMP2L
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.4846405126213079,0.720607196818109,0.8235294117647058,1.0,1.0,2/5,21.91%,ACADL;AIG1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.3545070927352213,-0.7204752824712638,0.9433962264150944,1.0,1.0,1/36,0.63%,CCN3
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.48038129869802176,0.7202648727329495,0.7708333333333334,1.0,1.0,1/5,4.45%,SLC8A1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.48038129869802176,0.7202648727329495,0.7708333333333334,1.0,1.0,1/5,4.45%,SLC8A1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.3490956813809222,0.7201619219490214,0.9130434782608695,1.0,1.0,3/29,6.12%,NTF3;MAGI2;ANKRD13D
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.3034675854134547,0.7199240343630259,0.9523809523809523,1.0,1.0,26/114,16.93%,PTPN20;IL1RAPL1;IL18R1;XAF1;SPHK1;SNCA;PTPN13;PTPN6;ASAH2;CSF1R;PRKCA;TIMP1;PTPN14;TIMP3;LIFR;AKAP6;CD274;BCL2;PID1;LDLRAP1;MAPK8;AFF3;SMAD3;RELA;NFAT5;PTPN12
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.3401802363767993,0.7197819182574164,0.8260869565217391,1.0,1.0,3/40,6.45%,PLA2G10;CYP4Z1;SCD
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.3694437485106597,-0.7193193792059991,0.896551724137931,1.0,1.0,5/33,11.78%,LCP1;RBM4;GRIPAP1;REEP6;CRYAB
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.4946543369396157,0.7191908464823965,0.8666666666666667,1.0,1.0,1/5,7.13%,TCF4
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.39726005348020954,-0.7190564080816363,0.75,1.0,1.0,13/22,35.02%,ISCU;NDOR1;NUBP1;ISCA2;NFS1;NUBPL;HSPA9;NFU1;HSCB;CIAO1;MMS19;CIAO2A;CIAO2B
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4165146516524618,-0.7190335696000036,0.8275862068965517,1.0,1.0,1/11,6.27%,SHANK3
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.37457328707401627,-0.7188044751323702,0.86,1.0,1.0,3/26,12.37%,CELF3;SF3A2;SF3A1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.4408173927601498,0.7187387883170139,0.8444444444444444,1.0,1.0,1/10,1.23%,KCNE4
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.38612458784492965,0.7184139045857505,0.8048780487804879,1.0,1.0,4/9,17.66%,KCNJ2;ATP12A;SLC12A2;ATP1A2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3906986221570664,-0.7183688390296223,0.8181818181818182,1.0,1.0,1/16,2.08%,SPA17
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.4065774317283479,0.71835079586009,0.8,1.0,1.0,4/12,23.80%,IKBIP;LIG4;NIPBL;MSH2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.3798886425085741,0.718305455677343,0.8333333333333334,1.0,1.0,5/31,8.80%,DOC2B;IRS2;SLC30A8;MCU;ACSL4
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.3380290999046821,-0.7181064420220253,0.875,1.0,1.0,4/46,5.76%,SFRP1;TTC23;TXNDC15;GPC3
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.4099031143178046,-0.7180915971642738,0.8148148148148148,1.0,1.0,3/9,13.43%,CD4;DCAF15;LEP
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.5169424384061709,0.7180706659459518,0.9111111111111111,1.0,1.0,1/5,6.69%,DMC1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3541871446812458,0.7179647483692718,0.8333333333333334,1.0,1.0,11/45,16.85%,LAMB4;NRP1;RADIL;FER;ITGAV;TMEFF2;USH2A;PIK3R1;ATRNL1;NTNG1;MEGF9
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.43849626480039583,-0.7176374868054795,0.8823529411764706,1.0,1.0,2/8,8.19%,BLVRB;AMBP
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.43849626480039583,-0.7176374868054795,0.8823529411764706,1.0,1.0,2/8,8.19%,BLVRB;AMBP
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.4180438892765803,0.7176141870405219,0.8958333333333334,1.0,1.0,3/14,13.82%,LDLR;NR1H3;ABHD5
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.4539055199270995,0.7174223991422034,0.8035714285714286,1.0,1.0,3/8,25.13%,FGF13;SEMA4D;DCC
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.3708312247368018,-0.717371161777533,0.8043478260869565,1.0,1.0,5/25,17.89%,MMP21;AHI1;NDRG4;CCDC39;SHH
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.47626626396489546,0.7164784608807431,0.9361702127659575,1.0,1.0,2/5,21.24%,MAP2;ABL1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.3224894407738737,0.7164416608404817,0.8913043478260869,1.0,1.0,11/46,14.51%,SULT2B1;SULT2A1;CYP39A1;HMGCR;LBR;MSMO1;CYP4V2;CYP7B1;LDLRAP1;INSIG2;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.409169948125142,-0.7164275586923321,0.7391304347826086,1.0,1.0,1/15,1.73%,CLU
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.2851961542577712,0.7164133701819997,0.96,1.0,1.0,30/191,15.94%,NRG1;EFNA5;PPP1R14C;LRRIQ1;FGF12;CNTN4;CYB561;KCTD1;RNF220;RNF128;FAIM;CLGN;VPS37D;CARNS1;IMPDH1;MLF1;PACRG;MEIS3;CCDC28B;PCLO;SPEF2;MEIG1;MAP2;TMEM178A;CERS5;KCNA5;FSTL5;CNGA4;DUSP8;ENDOD1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.38687054729930703,-0.7155801848753754,0.7924528301886793,1.0,1.0,4/16,12.96%,TYMS;APRT;GMPR;POLL
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.32810953247499247,0.7152966161839344,0.9574468085106383,1.0,1.0,14/70,23.16%,ZEB2;PDE2A;STX18;TMED9;EP300;USP6NL;PDE4DIP;SPATA4;MIEF2;PTK2;RAB33B;TMEM33;PLXNB1;CLN3
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.37137031028469736,-0.7150366093363566,0.8727272727272727,1.0,1.0,4/23,13.53%,SARDH;HSD17B10;IL4I1;KYNU
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.33163354317672317,-0.7148112080362199,0.9107142857142857,1.0,1.0,11/62,14.72%,INHA;NUPR1;TSPYL2;LATS2;RFPL1;INCA1;BTG1;NR4A1;BMP7;TAF6;CAMK2N1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.3242765822046317,-0.7146791829617014,0.9655172413793104,1.0,1.0,10/62,15.60%,DND1;WTIP;POLR2I;LIMD1;POLR2J;NUP133;NUP43;POLR2G;NUP155;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.4629122001186744,-0.7144235256399176,0.7592592592592593,1.0,1.0,1/8,7.06%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.4629122001186744,-0.7144235256399176,0.7592592592592593,1.0,1.0,1/8,7.06%,DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.4629122001186744,-0.7144235256399176,0.7592592592592593,1.0,1.0,1/8,7.06%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.32081477488301835,0.7138725518212232,0.9318181818181818,1.0,1.0,7/57,10.00%,FGFR2;SPHK1;EGFR;PSRC1;ANKRD17;PRKCA;MEIS2
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.4247840911847967,-0.7136581384287125,0.7843137254901961,1.0,1.0,2/6,13.59%,BST1;BMP7
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.37043592477960713,0.71359151058638,0.8363636363636363,1.0,1.0,2/23,4.20%,CSGALNACT1;SULF1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.3828448817946637,0.7135577665376989,0.7872340425531915,1.0,1.0,4/17,20.17%,STX18;USP6NL;PDE4DIP;RAB33B
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.38243353823841486,0.7134330901916647,0.9111111111111111,1.0,1.0,3/17,12.71%,MCM7;MCMDC2;POLD3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.427590194121754,0.7134014403598892,0.8936170212765957,1.0,1.0,2/9,8.16%,DCUN1D1;HIF1A
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.4161980920611321,0.7133943196590805,0.8085106382978723,1.0,1.0,1/9,3.81%,HEY1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.4426657914804865,0.713362873274468,0.7659574468085106,1.0,1.0,1/6,16.25%,SENP1
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),0.46546956109431803,0.7130874497836974,0.86,1.0,1.0,1/5,9.67%,PRKCA
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.3547430039912135,0.7129788663651245,0.8695652173913043,1.0,1.0,2/19,8.44%,LAMB4;GPM6B
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.3760301207011604,-0.7127695940821175,0.7931034482758621,1.0,1.0,9/26,28.40%,EXOSC10;CPSF3;SLBP;EXOSC4;MTPAP;CPSF2;LSM10;DCP2;LSM11
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.43431454548638,-0.7125917525255795,0.803921568627451,1.0,1.0,4/10,14.90%,TMSB4X;NOS2;PINK1;ENO1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.41666662095791296,-0.7124610246567283,0.8125,1.0,1.0,1/9,0.99%,PAH
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.44283997992622204,-0.7124464420303644,0.8490566037735849,1.0,1.0,2/9,8.74%,ZWILCH;SPDL1
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.44869155839966945,0.7124457231745648,0.7924528301886793,1.0,1.0,2/5,13.89%,STARD4;LDLRAP1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.3091701792018335,-0.7124305764296278,0.9298245614035088,1.0,1.0,12/82,16.21%,STX16;DCTN1;RAB7B;CLTCL1;VPS53;BAIAP3;SNX6;PREPL;YKT6;VPS52;RBSN;BET1L
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.32811807752000904,-0.7124009364345311,0.9814814814814815,1.0,1.0,9/46,22.33%,ANKLE2;LEMD2;NUP133;EMD;NUP43;NUP155;VRK1;CHMP2A;NUP85
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.32811807752000904,-0.7124009364345311,0.9814814814814815,1.0,1.0,9/46,22.33%,ANKLE2;LEMD2;NUP133;EMD;NUP43;NUP155;VRK1;CHMP2A;NUP85
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.43585997802227394,-0.7122089669759986,0.8409090909090909,1.0,1.0,1/10,0.46%,NCKAP1L
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),-0.4491117340768821,-0.7120356888270013,0.7222222222222222,1.0,1.0,1/5,13.03%,ABHD1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.3161362937266273,-0.7120290077776827,0.9122807017543859,1.0,1.0,7/66,9.81%,DACT2;RAC1;EPHA1;SPI1;PARVB;ATF4;PARVG
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.3067837926360809,0.711862783443274,0.9433962264150944,1.0,1.0,3/49,8.11%,IFI16;CCL5;PTPN6
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.3179274977150706,-0.7118225153526181,0.90625,1.0,1.0,16/51,28.04%,POLR2I;POLR2J;NUP133;NUP43;POLR2G;NUP155;POLR2C;EIF4G1;NUP85;NUP214;POLR2L;NUP50;POLR2K;SEC13;TPR;POLR2B
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.3179274977150706,-0.7118225153526181,0.90625,1.0,1.0,16/51,28.04%,POLR2I;POLR2J;NUP133;NUP43;POLR2G;NUP155;POLR2C;EIF4G1;NUP85;NUP214;POLR2L;NUP50;POLR2K;SEC13;TPR;POLR2B
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.41213094358074337,-0.7116714816703239,0.8297872340425532,1.0,1.0,2/14,4.74%,RAC1;IL11
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.4088665608996499,-0.7112233827232065,0.8113207547169812,1.0,1.0,4/13,14.90%,TMSB4X;PINK1;PARP1;ENO1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.34093509255769244,0.7109935117699838,0.975609756097561,1.0,1.0,4/32,12.39%,CLSPN;HINFP;SETMAR;RAD9B
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.4334803185376884,-0.7108612143491665,0.8163265306122449,1.0,1.0,5/13,24.85%,AASS;CHTOP;NNMT;CTR9;PAF1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.3345832982427757,-0.7103242078562098,0.896551724137931,1.0,1.0,5/50,6.05%,SFRP1;AMH;NODAL;ADAMTS12;DLX5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.391841965080932,0.7099999048308631,0.9111111111111111,1.0,1.0,4/23,11.09%,KLF2;HIF1A;ATF6;ATF3
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.29194720175388517,0.709941454347873,0.9215686274509803,1.0,1.0,16/71,22.58%,UBE2J1;TMEM67;DNAJB2;YOD1;SYVN1;FAM8A1;JKAMP;SEL1L;RHBDD2;RNF185;RNF103-CHMP3;DERL1;ERLIN1;UBE4A;EDEM1;UBE2J2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.4106941979964911,-0.7098784604494034,0.8867924528301887,1.0,1.0,1/13,1.16%,CD9
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.43334698479762224,0.7097984620866586,0.7777777777777778,1.0,1.0,4/7,29.64%,HMGCR;MVD;PDSS2;MVK
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.4181485721550364,-0.7095812561353271,0.9090909090909091,1.0,1.0,3/15,12.72%,NODAL;ZP3;WEE2
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.2976700612976543,-0.7095745795549825,0.9259259259259259,1.0,1.0,21/98,17.38%,TEC;RAC1;PSMA7;VAV3;SKP1;PSMD7;PSMB4;PSMC3;CALM1;CARD11;PSMD8;PSMB5;PIK3CB;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;PSME1;PSMD10
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.38953724527726385,-0.7095170069370363,0.82,1.0,1.0,4/18,13.41%,STX4;CRHR2;PLK2;PRKCZ
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.37546334039959617,-0.7093638470806444,0.9298245614035088,1.0,1.0,4/29,15.58%,B2M;PAX6;RTN4R;GDI1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.3965827519187469,0.7093314687485801,0.8571428571428571,1.0,1.0,4/13,20.69%,AUTS2;ARHGAP24;OGT;KBTBD7
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.4452977642032818,-0.7092821596337632,0.8085106382978723,1.0,1.0,1/5,2.45%,LDB1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.39468188103095697,-0.7092559118998025,0.7777777777777778,1.0,1.0,4/20,12.72%,EXOSC10;NOP14;NOP9;KRI1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.4283257284484083,0.709098257684206,0.8222222222222222,1.0,1.0,4/8,29.64%,HMGCR;MVD;PDSS2;MVK
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.3631455045974258,-0.7088940108213404,0.9032258064516129,1.0,1.0,2/27,3.35%,F8;SERPINE1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.3531191501077372,-0.7088773065670622,0.8695652173913043,1.0,1.0,9/38,22.73%,CALM1;TTBK1;ACTB;FGF9;CALM3;SEC16A;DYNLL1;INA;COX6B1
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),0.4706550748051826,0.7087123723924332,0.803921568627451,1.0,1.0,1/5,0.32%,LOXL2
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.3874998340406821,-0.708233723382788,0.8431372549019608,1.0,1.0,3/19,16.68%,SERPINE1;PROC;VTN
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.4000656146889473,0.7082317275619064,0.7948717948717948,1.0,1.0,5/13,37.93%,HNRNPD;TNKS;NEK7;MAP3K4;PRKCQ
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.414009142047934,-0.7081676016606204,0.7555555555555555,1.0,1.0,3/13,14.45%,HMGB3;HMGB2;TOP3A
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.41247940096068725,-0.7079282936850092,0.875,1.0,1.0,3/14,21.43%,EXOSC10;EXOSC4;MTPAP
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.3997744714256487,0.7077656410848083,0.9183673469387755,1.0,1.0,3/15,10.12%,SLC2A5;SLC2A11;SLC2A14
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3154623576136525,-0.7077633269633831,0.9259259259259259,1.0,1.0,12/82,14.58%,KIF25;NCAPH;KNSTRN;REC8;SMC4;SPDL1;ANKRD53;AKAP8L;NCAPD3;WRAP73;NCAPD2;INO80
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.3662785472959925,-0.707637400146477,0.84,1.0,1.0,3/22,7.58%,SIGIRR;CD74;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.4218729352396291,0.7076063207129965,0.8717948717948718,1.0,1.0,4/9,24.25%,NFATC2;NFATC3;PDCD4;PDGFB
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.46447645992420294,0.7073971893819916,0.8695652173913043,1.0,1.0,5/6,46.22%,ANAPC1;ANAPC7;CDC23;CDC27;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.46447645992420294,0.7073971893819916,0.8695652173913043,1.0,1.0,5/6,46.22%,ANAPC1;ANAPC7;CDC23;CDC27;TACC3
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.4131440614055216,-0.7072785669333036,0.8148148148148148,1.0,1.0,1/12,9.54%,CXCL14
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.4111138584276535,-0.7071140066270992,0.8297872340425532,1.0,1.0,1/8,12.59%,SVIP
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.34251344727101496,0.7069544807607714,0.85,1.0,1.0,3/29,10.35%,PPARGC1A;RPS6KA4;ZBTB7B
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.40291495286750056,0.7063307769729853,0.813953488372093,1.0,1.0,1/12,1.23%,KCNE4
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.33290161797629253,-0.7062864383521983,0.9821428571428571,1.0,1.0,6/35,14.73%,HMGB3;ERCC1;XRCC2;SUPV3L1;RPAIN;XRCC3
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.4247100627746112,-0.7060668922619714,0.7894736842105263,1.0,1.0,6/9,28.15%,SUPT5H;CCNT1;RNF20;CTR9;NELFE;CDK9
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.36872789951496926,0.7060533435041739,0.8043478260869565,1.0,1.0,1/14,1.57%,KCNJ3
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.4129802111357481,-0.7057842185780019,0.8,1.0,1.0,1/13,8.51%,CALM1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.30214623553470477,-0.7055577470535057,0.92,1.0,1.0,22/98,17.38%,TEC;RAC1;PSMA7;VAV3;SKP1;PSMD7;PSMB4;PSMC3;CALM1;CARD11;PSMD8;PSMB5;PIK3CB;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;NR4A3;PSMB8;PSME1;PSMD10
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3978862444125143,0.7054388435566844,0.7647058823529411,1.0,1.0,5/16,25.09%,BCS1L;COX19;SCO1;TIMM21;SCO2
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.4251892332831174,0.7053473343102573,0.7843137254901961,1.0,1.0,5/9,30.17%,PIK3R1;WDR81;RBL2;PPP2R5A;EEF1A2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.30571223895407407,0.7053291803009054,0.9782608695652174,1.0,1.0,16/61,19.02%,UHRF2;UBE3D;RNF220;CNOT4;MARCHF7;RAD18;RNF122;MARCHF5;UBE2D3;RNFT1;RNF19B;RAG1;MDM2;RNF185;CUL3;KLHL24
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.3174423937508478,-0.7051723780255856,0.8301886792452831,1.0,1.0,6/53,8.88%,ARIH2;RNF8;RBX1;DTX3L;UBE3A;IFI27
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.2660928091073973,0.7051022410467832,1.0,1.0,1.0,73/454,15.30%,UHRF2;MARCHF1;RFWD3;TRIM22;UBE2J1;KLHL21;RNF217;NEDD4;MARCHF8;UBE2E2;PELI2;MSL2;PELI1;UBE3D;UBE2U;PDZRN3;CUL1;RNF220;SPOP;PSMD13;DTX4;LMO7;FBXL7;UBR5;FBXO30;FBXW9;CNOT4;HIF1A;LZTR1;TRIM50;TRIM5;FBXO7;TSPAN17;ZNRF3;UBE2E3;PEX2;RNF139;SMURF2;FBXL3;ZSWIM8;FANCL;ARIH1;BTRC;CTNNB1;SIRT1;MARCHF7;PEX13;SHPRH;NEUROD2;SASH1;FBXO11;RAD18;BCL2;SMURF1;KLHL8;UBE2E1;KCTD10;SYVN1;RNF122;MARCHF5;UBE2D3;PSME4;PLK1;ANAPC16;KLHL13;RNF144A;COMMD1;MIB1;RNFT1;FBXL17;BARD1;NEDD4L;FBXL2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.44504217600822227,-0.7050423056074304,0.8409090909090909,1.0,1.0,1/9,6.30%,EXOSC10
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4100459491691914,0.7048346736378448,0.7719298245614035,1.0,1.0,2/11,12.98%,PARD3;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.39085010910768325,-0.7041948231009125,0.8909090909090909,1.0,1.0,4/21,11.11%,DUOX1;ETS1;CCDC25;STK11
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.4791277034275986,0.7041468320332235,0.9487179487179487,1.0,1.0,1/6,5.64%,IGLL1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.41214105901182996,-0.7039745478732798,0.8679245283018868,1.0,1.0,1/8,3.23%,RAC1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.3288449300151723,0.7039494749954791,0.8372093023255814,1.0,1.0,9/55,13.03%,PLCB1;SPHK1;EGFR;TGFBR1;H3-3A;CDKN2AIP;ADNP2;AKAP6;BCL2
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.3263078014747528,-0.7036001975256742,0.9215686274509803,1.0,1.0,10/33,23.55%,XRCC1;NTHL1;POLL;PARP1;MBD4;SMUG1;POLG;RPA3;APEX1;PARG
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.3800088923523011,-0.7035958220789418,0.8717948717948718,1.0,1.0,2/21,8.87%,FXYD7;SCN4B
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.39063004663848844,0.7033735678649632,0.7719298245614035,1.0,1.0,2/11,16.42%,ADIPOR1;VHL
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.41171954967145175,-0.7030547869803792,0.8392857142857143,1.0,1.0,1/13,3.88%,RAB17
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.41171954967145175,-0.7030547869803792,0.8392857142857143,1.0,1.0,1/13,3.88%,RAB17
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.39732540616323153,-0.7026515825617548,0.803921568627451,1.0,1.0,13/21,35.02%,ISCU;NDOR1;NUBP1;ISCA2;NFS1;NUBPL;HSPA9;NFU1;HSCB;CIAO1;MMS19;CIAO2A;CIAO2B
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.40234481103876796,0.7025975112633013,0.8695652173913043,1.0,1.0,3/17,21.98%,PRSS3;TCN2;CUBN
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.40234481103876796,0.7025975112633013,0.8695652173913043,1.0,1.0,3/17,21.98%,PRSS3;TCN2;CUBN
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.31762715307852396,-0.702468938591996,0.9074074074074074,1.0,1.0,2/62,3.48%,NCKAP1L;CD74
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.3828302728792521,-0.7024254162684083,0.8888888888888888,1.0,1.0,3/18,16.80%,SLX4;RBBP8;KAT5
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.3051661834371489,0.701959223672623,1.0,1.0,1.0,20/134,14.13%,ALDH1A1;ADIPOR2;HMGCS1;CEL;CIDEA;OSTC;PTPRG;ODC1;ACSL4;CRYZ;PRDX6;UGDH;ALDH3A2;ACADVL;GPD2;METAP1;ACSS1;FASN;LGALS1;BCKDHB
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.2973484826096551,0.7017839914842342,0.94,1.0,1.0,18/136,15.52%,NRG1;DNAI4;IMMP2L;ANLN;PSMD13;SNCA;TCF4;SMAD1;SMAD2;NCK1;SHQ1;PICALM;PSMG2;HSPA1A;DMD;SPAG1;MIS12;SMAD3
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3219306297793096,0.7012788776071832,1.0,1.0,1.0,21/94,20.26%,EFNA5;IQCJ-SCHIP1;EPHA3;RHOB;SORBS3;GPM6B;BICD1;PDGFRB;EPHA5;RHOBTB3;P2RX7;CLASP1;ROCK2;SPATA4;PTK2;PHLDB1;DMTN;CDK10;TESK1;PAK3;BAIAP2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.3508895691204855,0.7011513164185884,0.8478260869565217,1.0,1.0,3/35,10.05%,EFNA5;EPHA3;BICD1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.4312356539183221,0.7006628543524174,0.7692307692307693,1.0,1.0,1/6,7.86%,LDLR
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.32401072759902133,0.7005550022143986,0.9767441860465116,1.0,1.0,16/61,20.03%,ZFP36;SPHK1;CCL5;ZFP36L2;CRHBP;SIRT1;ERBIN;PID1;AFF3;SMPD4;RELA;ZFAND6;TRIM32;ZFP36L1;ADAM10;NFE2L2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.3164490594418958,-0.7002488766295822,0.9285714285714286,1.0,1.0,7/66,10.91%,FIP1L1;CPSF1;POLR1G;CPSF4;TTF1;TAF1D;GTF2H2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.3531130554394273,-0.7001814496125071,0.8867924528301887,1.0,1.0,7/25,18.71%,RAC1;DCTN1;ANKRD53;DRG1;MET;CKAP5;RPS3
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.4110995661327022,-0.7001031634088762,0.8888888888888888,1.0,1.0,1/24,1.15%,PLEKHH2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.2997897591558034,0.6998982744926878,0.9767441860465116,1.0,1.0,6/63,5.22%,ZFP36;HMGB1;CX3CR1;WNT5A;CCL5;PDE4B
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.3900302392613385,-0.6996091686728417,0.8823529411764706,1.0,1.0,4/11,25.41%,VIL1;MICAL2;CFL1;DSTN
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.36123735670949325,0.6995721000378816,0.8367346938775511,1.0,1.0,2/20,7.94%,IFI16;PCBP2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.33822238300832763,-0.6995667308338084,0.9111111111111111,1.0,1.0,3/33,6.51%,STX4;STX1B;CDK5
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.41358909660353904,-0.6993222737420199,0.8305084745762712,1.0,1.0,2/15,3.88%,PDXDC1;ENPP2
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.35826089933840677,0.6990371327244561,0.8367346938775511,1.0,1.0,7/13,25.91%,PDGFRB;MEF2A;NEBL;PROX1;FHOD3;TCAP;PDGFRA
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.49523404916491465,-0.6990201178234203,0.8653846153846154,1.0,1.0,2/5,13.40%,PDCD5;SGTB
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.38821602626783924,-0.698797573564324,0.8571428571428571,1.0,1.0,1/14,2.31%,NOG
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.3177144861543713,0.698789446703472,0.8780487804878049,1.0,1.0,18/86,16.02%,EGFR;ITGAM;EPHA3;ATP2B4;TP63;TCAF2;DPP10;PPP1R13B;ANK3;BCL2;SORBS1;TP53BP2;MTCL1;PIK3R1;MAPK8;AKT2;BAD;YWHAZ
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.2695527580301938,-0.6982247760657562,1.0,1.0,1.0,42/319,17.38%,CBLC;AURKA;UCHL1;PSMA7;ADRM1;ANAPC15;UBE2L6;ARIH2;RNF8;PSMD7;UBL7;RBX1;PSMB4;DTX3L;TBL1X;PSMC3;RNF213;IFI27;PRAME;RMND5B;NSFL1C;UFD1;TOM1L1;PINK1;RBCK1;DDB1;PSMD8;PSMB5;PSMC1;UHRF1;PSMB2;PSMC4;TAF1;PSMD2;PSMA1;WDR91;VPS28;KAT5;PSMB8;PSME1;TRPC4AP;PSMD10
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.3369494401731058,-0.6977928853181894,0.9183673469387755,1.0,1.0,7/35,17.58%,FABP6;FABP5;LIPC;LMF1;LIPI;PNPLA4;GK5
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.374141852068778,0.6972900953221515,0.8214285714285714,1.0,1.0,7/26,16.18%,KANK1;SLIT2;SNCA;DYRK1A;MAP2;SSH2;TWF1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.3002177963148057,0.6969303850057192,0.9767441860465116,1.0,1.0,10/48,19.87%,TYR;PRIMPOL;AANAT;MAPK8;FECH;CRY1;OPN5;TRIM32;DCT;MAPK10
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3628298784010219,-0.6967694227513083,0.8852459016393442,1.0,1.0,3/22,13.77%,SLC6A9;ATP1B1;STAC
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.38718192527645723,0.6967451473217684,0.7857142857142857,1.0,1.0,1/9,4.48%,ZEB2
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.4107586185926926,-0.6967044318962825,0.8571428571428571,1.0,1.0,1/8,2.59%,SLC1A7
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.3383239180504168,0.6965022018506302,0.9375,1.0,1.0,8/30,13.04%,RAB29;SYT1;GRIK2;SNCA;CDKN2AIP;RIMS2;EDN1;SOX11
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.38557140688754626,0.6962259398230223,0.9090909090909091,1.0,1.0,4/14,13.63%,MAGI2;PPP1R15B;PDGFRB;MEF2C
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.30460929961204664,-0.695880370557284,0.9782608695652174,1.0,1.0,7/94,8.80%,NCKAP1L;CD74;SPG7;FANCC;VIL1;CHCHD10;TUBGCP2
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.4481183117218245,0.6957925482952106,0.8,1.0,1.0,2/8,23.04%,PLA2G4C;FITM2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.3870002977333169,0.6957762927778944,0.8518518518518519,1.0,1.0,3/10,9.92%,LATS1;DUSP9;WWC1
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),-0.45392444589059966,-0.6957265282273065,0.8620689655172413,1.0,1.0,1/6,2.31%,NOG
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4333913608730814,-0.6954051372759346,0.9523809523809523,1.0,1.0,1/7,3.82%,DUOXA1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.33269479754405595,-0.6953796541824607,0.8863636363636364,1.0,1.0,1/25,6.10%,UBC
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.33269479754405595,-0.6953796541824607,0.8863636363636364,1.0,1.0,1/25,6.10%,UBC
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.45106377753773363,0.6952789851090921,0.8636363636363636,1.0,1.0,2/5,8.06%,HMGB1;MBP
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.2687080470670493,0.6952646827855511,1.0,1.0,1.0,59/379,15.72%,ARHGAP25;DAPK2;RIT2;NLGN1;DDIT4;PEX5L;AGER;EGFR;WNT5A;BANP;PIP4K2A;PKHD1;TNIK;HSPB1;ECT2;RHOB;TP63;SLC15A2;ARHGAP10;HDAC2;PTPN13;SGK1;FSHR;STYXL1;TAF3;TP53INP1;ITGAV;PRKAB2;WWC1;PHLPP1;ARHGAP30;GNAI1;PDE2A;DYRK2;PPP1R13B;CCNG1;STARD8;ARAP2;MAP2K6;GNA13;RAD9B;AKAP6;FGD4;EP300;SYDE2;TIAM2;RFC5;ARHGAP24;PREX1;TP53BP2;TAF2;TAF4B;SGMS1;ARHGAP5;BARD1;FBXL2;FAM13A;DIPK2A;CMKLR1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.34771262060377367,0.6948967623001329,0.8888888888888888,1.0,1.0,5/25,13.63%,PPARG;SULF1;ATOH8;PTPRM;MEF2C
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.32329361697393555,0.6948548412414582,0.9024390243902439,1.0,1.0,6/29,13.23%,SLC39A8;DDAH1;DDAH2;RIMKLB;MTHFS;GLYATL1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.4404053554593024,0.6948115918565192,0.9130434782608695,1.0,1.0,2/9,14.31%,ERN1;PIK3R1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.4332253633307278,-0.6947118969943368,0.7884615384615384,1.0,1.0,1/7,1.88%,GLYCTK
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4281714916811078,0.6946528174918005,0.8627450980392157,1.0,1.0,4/9,27.18%,SLC30A10;FYN;ABCD2;ABCB7
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.3784154722537569,0.6942223866088727,0.8913043478260869,1.0,1.0,8/17,30.27%,ASXL3;ACADVL;ACADL;ERLIN1;FBXW7;ABCA2;WNT4;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.2872637081320906,0.6940331315355024,1.0,1.0,1.0,29/163,15.64%,ARHGAP25;PPEF2;MAGI2;DDIT4;SLIT2;PKHD1;CD22;MINAR1;ATP2B4;TWIST1;RORA;TLE1;PDE4D;MSTN;ADIPOR1;PHLPP2;ITPR1;WWC1;PHLPP1;PDE3A;PDE2A;SIRT1;PPM1A;BCL2;DEPTOR;P2RX7;URI1;IFI35;PHLDA3
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.2810313100210068,0.6940078548860309,1.0,1.0,1.0,23/127,16.02%,ITGAM;RAB29;ECT2;TP63;HDAC3;UBR5;TCAF2;PCM1;ZDHHC2;HSPA1L;PPP1R13B;TENM1;ANK3;BCL2;TP53BP2;UBE2D3;MTCL1;PIK3R1;MAPK8;AKT2;SMAD3;BAD;YWHAZ
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.39309739685491374,0.6937872977784959,0.8085106382978723,1.0,1.0,3/16,12.23%,CSF1;CSF1R;OSTM1
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.32765887492513324,-0.6936006797463398,0.9074074074074074,1.0,1.0,10/43,16.85%,HK2;TOMM40;TIMM17B;TOMM20;PINK1;TOMM7;TIMM17A;TIMM50;FIS1;TIMM44
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.4296028853485736,0.6932592080295444,0.875,1.0,1.0,2/6,24.59%,MYO3B;MYO3A
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.3537076230513304,-0.692828343015853,0.8461538461538461,1.0,1.0,2/30,4.42%,ATP6V1E2;ATP6V1E1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.46276224928709125,0.6927812920236015,0.8297872340425532,1.0,1.0,1/5,8.09%,CEP120
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.4297653421189586,0.6927359661790542,0.8888888888888888,1.0,1.0,1/10,4.20%,CCL5
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.3986494036142507,-0.6926799337113583,0.8653846153846154,1.0,1.0,1/11,2.13%,WNT9B
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.3593812167229097,0.692620666892157,0.8222222222222222,1.0,1.0,4/15,19.28%,KLF2;MAPK8;SLCO1C1;NFKB1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.30129363103652457,0.6923869459548889,0.9090909090909091,1.0,1.0,11/47,16.62%,AKR1C1;SLC6A13;NCOA2;ABCC2;ABCC11;SLC16A7;SLC16A13;SLC10A1;SLCO1C1;ABCG2;SLC10A4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.43628249368632965,-0.691611938980203,0.8490566037735849,1.0,1.0,1/8,7.53%,EIF5A
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3397236511344831,-0.6913049300503926,0.9433962264150944,1.0,1.0,10/26,26.59%,CDC37;OAS3;METTL3;STAT2;RNASEL;ISG15;HSP90AB1;NLRC5;PTPN11;CACTIN
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.4094454376286556,-0.6911495206880529,0.7894736842105263,1.0,1.0,1/7,4.74%,BST1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.3164252262308535,0.6911343873723775,0.9047619047619048,1.0,1.0,6/52,8.85%,RALA;PLD6;PPARGC1A;MCU;ZNF205;FBXO7
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.33825779448642135,-0.6910939058783481,0.9230769230769231,1.0,1.0,5/53,8.80%,PLK3;TUBGCP5;DCTN1;TRPV4;TUBGCP2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.40713307408395655,-0.6910138903026697,0.7884615384615384,1.0,1.0,5/9,26.86%,ADAMTS12;PIK3CB;SPRY2;DAB2IP;IL12A
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.42085134233661203,-0.6909193198821492,0.8113207547169812,1.0,1.0,3/8,19.87%,TCIM;INO80;RPS6KA1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.30986568905580053,0.6909109565541152,0.967741935483871,1.0,1.0,15/92,15.40%,ZBTB1;BAHD1;ARID1A;ARID1B;NPM3;SRCAP;HDAC2;SMARCD3;SMARCE1;BAZ2B;SIRT1;ACTL6A;DR1;SMARCD2;KAT2B
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.35399854757562965,0.6907494743797199,0.84,1.0,1.0,3/16,17.16%,LDLR;LDLRAP1;LCAT
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.3146040462315702,-0.6905895042452843,0.92,1.0,1.0,5/50,9.00%,ASB9;RILP;GPC3;VIP;PLK2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.386464012855468,-0.690489517320332,0.9230769230769231,1.0,1.0,6/20,25.98%,RILP;WDR91;EEA1;PTPN23;EMP2;HOOK2
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.3794263808925939,0.6903543256214905,0.8666666666666667,1.0,1.0,5/12,20.84%,SLC8A1;PIK3CA;KCNJ2;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.3727395207163715,0.6903488671419066,0.8076923076923077,1.0,1.0,8/26,12.46%,CX3CR1;KLF2;GLA;ATP2B4;DDAH1;DDAH2;PTGS2;EDN1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.33428418618857253,-0.6900560964463395,0.8679245283018868,1.0,1.0,7/34,20.09%,SEPTIN5;SYT6;PREPL;SYT12;RAB3A;UNC13D;TRPV6
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.30036318110921206,-0.6891258577218072,0.94,1.0,1.0,8/92,13.47%,LOXL4;EEF1AKMT2;RNF113A;LOXL1;NUP133;PIAS3;NUP43;NDUFAB1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.3913006324948882,0.68905824465882,0.8431372549019608,1.0,1.0,1/14,3.48%,HMGB1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.44126407675010604,-0.6890449046902573,0.8571428571428571,1.0,1.0,2/6,6.63%,SKP1;RBX1
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.3659829196859789,0.6888720257232577,0.9534883720930233,1.0,1.0,2/13,9.82%,SLC30A10;ASXL3
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.4496979277135907,-0.6887979163309019,0.7931034482758621,1.0,1.0,4/8,27.76%,DRC1;HDAC6;HAP1;LAMP1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.3699353101110939,0.6887857127316978,0.8297872340425532,1.0,1.0,5/15,19.56%,EPCAM;SOX11;THPO;N4BP2L2;HNRNPU
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.3001555278531241,0.6887306133038616,0.9361702127659575,1.0,1.0,5/42,13.89%,ZBTB1;PRIMPOL;SIRT1;POLD3;RFC5
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.3979828318400921,0.6887182133484168,0.8627450980392157,1.0,1.0,1/12,5.02%,NRP1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.3705144686454385,0.6886699895456729,0.8363636363636363,1.0,1.0,2/10,9.78%,MCM7;MCMDC2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.429410209304266,-0.688598996584217,0.85,1.0,1.0,1/8,2.51%,DND1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.41646361986853153,-0.6881984509805623,0.8461538461538461,1.0,1.0,2/6,20.13%,AQP7;AQP9
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.2850285615398199,0.6880884006506875,1.0,1.0,1.0,19/140,12.83%,NFKBIZ;TRIM22;HMG20B;TFEB;AFF2;ZNF827;SLC8A1;CDK6;LDLR;PCBP2;HINFP;HIF1A;TRIM5;NOVA1;RFXANK;ADNP2;ZNF445;SORT1;ADNP
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.4436140757714805,0.6879866643903464,0.8936170212765957,1.0,1.0,2/6,7.98%,GRID2;CTNNA2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.41043250993349445,-0.6878163919197152,0.9137931034482759,1.0,1.0,2/11,8.88%,RBM4;IFI27
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.4017868031178267,0.6877230685973412,0.8222222222222222,1.0,1.0,3/9,13.10%,MAGI2;FST;ACVR1
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.4464974177729351,0.6876592703262524,0.82,1.0,1.0,2/5,23.65%,ROCK2;NCOA4
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.4464974177729351,0.6876592703262524,0.82,1.0,1.0,2/5,23.65%,ROCK2;NCOA4
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.3311067374183506,-0.6872113769189347,0.8909090909090909,1.0,1.0,2/34,3.52%,PIGO;PGAP2
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.43129911518374725,-0.6872047077575355,0.8490566037735849,1.0,1.0,3/8,25.14%,IFI27;PPIB;CFL1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.38214842360316664,0.6866884692922341,0.9038461538461539,1.0,1.0,8/13,28.81%,NPY;MAP2;NTRK2;RAPGEF2;B4GALT6;PTEN;B4GALT5;ARHGAP35
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.38417130544565664,-0.6865785354130529,0.8301886792452831,1.0,1.0,3/11,13.11%,SPI1;TAF7;THAP7
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.37745103143013226,0.6865494348392386,0.8867924528301887,1.0,1.0,3/13,11.75%,WNT5A;CAMK4;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.3566008897306274,-0.6863666820332106,0.8135593220338984,1.0,1.0,3/22,16.76%,APOD;ACE;SRC
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.39904827365778556,0.6863359341010999,0.84,1.0,1.0,5/14,13.86%,SLC30A10;CDK6;TWIST1;SIRT1;MARCHF5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.4307079309330076,-0.6861681131517994,0.7647058823529411,1.0,1.0,1/8,0.61%,NUPR1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.4102624114358202,-0.686085499814448,0.8947368421052632,1.0,1.0,1/7,6.28%,RYR1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.30644855088790157,-0.6859184972099162,0.9821428571428571,1.0,1.0,4/48,5.26%,CIDEB;NLRP3;NODAL;PDCD5
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.390464184473662,-0.6856984895875435,0.8846153846153846,1.0,1.0,5/15,19.69%,LIPC;HNF4A;APOA1;GCKR;IL18
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.38399701369661293,0.6855423500430782,0.8958333333333334,1.0,1.0,3/12,10.38%,MAGI2;PPP1R15B;PDGFRB
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.3197550751916531,-0.6855109185699917,0.9122807017543859,1.0,1.0,6/41,11.36%,CD4;PACSIN3;ADRA2A;CRACR2A;PLPP4;CAMK2G
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.4460798920659514,-0.6854403876092714,0.8043478260869565,1.0,1.0,1/6,7.58%,FOXP1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.3829606415177257,0.685408242431825,0.9555555555555556,1.0,1.0,1/14,4.12%,ARID1A
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.3018546336963875,0.68539790446571,0.9777777777777777,1.0,1.0,9/80,12.66%,TRPV2;SLC8A1;ATP2B4;MCU;MICU1;TRPC4;ITGAV;MAIP1;SLC24A2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.3046699907020505,-0.6853288877081362,0.9814814814814815,1.0,1.0,20/53,29.67%,NUP133;COX7A1;PINK1;NUP43;UQCC2;NUP155;FIS1;GCKR;ATP5IF1;EIF6;NUP85;COX7A2;NUP214;BEND3;ABCD1;NUP50;SEC13;TPR;SLC2A6;ZBTB7A
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.37440414628533963,0.6852847933163984,0.86,1.0,1.0,5/20,14.76%,GDAP1;PEX2;PEX13;ALDH3A2;ABCD3
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.3557008248638266,-0.6851740703039283,0.96,1.0,1.0,5/29,19.07%,DGAT2L6;DGKD;LMF1;GK5;DGKG
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.3569489615577043,-0.6851679373554678,0.9038461538461539,1.0,1.0,9/30,18.00%,CLU;HK2;DNM1L;IFI6;IFIT2;TIMM50;FIS1;CAMK2A;BAK1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.38439332671882204,-0.685066356348811,0.8431372549019608,1.0,1.0,3/13,30.24%,DNM1L;ALKBH7;ITPK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.2909652614105787,0.6850313925501649,1.0,1.0,1.0,19/131,16.48%,FAS;STAB1;MXRA5;FAM114A1;SULF1;POSTN;ACKR3;TMTC2;PDE3A;COL5A2;CXCL12;TIMP3;AMOTL2;TMEM184B;CALCRL;LTBP2;CMKLR1;TAMALIN;WWTR1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.4429259360354063,0.6847789230556237,0.8541666666666666,1.0,1.0,3/7,12.49%,AGER;DLL1;CD274
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.4397108310766968,-0.6845586971283877,0.8909090909090909,1.0,1.0,4/5,44.99%,ATCAY;BNIP2;PRUNE2;BNIPL
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.2737819318828137,0.6845325959594255,1.0,1.0,1.0,44/261,16.80%,RUNX1;ZFP36;CIDEA;DXO;ROBO1;ZFP36L2;H3-3A;RPS6KA4;HDAC9;ATP2B4;TWSG1;RIDA;NUDT16L1;SYNCRIP;ERN1;HINFP;EIF2AK3;HIF1A;BMPR1A;ABCC2;ATOH8;SH3GL2;HELLS;TIPARP;RNF139;ITGB8;NPTN;NDFIP2;SIRT1;EPC1;BTG2;SOX11;SHQ1;MEF2C;CAPRIN1;PICALM;CCDC3;HSPA1A;KAT2B;PTBP2;VEGFA;VHL;CPEB3;LSM14A
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.29846212950407214,0.6844830606936554,0.9782608695652174,1.0,1.0,3/33,9.20%,H3-3A;SPTY2D1;ASF1A
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.33424903894763963,-0.6843992606820626,0.8627450980392157,1.0,1.0,9/23,25.41%,VIL1;STMN1;STMN3;STMN2;CKAP5;KATNB1;MICAL2;CFL1;DSTN
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.3461764329765612,-0.6843748581333591,0.8863636363636364,1.0,1.0,2/18,8.67%,SKP1;CHCHD10
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.35278572233608463,-0.6843498698450049,0.8958333333333334,1.0,1.0,5/24,12.57%,GPR37;ATF4;PINK1;PDE8A;TXN
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.3279441273157256,0.6838740106615797,0.8541666666666666,1.0,1.0,2/31,4.50%,MCM7;POLE2
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.4635365977259415,-0.6837833234456402,0.88,1.0,1.0,2/5,17.23%,SRC;CAMK2A
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.44627046650888363,-0.6837240169899272,0.8679245283018868,1.0,1.0,1/5,13.53%,APH1B
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.3982485588815424,-0.6836855650043928,0.8448275862068966,1.0,1.0,2/10,12.86%,KCNE2;KCNQ1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.3845695636781953,0.6832581680841604,0.8541666666666666,1.0,1.0,4/14,14.64%,DMC1;NSMCE2;SMC5;TEP1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.39043326628972497,-0.6829068944052091,0.8636363636363636,1.0,1.0,3/9,25.36%,CLTA;AP2A1;AP2S1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.39043326628972497,-0.6829068944052091,0.8636363636363636,1.0,1.0,3/9,25.36%,CLTA;AP2A1;AP2S1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.3302545218696913,0.6825512809293669,0.9,1.0,1.0,5/24,13.04%,FGF10;CDH2;NFIB;MYRF;SOX11
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),0.40374800572727376,0.681822127869119,0.8958333333333334,1.0,1.0,2/8,8.39%,ARG1;ODC1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.4154418095192483,-0.6817204908089366,0.851063829787234,1.0,1.0,1/7,3.48%,CD74
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.3652443819129294,-0.6816202468566128,0.9259259259259259,1.0,1.0,5/16,19.03%,ASPG;FOLH1;NIT2;GOT2;ASS1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.31703122003496736,0.6813436420351872,1.0,1.0,1.0,8/50,11.71%,ITGAX;ITGAM;CSF2RA;LAIR1;MITF;TLR1;CSF1R;DDX60L
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.31059344775109266,0.6811148401724331,0.9574468085106383,1.0,1.0,10/51,16.09%,ACSM1;CYP39A1;LIPH;ACACA;SRR;CYP7B1;OSBPL6;ABCD3;OSBPL3;LPL
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3767092047368024,0.6809164995073934,0.7708333333333334,1.0,1.0,1/12,5.50%,TBXA2R
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.405276506414508,0.6808192352405674,0.8478260869565217,1.0,1.0,1/9,3.78%,SHROOM2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.34726485719972366,0.6806261795157452,0.8431372549019608,1.0,1.0,3/19,11.21%,MCU;MICU1;MAIP1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.38642447434519894,0.6804048515214199,0.9069767441860465,1.0,1.0,2/14,6.34%,DNAH5;CCDC63
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.3024761930467288,-0.6802558084426229,0.9583333333333334,1.0,1.0,16/76,20.40%,NDUFC1;NDUFB9;NDUFS5;NDUFAF3;NDUFA1;NDUFA3;NDUFS6;NDUFAB1;TMEM126B;UQCC2;NDUFS2;NDUFA5;NDUFA10;NDUFB10;NDUFA12;NDUFAF5
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.4101340616152388,-0.6799501123039029,0.8541666666666666,1.0,1.0,1/6,6.56%,XRCC1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.3185783994634348,-0.6799148414927901,1.0,1.0,1.0,6/48,7.73%,SEPTIN5;STX4;LLGL2;RHBDF2;RAB3B;HCRT
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.37204333005075946,-0.6798841592760957,0.9245283018867925,1.0,1.0,3/19,8.87%,KCNE1;KCNE2;SCN4B
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.3988432380298401,-0.6796911455084005,0.8888888888888888,1.0,1.0,1/11,3.48%,CD74
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.3104121799274858,-0.6794650895175149,0.9137931034482759,1.0,1.0,4/51,7.88%,CELA2A;PAX8;ADRA2A;HNF4A
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.4345955998812481,-0.6792221210247441,0.7959183673469388,1.0,1.0,2/5,25.96%,PTPRC;PTPRJ
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.45092833909714475,-0.6788291183366033,0.8571428571428571,1.0,1.0,4/6,42.51%,MTHFR;MTHFD1;GOT1;MTRR
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.45801806888944574,0.6784465906426698,0.8936170212765957,1.0,1.0,1/6,12.17%,LIG4
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.35750524885230067,-0.6784038877051769,0.8979591836734694,1.0,1.0,2/23,7.59%,B2M;LACC1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.35919717308852295,-0.6781096901170292,0.896551724137931,1.0,1.0,7/23,18.84%,CACNG5;GSG1L;SHANK3;CNIH3;SHANK1;CACNG4;PRRT1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.4350881306481392,-0.6780481895965063,0.8518518518518519,1.0,1.0,1/5,1.88%,GLYCTK
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.4350881306481392,-0.6780481895965063,0.8518518518518519,1.0,1.0,1/5,1.88%,GLYCTK
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.2651572486527106,0.6779266727507727,1.0,1.0,1.0,76/347,20.13%,UHRF2;DCUN1D1;RFWD3;TRIM22;KLHL21;KIAA1586;NEDD4;MSL2;PDZRN3;CUL1;RNF220;DTX4;LMO7;FBXL7;CNOT4;HIF1A;LZTR1;TRIM50;TRIM5;FBXO7;TSPAN17;ZNRF3;UBE2E3;PEX2;RNF139;SMURF2;FBXL3;ZSWIM8;MOCS3;ARIH1;BTRC;SIRT1;NSMCE2;PEX13;SHPRH;NEUROD2;FBXO11;RAD18;SMURF1;KLHL8;UBE2E1;KCTD10;SYVN1;UBE2D3;PLK1;ANAPC16;KLHL13;RNF144A;COMMD1;MIB1;FBXL17;BARD1;NEDD4L;FBXL2;VHL;OTULIN;HECW2;HERC2;BCL11A;NUP42;TRIML2;DTX2;MDM2;TRIM32;KLHL3;CUL3;KLHL24;RNF103-CHMP3;DERL1;RANBP2;FBXO10;WWP1;VCPIP1;ZNF598;NFE2L2;NUP54
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3320536307712306,0.6776356880523319,0.8888888888888888,1.0,1.0,2/25,6.22%,DCUN1D1;ARRDC3
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.35571851990718323,-0.677595055723729,0.8703703703703703,1.0,1.0,4/28,9.49%,SST;PAX6;NKX2-2;SRP14
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.42095880281573594,-0.6775221663701331,0.8846153846153846,1.0,1.0,2/10,6.77%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.3531716577869418,-0.6772433541916116,0.8958333333333334,1.0,1.0,3/13,13.45%,PPP1R15A;DDRGK1;RACK1
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.29338259935584077,-0.6765976477545144,0.9827586206896551,1.0,1.0,16/91,17.74%,STX16;M6PR;COPE;GNAS;ANP32E;CD63;ARF1;TOM1L1;ICA1;DNM1L;PPT1;YKT6;CLTA;RER1;NAPG;ATP1A1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4205151091815963,-0.676585730491048,0.8113207547169812,1.0,1.0,2/10,15.51%,CYP1B1;GSKIP
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.4337372736480264,-0.6765432489126413,0.8695652173913043,1.0,1.0,3/7,22.86%,NVL;NMD3;POLR1A
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.38855435328387145,0.6764678189824198,0.9,1.0,1.0,2/10,14.59%,ABHD17B;LYPLAL1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.3832079820432255,-0.6757184946165141,0.8596491228070176,1.0,1.0,2/16,6.67%,NOG;PAX8
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.427189372879051,-0.6756864959285209,0.9019607843137255,1.0,1.0,1/10,2.97%,SPACA3
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.28990131621782617,0.6756684456107486,0.9347826086956522,1.0,1.0,13/85,14.53%,KLRD1;MUC20;TAB3;SYK;CUL1;PSMD13;PRKACB;TAB2;MUC6;BTRC;EP300;MUC16;PSME4
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.28990131621782617,0.6756684456107486,0.9347826086956522,1.0,1.0,13/85,14.53%,KLRD1;MUC20;TAB3;SYK;CUL1;PSMD13;PRKACB;TAB2;MUC6;BTRC;EP300;MUC16;PSME4
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.28990131621782617,0.6756684456107486,0.9347826086956522,1.0,1.0,13/85,14.53%,KLRD1;MUC20;TAB3;SYK;CUL1;PSMD13;PRKACB;TAB2;MUC6;BTRC;EP300;MUC16;PSME4
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.4147235747419755,-0.6756190889625525,0.8653846153846154,1.0,1.0,3/7,14.90%,TMSB4X;PINK1;ENO1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.43004557231994467,0.675495501053161,0.7708333333333334,1.0,1.0,2/5,12.30%,FAH;QDPR
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.43004557231994467,0.675495501053161,0.7708333333333334,1.0,1.0,2/5,12.30%,FAH;QDPR
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.3918297407478383,0.6753162158283256,0.9111111111111111,1.0,1.0,3/11,14.81%,SNCA;DYRK1A;MAP2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3667476318109483,0.675019661440336,0.8444444444444444,1.0,1.0,6/13,26.11%,EME2;RAD9B;ATF2;RAD17;CHEK2;RAD9A
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.3917223313295711,0.6748381538977448,0.851063829787234,1.0,1.0,1/7,5.38%,GRIP1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.3015665323278891,-0.6746949832869074,1.0,1.0,1.0,21/118,16.01%,DDX11;MYB;PWWP3A;SMARCD1;SPI1;DAXX;HDAC5;SAFB;GATAD1;HIRIP3;HMGB2;MTA2;SOX15;KDM6B;SUPV3L1;KDM4D;INO80;NUCKS1;FAM50A;MORC2;HDAC11
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2638494381635074,0.6745818487094886,1.0,1.0,1.0,39/189,21.05%,SOCS6;NEDD4;PELI1;UBE3D;UBE2U;TRIM9;SPOP;PSMD13;TBL1XR1;PCBP2;RNF139;SMURF2;ZSWIM8;BTRC;CTNNB1;SIRT1;AGAP3;SMURF1;KCTD10;GID8;SYVN1;RNF122;UBE2D3;PSME4;FBXL17;NEDD4L;PSMF1;HECW2;SEL1L;MDM2;RNF185;CUL3;DERL1;WWP1;SPOPL;NFE2L2;KBTBD7;RHBDD1;ENC1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3552875315134163,-0.6744878067207077,0.9148936170212766,1.0,1.0,4/17,18.43%,ADAM19;SERPINF2;NOTCH4;FLOT1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.3361239867806307,0.6743988985141663,0.9433962264150944,1.0,1.0,3/29,6.79%,PPARGC1A;RPS6KA4;SNCA
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.30864622135924324,0.674363748984968,0.9130434782608695,1.0,1.0,4/49,10.15%,GDAP1;IMMP2L;FBXO7;DNAJC15
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.2858971153342101,0.6743517269306174,1.0,1.0,1.0,13/162,10.05%,U2AF1;HNRNPH1;PPARGC1A;SF3B1;ADARB2;CELF2;ELAVL4;ATXN1;SYNCRIP;MBNL1;NOVA1;CDK12;BICD1
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.43465328786479296,0.6740662464261999,0.8541666666666666,1.0,1.0,1/6,15.40%,KAT2B
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.3813922474569876,-0.6740145793931536,0.9166666666666666,1.0,1.0,1/12,2.59%,SLC1A7
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.451658985571313,0.6739859251371911,0.8888888888888888,1.0,1.0,1/6,4.18%,ADARB2
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.4046410741455718,0.6736664259394256,0.8333333333333334,1.0,1.0,3/7,15.14%,PDE6A;CNGB1;CNGA1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.3248676575573071,0.673554747157526,0.9333333333333333,1.0,1.0,2/26,9.54%,AGER;ZDHHC2
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.28337301163315465,0.673432445595192,1.0,1.0,1.0,15/109,13.30%,FZD1;PLCB1;GNAT2;WNT5A;NLK;PSMD13;PPP3CA;RYK;DVL2;SMURF2;PRICKLE1;CTNNB1;PDE6A;SMURF1;PRICKLE2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.32795764370901503,-0.673114203749007,0.9375,1.0,1.0,9/66,13.77%,CCN3;PRAG1;TSPEAR;LLGL2;CHAC1;TCIM;METTL3;TM2D3;SNW1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.348514135179353,0.6728145332210834,0.875,1.0,1.0,7/23,19.48%,AGER;MBP;AIM2;PICALM;ROCK2;EPHA4;FYN
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.3685629149340428,-0.6724726697125232,0.8448275862068966,1.0,1.0,1/16,7.38%,TRPV4
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.4049548770326892,0.6724583863665887,0.8979591836734694,1.0,1.0,4/11,25.65%,HIF1A;SPAST;TRAK2;SYBU
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.2940053932380616,-0.6724559361159991,0.9523809523809523,1.0,1.0,3/36,7.06%,ATXN7L3;RBX1;DTX3L
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.3310919889834474,-0.6723164419043561,0.875,1.0,1.0,3/37,6.72%,CLU;STARD5;LIPC
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.3146147373141922,0.672195063255934,0.8913043478260869,1.0,1.0,11/36,18.33%,CERS3;ST8SIA6;TLCD3B;ASAH2;ST6GALNAC4;ST8SIA4;SGMS1;CERS5;SMPD4;ST8SIA3;CERS6
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.33601360391370994,0.6720630976877544,0.926829268292683,1.0,1.0,5/21,16.79%,NLGN1;FOXO6;LLPH;CAPRIN1;CPEB3
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.3769263865521503,0.6720046316435405,0.8367346938775511,1.0,1.0,3/12,12.98%,SPHK1;ASAH2;PLPP1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.2881376063122936,-0.671812087769718,0.9838709677419355,1.0,1.0,29/92,26.43%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4;NUP133;NUP43;SRSF7;NUP155;CPSF3;GLE1;CHTOP;ALKBH5;NUP62CL;ALYREF;RNPS1;DHX38;SLBP;NUP85;CPSF2;MAGOHB;SMG6;NUP214;RAN;NXT1;THOC1;MCM3AP;NUP50;RBM15B
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.4048128916188089,0.6716933239281174,0.8333333333333334,1.0,1.0,4/9,8.76%,ARG1;SLC39A8;DDAH1;DDAH2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.32700691787818087,-0.6716843120245739,0.9615384615384616,1.0,1.0,11/52,18.00%,TOMM40;SPG7;TIMM17B;TOMM20;SLC25A5;KIFBP;TOMM7;TIMM17A;FIS1;TIMM44;BAK1
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.378616769672103,-0.6715386401664524,0.8085106382978723,1.0,1.0,4/8,30.74%,STK11;MME;IL12A;HYAL1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.3679608970376462,-0.6711306772158833,0.8627450980392157,1.0,1.0,1/12,3.48%,CD74
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3505428386694666,0.6709389899964869,0.9387755102040817,1.0,1.0,6/23,16.44%,TAB3;TAB2;MAP2K6;RELA;NOD1;OTULIN
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.4139072252405211,0.6709370441260079,0.8627450980392157,1.0,1.0,1/10,5.54%,RAB34
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.42284301234646426,-0.6704112437142686,0.9215686274509803,1.0,1.0,1/6,6.28%,RYR1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.41816233997177865,0.6701674752381799,0.7857142857142857,1.0,1.0,1/6,14.93%,P2RX7
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.31391085446278394,-0.6701013117807295,0.9591836734693877,1.0,1.0,11/65,17.38%,CLU;ITGA6;BCL2L2;TRIAP1;PINK1;SLC25A5;PRELID1;GSTP1;SRC;GHITM;PSMD10
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.3544934827851302,0.6700949678772081,0.8679245283018868,1.0,1.0,1/12,3.79%,SMAD7
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.3997730097821973,0.6698851594174099,0.8409090909090909,1.0,1.0,6/6,60.04%,PIH1D1;SMARCB1;DNMT3B;BRCA1;KDM1A;DNMT1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2851577590799545,-0.669593725354412,0.9846153846153847,1.0,1.0,17/89,20.74%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4;NUP133;NUP43;SRSF7;NUP155;CPSF3;GLE1;CHTOP;ALKBH5;ALYREF;RNPS1;DHX38;SLBP
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.3824602617070577,-0.6693939624485484,0.8,1.0,1.0,2/9,16.68%,IFIT1;CHTOP
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.41763721462378617,0.6693922400299704,0.8541666666666666,1.0,1.0,4/8,19.78%,CPEB2;CPEB3;DPH3;DPH2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.4044636719040185,-0.6692789236695138,0.8867924528301887,1.0,1.0,4/13,19.00%,ZWILCH;SPDL1;CTCF;IK
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.32957814584978895,0.6690226135033854,0.9285714285714286,1.0,1.0,7/36,14.77%,JPH1;SNCA;TRDN;PDE4D;ANK2;AKAP6;DMD
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.36856680792384433,0.6688655749095913,0.9230769230769231,1.0,1.0,1/15,3.74%,EGFR
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.3608926214720527,-0.6687614756739058,0.8666666666666667,1.0,1.0,6/20,22.81%,GLMN;CR1;IL4I1;BTN2A2;PDCD1LG2;GPNMB
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.41774583189085757,-0.6685856968269516,0.9,1.0,1.0,2/7,19.37%,APOA1;GPLD1
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),-0.4068477958407888,-0.6685630651587591,0.8653846153846154,1.0,1.0,2/6,21.47%,SHH;PAFAH1B1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.43058626545474454,-0.66839909025898,0.9090909090909091,1.0,1.0,2/6,12.65%,STARD5;APOA1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.43058626545474454,-0.66839909025898,0.9090909090909091,1.0,1.0,2/6,12.65%,STARD5;APOA1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.4022925458170003,0.6683282205490632,0.918918918918919,1.0,1.0,2/11,8.63%,SLC23A1;SLC2A11
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.40757989983899584,0.6681756515266911,0.8372093023255814,1.0,1.0,2/7,15.54%,NR1H3;IFI35
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.35049673353676947,0.6674582737450978,0.8909090909090909,1.0,1.0,2/26,8.43%,WNT5A;FSHR
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.39793473511796573,-0.6673368362971325,0.8947368421052632,1.0,1.0,5/10,28.43%,WLS;MESP2;SHH;RIPPLY2;FZD5
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.3936904444611924,0.6673223792657516,0.9183673469387755,1.0,1.0,2/11,7.15%,SGCZ;TRDN
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.42252586155192684,0.6672351110024755,0.8444444444444444,1.0,1.0,2/6,14.77%,ATP2B4;DMD
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.4100997085234722,0.6672311537950902,0.8269230769230769,1.0,1.0,1/7,16.38%,IPPK
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3599847112817999,0.666631761912195,0.86,1.0,1.0,7/19,18.92%,LRRTM3;AGER;PICALM;RELA;SLC2A13;ROCK2;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.3677500548486732,-0.665862190504527,0.8636363636363636,1.0,1.0,2/16,4.73%,ASCL1;B2M
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.41755894675061367,0.6657902206548,0.8679245283018868,1.0,1.0,2/7,15.40%,EP300;KAT2B
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.32864084265646243,-0.6655157177149037,0.9230769230769231,1.0,1.0,4/68,7.48%,FGF1;SEZ6L2;VAX2;ARHGEF25
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.3080651891148645,0.6655044649872717,1.0,1.0,1.0,11/64,13.19%,NLGN1;NRXN1;AGER;TSHZ3;SYT1;GRIK2;ZDHHC2;RIMS2;NPTN;SLC24A2;RGS14
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.32230822082775573,0.6653413385665568,0.9772727272727273,1.0,1.0,4/29,12.46%,AP1AR;ANKRD13D;ITGAV;EDN1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.28998470899513556,-0.6653176175747971,1.0,1.0,1.0,14/112,17.55%,NUPR1;MBTPS2;ATF4;RSL1D1;NUP133;CAMK2G;PINK1;CRYAB;NUP43;CHCHD2;NUP155;BAG4;CAMK2A;VASH1
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.45582791201142303,0.6652422256518233,0.8333333333333334,1.0,1.0,1/5,8.58%,FER
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.35866323788392657,0.6643759472906305,0.8245614035087719,1.0,1.0,8/14,24.23%,SLC30A10;SLC39A8;TRPC4;SLC11A2;TRPC1;ATP2C1;TRPC5;TRPC7
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.3189132059680402,0.6633486792337437,0.9743589743589743,1.0,1.0,10/35,22.55%,CASS4;GRM5;CSF1R;IL34;TGFA;EPHA4;FYN;NTRK2;SRCIN1;FBXW7
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.317394195234594,0.6633161766752212,1.0,1.0,1.0,6/32,23.16%,NUS1;AGPAT5;SGMS1;FDPS;FITM2;CLN3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.2791184828729702,-0.6632722564451882,1.0,1.0,1.0,12/96,15.02%,CELA2A;LLGL2;ADRA2A;RHBDF2;HNF4A;DRD3;NOS2;PER2;DNM1L;MYO18A;RSAD2;UQCC2
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.4090688530071577,-0.6630239108704504,0.7446808510638298,1.0,1.0,2/6,21.27%,RHOJ;NTN1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.3808634780159431,-0.66276861132067,0.9130434782608695,1.0,1.0,2/10,12.19%,LIPC;LMF1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.4329581620673584,-0.6626483809841935,0.9259259259259259,1.0,1.0,3/6,22.48%,PHF19;MACROH2A1;SUPT6H
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.31705142097356176,-0.6625732967262838,0.9354838709677419,1.0,1.0,5/54,10.51%,SFRP1;ATG14;WIPI1;WIPI2;MAP1LC3A
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.31474926082082666,-0.6625676182374363,0.9206349206349206,1.0,1.0,7/38,15.60%,GTF2F1;POLR2I;POLR2J;SUPT5H;CCNT1;POLR2G;POLR2C
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.31236397792008797,-0.6625435970896537,0.9642857142857143,1.0,1.0,8/46,19.63%,GADD45A;PRPF19;TRIAP1;HUS1;FBXO6;E2F7;USP10;CHEK1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.3981723944561726,0.6622613873370337,0.8723404255319149,1.0,1.0,2/8,9.78%,MCM7;MCMDC2
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.3718493228794861,-0.6622403742359856,0.8636363636363636,1.0,1.0,5/14,19.90%,TICRR;HUS1;ORC1;CDC6;ZNF830
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.3830180296492987,0.6620022742155118,0.8363636363636363,1.0,1.0,3/9,17.06%,SLC39A8;SLC40A1;SLC11A2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.27851129956242043,0.6619360101296164,0.9814814814814815,1.0,1.0,9/82,9.46%,PLCB1;TAB3;PELI2;PELI1;RPS6KA4;CUL1;PSMD13;TAB2;ST18
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.3864042680923118,-0.661137783407585,0.88,1.0,1.0,4/10,26.86%,CANX;STAT3;STAT1;IL12A
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.3324691795935316,-0.6610546930949377,0.8367346938775511,1.0,1.0,1/16,8.06%,IHO1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.4165877823076658,-0.6607245258472808,0.9019607843137255,1.0,1.0,2/9,12.65%,PRKACA;APOA1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.32886596128775036,-0.660466450413357,0.9215686274509803,1.0,1.0,1/31,1.73%,CLU
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.41369260070330494,0.6598202476988367,0.8888888888888888,1.0,1.0,2/6,30.04%,BMP6;WNT4
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.2820339507404726,0.6594815729860879,1.0,1.0,1.0,15/83,19.33%,PTPRK;ZBTB1;NEDD4;EGFR;CAT;PRIMPOL;EP300;EIF2S1;MAPK8;CASP9;RELA;BMF;RUVBL2;TRIM32;TMEM161A
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.3926304369909218,0.6594448893856749,0.8301886792452831,1.0,1.0,3/9,22.22%,GALK2;GALT;PGM2
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.3557896896732502,-0.6593504427909674,0.8260869565217391,1.0,1.0,5/12,27.26%,RGS2;KCNQ1;TRPM4;CHGA;APLN
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.37818759678997743,-0.6592780521441729,0.8518518518518519,1.0,1.0,3/17,9.75%,DCTN1;TPX2;ANKRD53
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.4149321206528147,0.6588584443167832,0.8867924528301887,1.0,1.0,2/5,21.55%,PRIMPOL;DNA2
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.3067325362351627,-0.6587611682850261,0.9310344827586207,1.0,1.0,15/62,20.15%,SFRP1;GHR;PAX8;ADRA2A;CTSH;LEP;BRD8;AKR1C2;SRC;NR4A3;CTSL;ATP1A1;UCP1;CTSB;STAT3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.46225408782852295,0.6583399016946324,0.8936170212765957,1.0,1.0,2/5,33.64%,TMEM33;RAB3GAP1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.4224873931382245,0.6579205110455535,0.8913043478260869,1.0,1.0,5/10,15.64%,WNT5A;GABRB2;FGF13;GABRA2;GABRB3
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.3890574529025001,0.6579026735455286,0.9166666666666666,1.0,1.0,1/9,7.86%,LDLR
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.4383307452500721,0.6578513347567291,0.9298245614035088,1.0,1.0,2/6,24.25%,PTPRO;PDGFB
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.4238784678904289,-0.6578438303407101,0.8604651162790697,1.0,1.0,2/8,15.05%,ATP6V0A2;NDUFS2
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.34703363421638456,-0.6577572244909101,0.9047619047619048,1.0,1.0,2/11,15.75%,P2RY11;TAF1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.37177200178826497,-0.6573817432548845,0.8518518518518519,1.0,1.0,1/9,9.40%,NSFL1C
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3461442857150598,0.6571005866256978,0.9230769230769231,1.0,1.0,2/21,7.89%,DYRK3;RAD51B
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.3971949458741302,-0.6569549149542747,0.859375,1.0,1.0,2/13,8.01%,OPALIN;DRD3
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.3503616723234941,0.6565184090060099,0.8571428571428571,1.0,1.0,4/23,14.76%,PEX11A;TMEM135;PEX2;ABCD3
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.40203288847630597,-0.6563396037217567,0.851063829787234,1.0,1.0,2/6,10.16%,RBP1;RBP2
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.43048521245794913,0.656302827888441,0.8666666666666667,1.0,1.0,3/7,27.96%,ABCD3;ABCD2;ACOX1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.40511729705830846,0.6558360591196472,0.875,1.0,1.0,2/8,20.33%,ACADVL;ACADL
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.3204721460168563,0.6557166054465622,0.9761904761904762,1.0,1.0,4/34,9.06%,CENPI;KNL1;SRCAP;SPTY2D1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.39413529459194724,0.6555743038827935,0.8076923076923077,1.0,1.0,1/7,12.49%,CD274
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.30930009650379586,0.6555420595098139,0.9302325581395349,1.0,1.0,15/62,13.61%,ELAPOR2;SULF1;TGFBR1;ZEB2;TWSG1;ACVR2A;BMPR1A;CRB2;MSTN;SMAD2;ACVR1B;SOX11;EP300;ACVR1;GDF10
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.2686912525596784,-0.6554592718967963,0.9830508474576272,1.0,1.0,26/154,19.71%,USP27X;CLU;CDC37;HPS4;A1CF;TBL1X;TAF9B;ATP1B1;CAMLG;PINK1;CRYAB;PIN1;APOA1;SAXO1;RPL23;EFNA1;TAF1;RPL5;BAG4;NAPG;TMEM88;WIZ;FLOT1;CCT2;ZSWIM7;SEC16A
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.44873780848073713,-0.6553816332079002,0.8723404255319149,1.0,1.0,1/5,5.55%,HMGCL
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.29703984129552014,0.6550754751650849,0.975609756097561,1.0,1.0,7/39,22.24%,WASHC4;FNBP1L;SORT1;AKTIP;EXOC8;ZFYVE16;PI4K2B
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3106972297599516,0.6547657054200774,0.94,1.0,1.0,4/49,5.58%,CCNH;CCNB3;CCNA2;CCNP
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),-0.41135069366970445,-0.6546385555590856,0.8695652173913043,1.0,1.0,2/6,20.34%,SHH;STAT1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.3437267870256887,0.6544701242636701,0.9019607843137255,1.0,1.0,3/19,14.84%,MSL2;JADE3;OGT
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3326868046723727,0.6543943630920384,0.9574468085106383,1.0,1.0,5/32,17.13%,KPTN;DYRK3;GPR137B;SESN1;SIK3
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.31596821383972407,-0.6540484001795659,1.0,1.0,1.0,10/27,23.49%,PPP1R15A;ANKLE2;CALM1;PTPA;PIN1;CALM3;ITGA1;HSP90AB1;TGFB1;MTOR
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.35444182719838596,0.6539556468678914,0.8780487804878049,1.0,1.0,5/19,17.82%,RSAD1;FECH;SLC25A38;ABCG2;COX10
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.2871021471534501,0.6538793055553194,0.975609756097561,1.0,1.0,18/82,19.07%,IFI16;TMEM117;FHIT;ZNF385B;CUL1;ERN1;ITPR1;PPP1R13B;BOK;BCL2;TP53BP2;CASP9;CASP2;BAD;MAP3K5;PDK2;CUL3;PDK1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.36793647621398456,-0.6538458156591919,0.8545454545454545,1.0,1.0,1/13,6.27%,SHANK3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.3370581713950851,-0.6537804047239304,0.8947368421052632,1.0,1.0,5/27,19.30%,AEBP2;SPI1;MORC2;PHF19;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.35625081185701457,-0.6537458512941615,0.8909090909090909,1.0,1.0,6/26,17.34%,PLK5;TCIM;DDRGK1;INO80;TAF1;PSME1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.3313609317014235,0.6533360133152655,0.8627450980392157,1.0,1.0,1/21,1.31%,RUNX1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.32983384090088214,-0.6526080197724866,0.9814814814814815,1.0,1.0,7/36,18.91%,SLC6A9;ATP1B1;SLC6A20;TRPM8;TRPM4;SLC7A5;SLC29A4
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.42791409317667634,0.6526073491488988,0.9302325581395349,1.0,1.0,3/9,11.68%,UNC5C;NRP1;CTNNB1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.3929398399350653,0.6525333922267718,0.9,1.0,1.0,3/11,14.14%,SLC22A2;TPD52;SLC22A6
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.2700764122358409,0.6520729998250312,0.9523809523809523,1.0,1.0,4/160,3.49%,EIF3E;PNLDC1;ZFP36;DXO
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.4183180370245715,-0.6516775770948176,0.8979591836734694,1.0,1.0,1/8,4.53%,PIK3IP1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.2922079574762251,-0.6514722324417109,1.0,1.0,1.0,9/54,23.90%,CHTF18;DSCC1;WRAP53;NVL;GREM1;CCT2;HSP90AB1;CCT6A;FGFR4
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.3876379376147377,0.6510012253209736,0.8979591836734694,1.0,1.0,1/14,10.71%,SEC23B
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.442305918379182,-0.6509875603155794,0.9,1.0,1.0,5/6,34.65%,BAK1;BCL2L11;DAB2IP;PTPN1;BAX
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.2961361709194043,0.6504093476468875,0.9772727272727273,1.0,1.0,4/74,4.81%,IFI16;TDG;SF3B1;H3-3A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.27216950604471973,-0.6503361677134013,0.9830508474576272,1.0,1.0,24/125,18.03%,CLU;INCENP;CD4;ADRA2A;DAXX;CALM1;TPX2;PAK6;LRP8;TOM1L1;STK11;ACE;TTBK1;AZU1;PTPRC;AGAP2;EFNA1;CENPE;CALM3;SRC;NRK;SYAP1;XRCC6;NAB2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.397008231197276,0.6502296375057792,0.8490566037735849,1.0,1.0,1/7,11.86%,LPCAT3
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.38292595027411036,-0.6501453985230075,0.9130434782608695,1.0,1.0,1/15,1.84%,SARS1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.28548149920830734,0.6495772706626305,0.9821428571428571,1.0,1.0,10/76,14.53%,FZD1;WNT5A;PKHD1;PSMD13;DVL2;SMURF2;PRICKLE1;SMURF1;PRICKLE2;PSME4
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.31845031059382656,-0.6495652788460402,0.9333333333333333,1.0,1.0,15/44,25.55%,H1-4;H1-0;DAXX;HMGB2;CHAF1A;H1-2;CTCF;SMARCA5;MACROH2A1;PADI4;HMGA2;POLE3;CHAF1B;PAF1;NPM1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.2769658243680082,0.6494585827136543,0.9803921568627451,1.0,1.0,18/56,26.72%,LIMK2;CEP120;TBC1D1;USP6NL;EVI5;TBC1D5;BBS4;CDK10;TESK1;TBC1D8;TBC1D15;KCTD17;EVI5L;CEP97;TBC1D2;CYLD;TAPT1;IFT20
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.3618680536642485,-0.6493242858380115,0.8431372549019608,1.0,1.0,2/13,12.22%,DCTN1;TMEM201
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.37715818999626227,0.6490260730952313,0.8541666666666666,1.0,1.0,4/13,16.64%,PPARGC1A;SLC25A12;GPD2;UQCRFS1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.3042115038484701,0.6488876901860854,0.98,1.0,1.0,12/37,20.98%,DDAH1;DDAH2;GPT;RIMKLB;NAALAD2;SRR;SLC25A12;RIMKLA;GNMT;ASPA;ALDH18A1;KYAT3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3569195903162521,-0.6488097360128189,0.9074074074074074,1.0,1.0,4/25,10.53%,AZGP1;HLA-DRA;SPI1;NOS2
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.30560685787797287,0.6483772292816298,0.9591836734693877,1.0,1.0,9/39,15.23%,CYP39A1;HMGCR;LBR;MSMO1;CYP7B1;OSBPL6;INSIG2;INSIG1;OSBPL3
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.4242700108260503,0.6483220262986052,0.8448275862068966,1.0,1.0,2/6,28.59%,NFE2L2;UBQLN1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.33138070096552463,0.6481750945800104,0.9166666666666666,1.0,1.0,4/21,15.23%,CYP39A1;CYP7B1;OSBPL6;OSBPL3
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3736772928807243,-0.6478698267113175,0.9347826086956522,1.0,1.0,4/17,24.86%,VIL1;TRIOBP;ADD2;FLII
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3736772928807243,-0.6478698267113175,0.9347826086956522,1.0,1.0,4/17,24.86%,VIL1;TRIOBP;ADD2;FLII
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.37729021174255467,0.6477776544293223,0.8913043478260869,1.0,1.0,2/13,7.50%,KIF2C;KIF19
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.4051966158840736,-0.6476840546224996,0.9298245614035088,1.0,1.0,2/7,15.02%,GPC1;UQCC2
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.36850372225737893,-0.6474092041062167,0.8775510204081632,1.0,1.0,4/12,21.61%,DCTN1;AKAP8L;VRK1;LPIN1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.35882068185994287,-0.6473785111289768,0.8775510204081632,1.0,1.0,2/9,12.30%,TRAF3IP1;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.37707356576849055,-0.6473358843075605,0.8571428571428571,1.0,1.0,5/16,22.08%,PTP4A3;WRAP53;CEP295;CCT2;CCT6A
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.28752959775423154,0.6470814998328666,0.98,1.0,1.0,16/88,17.27%,PLCB1;EGFR;CAB39L;FGF17;SMAD2;NCK1;ACACA;CAMK4;MAP2K6;UBE2D3;MAPK8;PRKCB;ACTR3;ADCY2;NOD1;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.3709725131632904,0.6468856604629377,0.8367346938775511,1.0,1.0,1/9,4.60%,FGF10
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.36276404085038555,0.6465469354076139,0.9761904761904762,1.0,1.0,5/13,20.84%,SLC8A1;PIK3CA;KCNJ2;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.29932213725735285,-0.6465465291196342,0.9830508474576272,1.0,1.0,12/56,18.84%,CACNG5;CRH;NPTXR;GSG1L;CNIH3;SHANK1;NPTX2;NEFL;CACNG4;CAMK2A;PSCA;PRRT1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2772537076751196,-0.6465144078727079,0.96,1.0,1.0,14/62,21.82%,SIGIRR;CDC37;CD74;IFNGR2;RBCK1;CD24;RACK1;PTPRC;IRAK1;SPATA2;RNASEL;STAT1;TNFRSF1A;HSP90AB1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.32564478754340104,0.6463371551004822,0.9387755102040817,1.0,1.0,2/24,8.16%,CCL5;HIF1A
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.2743449850130155,0.6463070405123403,0.9523809523809523,1.0,1.0,16/106,14.31%,GFAP;EGFR;SHROOM2;FGFR3;DDAH1;LRP4;ZNRF3;FMNL2;BCAR1;LIFR;SEMA3B;AMOTL2;MEIS3;MTCL1;ALCAM;SALL1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.41342485998429773,-0.6462113415558948,0.8653846153846154,1.0,1.0,2/5,11.69%,ATF4;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3620224442572384,-0.6460104859015616,0.8867924528301887,1.0,1.0,2/18,9.56%,LATS2;INCA1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.34183547980672746,0.6457600588766962,0.8604651162790697,1.0,1.0,10/25,28.46%,LRP4;FGF13;MAP2;KIAA0319;RNF6;PTEN;DCC;RUFY3;EFNB3;ARHGDIA
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.3455795538149428,0.6454986748154795,0.8863636363636364,1.0,1.0,4/12,18.86%,CEP120;CEP135;KIAA0586;OOEP
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.39899481193255515,0.6451598092614119,0.7674418604651163,1.0,1.0,5/5,60.11%,DPY19L1;DPY19L2;DPY19L3;DPM3;DPY19L4
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.39899481193255515,0.6451598092614119,0.7674418604651163,1.0,1.0,5/5,60.11%,DPY19L1;DPY19L2;DPY19L3;DPM3;DPY19L4
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.38099571375536573,0.6451319552500921,0.8809523809523809,1.0,1.0,1/11,1.08%,APOLD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.41003966884770493,0.6449689973460299,0.8043478260869565,1.0,1.0,1/6,10.48%,IL21R
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.41003966884770493,0.6449689973460299,0.8043478260869565,1.0,1.0,1/6,10.48%,IL21R
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.3356840840345799,-0.6449373515531743,0.9090909090909091,1.0,1.0,3/22,8.49%,GSTM3;COL18A1;MYADM
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.4031947958358107,0.6449036600232293,0.851063829787234,1.0,1.0,3/7,17.87%,STARD4;SIRT1;PROX1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.38332335384858174,-0.6446979631191638,0.9230769230769231,1.0,1.0,3/6,33.47%,SPATA18;BNIP3;YME1L1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.32932570369310893,0.644324900761376,0.9183673469387755,1.0,1.0,7/27,19.39%,TOGARAM1;PCM1;GORAB;IFT57;DISC1;BBS4;RPGRIP1L
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.41169608881818953,0.6442952697294778,0.8461538461538461,1.0,1.0,2/5,13.26%,UBE2E2;UBE2E1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3568276611839002,-0.6441578322236452,0.8909090909090909,1.0,1.0,3/19,14.72%,LATS2;INCA1;CAMK2N1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.34205382275924456,-0.6441481810898765,0.9423076923076923,1.0,1.0,3/33,4.85%,ATOX1;TRPC3;FTH1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.3683562912219349,0.6441460565569327,0.8627450980392157,1.0,1.0,1/6,10.96%,CXCL12
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.393734507322362,-0.6437200684375227,0.9230769230769231,1.0,1.0,1/10,2.34%,XG
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.33808505362311836,-0.643611528345815,0.92,1.0,1.0,9/22,30.59%,SUPT5H;SUPT16H;CCNT1;ALYREF;SUPT6H;THOC1;KAT7;LEO1;TCERG1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3495966173759495,-0.6435885645796585,0.9454545454545454,1.0,1.0,5/21,16.42%,CEMIP;CALM1;AZU1;BMP7;CALM3
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.42065780998819846,-0.6435264546535375,0.8846153846153846,1.0,1.0,4/6,39.33%,RAB11B;RAB11FIP5;PTPRN2;PTPRN
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.2812334244357222,-0.6435178008841873,0.9565217391304348,1.0,1.0,13/57,22.75%,STX4;DTX3L;DDRGK1;NECAB2;VPS28;MEAK7;RANGRF;MAP1A;YAP1;HSP90AB1;ENTR1;CARD10;TGFB1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.26986607311751715,0.642283068698644,1.0,1.0,1.0,23/99,20.92%,TMEM117;TMX1;PPP1R15B;ERN1;EIF2AK3;ITPR1;ATF6;NCK1;RNF139;ATF3;BCL2;SYVN1;THBS4;PIK3R1;EIF2S1;TMTC3;MAP3K5;SEL1L;RNF185;DERL1;PDIA2;TMEM33;RHBDD1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.348890437092764,-0.6420572267468776,0.9272727272727272,1.0,1.0,5/19,21.23%,GNB3;NR1H4;ABCB11;ASAH1;EPHX2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.3958825415691321,0.6419906115679592,0.8679245283018868,1.0,1.0,1/6,12.00%,INSYN2A
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.3696644430757015,0.641909743127606,0.8461538461538461,1.0,1.0,3/10,17.06%,STEAP4;SLC31A1;SLC11A2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.289684269209338,-0.6416824543834361,0.9827586206896551,1.0,1.0,6/65,15.82%,HCK;PLK2;TBC1D24;KIF9;NPRL2;CEP295
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.2772455643013182,-0.6415936071489549,1.0,1.0,1.0,25/94,24.15%,SLC51A;STARD5;FABP5;TRIAP1;NR1H4;CEACAM1;APOA1;NME4;SLC10A6;PRELID1;LBP;ABCC4;ABCB11;GOT2;PITPNA;ABCA5;CPTP;MFSD2A;ABCG5;ABCG4;OSBPL2;SLC27A1;SPNS2;SLCO2A1;PLTP
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.3320981559886676,0.6415568751723693,0.9361702127659575,1.0,1.0,2/19,6.08%,RALA;MCU
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.28740977721844824,0.641496281336323,0.972972972972973,1.0,1.0,15/83,17.48%,EIF3E;C8ORF88;RIDA;SYNCRIP;EIF2AK3;RNF139;BTG2;FTO;CPEB4;CAPRIN1;CPEB2;CPEB3;LSM14A;ROCK2;NANOS1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.37098118603104385,0.6412742140286322,0.8703703703703703,1.0,1.0,3/13,9.15%,ENPP1;DCTPP1;SMPDL3A
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.35247071971247246,0.6412487933778609,0.8913043478260869,1.0,1.0,3/11,13.70%,HS3ST5;EDN1;TFPI
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.33394653487391446,0.6409720697124978,0.8653846153846154,1.0,1.0,3/14,19.37%,DYRK3;CUL3;STXBP4
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.38706637488295625,0.6409125291841645,0.9649122807017544,1.0,1.0,3/9,13.63%,ENPP1;MITF;MEF2C
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),-0.4089789548852381,-0.6408436323664072,0.8666666666666667,1.0,1.0,2/7,4.63%,VAX2;ITGA6
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.32481340255447533,-0.6403675538622973,0.9193548387096774,1.0,1.0,6/28,17.98%,TMSB4X;SHANK3;CALM1;STAC;CALM3;JPH2
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.414318706021859,0.6403555238921012,0.8775510204081632,1.0,1.0,1/8,5.54%,RAB34
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.2955186855564847,-0.6402253119507687,0.9814814814814815,1.0,1.0,2/70,1.80%,AHNAK2;AKAP17A
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.37152163180683456,0.6399842701038236,0.9038461538461539,1.0,1.0,1/10,3.94%,WNT5A
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.265183613697358,-0.6397209089250053,1.0,1.0,1.0,16/135,15.21%,DUSP4;TPTE2;PPM1M;DUSP6;DUSP5;FAM220A;PGP;PPP2R3B;STK11;PLPP4;PTPN9;PTPRB;PPM1G;PTPRC;UBLCP1;TIMM50
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.3407078048203176,-0.6395284557756525,0.9166666666666666,1.0,1.0,7/25,15.92%,TTC12;ODAD1;DRC1;DNAH1;DNAH8;CFAP100;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3367813092359263,0.6394768377964357,0.925,1.0,1.0,9/30,21.24%,CASS4;NRP1;MDK;LIMS2;LIMS1;DOCK5;DMTN;TESK1;ABL1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.38710060935281976,0.6393481593740687,0.88,1.0,1.0,3/7,25.58%,CYP3A4;CUBN;LGMN
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3020684690559022,-0.6390604905500686,0.9583333333333334,1.0,1.0,12/61,20.30%,ADAMTS12;UBC;PRPF19;CTSO;CTSH;DDB1;HM13;HDAC6;CTSL;PSMA8;CTSB;ISG15
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.39493305372608456,-0.6387739870355427,0.8723404255319149,1.0,1.0,5/12,20.27%,AHI1;PCARE;CDHR1;RP1L1;MFSD2A
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.35987503720013925,0.6384311162153347,0.926829268292683,1.0,1.0,2/19,9.96%,NLGN1;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.3546856277904934,-0.6383386158664474,0.9056603773584906,1.0,1.0,3/20,16.68%,SERPINE1;PROC;VTN
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.30532580432409684,-0.6382951622653339,0.9454545454545454,1.0,1.0,7/42,13.71%,FTH1;SKP1;SCARA5;FRRS1;ISCU;ATP6V0A2;NUBP1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.24314071607986965,-0.6382405066417337,1.0,1.0,1.0,53/296,21.15%,AURKA;UCHL1;PSMA7;FBXO48;ANAPC15;ECRG4;SKP1;PSMD7;UBC;RBX1;PSMB4;TBL1X;PSMC3;IFI27;UBXN8;ANKZF1;PRAME;RMND5B;NSFL1C;UFD1;SEL1L2;RBCK1;DDB1;PSMD8;SGTB;PSMB5;PSMC1;FBXL13;PSMB2;PSMC4;TAF1;PSMD2;PSMA1;FBXO6;KAT5;PSMB8;SELENOS;FBXO2;PSME1;PSMD10;ANAPC2;TRIM25;PSMA8;FZR1;PSMD12;FBXL18;PSMB3;PSMB7;FBXL16;PSMC6;FBXL12;RNF175;NPLOC4
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.2890743993494475,0.6382257455312493,1.0,1.0,1.0,12/66,12.75%,WNT5A;SLIT2;ADAMTS9;NRP1;RHOB;PRKD1;ATOH8;PRKCA;PTPRM;BCAR1;EDN1;SASH1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.34114504514476884,0.6381449779486981,0.9090909090909091,1.0,1.0,1/10,6.97%,JMJD1C
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.3491637058241067,-0.6380599648177439,0.8867924528301887,1.0,1.0,3/22,14.16%,IFI27;EMD;RBM22
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.3976249171977977,0.638021392637212,0.9056603773584906,1.0,1.0,1/6,20.47%,VSTM5
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.25581568470025545,0.6377278205918513,1.0,1.0,1.0,29/286,11.82%,DCUN1D1;ASB17;SOCS6;AFP;KLHL21;EVA1A;TNC;CSF1;CUL1;PSMD13;LMO7;DNAJC3;FBXL7;DCAF5;FBXO30;FBXW9;HIF1A;CDH2;SOCS2;RCN1;RBBP5;FBXO7;C3;TIMP1;KCTD6;FBXL3;TF;BTRC;SENP8
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.365355950314873,-0.6377249032937246,0.8823529411764706,1.0,1.0,4/12,16.46%,STK11;ITFG2;DEPDC5;SZT2
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.34414239193305496,0.6373345541648825,0.9038461538461539,1.0,1.0,2/15,7.09%,FLRT3;NREP
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.3129239643485372,-0.6368980446938995,0.9433962264150944,1.0,1.0,4/36,11.12%,CYP2E1;PORCN;DGKD;PLPP4
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.2970462970511525,-0.6362836559323184,0.9516129032258065,1.0,1.0,5/55,13.75%,PLK3;KIF20B;DNM1L;RACK1;MYO18A
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.38717425663680805,-0.6362021502179336,0.9615384615384616,1.0,1.0,3/10,25.74%,SCN4B;PKP2;NOS1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.39432920316704734,0.6360315393040885,0.8863636363636364,1.0,1.0,1/6,5.38%,GRIP1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.32949612792866934,-0.6357078347099573,0.9649122807017544,1.0,1.0,5/20,27.58%,ZNF76;NAB2;BRF2;MTOR;AR
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.3538285678022884,-0.6356635919372577,0.9387755102040817,1.0,1.0,4/24,14.77%,EXOSC10;NUDT16;POP1;DIS3L
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.40042325612062973,0.6338791952254489,0.9245283018867925,1.0,1.0,3/6,22.91%,SRR;SERINC5;PSPH
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.26643968945655816,-0.6338728700067375,1.0,1.0,1.0,5/95,6.17%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.29277222730824176,0.6338010006801356,0.9782608695652174,1.0,1.0,6/27,22.64%,VCPKMT;TET2;OGT;ATPSCKMT;TET3;SETD3
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.353778617081122,-0.6337165944741728,0.9076923076923077,1.0,1.0,1/10,4.07%,ETS1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.40040768437584007,-0.6333932926246478,0.9583333333333334,1.0,1.0,1/7,12.82%,PTPRB
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.33476203879750127,-0.63339243282911,0.98,1.0,1.0,8/18,24.38%,GIPC1;STK11;SNW1;SDCBP;CDKN2B;HSP90AB1;CDKN1C;THBS1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.33476203879750127,-0.63339243282911,0.98,1.0,1.0,8/18,24.38%,GIPC1;STK11;SNW1;SDCBP;CDKN2B;HSP90AB1;CDKN1C;THBS1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.40980863398540635,0.6331851429417698,0.8541666666666666,1.0,1.0,2/6,11.73%,TRDN;ANK2
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.4201849633556267,-0.632966652321011,0.9310344827586207,1.0,1.0,4/6,32.91%,SAT2;SAT1;SRM;SMOX
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.29524887644498027,-0.6326761670883295,1.0,1.0,1.0,7/51,19.36%,HENMT1;AARS2;METTL3;NAT10;DTWD2;QTRT1;FTSJ3
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.44525777466304106,-0.6326242752221748,0.9298245614035088,1.0,1.0,1/5,2.51%,DND1
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.44525777466304106,-0.6326242752221748,0.9298245614035088,1.0,1.0,1/5,2.51%,DND1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.3495536381799019,-0.6325203457170144,0.92,1.0,1.0,1/17,1.73%,CLU
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.3591892418869792,-0.6324523391255256,0.9074074074074074,1.0,1.0,3/12,22.48%,AASS;MACROH2A1;SUPT6H
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.27069703831767505,-0.6320797988604129,1.0,1.0,1.0,37/112,24.93%,PSMA7;PSMD7;UBC;PSMB4;PSMC3;PKP1;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;YWHAB;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;CSDC2;PSMB7;PRR5L;PSMC6;SERBP1;EXOSC4;KHSRP;EIF4G1;IGF2BP2;PCBP4;APEX1;UBB;GTPBP1;PSMB1;NUP214;SET;PSMA5
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.28256014819246905,0.632026799778313,1.0,1.0,1.0,16/96,15.53%,DCUN1D1;SPHK1;SMAD7;BAG2;TGFBR1;MINAR1;HDAC3;DNAJB2;GNL3L;PRICKLE1;NDFIP2;SASH1;HSPA1A;OGT;COMMD1;CRY1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.3456193250557457,-0.6315765553391753,0.9310344827586207,1.0,1.0,4/20,12.13%,SARS1;NODAL;ATF4;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.27211089067659383,-0.6308822124956647,1.0,1.0,1.0,10/106,10.12%,RPS27L;LDB1;UPF3B;PPP1R3E;RBM3;UPF3A;SLC6A9;NIBAN1;CIRBP;BCAR3
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.2703701905435361,0.63023017754457,1.0,1.0,1.0,4/154,5.36%,VAPB;BET1;GOLT1A;RAB29
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.28789049647281467,-0.6300083128398857,0.9818181818181818,1.0,1.0,15/65,19.84%,DDX24;GTF2F1;DNASE1L1;POLR2I;POLR2J;KPNA2;METTL3;POLR2G;HNRNPL;POLR2C;RBMX;HNRNPH2;DDX54;HNRNPM;POLG
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.30864157448341056,0.6294720124943862,0.9361702127659575,1.0,1.0,5/23,13.04%,CDK6;DLL1;MDK;MYRF;SOX11
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.31113395439409863,-0.6293095988286296,1.0,1.0,1.0,6/28,24.68%,SCN11A;CACNG4;ATP5IF1;CACNA1A;P2RX4;CACNA1G
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.3021794105995071,0.6281064707054301,0.9534883720930233,1.0,1.0,5/31,15.52%,ECT2;HDAC3;UBR5;PIK3R1;SMAD3
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.31948997563583204,0.6279106445735211,0.9767441860465116,1.0,1.0,6/29,21.16%,ERN1;HSPA1L;PACRG;HSPA1A;RHBDD1;HSPA8
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.2954200321832997,0.6278146475482922,0.9642857142857143,1.0,1.0,8/46,16.41%,SSC5D;HMGB1;SYK;TLR1;F3;HSPA1A;RELA;NOD1
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.3702248970082507,0.6272266358517686,0.975609756097561,1.0,1.0,2/14,7.59%,SHROOM2;RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.3702248970082507,0.6272266358517686,0.975609756097561,1.0,1.0,2/14,7.59%,SHROOM2;RAB27A
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.3443254669914733,0.6271178684034044,0.95,1.0,1.0,5/14,17.55%,SLC30A10;IL16;ANK2;BCL2;STIM1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.42528504990355664,0.627050449682535,0.9454545454545454,1.0,1.0,5/6,27.35%,NLGN4X;CBLN1;PTEN;LRRK2;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2728588132249712,0.6269443670078888,0.9818181818181818,1.0,1.0,15/55,20.37%,ACKR3;HSPB1;CXCL12;SIRT1;BCL2;SYVN1;HSPA1A;URI1;CREB3;ARMC10;MDM2;TRIM32;TMEM161A;NFE2L2;BCL2L1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3501707282855959,0.6260152910526892,0.8947368421052632,1.0,1.0,1/11,4.36%,UQCRHL
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.4205894900987939,-0.6259268159180055,0.9230769230769231,1.0,1.0,1/6,8.51%,CALM1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.38842220830226803,-0.625748543871902,0.9285714285714286,1.0,1.0,1/7,2.58%,CRH
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.39644325715043566,-0.6253333730040549,0.8727272727272727,1.0,1.0,2/9,16.60%,ETFB;ETFDH
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.2960208925532882,-0.625319086979898,0.9824561403508771,1.0,1.0,5/40,13.53%,B2M;UBE2L6;UBC;APOA1;APH1B
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.3669365258697018,0.6250532186812372,0.9423076923076923,1.0,1.0,2/9,11.75%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.29799798593325577,-0.6250170253802341,0.967741935483871,1.0,1.0,7/41,18.07%,RNASET2;DNASE1L1;SUPV3L1;PABPC4;FBXO6;FBXO2;RAB12
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.39661692767430184,-0.6247095018393451,0.9259259259259259,1.0,1.0,2/6,15.75%,RBX1;TAF1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.4052948114857657,-0.6240946166421212,0.8545454545454545,1.0,1.0,1/5,9.85%,LRPAP1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.2740951511021301,-0.6240218718711291,1.0,1.0,1.0,22/66,28.72%,HTATIP2;NUP133;RPAIN;NUP155;GCKR;SNRPD2;NUP62CL;CSE1L;STAT3;NUP85;GEMIN4;FAM53A;NUP214;RAN;NXT1;SNRPD1;IPO7;NUP50;SEC13;TPR;SPRN;IPO13
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.4080337363237855,0.6239074352785051,0.975,1.0,1.0,1/6,5.83%,CAT
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.3887471631181113,-0.6238643913290085,0.9387755102040817,1.0,1.0,4/7,16.84%,DNM1L;PEX11B;FIS1;PEX11G
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.3026077940720795,0.6238623985463804,0.9591836734693877,1.0,1.0,6/35,12.46%,PPARG;CCL5;CDH13;PDGFRB;CTNNB1;EDN1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.3074399892391646,0.6235795191052377,0.9545454545454546,1.0,1.0,4/28,13.00%,CHPT1;SLC44A5;LPCAT3;PCYT1B
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3516811776194534,-0.6232453285923096,0.875,1.0,1.0,1/16,1.73%,CLU
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.31097516162627725,0.6230479650140451,0.9661016949152542,1.0,1.0,6/35,18.03%,SLC22A2;SLC6A13;SLC29A2;SLC11A2;ATP1A2;SLC1A3
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.337434838790506,0.6227942177655249,0.9130434782608695,1.0,1.0,3/17,11.69%,CTNNA2;WASF2;ARFIP1
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),-0.43034193318774583,-0.6220128925379925,0.8909090909090909,1.0,1.0,3/5,23.90%,NR1H4;ABCB11;FGFR4
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.2671280897945844,-0.6217120292689295,1.0,1.0,1.0,16/127,15.21%,DUSP4;TPTE2;PPM1M;PPP1R15A;DUSP6;DUSP5;FAM220A;PGP;PPP2R3B;STK11;PTPN9;PTPRB;PPM1G;PTPRC;UBLCP1;TIMM50
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.3291354208499278,0.6215853747761821,0.9555555555555556,1.0,1.0,8/27,19.48%,ITGAM;TCAF2;ANK3;MTCL1;AKT2;MIEF2;DMTN;FYN
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.27269956745858526,-0.6213489088585668,0.9655172413793104,1.0,1.0,15/109,16.36%,STX16;DCTN1;RILP;GAK;DOP1B;CLTCL1;VPS53;BAIAP3;SNX6;PREPL;YKT6;VPS52;RBSN;BET1L;WDR91
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.3943622795224415,-0.6211095696691677,0.8852459016393442,1.0,1.0,2/9,15.70%,PDHA1;MLYCD
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.30640186094777333,-0.6208058378437382,0.96875,1.0,1.0,7/25,23.42%,SHANK3;STMN1;MET;SHANK1;ARHGEF18;PFN1;CGNL1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3517866815546081,0.6206453799254739,0.9333333333333333,1.0,1.0,6/18,15.14%,GUCY2F;CAMKMT;PDE6A;CNGB1;METAP1;CNGA1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.2844328764444593,0.6200760447262127,1.0,1.0,1.0,5/42,11.75%,EGFR;FGF10;UBR5;RADX;SIRT1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.4096834314774293,-0.619532649261523,0.9411764705882353,1.0,1.0,1/6,13.99%,CNNM4
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.38848911617762266,-0.6195079649998454,0.8809523809523809,1.0,1.0,2/10,14.73%,ERCC1;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.34493797193147197,0.6190099522410843,0.9347826086956522,1.0,1.0,6/12,26.50%,ANK3;DMD;SLC9A1;ACTN4;GLRX;WNK1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.35524858240717994,0.6188063103472533,0.8620689655172413,1.0,1.0,2/14,11.68%,GNL3L;CTNNB1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.36013059863641445,-0.6187378164794061,0.9230769230769231,1.0,1.0,3/15,17.01%,CALY;CLTA;CLTB
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.3740606848714946,-0.6186988848200717,0.9574468085106383,1.0,1.0,1/8,8.49%,MYADM
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.3679238706636162,-0.6184130776995037,0.9074074074074074,1.0,1.0,4/8,23.66%,BBOF1;CCDC39;RSPH9;CCDC40
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.33204547949938684,0.6182673209644293,0.9148936170212766,1.0,1.0,2/20,5.36%,SHROOM2;RAB29
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.37408534258801385,0.6180758363307908,0.8461538461538461,1.0,1.0,2/9,11.75%,SNCA;SIRT1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.3248526503056285,0.6175112608337191,0.9591836734693877,1.0,1.0,4/22,12.24%,NYNRIN;ZC3H12C;ERN1;PCF11
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.2789515516431386,0.6173570896893951,1.0,1.0,1.0,7/59,12.79%,EFNA5;EPHA3;RHOB;GPM6B;PDGFRB;EPHA5;RHOBTB3
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.33604090874592246,0.6169152234359484,0.96,1.0,1.0,5/25,14.76%,GDAP1;PEX2;PEX13;ALDH3A2;ABCD3
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.34313280282189745,-0.6166154147513373,0.9830508474576272,1.0,1.0,4/17,19.78%,NFE2L1;UROS;PGRMC1;ATP5IF1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.26561214879051087,-0.6164496206684845,1.0,1.0,1.0,28/94,25.19%,TICRR;ORC3;MCM5;NT5M;MCM2;POLL;HUS1;PIF1;ORC1;TOP3A;RPAIN;RBBP8;KAT5;RMI1;KIN;CHEK1;CDC6;POLG;WDHD1;RPA3;ORC6;POLE3;ORC2;IGHMBP2;PTMS;MCM4;SET;CDC7
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.31382255063900916,-0.6162615648430652,0.9583333333333334,1.0,1.0,7/24,16.26%,TTC12;CFAP46;DRC1;RSPH4A;CCDC39;RP1L1;SPAG17
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.25589467637910546,0.6161765465524027,1.0,1.0,1.0,12/75,22.35%,BAG2;IER5;HSPA1L;SIRT1;EP300;HSPA1A;NUP42;RANBP2;NUP54;CAMK2D;HSPA8;BAG5
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.3593780249143254,0.6161061700032758,0.9210526315789473,1.0,1.0,1/12,10.54%,STARD4
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.2782770311790415,-0.6160958186335033,0.9545454545454546,1.0,1.0,6/50,15.68%,AKAP17A;IL11;HDAC5;SLC25A5;PTPRC;CD70
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.2986640788544412,-0.616079390824479,0.9649122807017544,1.0,1.0,2/33,6.10%,ANAPC15;UBC
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3357853007191094,-0.6158304516449821,0.9545454545454546,1.0,1.0,8/23,19.37%,STX4;ANO1;ADRA2A;NR1H4;BAIAP3;BRSK2;TRPM4;GPLD1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.39003494257021515,-0.6156917717156203,0.9433962264150944,1.0,1.0,2/7,22.75%,STAT3;TGFB1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.39302060958681506,-0.6156521475411775,0.9166666666666666,1.0,1.0,1/7,10.10%,GALK1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.3701851504093037,0.6155815850325205,0.9433962264150944,1.0,1.0,1/6,7.04%,ZNF675
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.29924481605794484,-0.6154880833036562,0.95,1.0,1.0,2/27,6.10%,SKP1;UBC
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.3545516294395755,0.6151200953266496,0.88,1.0,1.0,4/9,23.82%,SRR;SERINC5;PSPH;SHMT2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.31271642640215414,-0.6149892052717824,0.8823529411764706,1.0,1.0,7/22,16.40%,SLC51A;STARD5;NR1H4;CEACAM1;SLC10A6;ABCC4;ABCB11
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.3492338483512183,-0.6145381060649568,0.9215686274509803,1.0,1.0,3/16,13.86%,MORF4L1;MEAF6;BRD8
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.37262201432776154,-0.6141485356004941,0.9622641509433962,1.0,1.0,2/9,5.25%,NODAL;ADAM19
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.3822069126086219,0.6135289265619566,0.8936170212765957,1.0,1.0,6/10,37.54%,SESN1;RRAGD;KLHL22;SESN2;UBR2;SESN3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.3822069126086219,0.6135289265619566,0.8936170212765957,1.0,1.0,6/10,37.54%,SESN1;RRAGD;KLHL22;SESN2;UBR2;SESN3
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.28230258687676996,0.6132081059309361,0.9629629629629629,1.0,1.0,8/46,18.42%,MSL2;JADE3;EPC1;ACTL6A;EP300;OGT;RUVBL2;ATF2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.3637525189649422,0.6130384547909385,0.9090909090909091,1.0,1.0,2/11,17.02%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.316082583596459,-0.6129819548900428,0.9491525423728814,1.0,1.0,5/26,17.46%,BDH1;HMGCL;PPT1;LTC4S;HPGD
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.352167090052373,0.6128947529685964,0.9230769230769231,1.0,1.0,2/13,7.07%,SNCA;TWIST1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.3741813935474605,-0.6127912159948695,0.8793103448275862,1.0,1.0,1/9,7.92%,ACTC1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.3538977534637415,-0.6126814075139665,0.8979591836734694,1.0,1.0,1/7,5.30%,D2HGDH
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.35990945454096235,-0.6124473603440178,0.9636363636363636,1.0,1.0,6/18,28.15%,SUPT5H;CCNT1;RNF20;CTR9;NELFE;CDK9
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3012014488565189,0.6123662345273316,0.9791666666666666,1.0,1.0,6/24,21.61%,ESPL1;NSMCE2;PLK1;HECW2;CUL3;RIOK2
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.3946151527632966,-0.612330124167878,0.8723404255319149,1.0,1.0,2/6,33.59%,IMPACT;WRN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.2859552453470143,-0.6121891415808769,0.9318181818181818,1.0,1.0,2/35,3.48%,SERPINE1;CD74
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.39085512482626317,0.6115634935779564,0.86,1.0,1.0,3/6,13.63%,FGFR3;SCX;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.4031726607288102,-0.6113642418699576,0.9607843137254902,1.0,1.0,6/11,27.26%,DRD3;NOS2;SCPEP1;NOS3;NOS1;APLN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.346762329417895,0.6111561709164047,0.9285714285714286,1.0,1.0,5/14,20.84%,SLC8A1;ANK2;DMD;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.40037050702533544,-0.6108868791454657,0.8983050847457628,1.0,1.0,3/9,31.46%,IRAK1;EPG5;PIK3C3
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.3252353594416807,-0.6105086288235834,0.9444444444444444,1.0,1.0,7/15,22.12%,SPI1;SRC;STAT3;STAT1;YAP1;IL6R;CTR9
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.2764538616308744,-0.6101324738363848,1.0,1.0,1.0,5/58,12.92%,SLC25A10;SLC6A9;SLC6A20;SLC25A5;SLC13A3
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.3803176293149987,-0.6098004851005153,0.8727272727272727,1.0,1.0,2/8,18.43%,AZU1;FLOT1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.3192068332051775,0.6097423650262057,0.9361702127659575,1.0,1.0,5/27,14.76%,GDAP1;PEX2;PEX13;ALDH3A2;ABCD3
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.3612929238397699,0.609698065329407,0.8983050847457628,1.0,1.0,1/6,11.84%,GTF3C4
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.33996393249229284,-0.6095067589449968,0.8837209302325582,1.0,1.0,1/11,7.92%,ACTC1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.3521051578708778,-0.6094885732199941,0.813953488372093,1.0,1.0,3/6,30.30%,C1QBP;THBS1;JAK3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.41271391639851096,-0.6094351135960746,0.8913043478260869,1.0,1.0,1/5,19.71%,SEC16A
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.37963124600173476,0.6092859221416944,0.9361702127659575,1.0,1.0,1/9,7.09%,NREP
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.37567056208368543,-0.6092295033546999,0.8867924528301887,1.0,1.0,1/8,4.53%,PIK3IP1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.354339379334123,0.6092185896712499,0.9090909090909091,1.0,1.0,1/10,4.60%,FGF10
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.2699055032107763,0.6088834431143775,1.0,1.0,1.0,12/86,13.06%,SPHK1;EGFR;TGFBR1;H3-3A;SYT1;CDKN2AIP;RIMS2;ADNP2;EDN1;AKAP6;BCL2;SMURF1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.3300773723659239,0.6086164433802181,0.9565217391304348,1.0,1.0,1/14,4.07%,MCM7
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.2963825915088702,0.6082904272351494,0.9795918367346939,1.0,1.0,7/36,16.48%,LATS1;LIMK2;MFHAS1;EIF2AK3;PLK1;BYSL;WWTR1
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.37199976277618363,0.6078911353176545,0.9344262295081968,1.0,1.0,2/6,17.34%,SLCO1C1;SLC16A10
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.35463029585945793,0.6077942801167111,0.9230769230769231,1.0,1.0,1/10,3.17%,NRXN1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.30967972120744575,0.6072464085047121,0.9523809523809523,1.0,1.0,5/19,19.84%,NUS1;NR1H3;OSBPL6;NFKB1;YJEFN3
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.33494687722619865,-0.6069859329368861,0.9508196721311475,1.0,1.0,3/12,21.47%,EPHB6;SZT2;PAFAH1B1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.2667386430423347,-0.6066873373039294,1.0,1.0,1.0,2/77,2.06%,CLU;PXMP2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.3241913274139636,0.6066581175306808,0.9803921568627451,1.0,1.0,3/14,24.40%,SELENOI;ETNPPL;CEPT1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.36326911355990166,-0.6065750704169555,0.8936170212765957,1.0,1.0,1/14,5.48%,INTS5
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.3135033067944232,0.6064522886834314,0.9302325581395349,1.0,1.0,3/29,11.30%,DOC2B;SYT1;SYT15
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.39704959270192147,0.6063571661422976,0.8909090909090909,1.0,1.0,3/6,23.93%,NAIF1;ATF2;ACAA2
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.2764344798973494,0.606296940678437,0.9795918367346939,1.0,1.0,10/67,14.31%,EGFR;EPHA3;ATP2B4;ZDHHC2;DPP10;PID1;SORBS1;LDLRAP1;PICALM;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.2521865438065933,0.6058515312913252,0.9795918367346939,1.0,1.0,20/144,14.30%,RUNX1;AP1AR;ROBO1;ATP2B4;ANKRD13D;LDLR;HINFP;HIF1A;BMPR1A;ABCC2;ATOH8;SH3GL2;TIPARP;ITGB8;NDFIP2;SIRT1;SOX11;MEF2C;PICALM;CCDC3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.3263290472349064,-0.6055266184277557,0.9074074074074074,1.0,1.0,3/18,10.89%,GLMN;CR1;IL4I1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.3796454493160121,-0.6054631541050156,0.8852459016393442,1.0,1.0,3/9,20.16%,CR1;SLC25A5;ABCC6
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.2837012437144966,0.605359625997627,0.9787234042553191,1.0,1.0,3/28,12.42%,CLSPN;HINFP;STK33
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.2810500039911939,0.6049949353460302,0.9782608695652174,1.0,1.0,7/46,15.67%,PLCB1;SYT1;RIMS2;DLL1;SMURF1;NEDD4L;SYT2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.39037170555148115,0.6047470701645037,0.9,1.0,1.0,1/6,12.17%,LIG4
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.23065120596327707,0.6042724938898918,1.0,1.0,1.0,12/121,14.28%,FAM83H;BANP;TULP3;TSPAN17;TRAM1L1;BICD1;BBS9;ANK2;ALDH3A2;MARCHF5;TUB;CNTLN
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.3492108225833455,0.6042592437283837,0.8604651162790697,1.0,1.0,2/7,20.14%,CLASP1;CLASP2
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),0.37306149644858233,0.603858395369317,0.95,1.0,1.0,1/5,12.92%,TEX15
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3560177905357601,-0.6030811435775281,0.9473684210526315,1.0,1.0,6/14,26.45%,CEACAM1;PHPT1;PTPN22;SLA2;PTPRJ;EZR
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3123044639783113,0.6026340718374281,0.9534883720930233,1.0,1.0,4/31,20.22%,CTNNB1;ACD;HNRNPA2B1;NAF1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.2682302762963368,-0.6022421412053689,1.0,1.0,1.0,17/115,17.09%,B3GALT4;ST6GALNAC2;GOLGA2;ALG1L2;ST8SIA2;B3GNT9;B3GALT5;MPI;GALNT6;ALG8;FUT2;EOGT;ENTPD5;GALNT2;TMEM258;RPN1;ST3GAL1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.3076251103768501,-0.601888029502542,0.9454545454545454,1.0,1.0,10/40,27.25%,WRAP53;PIF1;NVL;GREM1;SRC;CCT2;HSP90AB1;SMG6;HSP90AA1;PARP4
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.3863941136040889,0.6017537803287836,0.9047619047619048,1.0,1.0,1/6,6.14%,CACNB2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.33661297667460277,0.6015219620267193,0.9387755102040817,1.0,1.0,7/16,23.16%,ZDHHC2;LDLRAP1;PLK1;SPTBN1;STX8;VAMP8;CLN3
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.35990417954596315,0.6011419289852985,0.9302325581395349,1.0,1.0,3/7,32.55%,ATG2B;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.35990417954596315,0.6011419289852985,0.9302325581395349,1.0,1.0,3/7,32.55%,ATG2B;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.2887811746927344,0.6000959564382281,0.9555555555555556,1.0,1.0,8/25,22.94%,SETMAR;RBBP5;TET2;OGT;WDR5B;KDM6A;TET3;KMT2C
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.30832526034885144,-0.5994187410749645,0.9814814814814815,1.0,1.0,3/24,9.83%,KCNE1;KCNE2;ATP1B1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.3810352505786716,-0.5993503999788156,0.9423076923076923,1.0,1.0,2/6,18.74%,DPH6;DPH7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.3810352505786716,-0.5993503999788156,0.9423076923076923,1.0,1.0,2/6,18.74%,DPH6;DPH7
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.27602153189391787,-0.5993482731284949,1.0,1.0,1.0,9/80,11.00%,SLC25A10;SLC51A;SLC16A8;STARD5;SLC7A7;SLC3A1;SLC6A20;NR1H4;CEACAM1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.3015475436921818,-0.5993365589766401,0.9846153846153847,1.0,1.0,3/24,9.40%,DCTN1;SPDL1;NSFL1C
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.346911579565919,-0.5991617725526159,0.9464285714285714,1.0,1.0,1/11,7.70%,VDAC2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.2689691941984782,0.5980023312409097,1.0,1.0,1.0,11/60,18.16%,PTPRK;ZBTB1;NEDD4;TIMP1;SIRT1;EP300;EIF2S1;CASP9;BMF;OPN5;RUVBL2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.3835492738355758,0.5979638986291694,0.92,1.0,1.0,3/12,8.49%,ARID1A;ARID1B;SERTAD2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.3239280270844115,-0.5978721598187734,0.9423076923076923,1.0,1.0,3/11,16.76%,TPM1;FGF9;NR4A3
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.3902442900106907,-0.5968490132883888,0.9090909090909091,1.0,1.0,2/5,24.25%,CTPS2;DCTD
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.40049085514295724,0.5967806670273677,0.92,1.0,1.0,1/5,9.57%,CADM1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.35817157731175114,-0.5964937068112023,0.9166666666666666,1.0,1.0,2/11,12.30%,NODAL;C1QBP
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.3457497598372171,0.5962042658606083,0.9347826086956522,1.0,1.0,3/14,12.46%,SLC30A8;RIMS2;EDN1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.2432321493543965,-0.5961357571016682,1.0,1.0,1.0,41/135,25.55%,DND1;PSMA7;PSMD7;UBC;PSMB4;VIP;PSMC3;CIRBP;METTL3;PSMD8;PSMB5;PSMC1;PSMB2;PSMC4;PSMD2;PSMA1;PSMB8;YWHAB;PSME1;PSMD10;PSMA8;PSMD12;PSMB3;CSDC2;PSMB7;PSMC6;SERBP1;EXOSC4;KHSRP;EIF4G1;IGF2BP2;TBRG4;PCBP4;APEX1;UBB;PSMB1;NUP214;SET;PSMA5;SAMD4A;NPM1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.3243218198139516,-0.5959510614022977,0.9672131147540983,1.0,1.0,4/17,21.15%,UFD1;HM13;SELENOS;NPLOC4
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.3803501945525294,0.5957707941997926,0.9090909090909091,1.0,1.0,5/5,61.98%,VPS13A;VPS13D;GOLPH3;SORL1;VPS13C
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.33916751794562366,0.5957615799795545,0.9473684210526315,1.0,1.0,6/25,21.16%,ERN1;HSPA1L;PACRG;HSPA1A;RHBDD1;HSPA8
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.3225863831960511,0.594674966403728,0.9791666666666666,1.0,1.0,2/16,10.34%,ROBO1;DLL1
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.32354109587904933,0.5941610691700986,0.9111111111111111,1.0,1.0,3/9,29.25%,NFKB1;ERLIN1;APOE
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.2740648684885343,0.5941058082796827,0.9772727272727273,1.0,1.0,14/38,28.01%,SYNJ2;PLPP1;PLPP6;MTMR12;PLPPR5;PIP4P2;MTMR11;SGPP2;PTEN;MTMR6;MTMR3;PLPPR4;MTMR2;INPP5F
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.2922962411721704,-0.5939333659337902,1.0,1.0,1.0,8/37,18.71%,RAC1;DCTN1;STMN1;ANKRD53;DRG1;MET;STMN2;RPS3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.30287020925018476,0.5939123825299707,0.9361702127659575,1.0,1.0,7/16,20.84%,PRKCA;MEF2A;EDN1;AKAP6;SLC9A1;ROCK2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.3316476319989075,-0.5935966088889675,0.9433962264150944,1.0,1.0,2/13,12.30%,TRAF3IP1;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.27119389867168636,-0.5927872288289924,0.9655172413793104,1.0,1.0,5/45,13.46%,HPS4;NMT1;ARIH2;PINK1;TOMM7
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.39302919085964205,-0.5927843101335373,0.9310344827586207,1.0,1.0,1/7,5.90%,DHX58
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.3896208194473515,0.5927475199884452,0.9152542372881356,1.0,1.0,1/5,10.22%,CHD7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.2992077269239714,0.592434041834549,1.0,1.0,1.0,7/45,14.31%,EGFR;EPHA3;ATP2B4;DPP10;GNAI1;SORBS1;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.36291958631913696,-0.5922230407859975,0.9642857142857143,1.0,1.0,4/12,34.28%,STAT1;HSPD1;MAVS;IRF3
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.27630927922222315,-0.5922015406099921,1.0,1.0,1.0,5/65,9.14%,MECR;PCCB;HSD17B10;ECHDC2;HADHA
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.28937050849762586,0.5919983152540476,0.9811320754716981,1.0,1.0,4/44,7.46%,KANK1;RAB29;MINAR1;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.3610750769950288,-0.5909624316414461,0.9272727272727272,1.0,1.0,2/11,7.57%,NODAL;RBPMS
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.31447932293341924,0.5906436420145404,0.9615384615384616,1.0,1.0,3/18,12.98%,SPHK1;ASAH2;PLPP1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.333987219070016,-0.5903387484908688,0.9180327868852459,1.0,1.0,4/13,20.47%,IGFBP4;IGFBP3;GHRHR;CDH3
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.3622710227207381,0.5901468859784477,0.9074074074074074,1.0,1.0,1/5,10.48%,NPY
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.3928070136487734,-0.5891635567524713,0.92,1.0,1.0,1/5,12.86%,KCNQ1
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.25239978863848933,-0.5889020667409538,1.0,1.0,1.0,13/105,16.01%,EPAS1;GPC1;MYH14;AGRN;COL18A1;VWA1;NFE2L1;ATP1B1;RAP1GAP;PPIC;ARHGEF10L;PPL;HDAC11
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.38183788413569864,-0.5888800636509238,0.9629629629629629,1.0,1.0,1/5,13.06%,KDM6B
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.3050573778176898,-0.5874821460806293,1.0,1.0,1.0,7/39,13.59%,ZWILCH;RFPL1;PLK2;TOM1L1;BTG1;WEE2;BMP7
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.3161907470556148,0.5874115843756053,0.975609756097561,1.0,1.0,6/15,27.76%,IGF1R;INSR;MTRF1;CLN3;ETF1;TBC1D25
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.29789510147568943,0.587076975722634,0.9772727272727273,1.0,1.0,3/21,16.82%,MAIP1;BAD;BMF
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.2998295899103556,-0.587062985151331,1.0,1.0,1.0,9/39,20.35%,ADRA2A;RAB3B;CRACR2A;SCN4B;DRD1;ORAI1;CAMK2A;PKP2;DRD4
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.38495253520529554,0.5870629781953717,0.9259259259259259,1.0,1.0,1/5,17.61%,SLC25A20
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.2668707512696434,0.5868931248290741,0.9791666666666666,1.0,1.0,7/50,21.74%,KIAA1586;NSMCE2;BCL11A;NUP42;RANBP2;NUP54;SAE1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.3487048598546388,0.5858991037446214,0.9433962264150944,1.0,1.0,1/8,8.11%,EIF2AK3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.2921451304578835,-0.5858843677701517,0.9824561403508771,1.0,1.0,5/29,12.86%,KCNE1;KCNE2;SCN4B;ATP1B1;KCNQ1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.32235630196181414,0.5856190949391987,0.9361702127659575,1.0,1.0,2/11,10.86%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.2871748266783621,0.585341647996919,0.9767441860465116,1.0,1.0,7/45,14.31%,EGFR;EPHA3;ATP2B4;ZDHHC2;DPP10;SORBS1;PIK3R1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.31977066758452327,-0.5853145071476457,0.9310344827586207,1.0,1.0,6/13,28.14%,ACTB;ARHGEF18;LSR;CGNL1;F11R;ACTG1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.31186023594365714,-0.5851768464804157,0.9245283018867925,1.0,1.0,4/26,15.12%,GNAS;PIK3CB;ACTB;TYRO3
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.26465499240069307,-0.5851127152027973,1.0,1.0,1.0,27/66,28.72%,HK2;NUP133;PINK1;LAMP3;RPAIN;NUP155;GCKR;NUP62CL;CSE1L;RAB11A;LRSAM1;LAMP5;STAT3;IL10RA;NUP85;FAM53A;NUP214;RAN;NXT1;IPO7;NUP50;SEC13;TPR;LAMP1;SPRN;HK1;IPO13
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.3663345384615271,-0.5848383667091683,0.9137931034482759,1.0,1.0,2/6,18.70%,SPI1;TRPM4
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),0.3865185021500246,0.5847781479289744,0.92,1.0,1.0,2/5,18.27%,LPL;PDK2
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.3616427797544701,0.5842791320070797,0.9333333333333333,1.0,1.0,1/6,12.44%,NEUROD2
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.3654389570959592,-0.5838577391558374,0.96,1.0,1.0,1/7,8.44%,CD63
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.36426255511279665,-0.5830477068173122,0.9069767441860465,1.0,1.0,1/5,12.91%,CD24
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.36426255511279665,-0.5830477068173122,0.9069767441860465,1.0,1.0,1/5,12.91%,CD24
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.30609228897035956,-0.5827076755991906,0.9464285714285714,1.0,1.0,5/20,22.75%,RHBDF2;DRD3;RSAD2;DRD4;CSK
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3134331389447419,-0.582515690705247,0.9183673469387755,1.0,1.0,7/25,18.00%,PPP1R15A;SELENOK;ATF4;CHAC1;ATP2A3;BRSK2;BAK1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.2586773861723578,0.5824945213940291,1.0,1.0,1.0,9/71,11.72%,NIPAL1;CCL5;SLC8A1;SLC30A8;SLC39A8;TRPC4;ITPR1;TUSC3;NDFIP2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.34135923626199355,-0.5824938806647201,0.9622641509433962,1.0,1.0,4/15,13.24%,WDR54;RHBDF2;CEACAM1;IFI6
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.3686282558641828,-0.5823823522697331,0.9574468085106383,1.0,1.0,2/8,25.45%,SNAPC5;SNAPC4
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.2859381378828853,0.5823191425990046,0.9777777777777777,1.0,1.0,7/31,21.92%,RORA;TLE1;SIRT1;PPM1A;NLRC3;TRIM59;ZMYND11
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.3851414597417031,-0.5822777163879586,0.9166666666666666,1.0,1.0,2/6,26.45%,PTPN22;EZR
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.370178643229675,-0.5821045197666329,0.9230769230769231,1.0,1.0,3/7,24.46%,KDM6B;HMGA2;ITGB4
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.2689481847550191,0.5817583617751392,0.9583333333333334,1.0,1.0,11/37,18.89%,PSRC1;RP1;RSPH6A;TOGARAM1;MTCL1;PLK1;SPAST;CLASP1;CFAP74;ZNF207;NCKAP5
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.3461080593053856,-0.5813062805131021,0.9583333333333334,1.0,1.0,2/12,8.44%,BST1;CD63
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.34824062311775505,0.5812570495341706,0.9,1.0,1.0,3/9,23.96%,PIGU;CRLF2;MGAT5
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.36725660659849546,-0.5812328681462242,0.9454545454545454,1.0,1.0,4/7,24.89%,KDM6B;KDR;EDF1;PECAM1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.3464636929957421,0.5807181110105145,0.9523809523809523,1.0,1.0,1/10,3.48%,HMGB1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.3310068057678718,-0.5805256112354381,0.9433962264150944,1.0,1.0,2/12,14.00%,DCTN1;CCDC68
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.26100012897414093,-0.5805170821714473,1.0,1.0,1.0,10/72,16.76%,RAC1;VAV3;EPHA1;EPHB6;SDC2;DNM1;APH1B;ACTB;EFNA1;SRC
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),-0.3834152697357656,-0.5797835714707562,0.9298245614035088,1.0,1.0,2/8,22.12%,CPNE7;CPNE6
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.284949599599781,0.5790603842629184,1.0,1.0,1.0,9/34,22.26%,GLRA2;GLRB;RNF139;SYVN1;SEL1L;RNF185;DERL1;RHBDD1;RCN3
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.39383036020215045,-0.5784437697421834,0.9090909090909091,1.0,1.0,1/5,16.76%,NR4A3
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.3508266626190385,-0.5778118322753607,0.9107142857142857,1.0,1.0,4/10,27.73%,NR1H4;ASAH1;FGFR4;EGR1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.33759551529540366,0.5776496986957667,0.9464285714285714,1.0,1.0,1/8,7.92%,ABL2
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.3649563141717649,-0.5775442613776798,0.8888888888888888,1.0,1.0,1/6,12.76%,CTSH
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.3649563141717649,-0.5775442613776798,0.8888888888888888,1.0,1.0,1/6,12.76%,CTSH
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.3178903188953268,0.5772846191022419,0.9318181818181818,1.0,1.0,3/8,19.07%,PDK4;PDK2;PDK1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.3178903188953268,0.5772846191022419,0.9318181818181818,1.0,1.0,3/8,19.07%,PDK4;PDK2;PDK1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.31426603974074974,0.5772147100976984,0.9433962264150944,1.0,1.0,4/12,26.25%,DESI2;SAE1;UBA3;UBA5
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.34223459772394904,0.5770852504891608,0.9777777777777777,1.0,1.0,3/10,22.91%,SRR;SERINC5;PSPH
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.2980212516939065,0.5758782338371616,0.9361702127659575,1.0,1.0,6/18,23.80%,LRWD1;PLK1;RUVBL2;FAM47E;NIPBL;MSH2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.3165705160412226,0.5754865570528274,0.9523809523809523,1.0,1.0,4/15,24.67%,PRKACB;ADCY2;ADCY3;ADCY9
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.29114958779907996,-0.575440094779142,0.9444444444444444,1.0,1.0,9/24,27.20%,MORF4L1;BRD8;TAF6;KAT5;ATAT1;BAG6;KAT2A;TAF6L;KAT7
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.35477956693854734,-0.5748925282076642,0.9767441860465116,1.0,1.0,3/12,22.08%,WRAP53;CCT2;CCT6A
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),-0.36889321227842625,-0.5748288821479542,0.8823529411764706,1.0,1.0,5/5,63.13%,TBX1;WDPCP;INTU;SIX4;WNT10A
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.3043363507145777,-0.5742237774091637,0.9791666666666666,1.0,1.0,1/18,5.48%,INTS5
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.30929353283250327,0.5740790445587909,0.9791666666666666,1.0,1.0,2/22,13.06%,NEDD4;SMURF1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.358206232948562,0.5738784399656925,0.8695652173913043,1.0,1.0,1/6,16.58%,ERC1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.31925655633590444,0.5738558300240354,0.9787234042553191,1.0,1.0,2/20,6.31%,SGCZ;PGM5
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2794635093351622,-0.5732330295578463,1.0,1.0,1.0,10/33,21.82%,GIPC1;CAMLG;DDRGK1;RPL23;TAF1;RPL5;MAP1A;SDCBP;RPL11;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.3461660325063746,-0.5725985252594377,0.9183673469387755,1.0,1.0,2/6,27.71%,XRCC3;TPR
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.3461660325063746,-0.5725985252594377,0.9183673469387755,1.0,1.0,2/6,27.71%,XRCC3;TPR
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.34660537729114843,0.5715805512530278,0.9375,1.0,1.0,1/9,8.16%,HIF1A
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.30350648574789874,-0.5710990604353509,0.9666666666666667,1.0,1.0,9/22,30.03%,IFIT1;HDAC6;CAMK2A;ATP5IF1;PHPT1;NOSIP;NOS1;MT3;OXA1L
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.34801880343966396,0.5708840267691105,0.9387755102040817,1.0,1.0,2/6,21.98%,TCN2;CUBN
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.3358104333235654,-0.5703848577674907,0.8958333333333334,1.0,1.0,4/12,33.06%,DYNC2I1;DYNC2LI1;WDR19;TTC21A
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.368780041809438,-0.5701492067367456,0.8548387096774194,1.0,1.0,3/7,18.69%,GSTP1;SELENOS;KDR
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.3557733707658366,0.5701486475808738,0.9090909090909091,1.0,1.0,1/5,21.71%,AEBP1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.3386044728611381,-0.569864924676916,0.9818181818181818,1.0,1.0,2/10,19.07%,DGKD;DGKG
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.3237765260123736,-0.5697330047856206,0.9259259259259259,1.0,1.0,7/18,31.60%,EXOSC10;CCT2;CCT6A;DCP2;NHP2;CCT8;DKC1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.3731278950703586,-0.5695167966965782,0.9230769230769231,1.0,1.0,1/7,10.86%,NDRG4
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.2948702914331499,-0.5691466956741223,0.9814814814814815,1.0,1.0,6/35,16.37%,ATRAID;RILP;TIMP4;PIN1;AGAP2;AZIN2
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.3354296153917259,0.5689459150851733,0.9375,1.0,1.0,1/7,18.63%,LYST
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.3037667614960197,0.5682206624936436,0.9512195121951219,1.0,1.0,2/14,22.28%,RGS14;XPO1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.37637141499051696,0.568131419513076,0.9615384615384616,1.0,1.0,1/5,13.28%,FTO
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.29040421824577023,0.5679403743223367,1.0,1.0,1.0,9/24,28.01%,SYNJ2;MTMR12;PIP4P2;MTMR11;PTEN;MTMR6;MTMR3;MTMR2;INPP5F
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.317900690281561,-0.5674437733991723,0.9,1.0,1.0,1/10,9.27%,CR1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.3642625334485725,0.567365976013834,0.9615384615384616,1.0,1.0,1/6,8.16%,HIF1A
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.335305559397405,0.56727773824985,0.9130434782608695,1.0,1.0,4/7,23.16%,PKDCC;CNST;ATP2C1;CLN3
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.35855211851028096,-0.5671732000427668,0.9285714285714286,1.0,1.0,3/8,27.01%,CARD11;MTOR;CLEC16A
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.3663760064368402,0.5669049846150355,0.9583333333333334,1.0,1.0,2/10,11.76%,ATP2B4;FOXO1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.2865166400852259,0.5657568436637485,0.9523809523809523,1.0,1.0,3/25,20.17%,ARL5A;ARL5B;RAB33B
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.3006086915377735,-0.5652851906219765,0.9642857142857143,1.0,1.0,2/35,6.59%,PHAX;HTATIP2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.2890055152132702,-0.565282575550044,0.9803921568627451,1.0,1.0,1/21,5.20%,KCNE1
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.3321422679367413,-0.5651402048854641,0.9245283018867925,1.0,1.0,1/12,2.10%,HK2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3410971086247335,-0.5650224877860563,0.9454545454545454,1.0,1.0,1/10,5.90%,DHX58
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.30538166196373573,-0.5649028104029233,0.9767441860465116,1.0,1.0,2/15,10.31%,DRD3;DRD1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.28550473257566006,0.5638016255102594,0.9787234042553191,1.0,1.0,3/28,12.12%,NUDT16L1;SETMAR;SHLD1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.38287529350742777,0.5631989812983335,0.9777777777777777,1.0,1.0,2/6,18.97%,LIN7A;RAB10
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.3235928487375892,-0.5625789737130394,0.94,1.0,1.0,1/13,10.91%,NUP133
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.3465951260242221,-0.5624519748484202,0.9482758620689655,1.0,1.0,1/8,16.16%,GLE1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.33159306466710864,-0.5620700390877897,0.9772727272727273,1.0,1.0,2/11,13.14%,CLDN1;SUPV3L1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.33833645161706993,0.5613279646751508,0.9565217391304348,1.0,1.0,4/13,16.09%,HDAC9;NR1H3;SORT1;LPL
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.316630610580471,-0.5612305628972424,0.9166666666666666,1.0,1.0,2/12,22.75%,HMCES;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.2860282382323671,-0.5610995175685406,1.0,1.0,1.0,7/29,16.35%,CDK5;TIMP4;CHAC1;CSTB;CAMK2N1;EFNA1;HDAC6
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.34487792158339303,-0.5608274877063203,0.9310344827586207,1.0,1.0,3/11,17.42%,KDELR1;KDELR3;RER1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.26133096181525156,0.560189209021676,1.0,1.0,1.0,3/43,8.37%,CCNA2;EGFR;ANKRD17
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.32726291640625604,0.5596209277233574,0.9333333333333333,1.0,1.0,1/6,21.42%,MINPP1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.3626045068832119,-0.55902805462774,0.94,1.0,1.0,1/7,5.62%,GHR
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.353900554599445,0.5590049037830243,0.9272727272727272,1.0,1.0,2/7,12.46%,TRDN;AKAP6
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.27756340982819694,-0.5589903715402763,0.9836065573770492,1.0,1.0,9/35,19.76%,RAB3B;TANGO2;SVBP;COPG2;RAB3A;PDIA4;RAB12;CANX;SCG2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.3100155070872007,0.5588951872128102,1.0,1.0,1.0,6/17,20.84%,SLC8A1;ANK2;DMD;SLC9A1;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.32832157890442604,-0.558812796741625,0.94,1.0,1.0,1/14,10.49%,HMCES
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.3431320775840846,0.5587586814540791,0.925,1.0,1.0,1/9,8.85%,FBXO7
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.3403390719067561,0.5585643055707219,0.95,1.0,1.0,6/14,19.07%,RORA;ADIPOR1;SIRT1;PDK4;PDK2;PDK1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.3291596019903136,-0.5584966216160773,0.9107142857142857,1.0,1.0,2/8,17.05%,AGRN;MTCH1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.3378371054778897,-0.558440434303098,1.0,1.0,1.0,4/8,31.26%,SHH;ENG;EFEMP2;SMO
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.28991188030879833,-0.5579337511332625,0.9454545454545454,1.0,1.0,1/20,3.19%,CDC37
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.34200689838610193,-0.5577860263845843,0.9245283018867925,1.0,1.0,1/11,5.09%,TCHP
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.38407932479751616,0.5571007111251409,0.9215686274509803,1.0,1.0,2/5,14.81%,MTCL1;MAP2
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3250730690666736,0.5568541718027995,1.0,1.0,1.0,3/13,14.74%,ZNF205;BOK;HSPA1A
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.26231826411423337,-0.5566940549865448,0.9827586206896551,1.0,1.0,14/37,27.81%,MAX;SOX15;RBBP8;RING1;CBX5;CHEK1;CDKN2B;L3MBTL2;DAB2IP;TFDP1;CDC7;FOXO4;UXT;CBX3
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.2952325402929662,-0.5563607687277918,0.98,1.0,1.0,3/18,16.35%,PINK1;DNM1L;HDAC6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.38675708230966827,-0.5550147345927245,0.9782608695652174,1.0,1.0,1/5,4.36%,TRPC3
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.2544165376501169,0.5540980388662775,1.0,1.0,1.0,7/44,15.86%,BAG2;HDAC2;BTRC;ADAM8;OGT;PLK1;BAD
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.2930933707669862,-0.5536072910708852,0.9803921568627451,1.0,1.0,5/29,21.82%,WRAP53;NVL;GREM1;CCT2;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.3193118230785656,0.5530984726874142,0.9583333333333334,1.0,1.0,1/8,17.92%,CNOT2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.26114502080708074,0.5522844704191016,0.98,1.0,1.0,7/32,20.63%,HDAC9;TPD52;BLNK;SYVN1;RAG1;CEBPG;KLF6
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.3176881043113282,-0.552080440134667,0.9433962264150944,1.0,1.0,2/11,20.11%,MORC2;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.27879415759146975,-0.5520253883535854,0.9811320754716981,1.0,1.0,6/39,16.37%,CLU;RILP;CRYAB;PIN1;AGAP2;AZIN2
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.27869827514751044,0.5513597849427709,1.0,1.0,1.0,3/29,12.93%,TFEB;MYO7A;CLVS1
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),-0.36503453314535805,-0.5493455703784923,0.9354838709677419,1.0,1.0,1/5,12.62%,XYLB
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.32195542164184926,-0.5481101371135391,0.9152542372881356,1.0,1.0,6/13,25.37%,ATF4;MEAK7;UCP1;EIF4G1;MTOR;FAM107A
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.30753186453672926,0.5475815426205888,0.95,1.0,1.0,1/12,4.88%,GLRA2
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.33793538551257235,0.5475427591818834,0.9782608695652174,1.0,1.0,1/10,7.86%,LDLR
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.3551801125145446,-0.5473008527282375,0.9122807017543859,1.0,1.0,2/5,25.01%,WRAP73;HAP1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.3584985053744048,0.547267968157324,0.9722222222222222,1.0,1.0,2/5,18.35%,TACR1;TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.3584985053744048,0.547267968157324,0.9722222222222222,1.0,1.0,2/5,18.35%,TACR1;TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.3584985053744048,0.547267968157324,0.9722222222222222,1.0,1.0,2/5,18.35%,TACR1;TACR3
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.32206860334582255,-0.5472470201660813,0.9782608695652174,1.0,1.0,4/12,27.09%,PROC;TNFRSF1A;S1PR3;F11R
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.2914331090678193,0.5462959428087427,0.9591836734693877,1.0,1.0,5/19,15.25%,TRDN;ANK2;AKAP6;SLC9A1;VMP1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.3402385862489621,-0.54602247679207,0.9807692307692307,1.0,1.0,2/10,16.76%,GPC3;NR4A3
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.2537888544025048,0.5460199297145247,1.0,1.0,1.0,12/66,18.42%,SUPT3H;JADE3;NAA50;EPC1;ACTL6A;EP300;KAT14;DR1;KAT2B;BRPF3;RUVBL2;ATF2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.2871430410026831,-0.5459194297926031,1.0,1.0,1.0,9/28,29.21%,POLR3H;BRF1;SNAPC5;GTF3C2;POLR2L;SNAPC4;POLR2K;POLR3GL;GTF3C3
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.29453470954334526,0.545880389561998,0.9491525423728814,1.0,1.0,3/17,11.41%,BCOR;RNF2;RYBP
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.37152791114095146,0.5454546321076278,0.9811320754716981,1.0,1.0,3/8,20.03%,EIF2AK3;EIF2S1;NFE2L2
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.3211080856618241,0.5451916305504261,0.9512195121951219,1.0,1.0,1/10,11.42%,TF
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.33062806195903116,-0.5444420356487413,0.9636363636363636,1.0,1.0,1/8,11.75%,NPY5R
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.2556833527812913,-0.5441647330200143,0.9827586206896551,1.0,1.0,6/36,17.21%,KIF17;TRAF3IP1;IFT27;DYNLRB1;DYNC2I1;IFT22
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3092052224734497,-0.5438722817038774,0.9491525423728814,1.0,1.0,5/12,19.90%,TICRR;HUS1;ORC1;CDC6;ZNF830
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.32031236242729044,0.5432457697108622,0.8444444444444444,1.0,1.0,2/6,18.35%,TACR1;TACR3
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3020356658463235,0.5428138875430251,0.9743589743589743,1.0,1.0,3/12,17.66%,SLC8A1;GJC1;ATP1A2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.37016893559620134,0.542533215406816,0.95,1.0,1.0,2/8,16.64%,BCS1L;UQCRFS1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.37016893559620134,0.542533215406816,0.95,1.0,1.0,2/8,16.64%,BCS1L;UQCRFS1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.33985294292516827,0.5423413976942966,0.8775510204081632,1.0,1.0,1/5,7.47%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.2991519196718514,-0.5417374686367306,0.9607843137254902,1.0,1.0,5/22,17.98%,CEMIP;CALM1;DRD1;CALM3;JPH2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.2545655933681529,-0.5416101920542957,1.0,1.0,1.0,8/47,24.19%,EXOSC10;PIF1;NAT10;SRC;STN1;CCT2;CCT6A;SMG6
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.30185137886247215,-0.5415650272146062,1.0,1.0,1.0,6/25,16.35%,SHANK3;ADRA2A;BTC;GREM1;TAF1;HDAC6
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.31304929937551285,-0.5414757352031677,0.9411764705882353,1.0,1.0,3/10,19.72%,PGP;DGKG;PIP5K1A
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.3020215644859101,0.5412616682238435,0.9523809523809523,1.0,1.0,1/10,8.39%,ODC1
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.3549426327025851,-0.5411955213805664,0.9411764705882353,1.0,1.0,3/5,25.85%,NR1H4;KHSRP;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2971478453568592,0.5407395872048779,1.0,1.0,1.0,3/15,20.22%,SHQ1;RUVBL2;NAF1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.32228080661064373,-0.5406800083935259,0.8979591836734694,1.0,1.0,2/10,19.71%,BRSK2;SEC16A
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.3392227262436821,0.5403921643641347,0.9777777777777777,1.0,1.0,1/6,11.75%,SIRT1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.3562558439904751,-0.5398200780349819,0.9814814814814815,1.0,1.0,1/6,15.15%,SRGN
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.29183679117169276,-0.539536978318176,0.9846153846153847,1.0,1.0,3/15,21.15%,UFD1;SELENOS;NPLOC4
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.323755398924609,-0.5393908648669489,0.9607843137254902,1.0,1.0,3/13,27.21%,CPTP;PLTP;ABCB1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.2939017307618745,-0.5388635632013121,1.0,1.0,1.0,6/20,19.69%,LIPC;HNF4A;NR1H4;APOA1;GCKR;IL18
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.2771323072317534,-0.538748589882737,1.0,1.0,1.0,8/25,24.38%,PAQR7;UBE3A;CATSPERG;ATP1A1;YAP1;TGFB1;MGARP;THBS1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.3567877206431427,0.5386807494198609,0.9433962264150944,1.0,1.0,1/5,14.84%,OGT
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.2681846721693372,0.5375814027782412,0.98,1.0,1.0,7/22,20.84%,PRKCA;MEF2A;EDN1;SLC9A1;ROCK2;SMAD4;CAMK2D
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.3004758709145987,-0.5372921043857309,0.9615384615384616,1.0,1.0,4/10,23.27%,ERMN;MFSD2A;SPRY2;NTNG2
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.3602536222905045,-0.5370346729479853,0.9310344827586207,1.0,1.0,1/5,9.48%,RGS2
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.31592610108719765,0.5369701787349452,0.9807692307692307,1.0,1.0,3/9,25.58%,SLC9A1;PKD1L3;LGMN
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.3336058371396782,-0.5368570932065496,0.9622641509433962,1.0,1.0,2/11,15.20%,GAK;RBSN
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.30569007209070587,-0.5366131618415559,0.9629629629629629,1.0,1.0,2/14,15.25%,SHANK3;SHANK1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.31491430776970175,-0.5357352692835596,1.0,1.0,1.0,6/12,27.84%,ARPC2;ARPC5;MAGEL2;IQGAP2;WHAMM;ARPC3
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.3457988181724858,0.5351885864198908,0.9180327868852459,1.0,1.0,2/7,23.37%,SASH1;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.34272481520054077,-0.5347548700459646,0.9661016949152542,1.0,1.0,2/9,13.59%,LRP8;BMP7
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.323060025429464,-0.5346635498308802,0.9615384615384616,1.0,1.0,2/7,14.71%,BMP7;ARHGAP12
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.32470410901586155,0.5341233766560084,0.9607843137254902,1.0,1.0,2/8,17.27%,SORT1;SLC2A1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.2996412273498079,-0.5338963083931919,0.9811320754716981,1.0,1.0,5/12,29.32%,LAMP3;AXL;EIF2AK2;TPR;IFNAR1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.282118634053512,-0.5338584980471958,0.9607843137254902,1.0,1.0,2/17,8.64%,CDK5;KIF5A
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.34517623779890544,-0.5329861927074407,0.8846153846153846,1.0,1.0,1/5,19.37%,GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.34517623779890544,-0.5329861927074407,0.8846153846153846,1.0,1.0,1/5,19.37%,GAS2L2
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.31823106260866096,-0.5327995018605001,0.9649122807017544,1.0,1.0,4/12,25.74%,NOS2;ORAI1;NOS3;NOS1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.3047241825861054,-0.532753978000669,0.9622641509433962,1.0,1.0,1/9,13.48%,NIT2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.35482909709452903,0.5324945925097444,0.9302325581395349,1.0,1.0,1/5,15.52%,SMAD3
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.35808424185438825,-0.5322547685894458,0.9347826086956522,1.0,1.0,2/5,38.22%,JAK3;TCF7
prerank,GO_Biological_Process_2021__regulation of system process (GO:0044057),0.35624974005986737,0.5312514093071578,0.9591836734693877,1.0,1.0,1/5,17.43%,ROCK2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.3169005480967528,-0.530684147864278,1.0,1.0,1.0,1/6,21.25%,TNFRSF1A
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.25604545563574993,0.5305133444186686,1.0,1.0,1.0,3/32,12.93%,TFEB;MYO7A;CLVS1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.31121849794366174,-0.5294012447519911,0.9636363636363636,1.0,1.0,3/12,26.43%,METTL3;RLIM;RBM15B
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.3267101631070352,0.529350560664877,0.9782608695652174,1.0,1.0,5/8,36.77%,ABL1;APOE;NRCAM;GSK3B;SIN3A
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.3104918339640194,0.5292834053449748,0.9090909090909091,1.0,1.0,2/7,18.50%,TMEM39A;PHF23
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.27151181657656015,0.5292063527749974,1.0,1.0,1.0,5/19,32.86%,HNRNPD;TNKS;TERF2;NBN;NEK7
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.3414778911671542,0.5289474350075939,0.9777777777777777,1.0,1.0,3/8,24.94%,PTK2;DMTN;ITGB1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.30634511736741277,0.5286827373789188,0.9433962264150944,1.0,1.0,2/8,21.28%,STIM1;GRAMD2A
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.2600908335995389,-0.5281200253993016,1.0,1.0,1.0,9/35,30.98%,DBNL;RTN4R;NTN1;LIMK1;DNM2;MAG;MT3;SEMA7A;ISLR2
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.29976129483251723,-0.5273269749392765,0.9444444444444444,1.0,1.0,3/13,20.14%,ACE;APH1B;MME
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.3231628026906042,0.5271046173414208,0.9347826086956522,1.0,1.0,3/8,24.25%,DOCK4;DOCK5;PDGFB
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3125807776700731,0.526947517948963,0.9795918367346939,1.0,1.0,2/7,25.62%,VEGFA;JCAD
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.2658986363627193,-0.5263072174040946,1.0,1.0,1.0,6/25,23.64%,PRPF6;PRPF4;MPHOSPH10;SRSF10;KHSRP;SF3B3
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.3318942702439794,0.5261574434873321,0.9574468085106383,1.0,1.0,3/7,21.34%,DUSP22;FYN;NTRK2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.256075086862943,-0.525939570543888,1.0,1.0,1.0,3/36,11.59%,RILP;DNM1;TMEM9
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.27290532398844064,-0.5256968141309591,1.0,1.0,1.0,2/24,8.87%,SCN11A;SCN4B
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.26262349280641956,-0.5248449614766195,1.0,1.0,1.0,5/23,21.15%,UFD1;SELENOS;RANGRF;SEC16A;NPLOC4
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.3270461991680234,0.5245427616674823,0.9591836734693877,1.0,1.0,1/6,9.20%,ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.3270461991680234,0.5245427616674823,0.9591836734693877,1.0,1.0,1/6,9.20%,ASF1A
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.2645968228869888,0.5233825779459086,1.0,1.0,1.0,6/32,16.94%,FHIT;EIF3H;RYBP;MARCHF7;OGT;PSMF1
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.3427600391150409,-0.5230783012413277,0.9454545454545454,1.0,1.0,2/5,19.07%,CARMIL2;MTPN
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3044063217451094,-0.5208971172852156,0.9622641509433962,1.0,1.0,2/12,20.11%,MORC2;SETDB1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.30164087609089885,0.5198992244305403,0.9473684210526315,1.0,1.0,1/7,11.84%,GTF3C4
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.2752803075650298,-0.5191038342631921,1.0,1.0,1.0,5/26,16.40%,GNB3;BCKDK;NR1H4;MLYCD;ABCB11
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.3201429087013149,-0.5190800558201313,0.9622641509433962,1.0,1.0,3/6,27.20%,ACE;EIF2AK2;KAT7
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.314237492791553,0.5189781774316814,1.0,1.0,1.0,2/8,13.63%,BCL2;MEF2C
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.3115737539912907,0.518725202056401,1.0,1.0,1.0,1/9,14.14%,CHMP1A
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.3115737539912907,0.518725202056401,1.0,1.0,1.0,1/9,14.14%,CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.3286193683298803,0.5187126359057318,0.9591836734693877,1.0,1.0,3/6,18.69%,HIF1A;SLCO1C1;ARNT
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.2755666309647899,0.5173395285060409,0.9803921568627451,1.0,1.0,5/22,21.71%,PIK3CA;MAP2;HSPA8;ABL1;AEBP1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.2992081490933425,0.5169294952582184,1.0,1.0,1.0,3/13,20.62%,ACADVL;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.31414829226113267,0.5164053197089556,0.9761904761904762,1.0,1.0,5/5,68.59%,SLC38A3;SLC38A5;SLC36A1;SLC1A4;SLC36A4
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.25780177131000176,0.5159480193519866,1.0,1.0,1.0,7/22,24.51%,TMEFF2;WASF2;PIK3R1;CLASP1;CLASP2;ARHGAP28;WAS
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.25755745496874727,-0.5158413141795767,1.0,1.0,1.0,8/26,21.82%,GIPC1;CAMLG;DDRGK1;SVIP;MAP1A;SDCBP;RPL11;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.3355634148963399,-0.5158379732171771,0.9807692307692307,1.0,1.0,1/5,13.45%,RACK1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.24861181278507255,0.5153798344037979,1.0,1.0,1.0,5/26,16.87%,TBX6;DLL1;ACVR1;MEF2C;BBS4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.33249954619719857,-0.5147517806675042,1.0,1.0,1.0,2/7,16.29%,ATF4;ANKRD2
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.29481817922232406,0.5143741477731761,1.0,1.0,1.0,2/12,10.86%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.29546504876219737,0.5140809194828587,0.98,1.0,1.0,3/11,16.87%,CTNNA2;SPEF2;BBS4
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.298989745541686,-0.5128594839040671,0.9642857142857143,1.0,1.0,3/11,25.14%,NUCKS1;PPIB;CFL1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.25785191144460723,0.5123618674704539,1.0,1.0,1.0,3/19,17.21%,CWC27;PPIL6;FKBP5
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.2715900462328046,-0.511953605442008,1.0,1.0,1.0,5/19,29.50%,TTLL2;PARP1;AGBL5;TTLL3;TTLL1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.3032547577854672,0.5116601519510225,1.0,1.0,1.0,13/13,69.70%,COQ7;PDSS2;UBIAD1;COQ8B;COQ2;PDSS1;COQ3;COQ9;COQ10A;COQ6;FDXR;COQ5;COQ10B
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.3032547577854672,0.5116601519510225,1.0,1.0,1.0,13/13,69.70%,COQ7;PDSS2;UBIAD1;COQ8B;COQ2;PDSS1;COQ3;COQ9;COQ10A;COQ6;FDXR;COQ5;COQ10B
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.3472958385301507,-0.5111292534707635,0.9629629629629629,1.0,1.0,2/5,25.50%,FLOT1;EMP2
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.34724098794790037,0.5108481324939965,0.9411764705882353,1.0,1.0,6/6,65.29%,SLC12A6;RHD;SLC12A4;RHCE;SLC12A7;RHCG
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.2906157066134666,0.5103839395078436,0.9772727272727273,1.0,1.0,3/9,26.39%,GRAMD1C;GRAMD1A;LRP6
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.31167525571224364,0.509749897014025,1.0,1.0,1.0,2/8,17.34%,SLCO1C1;SLC16A10
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.3332792909641159,0.5087269486599484,0.96,1.0,1.0,5/5,66.68%,BMPR2;ADRB1;PRCP;SOD2;GPR37L1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.2692994170209539,-0.508133980723028,1.0,1.0,1.0,3/23,17.43%,CALM1;PER2;GYS1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.22106924668459596,-0.5081072626895118,1.0,1.0,1.0,7/82,16.31%,STX4;FTH1;ARF1;AP1S1;DOP1B;CCDC93;CLTA
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.32573357564508393,-0.5080047449826107,0.9807692307692307,1.0,1.0,1/6,13.59%,BMP7
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.3191577453901216,-0.506519380182703,1.0,1.0,1.0,3/7,34.29%,RPUSD2;DKC1;PUS1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.3015974369124699,-0.5055203424101564,0.9777777777777777,1.0,1.0,2/8,19.84%,TWNK;POLG
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.310637742578395,-0.5049486554535095,0.9787234042553191,1.0,1.0,3/12,19.80%,PARP1;TOP3A;MPV17
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.28664919759454444,-0.504669728797175,0.9423076923076923,1.0,1.0,1/13,10.49%,HMCES
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.2806653772803763,0.5040028960695151,1.0,1.0,1.0,3/11,20.83%,FER;CD47;CD55
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.2564159986972902,-0.503978845589023,0.9782608695652174,1.0,1.0,6/23,23.66%,AHI1;NDRG4;CCDC39;SHH;MICAL2;CCDC40
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.3492526585187406,-0.5029276797059722,0.9473684210526315,1.0,1.0,2/5,24.01%,RAB3A;RAB11B
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.31366331356910593,0.5024409051283367,0.9454545454545454,1.0,1.0,3/8,28.01%,TCAP;RYR2;INPP5F
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.2697840686667821,-0.5021864862350824,0.967741935483871,1.0,1.0,2/23,8.74%,RFT1;ATP8B4
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2683676832451297,-0.5019019665571609,0.9787234042553191,1.0,1.0,1/18,7.07%,CCND1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3135241193261294,-0.5018757937115138,0.9818181818181818,1.0,1.0,2/9,16.42%,CALM1;CALM3
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3135241193261294,-0.5018757937115138,0.9818181818181818,1.0,1.0,2/9,16.42%,CALM1;CALM3
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.27797970018231644,0.5015472801087909,0.9830508474576272,1.0,1.0,2/13,15.98%,HIF1A;SPAST
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.2976377101464943,0.5012769288384329,1.0,1.0,1.0,10/10,70.25%,VCAN;CHST12;DCN;DSE;NCAN;BCAN;IDUA;CSPG5;UST;DSEL
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.32920731590033714,0.5009845241706764,0.8979591836734694,1.0,1.0,3/5,32.23%,PROX1;BMPR2;ACVR2B
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.31468060413671484,-0.500509697537087,0.9818181818181818,1.0,1.0,3/7,27.20%,MEAF6;BRPF1;KAT7
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.28230423746021105,-0.5002735326061418,0.9803921568627451,1.0,1.0,8/13,34.03%,GPLD1;RAB11B;MCOLN1;TRPV1;IMPACT;HYAL1;RAB11FIP5;HVCN1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.3017722257429523,0.5000077567983953,0.9285714285714286,1.0,1.0,1/6,9.38%,NPL
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.23486028803986203,-0.4996361987850565,1.0,1.0,1.0,13/41,29.67%,LACC1;NUP133;NUP43;NUP155;GCKR;EIF6;NUP85;NUP214;NUP50;SEC13;TPR;SLC2A6;ZBTB7A
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.3320244547811104,0.49955462327144456,0.9411764705882353,1.0,1.0,4/6,25.74%,EP300;CRY1;GCK;CLK2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.2518331334370943,0.4993034416613709,0.9607843137254902,1.0,1.0,4/28,15.44%,SETMAR;RBBP5;SETD6;WDR5B
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.26434071897083095,0.4991665038030896,0.9591836734693877,1.0,1.0,7/23,24.27%,RNF139;SYVN1;UGGT1;SEL1L;RNF185;EDEM1;DERL2
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.2639117159694231,0.49828830762407905,1.0,1.0,1.0,1/10,16.79%,CPEB3
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.2899203239764401,0.4977819954553115,0.9772727272727273,1.0,1.0,1/11,9.99%,CDK12
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.2959093846886999,0.4975642689293273,0.9487179487179487,1.0,1.0,1/11,11.20%,TTLL7
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.308410992008271,-0.49710917314467673,0.9629629629629629,1.0,1.0,2/13,14.25%,DGKD;PIK3CB
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.3065725921741937,-0.4969554876095997,0.9787234042553191,1.0,1.0,1/7,15.88%,SLC30A5
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.3145650505577233,-0.4965077604987214,0.9555555555555556,1.0,1.0,2/7,18.25%,ADGRE2;UNC13D
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.31662662830301924,-0.495725788365708,0.9642857142857143,1.0,1.0,3/8,29.63%,PEX1;ABCD1;LONP2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.26504494972799847,0.4953769970884487,1.0,1.0,1.0,3/29,20.22%,CTNNB1;ACD;NAF1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.2836254207767942,0.49437710483736413,1.0,1.0,1.0,1/12,14.96%,IDH1
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.31416527049667603,0.4943157909332903,0.9761904761904762,1.0,1.0,6/6,68.59%,SLC38A3;SLC36A1;SLC6A6;SLC6A17;SLC1A4;SLC36A4
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.2770810810810812,0.49413176627639693,1.0,1.0,1.0,9/9,72.31%,AHCTF1;NDC1;NUP153;NUP98;RTN4;NUP107;NUP205;NUP93;TPR
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.3144667142872225,-0.4938195638563181,1.0,1.0,1.0,1/7,12.69%,DNM1L
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.3110678772157372,0.49345087223479706,0.9555555555555556,1.0,1.0,5/5,68.90%,RC3H1;BLK;ATM;TNFRSF21;LYN
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.27380461135554635,-0.49318368188576817,0.9818181818181818,1.0,1.0,5/15,25.63%,CARD9;EIF2AK2;TAOK1;TAOK3;TAOK2
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.3000231122588186,-0.49271349594910235,0.9818181818181818,1.0,1.0,2/12,18.97%,ALG8;ALG9
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.2873951535448254,0.4918132572410067,0.9636363636363636,1.0,1.0,5/11,25.26%,GBE1;UGP2;PGM2;PPP1R3C;PGM1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.2873951535448254,0.4918132572410067,0.9636363636363636,1.0,1.0,5/11,25.26%,GBE1;UGP2;PGM2;PPP1R3C;PGM1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.2853072526533948,0.49087003689169173,1.0,1.0,1.0,5/18,18.90%,RNF139;SYVN1;UGGT1;SEL1L;RNF185
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.31604713189011274,-0.4907951937181447,0.9565217391304348,1.0,1.0,3/7,25.55%,EIF6;RAN;NPM1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.3199880447022776,-0.48942546111333113,0.9454545454545454,1.0,1.0,1/7,14.22%,PEX1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.3151751096536115,0.4891752219315212,1.0,1.0,1.0,5/8,28.89%,NEDD4L;CAB39;CAV3;ACTN2;BIN1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.27466882941335496,-0.488526621975232,1.0,1.0,1.0,14/14,72.56%,HNRNPM;RSRC1;SRSF9;DDX17;DHX9;SLU7;SCNM1;CELF4;RBM17;SFPQ;PQBP1;CDK13;DDX5;PUF60
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.30818592047405396,0.4881111673483617,1.0,1.0,1.0,3/8,20.43%,VIM;NOD1;RIPK2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.2635208425598232,-0.48803103252919056,1.0,1.0,1.0,6/15,24.45%,HMGB2;ACE;PTPRC;YAP1;HMGA2;EIF2AK2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.3167765646957086,-0.48713778181893347,0.9433962264150944,1.0,1.0,7/7,68.34%,AGO1;TARBP2;ADAR;AGO2;AGO4;DICER1;AGO3
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.25165343422853054,0.486659881345804,0.96,1.0,1.0,9/24,25.58%,DOCK10;IGF1R;CTNND2;INSR;FYN;PAK3;PTEN;PRNP;LGMN
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.29148205344322187,-0.4866270667772829,0.9807692307692307,1.0,1.0,2/9,27.58%,MTOR;AR
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.31637592498982725,-0.48656259348916436,0.9649122807017544,1.0,1.0,2/6,25.01%,WRAP73;HAP1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.33450889210714085,0.48607883437437915,0.98,1.0,1.0,2/5,27.35%,MTMR3;MTMR2
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.2978870257249324,0.4858175244638425,1.0,1.0,1.0,2/8,24.42%,SLC9A1;PKD1L3
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.2807868743291937,-0.48561484381351483,0.98,1.0,1.0,3/13,27.71%,MORC2;SETDB1;TPR
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.3150195704867966,0.48476822144463155,0.9803921568627451,1.0,1.0,3/7,17.29%,DNAH11;ODAD2;CFAP43
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.30979319683033146,0.4845015401848342,0.9423076923076923,1.0,1.0,2/7,29.43%,ROCK2;VCL
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.2976216216216217,0.4836943319731296,1.0,1.0,1.0,9/9,70.25%,VCAN;CHST12;DCN;DSE;NCAN;BCAN;CSPG5;UST;DSEL
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.32280874403400694,0.48341772630338753,0.9347826086956522,1.0,1.0,1/5,17.82%,COX10
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.3167765646957086,-0.48313547215499786,1.0,1.0,1.0,7/7,68.34%,AGO1;DHX36;DHX9;DDX3X;AGO2;AGO4;AGO3
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.29364617120532993,-0.48264390051168227,0.9655172413793104,1.0,1.0,3/13,20.16%,SLC25A5;ABCC4;ABCC6
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.28283322910243386,-0.4819326957239483,1.0,1.0,1.0,6/14,25.74%,NOS2;CYP1B1;CYB5R3;GCHFR;NOS3;NOS1
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.3293345042708119,0.48148797382041225,0.9782608695652174,1.0,1.0,1/5,11.86%,LPCAT3
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.3070621132389828,-0.4806520930063044,0.9148936170212766,1.0,1.0,1/7,19.03%,ASS1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.2837231567180635,-0.4793306077501147,1.0,1.0,1.0,6/13,25.74%,NOS2;CYP1B1;CYB5R3;GCHFR;NOS3;NOS1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.2611648960039142,-0.47830672392319323,1.0,1.0,1.0,6/15,24.38%,UBE3A;CATSPERG;SRC;YAP1;TGFB1;THBS1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.3057558584639342,0.47792942324767546,0.9583333333333334,1.0,1.0,3/5,30.74%,TGFB3;TGFB2;CUEDC2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.23661355736708667,0.477794608918941,1.0,1.0,1.0,3/20,20.15%,TBC1D12;ELAPOR1;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.2872023389891221,0.4777796301446414,0.9736842105263158,1.0,1.0,3/15,15.54%,MFHAS1;NR1H3;IFI35
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.32007368620953314,0.4767901091753801,1.0,1.0,1.0,3/7,21.61%,PLK1;HECW2;RIOK2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.3190121054907047,0.47675700355893147,0.9803921568627451,1.0,1.0,5/5,68.11%,AXIN1;GSK3B;CSNK1A1;APC;AMER1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.24792160914238667,0.4761705323082655,1.0,1.0,1.0,5/22,23.83%,HSPA1L;HSPA1A;DNAJB4;HSPA8;DNAJB1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.29353041476715847,0.4759800374934528,1.0,1.0,1.0,2/7,23.37%,MARCHF7;BIRC2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.2705426618812834,0.4758340634817853,0.9622641509433962,1.0,1.0,7/25,20.81%,NAV3;FGF13;HDGFL3;CLASP1;APC2;CLASP2;ATXN7
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.3023168629115744,-0.47532823345113273,1.0,1.0,1.0,1/7,12.62%,XYLB
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.28324734360510395,-0.4751083002461891,1.0,1.0,1.0,2/10,16.04%,AKAP8L;SAP30BP
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2574396470562445,-0.47472136393720593,1.0,1.0,1.0,3/17,16.39%,PINK1;HDAC6;SLC18A2
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.3180564665619806,0.4737436244775402,1.0,1.0,1.0,2/5,22.10%,MEF2C;PKD2
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.27418544531555833,0.47372579875498955,0.9795918367346939,1.0,1.0,1/10,6.29%,SYT1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.2706238512271597,-0.4732313078307435,1.0,1.0,1.0,11/11,72.96%,AP3S2;AP3D1;SNAPIN;BLOC1S4;BLOC1S2;AP3B2;AP3S1;DTNBP1;AP3M1;AP3B1;AP3M2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.2706238512271597,-0.4732313078307435,1.0,1.0,1.0,11/11,72.96%,AP3S2;AP3D1;SNAPIN;BLOC1S4;BLOC1S2;AP3B2;AP3S1;DTNBP1;AP3M1;AP3B1;AP3M2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.3167423259835711,-0.4720175298394484,0.9833333333333333,1.0,1.0,5/5,68.34%,AGO1;AGO2;AGO4;MOV10;AGO3
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.3019718354851024,-0.47048460256362895,0.98,1.0,1.0,1/6,19.66%,GBP5
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.24325923227865381,0.4704156137288672,1.0,1.0,1.0,3/19,20.21%,PRKACB;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.2683181856828481,0.47000653282302396,1.0,1.0,1.0,1/17,4.86%,CD22
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.3327568502405016,0.469436946399734,0.9761904761904762,1.0,1.0,6/6,66.74%,TBCA;TCP1;TBCC;TBCE;VBP1;TBCD
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.25455965134026204,0.4690767515042251,1.0,1.0,1.0,3/10,23.19%,UPP2;MACROD2;NT5C3A
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.31517883162889854,-0.46729956612348,1.0,1.0,1.0,2/7,14.45%,PARP1;TOP3A
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.2916918830677535,-0.46719901054321245,0.9583333333333334,1.0,1.0,1/6,13.17%,GART
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.29424197086905446,-0.4671893710528238,0.98,1.0,1.0,1/6,17.25%,RFTN1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.20630421247284692,0.4667722300822673,1.0,1.0,1.0,8/41,22.49%,HIF1A;EP300;OGT;NUP42;RANBP2;GCK;NUP54;JMJD8
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.27935135135135153,0.46616897544238123,1.0,1.0,1.0,9/9,72.08%,FDX1;TSPOAP1;STARD3;STARD3NL;AKR1B1;CACNA1H;STAR;FDXR;TSPO
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.2272214840197187,0.46517513183502013,1.0,1.0,1.0,4/35,12.50%,RNF2;RYBP;EPC1;YAF2
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.3100209650107704,-0.46503597533309665,0.9830508474576272,1.0,1.0,1/6,15.37%,ORAI1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.27381824246558273,-0.4643701476390337,0.9841269841269841,1.0,1.0,3/9,20.06%,KDM6B;KDR;EDF1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.28016216216216216,-0.4634968607915479,1.0,1.0,1.0,9/9,72.00%,RAB11B;EHD2;SORL1;EHD1;ARHGAP1;ATP9A;EIPR1;ACTN2;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.29216452899059026,0.4627963723053156,0.9782608695652174,1.0,1.0,1/5,17.43%,ROCK2
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.2825569415550041,-0.46155588180836027,1.0,1.0,1.0,4/8,29.21%,BRF1;GTF3C2;POLR2L;GTF3C3
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.2659399030650874,-0.46122466699912334,1.0,1.0,1.0,3/12,23.44%,PRR5L;KHSRP;GTPBP1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.2956677863171058,0.4597183087359619,1.0,1.0,1.0,1/7,10.54%,STARD4
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.29307800345598667,0.45835942997899964,0.9629629629629629,1.0,1.0,3/11,20.03%,EIF2AK3;EIF2S1;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.2972892331503699,0.45670290095127936,1.0,1.0,1.0,2/6,26.33%,ADARB1;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.2633264861508198,-0.45586340596395125,1.0,1.0,1.0,3/14,22.75%,NUDT16;NRDE2;TGFB1
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.2880901754200573,-0.4556061032591028,0.9827586206896551,1.0,1.0,2/7,16.76%,MET;SRC
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.2529467693160241,0.4552779886383781,1.0,1.0,1.0,2/10,14.77%,ANK3;DMD
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.28665885232239297,-0.45472283945508185,1.0,1.0,1.0,4/7,32.30%,VPS11;PTPN23;EZR;MSN
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.26131841574409953,-0.4531688783352692,1.0,1.0,1.0,1/9,9.00%,PLK2
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.2728728023232134,0.4524592141067285,1.0,1.0,1.0,3/7,28.14%,FBN1;LRP6;FBN2
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.27532176865103464,0.4521951980215343,0.9807692307692307,1.0,1.0,2/8,24.26%,MIS12;CENPA
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.30629802289695274,-0.4517596330532173,0.9807692307692307,1.0,1.0,1/6,16.14%,BAG4
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.2695925800367671,0.4514577512960636,0.9821428571428571,1.0,1.0,3/7,30.42%,GLDC;SHMT2;SDS
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.233133392463061,-0.4478617396307802,1.0,1.0,1.0,7/27,25.37%,BRD7;E2F7;SLFN11;CDKN2B;GPNMB;CDKN2D;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.23056204827081656,-0.44726214589683116,1.0,1.0,1.0,1/17,7.62%,GMIP
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.31516492129691703,-0.4441685428245653,0.9649122807017544,1.0,1.0,2/5,22.75%,GREM1;TGFB1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.20011071833963698,0.44370500707314936,1.0,1.0,1.0,15/90,22.23%,BANP;SYK;TAF3;TOR1AIP2;PRICKLE1;PPP1R10;PLK1;BBS4;MDM2;IPO8;HNRNPU;PIKFYVE;MSX1;IPO5;RANBP17
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.28901556133705897,-0.4433226308637845,0.9795918367346939,1.0,1.0,1/5,23.45%,SLF1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.24660528330940157,0.44269900538278156,1.0,1.0,1.0,5/11,28.80%,UGGT1;RNF185;DERL1;POMT2;TOR1A
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.27245121699505737,0.44249943673374903,0.9545454545454546,1.0,1.0,2/6,24.25%,NFKB1;PDGFB
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.27687465679575146,-0.4410958035570262,1.0,1.0,1.0,2/5,27.95%,SIGLEC15;ATP6AP1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.22342502033559022,0.43959707802087267,1.0,1.0,1.0,5/27,19.90%,RAB29;CD160;RELA;KCNN4;DGKZ
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.29775614434532593,-0.43954893084805075,1.0,1.0,1.0,1/6,11.39%,DNM1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.2723654945191486,0.4387593952927124,0.9814814814814815,1.0,1.0,3/8,25.12%,ADGRB1;CD53;MAPK14
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.28675890482410016,0.43564869811861695,0.9811320754716981,1.0,1.0,2/5,22.28%,LSG1;XPO1
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2240620863406479,0.4352335119969968,1.0,1.0,1.0,10/28,29.24%,DCP1B;PATL1;DIS3;EXOSC8;CNOT7;CNOT8;CNOT6;EXOSC2;EXOSC1;EXOSC9
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.27368511961518677,0.4340470049045118,0.9803921568627451,1.0,1.0,3/7,25.12%,ADGRB1;CD53;MAPK14
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.27500029752973526,-0.4329928449748895,1.0,1.0,1.0,2/9,18.61%,SHANK1;MAP1A
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.23917392009515057,0.4325861772557316,1.0,1.0,1.0,12/12,76.10%,ELOVL2;ELOVL5;ACOX1;ACSL1;ACAA1;HSD17B4;FADS2;ELOVL1;SCP2;ACOT8;ABCD1;FADS1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.27925201318705073,0.4292936356908674,1.0,1.0,1.0,6/6,72.08%,MEPCE;METTL16;METTL4;NOP10;DKC1;NHP2
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.1973837290760358,0.428589301204633,1.0,1.0,1.0,10/46,22.49%,HIF1A;EP300;NOA1;OGT;NUP42;RANBP2;GCK;NUP54;KHK;JMJD8
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.21730661336832355,0.42803330298291176,1.0,1.0,1.0,6/23,27.36%,SETD6;NTMT1;NSD1;PRMT5;SMYD3;EZH2
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.2875987401666581,-0.42590658173026485,0.9791666666666666,1.0,1.0,1/6,11.00%,CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.2704518075258263,-0.4246770373701771,0.9672131147540983,1.0,1.0,2/8,22.75%,GREM1;TGFB1
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),-0.27949723261210474,-0.4244687135850158,1.0,1.0,1.0,3/7,28.22%,ALYREF;THOC1;THOC3
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),-0.27949723261210474,-0.4244687135850158,1.0,1.0,1.0,3/7,28.22%,ALYREF;THOC1;THOC3
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.2699902754592276,0.423518244652009,1.0,1.0,1.0,2/7,23.82%,GMPS;SHMT2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.2455045297756736,-0.42280504474946307,1.0,1.0,1.0,5/14,27.71%,CENPE;CDC6;PTTG1;NEK6;TPR
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.23693496095402278,0.4216791532494716,1.0,1.0,1.0,1/12,12.51%,TMED9
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.2562399358011599,-0.41925644551793284,1.0,1.0,1.0,4/10,32.30%,VPS11;PTPN23;EZR;MSN
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.27097786288089276,0.41844807057469,1.0,1.0,1.0,4/7,28.52%,NEDD4L;CAB39;CAV3;ACTN2
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.2600553293915842,0.41682198777422214,1.0,1.0,1.0,3/8,26.90%,CD274;PRNP;RC3H1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.2342588749084969,-0.41492643360678233,1.0,1.0,1.0,4/14,23.90%,CARMIL2;TGFB1;CST3;FGFR4
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.2282068873995621,-0.41125331469900095,0.9821428571428571,1.0,1.0,4/15,24.33%,EIF2B4;EIF2B3;EIF2B1;EIF2B2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.27385735920575643,-0.4107058856997798,1.0,1.0,1.0,3/7,28.28%,DNM1;DNM2;AP3D1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.21821626091082605,0.41050851323890747,1.0,1.0,1.0,6/27,23.83%,HSPA1L;UGGT1;HSPA1A;DNAJB4;HSPA8;DNAJB1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.27702118460873315,0.4104776700265956,1.0,1.0,1.0,5/5,72.31%,PLSCR1;CSNK2A1;CSNK2A2;NUMA1;TPR
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.23477581083234816,0.4102516345364114,1.0,1.0,1.0,4/7,33.34%,RAP1A;FMR1;SLC30A1;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.2397342881808081,-0.40879077115863516,1.0,1.0,1.0,2/11,21.34%,DDB1;CHMP2A
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.21630563334348185,0.4086519388602322,1.0,1.0,1.0,4/24,23.25%,JMJD1C;KDM6A;KDM3A;PHF8
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.25367001311811127,0.4076438180505718,0.9811320754716981,1.0,1.0,2/7,24.16%,PDE12;RO60
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.21404419000039995,0.3993505836927737,1.0,1.0,1.0,8/18,28.81%,CEP120;BBS4;CEP135;KCTD17;TAPT1;SEPTIN9;CROCC;ARHGAP35
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.2284482850254898,-0.3971719743615376,1.0,1.0,1.0,6/17,27.84%,ARPC2;ARPC5;MAGEL2;IQGAP2;WHAMM;ARPC3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.2685922304666746,-0.3969896814639629,1.0,1.0,1.0,1/5,19.30%,MACROH2A1
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.2519910743899357,0.3959012062449486,1.0,1.0,1.0,2/6,25.12%,RELA;MAPK14
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.2519910743899357,0.3959012062449486,1.0,1.0,1.0,2/6,25.12%,RELA;MAPK14
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),0.27011585259432086,0.39457616575849036,1.0,1.0,1.0,2/5,25.43%,TCAP;RYR2
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.24137300057547212,0.3935375344545771,1.0,1.0,1.0,1/6,17.34%,SLC16A10
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.24498729935686114,0.39285434699797483,1.0,1.0,1.0,6/6,75.51%,RNF6;UBE2T;TRIM62;PRKN;UBE2D4;UBE2S
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.23849937834477541,-0.39181901671689956,0.9787234042553191,1.0,1.0,10/10,76.17%,FLOT1;ADAM9;EHD2;EHD1;RIPOR2;CAMK1;RAPGEF3;MAPK14;CD53;ADGRB1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.22541787518263223,-0.3914830279960576,1.0,1.0,1.0,7/16,32.12%,ATF4;WDR75;POLR2L;POLR2K;UTP15;LYAR;UBTF
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.26032209252053606,-0.3886022465605728,0.9772727272727273,1.0,1.0,5/5,73.98%,BEND3;KMT5C;SMYD5;KMT5B;SETD4
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.26032209252053606,-0.3886022465605728,0.9772727272727273,1.0,1.0,5/5,73.98%,BEND3;KMT5C;SMYD5;KMT5B;SETD4
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.22020791149395802,0.38733245917324766,1.0,1.0,1.0,2/15,19.39%,CD160;PDCD4
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.2369217466493731,-0.38522682534795083,1.0,1.0,1.0,5/5,76.32%,KIFC3;PLEKHA7;TJP1;CAMSAP3;FERMT2
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.215228497788808,0.3847207413761876,1.0,1.0,1.0,3/12,24.66%,MEF2A;TRAK2;LRRK2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.2240992490475998,-0.3814291827828298,1.0,1.0,1.0,5/15,34.28%,STAT1;HSPD1;HAVCR2;MAVS;IRF3
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.23487756094924067,0.3811766339002391,1.0,1.0,1.0,10/10,76.52%,SESN1;RRAGD;SESN2;RRAGB;SESN3;GCN1;LARS1;IMPACT;EIF2AK4;MTOR
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.2046122589390047,-0.3804609411753265,1.0,1.0,1.0,7/30,27.28%,COPG2;TMEM201;MAP1S;PAFAH1B1;UBB;HAP1;UXT
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.2319837640299499,-0.3785823662155746,1.0,0.9999559048752811,1.0,2/6,24.96%,SRC;BDNF
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.19502433747971876,-0.37469437856550397,1.0,0.9996972474329707,1.0,19/19,80.52%,DGCR8;KHSRP;RAN;DIS3L2;TUT4;PARN;DDX17;TARBP2;AGO2;XPO5;BCDIN3D;TRIM71;DROSHA;DICER1;LIN28B;SND1;PRKRA;TUT7;TENT4B
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.24221621621621628,0.37453507399881836,1.0,1.0,1.0,9/9,75.79%,PHF8;KDM4C;KDM7A;KDM2A;KDM8;KDM2B;RIOX2;RIOX1;KDM4B
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.23282992923882542,0.37282089185792777,1.0,1.0,1.0,4/5,37.79%,ERLIN1;APOE;ERLIN2;SCAP
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.23282992923882542,0.37282089185792777,1.0,1.0,1.0,4/5,37.79%,ERLIN1;APOE;ERLIN2;SCAP
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.23282992923882542,0.37282089185792777,1.0,1.0,1.0,4/5,37.79%,ERLIN1;APOE;ERLIN2;SCAP
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.23362136339301687,0.3726851228306132,1.0,1.0,1.0,2/5,28.27%,LZTFL1;CROCC
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.2033225834978109,0.37258217727280407,0.9761904761904762,1.0,1.0,3/15,24.42%,MTHFS;ALDH18A1;GCLC
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.236676490186544,-0.3718914735836218,0.98,0.999411119785017,1.0,3/10,26.20%,APOA1;SLC45A3;ABCD1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.21481335106092986,0.36908943425518415,1.0,1.0,1.0,3/12,22.16%,TET2;OGT;TET3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.22687165876979523,0.3665064037094071,1.0,1.0,1.0,3/7,29.24%,EXOSC8;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.22687165876979523,0.3665064037094071,1.0,1.0,1.0,3/7,29.24%,EXOSC8;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.2190335913896344,0.3664181675000887,1.0,1.0,1.0,5/12,31.24%,SLC25A41;SLC25A24;SLC35B2;LRRC8A;ABCC5
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.22536885910392898,0.366237605497794,1.0,1.0,1.0,6/6,77.47%,AKTIP;HOOK3;HOOK1;RNF26;HOOK2;SQSTM1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.2541612624297449,0.3658279288315737,1.0,1.0,1.0,5/5,74.59%,ITGB1;PLPP3;NPNT;ITGA4;ADAM9
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.23058422601433623,0.3626912745111361,1.0,0.9999556018946489,1.0,2/8,22.17%,PLXNB2;PLXNB1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.18387971569104894,0.3626745726434003,1.0,0.9996120925844824,1.0,6/30,21.09%,DCP1B;PATL1;DIS3;EXOSC8;CNOT7;CNOT8
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.2353536077265378,-0.3533605868932274,1.0,0.9995297599701259,1.0,2/5,31.88%,TRAIP;VCP
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.25435544124403325,0.3448962834595576,1.0,0.9997524043855374,1.0,1/5,18.87%,CA2
